data_1k3j_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1k3j _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.919 0.39 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -60.4 -45.05 94.96 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.5 -38.22 74.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.837 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.7 tp -60.7 -31.88 71.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.693 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.41 HG23 HD12 ' A' ' 20' ' ' ILE . 2.3 mt -72.17 -35.54 53.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.857 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -57.4 -44.45 84.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.918 0.39 . . . . 0.0 110.536 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.6 mtmm -67.07 -23.7 65.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.632 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -56.65 -47.56 79.49 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.253 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.2 t . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.954 179.991 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.509 -0.619 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.674 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.3 mm -76.62 133.89 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 CA-C-N 113.863 -1.517 . . . . 0.0 112.489 -177.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.48 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.8 t -91.7 -61.21 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-N 114.715 -1.129 . . . . 0.0 109.856 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.7 p -145.14 160.0 42.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.278 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.73 138.17 54.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.698 0.285 . . . . 0.0 111.37 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.0 t -109.66 122.6 64.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.836 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.7 mt -125.14 120.63 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.405 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.4 t -80.96 111.96 17.92 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.802 0.334 . . . . 0.0 110.441 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.21 -22.42 35.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.591 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.439 HG23 ' HB3' ' A' ' 142' ' ' SER . 81.2 p -79.94 -2.21 42.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.654 0.264 . . . . 0.0 111.446 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.99 74.23 0.42 Allowed Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.847 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -146.01 -42.82 0.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.852 0.358 . . . . 0.0 111.065 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.577 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.2 mt -116.57 141.88 28.73 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.577 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 43.0 Cg_endo -70.37 142.38 45.08 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.143 1.896 . . . . 0.0 112.186 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.6 mt -57.04 135.35 20.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.717 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -130.98 160.06 35.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.084 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.71 119.87 31.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.92 0.391 . . . . 0.0 111.91 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.537 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 8.8 mp -82.57 133.05 35.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.514 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.674 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -139.78 155.64 47.18 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 122.287 1.041 . . . . 0.0 113.793 -179.656 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.48 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -143.23 141.92 31.24 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 113.476 -1.693 . . . . 0.0 110.616 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 121.207 0.527 . . . . 0.0 111.249 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.869 0.366 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -128.27 130.55 48.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.856 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.463 HG13 ' HG2' ' A' ' 90' ' ' GLN . 8.4 t -126.52 139.12 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 121.289 0.566 . . . . 0.0 112.175 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.537 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 18.2 m-90 -102.98 139.17 38.89 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.969 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.415 ' HA ' ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.17 131.09 56.0 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 177.6 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.529 ' CD2' ' CB ' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -118.2 145.82 44.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.259 -178.683 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.29 -167.78 35.68 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.413 -0.899 . . . . 0.0 113.173 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -79.42 1.78 24.18 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -84.74 127.79 63.67 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.864 -0.153 . . . . 0.0 110.97 -179.804 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.435 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 18.8 Cg_exo -66.18 -12.19 34.46 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.348 2.032 . . . . 0.0 111.563 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.95 -43.15 16.77 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-O 121.834 0.826 . . . . 0.0 108.926 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -39.77 139.62 0.61 Allowed 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.735 179.478 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -56.25 -18.69 11.2 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.04 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.529 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 13.2 t80 -129.64 121.99 28.14 Favored 'General case' 0 N--CA 1.457 -0.086 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.915 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.435 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.8 t-160 . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 120.838 0.352 . . . . 0.0 110.636 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 33.3 mt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.795 0.331 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.8 m -58.25 -37.19 74.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.1 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.432 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 1.8 mmt180 -61.8 -17.04 54.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.305 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.41 ' HA ' ' HD1' ' A' ' 88' ' ' HIS . 20.6 mt -107.25 147.8 29.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.838 0.351 . . . . 0.0 111.251 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 51.6 p -93.08 164.89 13.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.48 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.62 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.0 m-20 -43.19 -52.74 5.43 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.426 0.632 . . . . 0.0 109.893 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.439 ' CB ' HD13 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -121.31 81.12 1.75 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 177.453 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.561 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.3 t60 -61.21 -45.93 92.56 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.161 -0.927 . . . . 0.0 113.008 -176.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.524 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 22.3 p90 -146.73 157.77 43.76 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.171 -0.611 . . . . 0.0 112.104 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.464 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.7 tt0 -135.6 140.85 44.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.24 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 16.1 mt -117.0 131.12 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.18 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.44 ' HB3' HG12 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -116.65 146.71 42.54 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.153 0.501 . . . . 0.0 111.932 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 15.3 tp . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.148 178.978 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.1 mp . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.838 0.351 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.3 mt -128.76 136.47 50.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.512 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.405 ' HG ' ' HB2' ' A' ' 122' ' ' GLN . 0.5 OUTLIER -112.83 122.6 48.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.08 179.586 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.439 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 63.6 t30 -114.85 121.99 44.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.015 0.436 . . . . 0.0 111.857 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.696 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 21.9 p30 -82.0 133.72 35.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.905 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.439 HD13 ' CB ' ' A' ' 87' ' ' LYS . 17.2 pt -139.55 37.82 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.568 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -96.34 156.25 16.42 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 120.927 0.394 . . . . 0.0 111.746 -178.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 87.8 m -68.91 -35.83 77.3 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.318 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.432 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -98.58 -19.74 17.42 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.46 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.568 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 121.04 161.57 11.42 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.192 -1.004 . . . . 0.0 113.914 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.2 m -117.5 138.04 52.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.905 -0.647 . . . . 0.0 109.299 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.81 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -112.22 148.55 33.86 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -177.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.06 113.32 18.23 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.484 -1.235 . . . . 0.0 108.192 177.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 44.29 43.5 6.0 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.05 -11.36 67.42 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 120.709 -0.758 . . . . 0.0 113.487 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.77 118.5 36.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.031 0.443 . . . . 0.0 110.679 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.81 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -72.36 128.55 35.97 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.371 -179.698 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.4 m -98.54 166.11 2.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.057 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.433 ' O ' ' HB3' ' A' ' 120' ' ' SER . 16.1 tt0 -69.9 126.71 30.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.483 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.696 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 32.6 tttt -54.27 163.4 0.84 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.9 OUTLIER 35.82 35.45 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.746 -179.231 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.433 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.7 p -111.9 145.04 40.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.601 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -95.14 129.54 42.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.846 0.355 . . . . 0.0 110.897 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.405 ' HB2' ' HG ' ' A' ' 101' ' ' LEU . 56.2 mm-40 -129.08 150.01 50.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.533 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.1 tp -72.55 132.27 43.59 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.276 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.414 ' CD2' HG12 ' A' ' 147' ' ' ILE . 61.4 tp -64.11 156.62 27.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.43 0.633 . . . . 0.0 111.633 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.441 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.57 154.09 41.16 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.926 -179.512 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.42 ' NE2' ' HB ' ' A' ' 147' ' ' ILE . 9.3 mm-40 -70.78 121.67 18.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.863 0.363 . . . . 0.0 110.061 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.13 22.85 50.8 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.033 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.441 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 26.5 t70 -53.62 171.77 0.08 Allowed 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.981 0.42 . . . . 0.0 111.037 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -145.26 135.34 23.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.097 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.0 mt -115.01 127.9 72.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.412 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.482 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 23.5 m -104.31 137.16 42.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.985 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.491 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 26.9 m -140.2 158.34 25.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.02 0.438 . . . . 0.0 112.022 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.55 37.67 10.47 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.618 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.451 ' HA ' HG12 ' A' ' 140' ' ' ILE . 50.4 t -79.71 140.47 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 121.705 0.764 . . . . 0.0 112.435 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.52 -36.8 0.63 Allowed Glycine 0 N--CA 1.436 -1.337 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.452 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 50.9 t -126.32 133.0 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-N 114.653 -0.774 . . . . 0.0 109.169 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -50.69 -44.64 57.96 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -93.3 6.51 47.86 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.452 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 4.9 t0 -117.25 29.37 7.93 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.482 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 3.8 mt -107.41 139.32 29.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.921 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.46 134.43 54.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.588 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.439 ' HB3' HG23 ' A' ' 40' ' ' THR . 38.0 t -114.9 150.38 35.73 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.567 0.698 . . . . 0.0 112.595 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -136.01 143.44 44.77 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.876 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.35 135.86 49.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.803 0.335 . . . . 0.0 110.957 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.9 mm -106.24 123.96 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.069 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.07 117.1 31.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.481 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.432 HG22 HD12 ' A' ' 147' ' ' ILE . 2.6 mt -84.97 134.04 27.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.451 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.24 109.9 16.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.759 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -60.7 -35.2 75.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.103 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.93 -44.06 91.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.73 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.7 t80 . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.04 -179.937 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.803 0.335 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.4 mtm180 -59.11 -48.02 83.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.917 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -59.49 -35.01 73.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.88 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.78 -44.03 97.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.92 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.472 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.9 mm -66.64 -35.17 74.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.189 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -57.21 -39.44 75.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.928 0.394 . . . . 0.0 110.334 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.3 tttp -67.28 -23.71 65.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.6 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.472 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.82 -47.48 80.17 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.146 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 C--N 1.326 -0.438 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.902 179.823 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.509 -0.607 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.66 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.3 mm -74.86 137.2 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 CA-C-N 113.786 -1.552 . . . . 0.0 112.437 -177.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.473 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.5 t -90.54 -58.54 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.745 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.8 m -149.8 162.84 39.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.701 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.1 138.09 53.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.754 0.311 . . . . 0.0 111.114 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.5 t -108.43 122.65 63.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.95 0.405 . . . . 0.0 110.81 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.8 mt -123.77 121.54 62.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.472 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 12.3 t -80.34 100.01 8.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.389 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.86 -27.2 69.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.828 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.471 HG21 ' HB3' ' A' ' 142' ' ' SER . 54.9 p -79.85 -2.2 42.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.734 0.302 . . . . 0.0 111.504 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.72 75.39 0.31 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.018 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -144.23 -47.56 0.27 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.856 0.36 . . . . 0.0 110.627 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.541 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.8 mm -104.24 141.74 23.16 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.749 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.541 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 53.7 Cg_endo -71.67 138.22 31.57 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.187 1.925 . . . . 0.0 112.164 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.1 mt -55.61 131.99 19.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.609 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.96 164.55 19.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.404 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.51 119.75 29.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.976 0.417 . . . . 0.0 111.957 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.553 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 6.9 mp -92.22 129.49 38.15 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.66 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -138.49 156.48 47.5 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 122.252 1.025 . . . . 0.0 113.692 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.473 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -154.54 141.89 19.59 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 113.493 -1.685 . . . . 0.0 110.856 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.178 0 CA-C-O 121.062 0.458 . . . . 0.0 111.317 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.692 0.282 . . . . 0.0 111.053 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.428 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.9 ttpt -144.03 133.21 23.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.183 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 6.3 t -128.1 137.67 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 121.259 0.552 . . . . 0.0 112.045 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.553 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 18.9 m-90 -101.79 139.65 37.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.242 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.494 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -113.1 132.26 55.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.831 0.348 . . . . 0.0 110.157 177.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.526 ' CD2' ' HB2' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -120.32 145.4 47.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.825 -179.315 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.636 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.66 -167.03 35.67 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.166 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.424 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 20.0 mtp180 -86.19 36.05 0.67 Allowed 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -118.44 132.53 23.76 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.468 0.175 . . . . 0.0 110.998 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.09 -17.06 58.32 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.522 2.148 . . . . 0.0 111.506 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.99 -42.52 17.46 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 121.806 0.812 . . . . 0.0 109.088 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.26 139.39 1.43 Allowed 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.12 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.2 m-20 -56.23 -18.38 10.2 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.059 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.526 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 2.5 t80 -129.12 118.67 22.84 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-O 120.914 0.387 . . . . 0.0 110.951 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.628 179.857 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.424 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 36.0 mt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.763 0.316 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.83 -35.86 64.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.004 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -63.37 -29.88 71.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.468 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.431 HD21 ' CE1' ' A' ' 88' ' ' HIS . 23.8 mt -99.99 150.5 22.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.857 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.7 p -98.37 166.69 11.26 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.636 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 m-20 -43.25 -52.54 5.63 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.397 0.618 . . . . 0.0 109.892 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.415 ' HB3' ' CD1' ' A' ' 104' ' ' ILE . 4.3 mttt -119.0 82.05 1.8 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 177.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.586 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 15.4 t60 -58.69 -45.75 88.79 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.847 -177.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.513 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 31.5 p90 -149.38 162.18 40.6 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.583 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.443 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 3.3 tt0 -136.32 140.84 43.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.298 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 78.1 mt -115.22 129.08 72.06 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.192 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.779 179.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.424 ' HB3' HG11 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -113.9 146.9 39.38 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.205 0.526 . . . . 0.0 111.937 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.4 ' CD1' ' HG ' ' A' ' 99' ' ' LEU . 23.7 tp . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.067 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.4 ' HG ' ' CD1' ' A' ' 93' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.761 0.315 . . . . 0.0 110.888 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.415 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 4.1 mm? -129.2 142.83 50.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.635 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 28.0 mt -112.61 122.32 47.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.912 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -117.11 135.61 53.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.152 0.501 . . . . 0.0 111.825 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.672 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 14.3 p30 -96.82 143.08 28.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.664 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.415 ' CD1' ' HB3' ' A' ' 87' ' ' LYS . 7.0 pt -147.62 28.28 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.468 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.561 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 10.8 t -92.26 157.69 16.53 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 121.433 0.635 . . . . 0.0 112.69 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 95.3 m -69.8 -52.12 27.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.954 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -82.84 -0.09 46.49 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.324 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.65 157.75 29.58 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.708 -0.758 . . . . 0.0 113.542 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.531 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.2 m -117.63 137.89 52.33 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.809 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -113.76 148.44 36.49 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -178.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.43 113.51 18.26 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.875 177.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 47.41 35.96 4.54 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.111 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.9 -7.23 79.26 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.487 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.51 118.39 36.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.979 0.419 . . . . 0.0 110.557 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.809 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 25.3 tptt -72.32 121.92 20.28 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.175 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.3 m -97.67 163.65 2.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.438 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 120' ' ' SER . 25.6 tt0 -69.98 128.13 35.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.453 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.672 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 66.7 tttt -52.56 161.94 0.63 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.789 0.328 . . . . 0.0 110.353 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.8 p30 35.15 34.89 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.202 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.25 143.18 43.74 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.975 179.469 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -85.39 132.52 34.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.889 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.415 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 35.0 mm-40 -129.56 147.68 51.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.665 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.2 tt -72.72 129.2 37.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.26 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 66.9 tp -62.16 155.17 25.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.513 0.673 . . . . 0.0 111.677 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.8 153.5 42.41 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.316 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 13.4 tp60 -71.15 119.79 15.79 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.55 23.95 63.4 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.657 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -49.02 167.15 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.921 0.391 . . . . 0.0 111.329 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 13.7 tt0 -145.1 135.4 24.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.965 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 11.8 mt -114.88 128.36 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.777 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.443 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.3 m -104.18 141.85 35.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.815 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.586 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 31.2 m -140.29 158.68 25.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.64 44.41 9.37 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.94 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.443 HG21 ' CD2' ' A' ' 110' ' ' TRP . 59.6 t -85.66 140.5 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-O 121.644 0.735 . . . . 0.0 112.459 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.03 -39.08 1.08 Allowed Glycine 0 N--CA 1.435 -1.404 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.8 t -126.51 118.91 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 CA-C-N 114.41 -0.895 . . . . 0.0 108.866 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -50.29 -26.37 4.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.738 0.304 . . . . 0.0 111.607 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.57 6.59 47.75 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.11 29.19 4.7 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.443 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 4.7 mt -107.14 139.14 29.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.719 178.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.4 tt -124.16 134.44 53.32 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.39 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.471 ' HB3' HG21 ' A' ' 40' ' ' THR . 37.6 t -108.15 150.19 27.54 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.782 0.801 . . . . 0.0 112.532 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 72.2 mt -135.93 145.0 45.78 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.383 -1.281 . . . . 0.0 110.622 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.9 t -117.07 139.49 43.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.837 0.351 . . . . 0.0 111.108 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.419 HG22 HD12 ' A' ' 145' ' ' ILE . 15.3 mt -106.17 123.02 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.952 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.04 119.5 39.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.87 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.7 mp -89.68 131.43 36.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.363 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.8 114.26 20.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.914 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -60.32 -29.18 68.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.35 -44.01 88.58 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.993 0.425 . . . . 0.0 110.609 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.0 t80 . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.841 179.82 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.84 0.352 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -60.14 -35.96 76.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.825 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.78 -35.0 77.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.825 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.6 mp -63.93 -44.05 94.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.888 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.446 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.3 mm -65.75 -35.16 74.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.206 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -57.16 -41.12 78.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.028 0.442 . . . . 0.0 110.351 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.6 mttm -67.21 -23.81 65.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.591 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.56 -47.56 79.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.109 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.0 p . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.836 179.873 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.509 -0.625 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.72 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 2.3 mm -81.86 94.41 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 CA-C-N 113.908 -1.496 . . . . 0.0 112.923 -177.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.459 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.5 t -46.88 -61.22 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.906 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 6.1 p -144.74 165.1 29.02 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.777 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.73 138.15 51.96 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.904 0.383 . . . . 0.0 111.54 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.1 m -101.73 122.85 54.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.741 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.8 mt -129.05 118.67 47.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 39.0 t -79.98 122.53 26.84 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.49 -21.99 17.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.798 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.442 HG23 ' HB3' ' A' ' 142' ' ' SER . 76.5 p -79.84 -2.15 42.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.699 0.285 . . . . 0.0 111.43 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.71 73.85 0.57 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.695 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -145.98 -39.08 0.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.715 0.293 . . . . 0.0 111.142 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.551 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.7 mt -125.11 141.47 38.63 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.007 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.551 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 53.4 Cg_endo -72.19 145.94 45.01 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.191 1.927 . . . . 0.0 112.223 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.0 mt -62.4 138.55 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.787 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.62 163.23 25.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.752 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.7 119.67 36.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.009 0.433 . . . . 0.0 111.858 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.53 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 0.6 OUTLIER -96.72 132.51 42.34 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.177 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.72 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -144.24 156.99 44.53 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -178.573 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.459 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -146.57 141.95 27.49 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.304 -1.771 . . . . 0.0 110.827 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 121.025 0.441 . . . . 0.0 110.977 -179.876 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.678 0.275 . . . . 0.0 111.127 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -141.5 135.66 30.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.863 0.363 . . . . 0.0 111.316 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.475 HG11 ' HG2' ' A' ' 90' ' ' GLN . 18.6 t -133.92 139.13 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-O 121.194 0.521 . . . . 0.0 111.782 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.582 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 16.5 m-90 -102.07 139.06 38.2 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.253 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -111.81 128.38 56.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.813 177.635 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.605 ' CD1' ' HB2' ' A' ' 76' ' ' TYR . 9.0 m-85 -120.45 145.57 47.09 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.714 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.587 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.97 -165.96 34.9 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.845 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.425 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 10.3 mtm105 -83.07 6.56 18.57 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.408 ' ND2' ' HD2' ' A' ' 72' ' ' PRO . 3.2 t-20 -84.71 140.04 37.93 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.556 0.217 . . . . 0.0 110.877 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.408 ' HD2' ' ND2' ' A' ' 71' ' ' ASN . 60.3 Cg_endo -73.57 -14.3 24.8 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.356 2.038 . . . . 0.0 111.302 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.1 -43.1 16.63 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -41.78 137.25 1.75 Allowed 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 113.63 -1.623 . . . . 0.0 110.906 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.4 OUTLIER -56.73 -19.23 15.72 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.191 179.162 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.605 ' HB2' ' CD1' ' A' ' 68' ' ' PHE . 15.6 t80 -130.22 120.2 24.11 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.641 0.258 . . . . 0.0 111.097 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.82 0.343 . . . . 0.0 110.724 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.1 mp . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.838 0.351 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.1 t -63.71 -36.81 85.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.03 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.52 -21.03 63.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.316 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 21.2 mt -105.9 148.9 27.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.721 0.296 . . . . 0.0 111.077 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.6 p -95.55 165.62 12.25 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.689 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.587 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.9 m-20 -43.91 -53.68 5.93 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.315 0.579 . . . . 0.0 109.897 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.417 ' HB2' HD13 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -118.54 80.34 1.52 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.362 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.616 ' CD2' ' HB2' ' A' ' 105' ' ' SER . 13.9 t60 -60.79 -45.94 92.45 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.866 -176.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.446 ' N ' ' CD1' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -145.05 153.34 41.35 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.047 -0.661 . . . . 0.0 112.171 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.489 ' CG ' ' O ' ' A' ' 66' ' ' TRP . 5.9 tt0 -135.5 139.89 44.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.418 -178.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.455 ' O ' ' CG1' ' A' ' 65' ' ' VAL . 24.9 mt -113.97 132.09 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.024 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.413 ' HB3' HG13 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -118.28 144.0 46.15 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.961 0.41 . . . . 0.0 111.603 -179.804 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 13.8 tp . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.49 179.497 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.808 0.337 . . . . 0.0 110.723 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.9 mp -131.07 144.49 51.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.321 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.7 123.54 50.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.199 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 90' ' ' GLN . 47.6 t30 -114.04 115.9 28.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.018 0.437 . . . . 0.0 111.684 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.664 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 10.8 p30 -81.01 118.81 22.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.224 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.417 HD13 ' HB2' ' A' ' 87' ' ' LYS . 9.9 pt -124.41 33.83 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.321 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.616 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 13.7 t -89.57 159.01 17.4 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-O 121.347 0.594 . . . . 0.0 112.444 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 49.5 m -69.59 -52.28 27.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.67 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -92.67 -19.82 21.46 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 136.06 153.33 6.57 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.618 -0.801 . . . . 0.0 114.02 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.472 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.2 m -117.29 137.89 52.11 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.796 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -113.65 148.62 35.96 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -178.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.95 113.31 18.29 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.204 177.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 45.08 43.05 7.19 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.28 -6.38 81.95 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.751 -0.737 . . . . 0.0 113.451 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -105.46 118.35 36.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.019 0.438 . . . . 0.0 110.76 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.796 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 7.9 tptt -73.42 115.75 13.16 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.267 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.4 m -92.36 159.56 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.356 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.1 tt0 -69.88 128.78 37.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.437 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.664 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 9.7 tttp -50.5 161.41 0.32 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.887 0.375 . . . . 0.0 110.472 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.441 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 3.6 p30 34.23 35.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.186 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.9 OUTLIER -112.04 122.48 47.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.083 179.665 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -68.59 126.03 28.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.032 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -129.38 147.37 51.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.598 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.1 tp -72.9 122.18 21.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.087 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -59.23 166.1 2.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.72 0.771 . . . . 0.0 111.888 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.442 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -125.43 153.27 43.72 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.387 179.393 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -71.35 116.25 11.46 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 62.99 27.89 71.15 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.776 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.442 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 20.6 t0 -59.31 174.81 0.37 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.018 0.437 . . . . 0.0 111.143 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 2.4 mt-10 -145.21 135.48 24.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.877 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 5.0 mt -111.33 128.48 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.269 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.455 ' HB ' ' HB2' ' A' ' 110' ' ' TRP . 2.8 m -103.93 141.45 36.13 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.556 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 33.3 m -140.43 158.61 25.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 77.0 44.35 14.3 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.11 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.459 HG23 ' CD2' ' A' ' 110' ' ' TRP . 76.1 t -83.8 140.4 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-O 121.691 0.758 . . . . 0.0 112.411 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.95 -38.92 1.23 Allowed Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.3 t -126.39 119.96 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-N 114.438 -0.881 . . . . 0.0 108.97 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.23 -27.64 6.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.743 0.306 . . . . 0.0 111.273 -178.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.2 m -93.56 6.59 47.75 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -127.34 25.81 6.09 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.448 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 4.9 mt -107.14 138.46 32.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.184 178.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.44 ' N ' HG22 ' A' ' 140' ' ' ILE . 2.6 tt -124.73 134.41 52.84 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.214 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.442 ' HB3' HG23 ' A' ' 40' ' ' THR . 36.7 t -112.72 150.16 31.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.66 0.743 . . . . 0.0 112.666 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 2.3 mm? -136.05 142.59 44.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.412 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.414 ' CG2' ' CG ' ' A' ' 129' ' ' GLU . 17.5 t -110.95 140.13 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.932 0.396 . . . . 0.0 111.334 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.7 mm -106.36 121.05 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.697 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.74 108.74 19.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.959 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.3 mp -84.84 129.01 38.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.19 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -75.8 128.53 35.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.079 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.08 -29.1 61.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.098 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -43.51 86.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.025 0.44 . . . . 0.0 110.534 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.5 t80 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.762 179.898 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.657 0.265 . . . . 0.0 111.137 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.7 mtm-85 -59.33 -35.89 74.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.229 0.538 . . . . 0.0 109.937 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.429 ' CD2' ' HE2' ' A' ' 22' ' ' LYS . 3.0 t80 -60.88 -34.93 75.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.924 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.6 tp -59.14 -41.26 87.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.788 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.527 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 11.5 mm -70.38 -34.96 60.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.051 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -57.01 -33.7 67.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.832 0.348 . . . . 0.0 110.494 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.429 ' HE2' ' CD2' ' A' ' 18' ' ' PHE . 2.5 mptp? -66.65 -23.68 66.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.787 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.527 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.67 -47.55 79.57 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.969 0.414 . . . . 0.0 111.171 -179.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.816 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.417 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.3 t-20 . . . . . 0 CA--C 1.508 -0.667 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.698 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -71.85 135.79 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-N 113.667 -1.606 . . . . 0.0 112.408 -177.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.504 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.6 t -91.71 -59.29 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.145 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.6 m -145.32 160.35 41.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.796 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.455 ' NE ' HG21 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -120.77 138.18 54.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.902 0.382 . . . . 0.0 111.216 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.403 HG11 ' CZ ' ' A' ' 76' ' ' TYR . 22.0 t -98.52 122.66 50.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.065 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.414 HD11 ' CE1' ' A' ' 146' ' ' PHE . 16.3 mt -129.89 120.57 50.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.123 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 39.7 t -86.29 109.36 18.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.514 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.1 -27.12 48.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.587 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.5 ' CG2' ' CB ' ' A' ' 142' ' ' SER . 8.7 p -79.86 -3.01 46.1 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.692 0.282 . . . . 0.0 111.455 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.25 78.92 0.2 Allowed Glycine 0 CA--C 1.52 0.376 0 C-N-CA 121.079 -0.582 . . . . 0.0 113.798 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -147.71 -45.25 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.902 0.382 . . . . 0.0 110.959 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.539 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 8.8 mt -116.38 141.3 27.71 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.228 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.539 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.0 Cg_endo -74.54 146.11 34.25 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.318 2.012 . . . . 0.0 112.094 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.455 HG21 ' NE ' ' A' ' 35' ' ' ARG . 17.2 mt -52.23 153.27 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.252 0.548 . . . . 0.0 111.788 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -142.58 161.69 37.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.93 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -119.62 119.71 34.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.158 0.504 . . . . 0.0 111.817 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.511 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 5.3 mt -101.08 137.06 39.95 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.698 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -144.35 158.45 43.74 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -178.767 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.504 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.4 143.64 30.2 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 113.631 -1.622 . . . . 0.0 110.862 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 121.075 0.464 . . . . 0.0 111.279 -179.607 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.3 tppm? . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.749 0.309 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.423 ' CE ' ' O ' ' A' ' 49' ' ' SER . 6.8 ttpt -144.92 132.59 21.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.234 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 15.4 t -128.43 139.42 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 121.373 0.606 . . . . 0.0 112.093 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.544 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 14.8 m-90 -100.57 139.98 35.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.142 -0.936 . . . . 0.0 112.255 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.489 HG21 ' HG2' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -108.9 127.23 53.87 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.17 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.548 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 3.4 m-85 -113.27 145.74 40.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.935 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.671 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.6 -173.96 38.06 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.115 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 27.4 mtm180 -79.12 0.75 26.83 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.733 0.271 . . . . 0.0 111.733 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.452 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -84.78 131.95 47.77 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.516 0.198 . . . . 0.0 110.774 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 14.8 Cg_exo -67.84 -8.31 22.14 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.492 2.128 . . . . 0.0 111.792 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.18 -43.55 16.02 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 121.922 0.867 . . . . 0.0 108.896 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -41.37 138.35 1.27 Allowed 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 113.697 -1.592 . . . . 0.0 110.71 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -56.46 -18.54 11.69 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.134 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.548 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 55.2 t80 -129.15 123.39 31.99 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-O 120.791 0.329 . . . . 0.0 110.756 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.908 179.898 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.402 HG22 HD12 ' A' ' 81' ' ' ILE . 30.7 mt . . . . . 0 N--CA 1.456 -0.125 0 CA-C-O 120.832 0.349 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.97 -41.28 96.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.891 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.41 -28.6 69.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.062 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 32.5 mt -96.57 152.1 18.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.055 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 93.0 p -97.55 164.21 12.53 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.529 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.671 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.7 m-20 -41.96 -53.04 3.97 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.326 0.584 . . . . 0.0 109.782 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.412 ' HB2' HD11 ' A' ' 104' ' ' ILE . 25.3 mttt -119.39 85.62 2.41 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 177.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.572 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.2 t60 -65.05 -44.21 89.77 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -176.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.506 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 37.7 p90 -153.26 163.27 40.21 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 119.984 -0.686 . . . . 0.0 112.461 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.489 ' HG2' HG21 ' A' ' 67' ' ' THR . 12.4 mt-30 -135.68 156.81 48.26 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.51 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 18.3 mt -127.8 132.35 68.96 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.205 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.451 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 1.0 OUTLIER -120.64 148.35 44.03 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.12 0.486 . . . . 0.0 111.791 -179.268 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.418 HD22 ' CZ ' ' A' ' 151' ' ' PHE . 48.2 tp . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.361 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 N--CA 1.458 -0.068 0 CA-C-O 120.769 0.319 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.435 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 2.9 mp -131.4 143.69 50.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.395 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.9 126.06 54.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.479 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.451 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.3 t30 -115.57 115.75 26.97 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.751 -0.379 . . . . 0.0 111.57 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.69 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 10.3 p30 -79.57 143.19 35.01 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.283 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.449 HG12 ' HG3' ' A' ' 90' ' ' GLN . 11.0 pt -150.3 35.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.572 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -95.1 151.23 19.38 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 120.942 0.401 . . . . 0.0 111.814 -178.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 50.6 m -68.8 -31.57 70.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.014 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -98.08 -19.72 17.79 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.549 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.39 154.92 9.63 Favored Glycine 0 N--CA 1.439 -1.164 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.609 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.531 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.5 m -117.53 137.69 52.4 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.832 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -116.39 148.35 40.74 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -178.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.23 113.43 18.28 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.437 177.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 44.89 43.37 7.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.227 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.17 -7.32 78.66 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.838 -0.696 . . . . 0.0 113.47 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -105.61 118.58 36.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.043 0.449 . . . . 0.0 110.724 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.832 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 15.0 tptt -74.02 121.55 21.23 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.239 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.6 m -95.6 164.03 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.124 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 120' ' ' SER . 28.3 tp10 -69.88 128.98 38.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.474 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.69 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 80.3 tttt -54.61 161.92 1.33 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.989 0.423 . . . . 0.0 110.599 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.455 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.0 m-80 34.67 33.97 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.437 -0.802 . . . . 0.0 112.105 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.4 145.18 40.58 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.025 179.441 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -88.78 131.35 35.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.949 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.435 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 39.9 mm-40 -129.27 150.36 50.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.379 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.3 tp -72.62 111.86 8.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.823 0.344 . . . . 0.0 110.309 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.415 ' CD2' HD13 ' A' ' 147' ' ' ILE . 7.7 tt -55.01 156.78 3.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.287 0.565 . . . . 0.0 111.541 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.29 153.47 41.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.812 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.424 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.5 122.2 20.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.025 0.441 . . . . 0.0 110.531 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.14 18.71 60.73 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.42 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -57.22 173.36 0.24 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.879 0.371 . . . . 0.0 110.973 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 13.0 tt0 -145.04 135.64 24.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.118 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 2.6 mt -108.89 128.3 64.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.45 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.482 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 25.4 m -104.24 141.16 36.76 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.102 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.534 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 27.2 m -140.25 158.43 25.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -178.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.55 42.93 8.77 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.241 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.438 ' HA ' HG12 ' A' ' 140' ' ' ILE . 71.7 t -84.59 140.38 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-O 121.617 0.722 . . . . 0.0 112.286 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.86 -40.66 1.12 Allowed Glycine 0 N--CA 1.436 -1.345 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.4 t -126.37 120.83 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 CA-C-N 114.462 -0.869 . . . . 0.0 109.049 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.5 -24.98 3.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.664 0.269 . . . . 0.0 111.473 -178.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.5 6.51 47.96 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -129.7 26.12 5.31 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.482 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.9 mt -106.87 139.07 29.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.094 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 24.9 tp -124.74 134.51 52.79 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.803 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.5 ' CB ' ' CG2' ' A' ' 40' ' ' THR . 0.9 OUTLIER -109.6 133.54 52.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.958 0.409 . . . . 0.0 111.548 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 1.4 mm? -128.29 134.5 48.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.688 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.6 t -110.98 135.55 49.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.816 0.341 . . . . 0.0 111.262 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.3 mm -106.31 134.79 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.414 ' CE1' HD11 ' A' ' 37' ' ' ILE . 14.9 m-85 -115.41 119.79 37.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.767 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.424 ' CD1' ' HA ' ' A' ' 126' ' ' GLN . 5.8 mt -84.82 134.01 27.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.499 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -75.89 116.4 16.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.663 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -58.22 -32.11 67.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.009 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.0 -46.09 90.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.59 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.418 ' CZ ' HD22 ' A' ' 93' ' ' LEU . 11.5 t80 . . . . . 0 N--CA 1.452 -0.336 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.027 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 . . . . . 0 N--CA 1.458 -0.062 0 CA-C-O 120.834 0.349 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -68.27 -39.17 82.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.857 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -56.99 -41.48 78.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.73 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.6 tp -58.45 -33.76 70.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.571 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.51 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.5 mt -73.16 -35.87 48.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.783 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -33.75 68.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.956 0.408 . . . . 0.0 110.904 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.1 mmpt? -58.73 -26.37 63.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.409 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.51 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.8 -48.48 77.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.268 0.556 . . . . 0.0 111.064 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 C--N 1.321 -0.635 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.062 179.875 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.436 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.9 m-20 . . . . . 0 CA--C 1.508 -0.654 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.635 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.5 mm -76.66 136.74 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-N 113.774 -1.557 . . . . 0.0 112.535 -177.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.478 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.1 t -91.05 -59.41 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.682 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 4.8 p -150.41 165.47 33.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.32 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.412 ' CD ' ' CG2' ' A' ' 45' ' ' ILE . 0.2 OUTLIER -128.01 138.15 52.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.804 0.335 . . . . 0.0 111.188 -179.411 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.401 HG13 ' CE2' ' A' ' 68' ' ' PHE . 3.1 m -106.48 122.76 60.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.852 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.3 mt -125.02 122.58 63.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.617 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 50.7 t -79.93 107.34 12.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.809 0.338 . . . . 0.0 110.402 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.3 t -70.97 -28.47 64.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.978 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.486 HG22 ' HB3' ' A' ' 142' ' ' SER . 69.8 p -79.87 -2.17 42.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.693 0.283 . . . . 0.0 111.527 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.1 80.56 0.11 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.947 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -146.86 -41.69 0.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.912 0.386 . . . . 0.0 110.932 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.588 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 5.3 mp -119.41 143.48 34.56 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.218 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.588 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 43.9 Cg_endo -70.27 146.11 56.07 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.325 2.017 . . . . 0.0 111.963 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.412 ' CG2' ' CD ' ' A' ' 35' ' ' ARG . 32.2 mt -62.81 131.64 28.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.924 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.459 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -117.25 146.36 43.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.91 179.144 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.67 119.66 39.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.986 0.422 . . . . 0.0 111.629 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.49 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 6.9 mp -92.05 125.5 36.76 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.635 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -135.82 156.98 47.96 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 122.285 1.04 . . . . 0.0 113.531 -179.427 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.478 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -150.23 141.88 23.59 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 113.613 -1.631 . . . . 0.0 110.721 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 121.029 0.442 . . . . 0.0 111.346 -179.594 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt . . . . . 0 CA--C 1.528 0.108 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.465 ' CE ' ' O ' ' A' ' 49' ' ' SER . 30.8 ttpt -144.34 123.05 12.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.853 0.358 . . . . 0.0 111.918 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.511 HG21 ' HB3' ' A' ' 92' ' ' LEU . 13.1 p -110.4 139.76 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.49 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 20.6 m-90 -100.81 139.85 35.91 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.033 -1.44 . . . . 0.0 112.227 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.444 ' HA ' ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -111.91 133.1 54.32 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 177.859 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.544 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.7 OUTLIER -120.01 145.5 46.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.556 -178.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.616 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.81 -169.41 36.47 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.489 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.458 ' NH1' ' O ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -85.29 7.48 22.06 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.733 0.267 . . . . 0.0 111.521 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -84.9 134.17 42.01 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-O 120.532 0.206 . . . . 0.0 110.783 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -65.84 -13.75 41.34 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.547 2.165 . . . . 0.0 111.843 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.2 -44.76 14.66 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 121.936 0.874 . . . . 0.0 109.186 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.75 137.63 2.19 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.728 -1.578 . . . . 0.0 111.485 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 67' ' ' THR . 21.9 m-20 -56.82 -18.88 14.53 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.231 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.459 ' CE1' ' HB2' ' A' ' 46' ' ' ARG . 7.8 t80 -129.8 103.28 6.73 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.817 0.342 . . . . 0.0 110.88 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.98 -179.912 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.401 ' N ' ' HD3' ' A' ' 70' ' ' ARG . 42.2 mm . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.884 0.373 . . . . 0.0 111.021 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.5 p -65.24 -40.52 94.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.45 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.466 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -60.66 -24.87 65.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.902 0.382 . . . . 0.0 110.646 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.431 ' HB2' ' CZ ' ' A' ' 70' ' ' ARG . 3.7 mp -107.5 152.69 23.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.507 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.458 ' O ' ' NH1' ' A' ' 70' ' ' ARG . 59.7 p -98.87 153.86 18.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.89 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.616 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.6 m-20 -30.33 -53.49 0.17 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.361 0.6 . . . . 0.0 110.549 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.403 ' HB3' HD11 ' A' ' 104' ' ' ILE . 0.5 OUTLIER -120.16 84.18 2.17 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 177.321 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.562 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.3 t60 -61.55 -46.3 90.5 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.034 -0.985 . . . . 0.0 112.593 -177.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.544 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 22.0 p90 -142.36 160.73 39.69 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.058 -0.657 . . . . 0.0 112.109 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.455 ' NE2' HG23 ' A' ' 65' ' ' VAL . 3.3 tt0 -135.98 143.39 44.8 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.034 -179.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 61.6 mt -122.39 132.14 71.73 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.196 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.511 ' HB3' HG21 ' A' ' 65' ' ' VAL . 0.4 OUTLIER -125.66 141.65 51.91 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.014 0.435 . . . . 0.0 111.842 -179.794 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.315 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.85 0.357 . . . . 0.0 110.84 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.5 mp -131.21 142.19 50.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.496 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.9 pp -113.42 124.7 53.04 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.187 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.499 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 54.8 t30 -116.03 120.29 38.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.056 0.455 . . . . 0.0 111.923 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.701 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 20.4 p30 -80.62 137.57 36.37 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.748 178.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.403 HD11 ' HB3' ' A' ' 87' ' ' LYS . 8.3 pt -144.58 39.33 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.562 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.12 162.28 13.44 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.073 0.463 . . . . 0.0 111.602 -179.278 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 89.1 m -69.11 -40.92 78.06 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.734 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -98.7 -19.94 17.22 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.096 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.471 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 126.58 160.69 10.66 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 119.948 -1.12 . . . . 0.0 114.205 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 13.9 m -117.63 138.02 52.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.853 -0.674 . . . . 0.0 109.253 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.847 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -111.97 148.36 33.94 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.21 113.52 18.41 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.491 -1.231 . . . . 0.0 108.197 177.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 44.5 42.79 5.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.47 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.71 -10.1 71.32 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.768 -0.729 . . . . 0.0 113.548 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -104.34 118.5 36.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.079 0.466 . . . . 0.0 110.696 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.847 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.0 tptm -73.82 126.88 31.39 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.194 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.7 m -99.51 166.51 2.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.384 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 120' ' ' SER . 3.0 tp10 -69.93 126.21 29.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.607 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.701 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 74.1 tttt -54.58 162.57 1.12 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.04 0.448 . . . . 0.0 110.534 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.0 OUTLIER 37.33 31.44 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.454 -0.793 . . . . 0.0 112.069 -179.218 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.65 143.94 43.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.847 179.095 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -94.01 135.52 35.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.921 0.391 . . . . 0.0 111.018 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 59.0 mm-40 -129.38 152.32 49.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.393 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -72.4 118.36 15.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.959 0.409 . . . . 0.0 110.336 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.4 tt -52.12 155.59 1.87 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.437 0.637 . . . . 0.0 111.788 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.412 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.7 OUTLIER -124.52 153.23 42.4 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.349 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -71.62 124.55 24.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.88 0.372 . . . . 0.0 110.478 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 56.94 22.08 40.34 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.257 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.412 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 19.9 t70 -54.86 173.14 0.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.946 0.403 . . . . 0.0 110.811 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 1.9 mt-10 -144.29 135.74 25.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.145 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.7 mt -113.11 127.56 70.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.791 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.465 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 4.0 m -104.45 137.79 41.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.741 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.484 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 33.9 m -140.25 158.29 25.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.68 28.92 25.35 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.135 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.454 ' HA ' HG12 ' A' ' 140' ' ' ILE . 70.4 t -70.89 140.39 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-O 121.62 0.724 . . . . 0.0 112.38 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.1 -38.98 0.83 Allowed Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.411 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 48.2 t -126.49 129.38 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-N 114.641 -0.779 . . . . 0.0 109.117 178.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -50.51 -36.07 32.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.807 0.337 . . . . 0.0 111.567 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.4 p -93.61 6.54 47.94 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.411 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 9.5 t0 -120.74 25.97 9.39 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.465 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.4 mt -107.1 139.15 29.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.102 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.6 tt -124.2 134.4 53.29 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.434 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.486 ' HB3' HG22 ' A' ' 40' ' ' THR . 38.5 t -108.01 150.24 27.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.721 0.772 . . . . 0.0 112.261 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.427 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 76.2 mt -135.87 155.7 49.92 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.903 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.5 t -123.6 140.16 47.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.73 0.3 . . . . 0.0 110.918 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.427 HG21 HD12 ' A' ' 145' ' ' ILE . 7.9 mt -106.22 120.87 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-O 120.93 0.395 . . . . 0.0 111.01 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.84 126.3 52.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.452 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.459 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 2.8 mp -99.19 131.51 46.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.284 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -76.05 112.0 12.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.841 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -58.5 -34.01 70.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.909 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.77 -46.2 91.4 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.741 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 32.0 t80 . . . . . 0 N--CA 1.452 -0.37 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.057 -179.918 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.795 0.331 . . . . 0.0 110.986 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -67.7 -35.94 79.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.989 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.7 -42.42 88.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.008 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.32 -44.92 95.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.494 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.7 mm -67.41 -35.0 72.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.269 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -57.17 -35.88 70.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.949 0.404 . . . . 0.0 110.469 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.2 -23.87 65.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.735 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.494 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.7 -47.37 80.07 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.281 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.3 t . . . . . 0 C--N 1.325 -0.464 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.889 179.989 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.7 OUTLIER . . . . . 0 CA--C 1.508 -0.67 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.652 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 6.0 mm -72.59 135.47 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 CA-C-N 113.612 -1.631 . . . . 0.0 112.638 -177.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.477 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.3 t -91.75 -59.16 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-N 114.68 -1.146 . . . . 0.0 109.715 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 4.9 p -147.31 165.32 30.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.46 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.06 127.01 44.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.723 0.297 . . . . 0.0 111.263 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.6 m -94.17 122.8 45.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.916 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.41 HD13 ' CD1' ' A' ' 146' ' ' PHE . 19.6 mt -129.34 121.84 54.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.634 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 52.3 t -81.27 124.34 29.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.254 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.96 -25.68 21.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.808 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.486 HG22 ' HB3' ' A' ' 142' ' ' SER . 81.8 p -79.87 -2.28 42.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.709 0.29 . . . . 0.0 111.562 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.07 74.42 0.46 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.93 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -144.43 -46.0 0.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.964 0.411 . . . . 0.0 110.789 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.54 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.8 mp -111.84 140.76 23.69 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.729 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.54 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.4 Cg_endo -73.4 143.78 35.42 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.147 1.898 . . . . 0.0 112.16 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.7 mt -56.33 142.93 10.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.575 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.442 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.4 OUTLIER -130.37 164.04 25.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.298 179.518 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.42 119.39 33.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.946 0.403 . . . . 0.0 111.529 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.518 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 7.8 mp -94.38 124.71 38.58 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.652 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -136.3 156.15 49.07 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 122.283 1.04 . . . . 0.0 113.67 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.477 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -151.46 141.92 22.54 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.45 -1.705 . . . . 0.0 110.989 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 121.128 0.49 . . . . 0.0 110.894 -179.895 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.847 0.356 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.449 ' HE2' ' O ' ' A' ' 49' ' ' SER . 3.7 ttpt -140.3 130.41 24.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.853 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 9.3 t -124.14 138.34 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 121.26 0.552 . . . . 0.0 112.123 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.518 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 17.8 m-90 -100.88 139.6 36.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.127 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -111.27 130.47 55.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.043 0.449 . . . . 0.0 109.97 177.922 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.532 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.4 OUTLIER -120.12 145.35 47.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.031 -179.07 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.589 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.35 -168.13 37.9 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.56 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.405 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 0.7 OUTLIER -79.46 -0.7 34.15 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.402 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.3 t30 -84.8 132.35 46.49 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.663 0.268 . . . . 0.0 111.148 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.8 Cg_exo -66.73 -13.52 40.25 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.639 2.226 . . . . 0.0 111.76 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.6 -43.06 17.47 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -41.11 141.04 0.69 Allowed 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 113.887 -1.506 . . . . 0.0 110.655 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 67' ' ' THR . 60.6 m-20 -56.31 -18.88 12.0 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.047 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.487 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 2.8 t80 -130.06 129.1 43.2 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-O 120.771 0.32 . . . . 0.0 111.325 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.462 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.405 ' N ' ' HD2' ' A' ' 70' ' ' ARG . 3.9 mp . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.894 0.378 . . . . 0.0 110.835 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.1 m -56.11 -37.08 68.93 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.102 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.54 -17.5 59.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.302 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.0 mt -104.56 152.03 22.9 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.681 0.277 . . . . 0.0 111.157 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 57.7 p -96.63 167.97 10.81 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.566 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.589 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 8.1 m-20 -42.84 -58.74 2.24 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.365 0.602 . . . . 0.0 109.81 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.401 ' HB3' HD11 ' A' ' 104' ' ' ILE . 0.5 OUTLIER -115.36 82.74 1.8 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 176.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.556 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.1 t60 -59.6 -46.86 87.69 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.517 -176.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.532 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 29.8 p90 -145.54 161.49 39.65 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.214 -0.594 . . . . 0.0 112.005 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.2 tt0 -136.06 144.02 44.98 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.911 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.513 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 81.4 mt -118.88 124.7 73.6 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.272 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.044 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.433 ' CA ' HG11 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -102.26 151.27 22.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.964 0.411 . . . . 0.0 111.723 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.4 tp . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.439 179.464 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.415 ' HB2' ' CD2' ' A' ' 124' ' ' LEU . 4.1 mm? . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.931 0.396 . . . . 0.0 110.759 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.466 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 3.2 mp -131.31 145.46 51.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.689 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.0 mp -112.71 121.07 43.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.028 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -115.49 115.44 26.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.93 0.395 . . . . 0.0 111.552 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.688 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 11.3 p30 -78.59 140.44 38.47 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.401 HD11 ' HB3' ' A' ' 87' ' ' LYS . 10.1 pt -148.99 38.36 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -178.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.573 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.29 152.7 19.14 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 121.013 0.435 . . . . 0.0 112.063 -178.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 50.8 m -68.89 -31.44 70.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.875 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -98.21 -19.91 17.58 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -178.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.573 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.91 156.67 10.39 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.355 -0.926 . . . . 0.0 113.713 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.516 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.1 m -117.43 137.78 52.28 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.814 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -115.96 148.58 39.94 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -177.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.12 113.58 18.54 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.483 177.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 44.72 43.27 6.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.444 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.58 -12.68 62.53 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.722 -0.752 . . . . 0.0 113.468 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.8 118.56 36.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.087 0.444 . . . . 0.0 110.605 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.814 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -71.44 131.71 43.74 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.48 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.6 m -101.59 165.87 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.966 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.4 mp0 -69.83 126.12 28.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.482 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.688 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 84.4 tttt -54.11 162.52 0.99 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.824 0.345 . . . . 0.0 110.654 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.3 m-80 34.21 35.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.109 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.454 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.19 145.17 40.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.035 179.531 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -88.0 132.03 34.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.919 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.466 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 45.1 mm-40 -129.33 150.2 50.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.611 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.6 tp -72.8 136.13 45.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.488 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.489 ' HG ' ' N ' ' A' ' 125' ' ' SER . 16.2 tp -62.43 152.69 33.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.628 0.727 . . . . 0.0 111.585 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.489 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.4 OUTLIER -125.3 152.59 44.47 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.505 179.442 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.455 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -72.28 122.57 21.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 0.0 110.177 179.595 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.03 23.98 48.73 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.054 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.415 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 28.8 t70 -49.08 167.96 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.93 0.395 . . . . 0.0 111.487 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 2.3 mt-10 -144.27 135.68 25.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.003 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.422 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 16.2 mt -115.71 127.3 73.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.804 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.453 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 4.0 m -104.59 139.16 39.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.873 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.52 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.2 m -140.38 158.41 25.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.5 28.86 26.02 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.161 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.452 ' HA ' HG12 ' A' ' 140' ' ' ILE . 78.1 t -71.35 140.39 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-O 121.626 0.727 . . . . 0.0 112.288 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.18 -39.5 0.92 Allowed Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 46.4 t -126.42 128.26 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 CA-C-N 114.689 -0.755 . . . . 0.0 109.068 177.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.51 -33.85 23.03 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.597 0.237 . . . . 0.0 111.632 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.8 m -93.53 6.46 48.14 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -178.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.4 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.6 OUTLIER -123.01 26.79 7.95 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -178.847 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.453 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.6 mt -107.06 138.96 30.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.102 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.0 tt -124.63 134.38 52.93 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.531 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.486 ' HB3' HG22 ' A' ' 40' ' ' THR . 38.0 t -108.59 150.33 27.65 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.567 0.698 . . . . 0.0 112.069 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 75.9 mt -135.78 155.12 50.84 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.861 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.411 ' CG2' ' CG ' ' A' ' 129' ' ' GLU . 20.0 t -127.6 138.14 55.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.784 0.326 . . . . 0.0 111.166 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 19.4 mt -106.45 129.06 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 CA-C-O 120.852 0.358 . . . . 0.0 110.885 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.41 ' CD1' HD13 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -113.12 122.92 49.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.916 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.455 ' CD1' ' HA ' ' A' ' 126' ' ' GLN . 3.3 mt -91.35 134.14 30.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.474 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.76 112.37 19.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.675 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.71 -31.86 68.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.072 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt -58.95 -45.13 91.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.999 0.428 . . . . 0.0 110.609 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.0 t80 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.985 -179.997 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.717 0.294 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 -61.63 -44.15 97.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -60.01 -36.49 77.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.063 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.9 tp -63.73 -45.99 87.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.963 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 40.3 mm -63.27 -39.61 85.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.226 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -57.88 -33.89 69.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.234 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -65.15 -30.86 71.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.479 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -57.06 -47.49 80.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.089 0.471 . . . . 0.0 111.116 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 C--N 1.326 -0.436 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.939 179.997 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.1 m120 . . . . . 0 CA--C 1.505 -0.772 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.585 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 7.6 mm -71.51 144.52 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 CA-C-N 113.695 -1.593 . . . . 0.0 112.477 -176.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.425 HG11 ' CH2' ' A' ' 66' ' ' TRP . 1.2 t -105.71 -56.35 5.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.717 -178.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.415 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 31.3 p -151.51 164.51 36.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.221 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.41 138.26 53.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.835 0.35 . . . . 0.0 111.477 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.431 HG12 ' CZ ' ' A' ' 76' ' ' TYR . 18.3 t -103.81 122.59 56.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.685 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.6 mt -127.0 115.82 42.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.461 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 37.7 t -79.97 124.75 28.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.82 0.343 . . . . 0.0 110.489 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.9 t -92.18 -26.99 17.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.556 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.441 HG23 ' HB3' ' A' ' 142' ' ' SER . 25.9 p -79.93 -2.17 42.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.521 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.05 75.7 0.37 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.915 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -146.01 -44.9 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.789 0.328 . . . . 0.0 111.002 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.52 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -112.73 140.61 24.16 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.831 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.52 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.6 Cg_endo -74.43 141.54 28.6 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.253 1.969 . . . . 0.0 112.361 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.9 mt -56.69 133.99 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.408 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.29 164.46 25.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.551 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.49 119.82 36.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.086 0.47 . . . . 0.0 111.774 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.516 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 17.8 mt -92.27 137.9 31.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.107 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.585 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -141.62 158.39 43.89 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 122.283 1.04 . . . . 0.0 113.756 -178.659 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.406 ' HA ' ' NZ ' ' A' ' 64' ' ' LYS . . . -146.5 141.81 27.43 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 113.447 -1.706 . . . . 0.0 110.43 178.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--N 1.33 -0.258 0 CA-C-O 121.066 0.46 . . . . 0.0 111.289 -179.456 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.408 ' CD ' ' N ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.635 0.255 . . . . 0.0 111.2 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.406 ' NZ ' ' HA ' ' A' ' 50' ' ' ALA . 4.4 ttpt -132.32 135.17 46.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.754 0.312 . . . . 0.0 111.746 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 17.0 t -134.03 139.55 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 121.182 0.515 . . . . 0.0 111.805 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.559 ' O ' ' HA ' ' A' ' 90' ' ' GLN . 16.4 m-90 -100.42 139.42 36.12 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.019 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.562 ' CG2' ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -110.09 132.86 53.78 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.649 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.542 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 2.0 m-85 -115.9 145.7 42.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.478 -178.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.658 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 173.96 -170.3 43.42 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.17 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 26.9 mtm180 -87.5 -13.44 43.08 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.463 ' ND2' ' HB2' ' A' ' 74' ' ' CYS . 0.2 OUTLIER -84.32 143.12 41.45 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.927 0.394 . . . . 0.0 111.364 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 7.2 Cg_exo -70.47 1.3 5.04 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.175 2.583 . . . . 0.0 111.958 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.51 -49.07 10.31 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 122.019 0.914 . . . . 0.0 108.838 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.463 ' HB2' ' ND2' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -46.73 140.74 4.32 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 113.596 -1.638 . . . . 0.0 110.774 179.563 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -56.28 -19.5 14.46 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.216 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.542 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 15.7 t80 -129.57 118.38 21.93 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-O 120.654 0.264 . . . . 0.0 110.979 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.588 179.72 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 27.5 mt . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.826 0.346 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.28 -40.5 71.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.071 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -22.56 64.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.164 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.42 ' CD2' ' CE1' ' A' ' 88' ' ' HIS . 47.1 mt -98.83 152.27 19.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.133 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 93.1 p -97.0 167.34 11.13 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.735 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.658 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 1.1 m120 -43.98 -54.09 5.69 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.424 0.63 . . . . 0.0 109.792 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.445 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.4 OUTLIER -118.2 83.09 1.95 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.247 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.565 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.4 t60 -61.77 -45.22 94.81 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.054 -176.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.503 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 29.1 p90 -149.19 161.51 41.85 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 119.987 -0.685 . . . . 0.0 112.303 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.562 ' HG3' ' CG2' ' A' ' 67' ' ' THR . 4.5 mt-30 -135.46 147.19 48.83 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.313 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 19.9 mt -118.92 131.89 70.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.161 178.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.433 ' HG ' ' CB ' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -119.7 138.06 53.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.124 0.488 . . . . 0.0 111.964 -178.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 tt . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.325 179.058 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.9 0.381 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.433 ' CB ' ' HG ' ' A' ' 92' ' ' LEU . 3.8 mm? -129.96 142.52 50.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.002 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.68 128.14 56.31 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.429 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 52.8 t30 -115.57 117.04 29.23 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.69 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 14.9 p30 -79.84 140.19 36.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.476 HD12 HG23 ' A' ' 67' ' ' THR . 15.9 pt -145.56 33.81 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 111.574 0.213 . . . . 0.0 111.574 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.597 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -93.96 150.35 20.43 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 120.996 0.427 . . . . 0.0 111.891 -178.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.1 m -68.59 -31.48 70.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.765 178.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -98.23 -19.62 17.73 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.597 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.12 156.23 10.02 Favored Glycine 0 N--CA 1.438 -1.21 0 C-N-CA 120.246 -0.978 . . . . 0.0 113.642 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.5 m -117.4 137.78 52.26 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.847 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -114.02 148.55 36.81 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -177.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.28 113.4 18.21 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.171 177.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 44.66 42.84 6.15 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.341 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.24 -10.52 70.84 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.504 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -104.77 118.54 36.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.078 0.466 . . . . 0.0 110.648 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.847 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.3 tptm -73.33 128.14 34.64 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.23 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.3 m -100.5 164.76 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.237 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 120' ' ' SER . 30.5 tt0 -70.05 127.09 31.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.514 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.69 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 24.2 tttt -53.09 162.38 0.68 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.857 0.361 . . . . 0.0 110.438 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.0 OUTLIER 35.4 33.99 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.14 -179.166 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.19 145.12 40.43 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.053 179.395 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -90.35 130.75 36.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.085 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -129.39 148.57 51.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.276 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.4 116.4 12.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.864 0.364 . . . . 0.0 110.354 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 65.3 tp -56.36 157.54 4.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.435 0.636 . . . . 0.0 111.587 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.3 t -124.4 153.31 42.08 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.327 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.404 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 30.1 mm100 -71.3 123.54 22.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.897 0.379 . . . . 0.0 110.046 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.08 21.55 59.39 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.866 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -55.86 173.92 0.13 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.965 0.412 . . . . 0.0 111.057 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 9.5 tt0 -145.07 135.47 24.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.287 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 13.5 mt -113.86 128.04 70.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.26 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.465 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.5 m -104.36 138.78 40.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.208 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.495 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 35.4 m -140.19 158.42 25.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.25 34.36 20.7 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.92 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.453 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.2 t -75.15 140.45 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-O 121.763 0.792 . . . . 0.0 112.533 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.97 -39.37 0.6 Allowed Glycine 0 N--CA 1.437 -1.249 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.414 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 47.9 t -126.35 131.84 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 114.731 -0.735 . . . . 0.0 109.201 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -50.6 -38.71 47.1 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -93.37 6.3 48.62 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.414 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 5.3 t70 -120.11 27.73 8.47 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.465 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.1 mt -107.26 139.5 28.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.022 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.0 tt -122.11 134.34 54.76 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.512 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.441 ' HB3' HG23 ' A' ' 40' ' ' THR . 47.0 t -113.8 150.79 32.98 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.611 0.72 . . . . 0.0 112.638 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 2.1 mm? -135.69 143.55 45.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.487 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.4 t -110.97 139.85 32.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.824 0.345 . . . . 0.0 111.138 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.456 HG21 HD11 ' A' ' 145' ' ' ILE . 16.2 mt -106.31 125.16 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.072 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.03 109.89 19.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.816 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.404 ' CD1' ' HA ' ' A' ' 126' ' ' GLN . 5.0 mp -85.96 134.07 28.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.416 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -86.06 127.7 34.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.844 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -74.03 -23.91 59.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.21 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -45.03 90.99 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.035 0.445 . . . . 0.0 110.649 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.4 t80 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.92 179.965 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.778 0.323 . . . . 0.0 110.805 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.6 mtm-85 -58.84 -46.08 88.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.972 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -61.39 -35.08 76.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.876 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.6 tt -61.18 -45.18 95.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.959 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.41 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 6.1 mm -62.64 -35.23 69.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.156 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.25 -44.59 84.01 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.9 0.381 . . . . 0.0 110.425 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -67.15 -23.74 65.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.419 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.41 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.75 -47.45 80.04 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.202 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.814 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.436 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER . . . . . 0 CA--C 1.51 -0.581 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.681 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.4 mm -73.02 137.08 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-N 113.598 -1.637 . . . . 0.0 112.658 -177.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.495 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.3 t -93.66 -59.82 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.658 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.94 156.46 42.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.229 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.425 ' NE ' HG23 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -119.88 138.14 53.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.815 0.34 . . . . 0.0 111.031 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.436 HG22 ' CD2' ' A' ' 76' ' ' TYR . 1.8 m -104.66 122.71 58.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.772 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.4 mt -125.0 124.17 67.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.572 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 52.8 t -80.02 108.74 13.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.859 0.361 . . . . 0.0 110.537 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.0 t -74.55 -25.46 59.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.639 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.493 HG22 ' HB3' ' A' ' 142' ' ' SER . 74.7 p -79.86 -2.35 43.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.46 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.15 76.73 0.24 Allowed Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.824 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -146.53 -43.86 0.19 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.913 0.387 . . . . 0.0 110.876 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.542 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.1 mt -117.93 141.3 29.01 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.005 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.542 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 52.5 Cg_endo -72.35 145.85 43.96 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.216 1.944 . . . . 0.0 111.788 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.425 HG23 ' NE ' ' A' ' 35' ' ' ARG . 68.6 mt -54.15 142.46 7.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.049 0.452 . . . . 0.0 111.829 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.486 ' HB2' ' CE2' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -124.67 133.99 53.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.861 178.873 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.08 119.92 32.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.141 0.496 . . . . 0.0 111.863 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.533 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 5.2 mt -98.04 131.96 44.0 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.681 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -143.55 157.55 44.34 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -178.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.495 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -141.07 146.29 36.94 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 113.694 -1.594 . . . . 0.0 110.993 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 121.045 0.45 . . . . 0.0 111.196 -179.532 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.767 0.318 . . . . 0.0 110.939 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.441 ' CE ' ' O ' ' A' ' 49' ' ' SER . 26.5 ttpt -141.06 144.09 34.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.016 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.483 HG12 ' HB3' ' A' ' 92' ' ' LEU . 14.4 t -127.72 139.5 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-O 121.29 0.567 . . . . 0.0 112.08 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.533 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 18.9 m-90 -100.77 139.32 36.62 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.144 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.79 126.97 55.8 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.521 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -118.06 145.23 44.96 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.79 -178.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.603 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.46 -172.69 37.73 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.084 -1.055 . . . . 0.0 113.593 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -74.28 -0.61 17.53 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -84.69 132.14 47.42 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.624 0.249 . . . . 0.0 111.29 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.417 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 14.7 Cg_exo -67.83 -12.1 34.26 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.58 2.186 . . . . 0.0 111.707 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.02 -43.19 16.63 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-O 121.914 0.864 . . . . 0.0 109.048 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -39.12 139.11 0.52 Allowed 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 113.701 -1.591 . . . . 0.0 111.089 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -56.44 -18.72 12.19 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.122 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.487 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 56.0 t80 -129.41 119.04 23.15 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.829 0.347 . . . . 0.0 110.915 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.417 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.8 t-160 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.961 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.417 ' HB ' HD12 ' A' ' 84' ' ' LEU . 2.4 mp . . . . . 0 CA--C 1.527 0.094 0 CA-C-O 120.795 0.331 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.27 -29.65 64.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.196 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.89 -23.25 65.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.059 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.417 HD12 ' HB ' ' A' ' 81' ' ' ILE . 4.1 mp -107.05 152.87 23.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.912 0.387 . . . . 0.0 110.958 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 61.1 p -96.46 166.71 11.56 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.891 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.603 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.2 m-20 -43.32 -53.19 5.4 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.318 0.58 . . . . 0.0 109.799 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.9 mttm -118.03 81.36 1.66 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.576 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 15.8 t60 -58.81 -47.45 84.73 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.423 -177.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.504 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 32.1 p90 -146.31 159.81 42.86 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.154 -0.618 . . . . 0.0 112.063 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.483 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.0 tt0 -135.59 141.95 45.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.212 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 45.7 mt -120.44 131.84 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.297 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.483 ' HB3' HG12 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -120.09 139.73 52.12 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.004 0.43 . . . . 0.0 111.566 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.307 179.159 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.407 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.715 0.293 . . . . 0.0 110.577 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 9.0 mt -120.3 142.1 49.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.897 0.38 . . . . 0.0 110.719 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.8 tt -112.95 125.0 53.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.059 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.452 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 59.8 t30 -119.09 115.93 25.3 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.688 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 11.8 p30 -77.94 137.55 38.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.779 178.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 8.4 pt -141.29 29.52 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 121.127 -0.229 . . . . 0.0 111.58 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.552 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 12.1 t -93.69 155.49 17.22 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.534 0.683 . . . . 0.0 112.838 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 69.5 m -70.06 -52.04 27.1 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.669 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -80.34 -0.54 37.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.281 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.0 156.24 30.66 Favored Glycine 0 N--CA 1.437 -1.25 0 C-N-CA 120.642 -0.789 . . . . 0.0 113.518 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.505 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 5.2 m -117.44 137.89 52.21 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.815 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -113.29 148.47 35.56 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -178.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.12 113.54 18.49 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.298 177.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 45.3 42.7 7.53 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.0 -7.69 76.6 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.462 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.59 118.51 36.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 117.041 0.421 . . . . 0.0 110.624 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.815 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 6.3 tptm -72.46 116.94 13.51 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.259 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.1 m -92.42 162.86 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.046 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' A' ' 120' ' ' SER . 0.6 OUTLIER -69.81 128.92 38.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.46 179.66 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.688 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 45.5 tttt -55.35 163.87 1.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.751 0.31 . . . . 0.0 110.195 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.7 OUTLIER 35.96 34.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.818 -179.162 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.43 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 2.7 p -112.12 143.58 42.91 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.458 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -94.22 132.28 38.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.045 0.45 . . . . 0.0 111.103 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 58.1 mm-40 -129.07 151.23 49.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.446 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 tp -72.56 128.56 35.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.843 0.354 . . . . 0.0 110.464 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.501 ' HG ' ' N ' ' A' ' 125' ' ' SER . 18.8 tp -57.55 155.28 9.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.375 0.607 . . . . 0.0 111.679 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.501 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -124.71 152.95 43.11 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.304 179.463 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.88 119.14 15.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.96 0.41 . . . . 0.0 110.07 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.32 24.71 63.87 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.124 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.4 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 32.0 t70 -52.95 170.31 0.08 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.928 0.394 . . . . 0.0 111.337 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 9.4 mt-10 -145.15 135.61 24.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.06 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.6 mt -111.64 128.08 68.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.459 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.463 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.6 m -104.25 140.39 37.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.01 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.576 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 22.7 m -140.36 158.75 25.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.44 43.7 10.18 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.167 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.46 ' HA ' HG12 ' A' ' 140' ' ' ILE . 74.0 t -83.01 140.44 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-O 121.609 0.719 . . . . 0.0 112.307 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.29 -40.17 0.95 Allowed Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.2 t -126.37 124.95 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-N 114.603 -0.799 . . . . 0.0 108.983 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -50.38 -30.73 12.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.769 0.319 . . . . 0.0 111.444 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.0 m -93.62 6.35 48.56 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -123.52 24.25 8.64 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.463 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 4.5 mt -107.0 139.07 29.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.313 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.31 134.49 53.17 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.202 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.493 ' HB3' HG22 ' A' ' 40' ' ' THR . 38.1 t -111.12 150.62 29.16 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.73 0.776 . . . . 0.0 112.46 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 3.5 mm? -135.66 149.12 49.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.125 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 13.8 t -118.81 140.09 43.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 111.382 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 28.1 mt -106.29 120.87 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.76 118.38 36.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.654 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.5 mt -84.98 134.03 27.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.495 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -81.84 115.72 21.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.723 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -63.74 -31.8 73.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.06 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -60.14 -46.06 90.91 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.005 0.431 . . . . 0.0 110.784 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.7 t80 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.983 -179.898 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.919 0.39 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -64.8 -41.81 95.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.867 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -57.93 -38.6 76.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.854 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.09 -31.85 70.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.811 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.415 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.0 mt -72.89 -35.4 49.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.831 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -57.38 -42.39 82.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.984 0.421 . . . . 0.0 110.493 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.1 tttt -67.08 -23.82 65.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.661 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.415 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.68 -47.52 79.67 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.261 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.941 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.423 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.7 OUTLIER . . . . . 0 CA--C 1.51 -0.564 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.689 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.1 mm -74.24 135.37 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-N 113.703 -1.589 . . . . 0.0 112.574 -177.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.5 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.9 t -93.51 -61.42 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.086 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.9 p -144.73 152.09 39.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.252 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.42 128.72 55.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.757 0.313 . . . . 0.0 111.339 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.0 t -96.67 122.91 48.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.867 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.6 mt -127.14 127.23 69.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.582 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 11.6 t -91.61 107.67 19.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.446 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 63.0 p -81.24 -24.88 37.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.636 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.529 ' CG2' ' HB2' ' A' ' 142' ' ' SER . 4.3 p -80.05 -2.71 45.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.662 0.268 . . . . 0.0 111.428 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.92 75.53 0.45 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.069 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -143.07 -40.88 0.31 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.92 0.39 . . . . 0.0 110.992 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.559 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.1 mp -125.7 142.15 41.24 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.927 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.559 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 52.7 Cg_endo -72.08 140.81 35.14 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.16 1.907 . . . . 0.0 112.227 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.7 mt -56.16 142.94 10.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.724 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -137.85 161.91 35.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.27 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.05 119.83 37.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.975 0.417 . . . . 0.0 111.746 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.55 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 4.4 mt -94.88 136.25 35.42 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.689 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.81 158.64 43.84 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -178.806 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.5 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -146.28 147.71 31.67 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 113.69 -1.596 . . . . 0.0 110.822 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 121.172 0.51 . . . . 0.0 111.261 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.9 mptt . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.749 0.309 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.432 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.4 ttpt -149.93 139.98 22.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.296 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 14.6 t -130.72 139.28 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.311 0.577 . . . . 0.0 112.092 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.55 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.3 m-90 -102.4 139.45 37.99 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.151 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -112.18 128.32 56.2 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.561 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.51 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.8 OUTLIER -120.09 145.3 47.01 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.179 -178.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.529 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.17 -169.56 37.56 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.176 -1.012 . . . . 0.0 113.733 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.8 ttt-85 -77.2 0.29 22.42 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 122.56 0.344 . . . . 0.0 111.869 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.411 ' HB2' ' CB ' ' A' ' 86' ' ' ASN . 6.9 t-20 -84.76 132.64 45.69 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.632 0.253 . . . . 0.0 111.41 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.432 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 15.4 Cg_exo -67.17 -13.5 39.87 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.573 2.182 . . . . 0.0 111.702 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.73 -44.63 15.39 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-O 121.858 0.837 . . . . 0.0 108.968 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -39.88 141.06 0.47 Allowed 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 113.707 -1.588 . . . . 0.0 110.951 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 67' ' ' THR . 72.0 m-20 -56.32 -19.09 12.86 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.048 179.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.496 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 2.2 t80 -129.96 125.36 35.25 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.709 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.432 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.5 t-160 . . . . . 0 C--N 1.328 -0.359 0 CA-C-O 120.919 0.39 . . . . 0.0 110.867 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.3 mp . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.848 0.356 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.88 -33.52 75.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.943 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.6 mmp_? -60.94 -23.36 65.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.099 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.419 HD23 ' CE1' ' A' ' 88' ' ' HIS . 16.4 mt -101.55 151.2 22.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.979 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 99.3 p -94.29 165.81 12.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.454 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.529 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 m-20 -42.8 -53.93 4.36 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.372 0.606 . . . . 0.0 109.694 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -118.82 81.86 1.76 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 177.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.536 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.8 t60 -59.42 -47.18 86.44 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.454 -177.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.51 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 33.3 p90 -143.62 159.86 41.7 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 119.967 -0.693 . . . . 0.0 112.041 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.6 tt0 -136.0 141.78 44.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.93 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 65.5 mt -117.82 128.68 74.94 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.093 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.424 ' HB3' HG13 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -113.94 147.24 38.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.018 0.437 . . . . 0.0 111.43 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.403 ' CD1' ' CG1' ' A' ' 33' ' ' VAL . 5.2 tp . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.386 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.2 mt . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.792 0.33 . . . . 0.0 110.802 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.408 ' CB ' ' HG ' ' A' ' 92' ' ' LEU . 4.5 mp -133.0 144.71 50.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.447 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -112.79 121.83 45.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.225 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.406 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.4 t30 -115.59 115.52 26.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.992 0.425 . . . . 0.0 111.617 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.681 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 8.4 p30 -79.1 136.89 37.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.906 178.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 9.0 pt -143.62 38.11 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.555 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.46 151.2 20.85 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 121.066 0.46 . . . . 0.0 111.735 -179.185 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 55.1 m -68.87 -31.63 70.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.996 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -98.09 -19.97 17.63 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.555 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.42 154.61 9.41 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.144 -1.027 . . . . 0.0 113.801 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.1 m -117.62 137.92 52.3 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.822 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -115.76 148.41 39.85 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -178.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.15 113.5 18.42 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.08 177.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.2 m120 44.65 43.18 6.42 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.15 -8.69 75.65 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.49 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -105.36 118.55 36.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.127 0.489 . . . . 0.0 110.774 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.822 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 14.8 tptp -73.21 119.34 17.31 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.282 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.1 m -91.06 164.37 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.278 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 120' ' ' SER . 4.1 tp10 -69.93 126.21 29.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.655 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.681 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 24.7 tttm -52.29 161.51 0.64 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.896 0.379 . . . . 0.0 110.694 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.6 p30 34.35 35.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.325 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.19 145.01 40.62 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.049 179.362 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -88.92 127.34 35.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.987 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -129.34 146.35 51.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.747 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -72.82 113.7 10.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.026 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -53.42 165.85 0.34 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.679 0.752 . . . . 0.0 112.003 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.448 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -125.29 153.3 43.45 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.383 179.347 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.51 120.08 16.59 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.85 21.39 65.36 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.064 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.448 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 9.4 t70 -57.93 173.69 0.31 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.963 0.411 . . . . 0.0 111.065 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 13.9 tt0 -145.26 135.52 24.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.246 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.2 mt -109.52 128.33 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.177 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.46 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.8 m -104.07 139.55 39.01 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.497 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.6 m -140.15 158.36 25.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.24 44.1 10.0 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.885 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.436 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.9 t -83.35 140.41 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-O 121.742 0.782 . . . . 0.0 112.393 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.77 -37.61 0.88 Allowed Glycine 0 N--CA 1.436 -1.319 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -126.39 123.72 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 114.598 -0.801 . . . . 0.0 109.155 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -50.48 -33.41 21.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.623 0.249 . . . . 0.0 111.585 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 40.2 t -93.43 6.49 47.99 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -125.51 28.29 6.3 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.46 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 4.9 mt -107.11 139.56 28.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.874 178.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.6 134.49 55.0 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.752 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.529 ' HB2' ' CG2' ' A' ' 40' ' ' THR . 0.8 OUTLIER -112.19 136.75 51.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.03 0.443 . . . . 0.0 111.704 -179.472 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.427 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 2.9 mm? -130.88 138.52 49.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.352 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 20.8 t -110.76 137.13 44.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.957 0.408 . . . . 0.0 111.608 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.468 HG22 HD12 ' A' ' 145' ' ' ILE . 49.6 mt -106.19 127.39 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.086 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.2 115.79 28.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.642 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.5 mt -84.76 129.32 37.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.893 0.378 . . . . 0.0 111.331 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -75.96 116.78 17.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.942 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -65.36 -31.13 72.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.891 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -58.7 -44.35 90.31 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.975 0.417 . . . . 0.0 110.568 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 30.5 t80 . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.777 179.911 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.853 0.359 . . . . 0.0 110.627 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -71.19 -35.78 71.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.615 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.29 -39.3 82.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.859 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.61 -40.83 93.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.852 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.48 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.2 mm -70.29 -35.1 61.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.199 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -57.03 -37.58 71.95 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.866 0.365 . . . . 0.0 110.454 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -67.29 -23.83 65.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.666 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.92 -47.27 81.01 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.169 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.833 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.499 ' O ' ' HB3' ' A' ' 49' ' ' SER . 4.7 m-20 . . . . . 0 CA--C 1.507 -0.682 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.672 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 6.9 mm -71.25 142.02 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 CA-C-N 113.678 -1.601 . . . . 0.0 112.495 -176.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.402 ' CG2' ' CB ' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -104.38 -46.84 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.551 -178.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 28.4 p -163.0 145.56 10.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.127 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.429 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.94 134.68 54.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.874 0.368 . . . . 0.0 111.674 -178.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.423 HG13 ' CE2' ' A' ' 68' ' ' PHE . 3.4 m -99.77 122.71 51.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.469 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.3 mt -128.01 121.03 55.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.605 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 12.6 t -84.04 124.71 31.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.636 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.7 t -95.36 -25.05 16.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.517 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.401 HG23 ' HB3' ' A' ' 142' ' ' SER . 17.5 p -79.88 -2.13 42.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.506 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.15 74.13 0.52 Allowed Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.532 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -145.31 -39.46 0.25 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.777 0.322 . . . . 0.0 111.168 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.535 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.2 mt -122.19 140.57 32.67 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.843 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.535 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.3 Cg_endo -73.59 138.93 27.54 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.236 1.957 . . . . 0.0 112.225 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.5 mt -57.49 141.46 14.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.562 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.96 164.28 28.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.343 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.429 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 1.4 p-10 -116.21 119.86 37.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.146 0.498 . . . . 0.0 111.932 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.57 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 4.4 mt -98.5 137.27 37.41 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.672 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.6 158.77 43.8 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -178.415 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.402 ' CB ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.06 141.83 29.2 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.519 -1.673 . . . . 0.0 110.673 178.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 121.123 0.487 . . . . 0.0 111.275 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.1 mmtm . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.813 0.34 . . . . 0.0 110.767 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.4 ' CE ' ' O ' ' A' ' 49' ' ' SER . 4.5 ttpt -145.71 130.62 18.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.172 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 13.0 t -126.93 139.11 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 121.264 0.554 . . . . 0.0 112.2 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.57 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.4 m-90 -100.87 139.8 36.05 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.144 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.482 ' HA ' ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.44 127.65 55.75 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.321 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.503 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.7 OUTLIER -119.64 145.21 46.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.96 -178.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.51 -169.66 38.62 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.199 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.56 1.43 22.58 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.401 ' HB2' ' CB ' ' A' ' 86' ' ' ASN . 10.5 t-20 -84.97 132.49 45.64 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.578 0.228 . . . . 0.0 111.36 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.444 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 15.9 Cg_exo -67.21 -13.23 38.85 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.678 2.252 . . . . 0.0 111.776 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.85 -43.69 16.33 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-O 121.901 0.858 . . . . 0.0 109.029 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -39.66 142.01 0.35 Allowed 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 113.688 -1.596 . . . . 0.0 111.2 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.1 m-20 -56.25 -19.12 12.61 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.981 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.487 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 5.8 t80 -129.63 127.61 40.96 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.666 0.269 . . . . 0.0 110.871 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.444 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.7 t-160 . . . . . 0 C--N 1.328 -0.346 0 CA-C-O 120.888 0.375 . . . . 0.0 110.905 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 24.5 mm . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.824 0.345 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.69 -35.28 77.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.984 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.91 -22.08 63.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.261 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 21.1 mt -96.22 152.08 18.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.014 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 45.6 p -96.87 164.68 12.45 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.515 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.547 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -41.43 -53.61 3.32 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.497 0.665 . . . . 0.0 109.811 179.161 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -119.86 83.59 2.07 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 177.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.564 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.6 t60 -60.53 -46.04 91.63 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.089 -0.959 . . . . 0.0 112.568 -177.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.5 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 18.1 p90 -143.72 162.64 35.47 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 119.863 -0.735 . . . . 0.0 112.441 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.559 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -135.57 135.06 40.01 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.059 -179.118 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 52.0 mt -113.26 129.12 69.56 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.773 178.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.415 ' HG ' ' HB2' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -113.97 147.99 37.64 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.0 0.429 . . . . 0.0 111.527 -179.582 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.416 HD22 ' CZ ' ' A' ' 151' ' ' PHE . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.517 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.749 0.309 . . . . 0.0 110.657 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.415 ' HB2' ' HG ' ' A' ' 92' ' ' LEU . 4.5 mm? -132.98 145.73 51.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.564 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.0 mt -112.7 127.94 56.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.03 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 90' ' ' GLN . 47.0 t30 -119.34 115.92 25.12 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.682 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 10.8 p30 -77.92 135.95 37.94 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.973 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 9.0 pt -143.84 40.1 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 111.56 0.208 . . . . 0.0 111.56 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.617 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.07 150.93 20.9 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-O 120.994 0.426 . . . . 0.0 111.877 -178.77 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 51.0 m -68.67 -31.89 71.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.694 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -98.56 -19.69 17.46 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.617 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.25 157.26 10.29 Favored Glycine 0 N--CA 1.439 -1.125 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.565 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.3 m -117.48 137.95 52.19 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.791 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -115.83 148.83 39.49 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -177.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.12 113.38 18.27 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.428 177.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 44.21 43.26 5.69 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.84 -17.34 53.51 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.416 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.8 tp60 -103.63 118.46 36.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.042 0.449 . . . . 0.0 110.471 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.791 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -70.4 138.87 51.66 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.264 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.4 m -105.91 165.81 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.853 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 120' ' ' SER . 22.6 mt-10 -69.8 124.93 25.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.631 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.682 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 14.7 tttt -52.53 163.11 0.46 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.778 0.323 . . . . 0.0 110.778 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.5 m-80 33.38 35.11 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.182 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.26 145.08 40.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.247 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -88.39 129.89 35.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.843 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 44.5 mm-40 -129.11 148.47 51.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.672 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.8 tp -72.49 122.12 20.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.876 0.37 . . . . 0.0 110.412 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.427 ' CD2' HG12 ' A' ' 147' ' ' ILE . 67.6 tp -58.86 155.89 12.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.456 0.646 . . . . 0.0 111.61 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.414 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -124.75 153.43 42.43 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.689 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -71.53 121.46 18.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.886 0.374 . . . . 0.0 110.122 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.22 22.22 57.94 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.199 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.414 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 21.8 t0 -54.92 173.93 0.08 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 120.877 0.37 . . . . 0.0 110.893 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -145.16 135.38 23.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.235 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.4 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 13.6 mt -113.9 128.18 70.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.081 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.466 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 4.9 m -104.25 138.28 40.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.062 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.515 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 33.5 m -140.28 158.13 25.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.86 32.12 18.95 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.852 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.45 ' HA ' HG12 ' A' ' 140' ' ' ILE . 55.3 t -73.79 140.37 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-O 121.679 0.752 . . . . 0.0 112.516 -179.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 159.26 -40.33 0.48 Allowed Glycine 0 N--CA 1.436 -1.307 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.144 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.438 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 49.1 t -126.36 137.51 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -50.69 -43.03 57.48 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.0 t -93.3 6.23 48.82 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.438 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 13.2 t0 -116.09 27.19 9.42 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -178.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.466 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.1 mt -107.43 139.46 29.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.127 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.425 ' CD2' HD23 ' A' ' 143' ' ' LEU . 4.3 tt -121.37 134.39 55.12 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.449 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.401 ' HB3' HG23 ' A' ' 40' ' ' THR . 48.1 t -111.33 151.08 28.82 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.592 0.711 . . . . 0.0 112.5 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.425 HD23 ' CD2' ' A' ' 141' ' ' LEU . 1.8 mm? -135.39 147.37 49.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.32 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.5 t -113.71 137.38 47.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.818 0.342 . . . . 0.0 111.125 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 39.8 mt -106.31 120.9 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.077 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.35 115.58 29.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.592 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.427 HG12 ' CD2' ' A' ' 124' ' ' LEU . 3.7 mt -84.65 133.16 29.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.33 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -83.55 108.46 16.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.939 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.19 -25.71 64.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.006 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.6 tptp -57.5 -42.95 83.73 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.013 0.435 . . . . 0.0 110.66 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.416 ' CZ ' HD22 ' A' ' 93' ' ' LEU . 28.4 t80 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.776 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.765 0.317 . . . . 0.0 111.015 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.09 -45.82 89.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.991 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -59.99 -35.0 74.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.956 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.25 -40.71 94.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.886 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.442 ' O ' ' CD2' ' A' ' 23' ' ' PHE . 43.0 mm -68.84 -48.17 72.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.037 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.75 -33.67 71.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.4 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -58.74 -47.1 85.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.372 -0.377 . . . . 0.0 112.0 -178.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 24' ' ' SER . 4.5 p90 -71.89 -47.38 53.1 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.967 0.413 . . . . 0.0 111.033 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.537 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 1.2 m . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.039 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.423 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 t-20 . . . . . 0 CA--C 1.509 -0.615 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.679 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.8 mm -71.93 136.16 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 CA-C-N 113.557 -1.656 . . . . 0.0 112.666 -177.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.484 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.8 t -92.28 -58.56 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.545 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.568 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.07 153.89 37.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.83 179.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.475 ' NE ' HG22 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -113.89 138.38 50.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.831 0.348 . . . . 0.0 111.02 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.432 ' HB ' ' CE1' ' A' ' 76' ' ' TYR . 19.8 t -103.32 122.96 56.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.212 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.426 ' HA ' HG12 ' A' ' 45' ' ' ILE . 19.8 mt -128.3 119.13 49.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.873 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 50.4 t -84.78 118.6 24.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.205 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.97 -22.11 27.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.911 -179.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.442 HG22 ' HB3' ' A' ' 142' ' ' SER . 69.6 p -79.81 -2.09 41.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.687 0.279 . . . . 0.0 111.579 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.14 73.18 0.56 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.83 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -145.28 -43.3 0.22 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.88 0.371 . . . . 0.0 111.014 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.519 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 7.7 mt -115.63 140.61 26.24 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.945 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.519 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 66.2 Cg_endo -76.1 146.08 28.47 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.295 1.997 . . . . 0.0 112.237 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.475 HG22 ' NE ' ' A' ' 35' ' ' ARG . 14.6 mt -57.35 148.2 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.549 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -139.41 161.76 36.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.348 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.68 119.77 37.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.065 0.459 . . . . 0.0 111.954 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.518 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 8.0 mt -95.69 134.46 38.57 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.679 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.91 157.46 43.9 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -178.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.484 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -143.63 141.97 30.82 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.421 -1.718 . . . . 0.0 110.505 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-O 121.336 0.589 . . . . 0.0 111.608 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.067 0 CA-C-O 120.813 0.34 . . . . 0.0 110.84 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.435 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.7 ttpt -140.35 131.33 26.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.965 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 7.8 t -127.75 139.06 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-O 121.266 0.555 . . . . 0.0 112.224 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.518 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.4 m-90 -101.04 139.26 36.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.882 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.458 ' HA ' ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -113.04 131.64 55.71 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.69 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.568 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -118.29 145.24 45.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.669 -178.291 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.614 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.95 -172.26 36.43 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.312 -0.946 . . . . 0.0 113.932 178.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.52 ' CZ ' ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -72.32 -3.67 25.2 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.88 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.424 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -84.51 128.85 59.82 Favored Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 121.191 -0.204 . . . . 0.0 111.036 -179.603 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.5 Cg_exo -67.24 -9.36 24.9 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.525 2.15 . . . . 0.0 111.574 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.8 -42.88 17.36 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -40.37 138.25 0.94 Allowed 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 113.879 -1.509 . . . . 0.0 110.247 179.165 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -56.33 -18.77 11.83 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.915 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.568 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 13.3 t80 -129.88 127.18 39.66 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.881 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.572 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.404 ' HB ' HD13 ' A' ' 84' ' ' LEU . 16.8 mt . . . . . 0 N--CA 1.463 0.185 0 CA-C-O 120.945 0.402 . . . . 0.0 111.04 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.2 m -60.83 -24.89 66.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.35 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.401 ' HB2' HG21 ' A' ' 81' ' ' ILE . 5.2 mmp_? -60.48 -26.71 67.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.642 0.258 . . . . 0.0 111.353 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.52 ' HB2' ' CZ ' ' A' ' 70' ' ' ARG . 4.8 mp -107.05 153.37 22.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.919 0.39 . . . . 0.0 111.184 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 79.9 p -89.28 167.7 12.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.427 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.614 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.5 m-20 -42.48 -54.89 3.68 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.363 0.601 . . . . 0.0 109.75 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.31 84.15 2.13 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 177.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.547 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 17.6 t60 -60.39 -46.31 90.43 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.752 -176.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.509 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 30.0 p90 -146.84 160.49 42.22 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.447 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.495 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 3.8 tt0 -135.66 143.18 45.34 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.015 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 56.6 mt -118.52 130.29 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.981 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.428 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -111.37 149.6 30.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.025 0.441 . . . . 0.0 111.87 -179.549 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 36.2 tp . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.344 179.23 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.8 mp . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.697 0.284 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.6 mt -132.84 143.86 49.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.412 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.78 128.43 56.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.244 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.428 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 52.6 t30 -118.58 115.78 25.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.911 0.386 . . . . 0.0 111.745 -179.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.695 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 13.5 p30 -77.73 139.98 39.45 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 8.3 pt -147.4 38.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 111.538 0.199 . . . . 0.0 111.538 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.611 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.0 150.96 21.44 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.05 0.452 . . . . 0.0 112.127 -178.538 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 39.8 m -68.79 -31.32 70.25 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.573 177.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -97.38 -19.79 18.24 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.609 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.611 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 115.77 156.31 10.93 Favored Glycine 0 N--CA 1.438 -1.21 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.671 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.529 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.0 m -117.53 137.84 52.3 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.833 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -114.83 148.5 38.42 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -178.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.15 113.42 18.31 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.415 177.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 44.37 43.26 5.99 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.74 -10.78 68.66 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.792 -0.718 . . . . 0.0 113.458 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -104.82 118.58 36.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.067 0.46 . . . . 0.0 110.635 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.833 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 15.1 tptp -73.37 122.25 21.75 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.318 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.3 m -93.94 165.53 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.242 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.422 ' O ' ' HB3' ' A' ' 120' ' ' SER . 16.7 mt-10 -69.86 128.51 36.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.522 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.695 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 15.9 tttp -54.47 163.93 0.8 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.9 OUTLIER 34.35 36.41 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.816 -179.183 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.422 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.7 p -111.96 145.09 40.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.914 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -94.62 129.59 41.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.932 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -129.08 149.42 50.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.389 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -72.63 122.05 20.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.874 0.369 . . . . 0.0 110.26 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 65.0 tp -54.16 156.44 3.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.397 0.618 . . . . 0.0 111.866 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.55 153.48 42.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.544 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.408 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 3.8 tp60 -71.59 122.26 20.2 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.95 22.58 57.89 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.928 -178.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -52.15 170.7 0.06 Allowed 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.941 0.4 . . . . 0.0 111.095 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 9.5 tt0 -145.11 135.47 24.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.266 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 17.6 mt -115.6 127.53 73.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.604 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.442 ' HB ' ' HB2' ' A' ' 110' ' ' TRP . 3.5 m -104.49 140.61 37.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.082 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.485 ' CG1' ' CD2' ' A' ' 88' ' ' HIS . 35.2 m -140.34 158.42 25.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 112.216 0.451 . . . . 0.0 112.216 -178.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.2 43.03 8.92 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.806 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.442 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.9 t -84.72 140.53 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 121.686 0.755 . . . . 0.0 112.502 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.98 -38.32 0.8 Allowed Glycine 0 N--CA 1.435 -1.401 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.7 t -126.39 120.2 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-N 114.518 -0.841 . . . . 0.0 109.001 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.45 -28.43 8.29 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.708 0.289 . . . . 0.0 111.494 -178.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.2 p -93.61 6.52 48.0 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.18 31.15 4.45 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -179.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.442 HG12 ' HA ' ' A' ' 134' ' ' VAL . 4.9 mt -107.16 139.47 28.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.647 178.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.5 tt -123.64 134.46 53.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.928 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.442 ' HB3' HG22 ' A' ' 40' ' ' THR . 45.2 t -109.73 150.4 28.37 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.618 0.723 . . . . 0.0 112.29 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 65.2 mt -135.81 139.12 43.23 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.963 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.2 t -112.4 139.08 38.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.858 0.361 . . . . 0.0 111.09 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 31.4 mt -106.3 129.6 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.029 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.415 ' CD1' HD13 ' A' ' 37' ' ' ILE . 0.9 OUTLIER -113.68 116.29 29.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.832 179.881 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.408 ' CD1' ' HA ' ' A' ' 126' ' ' GLN . 6.2 mt -84.88 134.14 27.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.681 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -88.7 109.77 20.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.699 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -62.36 -30.6 71.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.059 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -42.27 84.39 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.969 0.414 . . . . 0.0 110.721 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 22.3 t80 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.887 179.916 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 . . . . . 0 N--CA 1.458 -0.073 0 CA-C-O 120.822 0.344 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -70.94 -36.97 72.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -58.4 -39.88 80.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.793 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.42 -32.53 73.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.746 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.403 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.0 mt -73.04 -35.34 48.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.947 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -57.21 -43.53 82.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.912 0.387 . . . . 0.0 110.612 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -67.09 -24.26 65.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.529 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.403 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -57.0 -47.7 80.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.131 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.2 m . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.105 -179.972 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.419 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER . . . . . 0 CA--C 1.509 -0.598 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.642 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.5 mm -76.26 137.15 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 CA-C-N 113.706 -1.588 . . . . 0.0 112.603 -177.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.483 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.4 t -91.97 -58.47 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.641 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.419 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 66.2 m -146.18 165.28 29.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.466 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.74 124.52 31.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.773 0.321 . . . . 0.0 111.171 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.405 HG23 ' CD1' ' A' ' 48' ' ' LEU . 55.7 t -94.9 122.96 46.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.012 0.434 . . . . 0.0 111.132 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.9 mt -124.68 122.69 64.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.057 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 42.3 t -79.96 112.88 17.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.831 0.348 . . . . 0.0 110.544 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.48 -25.26 38.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.508 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.47 HG23 ' HB3' ' A' ' 142' ' ' SER . 82.3 p -80.04 -2.36 43.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.738 0.304 . . . . 0.0 111.422 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.97 76.48 0.25 Allowed Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.924 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -147.14 -44.12 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.88 0.372 . . . . 0.0 110.931 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.563 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.1 mt -114.99 141.7 27.34 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.944 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.563 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 45.5 Cg_endo -71.15 145.34 48.96 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.2 1.933 . . . . 0.0 112.285 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.0 mt -60.13 138.81 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.722 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.83 164.33 20.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.294 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -120.82 119.68 33.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.997 0.427 . . . . 0.0 111.839 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.529 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 6.9 mp -92.14 130.41 37.87 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.642 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -141.58 155.81 45.74 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 122.2 1.0 . . . . 0.0 113.641 -179.581 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.483 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.23 142.06 29.19 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.468 -1.696 . . . . 0.0 110.934 179.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 121.078 0.466 . . . . 0.0 111.102 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.069 0 CA-C-O 120.837 0.351 . . . . 0.0 110.75 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.419 ' CE ' ' O ' ' A' ' 49' ' ' SER . 3.9 ttpt -135.81 127.86 29.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.865 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.44 HG13 ' HG2' ' A' ' 90' ' ' GLN . 6.3 t -121.59 137.14 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 121.283 0.563 . . . . 0.0 111.876 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.547 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 19.5 m-90 -102.41 139.41 38.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.274 -0.876 . . . . 0.0 112.151 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -113.33 130.52 56.25 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 177.699 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.5 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.7 OUTLIER -117.65 145.49 44.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.392 -178.897 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.633 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.0 -169.05 36.52 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.776 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -81.7 4.26 22.48 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -84.77 132.47 46.2 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.469 0.176 . . . . 0.0 111.11 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.33 -13.81 41.47 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.488 2.125 . . . . 0.0 111.612 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.83 -42.7 17.51 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 121.921 0.867 . . . . 0.0 109.03 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -41.88 138.94 1.37 Allowed 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 113.831 -1.531 . . . . 0.0 111.081 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 67' ' ' THR . 20.3 m-20 -56.47 -18.6 11.93 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.981 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.462 ' CZ ' HG22 ' A' ' 43' ' ' ILE . 23.9 t80 -129.52 118.87 22.76 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-O 120.773 0.32 . . . . 0.0 110.998 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.728 179.851 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.8 mp . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.805 0.336 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.8 m -55.22 -33.92 63.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.995 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.96 -28.55 69.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.927 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.415 HD22 ' CE1' ' A' ' 88' ' ' HIS . 19.1 mt -100.43 151.98 20.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.979 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 91.6 p -95.1 165.61 12.34 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.647 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.633 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -43.09 -52.88 5.21 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.289 0.566 . . . . 0.0 109.641 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -118.94 82.44 1.86 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.546 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.4 t60 -59.92 -46.67 88.63 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.576 -177.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.5 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 26.4 p90 -145.41 160.05 42.15 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.755 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.44 ' HG2' HG13 ' A' ' 65' ' ' VAL . 4.5 tt0 -136.03 140.85 44.17 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.32 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.427 ' O ' ' CG1' ' A' ' 65' ' ' VAL . 71.2 mt -115.13 131.08 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.92 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.413 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.6 OUTLIER -112.59 147.06 37.46 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.141 0.496 . . . . 0.0 111.891 -179.602 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 28.6 tp . . . . . 0 C--O 1.233 0.229 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.438 179.361 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.801 0.334 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.412 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 3.9 mp -132.99 145.73 51.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.606 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.85 126.91 55.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.066 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.413 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 52.0 t30 -119.38 115.74 24.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.964 0.411 . . . . 0.0 112.069 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.663 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 10.1 p30 -76.38 141.04 41.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.739 178.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 8.3 pt -149.28 39.1 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.546 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -98.84 153.01 19.1 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-O 121.102 0.477 . . . . 0.0 111.847 -179.062 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.2 m -68.83 -31.72 70.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.058 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -98.29 -19.93 17.51 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.54 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 118.83 157.31 10.38 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.698 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.523 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.6 m -117.61 137.81 52.37 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 123.142 0.577 . . . . 0.0 109.492 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.847 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -115.61 148.66 39.37 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.16 113.62 18.56 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.478 177.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 52.6 m-20 43.41 43.9 4.59 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.76 -13.64 62.21 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.608 -0.806 . . . . 0.0 113.432 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -103.78 118.52 36.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.976 0.417 . . . . 0.0 110.571 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.847 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 12.0 tptt -72.93 124.2 24.97 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.408 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.8 m -90.01 176.59 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.084 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.9 pt-20 -83.25 124.43 30.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.497 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.663 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 20.4 tttt -50.5 159.78 0.47 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.025 0.441 . . . . 0.0 111.086 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.472 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 3.6 p30 34.65 33.99 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.621 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.52 145.15 40.78 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.95 179.181 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -87.37 132.43 33.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.861 0.362 . . . . 0.0 110.99 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.412 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 43.7 mm-40 -129.17 148.13 51.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.536 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.3 tp -72.71 118.53 15.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.056 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.415 ' CD2' HG12 ' A' ' 147' ' ' ILE . 66.9 tp -52.91 155.85 2.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.411 0.624 . . . . 0.0 111.719 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.447 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.76 153.29 42.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.585 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.41 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 1.2 tp60 -71.79 120.78 17.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.94 0.4 . . . . 0.0 110.417 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.21 24.82 56.11 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.357 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.447 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 21.5 t0 -56.67 174.5 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.87 0.367 . . . . 0.0 110.912 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -145.22 135.49 24.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.093 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 3.9 mt -114.99 128.27 72.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.483 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.468 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.6 m -104.24 140.21 38.16 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.021 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.514 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.1 m -140.31 158.33 25.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.4 35.66 19.54 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.086 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.438 ' HA ' HG12 ' A' ' 140' ' ' ILE . 63.3 t -76.1 140.4 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-O 121.666 0.746 . . . . 0.0 112.474 -179.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.4 -38.87 0.77 Allowed Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.434 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 51.2 t -126.33 132.88 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-N 114.754 -0.723 . . . . 0.0 109.206 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.61 -40.16 52.08 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.39 6.4 48.28 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -178.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.434 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 13.0 t0 -116.69 25.1 10.8 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.468 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 4.9 mt -107.36 139.42 29.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.244 178.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.7 tp -124.15 134.46 53.32 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.342 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.47 ' HB3' HG23 ' A' ' 40' ' ' THR . 37.2 t -113.04 150.46 31.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.59 0.71 . . . . 0.0 112.743 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -135.91 142.33 44.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.646 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.9 t -114.25 135.34 54.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.86 0.362 . . . . 0.0 111.254 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.2 mp -105.59 127.56 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.375 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.58 120.03 40.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.662 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.415 HG12 ' CD2' ' A' ' 124' ' ' LEU . 4.9 mt -84.92 134.08 27.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.48 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.4 106.81 13.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.775 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.42 -32.12 68.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.016 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.31 -45.14 92.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.59 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 17.6 t80 . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.915 179.97 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.911 0.386 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.4 ttm180 -63.73 -35.96 82.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.98 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -56.87 -42.29 79.51 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.885 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.65 -32.36 68.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.691 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.425 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.3 mt -73.14 -35.2 47.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.84 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -39.77 76.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.92 0.39 . . . . 0.0 110.503 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.1 -24.51 65.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.622 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.425 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -57.17 -47.59 80.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.619 -179.83 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.28 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.414 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.8 OUTLIER . . . . . 0 CA--C 1.509 -0.63 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.711 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.9 mm -73.21 134.76 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 CA-C-N 113.621 -1.627 . . . . 0.0 112.479 -177.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.487 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.2 t -89.91 -60.12 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.829 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 6.7 p -150.13 150.87 32.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.147 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.85 138.16 50.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.224 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.7 t -104.65 122.69 57.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.016 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.3 mt -125.78 125.69 68.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.42 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 44.3 t -82.11 120.08 24.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.844 0.354 . . . . 0.0 110.543 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.5 t -86.0 -27.75 24.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.499 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.469 HG23 ' HB3' ' A' ' 142' ' ' SER . 42.4 p -79.82 -2.26 42.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.554 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.97 77.91 0.2 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.86 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -146.73 -44.89 0.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.845 0.355 . . . . 0.0 110.921 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.556 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.5 mt -113.93 141.52 26.35 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.062 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.556 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 58.1 Cg_endo -73.32 140.8 31.04 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.156 1.904 . . . . 0.0 112.199 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.6 mt -55.16 141.44 11.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.737 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.402 ' HB2' ' CE2' ' A' ' 76' ' ' TYR . 0.4 OUTLIER -131.49 163.92 26.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.087 179.503 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.35 119.84 35.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.103 0.478 . . . . 0.0 111.78 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.507 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 1.3 mt -98.53 135.59 39.86 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.711 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.37 159.52 42.93 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -178.573 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.487 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -141.96 141.68 32.93 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.699 -1.591 . . . . 0.0 110.55 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 121.104 0.478 . . . . 0.0 111.445 -179.303 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.9 mmtm . . . . . 0 CA--C 1.528 0.1 0 CA-C-O 120.672 0.272 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.424 ' CE ' ' O ' ' A' ' 49' ' ' SER . 29.2 ttpt -134.77 139.72 45.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.866 0.365 . . . . 0.0 111.07 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.465 HG11 ' HG2' ' A' ' 90' ' ' GLN . 11.1 t -127.24 139.28 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 121.166 0.508 . . . . 0.0 111.703 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.545 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 19.2 m-90 -100.94 138.4 38.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.249 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.407 ' HA ' ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.46 127.11 55.99 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.364 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.532 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 0.7 OUTLIER -108.9 145.64 35.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.592 -178.255 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.753 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 173.01 -175.26 45.98 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.512 -0.852 . . . . 0.0 113.196 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.411 ' NH1' ' HB2' ' A' ' 70' ' ' ARG . 5.0 mtp-105 -82.93 -4.67 58.49 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.633 0.254 . . . . 0.0 111.454 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.444 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.6 p30 -88.3 139.56 30.26 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-O 120.789 0.328 . . . . 0.0 111.229 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 9.1 Cg_exo -69.46 -4.41 13.77 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.842 2.361 . . . . 0.0 111.809 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.64 -45.96 13.87 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-O 121.932 0.872 . . . . 0.0 108.936 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.26 139.45 1.91 Allowed 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 113.746 -1.57 . . . . 0.0 110.424 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -56.29 -19.19 13.15 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.013 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.532 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 39.3 t80 -130.13 121.44 26.31 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.905 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.417 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 . . . . . 0 C--N 1.329 -0.326 0 CA-C-O 120.804 0.335 . . . . 0.0 110.726 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.6 mp . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.821 0.343 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.95 -38.07 67.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.501 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.0 mmp_? -60.71 -19.93 59.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.764 0.316 . . . . 0.0 110.912 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.433 HD21 ' CE1' ' A' ' 88' ' ' HIS . 34.7 mt -101.91 152.33 21.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.792 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 86' ' ' ASN . 96.3 p -97.91 170.68 8.78 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.508 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.753 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.3 m-20 -41.05 -80.64 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.418 ' HB2' HD11 ' A' ' 104' ' ' ILE . 13.8 mttm -92.86 83.17 4.73 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.545 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 17.3 t60 -57.71 -46.14 84.77 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.033 -177.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.517 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 16.3 p90 -145.87 158.71 43.85 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.486 -0.486 . . . . 0.0 112.076 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.1 tt0 -135.72 142.04 44.97 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.254 -178.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.438 ' O ' ' CG1' ' A' ' 65' ' ' VAL . 59.3 mt -117.6 131.68 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.671 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.412 ' HB3' HG13 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -114.2 143.61 44.54 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.041 0.448 . . . . 0.0 111.876 -179.296 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.409 ' HG ' ' CG1' ' A' ' 33' ' ' VAL . 2.3 tm? . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.441 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 mt . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.814 0.34 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.412 ' CB ' ' HG ' ' A' ' 92' ' ' LEU . 4.0 mm? -129.9 142.35 50.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.275 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.5 mp -112.83 128.73 56.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.289 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -119.79 115.56 24.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.053 0.454 . . . . 0.0 111.692 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.68 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 11.1 p30 -78.53 137.04 37.71 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.418 HD11 ' HB2' ' A' ' 87' ' ' LYS . 10.2 pt -145.26 39.19 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -178.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.588 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.35 152.84 19.5 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 121.171 0.51 . . . . 0.0 111.867 -178.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 49.1 m -68.83 -31.58 70.66 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.857 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -98.19 -19.97 17.56 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.588 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.7 158.05 10.87 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.788 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.6 m -117.37 137.75 52.25 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.822 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -115.34 148.46 39.24 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -178.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.21 113.39 18.24 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.538 -1.21 . . . . 0.0 108.246 177.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 43.77 43.55 5.08 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.22 -10.99 68.92 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.481 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.69 118.61 37.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.087 0.47 . . . . 0.0 110.612 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.822 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 12.7 tptt -73.17 121.53 20.41 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.197 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.2 m -91.0 164.08 2.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.189 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 120' ' ' SER . 4.3 tp10 -69.82 125.35 26.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.572 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.68 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 73.9 tttt -51.96 161.35 0.59 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.858 0.361 . . . . 0.0 110.754 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.8 p30 34.78 34.75 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.309 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.27 145.17 40.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.078 179.498 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -89.32 129.04 35.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.04 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 47.0 mm-40 -129.18 147.43 51.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.556 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 tp -72.7 132.76 44.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.298 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 65.9 tp -62.78 156.71 23.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.487 0.661 . . . . 0.0 111.624 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.441 ' O ' HD12 ' A' ' 147' ' ' ILE . 0.4 OUTLIER -124.47 153.31 42.19 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.056 179.707 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.404 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.05 117.88 13.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.024 0.44 . . . . 0.0 110.244 -179.446 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.8 24.42 64.47 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.015 -178.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.409 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 16.9 t70 -53.43 171.92 0.07 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.901 0.381 . . . . 0.0 110.955 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.8 mt-10 -145.15 135.52 24.13 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.098 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 13.7 mt -114.25 126.57 71.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.483 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.458 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 4.3 m -104.42 139.09 39.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.955 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.486 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 35.2 m -140.25 158.32 25.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.74 32.87 17.31 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.84 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.448 ' HA ' HG12 ' A' ' 140' ' ' ILE . 54.6 t -75.75 140.48 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-O 121.629 0.728 . . . . 0.0 112.478 -179.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.01 -38.39 0.69 Allowed Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.7 t -126.32 124.45 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 CA-C-N 114.666 -0.767 . . . . 0.0 109.125 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.47 -32.65 18.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.73 0.3 . . . . 0.0 111.381 -178.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 31.3 t -93.45 6.47 48.06 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -127.93 30.62 5.24 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.458 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.6 mt -107.13 139.52 28.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.784 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.42 134.3 54.61 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.752 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.469 ' HB3' HG23 ' A' ' 40' ' ' THR . 46.6 t -110.82 150.58 28.93 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.59 0.709 . . . . 0.0 112.157 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 3.5 mm? -136.02 149.42 48.8 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.597 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.8 t -117.55 135.76 56.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.712 0.292 . . . . 0.0 110.978 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 3.6 mt -106.57 124.63 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-O 121.044 0.45 . . . . 0.0 111.046 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.93 139.68 42.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.365 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.441 HD12 ' O ' ' A' ' 125' ' ' SER . 3.3 mp -105.65 134.08 48.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.91 0.386 . . . . 0.0 111.552 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -85.93 112.27 21.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.625 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -57.52 -27.85 62.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.122 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -60.77 -46.02 92.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.809 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 29.1 t80 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.063 -179.886 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.82 0.343 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -66.94 -39.92 87.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.015 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -57.55 -40.15 78.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.915 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.15 -33.91 69.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.629 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.3 mt -73.14 -35.24 47.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.783 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -57.23 -35.2 69.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.454 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.1 mttp -67.03 -24.07 65.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.613 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -62.24 -47.85 82.57 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.645 -179.715 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.5 m . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.777 -179.184 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.429 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.3 m-20 . . . . . 0 CA--C 1.508 -0.644 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.654 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.5 mm -74.14 135.63 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 CA-C-N 113.641 -1.618 . . . . 0.0 112.492 -177.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.482 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.4 t -90.81 -58.97 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.436 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.2 p -145.76 158.92 43.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.059 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.36 124.99 41.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.745 0.307 . . . . 0.0 111.528 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.1 t -94.92 122.68 46.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.923 0.392 . . . . 0.0 110.957 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.7 mt -125.07 120.23 57.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.266 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.528 ' SG ' ' HB ' ' A' ' 43' ' ' ILE . 20.0 m -85.74 99.88 11.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.902 0.382 . . . . 0.0 110.532 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 82.3 p -79.09 -19.73 50.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.14 -178.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.552 HG22 ' CB ' ' A' ' 142' ' ' SER . 10.5 p -79.79 -2.7 44.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.729 0.299 . . . . 0.0 111.354 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.58 71.0 0.98 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.014 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -140.37 -39.95 0.43 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.764 0.316 . . . . 0.0 111.225 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.578 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.3 mt -133.88 145.33 55.49 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.668 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.578 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 41.9 Cg_endo -69.74 146.16 59.47 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.324 2.016 . . . . 0.0 112.594 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.8 mt -54.26 157.5 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.62 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.69 164.17 32.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.282 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.58 119.92 27.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.076 0.465 . . . . 0.0 111.902 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.514 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 7.9 mp -95.14 128.6 42.1 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.654 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -138.37 156.78 47.29 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -179.244 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -146.59 141.89 27.41 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.412 -1.722 . . . . 0.0 110.777 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.225 0 CA-C-O 121.153 0.501 . . . . 0.0 111.071 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.081 0 CA-C-O 120.73 0.3 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.7 ttpt -145.9 136.41 24.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.292 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.498 HG12 ' HG2' ' A' ' 90' ' ' GLN . 14.9 t -134.06 139.36 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 121.268 0.556 . . . . 0.0 112.003 -179.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.514 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 18.8 m-90 -103.51 139.29 39.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.226 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.45 126.38 54.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.102 0.477 . . . . 0.0 109.832 177.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.553 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -111.6 145.6 38.89 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.17 -178.859 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.634 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.39 -176.62 40.28 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.245 -0.978 . . . . 0.0 113.547 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.435 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 1.2 ttp180 -73.23 -7.39 51.26 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -84.81 135.51 40.07 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.791 0.329 . . . . 0.0 111.322 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.411 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 9.7 Cg_exo -70.14 -6.43 18.76 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.957 2.438 . . . . 0.0 112.087 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.63 -44.17 16.08 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-O 121.971 0.891 . . . . 0.0 108.63 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -41.91 138.7 1.45 Allowed 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 113.537 -1.665 . . . . 0.0 110.416 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -56.26 -19.31 13.5 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.024 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.553 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 21.1 t80 -130.21 122.55 28.33 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.661 179.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.411 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.2 t-160 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.774 0.321 . . . . 0.0 110.958 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.435 ' N ' ' HD2' ' A' ' 70' ' ' ARG . 2.9 mp . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.81 0.338 . . . . 0.0 110.786 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.4 m -55.22 -36.61 66.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.289 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -61.0 -18.83 59.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.279 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.401 HD21 ' CE1' ' A' ' 88' ' ' HIS . 18.9 mt -102.69 149.34 24.55 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.759 0.314 . . . . 0.0 111.026 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 88.2 p -92.41 167.17 12.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.711 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.634 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.8 m-20 -43.53 -53.25 5.7 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.286 0.565 . . . . 0.0 109.832 179.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.434 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 2.7 ptmt -120.88 82.46 1.92 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.551 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.8 t60 -59.62 -47.12 86.85 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.707 -176.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.506 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 28.2 p90 -146.48 159.8 42.94 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.666 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.498 ' HG2' HG12 ' A' ' 65' ' ' VAL . 7.3 tt0 -135.77 141.2 44.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.145 -179.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.438 ' O ' ' CG1' ' A' ' 65' ' ' VAL . 50.8 mt -114.28 131.03 67.49 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.205 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.126 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.433 ' CA ' HG11 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -112.64 149.04 33.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.009 0.433 . . . . 0.0 111.595 -179.674 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 29.1 tp . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.631 179.638 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.916 0.388 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.41 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 2.6 mp -133.14 146.56 51.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.151 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.43 ' N ' ' CD1' ' A' ' 101' ' ' LEU . 4.9 mp -112.65 129.35 56.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.259 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 90' ' ' GLN . 53.3 t30 -117.91 115.49 25.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.886 0.374 . . . . 0.0 111.829 -179.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.694 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 12.3 p30 -77.2 140.49 40.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.781 178.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.434 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 19.0 pt -149.5 38.74 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.579 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.1 152.6 19.67 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.095 0.474 . . . . 0.0 111.906 -178.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 47.9 m -68.93 -31.45 70.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.731 177.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -98.17 -19.81 17.67 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.579 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.84 157.18 10.55 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.359 -0.924 . . . . 0.0 113.895 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.1 m -117.42 137.88 52.2 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.783 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -116.67 148.37 41.08 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -177.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.33 113.56 18.38 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.043 177.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 47.43 35.77 4.41 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.141 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.81 -7.41 76.99 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.564 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.8 118.58 37.04 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.059 0.457 . . . . 0.0 110.736 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.783 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -71.52 128.06 34.59 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.219 -179.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.8 m -101.34 167.68 2.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.464 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 120' ' ' SER . 4.6 mm-40 -69.91 125.81 27.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.539 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.694 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 68.8 tttt -54.2 162.71 0.97 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.892 0.377 . . . . 0.0 110.618 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.5 m-80 35.21 34.02 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.241 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.29 145.14 40.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.027 179.481 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -85.87 132.13 34.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.021 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.41 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 32.5 mm-40 -129.46 146.27 51.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.768 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.98 122.92 22.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.312 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.419 ' CD2' HG12 ' A' ' 147' ' ' ILE . 59.6 tp -59.61 155.59 15.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.511 0.672 . . . . 0.0 111.554 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.435 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.8 153.2 42.86 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.33 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -71.74 120.49 17.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.986 0.422 . . . . 0.0 110.263 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.81 18.4 64.09 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.403 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.435 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 13.2 t70 -54.18 170.16 0.15 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.016 0.436 . . . . 0.0 111.257 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 5.0 tt0 -145.23 135.49 24.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.102 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 14.6 mt -111.27 128.22 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.346 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.464 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.7 m -104.22 139.32 39.42 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.186 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.475 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 34.6 m -140.18 158.25 25.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.086 0.47 . . . . 0.0 112.217 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.67 37.91 12.96 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.908 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.456 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.1 t -79.14 140.33 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-O 121.67 0.748 . . . . 0.0 112.33 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.89 -36.97 0.89 Allowed Glycine 0 N--CA 1.436 -1.341 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.02 -179.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.405 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 48.5 t -126.37 123.74 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-N 114.621 -0.79 . . . . 0.0 109.084 178.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.57 -33.21 21.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.691 0.282 . . . . 0.0 111.617 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.0 m -93.46 6.58 47.69 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.405 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 3.2 t0 -127.34 30.1 5.44 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.464 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.9 mt -106.61 139.68 27.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.797 178.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.76 134.55 54.9 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.827 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.552 ' CB ' HG22 ' A' ' 40' ' ' THR . 0.3 OUTLIER -116.13 127.06 54.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.218 0.532 . . . . 0.0 111.558 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.41 ' O ' ' CG ' ' A' ' 129' ' ' GLU . 2.3 mp -121.26 138.08 54.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.625 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 21.7 t -110.55 139.31 34.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.866 0.365 . . . . 0.0 111.18 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.472 HD13 HG21 ' A' ' 145' ' ' ILE . 49.0 mt -106.03 138.12 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.197 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.84 116.48 25.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.473 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.419 HG12 ' CD2' ' A' ' 124' ' ' LEU . 4.9 mt -84.88 134.04 27.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.499 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.18 105.85 15.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.595 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -58.19 -32.96 68.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.091 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -60.38 -46.02 91.44 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.031 0.444 . . . . 0.0 110.775 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 30.3 t80 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.038 -179.831 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.82 0.343 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.9 mmt85 -68.97 -37.2 78.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -58.24 -40.38 81.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.775 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.3 tp -59.37 -31.93 69.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.801 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.439 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -73.02 -35.37 48.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -57.55 -39.59 76.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.37 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.16 -23.86 65.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.672 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.439 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.64 -47.56 79.47 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.199 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.1 p . . . . . 0 C--N 1.326 -0.453 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.833 179.891 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.51 -0.594 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.653 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.6 mm -74.83 135.06 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 CA-C-N 113.694 -1.594 . . . . 0.0 112.532 -177.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.482 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.9 t -92.72 -60.84 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.836 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.7 p -140.73 164.88 29.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.214 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.45 122.09 22.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.809 0.337 . . . . 0.0 111.322 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.6 t -93.72 122.78 45.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.815 0.34 . . . . 0.0 111.04 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.0 mt -125.7 117.49 49.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.564 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.404 ' HA ' HD21 ' A' ' 143' ' ' LEU . 3.8 t -81.33 111.23 17.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.834 0.349 . . . . 0.0 110.34 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.1 t -86.89 -22.02 25.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.934 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.614 HG22 ' HB2' ' A' ' 142' ' ' SER . 81.6 p -79.84 -2.77 44.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.731 0.3 . . . . 0.0 111.429 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.24 75.77 0.4 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.882 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -146.9 -40.36 0.2 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.844 0.354 . . . . 0.0 111.02 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.577 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.3 mt -125.9 142.01 41.07 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.033 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.577 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 46.0 Cg_endo -70.48 146.05 54.65 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.172 1.915 . . . . 0.0 112.226 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.7 mt -58.91 149.5 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.824 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.32 163.88 31.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.054 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.06 119.85 28.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.058 0.456 . . . . 0.0 112.011 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.503 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 7.3 mp -89.57 130.89 35.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.246 178.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.653 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -140.8 156.15 46.22 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 122.412 1.101 . . . . 0.0 113.827 -179.578 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.64 141.83 28.49 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 113.352 -1.749 . . . . 0.0 110.64 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 121.159 0.505 . . . . 0.0 111.051 -179.586 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.851 0.358 . . . . 0.0 110.768 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.415 ' CE ' ' O ' ' A' ' 49' ' ' SER . 21.0 ttpt -136.3 137.57 40.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.471 HG13 ' HG2' ' A' ' 90' ' ' GLN . 5.4 t -124.69 138.81 52.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.085 0.469 . . . . 0.0 111.852 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.512 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 17.0 m-90 -103.4 138.64 39.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.959 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.17 127.01 55.82 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 177.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.521 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 0.4 OUTLIER -112.95 145.73 40.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.593 -178.456 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.688 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.45 -174.4 40.49 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.691 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.5 mtm180 -80.24 -2.82 46.68 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.44 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.0 t30 -84.87 135.99 39.35 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.791 0.329 . . . . 0.0 111.067 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.8 Cg_exo -68.86 -6.88 19.15 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.773 2.315 . . . . 0.0 111.834 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.76 -44.63 15.36 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-O 122.0 0.905 . . . . 0.0 108.56 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.07 136.68 4.72 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.694 -1.594 . . . . 0.0 110.16 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.419 ' OD2' ' CD1' ' A' ' 66' ' ' TRP . 0.7 OUTLIER -56.51 -18.92 13.13 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.89 179.431 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.521 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 53.7 t80 -130.19 130.69 45.01 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.772 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 CA-C-O 120.834 0.35 . . . . 0.0 110.944 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.8 mp . . . . . 0 CA--C 1.526 0.049 0 CA-C-O 120.806 0.336 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.4 t -58.52 -40.43 82.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.995 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -30.06 70.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.09 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.422 HD23 ' CE1' ' A' ' 88' ' ' HIS . 30.3 mt -94.65 152.12 18.74 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.844 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 89.5 p -95.44 165.24 12.46 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.689 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.688 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.5 m-20 -42.06 -52.8 4.14 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.276 0.56 . . . . 0.0 109.816 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.427 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 5.0 ptmt -120.92 84.29 2.21 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.567 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.6 t60 -61.56 -46.24 90.74 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.971 -1.013 . . . . 0.0 113.055 -176.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.5 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 24.6 p90 -144.72 157.94 43.98 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.136 -0.625 . . . . 0.0 112.105 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.471 ' HG2' HG13 ' A' ' 65' ' ' VAL . 5.9 tt0 -135.91 140.35 44.0 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.018 -179.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.464 HG21 HD13 ' A' ' 91' ' ' ILE . 38.5 mt -113.47 132.3 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 121.134 -0.227 . . . . 0.0 110.855 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.407 ' CA ' HG12 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -113.81 146.87 39.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.184 0.516 . . . . 0.0 112.022 -179.202 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 44.4 tp . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.439 179.456 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.655 0.264 . . . . 0.0 110.696 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.22 147.57 51.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.818 0.342 . . . . 0.0 110.768 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.87 125.26 53.84 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 90' ' ' GLN . 53.5 t30 -109.27 115.69 30.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.694 -179.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.701 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 18.3 p30 -76.89 131.76 38.75 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.649 178.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.427 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 21.6 pt -139.34 40.54 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -178.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.598 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.54 151.93 20.6 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 120.987 0.422 . . . . 0.0 111.64 -178.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.8 m -68.57 -31.87 71.38 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.776 178.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -98.41 -19.63 17.6 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.614 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.598 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.94 157.81 10.97 Favored Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.73 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.0 m -117.36 137.82 52.21 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.836 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -114.08 148.55 36.92 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -178.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.05 113.4 18.35 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.645 -1.161 . . . . 0.0 108.27 177.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 44.51 43.08 6.1 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.385 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.47 -8.82 75.82 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.829 -0.7 . . . . 0.0 113.43 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -105.17 118.38 36.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.104 0.452 . . . . 0.0 110.764 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.836 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 12.8 tptt -74.0 122.37 22.51 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.247 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.9 m -94.05 165.56 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.204 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 120' ' ' SER . 9.7 tp10 -69.87 125.95 28.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.598 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.701 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 14.6 tttt -54.13 162.83 0.91 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.955 0.407 . . . . 0.0 110.653 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.7 OUTLIER 37.15 31.27 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.109 -179.171 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.82 144.02 43.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.164 179.203 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -93.42 129.93 39.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.786 0.326 . . . . 0.0 110.287 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -129.0 149.34 50.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.974 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -72.69 111.64 8.03 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.88 168.17 1.9 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.318 0.58 . . . . 0.0 111.798 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -124.29 153.65 41.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.033 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.05 116.97 11.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.108 0.48 . . . . 0.0 110.257 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.62 18.36 73.78 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.364 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -59.84 -179.48 0.1 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.67 0.271 . . . . 0.0 110.62 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 4.1 mt-10 -145.32 135.69 24.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.682 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 14.9 mt -109.68 126.26 66.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.023 178.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.49 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.9 m -104.49 138.68 40.51 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.209 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.506 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.1 m -140.33 158.2 25.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.26 28.28 28.26 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.15 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.458 ' HA ' HG12 ' A' ' 140' ' ' ILE . 69.7 t -70.04 140.3 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-O 121.58 0.705 . . . . 0.0 112.326 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.69 -38.47 0.76 Allowed Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.425 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 49.8 t -126.33 132.94 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 CA-C-N 114.808 -0.696 . . . . 0.0 109.335 178.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -50.54 -39.81 50.17 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.7 m -93.3 6.49 47.89 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.425 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 15.3 t0 -118.74 26.82 9.29 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -179.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.49 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 6.5 mt -107.14 139.61 28.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.05 178.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.3 tt -119.3 134.51 55.17 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.582 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.614 ' HB2' HG22 ' A' ' 40' ' ' THR . 0.9 OUTLIER -111.39 135.63 51.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.066 0.46 . . . . 0.0 111.633 -179.673 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 51.0 mt -126.71 152.71 46.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.157 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 21.8 t -115.61 139.78 40.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.025 0.441 . . . . 0.0 111.606 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.463 HG22 HD13 ' A' ' 145' ' ' ILE . 18.3 mt -106.5 120.95 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.822 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.33 103.9 12.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.424 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 7.0 mt -84.86 134.05 27.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.991 0.424 . . . . 0.0 111.58 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -88.53 112.2 22.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.86 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.46 -25.9 68.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.083 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.91 -45.22 90.87 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.053 0.454 . . . . 0.0 110.664 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.0 t80 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.004 179.99 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.889 0.376 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.47 -36.33 82.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.801 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -39.45 79.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.809 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.78 -31.81 70.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.796 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.41 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.5 mt -72.62 -35.4 50.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.855 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -57.42 -42.69 82.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.941 0.401 . . . . 0.0 110.386 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.09 -23.93 65.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.657 179.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.41 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.55 -47.52 79.27 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.298 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.809 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.509 -0.622 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.649 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.4 mm -76.85 135.85 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 CA-C-N 113.708 -1.587 . . . . 0.0 112.571 -177.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.488 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.4 t -90.37 -58.99 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.683 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 30.1 p -150.7 161.27 42.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.014 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.76 138.3 54.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.805 0.336 . . . . 0.0 111.621 -179.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.4 m -106.85 122.52 60.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.825 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.9 mt -128.62 127.01 66.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.456 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 21.3 t -83.0 100.45 10.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.88 0.371 . . . . 0.0 110.459 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.7 t -69.46 -28.2 65.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.713 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.564 HG22 ' HB2' ' A' ' 142' ' ' SER . 59.5 p -80.08 -2.69 45.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.722 0.296 . . . . 0.0 111.578 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.18 79.84 0.17 Allowed Glycine 0 CA--C 1.517 0.193 0 C-N-CA 120.919 -0.658 . . . . 0.0 113.139 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -147.35 -39.88 0.19 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.78 0.324 . . . . 0.0 111.019 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.593 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.4 mt -123.84 142.58 39.78 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.988 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.593 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 37.8 Cg_endo -68.84 146.08 64.68 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.028 1.819 . . . . 0.0 112.247 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.4 mt -57.59 148.1 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.816 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.89 164.04 31.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.056 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -124.57 119.78 30.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.928 0.394 . . . . 0.0 111.973 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.513 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 7.6 mp -90.8 125.98 35.88 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.649 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -135.63 156.82 48.25 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -179.092 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.488 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -148.98 141.79 24.62 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.552 -1.658 . . . . 0.0 110.817 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 121.286 0.565 . . . . 0.0 111.239 -179.553 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.876 0.369 . . . . 0.0 110.842 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.414 ' CE ' ' O ' ' A' ' 49' ' ' SER . 6.7 ttpt -151.43 129.98 12.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.099 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 10.9 t -124.04 138.52 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 121.408 0.623 . . . . 0.0 112.021 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.543 ' O ' ' HA ' ' A' ' 90' ' ' GLN . 18.1 m-90 -100.97 139.86 36.06 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.824 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.504 ' HA ' ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.86 127.68 56.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.0 0.428 . . . . 0.0 109.862 177.936 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.52 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.4 OUTLIER -114.11 145.64 41.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.281 -178.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.648 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.68 -174.07 39.0 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.674 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.3 mtp180 -79.66 0.24 31.12 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.668 0.248 . . . . 0.0 111.668 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.447 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 10.2 t-20 -84.7 133.91 43.02 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.68 0.276 . . . . 0.0 111.056 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 13.5 Cg_exo -68.5 -8.61 23.61 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.618 2.212 . . . . 0.0 111.894 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.04 -43.14 16.67 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-O 121.963 0.887 . . . . 0.0 108.855 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.8 137.01 2.42 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 113.65 -1.613 . . . . 0.0 110.918 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -56.43 -18.73 12.17 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.016 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.511 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 63.7 t80 -129.79 123.03 29.97 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.896 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.327 -0.373 0 CA-C-O 120.876 0.369 . . . . 0.0 110.977 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 26.6 mm . . . . . 0 N--CA 1.458 -0.054 0 CA-C-O 120.861 0.362 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.6 t -54.94 -30.85 59.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.959 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.72 -26.62 65.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.781 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 33.7 mt -97.73 152.22 19.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.93 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.2 166.21 11.85 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.686 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.648 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -42.72 -52.83 4.8 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.471 0.653 . . . . 0.0 109.638 179.172 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -119.51 84.85 2.27 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 177.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.545 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.2 t60 -61.87 -45.83 92.07 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.877 -177.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.52 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 18.9 p90 -145.81 163.24 35.64 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.127 -0.629 . . . . 0.0 112.427 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.543 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -135.59 136.72 41.3 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.397 -178.878 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.509 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 35.3 mt -113.38 128.49 70.18 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.342 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.353 178.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.404 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.7 OUTLIER -114.36 148.35 37.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.086 0.469 . . . . 0.0 111.859 -179.415 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 16.8 tp . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.368 179.549 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.406 ' HB3' HD21 ' A' ' 124' ' ' LEU . 24.0 tp . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.813 0.339 . . . . 0.0 110.796 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.404 ' N ' ' HG ' ' A' ' 99' ' ' LEU . 4.1 mm? -124.91 145.56 49.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.326 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 mt -112.62 124.5 52.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.041 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 90' ' ' GLN . 50.6 t30 -116.99 115.7 25.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.892 0.377 . . . . 0.0 111.781 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.676 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 8.1 p30 -77.71 141.23 39.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.955 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 11.0 pt -148.46 38.33 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.545 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -98.34 152.35 19.55 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.051 0.453 . . . . 0.0 111.753 -179.093 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 47.6 m -68.92 -31.57 70.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.027 178.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -98.24 -19.75 17.66 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.524 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.18 155.65 9.86 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 120.178 -1.01 . . . . 0.0 113.747 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.8 m -117.65 137.82 52.39 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.836 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -116.01 148.46 40.12 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -178.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.01 113.52 18.53 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.356 177.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 43.93 43.81 5.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.36 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.55 -10.94 67.64 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.448 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.48 118.63 37.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.028 0.442 . . . . 0.0 110.638 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.836 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 12.2 tptp -73.01 122.28 21.48 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.239 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.2 m -93.18 164.61 2.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.249 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.5 tp10 -69.88 126.34 29.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.557 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.676 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 87.9 tttt -53.51 161.17 1.07 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.994 0.426 . . . . 0.0 110.727 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.8 p30 34.85 34.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.437 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.46 145.1 40.78 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.133 179.384 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -86.71 130.48 34.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.66 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -129.32 146.49 51.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.756 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.1 tp -72.78 124.84 26.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.073 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.407 HD22 HG13 ' A' ' 147' ' ' ILE . 65.4 tp -57.21 157.34 6.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.427 0.632 . . . . 0.0 111.684 -179.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.445 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.4 153.69 41.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.333 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 10.0 tp60 -70.96 119.05 14.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.004 0.431 . . . . 0.0 110.318 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.83 24.43 62.5 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.223 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.445 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 23.3 t0 -56.47 169.72 0.43 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.085 0.469 . . . . 0.0 111.107 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 17.2 tt0 -145.35 135.53 23.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.046 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.411 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 13.4 mt -109.15 128.05 65.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.477 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.5 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.0 m -104.5 139.61 39.16 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.96 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.502 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.6 m -140.36 158.52 25.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.95 33.54 23.7 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.734 -0.667 . . . . 0.0 112.234 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 140' ' ' ILE . 76.4 t -72.95 140.29 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-O 121.587 0.708 . . . . 0.0 112.386 -179.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.77 -42.17 0.8 Allowed Glycine 0 N--CA 1.436 -1.334 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -178.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.0 t -126.34 130.55 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-N 114.763 -0.719 . . . . 0.0 109.153 177.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -50.45 -34.0 23.15 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -178.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 69.0 m -93.35 6.24 48.79 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.08 22.41 11.45 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -178.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.5 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.3 mt -107.12 139.42 28.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.293 178.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.2 tt -122.22 134.41 54.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.273 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.564 ' HB2' HG22 ' A' ' 40' ' ' THR . 0.7 OUTLIER -109.1 140.66 42.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.053 0.454 . . . . 0.0 111.954 -179.134 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 2.7 mm? -134.57 136.03 42.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.333 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.1 t -110.68 140.22 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.873 0.368 . . . . 0.0 111.395 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 8.4 mt -106.16 134.75 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.918 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.53 116.3 27.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.69 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.407 HG13 HD22 ' A' ' 124' ' ' LEU . 4.6 mp -85.6 134.04 28.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.657 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -85.01 114.71 22.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.765 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -61.34 -31.89 71.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.951 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -59.64 -45.74 91.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.954 0.407 . . . . 0.0 110.686 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.6 t80 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.021 -179.91 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.82 0.343 . . . . 0.0 110.963 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -66.04 -36.03 82.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.647 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -59.93 -43.22 95.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.815 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 tp -58.44 -32.98 69.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.716 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.408 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.4 mt -73.1 -35.32 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.922 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -57.07 -38.76 73.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.964 0.411 . . . . 0.0 110.487 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -67.08 -26.8 66.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.404 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.98 -47.57 80.46 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.254 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.993 179.986 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' A' ' 49' ' ' SER . 2.3 m-80 . . . . . 0 CA--C 1.506 -0.748 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.564 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.3 mm -71.55 142.15 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.575 0 CA-C-N 113.744 -1.571 . . . . 0.0 112.634 -176.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.402 ' CG2' ' CB ' ' A' ' 50' ' ' ALA . 1.0 OUTLIER -106.54 -50.23 8.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.663 -178.885 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 0.5 OUTLIER -154.86 165.5 36.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.351 179.29 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.57 120.83 24.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.757 0.313 . . . . 0.0 111.012 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.416 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 25.0 t -94.7 122.67 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.854 0.359 . . . . 0.0 111.126 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.4 mt -124.49 122.49 64.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.252 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 46.9 t -79.87 127.33 32.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.445 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.9 t -94.31 -29.12 15.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.814 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.478 HG21 ' HB3' ' A' ' 142' ' ' SER . 43.2 p -79.87 -2.34 43.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.576 0.226 . . . . 0.0 111.462 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.22 80.86 0.21 Allowed Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.819 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -147.01 -43.78 0.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.804 0.335 . . . . 0.0 110.888 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.563 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.8 mp -120.42 142.08 33.23 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.209 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.563 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.5 Cg_endo -72.55 145.98 43.16 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.221 1.947 . . . . 0.0 112.007 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.2 mt -53.48 134.74 15.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.772 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.17 163.85 24.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.091 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -120.25 119.7 33.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.126 0.489 . . . . 0.0 112.002 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.57 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 5.0 mp -87.22 132.07 34.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.593 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -138.97 156.59 47.12 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 122.426 1.108 . . . . 0.0 113.572 -179.297 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.402 ' CB ' ' CG2' ' A' ' 33' ' ' VAL . . . -142.99 144.66 32.4 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.831 178.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 121.066 0.46 . . . . 0.0 111.296 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.735 0.302 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -143.39 130.41 20.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.34 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 13.0 t -126.32 139.34 51.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.292 0.567 . . . . 0.0 111.895 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.593 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 16.8 m-90 -100.76 139.85 35.87 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.165 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.453 HG22 HD13 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -108.3 126.26 52.63 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.573 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.558 ' CE2' ' CG ' ' A' ' 76' ' ' TYR . 3.0 m-85 -114.47 145.75 41.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.8 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.614 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.39 -174.35 36.28 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.188 -1.006 . . . . 0.0 113.362 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.41 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 6.7 mtm105 -75.61 0.49 17.31 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.419 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 9.5 t-20 -84.66 133.35 44.2 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.667 0.27 . . . . 0.0 111.414 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.451 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 12.8 Cg_exo -68.6 -10.46 29.11 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.655 2.236 . . . . 0.0 111.754 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.21 -43.45 16.11 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-O 121.915 0.864 . . . . 0.0 108.781 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -41.37 137.75 1.4 Allowed 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.959 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.32 -18.3 10.33 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.241 179.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.558 ' CG ' ' CE2' ' A' ' 68' ' ' PHE . 19.8 t80 -127.21 116.25 20.32 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.811 0.338 . . . . 0.0 110.64 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.451 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 2.0 t-160 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.159 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 24.8 mt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.877 0.37 . . . . 0.0 111.446 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 40.1 t -62.53 -38.75 91.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.768 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.49 -33.25 74.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.949 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.447 ' CD2' ' CE1' ' A' ' 88' ' ' HIS . 30.0 mt -91.21 152.24 20.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.015 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 92.3 p -97.14 165.53 12.01 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.53 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.614 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -42.81 -53.99 4.34 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.314 0.578 . . . . 0.0 109.745 179.326 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.467 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -118.22 83.81 2.07 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 177.144 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.559 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.0 t60 -61.19 -45.41 94.7 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.802 -1.09 . . . . 0.0 113.162 -176.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.531 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 29.5 p90 -145.98 163.23 35.83 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 119.966 -0.694 . . . . 0.0 112.552 -179.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.531 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 8.2 mt-30 -135.35 145.09 47.05 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.382 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 3.2 mp -118.62 132.36 68.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 178.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.422 ' HG ' ' CB ' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -118.01 148.93 41.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.227 0.537 . . . . 0.0 111.988 -179.018 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.417 HD11 ' CE2' ' A' ' 151' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.037 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.717 0.294 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.426 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 2.3 mp -132.69 142.89 49.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.999 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.76 129.47 56.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.341 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.413 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 50.1 t30 -117.8 115.7 25.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.862 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.677 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 12.0 p30 -78.65 141.41 38.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.999 178.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.467 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 14.9 pt -148.33 38.58 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -178.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.559 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -99.09 152.99 19.24 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.14 0.495 . . . . 0.0 111.676 -179.162 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 51.1 m -68.87 -31.84 71.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.961 178.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -98.46 -19.92 17.4 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.556 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.59 157.22 10.23 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.267 -0.968 . . . . 0.0 113.797 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.531 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.7 m -117.53 138.05 52.16 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.85 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -115.04 148.49 38.81 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -178.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.13 113.43 18.33 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.337 177.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 44.38 43.22 5.97 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.81 -9.96 72.09 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.408 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -105.27 118.57 36.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.007 0.432 . . . . 0.0 110.746 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.85 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 19.1 tptt -73.63 130.25 39.65 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.184 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.0 m -103.09 165.95 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.363 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.421 ' O ' ' HB3' ' A' ' 120' ' ' SER . 5.3 tp10 -69.95 127.0 31.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.564 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.677 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 30.3 tttp -52.62 161.96 0.64 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.739 0.305 . . . . 0.0 110.455 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.9 p30 35.08 35.68 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.132 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.421 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.2 p -112.01 145.15 40.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.644 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -93.33 129.53 39.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.757 0.313 . . . . 0.0 110.925 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.426 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 59.7 mm-40 -129.21 151.85 49.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.536 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.9 tp -72.6 112.23 8.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.85 0.357 . . . . 0.0 110.288 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.439 ' CD2' HG12 ' A' ' 147' ' ' ILE . 66.3 tp -53.05 158.91 1.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.266 0.555 . . . . 0.0 111.575 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.41 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -124.11 153.29 41.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.555 -179.779 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.32 122.55 20.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.87 0.367 . . . . 0.0 110.327 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.38 21.23 56.79 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.186 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.41 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 11.1 t70 -56.56 175.8 0.11 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.815 0.34 . . . . 0.0 110.9 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 4.6 mt-10 -145.27 135.75 24.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.242 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.3 mt -112.23 128.26 68.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.523 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.461 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.1 m -104.23 140.16 38.24 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.056 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.476 ' CG1' ' CD2' ' A' ' 88' ' ' HIS . 33.3 m -140.22 158.4 25.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.095 0.474 . . . . 0.0 112.233 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.95 44.56 8.98 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.86 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.432 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.3 t -84.33 140.5 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-O 121.684 0.754 . . . . 0.0 112.631 -178.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.64 -41.14 0.59 Allowed Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.2 t -126.45 125.43 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-N 114.674 -0.763 . . . . 0.0 109.07 177.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.46 -30.25 12.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.805 0.336 . . . . 0.0 111.279 -178.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.62 6.48 48.12 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -126.94 27.74 5.92 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.461 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 4.6 mt -107.18 139.44 28.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.283 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.7 tt -120.72 134.53 55.28 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.383 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.478 ' HB3' HG21 ' A' ' 40' ' ' THR . 44.0 t -113.58 150.68 32.69 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.694 0.759 . . . . 0.0 112.57 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 2.7 mm? -135.78 151.37 50.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.454 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.5 t -116.35 135.62 55.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.902 0.382 . . . . 0.0 111.265 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 40.9 mt -106.45 121.99 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.988 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.52 116.93 31.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.707 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.439 HG12 ' CD2' ' A' ' 124' ' ' LEU . 5.0 mt -84.82 134.2 27.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.581 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -82.05 115.44 21.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.776 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.89 -28.81 68.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.14 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -59.63 -45.77 90.97 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.989 0.423 . . . . 0.0 110.749 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.417 ' CE2' HD11 ' A' ' 93' ' ' LEU . 35.8 t80 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.892 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.783 0.325 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -60.67 -42.62 97.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.889 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -60.18 -39.11 85.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.909 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 mt -60.27 -44.79 95.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.875 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.3 mm -63.3 -40.15 87.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.168 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -57.91 -33.82 69.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.12 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -65.38 -33.79 76.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.257 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -56.9 -47.46 80.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.062 0.458 . . . . 0.0 111.058 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.5 p . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.787 179.97 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.42 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER . . . . . 0 CA--C 1.509 -0.632 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.653 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 2.7 mm -75.36 134.87 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 CA-C-N 113.897 -1.501 . . . . 0.0 112.363 -177.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.502 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.9 t -93.73 -61.19 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.232 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -143.97 154.07 42.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.724 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.17 138.1 51.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.832 0.349 . . . . 0.0 111.135 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.418 HG12 ' CZ ' ' A' ' 76' ' ' TYR . 18.8 t -105.29 122.67 58.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.054 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.3 mt -128.84 118.23 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.5 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 38.2 t -80.34 123.37 27.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.313 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.59 -25.55 19.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.677 -179.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.465 HG23 ' HB3' ' A' ' 142' ' ' SER . 43.1 p -79.81 -2.29 42.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.64 0.257 . . . . 0.0 111.541 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.12 75.19 0.41 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.851 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -146.21 -44.24 0.2 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.866 0.365 . . . . 0.0 110.963 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.522 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -114.95 140.88 26.1 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.784 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.522 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.2 Cg_endo -73.28 145.93 39.47 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.183 1.922 . . . . 0.0 112.33 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.2 mt -57.68 141.46 14.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.547 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -137.18 164.02 29.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.313 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.88 119.83 32.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.977 0.418 . . . . 0.0 111.614 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.536 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 6.0 mt -91.35 137.17 32.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.298 178.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.653 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -144.17 157.42 44.31 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 -179.123 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.502 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -151.04 148.49 28.4 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.874 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 121.192 0.52 . . . . 0.0 110.976 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.682 0.277 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.434 ' HE2' ' O ' ' A' ' 49' ' ' SER . 3.7 ttpt -140.85 132.86 27.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.384 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 9.6 t -129.34 139.28 52.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.245 0.545 . . . . 0.0 111.808 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.543 ' O ' ' HA ' ' A' ' 90' ' ' GLN . 16.0 m-90 -100.83 139.73 36.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.7 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.485 ' HA ' ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.83 126.85 55.29 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.574 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 1.6 m-85 -110.55 145.71 37.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.422 -178.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.686 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.34 -177.74 39.9 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.955 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -77.33 -2.51 35.32 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -84.85 134.78 40.99 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.656 0.265 . . . . 0.0 111.197 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -68.71 -6.81 18.8 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.76 2.307 . . . . 0.0 111.838 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.83 -43.73 16.3 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-O 121.958 0.885 . . . . 0.0 108.77 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.94 137.67 3.13 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 113.629 -1.623 . . . . 0.0 110.648 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -56.41 -19.21 13.84 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.984 179.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.574 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 29.9 t80 -129.98 116.57 18.78 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.016 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 120.838 0.351 . . . . 0.0 110.359 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.4 ' HB ' ' CD1' ' A' ' 84' ' ' LEU . 3.7 mp . . . . . 0 N--CA 1.458 -0.058 0 CA-C-O 120.82 0.343 . . . . 0.0 110.838 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 27.3 t -55.06 -31.39 61.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.323 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -60.9 -33.91 73.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.9 0.381 . . . . 0.0 111.131 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.4 ' CD1' ' HB ' ' A' ' 81' ' ' ILE . 5.8 mp -95.31 153.24 17.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.062 0.458 . . . . 0.0 110.919 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.2 p -94.13 166.3 12.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.739 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.686 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -42.72 -52.33 4.98 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.449 0.642 . . . . 0.0 109.591 179.145 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.8 mttp -120.5 84.69 2.26 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 177.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.558 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.0 t60 -61.14 -46.06 92.09 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.823 -176.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.543 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 12.3 p90 -145.18 162.37 37.26 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.059 -0.656 . . . . 0.0 112.351 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.543 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -135.67 136.22 40.74 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.584 -178.709 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.461 ' CD1' ' CE1' ' A' ' 68' ' ' PHE . 8.0 mt -113.88 129.47 69.72 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.16 178.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.64 148.84 33.77 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.024 0.44 . . . . 0.0 111.905 -179.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.402 ' HG ' ' CG1' ' A' ' 33' ' ' VAL . 2.3 tm? . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.524 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.233 0.198 0 CA-C-O 120.746 0.308 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.0 mt -130.12 142.17 50.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.484 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.1 tp -112.56 120.92 43.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.153 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.413 ' N ' ' O ' ' A' ' 90' ' ' GLN . 55.1 t30 -115.25 115.7 27.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.007 0.432 . . . . 0.0 111.645 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.688 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 14.3 p30 -77.36 139.29 39.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.081 178.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 10.5 pt -146.82 38.79 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.583 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.7 151.73 20.42 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.085 0.469 . . . . 0.0 111.908 -178.711 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 48.1 m -68.79 -31.62 70.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.85 177.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -98.2 -19.78 17.66 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.583 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.97 156.69 10.38 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 120.203 -0.999 . . . . 0.0 113.715 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.532 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.0 m -117.62 137.88 52.33 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.791 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -116.3 148.36 40.61 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -178.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.33 113.72 18.59 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.636 -1.166 . . . . 0.0 108.804 177.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 46.61 36.37 3.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.045 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.05 -3.31 80.45 Favored Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 120.854 -0.689 . . . . 0.0 113.557 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -106.56 118.57 37.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.097 0.475 . . . . 0.0 110.767 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.791 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.5 tptp -73.47 119.72 18.08 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.111 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.7 m -95.72 165.59 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.454 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.7 tt0 -69.92 126.37 29.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.637 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.688 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 67.9 tttt -52.9 162.5 0.61 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.811 0.338 . . . . 0.0 110.335 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.0 p30 35.41 34.66 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.241 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.5 OUTLIER -112.32 137.58 50.26 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.057 179.435 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -82.72 129.16 34.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.954 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -129.51 148.13 51.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.92 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.5 tp -72.87 119.01 16.52 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.009 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -58.05 164.86 2.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.816 0.817 . . . . 0.0 111.957 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.423 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -125.57 153.16 44.1 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.318 179.253 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.52 118.05 13.85 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 62.75 25.71 67.82 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.789 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.423 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 9.2 t70 -57.92 175.36 0.2 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.027 0.441 . . . . 0.0 111.154 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 1.0 OUTLIER -145.11 135.54 24.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.887 179.837 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.7 mt -114.38 128.48 71.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.505 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.463 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.1 m -103.95 139.26 39.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.993 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.484 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.3 m -140.27 158.38 25.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 82.95 35.85 17.28 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.993 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.445 ' HA ' HG12 ' A' ' 140' ' ' ILE . 56.8 t -76.41 140.49 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-O 121.733 0.778 . . . . 0.0 112.477 -178.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.69 -41.38 0.62 Allowed Glycine 0 N--CA 1.437 -1.262 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.074 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.427 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 46.5 t -126.33 132.19 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 114.787 -0.707 . . . . 0.0 109.204 178.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -50.53 -36.38 33.98 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 70.0 m -93.61 6.31 48.7 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.427 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 1.1 m-20 -120.2 25.66 9.73 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.463 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.2 mt -106.92 139.41 28.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.224 178.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.3 tt -123.46 134.51 53.92 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.26 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.465 ' HB3' HG23 ' A' ' 40' ' ' THR . 47.0 t -112.51 150.42 31.3 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.645 0.736 . . . . 0.0 112.585 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 2.4 mm? -135.67 148.46 48.93 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.432 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 23.8 t -117.19 131.14 70.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 0.0 111.174 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.1 mm -106.33 122.07 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.679 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.15 120.03 39.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.092 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 7.3 mt -84.79 129.27 37.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.837 0.351 . . . . 0.0 111.236 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -75.88 116.19 16.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.973 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -62.86 -30.0 71.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.009 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -57.88 -43.49 86.05 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.076 0.465 . . . . 0.0 110.571 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 30.2 t80 . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.764 179.791 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.855 0.359 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -36.32 79.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.771 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.38 -40.99 88.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.788 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.73 -32.18 72.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.763 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.411 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.0 mt -73.13 -35.41 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -57.46 -41.9 81.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.437 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -67.22 -24.06 65.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.623 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.411 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.82 -47.59 79.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.156 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.5 m . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.936 179.89 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.429 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.7 OUTLIER . . . . . 0 CA--C 1.509 -0.627 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.699 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 6.1 mm -75.87 132.14 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 113.702 -1.59 . . . . 0.0 112.587 -177.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.479 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.0 t -91.0 -60.93 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.073 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.0 p -148.67 152.15 36.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.267 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.09 138.15 50.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.918 0.389 . . . . 0.0 111.191 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.415 HG21 ' CE2' ' A' ' 68' ' ' PHE . 23.1 t -104.73 122.69 58.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.777 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.0 mt -125.12 120.55 58.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.468 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 34.2 t -80.49 112.29 17.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.489 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.4 t -82.08 -25.87 34.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.652 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.453 HG23 ' HB3' ' A' ' 142' ' ' SER . 34.1 p -79.88 -2.18 42.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.582 0.23 . . . . 0.0 111.501 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.74 78.08 0.27 Allowed Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.794 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -146.43 -44.03 0.19 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.945 0.403 . . . . 0.0 110.991 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.562 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.7 mp -120.03 141.47 31.57 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.046 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.562 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.0 Cg_endo -72.09 146.03 45.7 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.246 1.964 . . . . 0.0 112.21 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.3 mt -55.81 128.78 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.809 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.431 ' HG3' ' CE2' ' A' ' 76' ' ' TYR . 19.2 mtt180 -122.85 164.09 19.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.06 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -120.81 119.92 34.09 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.507 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 2.5 mt -93.3 137.29 32.76 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.699 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -147.93 158.04 43.84 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -178.56 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.479 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -140.32 141.79 35.68 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 113.28 -1.782 . . . . 0.0 110.237 178.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 121.197 0.522 . . . . 0.0 111.512 -179.291 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.804 0.335 . . . . 0.0 110.994 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.418 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.0 ttpt -150.11 136.31 18.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.026 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 11.7 t -128.48 139.2 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 121.261 0.553 . . . . 0.0 112.197 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.507 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.2 m-90 -103.24 139.36 38.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.984 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.88 125.39 53.6 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 177.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.563 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 2.6 m-85 -107.9 145.82 33.22 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.606 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.67 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.78 -178.15 40.05 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.916 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.435 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 6.1 mtp-105 -77.47 -3.39 40.19 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -84.88 135.72 39.66 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.767 0.318 . . . . 0.0 111.133 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.419 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 12.0 Cg_exo -69.07 -6.5 18.41 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.794 2.329 . . . . 0.0 111.884 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.86 -44.06 15.87 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 121.945 0.879 . . . . 0.0 108.651 179.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.86 138.61 2.67 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.734 -1.575 . . . . 0.0 110.41 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -56.27 -18.85 11.76 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.95 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.563 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 45.0 t80 -129.73 119.72 23.93 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.736 0.303 . . . . 0.0 110.818 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.419 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.2 t-160 . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.763 0.316 . . . . 0.0 110.611 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.435 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 3.6 mt . . . . . 0 CA--C 1.527 0.073 0 CA-C-O 120.839 0.352 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.9 t -54.73 -32.89 60.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.854 0.359 . . . . 0.0 111.246 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.31 -24.06 66.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.952 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.426 HD23 ' CE1' ' A' ' 88' ' ' HIS . 14.3 mt -105.53 152.08 23.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.968 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 92.9 p -94.7 166.19 12.13 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.704 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.67 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -43.16 -53.73 4.84 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.333 0.587 . . . . 0.0 109.831 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -118.9 82.86 1.93 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.565 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.8 t60 -60.13 -46.35 89.93 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.12 -0.946 . . . . 0.0 112.703 -176.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.524 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 20.1 p90 -147.13 159.46 43.59 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.721 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 5.0 tt0 -135.87 141.48 44.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.438 -179.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 2.7 mp -115.95 126.36 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.834 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.408 ' CD1' ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -104.37 151.97 22.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.064 0.459 . . . . 0.0 111.897 -179.552 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.311 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.404 ' CB ' HD22 ' A' ' 124' ' ' LEU . 3.0 mm? . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.806 0.336 . . . . 0.0 110.829 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 8.5 mt -133.1 142.1 48.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.82 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.403 ' CD2' ' CD1' ' A' ' 145' ' ' ILE . 1.3 mt -112.87 121.54 44.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.976 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' A' ' 90' ' ' GLN . 50.7 t30 -116.84 115.65 25.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.833 0.349 . . . . 0.0 111.853 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.692 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 12.2 p30 -77.86 139.99 39.32 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 10.3 pt -148.43 39.18 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 111.543 0.201 . . . . 0.0 111.543 -178.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.586 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.02 151.67 20.08 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 120.96 0.409 . . . . 0.0 111.946 -178.879 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 50.3 m -68.69 -31.71 71.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.807 177.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -98.21 -19.69 17.71 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.586 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.81 155.48 10.09 Favored Glycine 0 N--CA 1.438 -1.187 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.596 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.3 m -117.41 137.81 52.24 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.834 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -115.0 148.51 38.73 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 -178.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.05 113.44 18.39 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.293 177.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 44.61 43.04 6.23 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.83 -9.97 72.07 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.433 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.7 mp0 -105.06 118.57 36.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.086 0.469 . . . . 0.0 110.727 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.834 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 10.1 tptm -73.07 118.24 15.78 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.259 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.3 m -89.69 165.52 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.209 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.423 ' O ' ' HB3' ' A' ' 120' ' ' SER . 6.2 tt0 -69.9 126.87 30.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.481 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.692 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 29.2 tttt -53.85 163.53 0.71 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.782 0.325 . . . . 0.0 110.438 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.0 m-80 33.72 36.93 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.825 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.423 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.7 p -111.84 144.6 40.88 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.864 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -91.5 128.17 37.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.687 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 56.4 mm-40 -129.17 148.75 51.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.749 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -72.8 128.43 35.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.287 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.404 HD22 ' CB ' ' A' ' 99' ' ' LEU . 67.4 tp -57.9 155.74 10.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.437 0.637 . . . . 0.0 111.654 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.418 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -124.7 153.1 42.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.637 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.408 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.1 OUTLIER -71.86 123.32 22.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.917 0.389 . . . . 0.0 110.25 179.803 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.24 22.52 50.48 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.071 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.418 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 32.0 t70 -52.36 169.9 0.07 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.981 0.42 . . . . 0.0 111.239 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.416 ' CG ' ' CG2' ' A' ' 144' ' ' VAL . 2.0 mt-10 -145.12 135.45 24.11 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.946 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.46 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 15.7 mt -116.25 127.24 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-O 120.808 0.337 . . . . 0.0 110.458 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.461 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.7 m -104.43 141.18 36.8 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.164 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.497 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.8 m -140.26 158.49 25.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.05 44.2 9.18 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.821 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.453 HG22 ' CD2' ' A' ' 110' ' ' TRP . 54.0 t -85.23 140.53 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-O 121.677 0.751 . . . . 0.0 112.616 -178.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.11 -41.45 0.68 Allowed Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.9 t -126.48 121.97 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-N 114.567 -0.816 . . . . 0.0 108.998 177.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -50.33 -25.96 4.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.749 0.309 . . . . 0.0 111.506 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 73.8 m -93.55 6.56 47.84 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -131.42 29.19 4.6 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.461 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 4.9 mt -106.98 139.23 29.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.077 178.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.0 tt -124.23 134.55 53.23 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.531 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.453 ' HB3' HG23 ' A' ' 40' ' ' THR . 47.5 t -113.52 150.6 32.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.626 0.727 . . . . 0.0 112.42 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 1.8 mm? -135.7 141.84 44.98 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.349 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.416 ' CG2' ' CG ' ' A' ' 129' ' ' GLU . 13.2 t -110.87 137.74 42.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.813 0.34 . . . . 0.0 111.282 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.456 HG22 HD12 ' A' ' 145' ' ' ILE . 29.9 mt -106.29 128.09 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.142 -179.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.74 119.83 37.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.554 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.408 ' CD1' ' HA ' ' A' ' 126' ' ' GLN . 4.3 mt -84.87 134.04 27.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.527 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -90.44 105.58 17.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.798 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.4 -26.59 63.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.235 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.77 -42.21 83.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.014 0.435 . . . . 0.0 110.639 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 12.1 t80 . . . . . 0 N--CA 1.451 -0.384 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.948 179.944 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.791 0.329 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.402 ' HB2' ' NH1' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -61.32 -43.17 99.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.764 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -57.39 -38.49 74.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.822 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.02 -31.84 69.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.742 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.437 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.1 mt -72.69 -35.56 50.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.768 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -57.44 -39.82 77.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.932 0.396 . . . . 0.0 110.416 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.6 mtpt -67.06 -23.84 65.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.797 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.64 -47.36 79.9 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.213 -179.907 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.901 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 . . . . . 0 CA--C 1.513 -0.476 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.678 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 1.1 mm -89.63 96.54 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 CA-C-N 113.964 -1.471 . . . . 0.0 111.578 -177.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.47 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.3 t -55.38 -65.65 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.278 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.8 p -146.39 165.05 30.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.016 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.88 128.17 41.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.093 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.4 m -93.46 122.75 45.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.9 0.381 . . . . 0.0 111.11 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.1 mt -125.6 117.43 49.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.39 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 6.9 t -79.83 118.25 21.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.822 0.344 . . . . 0.0 110.387 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.07 -26.45 33.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.857 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.479 HG21 ' HB3' ' A' ' 142' ' ' SER . 33.5 p -79.93 -2.2 42.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.59 0.233 . . . . 0.0 111.357 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.49 47.42 90.77 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.855 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -113.81 -29.87 6.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.785 0.326 . . . . 0.0 110.884 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.567 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.8 mt -128.16 141.26 40.73 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.71 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.567 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 42.9 Cg_endo -70.46 134.35 26.31 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.125 1.884 . . . . 0.0 112.23 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.6 mt -55.17 130.02 17.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.608 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.8 163.42 17.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.305 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.24 119.74 36.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.989 0.423 . . . . 0.0 111.451 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.577 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 7.1 mt -98.45 136.15 39.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.404 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.678 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -148.71 157.76 43.67 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -179.162 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.47 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -144.1 142.0 30.35 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 113.643 -1.617 . . . . 0.0 110.864 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.202 0 CA-C-O 121.129 0.49 . . . . 0.0 111.039 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.903 0.382 . . . . 0.0 110.806 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -139.85 131.5 27.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.774 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 15.4 t -125.49 139.03 52.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.309 0.576 . . . . 0.0 112.181 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.577 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.0 m-90 -101.92 139.32 37.72 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.14 -0.937 . . . . 0.0 112.09 179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.406 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -114.49 126.52 55.04 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.08 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.515 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.9 OUTLIER -116.91 145.27 43.71 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.376 -178.447 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 165.18 -176.84 40.8 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.231 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.2 ttp85 -72.69 -3.03 22.57 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.426 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.3 t30 -84.8 135.04 40.64 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.738 0.304 . . . . 0.0 111.598 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.436 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 14.5 Cg_exo -67.57 -11.82 33.46 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.928 2.419 . . . . 0.0 112.036 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.38 -44.28 16.32 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-O 121.919 0.866 . . . . 0.0 109.029 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -41.62 142.36 0.64 Allowed 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 113.746 -1.57 . . . . 0.0 110.854 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.0 t0 -56.07 -18.57 10.04 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.204 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.464 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 8.1 t80 -129.14 131.12 47.15 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-O 120.771 0.319 . . . . 0.0 110.746 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.436 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.031 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.446 ' HB ' HD12 ' A' ' 84' ' ' LEU . 3.3 mp . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.786 0.327 . . . . 0.0 111.068 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.8 -25.89 43.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.216 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.91 -20.4 62.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.096 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.446 HD12 ' HB ' ' A' ' 81' ' ' ILE . 3.8 mp -104.9 153.01 21.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.817 0.341 . . . . 0.0 110.857 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.3 p -93.67 168.66 10.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.689 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.571 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 6.4 m-20 -41.41 -59.21 1.64 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.367 0.603 . . . . 0.0 109.657 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.04 84.11 2.06 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 176.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.553 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.9 t60 -58.92 -46.51 87.74 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.495 -176.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.515 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 27.1 p90 -144.91 159.8 42.33 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.9 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.4 tt0 -136.16 140.65 43.78 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.357 -179.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 65.9 mt -116.5 127.16 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 C-N-CA 121.164 -0.214 . . . . 0.0 110.809 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.412 ' HB3' HG12 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -113.12 144.94 41.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.02 0.438 . . . . 0.0 111.691 -179.727 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.9 tp . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.555 179.499 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.404 ' HB3' ' CD2' ' A' ' 124' ' ' LEU . 14.9 tp . . . . . 0 N--CA 1.46 0.057 0 CA-C-O 120.891 0.377 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 6.1 mp -125.55 144.81 50.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.441 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.3 tp -112.54 122.63 48.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.11 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.41 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 52.8 t30 -116.88 115.68 25.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.934 0.397 . . . . 0.0 111.921 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.683 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 10.0 p30 -76.63 138.7 40.25 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 9.5 pt -146.67 39.22 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 111.497 0.184 . . . . 0.0 111.497 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.595 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -97.99 150.94 20.83 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 121.171 0.51 . . . . 0.0 112.039 -178.681 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 42.9 m -68.79 -31.45 70.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.611 177.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -98.05 -19.78 17.77 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.595 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.22 155.23 10.15 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.251 -0.975 . . . . 0.0 113.559 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.515 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 5.8 m -117.35 137.69 52.28 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.832 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -115.75 148.55 39.69 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -177.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.02 113.58 18.6 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.385 177.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 43.87 43.85 5.45 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.79 -11.42 66.67 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.398 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -104.36 118.61 37.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.034 0.445 . . . . 0.0 110.62 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.832 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 9.1 tptp -72.28 115.89 12.06 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.293 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.5 m -84.45 164.24 2.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.13 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.426 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.2 tm-20 -69.83 125.03 25.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.496 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.683 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 55.6 tttt -53.02 162.0 0.71 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.914 0.388 . . . . 0.0 110.646 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.7 p30 34.78 34.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.423 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.29 145.09 40.61 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.089 179.457 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -88.3 129.86 35.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.795 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 41.4 mm-40 -129.6 147.84 51.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.035 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.9 128.98 37.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.983 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.431 HD13 ' N ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -58.07 159.6 5.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.415 0.626 . . . . 0.0 111.897 -178.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.431 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -125.0 153.26 43.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.156 179.59 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.412 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.23 116.74 11.91 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.819 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 62.81 25.58 67.79 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.545 -178.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.431 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 33.6 t0 -50.69 168.77 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.104 0.478 . . . . 0.0 111.457 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 15.5 tt0 -145.21 135.49 24.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.872 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.444 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 3.2 mt -114.75 127.35 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.513 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.468 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 4.2 m -104.64 138.41 41.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.944 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.529 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.2 m -140.2 158.24 25.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 82.24 39.6 11.11 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.944 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.424 ' HA ' HG12 ' A' ' 140' ' ' ILE . 54.9 t -79.41 140.41 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-O 121.688 0.756 . . . . 0.0 112.557 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 156.46 -41.76 0.56 Allowed Glycine 0 N--CA 1.436 -1.318 0 CA-C-N 114.471 -1.241 . . . . 0.0 110.018 -179.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.416 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 45.7 t -126.39 131.21 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-N 114.869 -0.666 . . . . 0.0 109.262 178.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -50.41 -35.4 28.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.669 0.271 . . . . 0.0 111.647 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.57 6.44 48.24 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.416 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 51.4 m-20 -121.85 26.75 8.48 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.468 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.0 mt -107.12 139.5 28.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.332 178.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.9 tt -120.69 134.5 55.28 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.292 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.479 ' HB3' HG21 ' A' ' 40' ' ' THR . 45.4 t -112.89 150.59 31.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.612 0.72 . . . . 0.0 112.716 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.419 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 70.8 mt -135.57 149.58 49.46 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.538 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 25.7 t -120.44 139.95 46.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.795 0.331 . . . . 0.0 111.28 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 5.4 mt -106.24 130.75 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.807 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -115.75 114.43 24.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.106 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 126' ' ' GLN . 6.0 mt -85.03 134.16 27.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.349 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -82.59 133.11 35.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.749 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -73.72 -37.75 65.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.209 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -46.13 91.55 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.907 0.384 . . . . 0.0 110.817 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.415 ' CE2' HG13 ' A' ' 33' ' ' VAL . 36.2 t80 . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.16 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.889 0.375 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.2 p -125.85 -60.51 1.29 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.91 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -68.15 -46.49 70.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.909 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -60.4 -45.05 94.96 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.5 -38.22 74.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.837 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.7 tp -60.7 -31.88 71.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.693 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.41 HG23 HD12 ' A' ' 20' ' ' ILE . 2.3 mt -72.17 -35.54 53.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.857 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -57.4 -44.45 84.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.918 0.39 . . . . 0.0 110.536 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.6 mtmm -67.07 -23.7 65.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.632 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -56.65 -47.56 79.49 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.253 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.2 t -76.56 -40.01 51.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.954 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -94.33 88.56 5.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -88.09 126.33 35.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.832 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -65.06 114.13 4.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.977 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.2 mm -82.26 138.35 19.6 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 CA-C-O 121.667 0.746 . . . . 0.0 111.749 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.29 35.88 1.06 Allowed Glycine 0 C--N 1.314 -0.664 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.412 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -77.48 -38.96 48.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.809 0.338 . . . . 0.0 111.019 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -171.98 35.23 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.674 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.3 mm -76.62 133.89 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 CA-C-N 113.863 -1.517 . . . . 0.0 112.489 -177.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.48 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.8 t -91.7 -61.21 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-N 114.715 -1.129 . . . . 0.0 109.856 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.7 p -145.14 160.0 42.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.278 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.73 138.17 54.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.698 0.285 . . . . 0.0 111.37 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.0 t -109.66 122.6 64.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.836 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.7 mt -125.14 120.63 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.405 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.4 t -80.96 111.96 17.92 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.802 0.334 . . . . 0.0 110.441 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.21 -22.42 35.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.591 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.439 HG23 ' HB3' ' A' ' 142' ' ' SER . 81.2 p -79.94 -2.21 42.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.654 0.264 . . . . 0.0 111.446 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.99 74.23 0.42 Allowed Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.847 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -146.01 -42.82 0.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.852 0.358 . . . . 0.0 111.065 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.577 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.2 mt -116.57 141.88 28.73 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.577 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 43.0 Cg_endo -70.37 142.38 45.08 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.143 1.896 . . . . 0.0 112.186 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.6 mt -57.04 135.35 20.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.717 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -130.98 160.06 35.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.084 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.71 119.87 31.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.92 0.391 . . . . 0.0 111.91 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.537 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 8.8 mp -82.57 133.05 35.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.514 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.674 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -139.78 155.64 47.18 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 122.287 1.041 . . . . 0.0 113.793 -179.656 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.48 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -143.23 141.92 31.24 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 113.476 -1.693 . . . . 0.0 110.616 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.49 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 0.9 OUTLIER -77.34 140.46 39.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.207 0.527 . . . . 0.0 111.249 -179.584 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.1 mt -64.37 -45.22 96.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.351 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.7 p -56.84 -41.05 77.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.24 0.543 . . . . 0.0 110.895 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.49 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 16.3 mt-30 -68.42 -36.88 79.73 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.654 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.2 t -68.66 -43.83 82.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.901 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.04 -39.09 72.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.798 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -70.08 -43.02 71.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.904 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.46 107.37 3.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.925 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.99 31.18 3.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.936 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -103.83 -177.45 3.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.848 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.52 -50.28 65.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.958 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 25.3 mm -116.94 158.76 17.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.133 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.46 -66.18 1.05 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.785 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -128.27 130.55 48.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.856 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.463 HG13 ' HG2' ' A' ' 90' ' ' GLN . 8.4 t -126.52 139.12 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 121.289 0.566 . . . . 0.0 112.175 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.537 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 18.2 m-90 -102.98 139.17 38.89 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.969 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.415 ' HA ' ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.17 131.09 56.0 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 177.6 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.529 ' CD2' ' CB ' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -118.2 145.82 44.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.259 -178.683 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.29 -167.78 35.68 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.413 -0.899 . . . . 0.0 113.173 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -79.42 1.78 24.18 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -84.74 127.79 63.67 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.864 -0.153 . . . . 0.0 110.97 -179.804 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.435 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 18.8 Cg_exo -66.18 -12.19 34.46 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.348 2.032 . . . . 0.0 111.563 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.95 -43.15 16.77 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-O 121.834 0.826 . . . . 0.0 108.926 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -39.77 139.62 0.61 Allowed 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.735 179.478 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -56.25 -18.69 11.2 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.04 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.529 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 13.2 t80 -129.64 121.99 28.14 Favored 'General case' 0 N--CA 1.457 -0.086 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.915 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.435 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.8 t-160 -95.5 107.95 20.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.838 0.352 . . . . 0.0 110.636 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 77.4 mt -71.97 -77.34 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.142 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 172.69 -102.68 0.18 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.538 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -156.24 64.95 0.56 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.87 0.367 . . . . 0.0 111.082 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 33.3 mt -111.97 118.82 58.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.99 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.8 m -58.25 -37.19 74.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.1 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.432 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 1.8 mmt180 -61.8 -17.04 54.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.305 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.41 ' HA ' ' HD1' ' A' ' 88' ' ' HIS . 20.6 mt -107.25 147.8 29.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.838 0.351 . . . . 0.0 111.251 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 51.6 p -93.08 164.89 13.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.48 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.62 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.0 m-20 -43.19 -52.74 5.43 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.426 0.632 . . . . 0.0 109.893 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.439 ' CB ' HD13 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -121.31 81.12 1.75 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 177.453 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.561 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.3 t60 -61.21 -45.93 92.56 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.161 -0.927 . . . . 0.0 113.008 -176.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.524 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 22.3 p90 -146.73 157.77 43.76 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.171 -0.611 . . . . 0.0 112.104 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.464 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.7 tt0 -135.6 140.85 44.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.24 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 16.1 mt -117.0 131.12 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.18 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.44 ' HB3' HG12 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -116.65 146.71 42.54 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.153 0.501 . . . . 0.0 111.932 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 15.3 tp -125.19 127.93 47.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.148 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -170.28 -35.36 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.888 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -47.97 172.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.878 0.371 . . . . 0.0 111.283 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.08 68.74 0.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.19 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.56 -23.58 29.72 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.852 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -81.21 172.05 14.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.896 0.379 . . . . 0.0 110.933 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.1 mp -121.79 160.06 25.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.971 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.3 mt -128.76 136.47 50.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.512 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.405 ' HG ' ' HB2' ' A' ' 122' ' ' GLN . 0.5 OUTLIER -112.83 122.6 48.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.08 179.586 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.439 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 63.6 t30 -114.85 121.99 44.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.015 0.436 . . . . 0.0 111.857 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.696 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 21.9 p30 -82.0 133.72 35.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.905 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.439 HD13 ' CB ' ' A' ' 87' ' ' LYS . 17.2 pt -139.55 37.82 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.568 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -96.34 156.25 16.42 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 120.927 0.394 . . . . 0.0 111.746 -178.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 87.8 m -68.91 -35.83 77.3 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.318 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.432 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -98.58 -19.74 17.42 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.46 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.568 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 121.04 161.57 11.42 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.192 -1.004 . . . . 0.0 113.914 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.2 m -117.5 138.04 52.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.905 -0.647 . . . . 0.0 109.299 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.81 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -112.22 148.55 33.86 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -177.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.06 113.32 18.23 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.484 -1.235 . . . . 0.0 108.192 177.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 44.29 43.5 6.0 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.05 -11.36 67.42 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 120.709 -0.758 . . . . 0.0 113.487 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.77 118.5 36.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.031 0.443 . . . . 0.0 110.679 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.81 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -72.36 128.55 35.97 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.371 -179.698 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.4 m -98.54 166.11 2.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.057 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.433 ' O ' ' HB3' ' A' ' 120' ' ' SER . 16.1 tt0 -69.9 126.71 30.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.483 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.696 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 32.6 tttt -54.27 163.4 0.84 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.9 OUTLIER 35.82 35.45 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.746 -179.231 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.433 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.7 p -111.9 145.04 40.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.601 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -95.14 129.54 42.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.846 0.355 . . . . 0.0 110.897 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.405 ' HB2' ' HG ' ' A' ' 101' ' ' LEU . 56.2 mm-40 -129.08 150.01 50.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.533 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.1 tp -72.55 132.27 43.59 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.276 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.414 ' CD2' HG12 ' A' ' 147' ' ' ILE . 61.4 tp -64.11 156.62 27.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.43 0.633 . . . . 0.0 111.633 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.441 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.57 154.09 41.16 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.926 -179.512 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.42 ' NE2' ' HB ' ' A' ' 147' ' ' ILE . 9.3 mm-40 -70.78 121.67 18.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.863 0.363 . . . . 0.0 110.061 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.13 22.85 50.8 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.033 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.441 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 26.5 t70 -53.62 171.77 0.08 Allowed 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.981 0.42 . . . . 0.0 111.037 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -145.26 135.34 23.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.097 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.0 mt -115.01 127.9 72.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.412 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.482 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 23.5 m -104.31 137.16 42.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.985 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.491 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 26.9 m -140.2 158.34 25.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.02 0.438 . . . . 0.0 112.022 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.55 37.67 10.47 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.618 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.451 ' HA ' HG12 ' A' ' 140' ' ' ILE . 50.4 t -79.71 140.47 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 121.705 0.764 . . . . 0.0 112.435 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.52 -36.8 0.63 Allowed Glycine 0 N--CA 1.436 -1.337 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.452 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 50.9 t -126.32 133.0 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-N 114.653 -0.774 . . . . 0.0 109.169 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -50.69 -44.64 57.96 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -93.3 6.51 47.86 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.452 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 4.9 t0 -117.25 29.37 7.93 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.482 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 3.8 mt -107.41 139.32 29.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.921 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.46 134.43 54.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.588 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.439 ' HB3' HG23 ' A' ' 40' ' ' THR . 38.0 t -114.9 150.38 35.73 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.567 0.698 . . . . 0.0 112.595 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -136.01 143.44 44.77 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.876 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.35 135.86 49.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.803 0.335 . . . . 0.0 110.957 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.9 mm -106.24 123.96 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.069 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.07 117.1 31.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.481 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.432 HG22 HD12 ' A' ' 147' ' ' ILE . 2.6 mt -84.97 134.04 27.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.451 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.24 109.9 16.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.759 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -60.7 -35.2 75.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.103 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.93 -44.06 91.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.73 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -59.29 -44.0 92.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.04 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -58.48 -36.3 73.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.11 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.01 -46.38 89.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.068 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.8 t -64.94 -45.04 87.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.064 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.95 -40.31 91.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.017 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.89 -36.39 81.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.058 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -88.36 -37.08 16.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.976 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.9 p30 42.77 71.74 0.21 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.428 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.43 144.71 40.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.868 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 8.1 p -103.07 141.13 19.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.052 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -138.68 32.7 2.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.93 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -147.24 31.08 0.92 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.856 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -94.07 130.66 42.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.064 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.938 179.988 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.793 0.33 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.3 t -138.93 -47.04 0.48 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.905 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.57 -45.73 92.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.882 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.4 mtm180 -59.11 -48.02 83.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.917 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -59.49 -35.01 73.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.88 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.78 -44.03 97.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.92 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.472 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.9 mm -66.64 -35.17 74.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.189 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -57.21 -39.44 75.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.928 0.394 . . . . 0.0 110.334 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.3 tttp -67.28 -23.71 65.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.6 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.472 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.82 -47.48 80.17 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.146 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.2 m -81.02 -38.98 26.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.902 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 60.4 30.32 19.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.789 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -101.01 141.62 33.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.867 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -93.67 142.23 27.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.85 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.3 mm -81.82 138.36 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 CA-C-O 121.661 0.743 . . . . 0.0 111.63 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.419 ' CA ' HG12 ' A' ' 32' ' ' ILE . . . 166.16 115.86 0.34 Allowed Glycine 0 C--N 1.314 -0.658 0 CA-C-N 114.539 -1.21 . . . . 0.0 112.522 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.7 -31.21 68.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.76 0.315 . . . . 0.0 111.036 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 178.84 38.56 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.66 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.3 mm -74.86 137.2 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 CA-C-N 113.786 -1.552 . . . . 0.0 112.437 -177.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.473 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.5 t -90.54 -58.54 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.745 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.8 m -149.8 162.84 39.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.701 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.1 138.09 53.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.754 0.311 . . . . 0.0 111.114 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.5 t -108.43 122.65 63.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.95 0.405 . . . . 0.0 110.81 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.8 mt -123.77 121.54 62.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.472 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 12.3 t -80.34 100.01 8.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.389 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.86 -27.2 69.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.828 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.471 HG21 ' HB3' ' A' ' 142' ' ' SER . 54.9 p -79.85 -2.2 42.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.734 0.302 . . . . 0.0 111.504 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.72 75.39 0.31 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.018 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -144.23 -47.56 0.27 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.856 0.36 . . . . 0.0 110.627 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.541 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.8 mm -104.24 141.74 23.16 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.749 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.541 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 53.7 Cg_endo -71.67 138.22 31.57 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.187 1.925 . . . . 0.0 112.164 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.1 mt -55.61 131.99 19.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.609 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.96 164.55 19.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.404 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.51 119.75 29.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.976 0.417 . . . . 0.0 111.957 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.553 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 6.9 mp -92.22 129.49 38.15 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.66 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -138.49 156.48 47.5 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 122.252 1.025 . . . . 0.0 113.692 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.473 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -154.54 141.89 19.59 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 113.493 -1.685 . . . . 0.0 110.856 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.505 ' HB2' ' HG3' ' A' ' 54' ' ' GLN . 0.5 OUTLIER -82.39 132.92 35.21 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.062 0.458 . . . . 0.0 111.317 -179.733 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.4 mp -64.32 -41.04 91.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.908 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.8 t -56.32 -38.14 70.9 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.743 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.505 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 0.3 OUTLIER -68.63 -40.58 80.25 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.355 179.719 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.1 t -67.69 -42.08 86.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.146 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.1 tp -71.05 -23.69 62.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.212 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.0 mtmm -92.69 -41.65 10.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.161 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -62.96 113.13 2.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.839 0.352 . . . . 0.0 110.947 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.72 -25.53 60.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.025 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -55.04 158.38 2.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.049 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.9 t -70.17 -38.63 75.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.987 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.0 tp -98.53 151.68 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.114 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.5 -65.83 1.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.428 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.9 ttpt -144.03 133.21 23.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.183 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 6.3 t -128.1 137.67 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 121.259 0.552 . . . . 0.0 112.045 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.553 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 18.9 m-90 -101.79 139.65 37.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.242 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.494 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -113.1 132.26 55.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.831 0.348 . . . . 0.0 110.157 177.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.526 ' CD2' ' HB2' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -120.32 145.4 47.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.825 -179.315 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.636 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.66 -167.03 35.67 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.166 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.424 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 20.0 mtp180 -86.19 36.05 0.67 Allowed 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -118.44 132.53 23.76 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.468 0.175 . . . . 0.0 110.998 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.09 -17.06 58.32 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.522 2.148 . . . . 0.0 111.506 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.99 -42.52 17.46 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 121.806 0.812 . . . . 0.0 109.088 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.26 139.39 1.43 Allowed 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.12 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.2 m-20 -56.23 -18.38 10.2 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.059 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.526 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 2.5 t80 -129.12 118.67 22.84 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-O 120.914 0.387 . . . . 0.0 110.951 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -96.78 107.84 20.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.628 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.404 ' CB ' ' CD1' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -116.21 170.64 8.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.025 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.45 144.25 43.42 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.334 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -71.58 88.97 0.96 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.764 0.316 . . . . 0.0 110.998 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.424 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 36.0 mt -106.64 125.69 62.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.008 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.83 -35.86 64.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.004 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -63.37 -29.88 71.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.468 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.431 HD21 ' CE1' ' A' ' 88' ' ' HIS . 23.8 mt -99.99 150.5 22.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.857 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.7 p -98.37 166.69 11.26 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.636 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 m-20 -43.25 -52.54 5.63 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.397 0.618 . . . . 0.0 109.892 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.415 ' HB3' ' CD1' ' A' ' 104' ' ' ILE . 4.3 mttt -119.0 82.05 1.8 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 177.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.586 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 15.4 t60 -58.69 -45.75 88.79 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.847 -177.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.513 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 31.5 p90 -149.38 162.18 40.6 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.583 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.443 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 3.3 tt0 -136.32 140.84 43.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.298 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 78.1 mt -115.22 129.08 72.06 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.192 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.779 179.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.424 ' HB3' HG11 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -113.9 146.9 39.38 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.205 0.526 . . . . 0.0 111.937 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.4 ' CD1' ' HG ' ' A' ' 99' ' ' LEU . 23.7 tp -125.1 123.12 39.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.067 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -114.41 -150.36 10.12 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.845 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -57.16 155.48 8.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.907 0.384 . . . . 0.0 111.164 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 54.94 176.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.101 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -66.13 -13.69 60.3 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.782 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -53.42 131.92 38.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.864 0.364 . . . . 0.0 111.062 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.4 ' HG ' ' CD1' ' A' ' 93' ' ' LEU . 0.5 OUTLIER -116.11 160.06 20.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.415 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 4.1 mm? -129.2 142.83 50.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.635 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 28.0 mt -112.61 122.32 47.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.912 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -117.11 135.61 53.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.152 0.501 . . . . 0.0 111.825 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.672 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 14.3 p30 -96.82 143.08 28.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.664 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.415 ' CD1' ' HB3' ' A' ' 87' ' ' LYS . 7.0 pt -147.62 28.28 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.468 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.561 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 10.8 t -92.26 157.69 16.53 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 121.433 0.635 . . . . 0.0 112.69 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 95.3 m -69.8 -52.12 27.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.954 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -82.84 -0.09 46.49 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.324 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.65 157.75 29.58 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.708 -0.758 . . . . 0.0 113.542 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.531 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.2 m -117.63 137.89 52.33 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.809 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -113.76 148.44 36.49 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -178.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.43 113.51 18.26 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.875 177.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 47.41 35.96 4.54 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.111 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.9 -7.23 79.26 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.487 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.51 118.39 36.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.979 0.419 . . . . 0.0 110.557 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.809 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 25.3 tptt -72.32 121.92 20.28 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.175 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.3 m -97.67 163.65 2.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.438 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 120' ' ' SER . 25.6 tt0 -69.98 128.13 35.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.453 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.672 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 66.7 tttt -52.56 161.94 0.63 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.789 0.328 . . . . 0.0 110.353 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.8 p30 35.15 34.89 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.202 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.25 143.18 43.74 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.975 179.469 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -85.39 132.52 34.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.889 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.415 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 35.0 mm-40 -129.56 147.68 51.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.665 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.2 tt -72.72 129.2 37.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.26 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 66.9 tp -62.16 155.17 25.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.513 0.673 . . . . 0.0 111.677 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.8 153.5 42.41 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.316 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 13.4 tp60 -71.15 119.79 15.79 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.55 23.95 63.4 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.657 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -49.02 167.15 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.921 0.391 . . . . 0.0 111.329 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 13.7 tt0 -145.1 135.4 24.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.965 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 11.8 mt -114.88 128.36 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.777 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.443 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.3 m -104.18 141.85 35.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.815 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.586 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 31.2 m -140.29 158.68 25.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.64 44.41 9.37 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.94 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.443 HG21 ' CD2' ' A' ' 110' ' ' TRP . 59.6 t -85.66 140.5 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-O 121.644 0.735 . . . . 0.0 112.459 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.03 -39.08 1.08 Allowed Glycine 0 N--CA 1.435 -1.404 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.8 t -126.51 118.91 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 CA-C-N 114.41 -0.895 . . . . 0.0 108.866 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -50.29 -26.37 4.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.738 0.304 . . . . 0.0 111.607 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.57 6.59 47.75 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.11 29.19 4.7 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.443 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 4.7 mt -107.14 139.14 29.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.719 178.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.4 tt -124.16 134.44 53.32 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.39 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.471 ' HB3' HG21 ' A' ' 40' ' ' THR . 37.6 t -108.15 150.19 27.54 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.782 0.801 . . . . 0.0 112.532 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 72.2 mt -135.93 145.0 45.78 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.383 -1.281 . . . . 0.0 110.622 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.9 t -117.07 139.49 43.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.837 0.351 . . . . 0.0 111.108 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.419 HG22 HD12 ' A' ' 145' ' ' ILE . 15.3 mt -106.17 123.02 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.952 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.04 119.5 39.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.87 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.7 mp -89.68 131.43 36.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.363 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.8 114.26 20.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.914 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -60.32 -29.18 68.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.35 -44.01 88.58 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.993 0.425 . . . . 0.0 110.609 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -58.16 -44.05 87.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.841 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 33.1 mttm -60.97 -37.17 81.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.959 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -62.05 -40.76 96.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.068 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.4 t -68.09 -43.47 78.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.94 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -68.55 -35.94 78.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.828 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -64.3 -42.29 96.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.825 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.423 ' O ' ' N ' ' A' ' 159' ' ' LYS . 0.7 OUTLIER -84.56 -33.05 23.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.712 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 42.89 -90.83 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.697 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 157' ' ' GLN . 55.4 tttp -60.81 115.71 3.88 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.89 0.376 . . . . 0.0 110.888 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.2 p -65.87 140.81 18.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.124 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -124.11 119.5 29.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.921 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 61.66 153.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.822 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 29.0 mm -88.89 115.74 29.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.152 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.9 ttm-85 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.902 -179.988 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.864 0.364 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 66.1 p -129.92 -69.92 0.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.975 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -68.7 -35.9 77.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -60.14 -35.96 76.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.825 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.78 -35.0 77.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.825 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.6 mp -63.93 -44.05 94.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.888 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.446 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.3 mm -65.75 -35.16 74.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.206 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -57.16 -41.12 78.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.028 0.442 . . . . 0.0 110.351 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.6 mttm -67.21 -23.81 65.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.591 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.56 -47.56 79.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.109 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.0 p -81.09 -29.97 34.8 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.836 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.17 -73.22 0.08 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.923 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -101.06 120.95 40.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.839 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -104.85 101.84 11.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.939 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.2 mm -90.26 138.45 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 121.63 0.729 . . . . 0.0 111.951 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 123.72 33.9 0.78 Allowed Glycine 0 C--N 1.314 -0.64 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.657 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -70.77 -44.72 66.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.911 0.386 . . . . 0.0 110.72 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -170.08 36.21 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.72 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 2.3 mm -81.86 94.41 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 CA-C-N 113.908 -1.496 . . . . 0.0 112.923 -177.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.459 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.5 t -46.88 -61.22 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.906 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 6.1 p -144.74 165.1 29.02 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.777 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.73 138.15 51.96 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.904 0.383 . . . . 0.0 111.54 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.1 m -101.73 122.85 54.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.741 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.8 mt -129.05 118.67 47.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 39.0 t -79.98 122.53 26.84 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.49 -21.99 17.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.798 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.442 HG23 ' HB3' ' A' ' 142' ' ' SER . 76.5 p -79.84 -2.15 42.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.699 0.285 . . . . 0.0 111.43 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.71 73.85 0.57 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.695 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -145.98 -39.08 0.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.715 0.293 . . . . 0.0 111.142 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.551 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.7 mt -125.11 141.47 38.63 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.007 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.551 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 53.4 Cg_endo -72.19 145.94 45.01 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.191 1.927 . . . . 0.0 112.223 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.0 mt -62.4 138.55 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.787 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.62 163.23 25.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.752 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.7 119.67 36.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.009 0.433 . . . . 0.0 111.858 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.53 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 0.6 OUTLIER -96.72 132.51 42.34 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.177 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.72 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -144.24 156.99 44.53 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -178.573 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.459 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -146.57 141.95 27.49 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.304 -1.771 . . . . 0.0 110.827 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.488 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 5.3 m-20 -81.45 134.54 35.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.025 0.441 . . . . 0.0 110.977 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.432 HD13 HG23 ' A' ' 52' ' ' ILE . 59.7 mt -64.3 -42.6 95.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.313 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.3 p -56.94 -42.02 79.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.267 0.556 . . . . 0.0 110.939 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.488 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 3.4 mt-30 -68.57 -37.73 80.14 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.957 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.0 t -68.74 -49.95 59.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.098 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 pp -66.56 -31.0 71.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.871 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -66.83 -47.42 72.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.898 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -80.37 134.59 36.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.04 29.84 0.97 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.007 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.2 ttm-85 -125.28 -55.81 1.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.783 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.31 -178.15 3.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.765 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.406 HG12 ' CG2' ' A' ' 65' ' ' VAL . 10.0 tp -59.77 152.64 4.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.069 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.42 -74.17 0.49 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.127 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -141.5 135.66 30.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.863 0.363 . . . . 0.0 111.316 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.475 HG11 ' HG2' ' A' ' 90' ' ' GLN . 18.6 t -133.92 139.13 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-O 121.194 0.521 . . . . 0.0 111.782 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.582 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 16.5 m-90 -102.07 139.06 38.2 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.253 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -111.81 128.38 56.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.813 177.635 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.605 ' CD1' ' HB2' ' A' ' 76' ' ' TYR . 9.0 m-85 -120.45 145.57 47.09 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.714 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.587 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.97 -165.96 34.9 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.845 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.425 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 10.3 mtm105 -83.07 6.56 18.57 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.408 ' ND2' ' HD2' ' A' ' 72' ' ' PRO . 3.2 t-20 -84.71 140.04 37.93 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.556 0.217 . . . . 0.0 110.877 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.408 ' HD2' ' ND2' ' A' ' 71' ' ' ASN . 60.3 Cg_endo -73.57 -14.3 24.8 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.356 2.038 . . . . 0.0 111.302 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.1 -43.1 16.63 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -41.78 137.25 1.75 Allowed 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 113.63 -1.623 . . . . 0.0 110.906 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.4 OUTLIER -56.73 -19.23 15.72 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.191 179.162 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.605 ' HB2' ' CD1' ' A' ' 68' ' ' PHE . 15.6 t80 -130.22 120.2 24.11 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.641 0.258 . . . . 0.0 111.097 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -98.23 118.57 35.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.82 0.343 . . . . 0.0 110.724 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.422 ' HA ' HG12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -124.11 73.3 1.22 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.317 -179.713 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 47.36 -129.24 14.12 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.825 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -163.3 84.73 0.5 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.73 0.3 . . . . 0.0 111.072 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.1 mp -97.39 141.05 16.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.03 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.1 t -63.71 -36.81 85.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.03 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.52 -21.03 63.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.316 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 21.2 mt -105.9 148.9 27.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.721 0.296 . . . . 0.0 111.077 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.6 p -95.55 165.62 12.25 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.689 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.587 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.9 m-20 -43.91 -53.68 5.93 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.315 0.579 . . . . 0.0 109.897 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.417 ' HB2' HD13 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -118.54 80.34 1.52 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.362 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.616 ' CD2' ' HB2' ' A' ' 105' ' ' SER . 13.9 t60 -60.79 -45.94 92.45 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.866 -176.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.446 ' N ' ' CD1' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -145.05 153.34 41.35 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.047 -0.661 . . . . 0.0 112.171 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.489 ' CG ' ' O ' ' A' ' 66' ' ' TRP . 5.9 tt0 -135.5 139.89 44.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.418 -178.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.455 ' O ' ' CG1' ' A' ' 65' ' ' VAL . 24.9 mt -113.97 132.09 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.024 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.413 ' HB3' HG13 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -118.28 144.0 46.15 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.961 0.41 . . . . 0.0 111.603 -179.804 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 13.8 tp -125.26 125.66 43.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.49 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -165.07 -162.56 16.41 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.505 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 59.42 -171.08 0.13 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.806 0.336 . . . . 0.0 110.902 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -78.81 61.94 3.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.789 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.84 -164.97 22.98 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.463 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.2 m120 61.66 152.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.762 0.315 . . . . 0.0 111.015 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.8 160.02 18.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.723 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.9 mp -131.07 144.49 51.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.321 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.7 123.54 50.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.199 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 90' ' ' GLN . 47.6 t30 -114.04 115.9 28.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.018 0.437 . . . . 0.0 111.684 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.664 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 10.8 p30 -81.01 118.81 22.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.224 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.417 HD13 ' HB2' ' A' ' 87' ' ' LYS . 9.9 pt -124.41 33.83 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.321 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.616 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 13.7 t -89.57 159.01 17.4 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-O 121.347 0.594 . . . . 0.0 112.444 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 49.5 m -69.59 -52.28 27.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.67 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -92.67 -19.82 21.46 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 136.06 153.33 6.57 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.618 -0.801 . . . . 0.0 114.02 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.472 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.2 m -117.29 137.89 52.11 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.796 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -113.65 148.62 35.96 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -178.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.95 113.31 18.29 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.204 177.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 45.08 43.05 7.19 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.28 -6.38 81.95 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.751 -0.737 . . . . 0.0 113.451 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -105.46 118.35 36.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.019 0.438 . . . . 0.0 110.76 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.796 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 7.9 tptt -73.42 115.75 13.16 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.267 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.4 m -92.36 159.56 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.356 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.1 tt0 -69.88 128.78 37.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.437 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.664 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 9.7 tttp -50.5 161.41 0.32 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.887 0.375 . . . . 0.0 110.472 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.441 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 3.6 p30 34.23 35.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.186 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.9 OUTLIER -112.04 122.48 47.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.083 179.665 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -68.59 126.03 28.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.032 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -129.38 147.37 51.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.598 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.1 tp -72.9 122.18 21.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.087 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -59.23 166.1 2.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.72 0.771 . . . . 0.0 111.888 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.442 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -125.43 153.27 43.72 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.387 179.393 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -71.35 116.25 11.46 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 62.99 27.89 71.15 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.776 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.442 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 20.6 t0 -59.31 174.81 0.37 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.018 0.437 . . . . 0.0 111.143 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 2.4 mt-10 -145.21 135.48 24.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.877 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 5.0 mt -111.33 128.48 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.269 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.455 ' HB ' ' HB2' ' A' ' 110' ' ' TRP . 2.8 m -103.93 141.45 36.13 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.556 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 33.3 m -140.43 158.61 25.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 77.0 44.35 14.3 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.11 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.459 HG23 ' CD2' ' A' ' 110' ' ' TRP . 76.1 t -83.8 140.4 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-O 121.691 0.758 . . . . 0.0 112.411 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.95 -38.92 1.23 Allowed Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.3 t -126.39 119.96 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-N 114.438 -0.881 . . . . 0.0 108.97 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.23 -27.64 6.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.743 0.306 . . . . 0.0 111.273 -178.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.2 m -93.56 6.59 47.75 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -127.34 25.81 6.09 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.448 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 4.9 mt -107.14 138.46 32.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.184 178.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.44 ' N ' HG22 ' A' ' 140' ' ' ILE . 2.6 tt -124.73 134.41 52.84 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.214 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.442 ' HB3' HG23 ' A' ' 40' ' ' THR . 36.7 t -112.72 150.16 31.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.66 0.743 . . . . 0.0 112.666 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 2.3 mm? -136.05 142.59 44.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.412 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.414 ' CG2' ' CG ' ' A' ' 129' ' ' GLU . 17.5 t -110.95 140.13 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.932 0.396 . . . . 0.0 111.334 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.7 mm -106.36 121.05 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.697 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.74 108.74 19.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.959 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.3 mp -84.84 129.01 38.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.19 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -75.8 128.53 35.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.079 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.08 -29.1 61.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.098 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -43.51 86.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.025 0.44 . . . . 0.0 110.534 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -58.9 -43.21 90.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.762 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.9 mtpt -63.87 -33.87 76.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.037 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -58.77 -47.08 85.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.932 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.9 t -68.0 -44.26 76.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.839 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.76 -36.25 78.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.805 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -60.15 -43.61 95.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.801 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.79 -37.07 30.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.6 p30 42.33 88.73 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.506 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -124.97 126.64 45.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.849 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.7 m -81.77 129.71 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.133 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -100.47 78.13 1.99 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.872 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 29.7 mtt85 -134.6 113.62 11.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.959 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.8 mp -92.45 133.07 35.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.106 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.927 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.684 0.278 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.538 ' HB ' ' CB ' ' A' ' 18' ' ' PHE . 0.2 OUTLIER 44.23 78.39 0.06 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.144 179.659 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.79 -47.39 85.89 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.137 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.7 mtm-85 -59.33 -35.89 74.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.229 0.538 . . . . 0.0 109.937 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.538 ' CB ' ' HB ' ' A' ' 15' ' ' THR . 3.0 t80 -60.88 -34.93 75.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.924 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.6 tp -59.14 -41.26 87.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.788 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.527 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 11.5 mm -70.38 -34.96 60.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.051 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -57.01 -33.7 67.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.832 0.348 . . . . 0.0 110.494 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.429 ' HE2' ' CD2' ' A' ' 18' ' ' PHE . 2.5 mptp? -66.65 -23.68 66.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.787 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.527 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.67 -47.55 79.57 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.969 0.414 . . . . 0.0 111.171 -179.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.17 -40.74 64.57 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.816 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -63.68 -65.87 0.62 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.826 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -84.98 138.25 32.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.852 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -88.37 116.24 26.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.926 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.6 mm -82.09 138.32 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 CA-C-O 121.621 0.724 . . . . 0.0 111.802 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -159.18 83.87 0.13 Allowed Glycine 0 C--N 1.314 -0.684 0 CA-C-N 114.541 -1.209 . . . . 0.0 112.435 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -60.18 -41.99 94.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.813 0.34 . . . . 0.0 110.966 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.417 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.3 t-20 175.71 39.82 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.698 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -71.85 135.79 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-N 113.667 -1.606 . . . . 0.0 112.408 -177.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.504 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.6 t -91.71 -59.29 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.145 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.6 m -145.32 160.35 41.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.796 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.455 ' NE ' HG21 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -120.77 138.18 54.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.902 0.382 . . . . 0.0 111.216 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.403 HG11 ' CZ ' ' A' ' 76' ' ' TYR . 22.0 t -98.52 122.66 50.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.065 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.414 HD11 ' CE1' ' A' ' 146' ' ' PHE . 16.3 mt -129.89 120.57 50.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.123 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 39.7 t -86.29 109.36 18.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.514 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.1 -27.12 48.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.587 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.5 ' CG2' ' CB ' ' A' ' 142' ' ' SER . 8.7 p -79.86 -3.01 46.1 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.692 0.282 . . . . 0.0 111.455 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.25 78.92 0.2 Allowed Glycine 0 CA--C 1.52 0.376 0 C-N-CA 121.079 -0.582 . . . . 0.0 113.798 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -147.71 -45.25 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.902 0.382 . . . . 0.0 110.959 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.539 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 8.8 mt -116.38 141.3 27.71 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.228 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.539 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.0 Cg_endo -74.54 146.11 34.25 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.318 2.012 . . . . 0.0 112.094 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.455 HG21 ' NE ' ' A' ' 35' ' ' ARG . 17.2 mt -52.23 153.27 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.252 0.548 . . . . 0.0 111.788 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -142.58 161.69 37.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.93 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -119.62 119.71 34.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.158 0.504 . . . . 0.0 111.817 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.511 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 5.3 mt -101.08 137.06 39.95 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.698 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -144.35 158.45 43.74 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -178.767 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.504 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.4 143.64 30.2 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 113.631 -1.622 . . . . 0.0 110.862 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.426 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 1.2 m-20 -74.9 120.65 20.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.075 0.464 . . . . 0.0 111.279 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.1 mt -64.62 -43.77 96.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.16 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -57.15 -40.31 76.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.285 0.564 . . . . 0.0 110.739 -179.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.426 ' CG ' ' HB2' ' A' ' 51' ' ' ASP . 9.1 mm-40 -68.66 -36.84 79.1 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.629 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.2 t -66.52 -48.38 80.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.887 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -70.94 -30.51 66.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.93 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.5 -42.53 71.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.013 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -97.31 136.95 37.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.896 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.41 65.56 1.52 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.699 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 -107.32 -68.14 0.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.856 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.69 -59.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.829 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.5 tp -104.3 143.0 16.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.036 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.3 tppm? -116.57 -66.84 1.04 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.002 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.423 ' CE ' ' O ' ' A' ' 49' ' ' SER . 6.8 ttpt -144.92 132.59 21.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.234 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 15.4 t -128.43 139.42 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 121.373 0.606 . . . . 0.0 112.093 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.544 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 14.8 m-90 -100.57 139.98 35.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.142 -0.936 . . . . 0.0 112.255 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.489 HG21 ' HG2' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -108.9 127.23 53.87 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.17 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.548 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 3.4 m-85 -113.27 145.74 40.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.935 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.671 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.6 -173.96 38.06 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.115 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 27.4 mtm180 -79.12 0.75 26.83 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.733 0.271 . . . . 0.0 111.733 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.452 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -84.78 131.95 47.77 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.516 0.198 . . . . 0.0 110.774 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 14.8 Cg_exo -67.84 -8.31 22.14 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.492 2.128 . . . . 0.0 111.792 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.18 -43.55 16.02 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 121.922 0.867 . . . . 0.0 108.896 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -41.37 138.35 1.27 Allowed 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 113.697 -1.592 . . . . 0.0 110.71 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -56.46 -18.54 11.69 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.134 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.548 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 55.2 t80 -129.15 123.39 31.99 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-O 120.791 0.329 . . . . 0.0 110.756 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -100.98 123.18 44.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.908 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.0 -72.17 0.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.843 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -170.47 -118.83 0.48 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.531 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -163.81 67.2 0.17 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.922 0.392 . . . . 0.0 110.914 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.402 HG22 HD12 ' A' ' 81' ' ' ILE . 30.7 mt -93.96 136.34 25.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.171 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.97 -41.28 96.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.891 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.41 -28.6 69.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.062 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 32.5 mt -96.57 152.1 18.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.055 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 93.0 p -97.55 164.21 12.53 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.529 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.671 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.7 m-20 -41.96 -53.04 3.97 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.326 0.584 . . . . 0.0 109.782 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.412 ' HB2' HD11 ' A' ' 104' ' ' ILE . 25.3 mttt -119.39 85.62 2.41 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 177.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.572 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.2 t60 -65.05 -44.21 89.77 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -176.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.506 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 37.7 p90 -153.26 163.27 40.21 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 119.984 -0.686 . . . . 0.0 112.461 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.489 ' HG2' HG21 ' A' ' 67' ' ' THR . 12.4 mt-30 -135.68 156.81 48.26 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.51 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 18.3 mt -127.8 132.35 68.96 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.205 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.451 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 1.0 OUTLIER -120.64 148.35 44.03 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.12 0.486 . . . . 0.0 111.791 -179.268 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.418 HD22 ' CZ ' ' A' ' 151' ' ' PHE . 48.2 tp -125.06 123.19 39.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.361 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.71 -175.08 30.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.754 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.27 81.06 1.38 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.788 0.328 . . . . 0.0 110.975 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -155.45 -45.16 0.08 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.986 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 137.51 44.25 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.481 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -170.54 162.57 8.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.796 0.331 . . . . 0.0 110.832 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -107.27 156.88 18.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.922 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.435 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 2.9 mp -131.4 143.69 50.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.395 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.9 126.06 54.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.479 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.451 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.3 t30 -115.57 115.75 26.97 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.751 -0.379 . . . . 0.0 111.57 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.69 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 10.3 p30 -79.57 143.19 35.01 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.283 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.449 HG12 ' HG3' ' A' ' 90' ' ' GLN . 11.0 pt -150.3 35.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.572 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -95.1 151.23 19.38 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 120.942 0.401 . . . . 0.0 111.814 -178.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 50.6 m -68.8 -31.57 70.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.014 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -98.08 -19.72 17.79 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.549 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.39 154.92 9.63 Favored Glycine 0 N--CA 1.439 -1.164 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.609 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.531 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.5 m -117.53 137.69 52.4 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.832 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -116.39 148.35 40.74 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -178.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.23 113.43 18.28 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.437 177.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 44.89 43.37 7.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.227 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.17 -7.32 78.66 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.838 -0.696 . . . . 0.0 113.47 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -105.61 118.58 36.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.043 0.449 . . . . 0.0 110.724 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.832 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 15.0 tptt -74.02 121.55 21.23 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.239 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.6 m -95.6 164.03 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.124 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 120' ' ' SER . 28.3 tp10 -69.88 128.98 38.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.474 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.69 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 80.3 tttt -54.61 161.92 1.33 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.989 0.423 . . . . 0.0 110.599 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.455 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.0 m-80 34.67 33.97 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.437 -0.802 . . . . 0.0 112.105 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.4 145.18 40.58 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.025 179.441 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -88.78 131.35 35.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.949 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.435 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 39.9 mm-40 -129.27 150.36 50.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.379 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.3 tp -72.62 111.86 8.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.823 0.344 . . . . 0.0 110.309 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.415 ' CD2' HD13 ' A' ' 147' ' ' ILE . 7.7 tt -55.01 156.78 3.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.287 0.565 . . . . 0.0 111.541 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.29 153.47 41.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.812 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.424 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.5 122.2 20.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.025 0.441 . . . . 0.0 110.531 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.14 18.71 60.73 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.42 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -57.22 173.36 0.24 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.879 0.371 . . . . 0.0 110.973 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 13.0 tt0 -145.04 135.64 24.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.118 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 2.6 mt -108.89 128.3 64.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.45 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.482 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 25.4 m -104.24 141.16 36.76 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.102 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.534 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 27.2 m -140.25 158.43 25.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -178.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.55 42.93 8.77 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.241 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.438 ' HA ' HG12 ' A' ' 140' ' ' ILE . 71.7 t -84.59 140.38 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-O 121.617 0.722 . . . . 0.0 112.286 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.86 -40.66 1.12 Allowed Glycine 0 N--CA 1.436 -1.345 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.4 t -126.37 120.83 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 CA-C-N 114.462 -0.869 . . . . 0.0 109.049 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.5 -24.98 3.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.664 0.269 . . . . 0.0 111.473 -178.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.5 6.51 47.96 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -129.7 26.12 5.31 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.482 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.9 mt -106.87 139.07 29.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.094 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 24.9 tp -124.74 134.51 52.79 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.803 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.5 ' CB ' ' CG2' ' A' ' 40' ' ' THR . 0.9 OUTLIER -109.6 133.54 52.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.958 0.409 . . . . 0.0 111.548 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 1.4 mm? -128.29 134.5 48.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.688 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.6 t -110.98 135.55 49.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.816 0.341 . . . . 0.0 111.262 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.3 mm -106.31 134.79 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.414 ' CE1' HD11 ' A' ' 37' ' ' ILE . 14.9 m-85 -115.41 119.79 37.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.767 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.424 ' CD1' ' HA ' ' A' ' 126' ' ' GLN . 5.8 mt -84.82 134.01 27.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.499 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -75.89 116.4 16.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.663 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -58.22 -32.11 67.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.009 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.0 -46.09 90.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.59 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.418 ' CZ ' HD22 ' A' ' 93' ' ' LEU . 11.5 t80 -59.14 -44.19 92.06 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.027 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.6 mtpm? -65.15 -39.72 93.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.986 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -58.81 -44.84 90.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.062 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.6 t -65.48 -44.15 88.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.983 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.94 -36.47 84.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.965 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.37 -34.07 77.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.949 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -89.61 -36.28 15.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.4 p30 42.61 91.69 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.432 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -75.19 118.85 18.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.88 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 10.4 m -81.54 125.98 39.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.175 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -66.73 -35.46 80.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.911 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.94 132.0 51.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.822 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.6 pt -96.3 115.59 36.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.055 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.897 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.785 0.326 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 70.26 -63.72 0.39 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.003 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -59.9 -34.24 72.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.03 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -68.27 -39.17 82.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.857 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -56.99 -41.48 78.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.73 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.6 tp -58.45 -33.76 70.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.571 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.51 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.5 mt -73.16 -35.87 48.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.783 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -33.75 68.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.956 0.408 . . . . 0.0 110.904 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.1 mmpt? -58.73 -26.37 63.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.409 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.51 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.8 -48.48 77.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.268 0.556 . . . . 0.0 111.064 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.1 m -81.15 -21.76 39.51 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.062 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 70.31 98.46 0.06 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.794 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -62.98 130.61 45.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.903 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -84.35 112.13 20.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.93 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.5 mm -81.94 138.45 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 CA-C-O 121.593 0.711 . . . . 0.0 111.692 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -146.13 47.71 0.71 Allowed Glycine 0 C--N 1.314 -0.646 0 CA-C-N 114.594 -1.184 . . . . 0.0 112.656 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -59.11 -42.86 91.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.923 0.392 . . . . 0.0 110.548 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.436 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.9 m-20 -177.29 36.29 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.635 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.5 mm -76.66 136.74 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-N 113.774 -1.557 . . . . 0.0 112.535 -177.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.478 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.1 t -91.05 -59.41 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.682 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 4.8 p -150.41 165.47 33.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.32 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.412 ' CD ' ' CG2' ' A' ' 45' ' ' ILE . 0.2 OUTLIER -128.01 138.15 52.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.804 0.335 . . . . 0.0 111.188 -179.411 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.401 HG13 ' CE2' ' A' ' 68' ' ' PHE . 3.1 m -106.48 122.76 60.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.852 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.3 mt -125.02 122.58 63.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.617 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 50.7 t -79.93 107.34 12.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.809 0.338 . . . . 0.0 110.402 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.3 t -70.97 -28.47 64.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.978 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.486 HG22 ' HB3' ' A' ' 142' ' ' SER . 69.8 p -79.87 -2.17 42.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.693 0.283 . . . . 0.0 111.527 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.1 80.56 0.11 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.947 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -146.86 -41.69 0.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.912 0.386 . . . . 0.0 110.932 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.588 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 5.3 mp -119.41 143.48 34.56 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.218 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.588 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 43.9 Cg_endo -70.27 146.11 56.07 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.325 2.017 . . . . 0.0 111.963 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.412 ' CG2' ' CD ' ' A' ' 35' ' ' ARG . 32.2 mt -62.81 131.64 28.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.924 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.459 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -117.25 146.36 43.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.91 179.144 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.67 119.66 39.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.986 0.422 . . . . 0.0 111.629 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.49 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 6.9 mp -92.05 125.5 36.76 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.635 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -135.82 156.98 47.96 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 122.285 1.04 . . . . 0.0 113.531 -179.427 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.478 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -150.23 141.88 23.59 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 113.613 -1.631 . . . . 0.0 110.721 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.476 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 3.7 m-20 -75.43 124.15 26.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.029 0.442 . . . . 0.0 111.346 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.451 HD12 HG21 ' A' ' 52' ' ' ILE . 43.4 mt -64.47 -41.89 93.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.428 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.8 m -59.34 -42.16 90.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.296 0.57 . . . . 0.0 111.03 -178.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.476 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 6.9 mt-30 -68.6 -36.78 79.16 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.795 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.6 t -68.84 -38.37 78.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.844 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.52 -30.51 67.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.862 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.92 -42.62 16.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -63.09 128.92 38.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.831 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.23 30.91 6.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.8 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.6 mtm105 -90.76 -178.13 5.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.963 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.6 t -78.69 -32.76 47.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.086 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.9 tp -134.44 160.65 41.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.129 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.433 ' HG2' ' CA ' ' A' ' 94' ' ' GLY . 1.3 mmtt -109.0 -70.51 0.8 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.465 ' CE ' ' O ' ' A' ' 49' ' ' SER . 30.8 ttpt -144.34 123.05 12.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.853 0.358 . . . . 0.0 111.918 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.511 HG21 ' HB3' ' A' ' 92' ' ' LEU . 13.1 p -110.4 139.76 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.49 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 20.6 m-90 -100.81 139.85 35.91 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.033 -1.44 . . . . 0.0 112.227 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.444 ' HA ' ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -111.91 133.1 54.32 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 177.859 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.544 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.7 OUTLIER -120.01 145.5 46.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.556 -178.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.616 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.81 -169.41 36.47 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.489 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.458 ' NH1' ' O ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -85.29 7.48 22.06 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.733 0.267 . . . . 0.0 111.521 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -84.9 134.17 42.01 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-O 120.532 0.206 . . . . 0.0 110.783 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -65.84 -13.75 41.34 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.547 2.165 . . . . 0.0 111.843 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.2 -44.76 14.66 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 121.936 0.874 . . . . 0.0 109.186 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.75 137.63 2.19 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.728 -1.578 . . . . 0.0 111.485 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 67' ' ' THR . 21.9 m-20 -56.82 -18.88 14.53 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.231 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.496 ' CD2' ' CD2' ' A' ' 78' ' ' LEU . 7.8 t80 -129.8 103.28 6.73 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.817 0.342 . . . . 0.0 110.88 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -85.89 121.79 29.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.98 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.496 ' CD2' ' CD2' ' A' ' 76' ' ' TYR . 2.4 mt -103.87 -67.55 0.89 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -173.91 -98.47 0.11 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.607 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.401 ' HA ' ' CB ' ' A' ' 70' ' ' ARG . 0.7 OUTLIER -177.91 46.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.007 0.432 . . . . 0.0 110.8 -179.888 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.401 ' N ' ' HD3' ' A' ' 70' ' ' ARG . 42.2 mm -76.51 134.85 28.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.021 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.5 p -65.24 -40.52 94.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.45 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.466 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -60.66 -24.87 65.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.902 0.382 . . . . 0.0 110.646 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.431 ' HB2' ' CZ ' ' A' ' 70' ' ' ARG . 3.7 mp -107.5 152.69 23.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.507 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.458 ' O ' ' NH1' ' A' ' 70' ' ' ARG . 59.7 p -98.87 153.86 18.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.89 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.616 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.6 m-20 -30.33 -53.49 0.17 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.361 0.6 . . . . 0.0 110.549 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.403 ' HB3' HD11 ' A' ' 104' ' ' ILE . 0.5 OUTLIER -120.16 84.18 2.17 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 177.321 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.562 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.3 t60 -61.55 -46.3 90.5 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.034 -0.985 . . . . 0.0 112.593 -177.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.544 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 22.0 p90 -142.36 160.73 39.69 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.058 -0.657 . . . . 0.0 112.109 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.455 ' NE2' HG23 ' A' ' 65' ' ' VAL . 3.3 tt0 -135.98 143.39 44.8 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.034 -179.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 61.6 mt -122.39 132.14 71.73 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.196 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.511 ' HB3' HG21 ' A' ' 65' ' ' VAL . 0.4 OUTLIER -125.66 141.65 51.91 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.014 0.435 . . . . 0.0 111.842 -179.794 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.36 132.66 52.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.315 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.433 ' CA ' ' HG2' ' A' ' 63' ' ' LYS . . . 168.51 -137.76 4.75 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.662 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 65.42 -77.57 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.843 0.354 . . . . 0.0 110.969 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -133.48 -46.36 0.82 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.928 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -178.39 -37.19 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.549 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -58.37 170.5 0.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.762 0.315 . . . . 0.0 110.94 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.23 154.34 21.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.84 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.5 mp -131.21 142.19 50.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.496 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.9 pp -113.42 124.7 53.04 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.187 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.499 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 54.8 t30 -116.03 120.29 38.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.056 0.455 . . . . 0.0 111.923 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.701 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 20.4 p30 -80.62 137.57 36.37 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.748 178.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.403 HD11 ' HB3' ' A' ' 87' ' ' LYS . 8.3 pt -144.58 39.33 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.562 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.12 162.28 13.44 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.073 0.463 . . . . 0.0 111.602 -179.278 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 89.1 m -69.11 -40.92 78.06 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.734 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -98.7 -19.94 17.22 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.096 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.471 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 126.58 160.69 10.66 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 119.948 -1.12 . . . . 0.0 114.205 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 13.9 m -117.63 138.02 52.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.853 -0.674 . . . . 0.0 109.253 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.847 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -111.97 148.36 33.94 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.21 113.52 18.41 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.491 -1.231 . . . . 0.0 108.197 177.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 44.5 42.79 5.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.47 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.71 -10.1 71.32 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.768 -0.729 . . . . 0.0 113.548 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -104.34 118.5 36.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.079 0.466 . . . . 0.0 110.696 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.847 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.0 tptm -73.82 126.88 31.39 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.194 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.7 m -99.51 166.51 2.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.384 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 120' ' ' SER . 3.0 tp10 -69.93 126.21 29.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.607 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.701 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 74.1 tttt -54.58 162.57 1.12 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.04 0.448 . . . . 0.0 110.534 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.0 OUTLIER 37.33 31.44 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.454 -0.793 . . . . 0.0 112.069 -179.218 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.65 143.94 43.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.847 179.095 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -94.01 135.52 35.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.921 0.391 . . . . 0.0 111.018 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 59.0 mm-40 -129.38 152.32 49.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.393 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -72.4 118.36 15.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.959 0.409 . . . . 0.0 110.336 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.4 tt -52.12 155.59 1.87 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.437 0.637 . . . . 0.0 111.788 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.412 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.7 OUTLIER -124.52 153.23 42.4 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.349 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -71.62 124.55 24.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.88 0.372 . . . . 0.0 110.478 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 56.94 22.08 40.34 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.257 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.412 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 19.9 t70 -54.86 173.14 0.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.946 0.403 . . . . 0.0 110.811 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 1.9 mt-10 -144.29 135.74 25.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.145 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.7 mt -113.11 127.56 70.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.791 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.465 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 4.0 m -104.45 137.79 41.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.741 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.484 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 33.9 m -140.25 158.29 25.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.68 28.92 25.35 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.135 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.454 ' HA ' HG12 ' A' ' 140' ' ' ILE . 70.4 t -70.89 140.39 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-O 121.62 0.724 . . . . 0.0 112.38 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.1 -38.98 0.83 Allowed Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.411 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 48.2 t -126.49 129.38 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-N 114.641 -0.779 . . . . 0.0 109.117 178.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -50.51 -36.07 32.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.807 0.337 . . . . 0.0 111.567 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.4 p -93.61 6.54 47.94 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.411 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 9.5 t0 -120.74 25.97 9.39 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.465 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.4 mt -107.1 139.15 29.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.102 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.6 tt -124.2 134.4 53.29 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.434 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.486 ' HB3' HG22 ' A' ' 40' ' ' THR . 38.5 t -108.01 150.24 27.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.721 0.772 . . . . 0.0 112.261 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.427 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 76.2 mt -135.87 155.7 49.92 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.903 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.5 t -123.6 140.16 47.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.73 0.3 . . . . 0.0 110.918 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.427 HG21 HD12 ' A' ' 145' ' ' ILE . 7.9 mt -106.22 120.87 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-O 120.93 0.395 . . . . 0.0 111.01 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.84 126.3 52.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.452 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.459 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 2.8 mp -99.19 131.51 46.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.284 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -76.05 112.0 12.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.841 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -58.5 -34.01 70.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.909 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.77 -46.2 91.4 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.741 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -61.53 -44.16 97.56 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.057 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.14 -35.21 80.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.935 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.05 -42.98 91.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.891 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.2 t -65.94 -46.02 79.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.968 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.14 -36.57 82.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.48 -39.43 87.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.79 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -86.64 -37.1 18.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.809 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.6 p30 44.07 -171.19 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.598 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.4 131.88 36.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.004 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 5.2 m -92.35 123.41 44.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.162 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -81.08 -31.46 34.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.981 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -131.07 126.04 34.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.941 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -85.93 133.01 30.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.097 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.159 -0.924 . . . . 0.0 110.848 -179.959 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.83 0.348 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.2 t -116.95 -35.83 4.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.087 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -46.94 87.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.986 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -67.7 -35.94 79.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.989 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.7 -42.42 88.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.008 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.32 -44.92 95.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.494 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.7 mm -67.41 -35.0 72.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.269 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -57.17 -35.88 70.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.949 0.404 . . . . 0.0 110.469 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.2 -23.87 65.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.735 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.494 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.7 -47.37 80.07 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.281 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.3 t -64.56 -33.68 76.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -83.42 68.62 9.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -86.04 130.05 34.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.75 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -79.17 106.28 11.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.001 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.5 mm -82.02 138.41 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 CA-C-O 121.651 0.739 . . . . 0.0 111.713 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.09 43.49 32.96 Favored Glycine 0 C--N 1.314 -0.671 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.289 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -72.2 -35.38 68.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.659 0.266 . . . . 0.0 111.265 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.7 OUTLIER 176.05 39.3 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.652 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 6.0 mm -72.59 135.47 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 CA-C-N 113.612 -1.631 . . . . 0.0 112.638 -177.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.477 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.3 t -91.75 -59.16 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-N 114.68 -1.146 . . . . 0.0 109.715 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 4.9 p -147.31 165.32 30.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.46 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.06 127.01 44.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.723 0.297 . . . . 0.0 111.263 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.6 m -94.17 122.8 45.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.916 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.41 HD13 ' CD1' ' A' ' 146' ' ' PHE . 19.6 mt -129.34 121.84 54.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.634 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 52.3 t -81.27 124.34 29.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.254 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.96 -25.68 21.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.808 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.486 HG22 ' HB3' ' A' ' 142' ' ' SER . 81.8 p -79.87 -2.28 42.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.709 0.29 . . . . 0.0 111.562 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.07 74.42 0.46 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.93 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -144.43 -46.0 0.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.964 0.411 . . . . 0.0 110.789 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.575 HG12 ' HA ' ' A' ' 78' ' ' LEU . 2.8 mp -111.84 140.76 23.69 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.729 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.54 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.4 Cg_endo -73.4 143.78 35.42 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.147 1.898 . . . . 0.0 112.16 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.7 mt -56.33 142.93 10.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.575 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.442 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.4 OUTLIER -130.37 164.04 25.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.298 179.518 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.42 119.39 33.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.946 0.403 . . . . 0.0 111.529 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.518 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 7.8 mp -94.38 124.71 38.58 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.652 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -136.3 156.15 49.07 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 122.283 1.04 . . . . 0.0 113.67 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.477 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -151.46 141.92 22.54 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.45 -1.705 . . . . 0.0 110.989 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.455 ' HB2' ' HG3' ' A' ' 54' ' ' GLN . 1.2 m-20 -74.95 128.81 36.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.128 0.49 . . . . 0.0 110.894 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.6 mt -64.17 -38.01 81.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.973 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 t -56.8 -42.04 78.81 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.886 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.455 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 2.1 mt-30 -68.58 -46.3 69.75 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.853 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.4 t -63.87 -38.06 81.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.29 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.7 tt -70.98 -41.99 70.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.301 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -76.96 -40.21 47.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.13 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -63.01 130.94 46.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.799 0.333 . . . . 0.0 110.923 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.97 37.54 2.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.011 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 74.7 mtt180 -107.9 170.96 7.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.019 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.4 p -72.01 -38.0 69.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.867 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.2 mm -121.48 143.79 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.039 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp -110.33 -59.46 1.94 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.844 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.449 ' HE2' ' O ' ' A' ' 49' ' ' SER . 3.7 ttpt -140.3 130.41 24.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.853 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 9.3 t -124.14 138.34 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 121.26 0.552 . . . . 0.0 112.123 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.518 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 17.8 m-90 -100.88 139.6 36.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.127 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -111.27 130.47 55.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.043 0.449 . . . . 0.0 109.97 177.922 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.532 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.4 OUTLIER -120.12 145.35 47.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.031 -179.07 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.589 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.35 -168.13 37.9 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.56 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.405 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 0.7 OUTLIER -79.46 -0.7 34.15 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.402 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.3 t30 -84.8 132.35 46.49 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.663 0.268 . . . . 0.0 111.148 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.8 Cg_exo -66.73 -13.52 40.25 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.639 2.226 . . . . 0.0 111.76 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.6 -43.06 17.47 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -41.11 141.04 0.69 Allowed 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 113.887 -1.506 . . . . 0.0 110.655 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 67' ' ' THR . 60.6 m-20 -56.31 -18.88 12.0 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.047 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.487 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 2.8 t80 -130.06 129.1 43.2 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-O 120.771 0.32 . . . . 0.0 111.325 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -106.79 107.65 18.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.462 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.575 ' HA ' HG12 ' A' ' 43' ' ' ILE . 20.7 mt -72.22 -70.57 0.33 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.385 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 170.5 -89.72 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.601 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -164.49 62.88 0.14 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.95 0.405 . . . . 0.0 111.189 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.405 ' N ' ' HD2' ' A' ' 70' ' ' ARG . 3.9 mp -104.63 111.87 35.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.835 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.1 m -56.11 -37.08 68.93 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.102 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.54 -17.5 59.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.302 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.0 mt -104.56 152.03 22.9 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.681 0.277 . . . . 0.0 111.157 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 57.7 p -96.63 167.97 10.81 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.566 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.589 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 8.1 m-20 -42.84 -58.74 2.24 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.365 0.602 . . . . 0.0 109.81 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.401 ' HB3' HD11 ' A' ' 104' ' ' ILE . 0.5 OUTLIER -115.36 82.74 1.8 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 176.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.556 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.1 t60 -59.6 -46.86 87.69 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.517 -176.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.532 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 29.8 p90 -145.54 161.49 39.65 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.214 -0.594 . . . . 0.0 112.005 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.2 tt0 -136.06 144.02 44.98 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.911 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.513 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 81.4 mt -118.88 124.7 73.6 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.272 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.044 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.433 ' CA ' HG11 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -102.26 151.27 22.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.964 0.411 . . . . 0.0 111.723 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.4 tp -125.29 122.97 38.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.439 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -172.22 -152.66 8.67 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.629 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 59.33 -173.19 0.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.795 0.331 . . . . 0.0 110.97 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -85.59 90.38 7.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 59.17 54.32 38.95 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.609 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -150.9 155.64 39.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.856 0.36 . . . . 0.0 110.844 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.415 ' HB2' ' CD2' ' A' ' 124' ' ' LEU . 4.1 mm? -114.17 160.07 19.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.759 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.466 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 3.2 mp -131.31 145.46 51.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.689 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.0 mp -112.71 121.07 43.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.028 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -115.49 115.44 26.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.93 0.395 . . . . 0.0 111.552 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.688 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 11.3 p30 -78.59 140.44 38.47 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.401 HD11 ' HB3' ' A' ' 87' ' ' LYS . 10.1 pt -148.99 38.36 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -178.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.573 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.29 152.7 19.14 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 121.013 0.435 . . . . 0.0 112.063 -178.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 50.8 m -68.89 -31.44 70.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.875 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -98.21 -19.91 17.58 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -178.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.573 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.91 156.67 10.39 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.355 -0.926 . . . . 0.0 113.713 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.516 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.1 m -117.43 137.78 52.28 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.814 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -115.96 148.58 39.94 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -177.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.12 113.58 18.54 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.483 177.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 44.72 43.27 6.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.444 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.58 -12.68 62.53 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.722 -0.752 . . . . 0.0 113.468 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.8 118.56 36.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.087 0.444 . . . . 0.0 110.605 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.814 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -71.44 131.71 43.74 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.48 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.6 m -101.59 165.87 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.966 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.4 mp0 -69.83 126.12 28.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.482 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.688 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 84.4 tttt -54.11 162.52 0.99 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.824 0.345 . . . . 0.0 110.654 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.3 m-80 34.21 35.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.109 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.454 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.19 145.17 40.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.035 179.531 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -88.0 132.03 34.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.919 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.466 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 45.1 mm-40 -129.33 150.2 50.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.611 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.6 tp -72.8 136.13 45.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.488 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.489 ' HG ' ' N ' ' A' ' 125' ' ' SER . 16.2 tp -62.43 152.69 33.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.628 0.727 . . . . 0.0 111.585 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.489 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.4 OUTLIER -125.3 152.59 44.47 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.505 179.442 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.455 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -72.28 122.57 21.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 0.0 110.177 179.595 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.03 23.98 48.73 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.054 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.415 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 28.8 t70 -49.08 167.96 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.93 0.395 . . . . 0.0 111.487 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 2.3 mt-10 -144.27 135.68 25.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.003 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.422 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 16.2 mt -115.71 127.3 73.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.804 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.453 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 4.0 m -104.59 139.16 39.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.873 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.52 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.2 m -140.38 158.41 25.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.5 28.86 26.02 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.161 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.452 ' HA ' HG12 ' A' ' 140' ' ' ILE . 78.1 t -71.35 140.39 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-O 121.626 0.727 . . . . 0.0 112.288 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.18 -39.5 0.92 Allowed Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 46.4 t -126.42 128.26 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 CA-C-N 114.689 -0.755 . . . . 0.0 109.068 177.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.51 -33.85 23.03 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.597 0.237 . . . . 0.0 111.632 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.8 m -93.53 6.46 48.14 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -178.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.4 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.6 OUTLIER -123.01 26.79 7.95 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -178.847 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.453 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.6 mt -107.06 138.96 30.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.102 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.0 tt -124.63 134.38 52.93 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.531 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.486 ' HB3' HG22 ' A' ' 40' ' ' THR . 38.0 t -108.59 150.33 27.65 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.567 0.698 . . . . 0.0 112.069 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 75.9 mt -135.78 155.12 50.84 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.861 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.411 ' CG2' ' CG ' ' A' ' 129' ' ' GLU . 20.0 t -127.6 138.14 55.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.784 0.326 . . . . 0.0 111.166 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 19.4 mt -106.45 129.06 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 CA-C-O 120.852 0.358 . . . . 0.0 110.885 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.41 ' CD1' HD13 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -113.12 122.92 49.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.916 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.455 ' CD1' ' HA ' ' A' ' 126' ' ' GLN . 3.3 mt -91.35 134.14 30.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.474 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.76 112.37 19.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.675 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.71 -31.86 68.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.072 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt -58.95 -45.13 91.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.999 0.428 . . . . 0.0 110.609 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -58.78 -44.17 90.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.985 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 28.9 mttp -65.26 -35.16 80.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.097 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -58.97 -47.1 86.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.284 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.0 t -61.15 -45.93 92.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.006 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.12 -36.53 77.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.925 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.94 -35.27 74.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.698 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -89.58 -34.86 16.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.813 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.6 p30 42.5 92.71 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.591 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.21 136.4 53.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.847 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 30.3 m -64.97 134.92 29.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.225 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -135.45 172.46 12.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.978 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 43.4 ttp85 -162.85 102.98 1.02 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.894 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.9 mp -99.42 135.15 35.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.093 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.123 -0.942 . . . . 0.0 110.936 179.932 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.832 0.349 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.8 p -149.34 -58.87 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -71.21 -46.93 60.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.927 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 -61.63 -44.15 97.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -60.01 -36.49 77.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.063 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.9 tp -63.73 -45.99 87.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.963 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 40.3 mm -63.27 -39.61 85.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.226 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -57.88 -33.89 69.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.234 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -65.15 -30.86 71.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.479 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -57.06 -47.49 80.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.089 0.471 . . . . 0.0 111.116 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.3 m -70.16 -29.53 66.45 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.939 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -43.85 69.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.959 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -78.78 136.84 37.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.976 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -100.35 114.09 27.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.832 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 29' ' ' GLY . 17.9 mm -85.01 138.32 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-O 121.603 0.716 . . . . 0.0 111.974 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.419 ' N ' HG22 ' A' ' 28' ' ' ILE . . . -78.26 65.43 3.34 Favored Glycine 0 C--N 1.313 -0.719 0 CA-C-N 114.546 -1.206 . . . . 0.0 112.327 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -65.53 -41.79 92.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.661 0.267 . . . . 0.0 111.323 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.1 m120 -178.32 38.1 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.585 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 7.6 mm -71.51 144.52 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 CA-C-N 113.695 -1.593 . . . . 0.0 112.477 -176.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.425 HG11 ' CH2' ' A' ' 66' ' ' TRP . 1.2 t -105.71 -56.35 5.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.717 -178.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.415 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 31.3 p -151.51 164.51 36.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.221 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.41 138.26 53.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.835 0.35 . . . . 0.0 111.477 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.431 HG12 ' CZ ' ' A' ' 76' ' ' TYR . 18.3 t -103.81 122.59 56.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.685 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.6 mt -127.0 115.82 42.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.461 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 37.7 t -79.97 124.75 28.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.82 0.343 . . . . 0.0 110.489 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.9 t -92.18 -26.99 17.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.556 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.441 HG23 ' HB3' ' A' ' 142' ' ' SER . 25.9 p -79.93 -2.17 42.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.521 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.05 75.7 0.37 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.915 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -146.01 -44.9 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.789 0.328 . . . . 0.0 111.002 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.52 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -112.73 140.61 24.16 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.831 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.52 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.6 Cg_endo -74.43 141.54 28.6 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.253 1.969 . . . . 0.0 112.361 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.9 mt -56.69 133.99 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.408 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.29 164.46 25.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.551 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.49 119.82 36.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.086 0.47 . . . . 0.0 111.774 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.516 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 17.8 mt -92.27 137.9 31.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.107 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.585 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -141.62 158.39 43.89 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 122.283 1.04 . . . . 0.0 113.756 -178.659 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.406 ' HA ' ' NZ ' ' A' ' 64' ' ' LYS . . . -146.5 141.81 27.43 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 113.447 -1.706 . . . . 0.0 110.43 178.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.495 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 1.6 m-20 -76.74 132.46 39.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.066 0.46 . . . . 0.0 111.289 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 77.9 mt -64.64 -44.15 96.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.488 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.9 t -59.64 -42.37 92.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.245 0.545 . . . . 0.0 111.087 -178.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.495 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 6.3 mt-30 -68.8 -36.8 78.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.084 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.467 ' HA ' ' HG2' ' A' ' 63' ' ' LYS . 56.3 t -69.85 -44.22 79.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.133 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 mp -67.78 -26.17 65.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.094 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -88.44 -52.9 4.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.136 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -67.17 127.34 32.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.039 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.72 39.79 2.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.8 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 76.8 mmt-85 -107.61 76.73 1.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.953 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.2 t 68.44 -68.82 0.16 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.054 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.428 ' CD1' ' HB2' ' A' ' 92' ' ' LEU . 9.0 tp -133.06 159.32 43.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.252 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.467 ' HG2' ' HA ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -110.43 -62.94 1.45 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.2 -179.765 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.406 ' NZ ' ' HA ' ' A' ' 50' ' ' ALA . 4.4 ttpt -132.32 135.17 46.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.754 0.312 . . . . 0.0 111.746 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 17.0 t -134.03 139.55 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 121.182 0.515 . . . . 0.0 111.805 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.559 ' O ' ' HA ' ' A' ' 90' ' ' GLN . 16.4 m-90 -100.42 139.42 36.12 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.019 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.562 ' CG2' ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -110.09 132.86 53.78 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.649 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.542 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 2.0 m-85 -115.9 145.7 42.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.478 -178.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.658 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 173.96 -170.3 43.42 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.17 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 26.9 mtm180 -87.5 -13.44 43.08 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.463 ' ND2' ' HB2' ' A' ' 74' ' ' CYS . 0.2 OUTLIER -84.32 143.12 41.45 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.927 0.394 . . . . 0.0 111.364 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 7.2 Cg_exo -70.47 1.3 5.04 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.175 2.583 . . . . 0.0 111.958 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.51 -49.07 10.31 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 122.019 0.914 . . . . 0.0 108.838 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.463 ' HB2' ' ND2' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -46.73 140.74 4.32 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 113.596 -1.638 . . . . 0.0 110.774 179.563 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -56.28 -19.5 14.46 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.216 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.542 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 15.7 t80 -129.57 118.38 21.93 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-O 120.654 0.264 . . . . 0.0 110.979 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -86.01 116.83 24.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.588 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.426 ' HA ' HG12 ' A' ' 43' ' ' ILE . 74.1 mt -91.81 -79.19 0.38 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.298 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -171.17 -102.21 0.15 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.541 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -176.46 61.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.895 0.379 . . . . 0.0 111.13 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 27.5 mt -99.73 125.88 53.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.906 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.28 -40.5 71.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.071 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -22.56 64.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.164 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.42 ' CD2' ' CE1' ' A' ' 88' ' ' HIS . 47.1 mt -98.83 152.27 19.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.133 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 93.1 p -97.0 167.34 11.13 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.735 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.658 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 1.1 m120 -43.98 -54.09 5.69 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.424 0.63 . . . . 0.0 109.792 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.445 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.4 OUTLIER -118.2 83.09 1.95 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.247 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.565 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.4 t60 -61.77 -45.22 94.81 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.054 -176.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.503 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 29.1 p90 -149.19 161.51 41.85 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 119.987 -0.685 . . . . 0.0 112.303 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.562 ' HG3' ' CG2' ' A' ' 67' ' ' THR . 4.5 mt-30 -135.46 147.19 48.83 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.313 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 19.9 mt -118.92 131.89 70.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.161 178.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.433 ' HG ' ' CB ' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -119.7 138.06 53.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.124 0.488 . . . . 0.0 111.964 -178.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 tt -125.24 131.14 53.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.325 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 153.13 -22.05 0.77 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.936 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.98 89.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.872 0.368 . . . . 0.0 111.053 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 52.39 30.3 7.99 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.146 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.96 -35.81 4.08 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.54 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -59.21 -171.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.903 0.382 . . . . 0.0 110.832 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.52 144.6 48.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.925 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.433 ' CB ' ' HG ' ' A' ' 92' ' ' LEU . 3.8 mm? -129.96 142.52 50.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.002 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.68 128.14 56.31 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.429 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 52.8 t30 -115.57 117.04 29.23 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.69 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 14.9 p30 -79.84 140.19 36.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.476 HD12 HG23 ' A' ' 67' ' ' THR . 15.9 pt -145.56 33.81 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 111.574 0.213 . . . . 0.0 111.574 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.597 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -93.96 150.35 20.43 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 120.996 0.427 . . . . 0.0 111.891 -178.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.1 m -68.59 -31.48 70.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.765 178.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -98.23 -19.62 17.73 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.597 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.12 156.23 10.02 Favored Glycine 0 N--CA 1.438 -1.21 0 C-N-CA 120.246 -0.978 . . . . 0.0 113.642 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.5 m -117.4 137.78 52.26 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.847 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -114.02 148.55 36.81 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -177.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.28 113.4 18.21 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.171 177.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 44.66 42.84 6.15 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.341 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.24 -10.52 70.84 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.504 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -104.77 118.54 36.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.078 0.466 . . . . 0.0 110.648 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.847 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.3 tptm -73.33 128.14 34.64 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.23 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.3 m -100.5 164.76 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.237 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 120' ' ' SER . 30.5 tt0 -70.05 127.09 31.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.514 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.69 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 24.2 tttt -53.09 162.38 0.68 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.857 0.361 . . . . 0.0 110.438 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.0 OUTLIER 35.4 33.99 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.14 -179.166 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.19 145.12 40.43 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.053 179.395 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -90.35 130.75 36.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.085 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -129.39 148.57 51.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.276 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.4 116.4 12.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.864 0.364 . . . . 0.0 110.354 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 65.3 tp -56.36 157.54 4.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.435 0.636 . . . . 0.0 111.587 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.3 t -124.4 153.31 42.08 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.327 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.404 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 30.1 mm100 -71.3 123.54 22.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.897 0.379 . . . . 0.0 110.046 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.08 21.55 59.39 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.866 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -55.86 173.92 0.13 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.965 0.412 . . . . 0.0 111.057 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 9.5 tt0 -145.07 135.47 24.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.287 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 13.5 mt -113.86 128.04 70.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.26 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.465 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.5 m -104.36 138.78 40.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.208 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.495 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 35.4 m -140.19 158.42 25.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.25 34.36 20.7 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.92 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.453 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.2 t -75.15 140.45 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-O 121.763 0.792 . . . . 0.0 112.533 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.97 -39.37 0.6 Allowed Glycine 0 N--CA 1.437 -1.249 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.414 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 47.9 t -126.35 131.84 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 114.731 -0.735 . . . . 0.0 109.201 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -50.6 -38.71 47.1 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -93.37 6.3 48.62 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.414 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 5.3 t70 -120.11 27.73 8.47 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.465 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.1 mt -107.26 139.5 28.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.022 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.0 tt -122.11 134.34 54.76 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.512 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.441 ' HB3' HG23 ' A' ' 40' ' ' THR . 47.0 t -113.8 150.79 32.98 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.611 0.72 . . . . 0.0 112.638 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 2.1 mm? -135.69 143.55 45.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.487 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.4 t -110.97 139.85 32.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.824 0.345 . . . . 0.0 111.138 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.456 HG21 HD11 ' A' ' 145' ' ' ILE . 16.2 mt -106.31 125.16 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.072 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.03 109.89 19.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.816 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.404 ' CD1' ' HA ' ' A' ' 126' ' ' GLN . 5.0 mp -85.96 134.07 28.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.416 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -86.06 127.7 34.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.844 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -74.03 -23.91 59.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.21 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -45.03 90.99 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.035 0.445 . . . . 0.0 110.649 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -58.82 -44.13 90.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.92 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -65.11 -39.11 92.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.924 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -59.19 -42.57 91.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.985 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.0 t -61.19 -45.97 92.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.056 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.11 -35.98 79.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.89 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -67.37 -37.2 82.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.912 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -86.99 -37.05 17.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.939 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.6 p30 42.34 77.39 0.06 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.467 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.05 121.14 27.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.974 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.1 m -78.49 141.0 16.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.164 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -159.33 106.87 1.76 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.866 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.63 -29.25 16.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.949 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -76.99 123.33 33.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.06 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.915 -179.939 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.787 0.327 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.9 p -135.5 -54.34 0.78 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.901 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.66 -38.65 70.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.805 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.6 mtm-85 -58.84 -46.08 88.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.972 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -61.39 -35.08 76.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.876 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.6 tt -61.18 -45.18 95.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.959 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.41 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 6.1 mm -62.64 -35.23 69.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.156 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.25 -44.59 84.01 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.9 0.381 . . . . 0.0 110.425 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -67.15 -23.74 65.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.419 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.41 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.75 -47.45 80.04 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.202 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.12 -47.05 14.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.814 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -175.45 158.32 2.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.882 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -87.25 149.59 24.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.846 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -81.22 101.87 9.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.982 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.5 mm -85.19 138.37 19.2 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 CA-C-O 121.706 0.765 . . . . 0.0 111.811 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.7 84.7 0.42 Allowed Glycine 0 C--N 1.315 -0.606 0 CA-C-N 114.507 -1.224 . . . . 0.0 112.448 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.11 -42.12 66.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.711 0.291 . . . . 0.0 111.022 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.436 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER 179.27 37.88 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -179.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.681 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.4 mm -73.02 137.08 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-N 113.598 -1.637 . . . . 0.0 112.658 -177.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.495 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.3 t -93.66 -59.82 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.658 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.94 156.46 42.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.229 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.425 ' NE ' HG23 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -119.88 138.14 53.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.815 0.34 . . . . 0.0 111.031 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.436 HG22 ' CD2' ' A' ' 76' ' ' TYR . 1.8 m -104.66 122.71 58.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.772 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.4 mt -125.0 124.17 67.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.572 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 52.8 t -80.02 108.74 13.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.859 0.361 . . . . 0.0 110.537 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.0 t -74.55 -25.46 59.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.639 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.493 HG22 ' HB3' ' A' ' 142' ' ' SER . 74.7 p -79.86 -2.35 43.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.46 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.15 76.73 0.24 Allowed Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.824 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -146.53 -43.86 0.19 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.913 0.387 . . . . 0.0 110.876 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.542 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.1 mt -117.93 141.3 29.01 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.005 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.542 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 52.5 Cg_endo -72.35 145.85 43.96 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.216 1.944 . . . . 0.0 111.788 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.425 HG23 ' NE ' ' A' ' 35' ' ' ARG . 68.6 mt -54.15 142.46 7.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.049 0.452 . . . . 0.0 111.829 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.486 ' HB2' ' CE2' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -124.67 133.99 53.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.861 178.873 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.08 119.92 32.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.141 0.496 . . . . 0.0 111.863 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.533 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 5.2 mt -98.04 131.96 44.0 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.681 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -143.55 157.55 44.34 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -178.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.495 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -141.07 146.29 36.94 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 113.694 -1.594 . . . . 0.0 110.993 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.419 ' HB3' ' HG2' ' A' ' 54' ' ' GLN . 66.4 m-20 -74.87 114.4 13.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.045 0.45 . . . . 0.0 111.196 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.2 mt -64.44 -42.45 95.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.734 -0.667 . . . . 0.0 112.024 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.31 -40.99 79.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.315 0.579 . . . . 0.0 110.586 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.419 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 35.1 mm-40 -68.52 -36.87 79.46 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.548 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 t -67.26 -49.16 74.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.018 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.87 -40.4 91.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.986 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -65.19 -43.79 90.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.907 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.2 108.44 19.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.837 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -86.16 79.47 9.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.796 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.6 mmt85 -118.08 169.19 9.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.98 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.8 t -78.38 -19.73 52.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.217 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.403 HD13 ' CG2' ' A' ' 65' ' ' VAL . 1.4 tp -134.45 138.65 49.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.771 0.32 . . . . 0.0 111.349 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -115.68 -71.09 0.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.939 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.441 ' CE ' ' O ' ' A' ' 49' ' ' SER . 26.5 ttpt -141.06 144.09 34.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.016 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.483 HG12 ' HB3' ' A' ' 92' ' ' LEU . 14.4 t -127.72 139.5 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-O 121.29 0.567 . . . . 0.0 112.08 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.533 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 18.9 m-90 -100.77 139.32 36.62 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.144 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.79 126.97 55.8 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.521 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -118.06 145.23 44.96 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.79 -178.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.603 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.46 -172.69 37.73 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.084 -1.055 . . . . 0.0 113.593 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -74.28 -0.61 17.53 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -84.69 132.14 47.42 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.624 0.249 . . . . 0.0 111.29 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.417 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 14.7 Cg_exo -67.83 -12.1 34.26 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.58 2.186 . . . . 0.0 111.707 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.02 -43.19 16.63 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-O 121.914 0.864 . . . . 0.0 109.048 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -39.12 139.11 0.52 Allowed 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 113.701 -1.591 . . . . 0.0 111.089 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -56.44 -18.72 12.19 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.122 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.487 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 56.0 t80 -129.41 119.04 23.15 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.829 0.347 . . . . 0.0 110.915 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.417 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.8 t-160 -97.63 124.6 41.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.961 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.51 -179.81 4.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.903 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -55.44 -171.41 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.494 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -110.63 80.45 1.31 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.83 0.348 . . . . 0.0 110.889 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.417 ' HB ' HD12 ' A' ' 84' ' ' LEU . 2.4 mp -112.02 120.85 63.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.193 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.27 -29.65 64.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.196 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.89 -23.25 65.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.059 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.417 HD12 ' HB ' ' A' ' 81' ' ' ILE . 4.1 mp -107.05 152.87 23.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.912 0.387 . . . . 0.0 110.958 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 61.1 p -96.46 166.71 11.56 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.891 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.603 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.2 m-20 -43.32 -53.19 5.4 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.318 0.58 . . . . 0.0 109.799 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.9 mttm -118.03 81.36 1.66 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.576 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 15.8 t60 -58.81 -47.45 84.73 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.423 -177.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.504 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 32.1 p90 -146.31 159.81 42.86 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.154 -0.618 . . . . 0.0 112.063 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.483 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.0 tt0 -135.59 141.95 45.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.212 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 45.7 mt -120.44 131.84 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.297 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.483 ' HB3' HG12 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -120.09 139.73 52.12 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.004 0.43 . . . . 0.0 111.566 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -125.24 134.34 52.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.307 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -128.89 172.55 19.56 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.705 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.23 106.65 5.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.783 0.325 . . . . 0.0 110.955 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -175.24 -41.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.933 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 134.32 -26.1 3.4 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.474 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -109.38 -178.03 3.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.835 0.35 . . . . 0.0 111.027 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.407 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.2 OUTLIER -128.12 159.67 34.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.577 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 9.0 mt -120.3 142.1 49.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.897 0.38 . . . . 0.0 110.719 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.8 tt -112.95 125.0 53.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.059 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.452 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 59.8 t30 -119.09 115.93 25.3 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.688 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 11.8 p30 -77.94 137.55 38.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.779 178.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 8.4 pt -141.29 29.52 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 121.127 -0.229 . . . . 0.0 111.58 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.552 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 12.1 t -93.69 155.49 17.22 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.534 0.683 . . . . 0.0 112.838 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 69.5 m -70.06 -52.04 27.1 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.669 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -80.34 -0.54 37.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.281 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.0 156.24 30.66 Favored Glycine 0 N--CA 1.437 -1.25 0 C-N-CA 120.642 -0.789 . . . . 0.0 113.518 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.505 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 5.2 m -117.44 137.89 52.21 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.815 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -113.29 148.47 35.56 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -178.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.12 113.54 18.49 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.298 177.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 45.3 42.7 7.53 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.0 -7.69 76.6 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.462 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.59 118.51 36.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 117.041 0.421 . . . . 0.0 110.624 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.815 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 6.3 tptm -72.46 116.94 13.51 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.259 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.1 m -92.42 162.86 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.046 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' A' ' 120' ' ' SER . 0.6 OUTLIER -69.81 128.92 38.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.46 179.66 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.688 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 45.5 tttt -55.35 163.87 1.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.751 0.31 . . . . 0.0 110.195 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.7 OUTLIER 35.96 34.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.818 -179.162 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.43 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 2.7 p -112.12 143.58 42.91 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.458 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -94.22 132.28 38.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.045 0.45 . . . . 0.0 111.103 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 58.1 mm-40 -129.07 151.23 49.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.446 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 tp -72.56 128.56 35.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.843 0.354 . . . . 0.0 110.464 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.501 ' HG ' ' N ' ' A' ' 125' ' ' SER . 18.8 tp -57.55 155.28 9.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.375 0.607 . . . . 0.0 111.679 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.501 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -124.71 152.95 43.11 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.304 179.463 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.88 119.14 15.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.96 0.41 . . . . 0.0 110.07 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.32 24.71 63.87 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.124 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.4 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 32.0 t70 -52.95 170.31 0.08 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.928 0.394 . . . . 0.0 111.337 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 9.4 mt-10 -145.15 135.61 24.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.06 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.6 mt -111.64 128.08 68.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.459 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.463 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.6 m -104.25 140.39 37.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.01 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.576 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 22.7 m -140.36 158.75 25.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.44 43.7 10.18 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.167 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.46 ' HA ' HG12 ' A' ' 140' ' ' ILE . 74.0 t -83.01 140.44 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-O 121.609 0.719 . . . . 0.0 112.307 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.29 -40.17 0.95 Allowed Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.2 t -126.37 124.95 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-N 114.603 -0.799 . . . . 0.0 108.983 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -50.38 -30.73 12.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.769 0.319 . . . . 0.0 111.444 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.0 m -93.62 6.35 48.56 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -123.52 24.25 8.64 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.463 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 4.5 mt -107.0 139.07 29.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.313 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.31 134.49 53.17 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.202 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.493 ' HB3' HG22 ' A' ' 40' ' ' THR . 38.1 t -111.12 150.62 29.16 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.73 0.776 . . . . 0.0 112.46 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 3.5 mm? -135.66 149.12 49.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.125 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 13.8 t -118.81 140.09 43.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 111.382 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 28.1 mt -106.29 120.87 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.76 118.38 36.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.654 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.5 mt -84.98 134.03 27.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.495 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -81.84 115.72 21.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.723 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -63.74 -31.8 73.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.06 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -60.14 -46.06 90.91 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.005 0.431 . . . . 0.0 110.784 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -58.88 -44.07 91.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.983 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -63.78 -37.74 88.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.925 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -59.62 -40.89 89.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.925 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.1 t -67.81 -44.21 77.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.953 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.89 -39.84 91.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.911 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -61.28 -44.09 97.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.876 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.68 -37.08 31.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.895 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.6 p30 42.27 35.07 0.56 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.501 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 9.7 mtmt -111.98 120.45 41.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.878 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 35.0 m -89.36 127.73 41.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.212 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.64 70.72 3.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.9 ttm180 -137.02 98.59 3.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.93 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -76.83 138.11 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.166 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.884 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.796 0.332 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 52.1 p -130.58 -46.06 1.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.855 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -37.38 85.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.932 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -64.8 -41.81 95.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.867 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -57.93 -38.6 76.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.854 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.09 -31.85 70.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.811 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.415 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.0 mt -72.89 -35.4 49.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.831 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -57.38 -42.39 82.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.984 0.421 . . . . 0.0 110.493 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.1 tttt -67.08 -23.82 65.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.661 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.415 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.68 -47.52 79.67 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.261 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.28 -46.99 59.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.941 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -93.48 64.28 3.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.882 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -79.99 124.12 28.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.907 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -78.9 131.55 36.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.932 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.3 mm -81.96 138.31 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-O 121.654 0.74 . . . . 0.0 111.769 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.41 53.88 0.01 OUTLIER Glycine 0 C--N 1.315 -0.636 0 CA-C-N 114.472 -1.24 . . . . 0.0 112.406 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.34 -41.88 96.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.739 0.304 . . . . 0.0 110.967 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.423 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.7 OUTLIER 178.1 38.17 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 -179.841 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.689 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.1 mm -74.24 135.37 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-N 113.703 -1.589 . . . . 0.0 112.574 -177.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.5 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.9 t -93.51 -61.42 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.086 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.9 p -144.73 152.09 39.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.252 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.42 128.72 55.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.757 0.313 . . . . 0.0 111.339 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.0 t -96.67 122.91 48.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.867 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.6 mt -127.14 127.23 69.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.582 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 11.6 t -91.61 107.67 19.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.446 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 63.0 p -81.24 -24.88 37.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.636 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.529 ' CG2' ' HB2' ' A' ' 142' ' ' SER . 4.3 p -80.05 -2.71 45.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.662 0.268 . . . . 0.0 111.428 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.92 75.53 0.45 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.069 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -143.07 -40.88 0.31 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.92 0.39 . . . . 0.0 110.992 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.559 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.1 mp -125.7 142.15 41.24 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.927 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.559 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 52.7 Cg_endo -72.08 140.81 35.14 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.16 1.907 . . . . 0.0 112.227 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.7 mt -56.16 142.94 10.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.724 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -137.85 161.91 35.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.27 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.05 119.83 37.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.975 0.417 . . . . 0.0 111.746 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.55 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 4.4 mt -94.88 136.25 35.42 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.689 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.81 158.64 43.84 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -178.806 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.5 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -146.28 147.71 31.67 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 113.69 -1.596 . . . . 0.0 110.822 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.478 ' HB2' ' HG3' ' A' ' 54' ' ' GLN . 0.9 OUTLIER -74.95 128.36 35.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.172 0.51 . . . . 0.0 111.261 -179.551 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 92.0 mt -64.54 -43.9 96.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.033 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.8 t -57.08 -38.86 73.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.314 0.578 . . . . 0.0 110.539 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.478 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 6.0 mm-40 -68.47 -36.93 79.67 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.521 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.2 t -70.32 -47.19 67.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.028 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -29.03 70.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.963 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.9 tptm -82.23 -49.34 10.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.038 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -62.98 121.29 13.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.873 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -138.89 34.98 2.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.853 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.51 -70.65 0.33 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.982 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 78.4 p -93.97 -175.89 3.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.965 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.9 tp -72.3 150.04 8.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.122 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -79.62 -67.03 0.8 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.051 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.432 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.4 ttpt -149.93 139.98 22.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.296 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 14.6 t -130.72 139.28 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.311 0.577 . . . . 0.0 112.092 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.55 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.3 m-90 -102.4 139.45 37.99 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.151 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -112.18 128.32 56.2 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.561 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.51 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.8 OUTLIER -120.09 145.3 47.01 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.179 -178.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.529 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.17 -169.56 37.56 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.176 -1.012 . . . . 0.0 113.733 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.8 ttt-85 -77.2 0.29 22.42 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 122.56 0.344 . . . . 0.0 111.869 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.411 ' HB2' ' CB ' ' A' ' 86' ' ' ASN . 6.9 t-20 -84.76 132.64 45.69 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.632 0.253 . . . . 0.0 111.41 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.432 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 15.4 Cg_exo -67.17 -13.5 39.87 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.573 2.182 . . . . 0.0 111.702 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.73 -44.63 15.39 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-O 121.858 0.837 . . . . 0.0 108.968 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -39.88 141.06 0.47 Allowed 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 113.707 -1.588 . . . . 0.0 110.951 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 67' ' ' THR . 72.0 m-20 -56.32 -19.09 12.86 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.048 179.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.496 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 2.2 t80 -129.96 125.36 35.25 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.709 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.432 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.5 t-160 -96.04 107.95 20.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.919 0.39 . . . . 0.0 110.867 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.456 ' HA ' HG12 ' A' ' 43' ' ' ILE . 8.0 mp -92.35 163.82 13.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.877 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.11 165.58 7.1 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.308 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -73.89 72.76 1.59 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.88 0.371 . . . . 0.0 111.017 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.3 mp -107.78 119.91 58.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.09 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.88 -33.52 75.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.943 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.6 mmp_? -60.94 -23.36 65.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.099 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.419 HD23 ' CE1' ' A' ' 88' ' ' HIS . 16.4 mt -101.55 151.2 22.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.979 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 99.3 p -94.29 165.81 12.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.454 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.529 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 m-20 -42.8 -53.93 4.36 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.372 0.606 . . . . 0.0 109.694 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -118.82 81.86 1.76 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 177.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.536 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.8 t60 -59.42 -47.18 86.44 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.454 -177.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.51 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 33.3 p90 -143.62 159.86 41.7 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 119.967 -0.693 . . . . 0.0 112.041 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.6 tt0 -136.0 141.78 44.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.93 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 65.5 mt -117.82 128.68 74.94 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.093 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.424 ' HB3' HG13 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -113.94 147.24 38.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.018 0.437 . . . . 0.0 111.43 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.403 ' CD1' ' CG1' ' A' ' 33' ' ' VAL . 5.2 tp -125.1 132.24 53.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.386 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 164.12 -157.84 30.25 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.334 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 57.18 92.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.756 0.313 . . . . 0.0 110.934 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 63.35 -79.89 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.95 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -174.3 43.69 0.14 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.41 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -121.68 170.14 10.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.87 0.367 . . . . 0.0 110.933 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.2 mt -107.4 151.01 26.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.802 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.408 ' CB ' ' HG ' ' A' ' 92' ' ' LEU . 4.5 mp -133.0 144.71 50.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.447 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -112.79 121.83 45.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.225 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.406 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.4 t30 -115.59 115.52 26.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.992 0.425 . . . . 0.0 111.617 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.681 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 8.4 p30 -79.1 136.89 37.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.906 178.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 9.0 pt -143.62 38.11 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.555 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.46 151.2 20.85 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 121.066 0.46 . . . . 0.0 111.735 -179.185 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 55.1 m -68.87 -31.63 70.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.996 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -98.09 -19.97 17.63 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.555 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.42 154.61 9.41 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.144 -1.027 . . . . 0.0 113.801 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.1 m -117.62 137.92 52.3 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.822 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -115.76 148.41 39.85 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -178.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.15 113.5 18.42 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.08 177.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.2 m120 44.65 43.18 6.42 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.15 -8.69 75.65 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.49 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -105.36 118.55 36.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.127 0.489 . . . . 0.0 110.774 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.822 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 14.8 tptp -73.21 119.34 17.31 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.282 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.1 m -91.06 164.37 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.278 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 120' ' ' SER . 4.1 tp10 -69.93 126.21 29.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.655 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.681 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 24.7 tttm -52.29 161.51 0.64 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.896 0.379 . . . . 0.0 110.694 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.6 p30 34.35 35.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.325 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.19 145.01 40.62 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.049 179.362 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -88.92 127.34 35.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.987 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -129.34 146.35 51.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.747 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -72.82 113.7 10.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.026 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -53.42 165.85 0.34 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.679 0.752 . . . . 0.0 112.003 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.448 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -125.29 153.3 43.45 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.383 179.347 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.51 120.08 16.59 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.85 21.39 65.36 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.064 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.448 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 9.4 t70 -57.93 173.69 0.31 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.963 0.411 . . . . 0.0 111.065 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 13.9 tt0 -145.26 135.52 24.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.246 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.2 mt -109.52 128.33 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.177 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.46 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.8 m -104.07 139.55 39.01 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.497 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.6 m -140.15 158.36 25.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.24 44.1 10.0 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.885 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.436 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.9 t -83.35 140.41 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-O 121.742 0.782 . . . . 0.0 112.393 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.77 -37.61 0.88 Allowed Glycine 0 N--CA 1.436 -1.319 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -126.39 123.72 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 114.598 -0.801 . . . . 0.0 109.155 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -50.48 -33.41 21.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.623 0.249 . . . . 0.0 111.585 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 40.2 t -93.43 6.49 47.99 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -125.51 28.29 6.3 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.46 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 4.9 mt -107.11 139.56 28.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.874 178.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.6 134.49 55.0 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.752 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.529 ' HB2' ' CG2' ' A' ' 40' ' ' THR . 0.8 OUTLIER -112.19 136.75 51.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.03 0.443 . . . . 0.0 111.704 -179.472 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.427 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 2.9 mm? -130.88 138.52 49.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.352 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 20.8 t -110.76 137.13 44.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.957 0.408 . . . . 0.0 111.608 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.468 HG22 HD12 ' A' ' 145' ' ' ILE . 49.6 mt -106.19 127.39 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.086 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.2 115.79 28.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.642 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.5 mt -84.76 129.32 37.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.893 0.378 . . . . 0.0 111.331 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -75.96 116.78 17.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.942 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -65.36 -31.13 72.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.891 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -58.7 -44.35 90.31 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.975 0.417 . . . . 0.0 110.568 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -58.65 -44.02 89.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.777 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -64.33 -39.02 93.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.918 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -60.27 -42.58 95.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.981 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.9 t -68.05 -45.03 75.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.94 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.08 -35.95 77.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.891 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -66.35 -47.89 71.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.989 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.52 -37.14 32.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.99 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.1 p30 44.56 -172.53 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.507 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.88 132.93 51.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.964 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -99.25 137.52 26.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.169 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.89 -37.02 85.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.67 146.01 24.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 5.0 mt -87.7 113.83 25.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.098 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.866 -179.927 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.913 0.387 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.5 p -99.23 35.2 1.97 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.988 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -60.0 -47.13 87.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.627 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -71.19 -35.78 71.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.615 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.29 -39.3 82.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.859 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.61 -40.83 93.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.852 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.48 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.2 mm -70.29 -35.1 61.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.199 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -57.03 -37.58 71.95 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.866 0.365 . . . . 0.0 110.454 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -67.29 -23.83 65.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.666 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.92 -47.27 81.01 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.169 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.11 -30.47 43.8 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.833 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -89.0 53.07 2.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.92 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.67 123.23 25.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.874 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -65.55 137.09 57.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.882 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.4 mm -82.04 138.39 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-O 121.729 0.776 . . . . 0.0 111.733 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 157.7 42.59 0.02 OUTLIER Glycine 0 C--N 1.314 -0.677 0 CA-C-N 114.453 -1.248 . . . . 0.0 112.613 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.56 -43.11 99.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 110.755 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.499 ' O ' ' HB3' ' A' ' 49' ' ' SER . 4.7 m-20 -178.84 37.95 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.672 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 6.9 mm -71.25 142.02 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 CA-C-N 113.678 -1.601 . . . . 0.0 112.495 -176.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.402 ' CG2' ' CB ' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -104.38 -46.84 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.551 -178.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 28.4 p -163.0 145.56 10.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.127 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.429 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.94 134.68 54.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.874 0.368 . . . . 0.0 111.674 -178.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.423 HG13 ' CE2' ' A' ' 68' ' ' PHE . 3.4 m -99.77 122.71 51.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.469 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.3 mt -128.01 121.03 55.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.605 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 12.6 t -84.04 124.71 31.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.636 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.7 t -95.36 -25.05 16.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.517 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.401 HG23 ' HB3' ' A' ' 142' ' ' SER . 17.5 p -79.88 -2.13 42.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.506 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.15 74.13 0.52 Allowed Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.532 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -145.31 -39.46 0.25 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.777 0.322 . . . . 0.0 111.168 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.535 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.2 mt -122.19 140.57 32.67 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.843 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.535 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.3 Cg_endo -73.59 138.93 27.54 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.236 1.957 . . . . 0.0 112.225 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.5 mt -57.49 141.46 14.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.562 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.96 164.28 28.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.343 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.429 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 1.4 p-10 -116.21 119.86 37.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.146 0.498 . . . . 0.0 111.932 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.57 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 4.4 mt -98.5 137.27 37.41 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.672 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.6 158.77 43.8 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -178.415 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.402 ' CB ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.06 141.83 29.2 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.519 -1.673 . . . . 0.0 110.673 178.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.539 ' O ' ' HG3' ' A' ' 54' ' ' GLN . 0.8 OUTLIER -81.18 136.59 35.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.123 0.487 . . . . 0.0 111.275 -179.544 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.6 mp -65.34 -44.58 94.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.282 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.6 m -59.52 -43.14 93.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.944 -178.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.539 ' HG3' ' O ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -68.62 -36.88 79.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.946 0.403 . . . . 0.0 110.654 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.1 t -68.74 -41.81 82.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.972 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.03 -30.18 66.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.795 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -64.83 -45.82 84.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.981 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -101.79 98.98 9.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.5 33.51 2.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.872 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.8 mtm180 -73.41 -65.21 0.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.942 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.9 m -177.35 -39.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.0 tp -115.44 148.55 18.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.995 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.1 mmtm -127.08 -63.8 1.04 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.767 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.4 ' CE ' ' O ' ' A' ' 49' ' ' SER . 4.5 ttpt -145.71 130.62 18.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.172 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 13.0 t -126.93 139.11 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 121.264 0.554 . . . . 0.0 112.2 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.57 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.4 m-90 -100.87 139.8 36.05 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.144 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.482 ' HA ' ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.44 127.65 55.75 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.321 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.503 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.7 OUTLIER -119.64 145.21 46.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.96 -178.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.51 -169.66 38.62 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.199 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.56 1.43 22.58 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.401 ' HB2' ' CB ' ' A' ' 86' ' ' ASN . 10.5 t-20 -84.97 132.49 45.64 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.578 0.228 . . . . 0.0 111.36 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.444 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 15.9 Cg_exo -67.21 -13.23 38.85 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.678 2.252 . . . . 0.0 111.776 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.85 -43.69 16.33 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-O 121.901 0.858 . . . . 0.0 109.029 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -39.66 142.01 0.35 Allowed 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 113.688 -1.596 . . . . 0.0 111.2 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.1 m-20 -56.25 -19.12 12.61 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.981 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.487 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 5.8 t80 -129.63 127.61 40.96 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.666 0.269 . . . . 0.0 110.871 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.444 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.7 t-160 -102.13 108.73 20.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.888 0.375 . . . . 0.0 110.905 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.457 ' CD2' ' CD2' ' A' ' 76' ' ' TYR . 14.0 mt -82.61 -174.72 5.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.91 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -68.27 -89.32 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.446 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -179.3 71.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.842 0.353 . . . . 0.0 110.829 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 24.5 mm -108.38 123.77 64.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.001 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.69 -35.28 77.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.984 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.91 -22.08 63.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.261 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 21.1 mt -96.22 152.08 18.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.014 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 45.6 p -96.87 164.68 12.45 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.515 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.547 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -41.43 -53.61 3.32 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.497 0.665 . . . . 0.0 109.811 179.161 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -119.86 83.59 2.07 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 177.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.564 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.6 t60 -60.53 -46.04 91.63 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.089 -0.959 . . . . 0.0 112.568 -177.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.5 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 18.1 p90 -143.72 162.64 35.47 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 119.863 -0.735 . . . . 0.0 112.441 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.559 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -135.57 135.06 40.01 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.059 -179.118 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 52.0 mt -113.26 129.12 69.56 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.773 178.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.415 ' HG ' ' HB2' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -113.97 147.99 37.64 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.0 0.429 . . . . 0.0 111.527 -179.582 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.416 HD22 ' CZ ' ' A' ' 151' ' ' PHE . 0.9 OUTLIER -125.01 122.9 38.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.517 179.567 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -151.22 -166.1 13.49 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.472 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 59.12 -172.84 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.772 0.32 . . . . 0.0 110.698 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.65 62.5 3.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.988 0.423 . . . . 0.0 110.927 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 101.2 -18.41 54.26 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.797 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.5 151.12 17.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.92 0.391 . . . . 0.0 110.985 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.51 147.81 49.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.657 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.415 ' HB2' ' HG ' ' A' ' 92' ' ' LEU . 4.5 mm? -132.98 145.73 51.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.564 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.0 mt -112.7 127.94 56.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.03 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 90' ' ' GLN . 47.0 t30 -119.34 115.92 25.12 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.682 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 10.8 p30 -77.92 135.95 37.94 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.973 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 9.0 pt -143.84 40.1 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 111.56 0.208 . . . . 0.0 111.56 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.617 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.07 150.93 20.9 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-O 120.994 0.426 . . . . 0.0 111.877 -178.77 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 51.0 m -68.67 -31.89 71.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.694 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -98.56 -19.69 17.46 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.617 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.25 157.26 10.29 Favored Glycine 0 N--CA 1.439 -1.125 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.565 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.3 m -117.48 137.95 52.19 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.791 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -115.83 148.83 39.49 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -177.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.12 113.38 18.27 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.428 177.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 44.21 43.26 5.69 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.84 -17.34 53.51 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.416 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.8 tp60 -103.63 118.46 36.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.042 0.449 . . . . 0.0 110.471 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.791 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -70.4 138.87 51.66 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.264 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.4 m -105.91 165.81 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.853 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 120' ' ' SER . 22.6 mt-10 -69.8 124.93 25.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.631 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.682 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 14.7 tttt -52.53 163.11 0.46 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.778 0.323 . . . . 0.0 110.778 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.5 m-80 33.38 35.11 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.182 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.26 145.08 40.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.247 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -88.39 129.89 35.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.843 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 44.5 mm-40 -129.11 148.47 51.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.672 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.8 tp -72.49 122.12 20.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.876 0.37 . . . . 0.0 110.412 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.427 ' CD2' HG12 ' A' ' 147' ' ' ILE . 67.6 tp -58.86 155.89 12.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.456 0.646 . . . . 0.0 111.61 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.414 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -124.75 153.43 42.43 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.689 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -71.53 121.46 18.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.886 0.374 . . . . 0.0 110.122 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.22 22.22 57.94 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.199 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.414 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 21.8 t0 -54.92 173.93 0.08 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 120.877 0.37 . . . . 0.0 110.893 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -145.16 135.38 23.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.235 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.4 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 13.6 mt -113.9 128.18 70.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.081 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.466 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 4.9 m -104.25 138.28 40.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.062 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.515 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 33.5 m -140.28 158.13 25.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.86 32.12 18.95 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.852 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.45 ' HA ' HG12 ' A' ' 140' ' ' ILE . 55.3 t -73.79 140.37 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-O 121.679 0.752 . . . . 0.0 112.516 -179.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 159.26 -40.33 0.48 Allowed Glycine 0 N--CA 1.436 -1.307 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.144 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.438 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 49.1 t -126.36 137.51 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -50.69 -43.03 57.48 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.0 t -93.3 6.23 48.82 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.438 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 13.2 t0 -116.09 27.19 9.42 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -178.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.466 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.1 mt -107.43 139.46 29.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.127 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.425 ' CD2' HD23 ' A' ' 143' ' ' LEU . 4.3 tt -121.37 134.39 55.12 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.449 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.401 ' HB3' HG23 ' A' ' 40' ' ' THR . 48.1 t -111.33 151.08 28.82 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.592 0.711 . . . . 0.0 112.5 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.425 HD23 ' CD2' ' A' ' 141' ' ' LEU . 1.8 mm? -135.39 147.37 49.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.32 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.5 t -113.71 137.38 47.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.818 0.342 . . . . 0.0 111.125 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 39.8 mt -106.31 120.9 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.077 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.35 115.58 29.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.592 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.427 HG12 ' CD2' ' A' ' 124' ' ' LEU . 3.7 mt -84.65 133.16 29.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.33 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -83.55 108.46 16.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.939 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.19 -25.71 64.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.006 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.6 tptp -57.5 -42.95 83.73 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.013 0.435 . . . . 0.0 110.66 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.416 ' CZ ' HD22 ' A' ' 93' ' ' LEU . 28.4 t80 -59.34 -43.95 92.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.776 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.64 -33.99 74.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.852 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -68.44 -46.46 69.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.858 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 7.6 t -68.07 -41.08 82.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.907 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.405 HD22 ' CZ ' ' A' ' 151' ' ' PHE . 0.4 OUTLIER -68.0 -41.08 82.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.859 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -59.14 -48.03 83.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -80.59 -32.63 36.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.836 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.0 p30 42.55 92.71 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.555 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.96 130.08 40.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.862 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 9.2 m -82.42 118.4 30.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.186 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.84 -31.14 8.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.917 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 62.14 116.19 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.951 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.7 pt -80.11 138.5 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.126 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 30.4 ttt180 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.865 179.997 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.781 0.324 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.6 p -132.64 -64.31 0.76 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.94 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -71.94 -47.08 54.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.015 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.09 -45.82 89.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.991 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -59.99 -35.0 74.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.956 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.25 -40.71 94.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.886 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.442 ' O ' ' CD2' ' A' ' 23' ' ' PHE . 43.0 mm -68.84 -48.17 72.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.037 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.75 -33.67 71.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.4 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -58.74 -47.1 85.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.372 -0.377 . . . . 0.0 112.0 -178.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 24' ' ' SER . 4.5 p90 -71.89 -47.38 53.1 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.967 0.413 . . . . 0.0 111.033 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.537 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 1.2 m -58.4 -46.87 85.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.039 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -121.15 108.98 14.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.884 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -66.23 131.65 46.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.816 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.71 106.9 19.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.928 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.6 mm -81.95 138.29 19.75 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-O 121.613 0.721 . . . . 0.0 111.673 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -174.76 66.16 0.1 Allowed Glycine 0 C--N 1.314 -0.683 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.474 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -77.04 -38.36 52.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.802 0.334 . . . . 0.0 110.845 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.423 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 t-20 175.52 39.55 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.679 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.8 mm -71.93 136.16 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 CA-C-N 113.557 -1.656 . . . . 0.0 112.666 -177.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.484 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.8 t -92.28 -58.56 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.545 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.568 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.07 153.89 37.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.83 179.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.475 ' NE ' HG22 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -113.89 138.38 50.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.831 0.348 . . . . 0.0 111.02 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.432 ' HB ' ' CE1' ' A' ' 76' ' ' TYR . 19.8 t -103.32 122.96 56.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.212 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.426 ' HA ' HG12 ' A' ' 45' ' ' ILE . 19.8 mt -128.3 119.13 49.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.873 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 50.4 t -84.78 118.6 24.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.205 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.97 -22.11 27.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.911 -179.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.442 HG22 ' HB3' ' A' ' 142' ' ' SER . 69.6 p -79.81 -2.09 41.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.687 0.279 . . . . 0.0 111.579 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.14 73.18 0.56 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.83 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -145.28 -43.3 0.22 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.88 0.371 . . . . 0.0 111.014 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.519 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 7.7 mt -115.63 140.61 26.24 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.945 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.519 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 66.2 Cg_endo -76.1 146.08 28.47 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.295 1.997 . . . . 0.0 112.237 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.475 HG22 ' NE ' ' A' ' 35' ' ' ARG . 14.6 mt -57.35 148.2 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.549 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -139.41 161.76 36.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.348 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.68 119.77 37.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.065 0.459 . . . . 0.0 111.954 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.518 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 8.0 mt -95.69 134.46 38.57 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.679 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.91 157.46 43.9 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -178.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.484 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -143.63 141.97 30.82 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.421 -1.718 . . . . 0.0 110.505 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.457 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -74.87 141.86 44.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.336 0.589 . . . . 0.0 111.608 -179.197 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.3 mt -64.93 -44.65 96.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.236 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.55 -42.39 87.74 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.486 -178.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.457 ' CG ' ' O ' ' A' ' 51' ' ' ASP . 3.1 pt20 -68.27 -36.85 80.03 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.492 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.5 t -71.54 -41.87 72.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.982 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.05 -38.32 72.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.962 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -43.98 70.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.959 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.19 128.3 33.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.866 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.68 31.09 2.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.056 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.37 -63.1 1.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.885 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.3 t -176.96 -50.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.867 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 24.7 mm -114.09 150.17 16.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.071 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.96 -59.47 1.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.84 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.435 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.7 ttpt -140.35 131.33 26.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.965 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 7.8 t -127.75 139.06 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-O 121.266 0.555 . . . . 0.0 112.224 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.518 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.4 m-90 -101.04 139.26 36.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.882 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.458 ' HA ' ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -113.04 131.64 55.71 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.69 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.568 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -118.29 145.24 45.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.669 -178.291 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.614 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.95 -172.26 36.43 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.312 -0.946 . . . . 0.0 113.932 178.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.52 ' CZ ' ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -72.32 -3.67 25.2 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.88 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.424 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -84.51 128.85 59.82 Favored Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 121.191 -0.204 . . . . 0.0 111.036 -179.603 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.5 Cg_exo -67.24 -9.36 24.9 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.525 2.15 . . . . 0.0 111.574 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.8 -42.88 17.36 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -40.37 138.25 0.94 Allowed 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 113.879 -1.509 . . . . 0.0 110.247 179.165 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -56.33 -18.77 11.83 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.915 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.568 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 13.3 t80 -129.88 127.18 39.66 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.881 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -101.65 121.14 41.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.572 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.409 HD13 ' CA ' ' A' ' 69' ' ' GLY . 6.5 mp -95.56 -82.48 0.38 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.241 -179.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.98 -135.95 1.96 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.733 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -133.07 57.3 1.81 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.916 0.388 . . . . 0.0 111.191 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.404 ' HB ' HD13 ' A' ' 84' ' ' LEU . 16.8 mt -107.06 121.53 60.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.04 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.2 m -60.83 -24.89 66.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.35 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.401 ' HB2' HG21 ' A' ' 81' ' ' ILE . 5.2 mmp_? -60.48 -26.71 67.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.642 0.258 . . . . 0.0 111.353 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.52 ' HB2' ' CZ ' ' A' ' 70' ' ' ARG . 4.8 mp -107.05 153.37 22.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.919 0.39 . . . . 0.0 111.184 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 79.9 p -89.28 167.7 12.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.427 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.614 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.5 m-20 -42.48 -54.89 3.68 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.363 0.601 . . . . 0.0 109.75 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.31 84.15 2.13 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 177.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.547 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 17.6 t60 -60.39 -46.31 90.43 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.752 -176.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.509 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 30.0 p90 -146.84 160.49 42.22 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.447 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.495 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 3.8 tt0 -135.66 143.18 45.34 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.015 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 56.6 mt -118.52 130.29 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.981 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.428 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -111.37 149.6 30.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.025 0.441 . . . . 0.0 111.87 -179.549 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 36.2 tp -125.13 122.89 38.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.344 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.84 -160.42 19.73 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.706 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.7 172.48 7.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.798 0.332 . . . . 0.0 111.005 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 58.34 -174.34 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.913 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -91.03 48.05 2.96 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.426 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -126.95 135.67 51.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.876 0.37 . . . . 0.0 110.851 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.8 mp -114.58 160.05 19.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.769 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.6 mt -132.84 143.86 49.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.412 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.78 128.43 56.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.244 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.428 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 52.6 t30 -118.58 115.78 25.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.911 0.386 . . . . 0.0 111.745 -179.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.695 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 13.5 p30 -77.73 139.98 39.45 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 8.3 pt -147.4 38.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 111.538 0.199 . . . . 0.0 111.538 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.611 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.0 150.96 21.44 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.05 0.452 . . . . 0.0 112.127 -178.538 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 39.8 m -68.79 -31.32 70.25 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.573 177.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -97.38 -19.79 18.24 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.609 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.611 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 115.77 156.31 10.93 Favored Glycine 0 N--CA 1.438 -1.21 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.671 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.529 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.0 m -117.53 137.84 52.3 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.833 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -114.83 148.5 38.42 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -178.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.15 113.42 18.31 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.415 177.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 44.37 43.26 5.99 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.74 -10.78 68.66 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.792 -0.718 . . . . 0.0 113.458 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -104.82 118.58 36.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.067 0.46 . . . . 0.0 110.635 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.833 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 15.1 tptp -73.37 122.25 21.75 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.318 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 7.3 m -93.94 165.53 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.242 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.422 ' O ' ' HB3' ' A' ' 120' ' ' SER . 16.7 mt-10 -69.86 128.51 36.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.522 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.695 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 15.9 tttp -54.47 163.93 0.8 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.9 OUTLIER 34.35 36.41 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.816 -179.183 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.422 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.7 p -111.96 145.09 40.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.914 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -94.62 129.59 41.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.932 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -129.08 149.42 50.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.389 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -72.63 122.05 20.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.874 0.369 . . . . 0.0 110.26 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 65.0 tp -54.16 156.44 3.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.397 0.618 . . . . 0.0 111.866 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.55 153.48 42.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.544 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.408 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 3.8 tp60 -71.59 122.26 20.2 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.95 22.58 57.89 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.928 -178.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -52.15 170.7 0.06 Allowed 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.941 0.4 . . . . 0.0 111.095 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 9.5 tt0 -145.11 135.47 24.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.266 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 17.6 mt -115.6 127.53 73.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.604 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.442 ' HB ' ' HB2' ' A' ' 110' ' ' TRP . 3.5 m -104.49 140.61 37.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.082 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.485 ' CG1' ' CD2' ' A' ' 88' ' ' HIS . 35.2 m -140.34 158.42 25.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 112.216 0.451 . . . . 0.0 112.216 -178.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.2 43.03 8.92 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.806 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.442 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.9 t -84.72 140.53 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 121.686 0.755 . . . . 0.0 112.502 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.98 -38.32 0.8 Allowed Glycine 0 N--CA 1.435 -1.401 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.7 t -126.39 120.2 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-N 114.518 -0.841 . . . . 0.0 109.001 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.45 -28.43 8.29 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.708 0.289 . . . . 0.0 111.494 -178.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.2 p -93.61 6.52 48.0 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.18 31.15 4.45 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -179.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.442 HG12 ' HA ' ' A' ' 134' ' ' VAL . 4.9 mt -107.16 139.47 28.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.647 178.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.5 tt -123.64 134.46 53.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.928 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.442 ' HB3' HG22 ' A' ' 40' ' ' THR . 45.2 t -109.73 150.4 28.37 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.618 0.723 . . . . 0.0 112.29 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 65.2 mt -135.81 139.12 43.23 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.963 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.2 t -112.4 139.08 38.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.858 0.361 . . . . 0.0 111.09 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 31.4 mt -106.3 129.6 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.029 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.415 ' CD1' HD13 ' A' ' 37' ' ' ILE . 0.9 OUTLIER -113.68 116.29 29.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.832 179.881 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.408 ' CD1' ' HA ' ' A' ' 126' ' ' GLN . 6.2 mt -84.88 134.14 27.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.681 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -88.7 109.77 20.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.699 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -62.36 -30.6 71.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.059 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -42.27 84.39 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.969 0.414 . . . . 0.0 110.721 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -60.66 -44.07 96.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.887 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 16.4 mtmm -64.32 -33.77 76.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.069 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -58.86 -44.09 90.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.118 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.8 t -63.79 -46.1 86.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.016 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.46 -35.81 81.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.922 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -61.21 -39.37 89.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.869 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 159' ' ' LYS . 28.8 mt-30 -88.96 -30.77 18.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.28 -90.82 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.63 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 157' ' ' GLN . 0.2 OUTLIER -104.51 127.64 52.26 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.846 0.355 . . . . 0.0 110.945 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 12.5 p -77.75 117.94 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.138 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -119.94 124.92 47.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.914 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 69.8 mtt-85 -109.35 79.72 1.24 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 10.8 tt -87.77 140.07 16.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.107 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.795 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.788 0.328 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.98 -53.26 2.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -64.44 -41.46 96.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.938 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -70.94 -36.97 72.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -58.4 -39.88 80.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.793 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.42 -32.53 73.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.746 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.403 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.0 mt -73.04 -35.34 48.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.947 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -57.21 -43.53 82.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.912 0.387 . . . . 0.0 110.612 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -67.09 -24.26 65.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.529 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.403 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -57.0 -47.7 80.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.131 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.2 m -81.11 -41.87 21.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.105 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 66.19 -174.14 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.582 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -62.87 127.92 33.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.893 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -75.87 104.55 6.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.877 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.6 mm -82.05 138.37 19.6 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-O 121.621 0.724 . . . . 0.0 111.685 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 147.77 120.23 1.15 Allowed Glycine 0 C--N 1.314 -0.679 0 CA-C-N 114.598 -1.183 . . . . 0.0 112.555 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -75.82 -28.65 58.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.767 0.318 . . . . 0.0 110.976 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.419 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER -178.48 37.16 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.642 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.5 mm -76.26 137.15 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 CA-C-N 113.706 -1.588 . . . . 0.0 112.603 -177.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.483 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.4 t -91.97 -58.47 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.641 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.419 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 66.2 m -146.18 165.28 29.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.466 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.74 124.52 31.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.773 0.321 . . . . 0.0 111.171 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.405 HG23 ' CD1' ' A' ' 48' ' ' LEU . 55.7 t -94.9 122.96 46.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.012 0.434 . . . . 0.0 111.132 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.9 mt -124.68 122.69 64.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.057 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 42.3 t -79.96 112.88 17.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.831 0.348 . . . . 0.0 110.544 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.48 -25.26 38.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.508 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.47 HG23 ' HB3' ' A' ' 142' ' ' SER . 82.3 p -80.04 -2.36 43.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.738 0.304 . . . . 0.0 111.422 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.97 76.48 0.25 Allowed Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.924 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -147.14 -44.12 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.88 0.372 . . . . 0.0 110.931 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.563 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.1 mt -114.99 141.7 27.34 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.944 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.563 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 45.5 Cg_endo -71.15 145.34 48.96 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.2 1.933 . . . . 0.0 112.285 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.0 mt -60.13 138.81 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.722 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.83 164.33 20.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.294 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -120.82 119.68 33.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.997 0.427 . . . . 0.0 111.839 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.529 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 6.9 mp -92.14 130.41 37.87 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.642 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -141.58 155.81 45.74 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 122.2 1.0 . . . . 0.0 113.641 -179.581 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.483 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.23 142.06 29.19 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.468 -1.696 . . . . 0.0 110.934 179.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.425 ' HB2' ' HG3' ' A' ' 54' ' ' GLN . 0.5 OUTLIER -75.46 127.42 33.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.078 0.466 . . . . 0.0 111.102 -179.657 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.3 mt -64.41 -43.1 96.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.029 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 t -61.0 -39.94 91.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.228 0.537 . . . . 0.0 110.581 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.425 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 24.5 mm-40 -68.53 -36.82 79.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.735 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 49.1 t -71.83 -42.97 69.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.012 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.5 tt -71.06 -42.02 69.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.981 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 15.0 mmtp -64.47 -38.91 92.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.946 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -73.15 132.35 43.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.879 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -106.04 32.9 4.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.946 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -106.17 178.24 4.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.88 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 75.3 m -86.81 -30.29 21.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.0 tp -108.77 147.2 13.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.087 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.86 -73.67 0.62 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.75 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.419 ' CE ' ' O ' ' A' ' 49' ' ' SER . 3.9 ttpt -135.81 127.86 29.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.865 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.44 HG13 ' HG2' ' A' ' 90' ' ' GLN . 6.3 t -121.59 137.14 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 121.283 0.563 . . . . 0.0 111.876 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.547 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 19.5 m-90 -102.41 139.41 38.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.274 -0.876 . . . . 0.0 112.151 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -113.33 130.52 56.25 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 177.699 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.5 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.7 OUTLIER -117.65 145.49 44.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.392 -178.897 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.633 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.0 -169.05 36.52 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.776 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -81.7 4.26 22.48 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -84.77 132.47 46.2 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.469 0.176 . . . . 0.0 111.11 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.33 -13.81 41.47 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.488 2.125 . . . . 0.0 111.612 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.83 -42.7 17.51 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 121.921 0.867 . . . . 0.0 109.03 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -41.88 138.94 1.37 Allowed 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 113.831 -1.531 . . . . 0.0 111.081 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 67' ' ' THR . 20.3 m-20 -56.47 -18.6 11.93 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.981 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.462 ' CZ ' HG22 ' A' ' 43' ' ' ILE . 23.9 t80 -129.52 118.87 22.76 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-O 120.773 0.32 . . . . 0.0 110.998 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -97.46 107.92 20.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.728 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.1 pp -112.57 177.33 4.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.812 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.69 146.64 34.28 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.482 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -79.08 87.37 4.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.827 0.346 . . . . 0.0 110.932 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.8 mp -107.33 126.12 63.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.945 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.8 m -55.22 -33.92 63.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.995 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.96 -28.55 69.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.927 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.415 HD22 ' CE1' ' A' ' 88' ' ' HIS . 19.1 mt -100.43 151.98 20.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.979 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 91.6 p -95.1 165.61 12.34 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.647 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.633 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -43.09 -52.88 5.21 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.289 0.566 . . . . 0.0 109.641 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -118.94 82.44 1.86 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.546 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.4 t60 -59.92 -46.67 88.63 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.576 -177.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.5 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 26.4 p90 -145.41 160.05 42.15 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.755 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.44 ' HG2' HG13 ' A' ' 65' ' ' VAL . 4.5 tt0 -136.03 140.85 44.17 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.32 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.427 ' O ' ' CG1' ' A' ' 65' ' ' VAL . 71.2 mt -115.13 131.08 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.92 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.413 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.6 OUTLIER -112.59 147.06 37.46 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.141 0.496 . . . . 0.0 111.891 -179.602 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 28.6 tp -125.21 122.83 38.14 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.438 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 171.82 -177.46 44.57 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.683 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 59.39 81.85 0.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.821 0.343 . . . . 0.0 110.931 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 60.09 -177.38 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.834 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -70.38 65.15 0.77 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.48 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -142.41 153.41 43.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.802 0.334 . . . . 0.0 110.926 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -115.85 153.87 30.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.862 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.412 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 3.9 mp -132.99 145.73 51.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.606 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.85 126.91 55.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.066 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.413 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 52.0 t30 -119.38 115.74 24.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.964 0.411 . . . . 0.0 112.069 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.663 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 10.1 p30 -76.38 141.04 41.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.739 178.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 8.3 pt -149.28 39.1 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.546 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -98.84 153.01 19.1 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-O 121.102 0.477 . . . . 0.0 111.847 -179.062 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.2 m -68.83 -31.72 70.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.058 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -98.29 -19.93 17.51 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.54 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 118.83 157.31 10.38 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.698 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.523 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.6 m -117.61 137.81 52.37 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 123.142 0.577 . . . . 0.0 109.492 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.847 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -115.61 148.66 39.37 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.16 113.62 18.56 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.478 177.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 52.6 m-20 43.41 43.9 4.59 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.76 -13.64 62.21 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.608 -0.806 . . . . 0.0 113.432 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -103.78 118.52 36.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.976 0.417 . . . . 0.0 110.571 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.847 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 12.0 tptt -72.93 124.2 24.97 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.408 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.8 m -90.01 176.59 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.084 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.9 pt-20 -83.25 124.43 30.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.497 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.663 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 20.4 tttt -50.5 159.78 0.47 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.025 0.441 . . . . 0.0 111.086 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.472 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 3.6 p30 34.65 33.99 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.621 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.52 145.15 40.78 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.95 179.181 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -87.37 132.43 33.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.861 0.362 . . . . 0.0 110.99 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.412 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 43.7 mm-40 -129.17 148.13 51.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.536 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.3 tp -72.71 118.53 15.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.056 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.415 ' CD2' HG12 ' A' ' 147' ' ' ILE . 66.9 tp -52.91 155.85 2.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.411 0.624 . . . . 0.0 111.719 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.447 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.76 153.29 42.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.585 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.41 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 1.2 tp60 -71.79 120.78 17.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.94 0.4 . . . . 0.0 110.417 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.21 24.82 56.11 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.357 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.447 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 21.5 t0 -56.67 174.5 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.87 0.367 . . . . 0.0 110.912 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -145.22 135.49 24.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.093 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 3.9 mt -114.99 128.27 72.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.483 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.468 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.6 m -104.24 140.21 38.16 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.021 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.514 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.1 m -140.31 158.33 25.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.4 35.66 19.54 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.086 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.438 ' HA ' HG12 ' A' ' 140' ' ' ILE . 63.3 t -76.1 140.4 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-O 121.666 0.746 . . . . 0.0 112.474 -179.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.4 -38.87 0.77 Allowed Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.434 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 51.2 t -126.33 132.88 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-N 114.754 -0.723 . . . . 0.0 109.206 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.61 -40.16 52.08 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.39 6.4 48.28 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -178.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.434 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 13.0 t0 -116.69 25.1 10.8 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.468 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 4.9 mt -107.36 139.42 29.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.244 178.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.7 tp -124.15 134.46 53.32 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.342 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.47 ' HB3' HG23 ' A' ' 40' ' ' THR . 37.2 t -113.04 150.46 31.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.59 0.71 . . . . 0.0 112.743 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -135.91 142.33 44.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.646 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.9 t -114.25 135.34 54.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.86 0.362 . . . . 0.0 111.254 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.2 mp -105.59 127.56 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.375 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.58 120.03 40.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.662 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.415 HG12 ' CD2' ' A' ' 124' ' ' LEU . 4.9 mt -84.92 134.08 27.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.48 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.4 106.81 13.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.775 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.42 -32.12 68.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.016 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.31 -45.14 92.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.59 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -59.0 -44.23 91.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.915 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.26 -36.52 84.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.072 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -59.0 -46.4 88.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.149 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 11.4 t -59.36 -44.63 92.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.03 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.13 -36.01 77.02 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.886 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.98 -48.15 59.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.987 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.51 -36.51 44.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.949 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.4 p30 42.63 85.78 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.487 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 11.0 tttt -110.03 115.84 30.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.921 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 5.9 m -100.09 119.98 48.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.116 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 22.8 t0 60.04 108.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.924 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.99 94.93 9.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.809 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.5 mt -79.02 118.92 27.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.078 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.941 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.801 0.334 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -158.92 -74.59 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.946 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -69.11 -46.92 66.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.833 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.4 ttm180 -63.73 -35.96 82.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.98 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -56.87 -42.29 79.51 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.885 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.65 -32.36 68.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.691 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.425 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.3 mt -73.14 -35.2 47.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.84 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -39.77 76.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.92 0.39 . . . . 0.0 110.503 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.405 ' HA ' ' HG3' ' A' ' 25' ' ' GLN . 0.8 OUTLIER -67.1 -24.51 65.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.622 179.303 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.425 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -57.17 -47.59 80.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.619 -179.83 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.34 -47.25 18.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.28 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.405 ' HG3' ' HA ' ' A' ' 22' ' ' LYS . 1.1 pp0? -84.54 114.75 22.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.899 0.381 . . . . 0.0 110.989 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -87.7 142.39 27.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.911 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -77.88 124.17 27.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.6 mm -81.97 138.39 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 CA-C-O 121.654 0.74 . . . . 0.0 111.705 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 140.11 110.26 0.86 Allowed Glycine 0 C--N 1.315 -0.614 0 CA-C-N 114.431 -1.258 . . . . 0.0 112.51 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.4 -28.31 34.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.826 0.346 . . . . 0.0 110.946 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.414 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.8 OUTLIER 178.59 38.29 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.711 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.9 mm -73.21 134.76 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 CA-C-N 113.621 -1.627 . . . . 0.0 112.479 -177.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.487 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.2 t -89.91 -60.12 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.829 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 6.7 p -150.13 150.87 32.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.147 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.85 138.16 50.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.224 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.7 t -104.65 122.69 57.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.016 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.3 mt -125.78 125.69 68.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.42 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 44.3 t -82.11 120.08 24.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.844 0.354 . . . . 0.0 110.543 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.5 t -86.0 -27.75 24.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.499 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.469 HG23 ' HB3' ' A' ' 142' ' ' SER . 42.4 p -79.82 -2.26 42.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.554 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.97 77.91 0.2 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.86 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -146.73 -44.89 0.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.845 0.355 . . . . 0.0 110.921 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.556 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.5 mt -113.93 141.52 26.35 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.062 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.556 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 58.1 Cg_endo -73.32 140.8 31.04 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.156 1.904 . . . . 0.0 112.199 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.6 mt -55.16 141.44 11.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.737 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.402 ' HB2' ' CE2' ' A' ' 76' ' ' TYR . 0.4 OUTLIER -131.49 163.92 26.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.087 179.503 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.35 119.84 35.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.103 0.478 . . . . 0.0 111.78 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.507 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 1.3 mt -98.53 135.59 39.86 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.711 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.37 159.52 42.93 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -178.573 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.487 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -141.96 141.68 32.93 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.699 -1.591 . . . . 0.0 110.55 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.408 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 45.3 m-20 -79.48 131.58 36.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.104 0.478 . . . . 0.0 111.445 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.421 HD12 ' CE1' ' A' ' 151' ' ' PHE . 31.2 mm -64.48 -45.04 96.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.971 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.6 m -59.41 -40.62 87.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.183 0.516 . . . . 0.0 110.744 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.408 ' CG ' ' HB2' ' A' ' 51' ' ' ASP . 10.0 mm-40 -68.45 -36.98 79.78 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.783 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.5 t -69.48 -41.5 80.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.95 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.19 -33.79 70.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.942 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.46 -44.34 19.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.085 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -62.87 117.43 6.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.007 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.1 -26.73 14.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.923 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -55.24 174.87 0.08 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.006 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.456 ' O ' ' CG2' ' A' ' 62' ' ' ILE . 59.9 p -69.21 133.08 47.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.01 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.456 ' CG2' ' O ' ' A' ' 61' ' ' SER . 9.1 tp 54.32 155.52 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.783 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.9 mmtm -105.17 -70.06 0.79 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.15 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.424 ' CE ' ' O ' ' A' ' 49' ' ' SER . 29.2 ttpt -134.77 139.72 45.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.866 0.365 . . . . 0.0 111.07 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.465 HG11 ' HG2' ' A' ' 90' ' ' GLN . 11.1 t -127.24 139.28 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 121.166 0.508 . . . . 0.0 111.703 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.545 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 19.2 m-90 -100.94 138.4 38.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.249 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.407 ' HA ' ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.46 127.11 55.99 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.364 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.532 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 0.7 OUTLIER -108.9 145.64 35.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.592 -178.255 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.753 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 173.01 -175.26 45.98 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.512 -0.852 . . . . 0.0 113.196 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.411 ' NH1' ' HB2' ' A' ' 70' ' ' ARG . 5.0 mtp-105 -82.93 -4.67 58.49 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.633 0.254 . . . . 0.0 111.454 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.444 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.6 p30 -88.3 139.56 30.26 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-O 120.789 0.328 . . . . 0.0 111.229 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 9.1 Cg_exo -69.46 -4.41 13.77 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.842 2.361 . . . . 0.0 111.809 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.64 -45.96 13.87 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-O 121.932 0.872 . . . . 0.0 108.936 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.26 139.45 1.91 Allowed 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 113.746 -1.57 . . . . 0.0 110.424 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -56.29 -19.19 13.15 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.013 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.532 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 39.3 t80 -130.13 121.44 26.31 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.905 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.417 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 -88.41 116.51 26.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.804 0.335 . . . . 0.0 110.726 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.6 mt -92.62 -82.87 0.32 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.229 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -170.3 -100.68 0.14 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.468 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -176.64 71.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.845 0.355 . . . . 0.0 111.285 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.6 mp -110.6 121.8 63.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.684 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.95 -38.07 67.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.501 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.0 mmp_? -60.71 -19.93 59.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.764 0.316 . . . . 0.0 110.912 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.433 HD21 ' CE1' ' A' ' 88' ' ' HIS . 34.7 mt -101.91 152.33 21.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.792 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 86' ' ' ASN . 96.3 p -97.91 170.68 8.78 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.508 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.753 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.3 m-20 -41.05 -80.64 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.418 ' HB2' HD11 ' A' ' 104' ' ' ILE . 13.8 mttm -92.86 83.17 4.73 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.545 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 17.3 t60 -57.71 -46.14 84.77 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.033 -177.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.517 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 16.3 p90 -145.87 158.71 43.85 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.486 -0.486 . . . . 0.0 112.076 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.1 tt0 -135.72 142.04 44.97 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.254 -178.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.438 ' O ' ' CG1' ' A' ' 65' ' ' VAL . 59.3 mt -117.6 131.68 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.671 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.412 ' HB3' HG13 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -114.2 143.61 44.54 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.041 0.448 . . . . 0.0 111.876 -179.296 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.409 ' HG ' ' CG1' ' A' ' 33' ' ' VAL . 2.3 tm? -125.34 126.56 45.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.441 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 169.84 -145.85 9.55 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.443 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 56.82 -172.8 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.643 0.259 . . . . 0.0 110.638 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -69.89 66.15 0.24 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.944 0.402 . . . . 0.0 110.675 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.24 -174.57 55.25 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.432 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 66.82 -178.04 0.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.871 0.367 . . . . 0.0 111.048 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 mt -130.86 160.21 35.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.866 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.412 ' CB ' ' HG ' ' A' ' 92' ' ' LEU . 4.0 mm? -129.9 142.35 50.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.275 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.5 mp -112.83 128.73 56.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.289 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -119.79 115.56 24.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.053 0.454 . . . . 0.0 111.692 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.68 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 11.1 p30 -78.53 137.04 37.71 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.418 HD11 ' HB2' ' A' ' 87' ' ' LYS . 10.2 pt -145.26 39.19 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -178.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.588 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.35 152.84 19.5 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 121.171 0.51 . . . . 0.0 111.867 -178.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 49.1 m -68.83 -31.58 70.66 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.857 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -98.19 -19.97 17.56 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.588 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.7 158.05 10.87 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.788 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.6 m -117.37 137.75 52.25 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.822 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -115.34 148.46 39.24 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -178.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.21 113.39 18.24 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.538 -1.21 . . . . 0.0 108.246 177.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 43.77 43.55 5.08 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.22 -10.99 68.92 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.481 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.69 118.61 37.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.087 0.47 . . . . 0.0 110.612 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.822 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 12.7 tptt -73.17 121.53 20.41 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.197 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.2 m -91.0 164.08 2.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.189 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 120' ' ' SER . 4.3 tp10 -69.82 125.35 26.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.572 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.68 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 73.9 tttt -51.96 161.35 0.59 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.858 0.361 . . . . 0.0 110.754 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.8 p30 34.78 34.75 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.309 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.27 145.17 40.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.078 179.498 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -89.32 129.04 35.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.04 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 47.0 mm-40 -129.18 147.43 51.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.556 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 tp -72.7 132.76 44.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.298 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 65.9 tp -62.78 156.71 23.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.487 0.661 . . . . 0.0 111.624 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.441 ' O ' HD12 ' A' ' 147' ' ' ILE . 0.4 OUTLIER -124.47 153.31 42.19 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.056 179.707 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.404 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.05 117.88 13.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.024 0.44 . . . . 0.0 110.244 -179.446 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.8 24.42 64.47 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.015 -178.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.409 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 16.9 t70 -53.43 171.92 0.07 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.901 0.381 . . . . 0.0 110.955 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.8 mt-10 -145.15 135.52 24.13 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.098 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 13.7 mt -114.25 126.57 71.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.483 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.458 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 4.3 m -104.42 139.09 39.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.955 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.486 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 35.2 m -140.25 158.32 25.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.74 32.87 17.31 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.84 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.448 ' HA ' HG12 ' A' ' 140' ' ' ILE . 54.6 t -75.75 140.48 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-O 121.629 0.728 . . . . 0.0 112.478 -179.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.01 -38.39 0.69 Allowed Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.7 t -126.32 124.45 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 CA-C-N 114.666 -0.767 . . . . 0.0 109.125 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.47 -32.65 18.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.73 0.3 . . . . 0.0 111.381 -178.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 31.3 t -93.45 6.47 48.06 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -127.93 30.62 5.24 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.458 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.6 mt -107.13 139.52 28.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.784 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.42 134.3 54.61 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.752 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.469 ' HB3' HG23 ' A' ' 40' ' ' THR . 46.6 t -110.82 150.58 28.93 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.59 0.709 . . . . 0.0 112.157 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 3.5 mm? -136.02 149.42 48.8 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.597 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.8 t -117.55 135.76 56.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.712 0.292 . . . . 0.0 110.978 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 3.6 mt -106.57 124.63 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-O 121.044 0.45 . . . . 0.0 111.046 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.93 139.68 42.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.365 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.441 HD12 ' O ' ' A' ' 125' ' ' SER . 3.3 mp -105.65 134.08 48.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.91 0.386 . . . . 0.0 111.552 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -85.93 112.27 21.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.625 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -57.52 -27.85 62.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.122 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -60.77 -46.02 92.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.809 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.421 ' CE1' HD12 ' A' ' 52' ' ' ILE . 29.1 t80 -59.95 -44.18 94.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.063 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -64.42 -41.35 96.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.953 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -59.28 -37.01 76.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.897 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.9 t -67.4 -43.84 80.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.923 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -64.71 -37.21 86.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.11 -38.32 90.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.917 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -87.04 -35.75 18.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.953 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.6 p30 42.5 43.77 3.27 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.459 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -124.79 114.01 18.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.888 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.3 p -87.13 138.31 19.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.098 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -169.6 96.64 0.31 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.935 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -140.01 -52.51 0.51 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.947 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.9 tt -98.02 132.75 42.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.153 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.898 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.796 0.332 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.6 p -151.39 89.74 1.52 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -72.04 -47.05 54.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.941 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -66.94 -39.92 87.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.015 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -57.55 -40.15 78.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.915 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.15 -33.91 69.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.629 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.3 mt -73.14 -35.24 47.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.783 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -57.23 -35.2 69.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.454 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.428 ' HA ' ' CG ' ' A' ' 25' ' ' GLN . 18.1 mttp -67.03 -24.07 65.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.613 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -62.24 -47.85 82.57 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.645 -179.715 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.5 m -65.7 -47.25 76.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.777 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.428 ' CG ' ' HA ' ' A' ' 22' ' ' LYS . 3.8 pt20 -68.81 120.13 14.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.93 0.395 . . . . 0.0 111.11 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -101.01 122.46 43.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.921 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -65.03 134.57 54.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.761 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.7 mm -81.99 138.35 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 121.644 0.735 . . . . 0.0 111.69 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -162.92 71.74 0.2 Allowed Glycine 0 C--N 1.314 -0.69 0 CA-C-N 114.559 -1.201 . . . . 0.0 112.578 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.56 -37.88 55.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.863 0.363 . . . . 0.0 110.929 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.429 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.3 m-20 177.99 38.32 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.654 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.5 mm -74.14 135.63 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 CA-C-N 113.641 -1.618 . . . . 0.0 112.492 -177.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.482 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.4 t -90.81 -58.97 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.436 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.2 p -145.76 158.92 43.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.059 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.36 124.99 41.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.745 0.307 . . . . 0.0 111.528 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.1 t -94.92 122.68 46.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.923 0.392 . . . . 0.0 110.957 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.7 mt -125.07 120.23 57.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.266 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.528 ' SG ' ' HB ' ' A' ' 43' ' ' ILE . 20.0 m -85.74 99.88 11.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.902 0.382 . . . . 0.0 110.532 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 82.3 p -79.09 -19.73 50.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.14 -178.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.552 HG22 ' CB ' ' A' ' 142' ' ' SER . 10.5 p -79.79 -2.7 44.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.729 0.299 . . . . 0.0 111.354 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.58 71.0 0.98 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.014 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -140.37 -39.95 0.43 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.764 0.316 . . . . 0.0 111.225 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.578 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.3 mt -133.88 145.33 55.49 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.668 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.578 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 41.9 Cg_endo -69.74 146.16 59.47 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.324 2.016 . . . . 0.0 112.594 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.8 mt -54.26 157.5 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.62 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.69 164.17 32.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.282 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.58 119.92 27.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.076 0.465 . . . . 0.0 111.902 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.514 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 7.9 mp -95.14 128.6 42.1 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.654 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -138.37 156.78 47.29 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -179.244 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -146.59 141.89 27.41 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.412 -1.722 . . . . 0.0 110.777 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.496 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -75.31 141.77 43.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.153 0.501 . . . . 0.0 111.071 -179.676 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 82.2 mt -64.19 -43.8 97.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.171 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 52.6 p -56.76 -42.19 78.91 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.024 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.496 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.6 OUTLIER -68.39 -37.01 79.99 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.827 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.4 t -72.76 -45.38 56.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.278 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.92 -30.6 66.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.092 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -81.32 -45.55 16.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.186 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.09 127.32 34.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.004 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.05 31.17 0.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.815 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -79.96 -60.98 2.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.975 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.64 -46.24 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.042 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.421 ' CD1' ' HB2' ' A' ' 92' ' ' LEU . 9.2 tp -140.12 154.06 22.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.894 0.378 . . . . 0.0 111.348 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.401 ' N ' HG13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -116.77 -59.15 2.0 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.913 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.7 ttpt -145.9 136.41 24.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.292 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.498 HG12 ' HG2' ' A' ' 90' ' ' GLN . 14.9 t -134.06 139.36 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 121.268 0.556 . . . . 0.0 112.003 -179.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.514 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 18.8 m-90 -103.51 139.29 39.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.226 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.45 126.38 54.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.102 0.477 . . . . 0.0 109.832 177.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.553 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -111.6 145.6 38.89 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.17 -178.859 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.634 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.39 -176.62 40.28 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.245 -0.978 . . . . 0.0 113.547 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.435 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 1.2 ttp180 -73.23 -7.39 51.26 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -84.81 135.51 40.07 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.791 0.329 . . . . 0.0 111.322 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.411 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 9.7 Cg_exo -70.14 -6.43 18.76 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.957 2.438 . . . . 0.0 112.087 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.63 -44.17 16.08 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-O 121.971 0.891 . . . . 0.0 108.63 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -41.91 138.7 1.45 Allowed 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 113.537 -1.665 . . . . 0.0 110.416 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -56.26 -19.31 13.5 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.024 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.553 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 21.1 t80 -130.21 122.55 28.33 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.661 179.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.411 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.2 t-160 -90.62 140.95 29.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.774 0.321 . . . . 0.0 110.958 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.2 mp -100.17 -89.5 0.33 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.145 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.51 -81.71 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.553 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -176.2 56.42 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.772 0.32 . . . . 0.0 111.426 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.435 ' N ' ' HD2' ' A' ' 70' ' ' ARG . 2.9 mp -104.88 111.83 35.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.786 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.4 m -55.22 -36.61 66.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.289 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -61.0 -18.83 59.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.279 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.401 HD21 ' CE1' ' A' ' 88' ' ' HIS . 18.9 mt -102.69 149.34 24.55 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.759 0.314 . . . . 0.0 111.026 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 88.2 p -92.41 167.17 12.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.711 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.634 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.8 m-20 -43.53 -53.25 5.7 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.286 0.565 . . . . 0.0 109.832 179.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.434 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 2.7 ptmt -120.88 82.46 1.92 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.551 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.8 t60 -59.62 -47.12 86.85 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.707 -176.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.506 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 28.2 p90 -146.48 159.8 42.94 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.666 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.498 ' HG2' HG12 ' A' ' 65' ' ' VAL . 7.3 tt0 -135.77 141.2 44.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.145 -179.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.438 ' O ' ' CG1' ' A' ' 65' ' ' VAL . 50.8 mt -114.28 131.03 67.49 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.205 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.126 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.433 ' CA ' HG11 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -112.64 149.04 33.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.009 0.433 . . . . 0.0 111.595 -179.674 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 29.1 tp -124.93 123.05 39.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.631 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.0 -163.83 17.81 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.475 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 59.39 20.16 8.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.699 0.285 . . . . 0.0 111.21 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 55.55 97.86 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.249 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.87 -54.61 3.71 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.671 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -56.61 154.26 9.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.808 0.337 . . . . 0.0 111.075 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.9 150.89 50.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.902 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.41 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 2.6 mp -133.14 146.56 51.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.151 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.43 ' N ' ' CD1' ' A' ' 101' ' ' LEU . 4.9 mp -112.65 129.35 56.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.259 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 90' ' ' GLN . 53.3 t30 -117.91 115.49 25.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.886 0.374 . . . . 0.0 111.829 -179.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.694 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 12.3 p30 -77.2 140.49 40.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.781 178.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.434 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 19.0 pt -149.5 38.74 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.579 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.1 152.6 19.67 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.095 0.474 . . . . 0.0 111.906 -178.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 47.9 m -68.93 -31.45 70.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.731 177.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -98.17 -19.81 17.67 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.579 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.84 157.18 10.55 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.359 -0.924 . . . . 0.0 113.895 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.1 m -117.42 137.88 52.2 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.783 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -116.67 148.37 41.08 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -177.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.33 113.56 18.38 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.043 177.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 47.43 35.77 4.41 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.141 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.81 -7.41 76.99 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.564 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.8 118.58 37.04 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.059 0.457 . . . . 0.0 110.736 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.783 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -71.52 128.06 34.59 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.219 -179.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.8 m -101.34 167.68 2.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.464 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 120' ' ' SER . 4.6 mm-40 -69.91 125.81 27.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.539 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.694 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 68.8 tttt -54.2 162.71 0.97 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.892 0.377 . . . . 0.0 110.618 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.5 m-80 35.21 34.02 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.241 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.29 145.14 40.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.027 179.481 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -85.87 132.13 34.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.021 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.41 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 32.5 mm-40 -129.46 146.27 51.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.768 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.98 122.92 22.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.312 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.419 ' CD2' HG12 ' A' ' 147' ' ' ILE . 59.6 tp -59.61 155.59 15.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.511 0.672 . . . . 0.0 111.554 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.435 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.8 153.2 42.86 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.33 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -71.74 120.49 17.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.986 0.422 . . . . 0.0 110.263 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.81 18.4 64.09 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.403 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.435 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 13.2 t70 -54.18 170.16 0.15 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.016 0.436 . . . . 0.0 111.257 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 5.0 tt0 -145.23 135.49 24.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.102 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 14.6 mt -111.27 128.22 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.346 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.464 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.7 m -104.22 139.32 39.42 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.186 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.475 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 34.6 m -140.18 158.25 25.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.086 0.47 . . . . 0.0 112.217 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.67 37.91 12.96 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.908 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.456 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.1 t -79.14 140.33 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-O 121.67 0.748 . . . . 0.0 112.33 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.89 -36.97 0.89 Allowed Glycine 0 N--CA 1.436 -1.341 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.02 -179.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.405 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 48.5 t -126.37 123.74 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-N 114.621 -0.79 . . . . 0.0 109.084 178.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.57 -33.21 21.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.691 0.282 . . . . 0.0 111.617 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.0 m -93.46 6.58 47.69 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.405 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 3.2 t0 -127.34 30.1 5.44 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.464 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.9 mt -106.61 139.68 27.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.797 178.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.76 134.55 54.9 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.827 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.552 ' CB ' HG22 ' A' ' 40' ' ' THR . 0.3 OUTLIER -116.13 127.06 54.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.218 0.532 . . . . 0.0 111.558 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.41 ' O ' ' CG ' ' A' ' 129' ' ' GLU . 2.3 mp -121.26 138.08 54.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.625 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 21.7 t -110.55 139.31 34.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.866 0.365 . . . . 0.0 111.18 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.472 HD13 HG21 ' A' ' 145' ' ' ILE . 49.0 mt -106.03 138.12 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.197 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.84 116.48 25.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.473 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.419 HG12 ' CD2' ' A' ' 124' ' ' LEU . 4.9 mt -84.88 134.04 27.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.499 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.18 105.85 15.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.595 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -58.19 -32.96 68.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.091 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -60.38 -46.02 91.44 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.031 0.444 . . . . 0.0 110.775 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -60.12 -44.12 95.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.038 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -65.11 -36.45 84.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.083 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -59.01 -40.54 85.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.102 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.4 t -68.25 -43.54 77.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.105 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.07 -50.09 51.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.385 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -33.66 71.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.073 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -87.25 -37.3 17.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.85 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.2 p30 41.53 33.42 0.29 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.502 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -109.62 135.19 50.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.893 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 30.0 m -87.62 135.32 25.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.069 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -137.43 151.91 49.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.945 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 38.8 mmm-85 -137.3 117.27 13.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.95 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -76.9 138.67 20.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.167 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.864 -179.952 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.879 0.371 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.0 m -137.13 -47.15 0.58 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.893 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -61.53 -38.26 86.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.908 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.9 mmt85 -68.97 -37.2 78.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -58.24 -40.38 81.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.775 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.3 tp -59.37 -31.93 69.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.801 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.439 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -73.02 -35.37 48.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -57.55 -39.59 76.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.37 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.16 -23.86 65.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.672 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.439 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.64 -47.56 79.47 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.199 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.1 p -71.16 -40.6 71.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.833 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 58.44 30.52 19.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.062 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.7 120.98 27.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -109.05 111.64 23.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.7 mm -81.97 138.36 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 CA-C-O 121.657 0.742 . . . . 0.0 111.689 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 164.56 111.6 0.25 Allowed Glycine 0 C--N 1.312 -0.757 0 CA-C-N 114.493 -1.231 . . . . 0.0 112.48 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -82.55 -27.01 31.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.74 0.305 . . . . 0.0 110.938 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 175.94 39.44 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.653 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.6 mm -74.83 135.06 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 CA-C-N 113.694 -1.594 . . . . 0.0 112.532 -177.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.482 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.9 t -92.72 -60.84 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.836 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.7 p -140.73 164.88 29.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.214 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.45 122.09 22.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.809 0.337 . . . . 0.0 111.322 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.6 t -93.72 122.78 45.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.815 0.34 . . . . 0.0 111.04 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.0 mt -125.7 117.49 49.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.564 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.404 ' HA ' HD21 ' A' ' 143' ' ' LEU . 3.8 t -81.33 111.23 17.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.834 0.349 . . . . 0.0 110.34 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.1 t -86.89 -22.02 25.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.934 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.614 HG22 ' HB2' ' A' ' 142' ' ' SER . 81.6 p -79.84 -2.77 44.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.731 0.3 . . . . 0.0 111.429 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.24 75.77 0.4 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.882 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -146.9 -40.36 0.2 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.844 0.354 . . . . 0.0 111.02 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.577 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.3 mt -125.9 142.01 41.07 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.033 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.577 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 46.0 Cg_endo -70.48 146.05 54.65 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.172 1.915 . . . . 0.0 112.226 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.7 mt -58.91 149.5 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.824 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.32 163.88 31.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.054 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.06 119.85 28.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.058 0.456 . . . . 0.0 112.011 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.503 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 7.3 mp -89.57 130.89 35.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.246 178.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.653 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -140.8 156.15 46.22 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 122.412 1.101 . . . . 0.0 113.827 -179.578 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.64 141.83 28.49 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 113.352 -1.749 . . . . 0.0 110.64 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.481 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 2.2 m-20 -77.4 132.02 38.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.159 0.505 . . . . 0.0 111.051 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.4 mm -64.22 -40.12 87.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.057 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.8 t -56.82 -42.09 78.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.906 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.481 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.5 OUTLIER -68.45 -36.97 79.78 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.799 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.7 t -67.54 -50.19 63.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.345 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 pp -64.94 -26.05 68.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.105 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.13 -53.82 6.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.907 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.21 118.48 14.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.021 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.17 28.12 4.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.824 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.3 mtt-85 -90.08 -175.76 4.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.758 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.72 31.93 2.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.977 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.5 tp -177.44 145.01 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.318 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.68 -72.05 0.71 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.768 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.415 ' CE ' ' O ' ' A' ' 49' ' ' SER . 21.0 ttpt -136.3 137.57 40.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.471 HG13 ' HG2' ' A' ' 90' ' ' GLN . 5.4 t -124.69 138.81 52.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.085 0.469 . . . . 0.0 111.852 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.512 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 17.0 m-90 -103.4 138.64 39.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.959 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.17 127.01 55.82 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 177.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.521 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 0.4 OUTLIER -112.95 145.73 40.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.593 -178.456 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.688 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.45 -174.4 40.49 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.691 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.5 mtm180 -80.24 -2.82 46.68 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.44 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.0 t30 -84.87 135.99 39.35 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.791 0.329 . . . . 0.0 111.067 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.8 Cg_exo -68.86 -6.88 19.15 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.773 2.315 . . . . 0.0 111.834 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.76 -44.63 15.36 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-O 122.0 0.905 . . . . 0.0 108.56 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.07 136.68 4.72 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.694 -1.594 . . . . 0.0 110.16 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.419 ' OD2' ' CD1' ' A' ' 66' ' ' TRP . 0.7 OUTLIER -56.51 -18.92 13.13 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.89 179.431 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.521 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 53.7 t80 -130.19 130.69 45.01 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.772 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -106.93 136.95 45.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.834 0.35 . . . . 0.0 110.944 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.25 78.43 1.66 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.269 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 47.25 -137.54 10.4 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.997 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -157.63 90.79 1.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.803 0.335 . . . . 0.0 111.089 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.8 mp -108.62 132.82 55.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.918 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.4 t -58.52 -40.43 82.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.995 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -30.06 70.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.09 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.422 HD23 ' CE1' ' A' ' 88' ' ' HIS . 30.3 mt -94.65 152.12 18.74 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.844 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 89.5 p -95.44 165.24 12.46 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.689 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.688 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.5 m-20 -42.06 -52.8 4.14 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.276 0.56 . . . . 0.0 109.816 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.427 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 5.0 ptmt -120.92 84.29 2.21 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.567 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.6 t60 -61.56 -46.24 90.74 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.971 -1.013 . . . . 0.0 113.055 -176.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.5 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 24.6 p90 -144.72 157.94 43.98 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.136 -0.625 . . . . 0.0 112.105 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.471 ' HG2' HG13 ' A' ' 65' ' ' VAL . 5.9 tt0 -135.91 140.35 44.0 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.018 -179.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.464 HG21 HD13 ' A' ' 91' ' ' ILE . 38.5 mt -113.47 132.3 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 121.134 -0.227 . . . . 0.0 110.855 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.407 ' CA ' HG12 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -113.81 146.87 39.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.184 0.516 . . . . 0.0 112.022 -179.202 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 44.4 tp -125.26 122.83 38.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.439 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 127.92 127.95 3.05 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.596 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 178.44 -67.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.865 0.364 . . . . 0.0 110.737 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -146.69 -46.86 0.19 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.758 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 178.94 36.04 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.438 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -156.22 -172.17 3.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.773 0.32 . . . . 0.0 110.929 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.91 155.29 34.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.696 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.22 147.57 51.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.818 0.342 . . . . 0.0 110.768 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.87 125.26 53.84 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 90' ' ' GLN . 53.5 t30 -109.27 115.69 30.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.694 -179.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.701 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 18.3 p30 -76.89 131.76 38.75 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.649 178.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.427 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 21.6 pt -139.34 40.54 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -178.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.598 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.54 151.93 20.6 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 120.987 0.422 . . . . 0.0 111.64 -178.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.8 m -68.57 -31.87 71.38 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.776 178.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -98.41 -19.63 17.6 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.614 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.598 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.94 157.81 10.97 Favored Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.73 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.0 m -117.36 137.82 52.21 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.836 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -114.08 148.55 36.92 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -178.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.05 113.4 18.35 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.645 -1.161 . . . . 0.0 108.27 177.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 44.51 43.08 6.1 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.385 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.47 -8.82 75.82 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.829 -0.7 . . . . 0.0 113.43 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -105.17 118.38 36.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.104 0.452 . . . . 0.0 110.764 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.836 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 12.8 tptt -74.0 122.37 22.51 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.247 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.9 m -94.05 165.56 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.204 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 120' ' ' SER . 9.7 tp10 -69.87 125.95 28.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.598 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.701 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 14.6 tttt -54.13 162.83 0.91 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.955 0.407 . . . . 0.0 110.653 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.7 OUTLIER 37.15 31.27 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.109 -179.171 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.82 144.02 43.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.164 179.203 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -93.42 129.93 39.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.786 0.326 . . . . 0.0 110.287 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -129.0 149.34 50.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.974 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -72.69 111.64 8.03 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.88 168.17 1.9 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.318 0.58 . . . . 0.0 111.798 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -124.29 153.65 41.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.033 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.05 116.97 11.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.108 0.48 . . . . 0.0 110.257 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.62 18.36 73.78 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.364 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -59.84 -179.48 0.1 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.67 0.271 . . . . 0.0 110.62 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 4.1 mt-10 -145.32 135.69 24.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.682 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 14.9 mt -109.68 126.26 66.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.023 178.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.49 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.9 m -104.49 138.68 40.51 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.209 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.506 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.1 m -140.33 158.2 25.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.26 28.28 28.26 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.15 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.458 ' HA ' HG12 ' A' ' 140' ' ' ILE . 69.7 t -70.04 140.3 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-O 121.58 0.705 . . . . 0.0 112.326 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.69 -38.47 0.76 Allowed Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.425 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 49.8 t -126.33 132.94 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 CA-C-N 114.808 -0.696 . . . . 0.0 109.335 178.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -50.54 -39.81 50.17 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.7 m -93.3 6.49 47.89 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.425 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 15.3 t0 -118.74 26.82 9.29 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -179.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.49 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 6.5 mt -107.14 139.61 28.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.05 178.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.3 tt -119.3 134.51 55.17 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.582 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.614 ' HB2' HG22 ' A' ' 40' ' ' THR . 0.9 OUTLIER -111.39 135.63 51.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.066 0.46 . . . . 0.0 111.633 -179.673 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 51.0 mt -126.71 152.71 46.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.157 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 21.8 t -115.61 139.78 40.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.025 0.441 . . . . 0.0 111.606 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.463 HG22 HD13 ' A' ' 145' ' ' ILE . 18.3 mt -106.5 120.95 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.822 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.33 103.9 12.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.424 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 7.0 mt -84.86 134.05 27.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.991 0.424 . . . . 0.0 111.58 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -88.53 112.2 22.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.86 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.46 -25.9 68.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.083 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.91 -45.22 90.87 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.053 0.454 . . . . 0.0 110.664 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -58.25 -44.05 88.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.004 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -62.26 -41.21 98.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.954 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -64.74 -40.67 95.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.068 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.0 t -65.7 -45.03 84.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.976 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.63 -36.04 80.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.883 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.2 -43.24 98.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.785 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.41 ' O ' ' N ' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -84.67 -31.93 23.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.884 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 42.92 -90.83 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.724 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 157' ' ' GLN . 0.9 OUTLIER -72.93 114.19 10.81 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.802 0.334 . . . . 0.0 110.991 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -87.87 140.89 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.185 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -148.89 -47.35 0.15 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.921 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.81 -57.24 13.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.953 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.6 mp -93.27 137.92 21.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.172 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.945 179.982 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.76 0.314 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 38.6 p -140.26 -50.84 0.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -72.05 -31.43 66.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.99 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.47 -36.33 82.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.801 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -39.45 79.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.809 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.78 -31.81 70.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.796 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.41 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.5 mt -72.62 -35.4 50.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.855 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -57.42 -42.69 82.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.941 0.401 . . . . 0.0 110.386 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.09 -23.93 65.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.657 179.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.41 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.55 -47.52 79.27 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.298 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.85 -38.96 83.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.809 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -167.95 99.51 0.46 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.893 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -73.47 127.32 32.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.902 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -82.01 114.43 20.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.818 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.0 mm -82.3 138.35 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 CA-C-O 121.687 0.756 . . . . 0.0 111.834 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -140.03 49.42 0.8 Allowed Glycine 0 C--N 1.316 -0.571 0 CA-C-N 114.435 -1.257 . . . . 0.0 112.419 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -63.63 -40.31 96.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.778 0.323 . . . . 0.0 110.888 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -177.99 37.0 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.649 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.4 mm -76.85 135.85 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 CA-C-N 113.708 -1.587 . . . . 0.0 112.571 -177.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.488 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.4 t -90.37 -58.99 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.683 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 30.1 p -150.7 161.27 42.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.014 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.76 138.3 54.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.805 0.336 . . . . 0.0 111.621 -179.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.4 m -106.85 122.52 60.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.825 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.9 mt -128.62 127.01 66.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.456 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 21.3 t -83.0 100.45 10.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.88 0.371 . . . . 0.0 110.459 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.7 t -69.46 -28.2 65.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.713 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.564 HG22 ' HB2' ' A' ' 142' ' ' SER . 59.5 p -80.08 -2.69 45.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.722 0.296 . . . . 0.0 111.578 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.18 79.84 0.17 Allowed Glycine 0 CA--C 1.517 0.193 0 C-N-CA 120.919 -0.658 . . . . 0.0 113.139 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -147.35 -39.88 0.19 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.78 0.324 . . . . 0.0 111.019 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.593 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.4 mt -123.84 142.58 39.78 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.988 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.593 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 37.8 Cg_endo -68.84 146.08 64.68 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.028 1.819 . . . . 0.0 112.247 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.4 mt -57.59 148.1 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.816 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.89 164.04 31.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.056 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -124.57 119.78 30.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.928 0.394 . . . . 0.0 111.973 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.513 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 7.6 mp -90.8 125.98 35.88 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.649 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -135.63 156.82 48.25 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -179.092 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.488 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -148.98 141.79 24.62 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.552 -1.658 . . . . 0.0 110.817 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.54 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 1.4 m-20 -76.81 125.28 29.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.286 0.565 . . . . 0.0 111.239 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.1 mt -64.58 -42.83 96.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.69 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.07 -42.29 80.38 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.116 -178.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.54 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -68.72 -37.02 79.17 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.894 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.9 t -65.9 -44.72 92.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.094 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.99 -30.48 66.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.916 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.5 mttp -73.41 -46.72 47.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.919 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.59 131.52 42.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.32 22.87 8.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.027 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -91.27 170.96 9.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.86 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.74 -53.32 8.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.4 mm -94.52 149.82 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.206 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.62 -53.97 2.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.842 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.414 ' CE ' ' O ' ' A' ' 49' ' ' SER . 6.7 ttpt -151.43 129.98 12.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.099 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 10.9 t -124.04 138.52 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 121.408 0.623 . . . . 0.0 112.021 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.543 ' O ' ' HA ' ' A' ' 90' ' ' GLN . 18.1 m-90 -100.97 139.86 36.06 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.824 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.504 ' HA ' ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.86 127.68 56.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.0 0.428 . . . . 0.0 109.862 177.936 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.52 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.4 OUTLIER -114.11 145.64 41.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.281 -178.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.648 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.68 -174.07 39.0 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.674 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.3 mtp180 -79.66 0.24 31.12 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.668 0.248 . . . . 0.0 111.668 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.447 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 10.2 t-20 -84.7 133.91 43.02 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.68 0.276 . . . . 0.0 111.056 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 13.5 Cg_exo -68.5 -8.61 23.61 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.618 2.212 . . . . 0.0 111.894 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.04 -43.14 16.67 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-O 121.963 0.887 . . . . 0.0 108.855 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.8 137.01 2.42 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 113.65 -1.613 . . . . 0.0 110.918 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -56.43 -18.73 12.17 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.016 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.511 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 63.7 t80 -129.79 123.03 29.97 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.896 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -100.71 124.81 46.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.876 0.369 . . . . 0.0 110.977 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.68 -178.4 4.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.64 149.33 46.48 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.434 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -78.62 93.52 4.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.886 0.374 . . . . 0.0 110.96 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 26.6 mm -112.09 122.14 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.958 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.6 t -54.94 -30.85 59.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.959 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.72 -26.62 65.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.781 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 33.7 mt -97.73 152.22 19.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.93 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.2 166.21 11.85 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.686 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.648 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -42.72 -52.83 4.8 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.471 0.653 . . . . 0.0 109.638 179.172 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -119.51 84.85 2.27 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 177.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.545 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.2 t60 -61.87 -45.83 92.07 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.877 -177.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.52 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 18.9 p90 -145.81 163.24 35.64 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.127 -0.629 . . . . 0.0 112.427 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.543 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -135.59 136.72 41.3 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.397 -178.878 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.509 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 35.3 mt -113.38 128.49 70.18 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.342 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.353 178.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.404 ' CD2' ' HB2' ' A' ' 102' ' ' ASN . 0.7 OUTLIER -114.36 148.35 37.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.086 0.469 . . . . 0.0 111.859 -179.415 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 16.8 tp -125.22 123.1 38.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.368 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.68 -156.91 16.75 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.665 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -62.98 168.49 3.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.796 0.331 . . . . 0.0 110.995 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 59.4 -168.27 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.912 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -97.2 28.24 14.88 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.468 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -103.73 129.44 51.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.918 0.39 . . . . 0.0 110.923 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.406 ' HB3' HD21 ' A' ' 124' ' ' LEU . 24.0 tp -107.2 154.97 20.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.796 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.404 ' N ' ' HG ' ' A' ' 99' ' ' LEU . 4.1 mm? -124.91 145.56 49.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.326 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 mt -112.62 124.5 52.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.041 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 90' ' ' GLN . 50.6 t30 -116.99 115.7 25.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.892 0.377 . . . . 0.0 111.781 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.676 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 8.1 p30 -77.71 141.23 39.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.955 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 11.0 pt -148.46 38.33 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.545 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -98.34 152.35 19.55 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.051 0.453 . . . . 0.0 111.753 -179.093 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 47.6 m -68.92 -31.57 70.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.027 178.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -98.24 -19.75 17.66 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.524 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.18 155.65 9.86 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 120.178 -1.01 . . . . 0.0 113.747 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.8 m -117.65 137.82 52.39 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.836 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -116.01 148.46 40.12 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -178.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.01 113.52 18.53 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.356 177.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 43.93 43.81 5.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.36 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.55 -10.94 67.64 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.448 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.48 118.63 37.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.028 0.442 . . . . 0.0 110.638 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.836 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 12.2 tptp -73.01 122.28 21.48 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.239 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.2 m -93.18 164.61 2.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.249 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.5 tp10 -69.88 126.34 29.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.557 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.676 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 87.9 tttt -53.51 161.17 1.07 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.994 0.426 . . . . 0.0 110.727 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.8 p30 34.85 34.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.437 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.46 145.1 40.78 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.133 179.384 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -86.71 130.48 34.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.66 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -129.32 146.49 51.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.756 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.1 tp -72.78 124.84 26.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.073 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.407 HD22 HG13 ' A' ' 147' ' ' ILE . 65.4 tp -57.21 157.34 6.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.427 0.632 . . . . 0.0 111.684 -179.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.445 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.4 153.69 41.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.333 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 10.0 tp60 -70.96 119.05 14.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.004 0.431 . . . . 0.0 110.318 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.83 24.43 62.5 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.223 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.445 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 23.3 t0 -56.47 169.72 0.43 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.085 0.469 . . . . 0.0 111.107 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 17.2 tt0 -145.35 135.53 23.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.046 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.411 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 13.4 mt -109.15 128.05 65.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.477 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.5 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.0 m -104.5 139.61 39.16 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.96 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.502 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.6 m -140.36 158.52 25.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.95 33.54 23.7 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.734 -0.667 . . . . 0.0 112.234 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 140' ' ' ILE . 76.4 t -72.95 140.29 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-O 121.587 0.708 . . . . 0.0 112.386 -179.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.77 -42.17 0.8 Allowed Glycine 0 N--CA 1.436 -1.334 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -178.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.0 t -126.34 130.55 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-N 114.763 -0.719 . . . . 0.0 109.153 177.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -50.45 -34.0 23.15 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -178.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 69.0 m -93.35 6.24 48.79 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.08 22.41 11.45 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -178.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.5 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.3 mt -107.12 139.42 28.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.293 178.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.2 tt -122.22 134.41 54.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.273 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.564 ' HB2' HG22 ' A' ' 40' ' ' THR . 0.7 OUTLIER -109.1 140.66 42.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.053 0.454 . . . . 0.0 111.954 -179.134 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 2.7 mm? -134.57 136.03 42.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.333 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.1 t -110.68 140.22 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.873 0.368 . . . . 0.0 111.395 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 8.4 mt -106.16 134.75 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.918 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.53 116.3 27.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.69 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.407 HG13 HD22 ' A' ' 124' ' ' LEU . 4.6 mp -85.6 134.04 28.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.657 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -85.01 114.71 22.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.765 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -61.34 -31.89 71.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.951 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -59.64 -45.74 91.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.954 0.407 . . . . 0.0 110.686 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.412 ' CZ ' HD23 ' A' ' 155' ' ' LEU . 34.6 t80 -58.6 -44.05 89.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.021 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -62.24 -37.51 85.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.962 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -64.57 -47.04 80.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.05 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.3 t -63.46 -45.94 88.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.017 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.412 HD23 ' CZ ' ' A' ' 151' ' ' PHE . 3.0 mm? -60.84 -36.09 78.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.878 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -61.61 -34.76 76.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.79 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.8 -37.12 13.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.852 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.9 p30 44.66 -172.18 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.535 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.57 141.74 28.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.838 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 29.2 m -102.98 131.42 51.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.1 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -102.08 116.46 32.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.894 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.7 162.15 33.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.762 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.0 mt -95.78 124.62 48.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.035 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 44.0 ttm-85 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.869 -179.891 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.414 ' O ' ' CB ' ' A' ' 15' ' ' THR . . . . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.691 0.281 . . . . 0.0 111.048 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.414 ' CB ' ' O ' ' A' ' 14' ' ' ALA . 1.6 m 80.95 -46.75 0.25 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.453 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.69 -30.7 68.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.82 0.343 . . . . 0.0 110.963 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -66.04 -36.03 82.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.647 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -59.93 -43.22 95.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.815 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 tp -58.44 -32.98 69.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.716 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.408 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.4 mt -73.1 -35.32 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.922 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -57.07 -38.76 73.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.964 0.411 . . . . 0.0 110.487 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -67.08 -26.8 66.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.404 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.98 -47.57 80.46 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.254 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.1 m -77.06 -26.36 53.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.993 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -68.75 70.47 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.859 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -93.26 138.1 31.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -64.98 104.28 0.84 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.887 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.411 HG21 ' N ' ' A' ' 29' ' ' GLY . 18.5 mm -81.95 138.2 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.442 0 CA-C-O 121.649 0.737 . . . . 0.0 111.617 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.411 ' N ' HG21 ' A' ' 28' ' ' ILE . . . -139.2 51.43 0.75 Allowed Glycine 0 C--N 1.313 -0.729 0 CA-C-N 114.456 -1.247 . . . . 0.0 112.641 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.06 -44.02 20.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.807 0.337 . . . . 0.0 110.742 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' A' ' 49' ' ' SER . 2.3 m-80 178.79 38.79 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.564 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.3 mm -71.55 142.15 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.575 0 CA-C-N 113.744 -1.571 . . . . 0.0 112.634 -176.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.402 ' CG2' ' CB ' ' A' ' 50' ' ' ALA . 1.0 OUTLIER -106.54 -50.23 8.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.663 -178.885 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 0.5 OUTLIER -154.86 165.5 36.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.351 179.29 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.57 120.83 24.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.757 0.313 . . . . 0.0 111.012 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.416 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 25.0 t -94.7 122.67 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.854 0.359 . . . . 0.0 111.126 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.4 mt -124.49 122.49 64.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.252 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 46.9 t -79.87 127.33 32.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.445 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.9 t -94.31 -29.12 15.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.814 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.478 HG21 ' HB3' ' A' ' 142' ' ' SER . 43.2 p -79.87 -2.34 43.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.576 0.226 . . . . 0.0 111.462 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.22 80.86 0.21 Allowed Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.819 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -147.01 -43.78 0.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.804 0.335 . . . . 0.0 110.888 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.563 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.8 mp -120.42 142.08 33.23 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.209 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.563 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 56.5 Cg_endo -72.55 145.98 43.16 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.221 1.947 . . . . 0.0 112.007 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.2 mt -53.48 134.74 15.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.772 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.17 163.85 24.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.091 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -120.25 119.7 33.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.126 0.489 . . . . 0.0 112.002 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.57 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 5.0 mp -87.22 132.07 34.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.593 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -138.97 156.59 47.12 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 122.426 1.108 . . . . 0.0 113.572 -179.297 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.402 ' CB ' ' CG2' ' A' ' 33' ' ' VAL . . . -142.99 144.66 32.4 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.831 178.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.431 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 0.9 OUTLIER -74.84 119.32 18.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.066 0.46 . . . . 0.0 111.296 -179.68 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.9 mt -64.46 -43.75 96.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.071 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.8 m -59.76 -40.64 88.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.223 0.535 . . . . 0.0 110.737 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.431 ' CG ' ' HB2' ' A' ' 51' ' ' ASP . 28.4 mm-40 -68.55 -36.81 79.31 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.711 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.02 -43.41 81.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.93 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.16 -31.63 67.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.785 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -74.34 -48.29 29.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.921 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -69.94 134.99 48.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.991 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.28 29.48 7.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.93 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.8 mtm-85 -92.31 -172.41 3.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.795 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.3 m -85.96 -55.93 3.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.6 tp -92.93 147.22 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.051 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -116.98 -68.78 0.89 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -143.39 130.41 20.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.34 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 13.0 t -126.32 139.34 51.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.292 0.567 . . . . 0.0 111.895 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.593 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 16.8 m-90 -100.76 139.85 35.87 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.165 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.453 HG22 HD13 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -108.3 126.26 52.63 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.573 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.558 ' CE2' ' CG ' ' A' ' 76' ' ' TYR . 3.0 m-85 -114.47 145.75 41.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.8 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.614 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.39 -174.35 36.28 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.188 -1.006 . . . . 0.0 113.362 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.41 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 6.7 mtm105 -75.61 0.49 17.31 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.419 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 9.5 t-20 -84.66 133.35 44.2 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.667 0.27 . . . . 0.0 111.414 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.451 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 12.8 Cg_exo -68.6 -10.46 29.11 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.655 2.236 . . . . 0.0 111.754 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.21 -43.45 16.11 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-O 121.915 0.864 . . . . 0.0 108.781 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -41.37 137.75 1.4 Allowed 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.959 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.32 -18.3 10.33 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.241 179.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.558 ' CG ' ' CE2' ' A' ' 68' ' ' PHE . 19.8 t80 -127.21 116.25 20.32 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.811 0.338 . . . . 0.0 110.64 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.451 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 2.0 t-160 -94.14 118.32 31.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.159 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.424 ' HA ' HG12 ' A' ' 43' ' ' ILE . 0.7 OUTLIER -125.43 -178.08 4.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.557 179.689 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -54.42 -175.23 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.231 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -120.27 90.64 3.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.832 0.349 . . . . 0.0 110.607 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 24.8 mt -107.08 137.43 38.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.446 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 40.1 t -62.53 -38.75 91.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.768 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.49 -33.25 74.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.949 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.447 ' CD2' ' CE1' ' A' ' 88' ' ' HIS . 30.0 mt -91.21 152.24 20.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.015 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 92.3 p -97.14 165.53 12.01 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.53 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.614 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -42.81 -53.99 4.34 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.314 0.578 . . . . 0.0 109.745 179.326 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.467 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -118.22 83.81 2.07 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 177.144 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.559 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.0 t60 -61.19 -45.41 94.7 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.802 -1.09 . . . . 0.0 113.162 -176.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.531 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 29.5 p90 -145.98 163.23 35.83 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 119.966 -0.694 . . . . 0.0 112.552 -179.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.531 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 8.2 mt-30 -135.35 145.09 47.05 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.382 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 3.2 mp -118.62 132.36 68.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 178.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.422 ' HG ' ' CB ' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -118.01 148.93 41.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.227 0.537 . . . . 0.0 111.988 -179.018 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.417 HD11 ' CE2' ' A' ' 151' ' ' PHE . 0.5 OUTLIER -125.1 122.88 38.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.037 179.143 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.68 174.64 21.93 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.871 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.63 95.22 9.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.766 0.317 . . . . 0.0 110.849 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -171.89 -41.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.838 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 136.93 -19.07 3.51 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.645 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -102.16 175.46 5.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.752 0.31 . . . . 0.0 110.995 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -122.01 160.0 25.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.876 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.426 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 2.3 mp -132.69 142.89 49.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.999 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.76 129.47 56.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.341 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.413 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 50.1 t30 -117.8 115.7 25.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.862 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.677 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 12.0 p30 -78.65 141.41 38.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.999 178.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.467 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 14.9 pt -148.33 38.58 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -178.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.559 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -99.09 152.99 19.24 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.14 0.495 . . . . 0.0 111.676 -179.162 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 51.1 m -68.87 -31.84 71.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.961 178.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -98.46 -19.92 17.4 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.556 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.59 157.22 10.23 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.267 -0.968 . . . . 0.0 113.797 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.531 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.7 m -117.53 138.05 52.16 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.85 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -115.04 148.49 38.81 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -178.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.13 113.43 18.33 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.337 177.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 44.38 43.22 5.97 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.81 -9.96 72.09 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.408 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -105.27 118.57 36.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.007 0.432 . . . . 0.0 110.746 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.85 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 19.1 tptt -73.63 130.25 39.65 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.184 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.0 m -103.09 165.95 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.363 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.421 ' O ' ' HB3' ' A' ' 120' ' ' SER . 5.3 tp10 -69.95 127.0 31.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.564 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.677 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 30.3 tttp -52.62 161.96 0.64 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.739 0.305 . . . . 0.0 110.455 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.9 p30 35.08 35.68 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.132 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.421 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.2 p -112.01 145.15 40.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.644 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -93.33 129.53 39.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.757 0.313 . . . . 0.0 110.925 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.426 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 59.7 mm-40 -129.21 151.85 49.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.536 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.9 tp -72.6 112.23 8.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.85 0.357 . . . . 0.0 110.288 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.439 ' CD2' HG12 ' A' ' 147' ' ' ILE . 66.3 tp -53.05 158.91 1.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.266 0.555 . . . . 0.0 111.575 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.41 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -124.11 153.29 41.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.555 -179.779 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.32 122.55 20.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.87 0.367 . . . . 0.0 110.327 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.38 21.23 56.79 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.186 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.41 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 11.1 t70 -56.56 175.8 0.11 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.815 0.34 . . . . 0.0 110.9 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 4.6 mt-10 -145.27 135.75 24.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.242 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.3 mt -112.23 128.26 68.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.523 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.461 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.1 m -104.23 140.16 38.24 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.056 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.476 ' CG1' ' CD2' ' A' ' 88' ' ' HIS . 33.3 m -140.22 158.4 25.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.095 0.474 . . . . 0.0 112.233 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.95 44.56 8.98 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.86 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.432 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.3 t -84.33 140.5 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-O 121.684 0.754 . . . . 0.0 112.631 -178.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.64 -41.14 0.59 Allowed Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.2 t -126.45 125.43 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-N 114.674 -0.763 . . . . 0.0 109.07 177.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.46 -30.25 12.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.805 0.336 . . . . 0.0 111.279 -178.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.62 6.48 48.12 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -126.94 27.74 5.92 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.461 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 4.6 mt -107.18 139.44 28.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.283 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.7 tt -120.72 134.53 55.28 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.383 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.478 ' HB3' HG21 ' A' ' 40' ' ' THR . 44.0 t -113.58 150.68 32.69 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.694 0.759 . . . . 0.0 112.57 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 2.7 mm? -135.78 151.37 50.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.454 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.5 t -116.35 135.62 55.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.902 0.382 . . . . 0.0 111.265 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 40.9 mt -106.45 121.99 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.988 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.52 116.93 31.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.707 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.439 HG12 ' CD2' ' A' ' 124' ' ' LEU . 5.0 mt -84.82 134.2 27.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.581 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -82.05 115.44 21.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.776 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.89 -28.81 68.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.14 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -59.63 -45.77 90.97 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.989 0.423 . . . . 0.0 110.749 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.417 ' CE2' HD11 ' A' ' 93' ' ' LEU . 35.8 t80 -59.06 -44.13 91.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.892 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 25.9 mtpt -65.0 -34.38 78.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.975 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.12 -44.22 89.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.952 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.2 t -68.07 -42.44 80.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.965 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.82 -37.74 88.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.963 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.67 -40.41 92.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.952 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -87.02 -36.93 17.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.023 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.6 p30 44.8 -172.42 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.599 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -73.69 143.35 46.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.968 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 23.5 m -100.78 134.21 41.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.051 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -111.8 33.08 4.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.887 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 14.9 ttt-85 -95.16 154.59 17.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.942 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.1 mp -77.8 138.08 21.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.13 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 8.5 ttt85 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.977 179.94 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.058 0 CA-C-O 120.859 0.361 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.5 -60.78 0.14 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.962 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -70.4 -44.76 67.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -60.67 -42.62 97.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.889 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -60.18 -39.11 85.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.909 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 mt -60.27 -44.79 95.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.875 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.3 mm -63.3 -40.15 87.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.168 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -57.91 -33.82 69.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.12 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -65.38 -33.79 76.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.257 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -56.9 -47.46 80.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.062 0.458 . . . . 0.0 111.058 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.5 p -64.3 -43.0 96.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.787 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 59.45 100.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.92 141.69 33.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.51 107.02 17.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.927 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.4 mm -82.33 138.32 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 CA-C-O 121.684 0.754 . . . . 0.0 111.792 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.59 43.54 0.22 Allowed Glycine 0 C--N 1.315 -0.619 0 CA-C-N 114.552 -1.204 . . . . 0.0 112.47 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -78.44 -41.67 32.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.775 0.322 . . . . 0.0 111.09 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.42 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER -171.06 34.72 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -179.822 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.653 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 2.7 mm -75.36 134.87 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 CA-C-N 113.897 -1.501 . . . . 0.0 112.363 -177.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.502 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.9 t -93.73 -61.19 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.232 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -143.97 154.07 42.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.724 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.17 138.1 51.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.832 0.349 . . . . 0.0 111.135 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.418 HG12 ' CZ ' ' A' ' 76' ' ' TYR . 18.8 t -105.29 122.67 58.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.054 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.3 mt -128.84 118.23 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.5 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 38.2 t -80.34 123.37 27.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.313 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.59 -25.55 19.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.677 -179.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.465 HG23 ' HB3' ' A' ' 142' ' ' SER . 43.1 p -79.81 -2.29 42.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.64 0.257 . . . . 0.0 111.541 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.12 75.19 0.41 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.851 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -146.21 -44.24 0.2 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.866 0.365 . . . . 0.0 110.963 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.522 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -114.95 140.88 26.1 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.784 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.522 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.2 Cg_endo -73.28 145.93 39.47 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.183 1.922 . . . . 0.0 112.33 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.2 mt -57.68 141.46 14.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.547 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -137.18 164.02 29.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.313 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.88 119.83 32.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.977 0.418 . . . . 0.0 111.614 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.536 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 6.0 mt -91.35 137.17 32.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.298 178.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.653 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -144.17 157.42 44.31 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 -179.123 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.502 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -151.04 148.49 28.4 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.874 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.494 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 0.8 OUTLIER -75.02 125.24 28.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.192 0.52 . . . . 0.0 110.976 -179.727 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.45 HD11 HG21 ' A' ' 52' ' ' ILE . 48.7 mt -64.42 -41.48 92.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.672 -179.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.91 -42.29 79.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.294 0.569 . . . . 0.0 111.074 -178.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.494 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 2.9 mt-30 -68.67 -36.83 79.06 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.013 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.2 t -72.35 -37.96 59.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.327 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.92 -42.01 70.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.205 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.15 -28.53 63.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.185 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -94.63 119.55 33.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.858 0.361 . . . . 0.0 110.843 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.8 pttt -108.88 -26.45 10.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.986 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 10.0 ttp85 -104.87 159.16 16.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.942 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 58.47 -177.46 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.2 tp -94.53 158.41 2.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.65 -64.65 1.03 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.165 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.434 ' HE2' ' O ' ' A' ' 49' ' ' SER . 3.7 ttpt -140.85 132.86 27.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.384 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 9.6 t -129.34 139.28 52.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.245 0.545 . . . . 0.0 111.808 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.543 ' O ' ' HA ' ' A' ' 90' ' ' GLN . 16.0 m-90 -100.83 139.73 36.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.7 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.485 ' HA ' ' HG2' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.83 126.85 55.29 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.574 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 1.6 m-85 -110.55 145.71 37.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.422 -178.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.686 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.34 -177.74 39.9 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.955 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -77.33 -2.51 35.32 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -84.85 134.78 40.99 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.656 0.265 . . . . 0.0 111.197 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -68.71 -6.81 18.8 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.76 2.307 . . . . 0.0 111.838 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.83 -43.73 16.3 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-O 121.958 0.885 . . . . 0.0 108.77 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.94 137.67 3.13 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 113.629 -1.623 . . . . 0.0 110.648 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -56.41 -19.21 13.84 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.984 179.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.574 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 29.9 t80 -129.98 116.57 18.78 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.016 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -86.0 107.87 17.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.838 0.351 . . . . 0.0 110.359 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.421 ' HA ' HG12 ' A' ' 43' ' ' ILE . 81.7 mt -78.37 -82.87 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.354 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.04 -102.92 0.17 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.394 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -175.93 65.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.802 0.334 . . . . 0.0 111.267 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.4 ' HB ' ' CD1' ' A' ' 84' ' ' LEU . 3.7 mp -112.13 125.49 69.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.838 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 27.3 t -55.06 -31.39 61.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.323 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -60.9 -33.91 73.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.9 0.381 . . . . 0.0 111.131 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.4 ' CD1' ' HB ' ' A' ' 81' ' ' ILE . 5.8 mp -95.31 153.24 17.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.062 0.458 . . . . 0.0 110.919 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.2 p -94.13 166.3 12.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.739 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.686 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -42.72 -52.33 4.98 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.449 0.642 . . . . 0.0 109.591 179.145 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.8 mttp -120.5 84.69 2.26 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 177.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.558 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.0 t60 -61.14 -46.06 92.09 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.823 -176.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.543 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 12.3 p90 -145.18 162.37 37.26 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.059 -0.656 . . . . 0.0 112.351 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.543 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -135.67 136.22 40.74 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.584 -178.709 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.461 ' CD1' ' CE1' ' A' ' 68' ' ' PHE . 8.0 mt -113.88 129.47 69.72 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.16 178.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.64 148.84 33.77 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.024 0.44 . . . . 0.0 111.905 -179.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.402 ' HG ' ' CG1' ' A' ' 33' ' ' VAL . 2.3 tm? -125.25 124.95 42.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.524 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 167.38 -167.2 39.76 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.54 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 61.25 95.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.801 0.334 . . . . 0.0 110.95 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 63.13 -80.57 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.975 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -177.94 36.19 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.411 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -110.35 168.81 9.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.86 0.362 . . . . 0.0 110.857 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.99 145.71 31.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.973 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.0 mt -130.12 142.17 50.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.484 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.1 tp -112.56 120.92 43.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.153 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.413 ' N ' ' O ' ' A' ' 90' ' ' GLN . 55.1 t30 -115.25 115.7 27.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.007 0.432 . . . . 0.0 111.645 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.688 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 14.3 p30 -77.36 139.29 39.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.081 178.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 10.5 pt -146.82 38.79 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.583 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.7 151.73 20.42 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.085 0.469 . . . . 0.0 111.908 -178.711 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 48.1 m -68.79 -31.62 70.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.85 177.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -98.2 -19.78 17.66 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.583 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.97 156.69 10.38 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 120.203 -0.999 . . . . 0.0 113.715 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.532 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.0 m -117.62 137.88 52.33 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.791 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -116.3 148.36 40.61 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -178.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.33 113.72 18.59 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.636 -1.166 . . . . 0.0 108.804 177.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 46.61 36.37 3.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.045 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.05 -3.31 80.45 Favored Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 120.854 -0.689 . . . . 0.0 113.557 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -106.56 118.57 37.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.097 0.475 . . . . 0.0 110.767 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.791 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.5 tptp -73.47 119.72 18.08 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.111 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.7 m -95.72 165.59 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.454 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.7 tt0 -69.92 126.37 29.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.637 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.688 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 67.9 tttt -52.9 162.5 0.61 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.811 0.338 . . . . 0.0 110.335 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.0 p30 35.41 34.66 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.241 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.5 OUTLIER -112.32 137.58 50.26 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.057 179.435 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -82.72 129.16 34.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.954 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -129.51 148.13 51.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.92 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.5 tp -72.87 119.01 16.52 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.009 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -58.05 164.86 2.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.816 0.817 . . . . 0.0 111.957 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.423 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -125.57 153.16 44.1 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.318 179.253 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.52 118.05 13.85 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 62.75 25.71 67.82 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.789 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.423 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 9.2 t70 -57.92 175.36 0.2 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.027 0.441 . . . . 0.0 111.154 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 1.0 OUTLIER -145.11 135.54 24.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.887 179.837 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.7 mt -114.38 128.48 71.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.505 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.463 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.1 m -103.95 139.26 39.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.993 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.484 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.3 m -140.27 158.38 25.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 82.95 35.85 17.28 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.993 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.445 ' HA ' HG12 ' A' ' 140' ' ' ILE . 56.8 t -76.41 140.49 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-O 121.733 0.778 . . . . 0.0 112.477 -178.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.69 -41.38 0.62 Allowed Glycine 0 N--CA 1.437 -1.262 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.074 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.427 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 46.5 t -126.33 132.19 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 114.787 -0.707 . . . . 0.0 109.204 178.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -50.53 -36.38 33.98 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 70.0 m -93.61 6.31 48.7 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.427 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 1.1 m-20 -120.2 25.66 9.73 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.463 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.2 mt -106.92 139.41 28.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.224 178.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.3 tt -123.46 134.51 53.92 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.26 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.465 ' HB3' HG23 ' A' ' 40' ' ' THR . 47.0 t -112.51 150.42 31.3 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.645 0.736 . . . . 0.0 112.585 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 2.4 mm? -135.67 148.46 48.93 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.432 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 23.8 t -117.19 131.14 70.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 0.0 111.174 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.1 mm -106.33 122.07 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.679 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.15 120.03 39.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.092 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 7.3 mt -84.79 129.27 37.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.837 0.351 . . . . 0.0 111.236 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -75.88 116.19 16.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.973 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -62.86 -30.0 71.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.009 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -57.88 -43.49 86.05 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.076 0.465 . . . . 0.0 110.571 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -58.98 -44.01 91.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.764 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 41.5 tttm -65.11 -41.09 95.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.978 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.23 -45.02 92.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.924 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 13.0 t -60.03 -46.05 90.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.957 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.14 -35.89 76.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.62 -36.22 75.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -91.87 -33.61 14.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.868 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.2 p30 42.45 82.13 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.506 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.2 tttm -115.95 138.16 51.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.908 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.1 p -64.98 133.09 30.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.119 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 60.97 161.37 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 62.3 mtm180 -94.57 46.17 1.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.871 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.1 pp -92.62 123.91 44.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.116 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.303 -0.856 . . . . 0.0 110.895 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.79 0.328 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.5 m 70.24 -63.63 0.39 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.975 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -59.93 -31.58 69.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.926 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -36.32 79.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.771 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.38 -40.99 88.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.788 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.73 -32.18 72.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.763 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.411 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.0 mt -73.13 -35.41 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -57.46 -41.9 81.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.437 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -67.22 -24.06 65.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.623 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.411 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.82 -47.59 79.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.156 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.5 m -80.99 -27.11 36.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.936 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.99 30.32 11.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.882 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -75.55 139.49 42.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.87 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -65.01 113.71 4.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.839 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.1 mm -81.87 138.4 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-O 121.716 0.769 . . . . 0.0 111.653 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 175.25 90.87 0.08 OUTLIER Glycine 0 C--N 1.315 -0.638 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.464 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.12 -39.19 75.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.766 0.317 . . . . 0.0 110.988 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.429 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.7 OUTLIER -170.69 33.8 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.699 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 6.1 mm -75.87 132.14 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 113.702 -1.59 . . . . 0.0 112.587 -177.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.479 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 3.0 t -91.0 -60.93 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.073 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.0 p -148.67 152.15 36.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.267 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.09 138.15 50.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.918 0.389 . . . . 0.0 111.191 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.415 HG21 ' CE2' ' A' ' 68' ' ' PHE . 23.1 t -104.73 122.69 58.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.777 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.0 mt -125.12 120.55 58.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.468 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 34.2 t -80.49 112.29 17.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.489 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.4 t -82.08 -25.87 34.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.652 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.453 HG23 ' HB3' ' A' ' 142' ' ' SER . 34.1 p -79.88 -2.18 42.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.582 0.23 . . . . 0.0 111.501 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.74 78.08 0.27 Allowed Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.794 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -146.43 -44.03 0.19 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.945 0.403 . . . . 0.0 110.991 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.562 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.7 mp -120.03 141.47 31.57 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.046 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.562 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.0 Cg_endo -72.09 146.03 45.7 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.246 1.964 . . . . 0.0 112.21 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.3 mt -55.81 128.78 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.809 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.431 ' HG3' ' CE2' ' A' ' 76' ' ' TYR . 19.2 mtt180 -122.85 164.09 19.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.06 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -120.81 119.92 34.09 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.507 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 2.5 mt -93.3 137.29 32.76 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.699 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -147.93 158.04 43.84 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -178.56 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.479 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -140.32 141.79 35.68 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 113.28 -1.782 . . . . 0.0 110.237 178.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.433 ' CB ' ' HG2' ' A' ' 54' ' ' GLN . 51.2 m-20 -82.17 131.82 35.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.197 0.522 . . . . 0.0 111.512 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.1 mp -64.17 -45.18 97.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.297 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.0 t -56.6 -38.6 72.24 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.282 0.563 . . . . 0.0 110.606 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.433 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 41.2 mm-40 -68.41 -37.1 80.02 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.399 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.0 t -68.32 -40.38 82.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.799 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.1 tp -70.95 -37.63 72.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.808 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.77 -41.54 64.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.878 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -64.01 123.88 20.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.911 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.9 32.92 3.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.823 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -114.29 176.6 4.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.797 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 99.8 p -80.13 -33.59 38.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.866 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.6 tp -100.4 146.31 9.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.052 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.33 -62.73 1.55 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.994 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.418 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.0 ttpt -150.11 136.31 18.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.026 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 11.7 t -128.48 139.2 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 121.261 0.553 . . . . 0.0 112.197 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.507 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.2 m-90 -103.24 139.36 38.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.984 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.88 125.39 53.6 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 177.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.563 ' CD2' ' CG ' ' A' ' 76' ' ' TYR . 2.6 m-85 -107.9 145.82 33.22 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.606 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.67 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.78 -178.15 40.05 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.916 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.435 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 6.1 mtp-105 -77.47 -3.39 40.19 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -84.88 135.72 39.66 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.767 0.318 . . . . 0.0 111.133 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.419 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 12.0 Cg_exo -69.07 -6.5 18.41 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.794 2.329 . . . . 0.0 111.884 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.86 -44.06 15.87 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 121.945 0.879 . . . . 0.0 108.651 179.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.86 138.61 2.67 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.734 -1.575 . . . . 0.0 110.41 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -56.27 -18.85 11.76 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.95 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.563 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 45.0 t80 -129.73 119.72 23.93 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.736 0.303 . . . . 0.0 110.818 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.419 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.2 t-160 -87.66 107.94 18.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.763 0.316 . . . . 0.0 110.611 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 79.9 mt -80.7 -81.93 0.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.255 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.25 -106.9 0.19 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.526 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -172.76 57.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.854 0.359 . . . . 0.0 111.196 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.435 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 3.6 mt -103.18 125.14 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.822 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.9 t -54.73 -32.89 60.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.854 0.359 . . . . 0.0 111.246 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.31 -24.06 66.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.952 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.426 HD23 ' CE1' ' A' ' 88' ' ' HIS . 14.3 mt -105.53 152.08 23.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.968 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 92.9 p -94.7 166.19 12.13 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.704 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.67 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -43.16 -53.73 4.84 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.333 0.587 . . . . 0.0 109.831 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -118.9 82.86 1.93 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.565 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.8 t60 -60.13 -46.35 89.93 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.12 -0.946 . . . . 0.0 112.703 -176.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.524 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 20.1 p90 -147.13 159.46 43.59 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.721 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 5.0 tt0 -135.87 141.48 44.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.438 -179.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 2.7 mp -115.95 126.36 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.834 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.408 ' CD1' ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -104.37 151.97 22.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.064 0.459 . . . . 0.0 111.897 -179.552 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.51 122.87 39.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.311 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.95 -174.94 28.31 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.568 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 61.03 -167.42 0.19 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.878 0.371 . . . . 0.0 110.905 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.76 98.24 7.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.019 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.04 36.88 44.97 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.707 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -139.7 135.79 33.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.804 0.335 . . . . 0.0 110.764 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.404 ' CB ' HD22 ' A' ' 124' ' ' LEU . 3.0 mm? -110.99 159.36 17.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.829 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 8.5 mt -133.1 142.1 48.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.82 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.403 ' CD2' ' CD1' ' A' ' 145' ' ' ILE . 1.3 mt -112.87 121.54 44.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.976 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' A' ' 90' ' ' GLN . 50.7 t30 -116.84 115.65 25.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.833 0.349 . . . . 0.0 111.853 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.692 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 12.2 p30 -77.86 139.99 39.32 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 10.3 pt -148.43 39.18 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 111.543 0.201 . . . . 0.0 111.543 -178.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.586 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.02 151.67 20.08 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 120.96 0.409 . . . . 0.0 111.946 -178.879 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 50.3 m -68.69 -31.71 71.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.807 177.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -98.21 -19.69 17.71 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.586 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.81 155.48 10.09 Favored Glycine 0 N--CA 1.438 -1.187 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.596 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.3 m -117.41 137.81 52.24 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.834 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -115.0 148.51 38.73 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 -178.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.05 113.44 18.39 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.293 177.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 44.61 43.04 6.23 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.83 -9.97 72.07 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.433 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.7 mp0 -105.06 118.57 36.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.086 0.469 . . . . 0.0 110.727 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.834 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 10.1 tptm -73.07 118.24 15.78 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.259 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.3 m -89.69 165.52 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.209 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.423 ' O ' ' HB3' ' A' ' 120' ' ' SER . 6.2 tt0 -69.9 126.87 30.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.481 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.692 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 29.2 tttt -53.85 163.53 0.71 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.782 0.325 . . . . 0.0 110.438 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.0 m-80 33.72 36.93 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.825 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.423 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.7 p -111.84 144.6 40.88 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.864 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -91.5 128.17 37.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.687 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 56.4 mm-40 -129.17 148.75 51.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.749 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -72.8 128.43 35.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.287 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.404 HD22 ' CB ' ' A' ' 99' ' ' LEU . 67.4 tp -57.9 155.74 10.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.437 0.637 . . . . 0.0 111.654 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.418 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -124.7 153.1 42.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.637 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.408 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.1 OUTLIER -71.86 123.32 22.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.917 0.389 . . . . 0.0 110.25 179.803 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.24 22.52 50.48 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.071 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.418 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 32.0 t70 -52.36 169.9 0.07 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.981 0.42 . . . . 0.0 111.239 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.416 ' CG ' ' CG2' ' A' ' 144' ' ' VAL . 2.0 mt-10 -145.12 135.45 24.11 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.946 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.46 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 15.7 mt -116.25 127.24 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-O 120.808 0.337 . . . . 0.0 110.458 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.461 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 2.7 m -104.43 141.18 36.8 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.164 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.497 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.8 m -140.26 158.49 25.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.05 44.2 9.18 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.821 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.453 HG22 ' CD2' ' A' ' 110' ' ' TRP . 54.0 t -85.23 140.53 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-O 121.677 0.751 . . . . 0.0 112.616 -178.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.11 -41.45 0.68 Allowed Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.9 t -126.48 121.97 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-N 114.567 -0.816 . . . . 0.0 108.998 177.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -50.33 -25.96 4.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.749 0.309 . . . . 0.0 111.506 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 73.8 m -93.55 6.56 47.84 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -131.42 29.19 4.6 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.461 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 4.9 mt -106.98 139.23 29.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.077 178.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.0 tt -124.23 134.55 53.23 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.531 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.453 ' HB3' HG23 ' A' ' 40' ' ' THR . 47.5 t -113.52 150.6 32.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.626 0.727 . . . . 0.0 112.42 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 1.8 mm? -135.7 141.84 44.98 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.349 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.416 ' CG2' ' CG ' ' A' ' 129' ' ' GLU . 13.2 t -110.87 137.74 42.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.813 0.34 . . . . 0.0 111.282 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.456 HG22 HD12 ' A' ' 145' ' ' ILE . 29.9 mt -106.29 128.09 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.142 -179.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.74 119.83 37.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.554 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.408 ' CD1' ' HA ' ' A' ' 126' ' ' GLN . 4.3 mt -84.87 134.04 27.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.527 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -90.44 105.58 17.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.798 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.4 -26.59 63.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.235 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.77 -42.21 83.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.014 0.435 . . . . 0.0 110.639 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -60.71 -43.98 97.14 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.948 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 8.1 mtpt -61.81 -33.97 75.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.975 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.67 -42.91 81.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.883 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.1 t -63.5 -42.28 98.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.911 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.69 -36.7 81.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.012 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -60.45 -47.91 84.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.833 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.57 -15.09 59.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.281 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -130.78 79.9 1.92 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.803 0.335 . . . . 0.0 110.93 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -87.01 155.18 20.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 12.2 p -69.53 126.39 29.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.036 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 12.1 p30 -154.77 175.49 13.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.978 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.76 118.83 13.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.001 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -96.34 134.25 34.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.135 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.927 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.836 0.35 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -159.48 -45.56 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.9 -37.19 83.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.851 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.402 ' HB2' ' NH1' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -61.32 -43.17 99.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.764 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -57.39 -38.49 74.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.822 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.02 -31.84 69.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.742 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.437 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.1 mt -72.69 -35.56 50.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.768 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -57.44 -39.82 77.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.932 0.396 . . . . 0.0 110.416 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.6 mtpt -67.06 -23.84 65.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.797 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.64 -47.36 79.9 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.213 -179.907 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.56 -30.91 57.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.901 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -81.35 86.54 6.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -94.04 153.41 18.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.006 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.15 127.43 32.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.904 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.8 mm -83.15 138.35 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-O 121.629 0.728 . . . . 0.0 111.88 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.86 63.68 1.23 Allowed Glycine 0 C--N 1.315 -0.635 0 CA-C-N 114.481 -1.236 . . . . 0.0 112.394 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.25 -24.02 43.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.628 0.251 . . . . 0.0 111.181 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 178.14 35.22 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.678 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 1.1 mm -89.63 96.54 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 CA-C-N 113.964 -1.471 . . . . 0.0 111.578 -177.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.47 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.3 t -55.38 -65.65 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.278 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.8 p -146.39 165.05 30.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.016 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.88 128.17 41.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.093 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.4 m -93.46 122.75 45.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.9 0.381 . . . . 0.0 111.11 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.1 mt -125.6 117.43 49.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.39 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 6.9 t -79.83 118.25 21.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.822 0.344 . . . . 0.0 110.387 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.07 -26.45 33.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.857 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.479 HG21 ' HB3' ' A' ' 142' ' ' SER . 33.5 p -79.93 -2.2 42.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.59 0.233 . . . . 0.0 111.357 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.49 47.42 90.77 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.855 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -113.81 -29.87 6.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.785 0.326 . . . . 0.0 110.884 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.567 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.8 mt -128.16 141.26 40.73 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.71 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.567 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 42.9 Cg_endo -70.46 134.35 26.31 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.125 1.884 . . . . 0.0 112.23 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.6 mt -55.17 130.02 17.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.608 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.8 163.42 17.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.305 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.24 119.74 36.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.989 0.423 . . . . 0.0 111.451 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.577 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 7.1 mt -98.45 136.15 39.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.404 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.678 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -148.71 157.76 43.67 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -179.162 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.47 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -144.1 142.0 30.35 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 113.643 -1.617 . . . . 0.0 110.864 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.486 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -78.37 133.27 37.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.129 0.49 . . . . 0.0 111.039 -179.901 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 71.0 mt -63.97 -40.39 88.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.965 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.62 -41.01 76.36 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.926 -178.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.486 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -68.53 -39.62 81.1 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.572 179.776 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.8 t -66.45 -41.7 89.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.167 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -71.0 -34.53 71.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.962 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -75.44 -47.55 26.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.901 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.88 115.43 19.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.872 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.06 30.0 7.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.895 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 10.4 mtp180 -105.8 27.46 8.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.999 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.5 m 62.94 141.85 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.972 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.3 mm 64.51 100.02 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.213 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.36 -57.99 2.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.806 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -139.85 131.5 27.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.774 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 15.4 t -125.49 139.03 52.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.309 0.576 . . . . 0.0 112.181 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.577 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.0 m-90 -101.92 139.32 37.72 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.14 -0.937 . . . . 0.0 112.09 179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.406 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -114.49 126.52 55.04 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.08 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.515 ' CG ' ' CE2' ' A' ' 89' ' ' PHE . 0.9 OUTLIER -116.91 145.27 43.71 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.376 -178.447 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 165.18 -176.84 40.8 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.231 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.2 ttp85 -72.69 -3.03 22.57 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.426 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.3 t30 -84.8 135.04 40.64 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.738 0.304 . . . . 0.0 111.598 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.436 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 14.5 Cg_exo -67.57 -11.82 33.46 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.928 2.419 . . . . 0.0 112.036 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.38 -44.28 16.32 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-O 121.919 0.866 . . . . 0.0 109.029 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -41.62 142.36 0.64 Allowed 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 113.746 -1.57 . . . . 0.0 110.854 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.0 t0 -56.07 -18.57 10.04 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.204 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.464 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 8.1 t80 -129.14 131.12 47.15 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-O 120.771 0.319 . . . . 0.0 110.746 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.436 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 -104.17 115.32 30.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.031 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.455 ' CD2' ' CD2' ' A' ' 76' ' ' TYR . 12.4 mt -91.41 177.02 6.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.751 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.63 -92.04 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.361 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -179.19 68.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.849 0.357 . . . . 0.0 110.719 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.446 ' HB ' HD12 ' A' ' 84' ' ' LEU . 3.3 mp -112.12 116.52 52.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.068 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.8 -25.89 43.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.216 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.91 -20.4 62.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.096 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.446 HD12 ' HB ' ' A' ' 81' ' ' ILE . 3.8 mp -104.9 153.01 21.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.817 0.341 . . . . 0.0 110.857 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.3 p -93.67 168.66 10.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.689 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.571 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 6.4 m-20 -41.41 -59.21 1.64 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.367 0.603 . . . . 0.0 109.657 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.04 84.11 2.06 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 176.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.553 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.9 t60 -58.92 -46.51 87.74 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.495 -176.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.515 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 27.1 p90 -144.91 159.8 42.33 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.9 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.4 tt0 -136.16 140.65 43.78 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.357 -179.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 65.9 mt -116.5 127.16 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 C-N-CA 121.164 -0.214 . . . . 0.0 110.809 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.412 ' HB3' HG12 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -113.12 144.94 41.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.02 0.438 . . . . 0.0 111.691 -179.727 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.9 tp -125.25 122.97 38.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.555 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.58 -139.23 2.93 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.592 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 66.32 -73.91 0.07 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.787 0.327 . . . . 0.0 110.893 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -155.99 -45.14 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.873 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -163.13 -40.02 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.545 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -57.86 161.33 3.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.902 0.382 . . . . 0.0 111.086 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.404 ' HB3' ' CD2' ' A' ' 124' ' ' LEU . 14.9 tp -106.95 154.23 21.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.822 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 6.1 mp -125.55 144.81 50.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.441 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.3 tp -112.54 122.63 48.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.11 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.41 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 52.8 t30 -116.88 115.68 25.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.934 0.397 . . . . 0.0 111.921 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.683 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 10.0 p30 -76.63 138.7 40.25 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 9.5 pt -146.67 39.22 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 111.497 0.184 . . . . 0.0 111.497 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.595 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -97.99 150.94 20.83 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 121.171 0.51 . . . . 0.0 112.039 -178.681 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 42.9 m -68.79 -31.45 70.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.611 177.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -98.05 -19.78 17.77 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.595 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.22 155.23 10.15 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.251 -0.975 . . . . 0.0 113.559 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.515 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 5.8 m -117.35 137.69 52.28 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.832 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -115.75 148.55 39.69 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -177.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.02 113.58 18.6 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.385 177.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 43.87 43.85 5.45 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.79 -11.42 66.67 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.398 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -104.36 118.61 37.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.034 0.445 . . . . 0.0 110.62 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.832 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 9.1 tptp -72.28 115.89 12.06 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.293 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.5 m -84.45 164.24 2.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.13 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.426 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.2 tm-20 -69.83 125.03 25.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.496 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.683 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 55.6 tttt -53.02 162.0 0.71 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.914 0.388 . . . . 0.0 110.646 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.7 p30 34.78 34.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.423 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.29 145.09 40.61 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.089 179.457 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -88.3 129.86 35.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.795 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 41.4 mm-40 -129.6 147.84 51.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.035 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.9 128.98 37.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.983 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.431 HD13 ' N ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -58.07 159.6 5.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.415 0.626 . . . . 0.0 111.897 -178.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.431 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -125.0 153.26 43.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.156 179.59 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.412 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.23 116.74 11.91 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.819 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 62.81 25.58 67.79 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.545 -178.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.431 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 33.6 t0 -50.69 168.77 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.104 0.478 . . . . 0.0 111.457 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 15.5 tt0 -145.21 135.49 24.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.872 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.444 ' CG2' ' CG2' ' A' ' 109' ' ' THR . 3.2 mt -114.75 127.35 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.513 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.468 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 4.2 m -104.64 138.41 41.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.944 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.529 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.2 m -140.2 158.24 25.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 82.24 39.6 11.11 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.944 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.424 ' HA ' HG12 ' A' ' 140' ' ' ILE . 54.9 t -79.41 140.41 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-O 121.688 0.756 . . . . 0.0 112.557 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 156.46 -41.76 0.56 Allowed Glycine 0 N--CA 1.436 -1.318 0 CA-C-N 114.471 -1.241 . . . . 0.0 110.018 -179.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.416 ' HB ' ' HB2' ' A' ' 139' ' ' ASP . 45.7 t -126.39 131.21 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-N 114.869 -0.666 . . . . 0.0 109.262 178.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -50.41 -35.4 28.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.669 0.271 . . . . 0.0 111.647 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.57 6.44 48.24 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.416 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 51.4 m-20 -121.85 26.75 8.48 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.468 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 5.0 mt -107.12 139.5 28.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.332 178.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.9 tt -120.69 134.5 55.28 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.292 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.479 ' HB3' HG21 ' A' ' 40' ' ' THR . 45.4 t -112.89 150.59 31.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.612 0.72 . . . . 0.0 112.716 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.419 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 70.8 mt -135.57 149.58 49.46 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.538 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 25.7 t -120.44 139.95 46.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.795 0.331 . . . . 0.0 111.28 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 5.4 mt -106.24 130.75 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.807 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -115.75 114.43 24.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.106 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 126' ' ' GLN . 6.0 mt -85.03 134.16 27.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.349 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -82.59 133.11 35.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.749 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -73.72 -37.75 65.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.209 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -46.13 91.55 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.907 0.384 . . . . 0.0 110.817 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.427 ' CD2' HD23 ' A' ' 155' ' ' LEU . 36.2 t80 -61.02 -44.02 98.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.16 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -63.09 -40.34 97.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.191 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -59.06 -47.08 86.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.184 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.9 t -68.15 -45.47 73.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.089 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.427 HD23 ' CD2' ' A' ' 151' ' ' PHE . 4.0 mm? -61.1 -39.61 90.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.07 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -60.45 -36.41 78.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.012 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -87.83 -36.96 16.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.996 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.0 p30 42.44 62.37 1.72 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.489 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.26 145.83 32.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.855 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 12.4 p -74.83 122.97 29.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.095 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -125.97 108.59 11.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.914 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 39.6 ttm-85 -90.94 -54.16 4.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.872 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.1 pt -78.52 132.05 33.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.199 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.919 179.968 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.919 0.39 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -60.4 -45.05 94.96 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.5 -38.22 74.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.837 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.7 tp -60.7 -31.88 71.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.693 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.41 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.3 mt -72.17 -35.54 53.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.857 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -57.4 -44.45 84.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.918 0.39 . . . . 0.0 110.536 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.6 mtmm -67.07 -23.7 65.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.632 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.41 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.65 -47.56 79.49 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.253 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.2 t . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.954 179.991 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.405 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER . . . . . 0 CA--C 1.509 -0.619 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.687 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.3 mm -76.62 133.89 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 CA-C-N 113.863 -1.517 . . . . 0.0 112.489 -177.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.962 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -91.7 -61.21 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-N 114.715 -1.129 . . . . 0.0 109.856 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.401 ' SG ' HD22 ' A' ' 48' ' ' LEU . 5.7 p -145.14 160.0 42.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.278 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.73 138.17 54.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.698 0.285 . . . . 0.0 111.37 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.674 HG21 ' HE2' ' A' ' 68' ' ' PHE . 37.0 t -109.66 122.6 64.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.836 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.843 HG23 HG12 ' A' ' 45' ' ' ILE . 17.7 mt -125.14 120.63 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.405 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.722 ' HA ' HD13 ' A' ' 143' ' ' LEU . 49.4 t -80.96 111.96 17.92 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.802 0.334 . . . . 0.0 110.441 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.21 -22.42 35.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.591 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.469 HG23 ' HB3' ' A' ' 142' ' ' SER . 81.2 p -79.94 -2.21 42.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.654 0.264 . . . . 0.0 111.446 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.99 74.23 0.42 Allowed Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.847 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.513 ' HB2' HD11 ' A' ' 141' ' ' LEU . 11.2 mt-30 -146.01 -42.82 0.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.852 0.358 . . . . 0.0 111.065 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.592 ' CD1' HD21 ' A' ' 141' ' ' LEU . 3.2 mt -116.57 141.88 28.73 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.586 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 43.0 Cg_endo -70.37 142.38 45.08 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.143 1.896 . . . . 0.0 112.186 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.843 HG12 HG23 ' A' ' 37' ' ' ILE . 36.6 mt -57.04 135.35 20.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.717 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -130.98 160.06 35.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.084 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.71 119.87 31.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.92 0.391 . . . . 0.0 111.91 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.787 HD23 ' CD2' ' A' ' 66' ' ' TRP . 8.8 mp -82.57 133.05 35.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.514 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.962 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -139.78 155.64 47.18 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 122.287 1.041 . . . . 0.0 113.793 -179.656 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.48 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -143.23 141.92 31.24 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 113.476 -1.693 . . . . 0.0 110.616 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 121.207 0.527 . . . . 0.0 111.249 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.869 0.366 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.408 ' HE2' ' O ' ' A' ' 49' ' ' SER . 4.9 ttpt -128.27 130.55 48.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.856 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.683 HG12 ' HG2' ' A' ' 90' ' ' GLN . 8.4 t -126.52 139.12 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 121.289 0.566 . . . . 0.0 112.175 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.787 ' CD2' HD23 ' A' ' 48' ' ' LEU . 18.2 m-90 -102.98 139.17 38.89 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.969 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.527 HG22 ' HB3' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -113.17 131.09 56.0 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 177.6 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.863 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -118.2 145.82 44.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.259 -178.683 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.624 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.29 -167.78 35.68 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.413 -0.899 . . . . 0.0 113.173 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -79.42 1.78 24.18 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -84.74 127.79 63.67 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.864 -0.153 . . . . 0.0 110.97 -179.804 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -66.18 -12.19 34.46 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.348 2.032 . . . . 0.0 111.563 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.95 -43.15 16.77 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-O 121.834 0.826 . . . . 0.0 108.926 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -39.77 139.62 0.61 Allowed 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.735 179.478 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -56.25 -18.69 11.2 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.04 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.529 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 13.2 t80 -129.64 121.99 28.14 Favored 'General case' 0 N--CA 1.457 -0.086 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.915 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.2 t60 . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 120.838 0.352 . . . . 0.0 110.636 179.686 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.419 HD11 HD13 ' A' ' 141' ' ' LEU . 33.3 mt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.795 0.331 . . . . 0.0 110.99 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.8 m -58.25 -37.19 74.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.1 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.432 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 1.8 mmt180 -61.8 -17.04 54.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.305 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.6 mt -107.25 147.8 29.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.838 0.351 . . . . 0.0 111.251 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 51.6 p -93.08 164.89 13.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.48 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.624 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.0 m-20 -43.19 -52.74 5.43 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.426 0.632 . . . . 0.0 109.893 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.527 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -121.31 81.12 1.75 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 177.453 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.564 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.3 t60 -61.21 -45.93 92.56 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.161 -0.927 . . . . 0.0 113.008 -176.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.524 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 22.3 p90 -146.73 157.77 43.76 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.171 -0.611 . . . . 0.0 112.104 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.683 ' HG2' HG12 ' A' ' 65' ' ' VAL . 22.7 tt0 -135.6 140.85 44.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.24 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.863 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 16.1 mt -117.0 131.12 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.18 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.685 HD21 ' HB2' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -116.65 146.71 42.54 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.153 0.501 . . . . 0.0 111.932 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.776 HD22 ' CG1' ' A' ' 33' ' ' VAL . 15.3 tp . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.148 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.752 HD21 HG12 ' A' ' 33' ' ' VAL . 3.1 mp . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.838 0.351 . . . . 0.0 110.971 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.794 HD23 ' O ' ' A' ' 122' ' ' GLN . 9.3 mt -128.76 136.47 50.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.512 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.83 122.6 48.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.08 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.685 ' HB2' HD21 ' A' ' 92' ' ' LEU . 63.6 t30 -114.85 121.99 44.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.015 0.436 . . . . 0.0 111.857 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.773 ' OD2' HG23 ' A' ' 116' ' ' VAL . 21.9 p30 -82.0 133.72 35.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.905 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.497 HD13 ' HB2' ' A' ' 90' ' ' GLN . 17.2 pt -139.55 37.82 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.654 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -96.34 156.25 16.42 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 120.927 0.394 . . . . 0.0 111.746 -178.943 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 87.8 m -68.91 -35.83 77.3 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.318 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.432 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -98.58 -19.74 17.42 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.46 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.654 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 121.04 161.57 11.42 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.192 -1.004 . . . . 0.0 113.914 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.548 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.2 m -117.5 138.04 52.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.905 -0.647 . . . . 0.0 109.299 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.84 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -112.22 148.55 33.86 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -177.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.466 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.06 113.32 18.23 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.484 -1.235 . . . . 0.0 108.192 177.216 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.419 ' N ' HD12 ' A' ' 111' ' ' LEU . 93.0 m-20 44.29 43.5 6.0 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.05 -11.36 67.42 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 120.709 -0.758 . . . . 0.0 113.487 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.77 118.5 36.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.031 0.443 . . . . 0.0 110.679 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.84 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -72.36 128.55 35.97 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.371 -179.698 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.773 HG23 ' OD2' ' A' ' 103' ' ' ASP . 8.4 m -98.54 166.11 2.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.057 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 120' ' ' SER . 16.1 tt0 -69.9 126.71 30.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.483 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.693 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 32.6 tttt -54.27 163.4 0.84 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.9 OUTLIER 35.82 35.45 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.746 -179.231 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.7 p -111.9 145.04 40.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.601 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.566 ' HB3' HD22 ' A' ' 100' ' ' LEU . 38.3 m-80 -95.14 129.54 42.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.846 0.355 . . . . 0.0 110.897 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.794 ' O ' HD23 ' A' ' 100' ' ' LEU . 56.2 mm-40 -129.08 150.01 50.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.533 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.1 tp -72.55 132.27 43.59 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.276 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.957 HD11 HG21 ' A' ' 145' ' ' ILE . 61.4 tp -64.11 156.62 27.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.43 0.633 . . . . 0.0 111.633 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.443 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.57 154.09 41.16 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.926 -179.512 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -70.78 121.67 18.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.863 0.363 . . . . 0.0 110.061 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.13 22.85 50.8 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.033 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.443 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 26.5 t70 -53.62 171.77 0.08 Allowed 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.981 0.42 . . . . 0.0 111.037 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -145.26 135.34 23.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.097 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.457 ' CG2' HG22 ' A' ' 109' ' ' THR . 16.0 mt -115.01 127.9 72.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.412 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.513 HG22 ' CG2' ' A' ' 140' ' ' ILE . 23.5 m -104.31 137.16 42.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.985 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.501 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 26.9 m -140.2 158.34 25.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.02 0.438 . . . . 0.0 112.022 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.55 37.67 10.47 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.618 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 140' ' ' ILE . 50.4 t -79.71 140.47 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 121.705 0.764 . . . . 0.0 112.435 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.52 -36.8 0.63 Allowed Glycine 0 N--CA 1.436 -1.337 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.465 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 50.9 t -126.32 133.0 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-N 114.653 -0.774 . . . . 0.0 109.169 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -50.69 -44.64 57.96 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -93.3 6.51 47.86 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.465 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 4.9 t0 -117.25 29.37 7.93 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.513 ' CG2' HG22 ' A' ' 131' ' ' THR . 3.8 mt -107.41 139.32 29.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.921 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.592 HD21 ' CD1' ' A' ' 43' ' ' ILE . 1.0 OUTLIER -116.46 134.43 54.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.588 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.564 ' C ' HD22 ' A' ' 143' ' ' LEU . 38.0 t -114.9 150.38 35.73 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.567 0.698 . . . . 0.0 112.595 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.722 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.5 mm? -136.01 143.44 44.77 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.876 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.35 135.86 49.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.803 0.335 . . . . 0.0 110.957 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.957 HG21 HD11 ' A' ' 124' ' ' LEU . 2.9 mm -106.24 123.96 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.069 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.07 117.1 31.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.481 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.636 HG12 HD21 ' A' ' 124' ' ' LEU . 2.6 mt -84.97 134.04 27.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.451 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.24 109.9 16.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.759 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -60.7 -35.2 75.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.103 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.93 -44.06 91.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.73 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.7 t80 . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.04 -179.937 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.803 0.335 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.4 mtm180 -59.11 -48.02 83.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.917 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -59.49 -35.01 73.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.88 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.78 -44.03 97.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.92 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.5 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.9 mm -66.64 -35.17 74.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.189 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -57.21 -39.44 75.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.928 0.394 . . . . 0.0 110.334 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.3 tttp -67.28 -23.71 65.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.6 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.5 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.82 -47.48 80.17 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.146 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 C--N 1.326 -0.438 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.902 179.823 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.414 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.8 OUTLIER . . . . . 0 CA--C 1.509 -0.607 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.663 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.3 mm -74.86 137.2 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 CA-C-N 113.786 -1.552 . . . . 0.0 112.437 -177.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.96 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.5 t -90.54 -58.54 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.745 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.728 ' SG ' HD22 ' A' ' 99' ' ' LEU . 1.8 m -149.8 162.84 39.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.701 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.401 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -127.1 138.09 53.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.754 0.311 . . . . 0.0 111.114 -179.768 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.669 HG21 ' CE2' ' A' ' 68' ' ' PHE . 47.5 t -108.43 122.65 63.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.95 0.405 . . . . 0.0 110.81 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.599 HG23 HG12 ' A' ' 45' ' ' ILE . 15.8 mt -123.77 121.54 62.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.472 -179.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.609 ' HA ' HD23 ' A' ' 143' ' ' LEU . 12.3 t -80.34 100.01 8.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.389 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.484 HG23 HG21 ' A' ' 144' ' ' VAL . 0.4 OUTLIER -63.86 -27.2 69.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.828 -179.261 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.517 HG21 ' H ' ' A' ' 142' ' ' SER . 54.9 p -79.85 -2.2 42.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.734 0.302 . . . . 0.0 111.504 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.72 75.39 0.31 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.018 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.428 ' HB2' HD11 ' A' ' 141' ' ' LEU . 6.9 mt-30 -144.23 -47.56 0.27 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.856 0.36 . . . . 0.0 110.627 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.668 HG21 ' CE2' ' A' ' 76' ' ' TYR . 2.8 mm -104.24 141.74 23.16 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.749 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.62 ' HD2' HG22 ' A' ' 43' ' ' ILE . 53.7 Cg_endo -71.67 138.22 31.57 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.187 1.925 . . . . 0.0 112.164 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.599 HG12 HG23 ' A' ' 37' ' ' ILE . 35.1 mt -55.61 131.99 19.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.609 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.96 164.55 19.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.404 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.401 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.8 OUTLIER -125.51 119.75 29.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.976 0.417 . . . . 0.0 111.957 -179.556 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.818 HD23 ' CD2' ' A' ' 66' ' ' TRP . 6.9 mp -92.22 129.49 38.15 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.96 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -138.49 156.48 47.5 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 122.252 1.025 . . . . 0.0 113.692 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.473 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -154.54 141.89 19.59 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 113.493 -1.685 . . . . 0.0 110.856 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.178 0 CA-C-O 121.062 0.458 . . . . 0.0 111.317 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.692 0.282 . . . . 0.0 111.053 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.448 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.9 ttpt -144.03 133.21 23.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.183 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.595 HG12 ' HG2' ' A' ' 90' ' ' GLN . 6.3 t -128.1 137.67 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 121.259 0.552 . . . . 0.0 112.045 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.818 ' CD2' HD23 ' A' ' 48' ' ' LEU . 18.9 m-90 -101.79 139.65 37.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.242 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.654 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -113.1 132.26 55.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.831 0.348 . . . . 0.0 110.157 177.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.722 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -120.32 145.4 47.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.825 -179.315 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.64 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.66 -167.03 35.67 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.166 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.428 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 20.0 mtp180 -86.19 36.05 0.67 Allowed 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.549 HD22 ' HB3' ' A' ' 73' ' ' ALA . 2.2 t30 -118.44 132.53 23.76 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.468 0.175 . . . . 0.0 110.998 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.09 -17.06 58.32 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.522 2.148 . . . . 0.0 111.506 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.549 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.99 -42.52 17.46 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 121.806 0.812 . . . . 0.0 109.088 178.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.26 139.39 1.43 Allowed 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.12 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.2 m-20 -56.23 -18.38 10.2 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.059 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.668 ' CE2' HG21 ' A' ' 43' ' ' ILE . 2.5 t80 -129.12 118.67 22.84 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-O 120.914 0.387 . . . . 0.0 110.951 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.628 179.857 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.523 HD12 ' CD1' ' A' ' 84' ' ' LEU . 36.0 mt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.763 0.316 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.83 -35.86 64.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.004 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.461 ' H ' HG22 ' A' ' 81' ' ' ILE . 5.4 mmp_? -63.37 -29.88 71.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.468 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.568 HD21 HG23 ' A' ' 132' ' ' VAL . 23.8 mt -99.99 150.5 22.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.857 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.7 p -98.37 166.69 11.26 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.64 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 m-20 -43.25 -52.54 5.63 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.397 0.618 . . . . 0.0 109.892 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.606 ' CB ' HD12 ' A' ' 104' ' ' ILE . 4.3 mttt -119.0 82.05 1.8 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 177.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.613 ' CE1' ' CG1' ' A' ' 132' ' ' VAL . 61.4 t-80 -58.69 -45.75 88.79 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.847 -177.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.513 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 31.5 p90 -149.38 162.18 40.6 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.583 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.654 ' HG3' HG23 ' A' ' 67' ' ' THR . 3.3 tt0 -136.32 140.84 43.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.298 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.711 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 78.1 mt -115.22 129.08 72.06 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.192 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.779 179.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.426 ' CA ' HG13 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -113.9 146.9 39.38 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.205 0.526 . . . . 0.0 111.937 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.724 HD22 HG11 ' A' ' 33' ' ' VAL . 23.7 tp . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.067 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.728 HD22 ' SG ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.761 0.315 . . . . 0.0 110.888 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.813 HD13 ' O ' ' A' ' 122' ' ' GLN . 4.1 mm? -129.2 142.83 50.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.635 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.546 HD21 HD13 ' A' ' 124' ' ' LEU . 28.0 mt -112.61 122.32 47.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.912 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.42 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 63.4 t30 -117.11 135.61 53.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.152 0.501 . . . . 0.0 111.825 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.811 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.3 p30 -96.82 143.08 28.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.664 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.606 HD12 ' CB ' ' A' ' 87' ' ' LYS . 7.0 pt -147.62 28.28 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.468 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.569 ' HB2' ' CG ' ' A' ' 88' ' ' HIS . 10.8 t -92.26 157.69 16.53 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 121.433 0.635 . . . . 0.0 112.69 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 95.3 m -69.8 -52.12 27.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.954 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -82.84 -0.09 46.49 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.324 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.65 157.75 29.58 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.708 -0.758 . . . . 0.0 113.542 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.514 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.2 m -117.63 137.89 52.33 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.841 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -113.76 148.44 36.49 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -178.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.82 HD12 HG11 ' A' ' 116' ' ' VAL . 0.8 OUTLIER -124.43 113.51 18.26 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.875 177.253 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 47.41 35.96 4.54 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.111 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.9 -7.23 79.26 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.487 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.51 118.39 36.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.979 0.419 . . . . 0.0 110.557 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.841 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 25.3 tptt -72.32 121.92 20.28 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.175 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.82 HG11 HD12 ' A' ' 111' ' ' LEU . 8.3 m -97.67 163.65 2.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.438 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 120' ' ' SER . 25.6 tt0 -69.98 128.13 35.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.453 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.67 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 66.7 tttt -52.56 161.94 0.63 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.789 0.328 . . . . 0.0 110.353 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 35.15 34.89 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.202 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.25 143.18 43.74 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.975 179.469 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.534 ' HB3' HD12 ' A' ' 100' ' ' LEU . 6.0 m-80 -85.39 132.52 34.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.889 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.813 ' O ' HD13 ' A' ' 100' ' ' LEU . 35.0 mm-40 -129.56 147.68 51.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.665 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.76 HD23 ' O ' ' A' ' 124' ' ' LEU . 7.2 tt -72.72 129.2 37.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.26 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.76 ' O ' HD23 ' A' ' 123' ' ' LEU . 66.9 tp -62.16 155.17 25.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.513 0.673 . . . . 0.0 111.677 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.5 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.3 OUTLIER -124.8 153.5 42.41 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.316 179.768 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.613 ' HA ' HD13 ' A' ' 147' ' ' ILE . 13.4 tp60 -71.15 119.79 15.79 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.55 23.95 63.4 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.657 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.437 ' OD2' HD23 ' A' ' 111' ' ' LEU . 22.2 t70 -49.02 167.15 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.921 0.391 . . . . 0.0 111.329 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 13.7 tt0 -145.1 135.4 24.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.965 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.509 HD11 HD11 ' A' ' 145' ' ' ILE . 11.8 mt -114.88 128.36 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.777 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.644 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.3 m -104.18 141.85 35.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.815 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.613 ' CG1' ' CE1' ' A' ' 88' ' ' HIS . 31.2 m -140.29 158.68 25.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.64 44.41 9.37 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.94 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.47 ' HA ' HG12 ' A' ' 140' ' ' ILE . 59.6 t -85.66 140.5 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-O 121.644 0.735 . . . . 0.0 112.459 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.03 -39.08 1.08 Allowed Glycine 0 N--CA 1.435 -1.404 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.565 HG12 ' H ' ' A' ' 138' ' ' SER . 58.8 t -126.51 118.91 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 CA-C-N 114.41 -0.895 . . . . 0.0 108.866 177.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.443 ' HA ' HD12 ' A' ' 140' ' ' ILE . 7.3 pt-20 -50.29 -26.37 4.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.738 0.304 . . . . 0.0 111.607 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.565 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -93.57 6.59 47.75 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -179.243 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.419 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.6 OUTLIER -131.11 29.19 4.7 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -178.901 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.644 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.7 mt -107.14 139.14 29.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.719 178.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.512 HD23 ' C ' ' A' ' 141' ' ' LEU . 9.4 tt -124.16 134.44 53.32 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.39 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.517 ' H ' HG21 ' A' ' 40' ' ' THR . 37.6 t -108.15 150.19 27.54 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.782 0.801 . . . . 0.0 112.532 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.609 HD23 ' HA ' ' A' ' 38' ' ' CYS . 72.2 mt -135.93 145.0 45.78 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.383 -1.281 . . . . 0.0 110.622 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.484 HG21 HG23 ' A' ' 39' ' ' THR . 21.9 t -117.07 139.49 43.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.837 0.351 . . . . 0.0 111.108 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.61 HG21 HD11 ' A' ' 124' ' ' LEU . 15.3 mt -106.17 123.02 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.952 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.04 119.5 39.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.87 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.613 HD13 ' HA ' ' A' ' 126' ' ' GLN . 4.7 mp -89.68 131.43 36.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.363 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.8 114.26 20.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.914 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -60.32 -29.18 68.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.35 -44.01 88.58 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.993 0.425 . . . . 0.0 110.609 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.0 t80 . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.841 179.82 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.84 0.352 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -60.14 -35.96 76.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.825 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.78 -35.0 77.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.825 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.6 mp -63.93 -44.05 94.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.888 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.3 mm -65.75 -35.16 74.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.206 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -57.16 -41.12 78.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.028 0.442 . . . . 0.0 110.351 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.6 mttm -67.21 -23.81 65.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.591 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.473 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.56 -47.56 79.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.109 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.0 p . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.836 179.873 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.406 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.5 OUTLIER . . . . . 0 CA--C 1.509 -0.625 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.743 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 2.3 mm -81.86 94.41 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 CA-C-N 113.908 -1.496 . . . . 0.0 112.923 -177.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.913 HG12 HD11 ' A' ' 99' ' ' LEU . 3.5 t -46.88 -61.22 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.906 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.559 ' SG ' HD12 ' A' ' 48' ' ' LEU . 6.1 p -144.74 165.1 29.02 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.777 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.73 138.15 51.96 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.904 0.383 . . . . 0.0 111.54 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.905 HG13 HD11 ' A' ' 48' ' ' LEU . 5.1 m -101.73 122.85 54.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.741 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.838 HG23 HG12 ' A' ' 45' ' ' ILE . 20.8 mt -129.05 118.67 47.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.733 ' HA ' HD13 ' A' ' 143' ' ' LEU . 39.0 t -79.98 122.53 26.84 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.49 -21.99 17.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.798 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.465 HG23 ' HB3' ' A' ' 142' ' ' SER . 76.5 p -79.84 -2.15 42.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.699 0.285 . . . . 0.0 111.43 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.71 73.85 0.57 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.695 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -145.98 -39.08 0.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.715 0.293 . . . . 0.0 111.142 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.563 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.7 mt -125.11 141.47 38.63 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.007 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.563 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 53.4 Cg_endo -72.19 145.94 45.01 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.191 1.927 . . . . 0.0 112.223 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.838 HG12 HG23 ' A' ' 37' ' ' ILE . 37.0 mt -62.4 138.55 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.787 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.62 163.23 25.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.752 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.7 119.67 36.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.009 0.433 . . . . 0.0 111.858 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.905 HD11 HG13 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -96.72 132.51 42.34 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.177 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.743 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -144.24 156.99 44.53 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -178.573 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.628 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -146.57 141.95 27.49 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.304 -1.771 . . . . 0.0 110.827 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 121.025 0.441 . . . . 0.0 110.977 -179.876 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.678 0.275 . . . . 0.0 111.127 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.5 ttpt -141.5 135.66 30.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.863 0.363 . . . . 0.0 111.316 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.634 HG13 ' O ' ' A' ' 91' ' ' ILE . 18.6 t -133.92 139.13 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-O 121.194 0.521 . . . . 0.0 111.782 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.61 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 16.5 m-90 -102.07 139.06 38.2 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.253 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.506 HG22 ' HB3' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -111.81 128.38 56.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.813 177.635 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.64 ' CD1' ' HB2' ' A' ' 76' ' ' TYR . 9.0 m-85 -120.45 145.57 47.09 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.714 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.592 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.97 -165.96 34.9 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.845 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.434 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 10.3 mtm105 -83.07 6.56 18.57 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.435 ' ND2' ' HD2' ' A' ' 72' ' ' PRO . 3.2 t-20 -84.71 140.04 37.93 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.556 0.217 . . . . 0.0 110.877 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.435 ' HD2' ' ND2' ' A' ' 71' ' ' ASN . 60.3 Cg_endo -73.57 -14.3 24.8 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.356 2.038 . . . . 0.0 111.302 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.1 -43.1 16.63 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -41.78 137.25 1.75 Allowed 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 113.63 -1.623 . . . . 0.0 110.906 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.4 OUTLIER -56.73 -19.23 15.72 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.191 179.162 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.64 ' HB2' ' CD1' ' A' ' 68' ' ' PHE . 15.6 t80 -130.22 120.2 24.11 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.641 0.258 . . . . 0.0 111.097 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.82 0.343 . . . . 0.0 110.724 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 1.066 HD13 HD12 ' A' ' 84' ' ' LEU . 4.1 mp . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.838 0.351 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.1 t -63.71 -36.81 85.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.03 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.547 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -69.52 -21.03 63.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.316 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.066 HD12 HD13 ' A' ' 81' ' ' ILE . 21.2 mt -105.9 148.9 27.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.721 0.296 . . . . 0.0 111.077 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.6 p -95.55 165.62 12.25 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.689 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.592 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.9 m-20 -43.91 -53.68 5.93 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.315 0.579 . . . . 0.0 109.897 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.534 ' HB2' HD12 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -118.54 80.34 1.52 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.362 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.662 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 63.5 t-80 -60.79 -45.94 92.45 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.866 -176.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.455 ' CD1' ' HB2' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -145.05 153.34 41.35 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.047 -0.661 . . . . 0.0 112.171 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.607 ' HG2' HG12 ' A' ' 65' ' ' VAL . 33.8 tt0 -135.5 139.89 44.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.418 -178.184 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.691 HD11 HD11 ' A' ' 145' ' ' ILE . 24.9 mt -113.97 132.09 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.024 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.4 ' CA ' HG13 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -118.28 144.0 46.15 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.961 0.41 . . . . 0.0 111.603 -179.804 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.646 HD22 HG11 ' A' ' 33' ' ' VAL . 13.8 tp . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.49 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.913 HD11 HG12 ' A' ' 33' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.808 0.337 . . . . 0.0 110.723 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.713 HD12 ' O ' ' A' ' 99' ' ' LEU . 5.9 mp -131.07 144.49 51.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.321 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.704 HD11 HD11 ' A' ' 130' ' ' ILE . 0.3 OUTLIER -112.7 123.54 50.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.199 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -114.04 115.9 28.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.018 0.437 . . . . 0.0 111.684 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.875 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.8 p30 -81.01 118.81 22.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.224 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.534 HD12 ' HB2' ' A' ' 87' ' ' LYS . 9.9 pt -124.41 33.83 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.321 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.579 ' HG ' ' CE1' ' A' ' 88' ' ' HIS . 13.7 t -89.57 159.01 17.4 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-O 121.347 0.594 . . . . 0.0 112.444 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 49.5 m -69.59 -52.28 27.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.67 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -92.67 -19.82 21.46 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 136.06 153.33 6.57 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.618 -0.801 . . . . 0.0 114.02 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.459 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.2 m -117.29 137.89 52.11 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.826 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -113.65 148.62 35.96 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -178.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.571 HD13 ' OD2' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -123.95 113.31 18.29 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.204 177.253 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.411 ' N ' HD12 ' A' ' 111' ' ' LEU . 82.6 m-20 45.08 43.05 7.19 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.28 -6.38 81.95 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.751 -0.737 . . . . 0.0 113.451 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -105.46 118.35 36.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.019 0.438 . . . . 0.0 110.76 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.826 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 7.9 tptt -73.42 115.75 13.16 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.267 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.875 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.4 m -92.36 159.56 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.356 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.1 tt0 -69.88 128.78 37.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.437 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.666 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 9.7 tttp -50.5 161.41 0.32 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.887 0.375 . . . . 0.0 110.472 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.459 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.9 p-10 34.23 35.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.186 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.9 OUTLIER -112.04 122.48 47.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.083 179.665 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.682 ' HB3' HD23 ' A' ' 100' ' ' LEU . 6.7 m-80 -68.59 126.03 28.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.032 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -129.38 147.37 51.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.598 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.1 tp -72.9 122.18 21.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.087 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.576 ' CD1' HD12 ' A' ' 101' ' ' LEU . 1.3 mm? -59.23 166.1 2.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.72 0.771 . . . . 0.0 111.888 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.574 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.4 OUTLIER -125.43 153.27 43.72 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.387 179.393 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.655 ' HA ' HD13 ' A' ' 147' ' ' ILE . 15.7 mm100 -71.35 116.25 11.46 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 62.99 27.89 71.15 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.776 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.571 ' OD2' HD13 ' A' ' 111' ' ' LEU . 20.6 t0 -59.31 174.81 0.37 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.018 0.437 . . . . 0.0 111.143 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.934 ' CG ' HG22 ' A' ' 144' ' ' VAL . 2.4 mt-10 -145.21 135.48 24.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.877 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.704 HD11 HD11 ' A' ' 101' ' ' LEU . 5.0 mt -111.33 128.48 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.269 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.664 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.8 m -103.93 141.45 36.13 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.662 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 33.3 m -140.43 158.61 25.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 77.0 44.35 14.3 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.11 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.454 ' HA ' HG12 ' A' ' 140' ' ' ILE . 76.1 t -83.8 140.4 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-O 121.691 0.758 . . . . 0.0 112.411 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.95 -38.92 1.23 Allowed Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.56 HG12 ' H ' ' A' ' 138' ' ' SER . 48.3 t -126.39 119.96 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-N 114.438 -0.881 . . . . 0.0 108.97 177.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.404 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.1 OUTLIER -50.23 -27.64 6.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.743 0.306 . . . . 0.0 111.273 -178.835 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.56 ' H ' HG12 ' A' ' 136' ' ' VAL . 15.2 m -93.56 6.59 47.75 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -127.34 25.81 6.09 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.664 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.9 mt -107.14 138.46 32.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.184 178.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.537 ' O ' HG22 ' A' ' 132' ' ' VAL . 2.6 tt -124.73 134.41 52.84 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.214 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.531 ' N ' HD23 ' A' ' 141' ' ' LEU . 36.7 t -112.72 150.16 31.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.66 0.743 . . . . 0.0 112.666 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.733 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.3 mm? -136.05 142.59 44.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.412 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.934 HG22 ' CG ' ' A' ' 129' ' ' GLU . 17.5 t -110.95 140.13 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.932 0.396 . . . . 0.0 111.334 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.691 HD11 HD11 ' A' ' 91' ' ' ILE . 2.7 mm -106.36 121.05 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.697 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.74 108.74 19.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.959 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.655 HD13 ' HA ' ' A' ' 126' ' ' GLN . 4.3 mp -84.84 129.01 38.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.19 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 32' ' ' ILE . 1.4 t-20 -75.8 128.53 35.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.079 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.08 -29.1 61.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.098 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -43.51 86.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.025 0.44 . . . . 0.0 110.534 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.5 t80 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.762 179.898 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.657 0.265 . . . . 0.0 111.137 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.7 mtm-85 -59.33 -35.89 74.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.229 0.538 . . . . 0.0 109.937 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.427 ' CD2' ' HE2' ' A' ' 22' ' ' LYS . 3.0 t80 -60.88 -34.93 75.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.924 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.6 tp -59.14 -41.26 87.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.788 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.554 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 11.5 mm -70.38 -34.96 60.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.051 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -57.01 -33.7 67.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.832 0.348 . . . . 0.0 110.494 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.427 ' HE2' ' CD2' ' A' ' 18' ' ' PHE . 2.5 mptp? -66.65 -23.68 66.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.787 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.554 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.67 -47.55 79.57 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.969 0.414 . . . . 0.0 111.171 -179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.816 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.434 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.3 t-20 . . . . . 0 CA--C 1.508 -0.667 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.708 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -71.85 135.79 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-N 113.667 -1.606 . . . . 0.0 112.408 -177.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.009 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.6 t -91.71 -59.29 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.145 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.6 m -145.32 160.35 41.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.796 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.483 ' NH2' HD13 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -120.77 138.18 54.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.902 0.382 . . . . 0.0 111.216 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.672 HG21 ' CE2' ' A' ' 68' ' ' PHE . 22.0 t -98.52 122.66 50.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.065 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.78 HD12 ' CD1' ' A' ' 146' ' ' PHE . 16.3 mt -129.89 120.57 50.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.123 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.672 ' HA ' HD13 ' A' ' 143' ' ' LEU . 39.7 t -86.29 109.36 18.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.514 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.1 -27.12 48.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.587 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.59 HG21 ' H ' ' A' ' 142' ' ' SER . 8.7 p -79.86 -3.01 46.1 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.692 0.282 . . . . 0.0 111.455 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.25 78.92 0.2 Allowed Glycine 0 CA--C 1.52 0.376 0 C-N-CA 121.079 -0.582 . . . . 0.0 113.798 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -147.71 -45.25 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.902 0.382 . . . . 0.0 110.959 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.546 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 8.8 mt -116.38 141.3 27.71 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.228 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.546 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.0 Cg_endo -74.54 146.11 34.25 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.318 2.012 . . . . 0.0 112.094 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.483 HD13 ' NH2' ' A' ' 35' ' ' ARG . 17.2 mt -52.23 153.27 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.252 0.548 . . . . 0.0 111.788 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -142.58 161.69 37.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.93 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -119.62 119.71 34.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.158 0.504 . . . . 0.0 111.817 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.523 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 5.3 mt -101.08 137.06 39.95 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.009 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -144.35 158.45 43.74 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -178.767 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.504 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.4 143.64 30.2 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 113.631 -1.622 . . . . 0.0 110.862 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 121.075 0.464 . . . . 0.0 111.279 -179.607 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.3 tppm? . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.749 0.309 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.423 ' CE ' ' O ' ' A' ' 49' ' ' SER . 6.8 ttpt -144.92 132.59 21.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.234 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.649 HG22 ' CB ' ' A' ' 92' ' ' LEU . 15.4 t -128.43 139.42 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 121.373 0.606 . . . . 0.0 112.093 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.547 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 14.8 m-90 -100.57 139.98 35.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.142 -0.936 . . . . 0.0 112.255 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.673 HG23 ' CD ' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -108.9 127.23 53.87 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.17 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.672 ' CE2' HG21 ' A' ' 36' ' ' VAL . 3.4 m-85 -113.27 145.74 40.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.935 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.682 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.6 -173.96 38.06 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.115 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 27.4 mtm180 -79.12 0.75 26.83 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.733 0.271 . . . . 0.0 111.733 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.475 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -84.78 131.95 47.77 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.516 0.198 . . . . 0.0 110.774 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 14.8 Cg_exo -67.84 -8.31 22.14 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.492 2.128 . . . . 0.0 111.792 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.18 -43.55 16.02 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 121.922 0.867 . . . . 0.0 108.896 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -41.37 138.35 1.27 Allowed 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 113.697 -1.592 . . . . 0.0 110.71 179.538 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -56.46 -18.54 11.69 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.134 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.548 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 55.2 t80 -129.15 123.39 31.99 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-O 120.791 0.329 . . . . 0.0 110.756 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.908 179.898 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.622 HD12 ' CD1' ' A' ' 84' ' ' LEU . 30.7 mt . . . . . 0 N--CA 1.456 -0.125 0 CA-C-O 120.832 0.349 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.97 -41.28 96.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.891 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.4 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -62.41 -28.6 69.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.062 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.622 ' CD1' HD12 ' A' ' 81' ' ' ILE . 32.5 mt -96.57 152.1 18.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.055 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 93.0 p -97.55 164.21 12.53 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.529 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.682 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.7 m-20 -41.96 -53.04 3.97 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.326 0.584 . . . . 0.0 109.782 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.465 ' HB3' HD11 ' A' ' 104' ' ' ILE . 25.3 mttt -119.39 85.62 2.41 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 177.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.573 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.2 t60 -65.05 -44.21 89.77 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -176.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.506 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 37.7 p90 -153.26 163.27 40.21 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 119.984 -0.686 . . . . 0.0 112.461 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.673 ' CD ' HG23 ' A' ' 67' ' ' THR . 12.4 mt-30 -135.68 156.81 48.26 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.51 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.496 ' O ' HG13 ' A' ' 65' ' ' VAL . 18.3 mt -127.8 132.35 68.96 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.205 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.649 ' CB ' HG22 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -120.64 148.35 44.03 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.12 0.486 . . . . 0.0 111.791 -179.268 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.804 HD22 ' CG1' ' A' ' 33' ' ' VAL . 48.2 tp . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.361 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.606 ' HB3' HD13 ' A' ' 124' ' ' LEU . 3.9 mm? . . . . . 0 N--CA 1.458 -0.068 0 CA-C-O 120.769 0.319 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.572 HD12 ' O ' ' A' ' 99' ' ' LEU . 2.9 mp -131.4 143.69 50.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.395 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.494 HD22 HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -114.9 126.06 54.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.479 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.473 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.3 t30 -115.57 115.75 26.97 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.751 -0.379 . . . . 0.0 111.57 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.795 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.3 p30 -79.57 143.19 35.01 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.283 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.503 HG21 ' OE1' ' A' ' 90' ' ' GLN . 11.0 pt -150.3 35.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.624 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -95.1 151.23 19.38 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 120.942 0.401 . . . . 0.0 111.814 -178.876 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 50.6 m -68.8 -31.57 70.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.014 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -98.08 -19.72 17.79 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.624 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.39 154.92 9.63 Favored Glycine 0 N--CA 1.439 -1.164 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.609 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.508 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.5 m -117.53 137.69 52.4 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.857 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -116.39 148.35 40.74 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -178.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.459 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.23 113.43 18.28 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.437 177.482 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.404 ' N ' HD12 ' A' ' 111' ' ' LEU . 3.6 m120 44.89 43.37 7.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.227 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.17 -7.32 78.66 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.838 -0.696 . . . . 0.0 113.47 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -105.61 118.58 36.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.043 0.449 . . . . 0.0 110.724 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.857 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 15.0 tptt -74.02 121.55 21.23 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.239 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.795 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.6 m -95.6 164.03 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.124 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 120' ' ' SER . 28.3 tp10 -69.88 128.98 38.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.474 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.693 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 80.3 tttt -54.61 161.92 1.33 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.989 0.423 . . . . 0.0 110.599 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.455 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.0 m-80 34.67 33.97 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.437 -0.802 . . . . 0.0 112.105 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.4 145.18 40.58 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.025 179.441 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.535 ' HB3' HD23 ' A' ' 100' ' ' LEU . 34.2 m-80 -88.78 131.35 35.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.949 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.451 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 39.9 mm-40 -129.27 150.36 50.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.379 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.3 tp -72.62 111.86 8.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.823 0.344 . . . . 0.0 110.309 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.639 ' CD2' HD11 ' A' ' 147' ' ' ILE . 7.7 tt -55.01 156.78 3.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.287 0.565 . . . . 0.0 111.541 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.29 153.47 41.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.812 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.434 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.5 122.2 20.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.025 0.441 . . . . 0.0 110.531 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.14 18.71 60.73 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.42 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -57.22 173.36 0.24 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.879 0.371 . . . . 0.0 110.973 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 13.0 tt0 -145.04 135.64 24.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.118 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.481 ' CG2' HG22 ' A' ' 109' ' ' THR . 2.6 mt -108.89 128.3 64.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.45 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.482 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 25.4 m -104.24 141.16 36.76 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.102 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.547 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 27.2 m -140.25 158.43 25.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -178.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.55 42.93 8.77 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.241 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.466 ' HA ' HG12 ' A' ' 140' ' ' ILE . 71.7 t -84.59 140.38 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-O 121.617 0.722 . . . . 0.0 112.286 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.86 -40.66 1.12 Allowed Glycine 0 N--CA 1.436 -1.345 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.596 HG12 ' H ' ' A' ' 138' ' ' SER . 48.4 t -126.37 120.83 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 CA-C-N 114.462 -0.869 . . . . 0.0 109.049 177.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.491 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.5 OUTLIER -50.5 -24.98 3.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.664 0.269 . . . . 0.0 111.473 -178.785 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.596 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -93.5 6.51 47.96 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -179.363 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -129.7 26.12 5.31 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.491 HD12 ' HA ' ' A' ' 137' ' ' GLU . 5.9 mt -106.87 139.07 29.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.094 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.428 HD12 ' H ' ' A' ' 142' ' ' SER . 24.9 tp -124.74 134.51 52.79 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.803 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.59 ' H ' HG21 ' A' ' 40' ' ' THR . 0.9 OUTLIER -109.6 133.54 52.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.958 0.409 . . . . 0.0 111.548 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.672 HD13 ' HA ' ' A' ' 38' ' ' CYS . 1.4 mm? -128.29 134.5 48.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.688 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 21.6 t -110.98 135.55 49.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.816 0.341 . . . . 0.0 111.262 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.3 mm -106.31 134.79 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.78 ' CD1' HD12 ' A' ' 37' ' ' ILE . 14.9 m-85 -115.41 119.79 37.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.767 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.639 HD11 ' CD2' ' A' ' 124' ' ' LEU . 5.8 mt -84.82 134.01 27.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.499 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -75.89 116.4 16.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.663 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -58.22 -32.11 67.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.009 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.0 -46.09 90.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.59 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.494 ' CZ ' HD21 ' A' ' 93' ' ' LEU . 11.5 t80 . . . . . 0 N--CA 1.452 -0.336 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.027 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 . . . . . 0 N--CA 1.458 -0.062 0 CA-C-O 120.834 0.349 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -68.27 -39.17 82.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.857 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -56.99 -41.48 78.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.73 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.6 tp -58.45 -33.76 70.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.571 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.539 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.5 mt -73.16 -35.87 48.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.783 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -33.75 68.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.956 0.408 . . . . 0.0 110.904 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.1 mmpt? -58.73 -26.37 63.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.409 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.539 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.8 -48.48 77.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.268 0.556 . . . . 0.0 111.064 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 C--N 1.321 -0.635 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.062 179.875 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.452 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.9 m-20 . . . . . 0 CA--C 1.508 -0.654 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.653 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.5 mm -76.66 136.74 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-N 113.774 -1.557 . . . . 0.0 112.535 -177.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.966 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.1 t -91.05 -59.41 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.682 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 4.8 p -150.41 165.47 33.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.32 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.412 ' CD ' ' CG2' ' A' ' 45' ' ' ILE . 0.2 OUTLIER -128.01 138.15 52.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.804 0.335 . . . . 0.0 111.188 -179.411 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.736 HG11 ' CE2' ' A' ' 68' ' ' PHE . 3.1 m -106.48 122.76 60.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.852 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.675 HG23 HG12 ' A' ' 45' ' ' ILE . 17.3 mt -125.02 122.58 63.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.617 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.764 ' HA ' HD23 ' A' ' 143' ' ' LEU . 50.7 t -79.93 107.34 12.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.809 0.338 . . . . 0.0 110.402 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.3 t -70.97 -28.47 64.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.978 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.518 HG21 ' H ' ' A' ' 142' ' ' SER . 69.8 p -79.87 -2.17 42.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.693 0.283 . . . . 0.0 111.527 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.1 80.56 0.11 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.947 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.543 ' HB2' HD12 ' A' ' 43' ' ' ILE . 9.8 mt-30 -146.86 -41.69 0.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.912 0.386 . . . . 0.0 110.932 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.692 HG23 ' HD2' ' A' ' 44' ' ' PRO . 5.3 mp -119.41 143.48 34.56 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.218 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.692 ' HD2' HG23 ' A' ' 43' ' ' ILE . 43.9 Cg_endo -70.27 146.11 56.07 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.325 2.017 . . . . 0.0 111.963 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.675 HG12 HG23 ' A' ' 37' ' ' ILE . 32.2 mt -62.81 131.64 28.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.924 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.459 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -117.25 146.36 43.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.91 179.144 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.67 119.66 39.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.986 0.422 . . . . 0.0 111.629 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.829 HD23 ' CD2' ' A' ' 66' ' ' TRP . 6.9 mp -92.05 125.5 36.76 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.966 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -135.82 156.98 47.96 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 122.285 1.04 . . . . 0.0 113.531 -179.427 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.478 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -150.23 141.88 23.59 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 113.613 -1.631 . . . . 0.0 110.721 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 121.029 0.442 . . . . 0.0 111.346 -179.594 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt . . . . . 0 CA--C 1.528 0.108 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.465 ' CE ' ' O ' ' A' ' 49' ' ' SER . 30.8 ttpt -144.34 123.05 12.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.853 0.358 . . . . 0.0 111.918 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.698 HG22 ' HG2' ' A' ' 90' ' ' GLN . 13.1 p -110.4 139.76 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.829 ' CD2' HD23 ' A' ' 48' ' ' LEU . 20.6 m-90 -100.81 139.85 35.91 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.033 -1.44 . . . . 0.0 112.227 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.683 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -111.91 133.1 54.32 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 177.859 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.736 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -120.01 145.5 46.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.556 -178.937 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.621 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.81 -169.41 36.47 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.489 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.542 ' NH2' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -85.29 7.48 22.06 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.733 0.267 . . . . 0.0 111.521 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.438 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 6.4 t-20 -84.9 134.17 42.01 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-O 120.532 0.206 . . . . 0.0 110.783 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -65.84 -13.75 41.34 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.547 2.165 . . . . 0.0 111.843 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.438 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -83.2 -44.76 14.66 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 121.936 0.874 . . . . 0.0 109.186 178.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.75 137.63 2.19 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.728 -1.578 . . . . 0.0 111.485 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 67' ' ' THR . 21.9 m-20 -56.82 -18.88 14.53 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.231 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.459 ' CE1' ' HB2' ' A' ' 46' ' ' ARG . 7.8 t80 -129.8 103.28 6.73 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.817 0.342 . . . . 0.0 110.88 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.4 t60 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.98 -179.912 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.59 ' HB ' HD13 ' A' ' 84' ' ' LEU . 42.2 mm . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.884 0.373 . . . . 0.0 111.021 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.5 p -65.24 -40.52 94.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.45 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.466 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -60.66 -24.87 65.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.902 0.382 . . . . 0.0 110.646 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.624 ' N ' HD12 ' A' ' 84' ' ' LEU . 3.7 mp -107.5 152.69 23.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.507 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.458 ' O ' ' NH1' ' A' ' 70' ' ' ARG . 59.7 p -98.87 153.86 18.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.89 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.621 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.6 m-20 -30.33 -53.49 0.17 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.361 0.6 . . . . 0.0 110.549 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.674 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.5 OUTLIER -120.16 84.18 2.17 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 177.321 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.565 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.3 t60 -61.55 -46.3 90.5 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.034 -0.985 . . . . 0.0 112.593 -177.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.544 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 22.0 p90 -142.36 160.73 39.69 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.058 -0.657 . . . . 0.0 112.109 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.698 ' HG2' HG22 ' A' ' 65' ' ' VAL . 3.3 tt0 -135.98 143.39 44.8 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.034 -179.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.675 ' C ' HG23 ' A' ' 65' ' ' VAL . 61.6 mt -122.39 132.14 71.73 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.196 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.688 HD21 ' OD1' ' A' ' 121' ' ' ASN . 0.4 OUTLIER -125.66 141.65 51.91 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.014 0.435 . . . . 0.0 111.842 -179.794 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.711 HD22 ' CG1' ' A' ' 33' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.315 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.532 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.85 0.357 . . . . 0.0 110.84 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.532 HD12 ' O ' ' A' ' 99' ' ' LEU . 2.5 mp -131.21 142.19 50.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.496 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.9 pp -113.42 124.7 53.04 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.187 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.619 ' HB2' HD21 ' A' ' 92' ' ' LEU . 54.8 t30 -116.03 120.29 38.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.056 0.455 . . . . 0.0 111.923 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.76 ' OD2' HG23 ' A' ' 116' ' ' VAL . 20.4 p30 -80.62 137.57 36.37 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.748 178.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.517 HD12 ' HB2' ' A' ' 87' ' ' LYS . 8.3 pt -144.58 39.33 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.565 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -97.12 162.28 13.44 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.073 0.463 . . . . 0.0 111.602 -179.278 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 89.1 m -69.11 -40.92 78.06 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.734 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -98.7 -19.94 17.22 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.096 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.565 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 126.58 160.69 10.66 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 119.948 -1.12 . . . . 0.0 114.205 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.538 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 13.9 m -117.63 138.02 52.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.853 -0.674 . . . . 0.0 109.253 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.876 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -111.97 148.36 33.94 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.405 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.21 113.52 18.41 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.491 -1.231 . . . . 0.0 108.197 177.399 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 44.5 42.79 5.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.47 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.71 -10.1 71.32 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.768 -0.729 . . . . 0.0 113.548 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -104.34 118.5 36.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.079 0.466 . . . . 0.0 110.696 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.876 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.0 tptm -73.82 126.88 31.39 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.194 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.76 HG23 ' OD2' ' A' ' 103' ' ' ASP . 8.7 m -99.51 166.51 2.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.384 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 120' ' ' SER . 3.0 tp10 -69.93 126.21 29.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.607 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.704 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 74.1 tttt -54.58 162.57 1.12 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.04 0.448 . . . . 0.0 110.534 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.0 OUTLIER 37.33 31.44 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.454 -0.793 . . . . 0.0 112.069 -179.218 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.479 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.65 143.94 43.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.847 179.095 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.688 ' OD1' HD21 ' A' ' 92' ' ' LEU . 23.4 m-80 -94.01 135.52 35.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.921 0.391 . . . . 0.0 111.018 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 59.0 mm-40 -129.38 152.32 49.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.393 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.458 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.6 tm? -72.4 118.36 15.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.959 0.409 . . . . 0.0 110.336 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.57 HD21 ' CG1' ' A' ' 147' ' ' ILE . 7.4 tt -52.12 155.59 1.87 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.437 0.637 . . . . 0.0 111.788 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.408 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.7 OUTLIER -124.52 153.23 42.4 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.349 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.605 ' HA ' HD13 ' A' ' 147' ' ' ILE . 27.3 mm100 -71.62 124.55 24.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.88 0.372 . . . . 0.0 110.478 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 56.94 22.08 40.34 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.257 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.408 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 19.9 t70 -54.86 173.14 0.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.946 0.403 . . . . 0.0 110.811 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.9 ' CG ' HG22 ' A' ' 144' ' ' VAL . 1.9 mt-10 -144.29 135.74 25.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.145 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.791 HD11 HD11 ' A' ' 145' ' ' ILE . 12.7 mt -113.11 127.56 70.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.791 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.614 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.0 m -104.45 137.79 41.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.741 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.543 HG23 HD21 ' A' ' 84' ' ' LEU . 33.9 m -140.25 158.29 25.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.68 28.92 25.35 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.135 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.488 ' HA ' HG12 ' A' ' 140' ' ' ILE . 70.4 t -70.89 140.39 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-O 121.62 0.724 . . . . 0.0 112.38 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.1 -38.98 0.83 Allowed Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.492 HG12 ' H ' ' A' ' 138' ' ' SER . 48.2 t -126.49 129.38 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-N 114.641 -0.779 . . . . 0.0 109.117 178.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -50.51 -36.07 32.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.807 0.337 . . . . 0.0 111.567 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.492 ' H ' HG12 ' A' ' 136' ' ' VAL . 3.4 p -93.61 6.54 47.94 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.422 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 9.5 t0 -120.74 25.97 9.39 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.614 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.4 mt -107.1 139.15 29.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.102 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.409 HD23 ' C ' ' A' ' 141' ' ' LEU . 9.6 tt -124.2 134.4 53.29 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.434 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.518 ' H ' HG21 ' A' ' 40' ' ' THR . 38.5 t -108.01 150.24 27.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.721 0.772 . . . . 0.0 112.261 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.764 HD23 ' HA ' ' A' ' 38' ' ' CYS . 76.2 mt -135.87 155.7 49.92 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.903 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.9 HG22 ' CG ' ' A' ' 129' ' ' GLU . 21.5 t -123.6 140.16 47.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.73 0.3 . . . . 0.0 110.918 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.791 HD11 HD11 ' A' ' 130' ' ' ILE . 7.9 mt -106.22 120.87 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-O 120.93 0.395 . . . . 0.0 111.01 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.84 126.3 52.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.452 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.694 ' N ' HD12 ' A' ' 147' ' ' ILE . 2.8 mp -99.19 131.51 46.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.284 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -76.05 112.0 12.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.841 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -58.5 -34.01 70.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.909 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.77 -46.2 91.4 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.741 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 32.0 t80 . . . . . 0 N--CA 1.452 -0.37 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.057 -179.918 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.795 0.331 . . . . 0.0 110.986 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -67.7 -35.94 79.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.989 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.7 -42.42 88.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.008 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.32 -44.92 95.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.52 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.7 mm -67.41 -35.0 72.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.269 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -57.17 -35.88 70.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.949 0.404 . . . . 0.0 110.469 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.2 -23.87 65.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.735 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.52 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.7 -47.37 80.07 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.281 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.3 t . . . . . 0 C--N 1.325 -0.464 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.889 179.989 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.424 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.7 OUTLIER . . . . . 0 CA--C 1.508 -0.67 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.663 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 6.0 mm -72.59 135.47 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 CA-C-N 113.612 -1.631 . . . . 0.0 112.638 -177.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.963 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.3 t -91.75 -59.16 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-N 114.68 -1.146 . . . . 0.0 109.715 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.548 ' SG ' HD22 ' A' ' 48' ' ' LEU . 4.9 p -147.31 165.32 30.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.46 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.549 ' NH1' HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -127.06 127.01 44.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.723 0.297 . . . . 0.0 111.263 -179.57 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.693 HG11 ' CE2' ' A' ' 68' ' ' PHE . 4.6 m -94.17 122.8 45.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.916 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.823 HG23 HG12 ' A' ' 45' ' ' ILE . 19.6 mt -129.34 121.84 54.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.634 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.533 ' HA ' HD23 ' A' ' 143' ' ' LEU . 52.3 t -81.27 124.34 29.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.254 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.96 -25.68 21.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.808 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.517 HG23 ' HB3' ' A' ' 142' ' ' SER . 81.8 p -79.87 -2.28 42.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.709 0.29 . . . . 0.0 111.562 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.07 74.42 0.46 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.93 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.455 ' HB2' HD11 ' A' ' 141' ' ' LEU . 7.7 mt-30 -144.43 -46.0 0.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.964 0.411 . . . . 0.0 110.789 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.599 HD13 HD21 ' A' ' 143' ' ' LEU . 2.8 mp -111.84 140.76 23.69 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.729 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.553 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.4 Cg_endo -73.4 143.78 35.42 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.147 1.898 . . . . 0.0 112.16 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.823 HG12 HG23 ' A' ' 37' ' ' ILE . 35.7 mt -56.33 142.93 10.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.575 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.452 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.4 OUTLIER -130.37 164.04 25.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.298 179.518 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.42 119.39 33.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.946 0.403 . . . . 0.0 111.529 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.792 HD21 ' HZ ' ' A' ' 68' ' ' PHE . 7.8 mp -94.38 124.71 38.58 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.963 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -136.3 156.15 49.07 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 122.283 1.04 . . . . 0.0 113.67 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.477 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -151.46 141.92 22.54 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.45 -1.705 . . . . 0.0 110.989 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 121.128 0.49 . . . . 0.0 110.894 -179.895 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.847 0.356 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.472 ' HE2' ' O ' ' A' ' 49' ' ' SER . 3.7 ttpt -140.3 130.41 24.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.853 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.737 HG12 ' HG2' ' A' ' 90' ' ' GLN . 9.3 t -124.14 138.34 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 121.26 0.552 . . . . 0.0 112.123 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.649 ' CD2' HD23 ' A' ' 48' ' ' LEU . 17.8 m-90 -100.88 139.6 36.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.127 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.605 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.27 130.47 55.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.043 0.449 . . . . 0.0 109.97 177.922 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.792 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -120.12 145.35 47.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.031 -179.07 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.595 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.35 -168.13 37.9 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.56 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.427 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 0.7 OUTLIER -79.46 -0.7 34.15 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.561 HD22 ' HB3' ' A' ' 73' ' ' ALA . 2.3 t30 -84.8 132.35 46.49 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.663 0.268 . . . . 0.0 111.148 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.8 Cg_exo -66.73 -13.52 40.25 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.639 2.226 . . . . 0.0 111.76 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.561 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.6 -43.06 17.47 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -41.11 141.04 0.69 Allowed 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 113.887 -1.506 . . . . 0.0 110.655 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 67' ' ' THR . 60.6 m-20 -56.31 -18.88 12.0 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.047 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.53 ' CE2' HG21 ' A' ' 43' ' ' ILE . 2.8 t80 -130.06 129.1 43.2 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-O 120.771 0.32 . . . . 0.0 111.325 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.462 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.815 HD13 HD12 ' A' ' 84' ' ' LEU . 3.9 mp . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.894 0.378 . . . . 0.0 110.835 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.1 m -56.11 -37.08 68.93 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.102 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.54 -17.5 59.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.302 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.815 HD12 HD13 ' A' ' 81' ' ' ILE . 20.0 mt -104.56 152.03 22.9 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.681 0.277 . . . . 0.0 111.157 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 57.7 p -96.63 167.97 10.81 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.566 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.595 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 8.1 m-20 -42.84 -58.74 2.24 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.365 0.602 . . . . 0.0 109.81 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.537 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.5 OUTLIER -115.36 82.74 1.8 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 176.975 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.556 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.1 t60 -59.6 -46.86 87.69 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.517 -176.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.532 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 29.8 p90 -145.54 161.49 39.65 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.214 -0.594 . . . . 0.0 112.005 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.737 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.2 tt0 -136.06 144.02 44.98 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.911 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.755 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 81.4 mt -118.88 124.7 73.6 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.272 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.044 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.669 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -102.26 151.27 22.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.964 0.411 . . . . 0.0 111.723 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.776 HD22 HG11 ' A' ' 33' ' ' VAL . 25.4 tp . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.439 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.777 ' HB2' HD22 ' A' ' 124' ' ' LEU . 4.1 mm? . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.931 0.396 . . . . 0.0 110.759 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.642 ' HB3' HD12 ' A' ' 92' ' ' LEU . 3.2 mp -131.31 145.46 51.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.689 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.726 HD21 HD12 ' A' ' 145' ' ' ILE . 11.0 mp -112.71 121.07 43.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.028 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.669 ' HB2' HD11 ' A' ' 92' ' ' LEU . 44.2 t30 -115.49 115.44 26.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.93 0.395 . . . . 0.0 111.552 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.828 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.3 p30 -78.59 140.44 38.47 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.536 HD12 ' HB2' ' A' ' 87' ' ' LYS . 10.1 pt -148.99 38.36 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -178.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.648 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.29 152.7 19.14 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 121.013 0.435 . . . . 0.0 112.063 -178.889 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 50.8 m -68.89 -31.44 70.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.875 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -98.21 -19.91 17.58 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -178.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.648 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.91 156.67 10.39 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.355 -0.926 . . . . 0.0 113.713 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.502 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.1 m -117.43 137.78 52.28 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.844 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -115.96 148.58 39.94 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -177.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.12 113.58 18.54 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.483 177.657 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.2 m120 44.72 43.27 6.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.444 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.58 -12.68 62.53 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.722 -0.752 . . . . 0.0 113.468 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.8 118.56 36.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.087 0.444 . . . . 0.0 110.605 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.844 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -71.44 131.71 43.74 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.48 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.828 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.6 m -101.59 165.87 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.966 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.4 mp0 -69.83 126.12 28.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.482 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.69 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 84.4 tttt -54.11 162.52 0.99 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.824 0.345 . . . . 0.0 110.654 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.3 m-80 34.21 35.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.109 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.19 145.17 40.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.035 179.531 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.641 ' HB3' HD23 ' A' ' 100' ' ' LEU . 1.1 m-80 -88.0 132.03 34.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.919 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.477 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 45.1 mm-40 -129.33 150.2 50.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.611 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.6 tp -72.8 136.13 45.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.488 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.854 HD21 HG12 ' A' ' 147' ' ' ILE . 16.2 tp -62.43 152.69 33.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.628 0.727 . . . . 0.0 111.585 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.503 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.4 OUTLIER -125.3 152.59 44.47 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.505 179.442 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.463 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 6.7 mm-40 -72.28 122.57 21.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 0.0 110.177 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.03 23.98 48.73 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.054 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.414 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 28.8 t70 -49.08 167.96 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.93 0.395 . . . . 0.0 111.487 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.938 ' CG ' HG22 ' A' ' 144' ' ' VAL . 2.3 mt-10 -144.27 135.68 25.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.003 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.484 ' CG2' HG22 ' A' ' 109' ' ' THR . 16.2 mt -115.71 127.3 73.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.804 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.589 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.0 m -104.59 139.16 39.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.873 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.533 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.2 m -140.38 158.41 25.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.5 28.86 26.02 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.161 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.488 ' HA ' HG12 ' A' ' 140' ' ' ILE . 78.1 t -71.35 140.39 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-O 121.626 0.727 . . . . 0.0 112.288 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.18 -39.5 0.92 Allowed Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.514 HG12 ' H ' ' A' ' 138' ' ' SER . 46.4 t -126.42 128.26 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 CA-C-N 114.689 -0.755 . . . . 0.0 109.068 177.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.51 -33.85 23.03 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.597 0.237 . . . . 0.0 111.632 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.514 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.8 m -93.53 6.46 48.14 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.01 26.79 7.95 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.589 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.6 mt -107.06 138.96 30.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.102 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.455 HD11 ' HB2' ' A' ' 42' ' ' GLN . 7.0 tt -124.63 134.38 52.93 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.531 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.517 ' HB3' HG23 ' A' ' 40' ' ' THR . 38.0 t -108.59 150.33 27.65 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.567 0.698 . . . . 0.0 112.069 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.599 HD21 HD13 ' A' ' 43' ' ' ILE . 75.9 mt -135.78 155.12 50.84 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.861 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.938 HG22 ' CG ' ' A' ' 129' ' ' GLU . 20.0 t -127.6 138.14 55.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.784 0.326 . . . . 0.0 111.166 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.726 HD12 HD21 ' A' ' 101' ' ' LEU . 19.4 mt -106.45 129.06 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 CA-C-O 120.852 0.358 . . . . 0.0 110.885 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.12 122.92 49.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.916 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.854 HG12 HD21 ' A' ' 124' ' ' LEU . 3.3 mt -91.35 134.14 30.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.474 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.76 112.37 19.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.675 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.71 -31.86 68.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.072 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt -58.95 -45.13 91.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.999 0.428 . . . . 0.0 110.609 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.0 t80 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.985 -179.997 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.717 0.294 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 -61.63 -44.15 97.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -60.01 -36.49 77.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.063 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.9 tp -63.73 -45.99 87.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.963 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 40.3 mm -63.27 -39.61 85.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.226 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -57.88 -33.89 69.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.234 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -65.15 -30.86 71.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.479 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -57.06 -47.49 80.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.089 0.471 . . . . 0.0 111.116 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 C--N 1.326 -0.436 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.939 179.997 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.433 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.1 m120 . . . . . 0 CA--C 1.505 -0.772 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.587 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 7.6 mm -71.51 144.52 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 CA-C-N 113.695 -1.593 . . . . 0.0 112.477 -176.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.799 HG22 HD13 ' A' ' 93' ' ' LEU . 1.2 t -105.71 -56.35 5.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.717 -178.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.757 ' SG ' HD12 ' A' ' 48' ' ' LEU . 31.3 p -151.51 164.51 36.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.221 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.41 138.26 53.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.835 0.35 . . . . 0.0 111.477 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.655 HG21 ' CE2' ' A' ' 68' ' ' PHE . 18.3 t -103.81 122.59 56.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.685 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.52 HG23 HG12 ' A' ' 45' ' ' ILE . 20.6 mt -127.0 115.82 42.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.461 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.576 ' HA ' HD13 ' A' ' 143' ' ' LEU . 37.7 t -79.97 124.75 28.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.82 0.343 . . . . 0.0 110.489 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.9 t -92.18 -26.99 17.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.556 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.518 HG21 ' H ' ' A' ' 142' ' ' SER . 25.9 p -79.93 -2.17 42.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.521 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.05 75.7 0.37 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.915 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -146.01 -44.9 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.789 0.328 . . . . 0.0 111.002 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.618 ' CD1' HD21 ' A' ' 143' ' ' LEU . 1.0 OUTLIER -112.73 140.61 24.16 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.831 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.534 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.6 Cg_endo -74.43 141.54 28.6 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.253 1.969 . . . . 0.0 112.361 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.52 HG12 HG23 ' A' ' 37' ' ' ILE . 35.9 mt -56.69 133.99 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.408 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.29 164.46 25.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.551 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.49 119.82 36.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.086 0.47 . . . . 0.0 111.774 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.857 HD22 ' CD1' ' A' ' 66' ' ' TRP . 17.8 mt -92.27 137.9 31.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.107 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.587 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -141.62 158.39 43.89 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 122.283 1.04 . . . . 0.0 113.756 -178.659 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.649 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . -146.5 141.81 27.43 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 113.447 -1.706 . . . . 0.0 110.43 178.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--N 1.33 -0.258 0 CA-C-O 121.066 0.46 . . . . 0.0 111.289 -179.456 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.408 ' CD ' ' N ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.635 0.255 . . . . 0.0 111.2 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.417 ' HE2' ' O ' ' A' ' 49' ' ' SER . 4.4 ttpt -132.32 135.17 46.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.754 0.312 . . . . 0.0 111.746 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 91' ' ' ILE . 17.0 t -134.03 139.55 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 121.182 0.515 . . . . 0.0 111.805 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.857 ' CD1' HD22 ' A' ' 48' ' ' LEU . 16.4 m-90 -100.42 139.42 36.12 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.019 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.898 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -110.09 132.86 53.78 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.649 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.738 ' HZ ' HD11 ' A' ' 48' ' ' LEU . 2.0 m-85 -115.9 145.7 42.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.478 -178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.673 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 173.96 -170.3 43.42 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.17 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 26.9 mtm180 -87.5 -13.44 43.08 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.472 ' ND2' ' H ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -84.32 143.12 41.45 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.927 0.394 . . . . 0.0 111.364 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 7.2 Cg_exo -70.47 1.3 5.04 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.175 2.583 . . . . 0.0 111.958 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.51 -49.07 10.31 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 122.019 0.914 . . . . 0.0 108.838 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.47 ' HB2' ' ND2' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -46.73 140.74 4.32 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 113.596 -1.638 . . . . 0.0 110.774 179.563 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -56.28 -19.5 14.46 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.216 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.542 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 15.7 t80 -129.57 118.38 21.93 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-O 120.654 0.264 . . . . 0.0 110.979 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.588 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.757 HD12 ' CD1' ' A' ' 84' ' ' LEU . 27.5 mt . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.826 0.346 . . . . 0.0 110.906 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.28 -40.5 71.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.071 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -22.56 64.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.164 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.757 ' CD1' HD12 ' A' ' 81' ' ' ILE . 47.1 mt -98.83 152.27 19.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.133 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 93.1 p -97.0 167.34 11.13 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.735 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.673 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -43.98 -54.09 5.69 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.424 0.63 . . . . 0.0 109.792 179.136 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.578 ' HB2' HD12 ' A' ' 104' ' ' ILE . 0.4 OUTLIER -118.2 83.09 1.95 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.247 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.568 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.4 t60 -61.77 -45.22 94.81 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.054 -176.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.523 ' HA ' HG12 ' A' ' 104' ' ' ILE . 29.1 p90 -149.19 161.51 41.85 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 119.987 -0.685 . . . . 0.0 112.303 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.898 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.5 mt-30 -135.46 147.19 48.83 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.313 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.661 HD12 ' CE1' ' A' ' 68' ' ' PHE . 19.9 mt -118.92 131.89 70.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.161 178.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.45 ' CB ' HG22 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -119.7 138.06 53.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.124 0.488 . . . . 0.0 111.964 -178.985 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.799 HD13 HG22 ' A' ' 33' ' ' VAL . 1.4 tt . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.325 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.716 ' O ' HD22 ' A' ' 100' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.9 0.381 . . . . 0.0 110.925 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.89 HD13 ' O ' ' A' ' 122' ' ' GLN . 3.8 mm? -129.96 142.52 50.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.002 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.68 128.14 56.31 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.446 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 52.8 t30 -115.57 117.04 29.23 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.823 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.9 p30 -79.84 140.19 36.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.578 HD12 ' HB2' ' A' ' 87' ' ' LYS . 15.9 pt -145.56 33.81 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 111.574 0.213 . . . . 0.0 111.574 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.676 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -93.96 150.35 20.43 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 120.996 0.427 . . . . 0.0 111.891 -178.832 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.1 m -68.59 -31.48 70.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.765 178.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -98.23 -19.62 17.73 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.676 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.12 156.23 10.02 Favored Glycine 0 N--CA 1.438 -1.21 0 C-N-CA 120.246 -0.978 . . . . 0.0 113.642 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.516 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.5 m -117.4 137.78 52.26 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.877 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -114.02 148.55 36.81 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -177.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.465 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.28 113.4 18.21 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.171 177.386 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.415 ' N ' HD12 ' A' ' 111' ' ' LEU . 3.8 m120 44.66 42.84 6.15 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.341 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.24 -10.52 70.84 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.504 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -104.77 118.54 36.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.078 0.466 . . . . 0.0 110.648 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.877 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.3 tptm -73.33 128.14 34.64 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.23 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.823 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.3 m -100.5 164.76 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.237 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 120' ' ' SER . 30.5 tt0 -70.05 127.09 31.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.514 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.689 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 24.2 tttt -53.09 162.38 0.68 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.857 0.361 . . . . 0.0 110.438 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.0 OUTLIER 35.4 33.99 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.14 -179.166 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.487 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.19 145.12 40.43 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.053 179.395 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.663 ' HB3' HD12 ' A' ' 100' ' ' LEU . 5.6 m-80 -90.35 130.75 36.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.085 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.89 ' O ' HD13 ' A' ' 100' ' ' LEU . 42.3 mm-40 -129.39 148.57 51.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.276 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.4 116.4 12.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.864 0.364 . . . . 0.0 110.354 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.704 HD11 HG21 ' A' ' 145' ' ' ILE . 65.3 tp -56.36 157.54 4.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.435 0.636 . . . . 0.0 111.587 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.471 ' O ' HD11 ' A' ' 147' ' ' ILE . 1.3 t -124.4 153.31 42.08 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.327 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.682 ' HA ' HD13 ' A' ' 147' ' ' ILE . 30.1 mm100 -71.3 123.54 22.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.897 0.379 . . . . 0.0 110.046 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.08 21.55 59.39 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.866 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -55.86 173.92 0.13 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.965 0.412 . . . . 0.0 111.057 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.708 ' HG3' HG22 ' A' ' 144' ' ' VAL . 9.5 tt0 -145.07 135.47 24.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.287 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.763 HD11 HD11 ' A' ' 145' ' ' ILE . 13.5 mt -113.86 128.04 70.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.26 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.674 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.5 m -104.36 138.78 40.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.208 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.5 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 35.4 m -140.19 158.42 25.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.25 34.36 20.7 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.92 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.2 t -75.15 140.45 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-O 121.763 0.792 . . . . 0.0 112.533 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.97 -39.37 0.6 Allowed Glycine 0 N--CA 1.437 -1.249 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.444 HG12 ' H ' ' A' ' 138' ' ' SER . 47.9 t -126.35 131.84 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 114.731 -0.735 . . . . 0.0 109.201 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -50.6 -38.71 47.1 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.444 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.6 OUTLIER -93.37 6.3 48.62 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.852 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.427 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 5.3 t70 -120.11 27.73 8.47 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.674 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.1 mt -107.26 139.5 28.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.022 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.715 HD12 HD11 ' A' ' 81' ' ' ILE . 3.0 tt -122.11 134.34 54.76 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.512 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.697 ' N ' HD23 ' A' ' 141' ' ' LEU . 47.0 t -113.8 150.79 32.98 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.611 0.72 . . . . 0.0 112.638 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.618 HD21 ' CD1' ' A' ' 43' ' ' ILE . 2.1 mm? -135.69 143.55 45.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.487 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.708 HG22 ' HG3' ' A' ' 129' ' ' GLU . 17.4 t -110.97 139.85 32.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.824 0.345 . . . . 0.0 111.138 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.763 HD11 HD11 ' A' ' 130' ' ' ILE . 16.2 mt -106.31 125.16 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.072 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.03 109.89 19.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.816 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.682 HD13 ' HA ' ' A' ' 126' ' ' GLN . 5.0 mp -85.96 134.07 28.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.416 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -86.06 127.7 34.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.844 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -74.03 -23.91 59.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.21 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -45.03 90.99 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.035 0.445 . . . . 0.0 110.649 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.4 t80 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.92 179.965 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.778 0.323 . . . . 0.0 110.805 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.6 mtm-85 -58.84 -46.08 88.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.972 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -61.39 -35.08 76.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.876 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.6 tt -61.18 -45.18 95.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.959 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.435 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 6.1 mm -62.64 -35.23 69.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.156 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.25 -44.59 84.01 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.9 0.381 . . . . 0.0 110.425 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -67.15 -23.74 65.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.419 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.75 -47.45 80.04 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.202 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.814 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.454 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER . . . . . 0 CA--C 1.51 -0.581 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.688 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.4 mm -73.02 137.08 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-N 113.598 -1.637 . . . . 0.0 112.658 -177.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.987 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.3 t -93.66 -59.82 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.658 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.94 156.46 42.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.229 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.842 ' NE ' HG21 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -119.88 138.14 53.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.815 0.34 . . . . 0.0 111.031 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.51 HG11 ' CE2' ' A' ' 68' ' ' PHE . 1.8 m -104.66 122.71 58.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.772 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.676 HG23 HG12 ' A' ' 45' ' ' ILE . 14.4 mt -125.0 124.17 67.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.572 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.757 ' HA ' HD13 ' A' ' 143' ' ' LEU . 52.8 t -80.02 108.74 13.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.859 0.361 . . . . 0.0 110.537 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.0 t -74.55 -25.46 59.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.639 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.539 HG23 ' HB3' ' A' ' 142' ' ' SER . 74.7 p -79.86 -2.35 43.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.46 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.15 76.73 0.24 Allowed Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.824 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -146.53 -43.86 0.19 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.913 0.387 . . . . 0.0 110.876 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.554 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.1 mt -117.93 141.3 29.01 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.005 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.554 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 52.5 Cg_endo -72.35 145.85 43.96 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.216 1.944 . . . . 0.0 111.788 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.842 HG21 ' NE ' ' A' ' 35' ' ' ARG . 68.6 mt -54.15 142.46 7.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.049 0.452 . . . . 0.0 111.829 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.507 ' HB2' ' CE2' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -124.67 133.99 53.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.861 178.873 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.08 119.92 32.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.141 0.496 . . . . 0.0 111.863 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.546 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 5.2 mt -98.04 131.96 44.0 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.987 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -143.55 157.55 44.34 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -178.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.495 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -141.07 146.29 36.94 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 113.694 -1.594 . . . . 0.0 110.993 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 121.045 0.45 . . . . 0.0 111.196 -179.532 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.767 0.318 . . . . 0.0 110.939 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.441 ' CE ' ' O ' ' A' ' 49' ' ' SER . 26.5 ttpt -141.06 144.09 34.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.016 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.658 HG12 ' HG2' ' A' ' 90' ' ' GLN . 14.4 t -127.72 139.5 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-O 121.29 0.567 . . . . 0.0 112.08 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.546 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 18.9 m-90 -100.77 139.32 36.62 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.144 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.689 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.79 126.97 55.8 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.459 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.521 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -118.06 145.23 44.96 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.79 -178.767 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.603 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.46 -172.69 37.73 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.084 -1.055 . . . . 0.0 113.593 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.415 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 0.8 OUTLIER -74.28 -0.61 17.53 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.409 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 25.2 t-20 -84.69 132.14 47.42 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.624 0.249 . . . . 0.0 111.29 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 14.7 Cg_exo -67.83 -12.1 34.26 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.58 2.186 . . . . 0.0 111.707 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.02 -43.19 16.63 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-O 121.914 0.864 . . . . 0.0 109.048 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -39.12 139.11 0.52 Allowed 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 113.701 -1.591 . . . . 0.0 111.089 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -56.44 -18.72 12.19 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.122 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.507 ' CE2' ' HB2' ' A' ' 46' ' ' ARG . 56.0 t80 -129.41 119.04 23.15 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.829 0.347 . . . . 0.0 110.915 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.2 t60 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.961 -179.969 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.76 ' HB ' HD13 ' A' ' 84' ' ' LEU . 2.4 mp . . . . . 0 CA--C 1.527 0.094 0 CA-C-O 120.795 0.331 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.27 -29.65 64.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.196 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.534 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -60.89 -23.25 65.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.059 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.76 HD13 ' HB ' ' A' ' 81' ' ' ILE . 4.1 mp -107.05 152.87 23.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.912 0.387 . . . . 0.0 110.958 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 61.1 p -96.46 166.71 11.56 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.891 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.603 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.2 m-20 -43.32 -53.19 5.4 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.318 0.58 . . . . 0.0 109.799 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.545 ' CB ' HD12 ' A' ' 104' ' ' ILE . 10.9 mttm -118.03 81.36 1.66 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.627 ' CE1' ' CG1' ' A' ' 132' ' ' VAL . 60.8 t-80 -58.81 -47.45 84.73 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.423 -177.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.504 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 32.1 p90 -146.31 159.81 42.86 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.154 -0.618 . . . . 0.0 112.063 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.689 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.0 tt0 -135.59 141.95 45.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.212 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.583 ' O ' HG13 ' A' ' 65' ' ' VAL . 45.7 mt -120.44 131.84 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.297 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.762 HD21 ' OD1' ' A' ' 121' ' ' ASN . 0.5 OUTLIER -120.09 139.73 52.12 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.004 0.43 . . . . 0.0 111.566 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.692 HD23 ' HG ' ' A' ' 99' ' ' LEU . 1.7 tm? . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.307 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.692 ' HG ' HD23 ' A' ' 93' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.715 0.293 . . . . 0.0 110.577 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.794 HD23 ' O ' ' A' ' 122' ' ' GLN . 9.0 mt -120.3 142.1 49.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.897 0.38 . . . . 0.0 110.719 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.926 HD11 HD11 ' A' ' 130' ' ' ILE . 3.8 tt -112.95 125.0 53.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.059 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.478 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 59.8 t30 -119.09 115.93 25.3 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.837 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.8 p30 -77.94 137.55 38.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.779 178.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.545 HD12 ' CB ' ' A' ' 87' ' ' LYS . 8.4 pt -141.29 29.52 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 121.127 -0.229 . . . . 0.0 111.58 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.531 ' HB2' ' CG ' ' A' ' 88' ' ' HIS . 12.1 t -93.69 155.49 17.22 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.534 0.683 . . . . 0.0 112.838 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 69.5 m -70.06 -52.04 27.1 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.669 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -80.34 -0.54 37.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.281 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.0 156.24 30.66 Favored Glycine 0 N--CA 1.437 -1.25 0 C-N-CA 120.642 -0.789 . . . . 0.0 113.518 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.502 HG22 ' CG2' ' A' ' 130' ' ' ILE . 5.2 m -117.44 137.89 52.21 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.845 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -113.29 148.47 35.56 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -178.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.409 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.12 113.54 18.49 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.298 177.328 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 45.3 42.7 7.53 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.0 -7.69 76.6 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.462 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.59 118.51 36.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 117.041 0.421 . . . . 0.0 110.624 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.845 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 6.3 tptm -72.46 116.94 13.51 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.259 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.837 HG23 ' OD2' ' A' ' 103' ' ' ASP . 13.1 m -92.42 162.86 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.046 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.421 ' HB3' ' HB3' ' A' ' 120' ' ' SER . 0.6 OUTLIER -69.81 128.92 38.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.46 179.66 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.684 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 45.5 tttt -55.35 163.87 1.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.751 0.31 . . . . 0.0 110.195 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.7 OUTLIER 35.96 34.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.818 -179.162 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.421 ' HB3' ' HB3' ' A' ' 117' ' ' GLU . 2.7 p -112.12 143.58 42.91 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.458 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.762 ' OD1' HD21 ' A' ' 92' ' ' LEU . 18.1 m-80 -94.22 132.28 38.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.045 0.45 . . . . 0.0 111.103 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.794 ' O ' HD23 ' A' ' 100' ' ' LEU . 58.1 mm-40 -129.07 151.23 49.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.446 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 tp -72.56 128.56 35.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.843 0.354 . . . . 0.0 110.464 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.817 HD21 HG12 ' A' ' 147' ' ' ILE . 18.8 tp -57.55 155.28 9.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.375 0.607 . . . . 0.0 111.679 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.518 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -124.71 152.95 43.11 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.304 179.463 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -71.88 119.14 15.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.96 0.41 . . . . 0.0 110.07 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.32 24.71 63.87 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.124 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.402 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 32.0 t70 -52.95 170.31 0.08 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.928 0.394 . . . . 0.0 111.337 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.9 ' CG ' HG22 ' A' ' 144' ' ' VAL . 9.4 mt-10 -145.15 135.61 24.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.06 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.926 HD11 HD11 ' A' ' 101' ' ' LEU . 6.6 mt -111.64 128.08 68.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.459 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.654 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.6 m -104.25 140.39 37.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.01 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.627 ' CG1' ' CE1' ' A' ' 88' ' ' HIS . 22.7 m -140.36 158.75 25.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.44 43.7 10.18 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.167 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 140' ' ' ILE . 74.0 t -83.01 140.44 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-O 121.609 0.719 . . . . 0.0 112.307 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.29 -40.17 0.95 Allowed Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.541 HG12 ' H ' ' A' ' 138' ' ' SER . 48.2 t -126.37 124.95 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-N 114.603 -0.799 . . . . 0.0 108.983 177.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -50.38 -30.73 12.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.769 0.319 . . . . 0.0 111.444 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.541 ' H ' HG12 ' A' ' 136' ' ' VAL . 4.0 m -93.62 6.35 48.56 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -123.52 24.25 8.64 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.654 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.5 mt -107.0 139.07 29.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.313 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.31 134.49 53.17 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.202 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.641 ' C ' HD22 ' A' ' 143' ' ' LEU . 38.1 t -111.12 150.62 29.16 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.73 0.776 . . . . 0.0 112.46 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.757 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.5 mm? -135.66 149.12 49.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.125 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.9 HG22 ' CG ' ' A' ' 129' ' ' GLU . 13.8 t -118.81 140.09 43.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 111.382 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.797 HD11 HD11 ' A' ' 130' ' ' ILE . 28.1 mt -106.29 120.87 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.76 118.38 36.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.654 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.817 HG12 HD21 ' A' ' 124' ' ' LEU . 5.5 mt -84.98 134.03 27.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.495 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.84 115.72 21.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.723 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -63.74 -31.8 73.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.06 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -60.14 -46.06 90.91 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.005 0.431 . . . . 0.0 110.784 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.7 t80 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.983 -179.898 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.919 0.39 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -64.8 -41.81 95.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.867 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -57.93 -38.6 76.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.854 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.521 HD13 ' O ' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -60.09 -31.85 70.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.811 179.781 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.439 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.0 mt -72.89 -35.4 49.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.831 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -57.38 -42.39 82.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.984 0.421 . . . . 0.0 110.493 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.1 tttt -67.08 -23.82 65.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.661 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.439 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.68 -47.52 79.67 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.261 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.941 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.44 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.7 OUTLIER . . . . . 0 CA--C 1.51 -0.564 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.688 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.1 mm -74.24 135.37 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-N 113.703 -1.589 . . . . 0.0 112.574 -177.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.0 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -93.51 -61.42 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.086 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.711 ' SG ' HD12 ' A' ' 48' ' ' LEU . 2.9 p -144.73 152.09 39.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.252 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.404 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -117.42 128.72 55.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.757 0.313 . . . . 0.0 111.339 -179.486 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.724 HG23 HD11 ' A' ' 48' ' ' LEU . 38.0 t -96.67 122.91 48.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.867 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.863 HG23 HG12 ' A' ' 45' ' ' ILE . 21.6 mt -127.14 127.23 69.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.582 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.528 ' HA ' HD13 ' A' ' 143' ' ' LEU . 11.6 t -91.61 107.67 19.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.446 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.434 ' CG2' HG21 ' A' ' 144' ' ' VAL . 63.0 p -81.24 -24.88 37.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.636 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.536 HG21 ' OG ' ' A' ' 142' ' ' SER . 4.3 p -80.05 -2.71 45.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.662 0.268 . . . . 0.0 111.428 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.92 75.53 0.45 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.069 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.659 ' HB2' HD12 ' A' ' 43' ' ' ILE . 3.5 mt-30 -143.07 -40.88 0.31 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.92 0.39 . . . . 0.0 110.992 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.659 HD12 ' HB2' ' A' ' 42' ' ' GLN . 4.1 mp -125.7 142.15 41.24 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.927 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.566 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 52.7 Cg_endo -72.08 140.81 35.14 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.16 1.907 . . . . 0.0 112.227 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.863 HG12 HG23 ' A' ' 37' ' ' ILE . 33.7 mt -56.16 142.94 10.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.724 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -137.85 161.91 35.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.27 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.404 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 1.1 m-20 -116.05 119.83 37.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.975 0.417 . . . . 0.0 111.746 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.724 HD11 HG23 ' A' ' 36' ' ' VAL . 4.4 mt -94.88 136.25 35.42 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.0 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.81 158.64 43.84 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -178.806 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.5 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -146.28 147.71 31.67 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 113.69 -1.596 . . . . 0.0 110.822 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 121.172 0.51 . . . . 0.0 111.261 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.9 mptt . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.749 0.309 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.432 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.4 ttpt -149.93 139.98 22.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.296 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.68 HG12 ' HG2' ' A' ' 90' ' ' GLN . 14.6 t -130.72 139.28 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.311 0.577 . . . . 0.0 112.092 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.563 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.3 m-90 -102.4 139.45 37.99 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.151 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.605 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.18 128.32 56.2 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.561 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.689 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -120.09 145.3 47.01 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.179 -178.759 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.529 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.17 -169.56 37.56 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.176 -1.012 . . . . 0.0 113.733 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.8 ttt-85 -77.2 0.29 22.42 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 122.56 0.344 . . . . 0.0 111.869 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.743 ' ND2' ' HB3' ' A' ' 73' ' ' ALA . 38.5 t30 -84.76 132.64 45.69 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.632 0.253 . . . . 0.0 111.41 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.423 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 15.4 Cg_exo -67.17 -13.5 39.87 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.573 2.182 . . . . 0.0 111.702 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.743 ' HB3' ' ND2' ' A' ' 71' ' ' ASN . . . -82.73 -44.63 15.39 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-O 121.858 0.837 . . . . 0.0 108.968 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -39.88 141.06 0.47 Allowed 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 113.707 -1.588 . . . . 0.0 110.951 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 67' ' ' THR . 72.0 m-20 -56.32 -19.09 12.86 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.048 179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.508 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 2.2 t80 -129.96 125.36 35.25 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.709 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.423 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.5 t-160 . . . . . 0 C--N 1.328 -0.359 0 CA-C-O 120.919 0.39 . . . . 0.0 110.867 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.404 HD13 HD12 ' A' ' 141' ' ' LEU . 2.3 mp . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.848 0.356 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.88 -33.52 75.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.943 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.6 mmp_? -60.94 -23.36 65.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.099 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.4 mt -101.55 151.2 22.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.979 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 99.3 p -94.29 165.81 12.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.454 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.529 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 m-20 -42.8 -53.93 4.36 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.372 0.606 . . . . 0.0 109.694 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.654 ' HB2' HD12 ' A' ' 104' ' ' ILE . 4.6 mttm -118.82 81.86 1.76 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 177.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.537 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.8 t60 -59.42 -47.18 86.44 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.454 -177.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.51 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 33.3 p90 -143.62 159.86 41.7 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 119.967 -0.693 . . . . 0.0 112.041 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.68 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.6 tt0 -136.0 141.78 44.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.93 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.597 ' C ' HG13 ' A' ' 65' ' ' VAL . 65.5 mt -117.82 128.68 74.94 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.093 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.546 HD11 ' CD2' ' A' ' 100' ' ' LEU . 0.7 OUTLIER -113.94 147.24 38.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.018 0.437 . . . . 0.0 111.43 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.841 HD13 ' CG1' ' A' ' 33' ' ' VAL . 5.2 tp . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.386 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.708 ' O ' HD12 ' A' ' 100' ' ' LEU . 1.2 mt . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.792 0.33 . . . . 0.0 110.802 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.708 HD12 ' O ' ' A' ' 99' ' ' LEU . 4.5 mp -133.0 144.71 50.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.447 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.633 HD11 HD12 ' A' ' 145' ' ' ILE . 0.7 OUTLIER -112.79 121.83 45.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.225 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.516 ' HB2' HD23 ' A' ' 92' ' ' LEU . 49.4 t30 -115.59 115.52 26.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.992 0.425 . . . . 0.0 111.617 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.845 ' OD2' HG23 ' A' ' 116' ' ' VAL . 8.4 p30 -79.1 136.89 37.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.906 178.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.654 HD12 ' HB2' ' A' ' 87' ' ' LYS . 9.0 pt -143.62 38.11 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.636 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.46 151.2 20.85 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 121.066 0.46 . . . . 0.0 111.735 -179.185 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 55.1 m -68.87 -31.63 70.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.996 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -98.09 -19.97 17.63 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.636 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.42 154.61 9.41 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.144 -1.027 . . . . 0.0 113.801 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.508 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.1 m -117.62 137.92 52.3 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.849 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -115.76 148.41 39.85 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -178.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.409 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.15 113.5 18.42 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.08 177.423 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.2 m120 44.65 43.18 6.42 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.15 -8.69 75.65 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.49 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -105.36 118.55 36.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.127 0.489 . . . . 0.0 110.774 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.849 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 14.8 tptp -73.21 119.34 17.31 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.282 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.845 HG23 ' OD2' ' A' ' 103' ' ' ASP . 13.1 m -91.06 164.37 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.278 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 120' ' ' SER . 4.1 tp10 -69.93 126.21 29.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.655 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.685 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 24.7 tttm -52.29 161.51 0.64 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.896 0.379 . . . . 0.0 110.694 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 34.35 35.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.325 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.19 145.01 40.62 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.049 179.362 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.541 ' HB3' HD23 ' A' ' 100' ' ' LEU . 68.8 m-20 -88.92 127.34 35.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.987 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -129.34 146.35 51.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.747 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.434 HD13 ' C ' ' A' ' 123' ' ' LEU . 1.6 tm? -72.82 113.7 10.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.026 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.615 HD11 ' HG ' ' A' ' 101' ' ' LEU . 1.0 OUTLIER -53.42 165.85 0.34 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.679 0.752 . . . . 0.0 112.003 -178.898 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.448 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -125.29 153.3 43.45 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.383 179.347 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.553 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.7 OUTLIER -71.51 120.08 16.59 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.85 21.39 65.36 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.064 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.448 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 9.4 t70 -57.93 173.69 0.31 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.963 0.411 . . . . 0.0 111.065 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 13.9 tt0 -145.26 135.52 24.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.246 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 1.068 HD11 HD11 ' A' ' 145' ' ' ILE . 4.2 mt -109.52 128.33 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.177 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.668 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.8 m -104.07 139.55 39.01 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.506 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.6 m -140.15 158.36 25.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.24 44.1 10.0 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.885 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.473 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.9 t -83.35 140.41 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-O 121.742 0.782 . . . . 0.0 112.393 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.77 -37.61 0.88 Allowed Glycine 0 N--CA 1.436 -1.319 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.473 HG12 ' H ' ' A' ' 138' ' ' SER . 48.8 t -126.39 123.72 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 114.598 -0.801 . . . . 0.0 109.155 178.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -50.48 -33.41 21.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.623 0.249 . . . . 0.0 111.585 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.473 ' H ' HG12 ' A' ' 136' ' ' VAL . 40.2 t -93.43 6.49 47.99 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.426 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 5.6 t0 -125.51 28.29 6.3 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.668 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.9 mt -107.11 139.56 28.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.874 178.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.674 HD22 ' CD2' ' A' ' 143' ' ' LEU . 1.0 OUTLIER -115.6 134.49 55.0 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.752 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.536 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.8 OUTLIER -112.19 136.75 51.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.03 0.443 . . . . 0.0 111.704 -179.472 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.674 ' CD2' HD22 ' A' ' 141' ' ' LEU . 2.9 mm? -130.88 138.52 49.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.352 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.434 HG21 ' CG2' ' A' ' 39' ' ' THR . 20.8 t -110.76 137.13 44.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.957 0.408 . . . . 0.0 111.608 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 1.068 HD11 HD11 ' A' ' 130' ' ' ILE . 49.6 mt -106.19 127.39 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.086 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.2 115.79 28.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.642 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.553 HD12 ' HA ' ' A' ' 126' ' ' GLN . 6.5 mt -84.76 129.32 37.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.893 0.378 . . . . 0.0 111.331 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.96 116.78 17.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.942 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -65.36 -31.13 72.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.891 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -58.7 -44.35 90.31 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.975 0.417 . . . . 0.0 110.568 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 30.5 t80 . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.777 179.911 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.853 0.359 . . . . 0.0 110.627 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -71.19 -35.78 71.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.615 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.29 -39.3 82.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.859 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.61 -40.83 93.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.852 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.508 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.2 mm -70.29 -35.1 61.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.199 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -57.03 -37.58 71.95 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.866 0.365 . . . . 0.0 110.454 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -67.29 -23.83 65.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.666 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.508 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.92 -47.27 81.01 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.169 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.833 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.524 ' O ' ' HB3' ' A' ' 49' ' ' SER . 4.7 m-20 . . . . . 0 CA--C 1.507 -0.682 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.682 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 6.9 mm -71.25 142.02 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 CA-C-N 113.678 -1.601 . . . . 0.0 112.495 -176.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.727 HG21 HD22 ' A' ' 93' ' ' LEU . 0.9 OUTLIER -104.38 -46.84 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.551 -178.933 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.67 ' SG ' HD12 ' A' ' 48' ' ' LEU . 28.4 p -163.0 145.56 10.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.127 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.461 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.94 134.68 54.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.874 0.368 . . . . 0.0 111.674 -178.867 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.594 HG13 HD11 ' A' ' 48' ' ' LEU . 3.4 m -99.77 122.71 51.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.469 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.775 HG23 HG12 ' A' ' 45' ' ' ILE . 19.3 mt -128.01 121.03 55.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.605 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.581 ' HA ' HD13 ' A' ' 143' ' ' LEU . 12.6 t -84.04 124.71 31.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.636 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.7 t -95.36 -25.05 16.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.517 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.546 HG21 ' H ' ' A' ' 142' ' ' SER . 17.5 p -79.88 -2.13 42.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.506 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.15 74.13 0.52 Allowed Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.532 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.506 ' CB ' HD11 ' A' ' 141' ' ' LEU . 2.3 mt-30 -145.31 -39.46 0.25 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.777 0.322 . . . . 0.0 111.168 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.545 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.2 mt -122.19 140.57 32.67 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.843 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.545 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.3 Cg_endo -73.59 138.93 27.54 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.236 1.957 . . . . 0.0 112.225 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.775 HG12 HG23 ' A' ' 37' ' ' ILE . 39.5 mt -57.49 141.46 14.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.562 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.96 164.28 28.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.343 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.461 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 1.4 p-10 -116.21 119.86 37.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.146 0.498 . . . . 0.0 111.932 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.67 HD12 ' SG ' ' A' ' 34' ' ' CYS . 4.4 mt -98.5 137.27 37.41 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.682 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.6 158.77 43.8 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -178.415 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.708 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . -145.06 141.83 29.2 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.519 -1.673 . . . . 0.0 110.673 178.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 121.123 0.487 . . . . 0.0 111.275 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.1 mmtm . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.813 0.34 . . . . 0.0 110.767 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.401 ' HE2' ' O ' ' A' ' 49' ' ' SER . 4.5 ttpt -145.71 130.62 18.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.172 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.59 HG13 ' C ' ' A' ' 91' ' ' ILE . 13.0 t -126.93 139.11 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 121.264 0.554 . . . . 0.0 112.2 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.613 ' CD1' HD22 ' A' ' 48' ' ' LEU . 16.4 m-90 -100.87 139.8 36.05 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.144 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.973 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.44 127.65 55.75 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.321 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.546 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -119.64 145.21 46.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.96 -178.944 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.548 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.51 -169.66 38.62 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.199 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.56 1.43 22.58 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.914 ' ND2' ' HB3' ' A' ' 73' ' ' ALA . 57.2 t30 -84.97 132.49 45.64 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.578 0.228 . . . . 0.0 111.36 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.43 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 15.9 Cg_exo -67.21 -13.23 38.85 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.678 2.252 . . . . 0.0 111.776 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.914 ' HB3' ' ND2' ' A' ' 71' ' ' ASN . . . -82.85 -43.69 16.33 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-O 121.901 0.858 . . . . 0.0 109.029 178.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.428 ' HG ' ' HA ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -39.66 142.01 0.35 Allowed 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 113.688 -1.596 . . . . 0.0 111.2 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.1 m-20 -56.25 -19.12 12.61 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.981 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.501 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 5.8 t80 -129.63 127.61 40.96 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.666 0.269 . . . . 0.0 110.871 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.43 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.7 t-160 . . . . . 0 C--N 1.328 -0.346 0 CA-C-O 120.888 0.375 . . . . 0.0 110.905 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 24.5 mm . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.824 0.345 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.69 -35.28 77.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.984 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.91 -22.08 63.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.261 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.558 HD21 HG23 ' A' ' 132' ' ' VAL . 21.1 mt -96.22 152.08 18.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.014 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 45.6 p -96.87 164.68 12.45 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.515 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.548 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -41.43 -53.61 3.32 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.497 0.665 . . . . 0.0 109.811 179.161 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.634 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.6 OUTLIER -119.86 83.59 2.07 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 177.324 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.567 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.6 t60 -60.53 -46.04 91.63 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.089 -0.959 . . . . 0.0 112.568 -177.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.5 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 18.1 p90 -143.72 162.64 35.47 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 119.863 -0.735 . . . . 0.0 112.441 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.973 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.57 135.06 40.01 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.059 -179.118 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.59 ' C ' HG13 ' A' ' 65' ' ' VAL . 52.0 mt -113.26 129.12 69.56 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.773 178.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.514 ' CB ' HG22 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -113.97 147.99 37.64 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.0 0.429 . . . . 0.0 111.527 -179.582 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.828 HD12 ' HG ' ' A' ' 99' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.517 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.828 ' HG ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.749 0.309 . . . . 0.0 110.657 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.743 HD13 ' O ' ' A' ' 122' ' ' GLN . 4.5 mm? -132.98 145.73 51.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.564 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 1.099 HD21 HD13 ' A' ' 124' ' ' LEU . 6.0 mt -112.7 127.94 56.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.03 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.43 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 47.0 t30 -119.34 115.92 25.12 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.828 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.8 p30 -77.92 135.95 37.94 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.973 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.434 HD12 ' HB2' ' A' ' 87' ' ' LYS . 9.0 pt -143.84 40.1 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 111.56 0.208 . . . . 0.0 111.56 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.713 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.07 150.93 20.9 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-O 120.994 0.426 . . . . 0.0 111.877 -178.77 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 51.0 m -68.67 -31.89 71.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.694 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -98.56 -19.69 17.46 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.713 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.25 157.26 10.29 Favored Glycine 0 N--CA 1.439 -1.125 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.565 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.495 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.3 m -117.48 137.95 52.19 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.824 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -115.83 148.83 39.49 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -177.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.47 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.12 113.38 18.27 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.428 177.654 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.418 ' N ' HD12 ' A' ' 111' ' ' LEU . 3.4 m120 44.21 43.26 5.69 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.84 -17.34 53.51 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.416 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.8 tp60 -103.63 118.46 36.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.042 0.449 . . . . 0.0 110.471 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.824 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -70.4 138.87 51.66 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.264 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.828 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.4 m -105.91 165.81 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.853 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 120' ' ' SER . 22.6 mt-10 -69.8 124.93 25.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.631 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.687 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 14.7 tttt -52.53 163.11 0.46 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.778 0.323 . . . . 0.0 110.778 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.5 m-80 33.38 35.11 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.182 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.26 145.08 40.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.247 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -88.39 129.89 35.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.843 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.743 ' O ' HD13 ' A' ' 100' ' ' LEU . 44.5 mm-40 -129.11 148.47 51.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.672 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.8 tp -72.49 122.12 20.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.876 0.37 . . . . 0.0 110.412 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 1.099 HD13 HD21 ' A' ' 101' ' ' LEU . 67.6 tp -58.86 155.89 12.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.456 0.646 . . . . 0.0 111.61 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.417 ' H ' HD12 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -124.75 153.43 42.43 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.689 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.417 ' OE1' HD12 ' A' ' 147' ' ' ILE . 7.2 mm100 -71.53 121.46 18.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.886 0.374 . . . . 0.0 110.122 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.22 22.22 57.94 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.199 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.411 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 21.8 t0 -54.92 173.93 0.08 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 120.877 0.37 . . . . 0.0 110.893 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.866 ' CG ' HG22 ' A' ' 144' ' ' VAL . 10.4 mt-10 -145.16 135.38 23.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.235 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.887 HD11 HD11 ' A' ' 145' ' ' ILE . 13.6 mt -113.9 128.18 70.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.081 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.566 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.9 m -104.25 138.28 40.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.062 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.558 HG23 HD21 ' A' ' 84' ' ' LEU . 33.5 m -140.28 158.13 25.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.86 32.12 18.95 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.852 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 140' ' ' ILE . 55.3 t -73.79 140.37 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-O 121.679 0.752 . . . . 0.0 112.516 -179.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 159.26 -40.33 0.48 Allowed Glycine 0 N--CA 1.436 -1.307 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.144 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.449 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 49.1 t -126.36 137.51 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -50.69 -43.03 57.48 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.0 t -93.3 6.23 48.82 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.449 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 13.2 t0 -116.09 27.19 9.42 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -178.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.566 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.1 mt -107.43 139.46 29.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.127 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.763 HD23 ' N ' ' A' ' 142' ' ' SER . 4.3 tt -121.37 134.39 55.12 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.449 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.763 ' N ' HD23 ' A' ' 141' ' ' LEU . 48.1 t -111.33 151.08 28.82 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.592 0.711 . . . . 0.0 112.5 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.581 HD13 ' HA ' ' A' ' 38' ' ' CYS . 1.8 mm? -135.39 147.37 49.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.32 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.866 HG22 ' CG ' ' A' ' 129' ' ' GLU . 18.5 t -113.71 137.38 47.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.818 0.342 . . . . 0.0 111.125 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.887 HD11 HD11 ' A' ' 130' ' ' ILE . 39.8 mt -106.31 120.9 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.077 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.35 115.58 29.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.592 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.753 HG12 HD21 ' A' ' 124' ' ' LEU . 3.7 mt -84.65 133.16 29.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.33 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -83.55 108.46 16.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.939 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.19 -25.71 64.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.006 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.6 tptp -57.5 -42.95 83.73 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.013 0.435 . . . . 0.0 110.66 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.423 ' CZ ' HD21 ' A' ' 93' ' ' LEU . 28.4 t80 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.776 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.765 0.317 . . . . 0.0 111.015 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.09 -45.82 89.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.991 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -59.99 -35.0 74.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.956 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.25 -40.71 94.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.886 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.632 HG23 ' CE2' ' A' ' 23' ' ' PHE . 43.0 mm -68.84 -48.17 72.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.037 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.75 -33.67 71.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.4 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -58.74 -47.1 85.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.372 -0.377 . . . . 0.0 112.0 -178.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.632 ' CE2' HG23 ' A' ' 20' ' ' ILE . 4.5 p90 -71.89 -47.38 53.1 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.967 0.413 . . . . 0.0 111.033 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.537 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 1.2 m . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.039 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.439 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 t-20 . . . . . 0 CA--C 1.509 -0.615 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.686 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.8 mm -71.93 136.16 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 CA-C-N 113.557 -1.656 . . . . 0.0 112.666 -177.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.966 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.8 t -92.28 -58.56 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.545 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.568 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.07 153.89 37.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.83 179.29 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.462 ' NH2' HD13 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -113.89 138.38 50.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.831 0.348 . . . . 0.0 111.02 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.811 HG21 ' HE2' ' A' ' 68' ' ' PHE . 19.8 t -103.32 122.96 56.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.212 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.698 HG23 HD11 ' A' ' 45' ' ' ILE . 19.8 mt -128.3 119.13 49.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.873 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 50.4 t -84.78 118.6 24.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.205 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.97 -22.11 27.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.911 -179.002 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.528 HG21 ' H ' ' A' ' 142' ' ' SER . 69.6 p -79.81 -2.09 41.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.687 0.279 . . . . 0.0 111.579 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.14 73.18 0.56 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.83 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.413 ' HB2' HD11 ' A' ' 141' ' ' LEU . 7.8 mt-30 -145.28 -43.3 0.22 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.88 0.371 . . . . 0.0 111.014 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.529 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 7.7 mt -115.63 140.61 26.24 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.945 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.529 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 66.2 Cg_endo -76.1 146.08 28.47 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.295 1.997 . . . . 0.0 112.237 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.698 HD11 HG23 ' A' ' 37' ' ' ILE . 14.6 mt -57.35 148.2 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.549 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -139.41 161.76 36.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.348 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.68 119.77 37.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.065 0.459 . . . . 0.0 111.954 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.538 HD22 ' CD1' ' A' ' 66' ' ' TRP . 8.0 mt -95.69 134.46 38.57 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.126 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.966 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.91 157.46 43.9 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -178.952 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.484 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -143.63 141.97 30.82 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.421 -1.718 . . . . 0.0 110.505 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-O 121.336 0.589 . . . . 0.0 111.608 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.067 0 CA-C-O 120.813 0.34 . . . . 0.0 110.84 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.435 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.7 ttpt -140.35 131.33 26.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.965 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.678 HG12 ' HG2' ' A' ' 90' ' ' GLN . 7.8 t -127.75 139.06 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-O 121.266 0.555 . . . . 0.0 112.224 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.538 ' CD1' HD22 ' A' ' 48' ' ' LEU . 16.4 m-90 -101.04 139.26 36.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.882 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.632 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -113.04 131.64 55.71 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.69 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.811 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -118.29 145.24 45.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.669 -178.291 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.95 -172.26 36.43 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.312 -0.946 . . . . 0.0 113.932 178.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.734 ' NH2' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -72.32 -3.67 25.2 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.88 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.453 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -84.51 128.85 59.82 Favored Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 121.191 -0.204 . . . . 0.0 111.036 -179.603 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.5 Cg_exo -67.24 -9.36 24.9 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.525 2.15 . . . . 0.0 111.574 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.8 -42.88 17.36 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -40.37 138.25 0.94 Allowed 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 113.879 -1.509 . . . . 0.0 110.247 179.165 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -56.33 -18.77 11.83 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.915 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.568 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 13.3 t80 -129.88 127.18 39.66 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.881 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.572 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.452 HG22 ' H ' ' A' ' 83' ' ' ARG . 16.8 mt . . . . . 0 N--CA 1.463 0.185 0 CA-C-O 120.945 0.402 . . . . 0.0 111.04 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.2 m -60.83 -24.89 66.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.35 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.452 ' H ' HG22 ' A' ' 81' ' ' ILE . 5.2 mmp_? -60.48 -26.71 67.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.642 0.258 . . . . 0.0 111.353 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.736 HD21 ' CG2' ' A' ' 132' ' ' VAL . 4.8 mp -107.05 153.37 22.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.919 0.39 . . . . 0.0 111.184 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 79.9 p -89.28 167.7 12.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.427 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.625 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.5 m-20 -42.48 -54.89 3.68 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.363 0.601 . . . . 0.0 109.75 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.519 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -118.31 84.15 2.13 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 177.009 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.55 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 17.6 t60 -60.39 -46.31 90.43 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.752 -176.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.509 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 30.0 p90 -146.84 160.49 42.22 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.447 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.678 ' HG2' HG12 ' A' ' 65' ' ' VAL . 3.8 tt0 -135.66 143.18 45.34 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.015 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.765 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 56.6 mt -118.52 130.29 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.981 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.506 HD11 HD13 ' A' ' 100' ' ' LEU . 0.5 OUTLIER -111.37 149.6 30.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.025 0.441 . . . . 0.0 111.87 -179.549 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.676 HD22 HG11 ' A' ' 33' ' ' VAL . 36.2 tp . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.344 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.805 HD21 HG12 ' A' ' 33' ' ' VAL . 4.8 mp . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.697 0.284 . . . . 0.0 110.769 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.942 HD22 ' HB3' ' A' ' 121' ' ' ASN . 4.6 mt -132.84 143.86 49.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.412 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.78 128.43 56.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.244 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.446 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 52.6 t30 -118.58 115.78 25.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.911 0.386 . . . . 0.0 111.745 -179.252 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.763 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.5 p30 -77.73 139.98 39.45 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.508 HD12 ' HB2' ' A' ' 87' ' ' LYS . 8.3 pt -147.4 38.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 111.538 0.199 . . . . 0.0 111.538 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.688 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.0 150.96 21.44 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.05 0.452 . . . . 0.0 112.127 -178.538 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 39.8 m -68.79 -31.32 70.25 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.573 177.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -97.38 -19.79 18.24 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.609 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.688 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 115.77 156.31 10.93 Favored Glycine 0 N--CA 1.438 -1.21 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.671 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.0 m -117.53 137.84 52.3 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.859 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -114.83 148.5 38.42 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -178.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.475 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.15 113.42 18.31 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.415 177.536 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.415 ' N ' HD12 ' A' ' 111' ' ' LEU . 91.7 m-20 44.37 43.26 5.99 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.74 -10.78 68.66 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.792 -0.718 . . . . 0.0 113.458 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -104.82 118.58 36.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.067 0.46 . . . . 0.0 110.635 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.859 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 15.1 tptp -73.37 122.25 21.75 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.318 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.763 HG23 ' OD2' ' A' ' 103' ' ' ASP . 7.3 m -93.94 165.53 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.242 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 120' ' ' SER . 16.7 mt-10 -69.86 128.51 36.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.522 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.69 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 15.9 tttp -54.47 163.93 0.8 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.9 OUTLIER 34.35 36.41 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.816 -179.183 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.407 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.7 p -111.96 145.09 40.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.914 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.942 ' HB3' HD22 ' A' ' 100' ' ' LEU . 3.4 m-80 -94.62 129.59 41.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.932 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.781 ' O ' HD23 ' A' ' 100' ' ' LEU . 62.5 mm-40 -129.08 149.42 50.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.389 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.522 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.6 tm? -72.63 122.05 20.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.874 0.369 . . . . 0.0 110.26 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.575 HD21 HG12 ' A' ' 147' ' ' ILE . 65.0 tp -54.16 156.44 3.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.397 0.618 . . . . 0.0 111.866 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.401 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.4 OUTLIER -124.55 153.48 42.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.544 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.457 ' HA ' HD12 ' A' ' 147' ' ' ILE . 2.2 tp-100 -71.59 122.26 20.2 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.95 22.58 57.89 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.928 -178.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -52.15 170.7 0.06 Allowed 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.941 0.4 . . . . 0.0 111.095 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.688 ' HG3' HG22 ' A' ' 144' ' ' VAL . 9.5 tt0 -145.11 135.47 24.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.266 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.481 HD11 HD11 ' A' ' 145' ' ' ILE . 17.6 mt -115.6 127.53 73.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.604 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.596 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.5 m -104.49 140.61 37.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.082 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.736 ' CG2' HD21 ' A' ' 84' ' ' LEU . 35.2 m -140.34 158.42 25.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 112.216 0.451 . . . . 0.0 112.216 -178.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.2 43.03 8.92 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.806 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.474 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.9 t -84.72 140.53 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 121.686 0.755 . . . . 0.0 112.502 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.98 -38.32 0.8 Allowed Glycine 0 N--CA 1.435 -1.401 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.533 HG12 ' H ' ' A' ' 138' ' ' SER . 57.7 t -126.39 120.2 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-N 114.518 -0.841 . . . . 0.0 109.001 177.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.408 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -50.45 -28.43 8.29 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.708 0.289 . . . . 0.0 111.494 -178.555 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.533 ' H ' HG12 ' A' ' 136' ' ' VAL . 2.2 p -93.61 6.52 48.0 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.43 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.6 OUTLIER -131.18 31.15 4.45 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -179.017 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.596 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.9 mt -107.16 139.47 28.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.647 178.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.455 HD23 ' C ' ' A' ' 141' ' ' LEU . 9.5 tt -123.64 134.46 53.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.928 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.528 ' H ' HG21 ' A' ' 40' ' ' THR . 45.2 t -109.73 150.4 28.37 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.618 0.723 . . . . 0.0 112.29 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 65.2 mt -135.81 139.12 43.23 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.963 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.688 HG22 ' HG3' ' A' ' 129' ' ' GLU . 19.2 t -112.4 139.08 38.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.858 0.361 . . . . 0.0 111.09 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.481 HD11 HD11 ' A' ' 130' ' ' ILE . 31.4 mt -106.3 129.6 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.029 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.62 ' CD1' HD12 ' A' ' 37' ' ' ILE . 0.9 OUTLIER -113.68 116.29 29.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.832 179.881 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.575 HG12 HD21 ' A' ' 124' ' ' LEU . 6.2 mt -84.88 134.14 27.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.681 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.7 109.77 20.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.699 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -62.36 -30.6 71.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.059 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -42.27 84.39 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.969 0.414 . . . . 0.0 110.721 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 22.3 t80 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.887 179.916 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 . . . . . 0 N--CA 1.458 -0.073 0 CA-C-O 120.822 0.344 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -70.94 -36.97 72.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -58.4 -39.88 80.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.793 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.42 -32.53 73.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.746 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.429 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.0 mt -73.04 -35.34 48.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.947 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -57.21 -43.53 82.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.912 0.387 . . . . 0.0 110.612 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -67.09 -24.26 65.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.529 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.429 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -57.0 -47.7 80.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.131 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.2 m . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.105 -179.972 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.436 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER . . . . . 0 CA--C 1.509 -0.598 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.66 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.5 mm -76.26 137.15 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 CA-C-N 113.706 -1.588 . . . . 0.0 112.603 -177.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.965 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.4 t -91.97 -58.47 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.641 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 66.2 m -146.18 165.28 29.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.466 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.74 124.52 31.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.773 0.321 . . . . 0.0 111.171 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.69 HG21 ' HE2' ' A' ' 68' ' ' PHE . 55.7 t -94.9 122.96 46.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.012 0.434 . . . . 0.0 111.132 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.786 HG23 HG12 ' A' ' 45' ' ' ILE . 20.9 mt -124.68 122.69 64.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.057 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.714 ' HA ' HD13 ' A' ' 143' ' ' LEU . 42.3 t -79.96 112.88 17.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.831 0.348 . . . . 0.0 110.544 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.452 ' CG2' HG21 ' A' ' 144' ' ' VAL . 0.3 OUTLIER -80.48 -25.26 38.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.508 -179.301 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.504 HG23 ' HB3' ' A' ' 142' ' ' SER . 82.3 p -80.04 -2.36 43.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.738 0.304 . . . . 0.0 111.422 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.97 76.48 0.25 Allowed Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.924 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.436 ' HB2' HD11 ' A' ' 141' ' ' LEU . 12.5 mt-30 -147.14 -44.12 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.88 0.372 . . . . 0.0 110.931 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.576 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.1 mt -114.99 141.7 27.34 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.944 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.576 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 45.5 Cg_endo -71.15 145.34 48.96 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.2 1.933 . . . . 0.0 112.285 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.786 HG12 HG23 ' A' ' 37' ' ' ILE . 36.0 mt -60.13 138.81 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.722 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.83 164.33 20.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.294 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -120.82 119.68 33.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.997 0.427 . . . . 0.0 111.839 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.764 HD23 ' CD2' ' A' ' 66' ' ' TRP . 6.9 mp -92.14 130.41 37.87 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.965 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -141.58 155.81 45.74 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 122.2 1.0 . . . . 0.0 113.641 -179.581 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.483 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.23 142.06 29.19 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.468 -1.696 . . . . 0.0 110.934 179.049 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 121.078 0.466 . . . . 0.0 111.102 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.069 0 CA-C-O 120.837 0.351 . . . . 0.0 110.75 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.419 ' CE ' ' O ' ' A' ' 49' ' ' SER . 3.9 ttpt -135.81 127.86 29.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.865 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.626 HG12 ' HG2' ' A' ' 90' ' ' GLN . 6.3 t -121.59 137.14 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 121.283 0.563 . . . . 0.0 111.876 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.764 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.5 m-90 -102.41 139.41 38.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.274 -0.876 . . . . 0.0 112.151 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.663 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.33 130.52 56.25 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 177.699 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.698 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.7 OUTLIER -117.65 145.49 44.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.392 -178.897 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.637 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.0 -169.05 36.52 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.776 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -81.7 4.26 22.48 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -84.77 132.47 46.2 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.469 0.176 . . . . 0.0 111.11 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.33 -13.81 41.47 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.488 2.125 . . . . 0.0 111.612 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.83 -42.7 17.51 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 121.921 0.867 . . . . 0.0 109.03 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -41.88 138.94 1.37 Allowed 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 113.831 -1.531 . . . . 0.0 111.081 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 67' ' ' THR . 20.3 m-20 -56.47 -18.6 11.93 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.981 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.481 ' CZ ' HG21 ' A' ' 43' ' ' ILE . 23.9 t80 -129.52 118.87 22.76 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-O 120.773 0.32 . . . . 0.0 110.998 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.728 179.851 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.522 HG22 ' H ' ' A' ' 83' ' ' ARG . 3.8 mp . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.805 0.336 . . . . 0.0 110.945 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.8 m -55.22 -33.92 63.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.995 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.522 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -63.96 -28.55 69.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.927 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.468 HD12 HD13 ' A' ' 81' ' ' ILE . 19.1 mt -100.43 151.98 20.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.979 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 91.6 p -95.1 165.61 12.34 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.647 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.637 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -43.09 -52.88 5.21 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.289 0.566 . . . . 0.0 109.641 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.558 ' HB3' HG22 ' A' ' 67' ' ' THR . 2.0 mttp -118.94 82.44 1.86 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.55 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.4 t60 -59.92 -46.67 88.63 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.576 -177.052 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.5 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 26.4 p90 -145.41 160.05 42.15 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.755 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.663 ' HG3' HG23 ' A' ' 67' ' ' THR . 20.9 tt0 -136.03 140.85 44.17 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.32 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.698 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 71.2 mt -115.13 131.08 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.92 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.441 ' CA ' HG13 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -112.59 147.06 37.46 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.141 0.496 . . . . 0.0 111.891 -179.602 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.828 HD22 HG11 ' A' ' 33' ' ' VAL . 28.6 tp . . . . . 0 C--O 1.233 0.229 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.438 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.692 ' O ' HD12 ' A' ' 100' ' ' LEU . 4.3 mm? . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.801 0.334 . . . . 0.0 110.862 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.692 HD12 ' O ' ' A' ' 99' ' ' LEU . 3.9 mp -132.99 145.73 51.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.606 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.998 HD11 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -112.85 126.91 55.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.066 179.695 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.43 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 52.0 t30 -119.38 115.74 24.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.964 0.411 . . . . 0.0 112.069 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.836 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.1 p30 -76.38 141.04 41.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.739 178.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.465 HD12 ' HB2' ' A' ' 87' ' ' LYS . 8.3 pt -149.28 39.1 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.618 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.84 153.01 19.1 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-O 121.102 0.477 . . . . 0.0 111.847 -179.062 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.2 m -68.83 -31.72 70.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.058 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -98.29 -19.93 17.51 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.618 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 118.83 157.31 10.38 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.698 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.6 m -117.61 137.81 52.37 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 123.142 0.577 . . . . 0.0 109.492 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.879 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -115.61 148.66 39.37 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.465 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.16 113.62 18.56 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.478 177.535 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.42 ' N ' HD12 ' A' ' 111' ' ' LEU . 52.6 m-20 43.41 43.9 4.59 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.76 -13.64 62.21 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.608 -0.806 . . . . 0.0 113.432 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -103.78 118.52 36.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.976 0.417 . . . . 0.0 110.571 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.879 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 12.0 tptt -72.93 124.2 24.97 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.408 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.836 HG23 ' OD2' ' A' ' 103' ' ' ASP . 15.8 m -90.01 176.59 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.084 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.9 pt-20 -83.25 124.43 30.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.497 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.672 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 20.4 tttt -50.5 159.78 0.47 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.025 0.441 . . . . 0.0 111.086 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.488 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.7 p-10 34.65 33.99 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.621 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.52 145.15 40.78 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.95 179.181 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.629 ' HB3' HD23 ' A' ' 100' ' ' LEU . 77.2 m-20 -87.37 132.43 33.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.861 0.362 . . . . 0.0 110.99 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 10.1 mm100 -129.17 148.13 51.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.536 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.3 tp -72.71 118.53 15.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.056 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.689 HD21 HG12 ' A' ' 147' ' ' ILE . 66.9 tp -52.91 155.85 2.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.411 0.624 . . . . 0.0 111.719 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.445 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.76 153.29 42.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.585 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.416 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 1.2 tp60 -71.79 120.78 17.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.94 0.4 . . . . 0.0 110.417 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.21 24.82 56.11 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.357 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.478 ' HB3' HD13 ' A' ' 145' ' ' ILE . 21.5 t0 -56.67 174.5 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.87 0.367 . . . . 0.0 110.912 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -145.22 135.49 24.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.093 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.998 HD11 HD11 ' A' ' 101' ' ' LEU . 3.9 mt -114.99 128.27 72.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.483 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.673 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.6 m -104.24 140.21 38.16 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.021 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.525 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.1 m -140.31 158.33 25.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.4 35.66 19.54 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.086 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.474 ' HA ' HG12 ' A' ' 140' ' ' ILE . 63.3 t -76.1 140.4 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-O 121.666 0.746 . . . . 0.0 112.474 -179.037 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.4 -38.87 0.77 Allowed Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.445 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 51.2 t -126.33 132.88 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-N 114.754 -0.723 . . . . 0.0 109.206 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.61 -40.16 52.08 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.408 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -93.39 6.4 48.28 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -178.647 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.445 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 13.0 t0 -116.69 25.1 10.8 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.673 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.9 mt -107.36 139.42 29.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.244 178.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.499 HD21 ' CD1' ' A' ' 43' ' ' ILE . 2.7 tp -124.15 134.46 53.32 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.342 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.551 ' C ' HD22 ' A' ' 143' ' ' LEU . 37.2 t -113.04 150.46 31.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.59 0.71 . . . . 0.0 112.743 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.714 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.5 mm? -135.91 142.33 44.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.646 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.452 HG21 ' CG2' ' A' ' 39' ' ' THR . 21.9 t -114.25 135.34 54.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.86 0.362 . . . . 0.0 111.254 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.594 HD11 HG13 ' A' ' 130' ' ' ILE . 1.2 mp -105.59 127.56 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.375 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.58 120.03 40.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.662 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.689 HG12 HD21 ' A' ' 124' ' ' LEU . 4.9 mt -84.92 134.08 27.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.48 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -81.4 106.81 13.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.775 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.42 -32.12 68.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.016 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.31 -45.14 92.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.59 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 17.6 t80 . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.915 179.97 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.911 0.386 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.4 ttm180 -63.73 -35.96 82.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.98 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -56.87 -42.29 79.51 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.885 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.65 -32.36 68.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.691 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.451 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.3 mt -73.14 -35.2 47.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.84 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -39.77 76.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.92 0.39 . . . . 0.0 110.503 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.1 -24.51 65.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.622 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.451 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -57.17 -47.59 80.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.619 -179.83 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.28 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.433 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.8 OUTLIER . . . . . 0 CA--C 1.509 -0.63 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.721 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.9 mm -73.21 134.76 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 CA-C-N 113.621 -1.627 . . . . 0.0 112.479 -177.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.037 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -89.91 -60.12 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.829 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.602 ' SG ' HD12 ' A' ' 48' ' ' LEU . 6.7 p -150.13 150.87 32.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.147 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.421 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.85 138.16 50.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.224 -179.416 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.779 HG21 ' HE2' ' A' ' 68' ' ' PHE . 22.7 t -104.65 122.69 57.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.016 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.783 HG23 HG12 ' A' ' 45' ' ' ILE . 16.3 mt -125.78 125.69 68.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.42 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.711 ' HA ' HD13 ' A' ' 143' ' ' LEU . 44.3 t -82.11 120.08 24.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.844 0.354 . . . . 0.0 110.543 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.5 t -86.0 -27.75 24.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.499 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.535 HG21 ' H ' ' A' ' 142' ' ' SER . 42.4 p -79.82 -2.26 42.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.554 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.97 77.91 0.2 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.86 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.607 ' CD ' HD11 ' A' ' 141' ' ' LEU . 11.1 mt-30 -146.73 -44.89 0.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.845 0.355 . . . . 0.0 110.921 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.562 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.5 mt -113.93 141.52 26.35 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.062 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.562 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 58.1 Cg_endo -73.32 140.8 31.04 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.156 1.904 . . . . 0.0 112.199 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.783 HG12 HG23 ' A' ' 37' ' ' ILE . 33.6 mt -55.16 141.44 11.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.737 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.425 ' HB2' ' CE2' ' A' ' 76' ' ' TYR . 0.4 OUTLIER -131.49 163.92 26.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.087 179.503 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.421 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.3 OUTLIER -119.35 119.84 35.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.103 0.478 . . . . 0.0 111.78 -179.659 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.608 HD11 HG23 ' A' ' 36' ' ' VAL . 1.3 mt -98.53 135.59 39.86 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.037 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.37 159.52 42.93 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -178.573 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.487 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -141.96 141.68 32.93 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.699 -1.591 . . . . 0.0 110.55 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 121.104 0.478 . . . . 0.0 111.445 -179.303 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.9 mmtm . . . . . 0 CA--C 1.528 0.1 0 CA-C-O 120.672 0.272 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.424 ' CE ' ' O ' ' A' ' 49' ' ' SER . 29.2 ttpt -134.77 139.72 45.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.866 0.365 . . . . 0.0 111.07 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.666 HG12 ' HG2' ' A' ' 90' ' ' GLN . 11.1 t -127.24 139.28 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 121.166 0.508 . . . . 0.0 111.703 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.55 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 19.2 m-90 -100.94 138.4 38.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.249 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.709 HG22 ' HB3' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -113.46 127.11 55.99 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.364 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.779 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -108.9 145.64 35.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.592 -178.255 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.777 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 173.01 -175.26 45.98 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.512 -0.852 . . . . 0.0 113.196 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.415 ' NH1' ' HB2' ' A' ' 70' ' ' ARG . 5.0 mtp-105 -82.93 -4.67 58.49 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.633 0.254 . . . . 0.0 111.454 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.463 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.6 p30 -88.3 139.56 30.26 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-O 120.789 0.328 . . . . 0.0 111.229 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 9.1 Cg_exo -69.46 -4.41 13.77 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.842 2.361 . . . . 0.0 111.809 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.64 -45.96 13.87 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-O 121.932 0.872 . . . . 0.0 108.936 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.26 139.45 1.91 Allowed 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 113.746 -1.57 . . . . 0.0 110.424 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -56.29 -19.19 13.15 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.013 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.532 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 39.3 t80 -130.13 121.44 26.31 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.905 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.6 t60 . . . . . 0 C--N 1.329 -0.326 0 CA-C-O 120.804 0.335 . . . . 0.0 110.726 179.774 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.541 HD13 HD12 ' A' ' 84' ' ' LEU . 4.6 mp . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.821 0.343 . . . . 0.0 110.684 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.95 -38.07 67.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.501 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.0 mmp_? -60.71 -19.93 59.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.764 0.316 . . . . 0.0 110.912 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.541 HD12 HD13 ' A' ' 81' ' ' ILE . 34.7 mt -101.91 152.33 21.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.792 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 86' ' ' ASN . 96.3 p -97.91 170.68 8.78 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.508 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.777 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.3 m-20 -41.05 -80.64 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.709 ' HB3' HG22 ' A' ' 67' ' ' THR . 13.8 mttm -92.86 83.17 4.73 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.547 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 17.3 t60 -57.71 -46.14 84.77 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.033 -177.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.517 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 16.3 p90 -145.87 158.71 43.85 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.486 -0.486 . . . . 0.0 112.076 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.688 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.1 tt0 -135.72 142.04 44.97 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.254 -178.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.592 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 59.3 mt -117.6 131.68 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.671 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.423 ' O ' HD23 ' A' ' 99' ' ' LEU . 0.6 OUTLIER -114.2 143.61 44.54 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.041 0.448 . . . . 0.0 111.876 -179.296 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.734 HD23 ' HG ' ' A' ' 99' ' ' LEU . 2.3 tm? . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.441 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.945 HD11 HG12 ' A' ' 33' ' ' VAL . 1.1 mt . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.814 0.34 . . . . 0.0 110.866 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.796 HD13 ' O ' ' A' ' 122' ' ' GLN . 4.0 mm? -129.9 142.35 50.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.275 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.711 HD11 ' HA ' ' A' ' 124' ' ' LEU . 3.5 mp -112.83 128.73 56.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.289 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.411 ' HB2' HD23 ' A' ' 92' ' ' LEU . 47.1 t30 -119.79 115.56 24.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.053 0.454 . . . . 0.0 111.692 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.836 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.1 p30 -78.53 137.04 37.71 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.6 HD12 ' HB2' ' A' ' 87' ' ' LYS . 10.2 pt -145.26 39.19 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -178.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.67 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.35 152.84 19.5 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 121.171 0.51 . . . . 0.0 111.867 -178.98 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 49.1 m -68.83 -31.58 70.66 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.857 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -98.19 -19.97 17.56 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.67 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.7 158.05 10.87 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.788 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.6 m -117.37 137.75 52.25 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.848 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -115.34 148.46 39.24 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -178.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.41 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.21 113.39 18.24 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.538 -1.21 . . . . 0.0 108.246 177.526 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 43.77 43.55 5.08 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.22 -10.99 68.92 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.481 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.69 118.61 37.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.087 0.47 . . . . 0.0 110.612 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.848 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 12.7 tptt -73.17 121.53 20.41 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.197 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.836 HG23 ' OD2' ' A' ' 103' ' ' ASP . 13.2 m -91.0 164.08 2.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.189 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 120' ' ' SER . 4.3 tp10 -69.82 125.35 26.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.572 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.684 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 73.9 tttt -51.96 161.35 0.59 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.858 0.361 . . . . 0.0 110.754 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 34.78 34.75 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.309 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.27 145.17 40.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.078 179.498 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.545 ' HB3' HD12 ' A' ' 100' ' ' LEU . 77.0 m-20 -89.32 129.04 35.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.04 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.796 ' O ' HD13 ' A' ' 100' ' ' LEU . 47.0 mm-40 -129.18 147.43 51.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.556 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 tp -72.7 132.76 44.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.298 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.74 HD21 HG13 ' A' ' 147' ' ' ILE . 65.9 tp -62.78 156.71 23.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.487 0.661 . . . . 0.0 111.624 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.406 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.47 153.31 42.19 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.056 179.707 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.554 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.05 117.88 13.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.024 0.44 . . . . 0.0 110.244 -179.446 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.8 24.42 64.47 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.015 -178.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.406 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 16.9 t70 -53.43 171.92 0.07 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.901 0.381 . . . . 0.0 110.955 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.83 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.8 mt-10 -145.15 135.52 24.13 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.098 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.651 HD11 HD23 ' A' ' 101' ' ' LEU . 13.7 mt -114.25 126.57 71.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.483 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.553 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.3 m -104.42 139.09 39.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.955 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.496 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.2 m -140.25 158.32 25.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.74 32.87 17.31 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.84 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.484 ' HA ' HG12 ' A' ' 140' ' ' ILE . 54.6 t -75.75 140.48 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-O 121.629 0.728 . . . . 0.0 112.478 -179.041 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.01 -38.39 0.69 Allowed Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.517 HG12 ' H ' ' A' ' 138' ' ' SER . 49.7 t -126.32 124.45 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 CA-C-N 114.666 -0.767 . . . . 0.0 109.125 178.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.47 -32.65 18.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.73 0.3 . . . . 0.0 111.381 -178.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.517 ' H ' HG12 ' A' ' 136' ' ' VAL . 31.3 t -93.45 6.47 48.06 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.283 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.414 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 5.7 t0 -127.93 30.62 5.24 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.553 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.6 mt -107.13 139.52 28.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.784 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.607 HD11 ' CD ' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -122.42 134.3 54.61 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.752 -179.793 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.644 ' C ' HD22 ' A' ' 143' ' ' LEU . 46.6 t -110.82 150.58 28.93 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.59 0.709 . . . . 0.0 112.157 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.711 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.5 mm? -136.02 149.42 48.8 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.597 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.83 HG22 ' CG ' ' A' ' 129' ' ' GLU . 11.8 t -117.55 135.76 56.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.712 0.292 . . . . 0.0 110.978 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.657 HG21 HD11 ' A' ' 124' ' ' LEU . 3.6 mt -106.57 124.63 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-O 121.044 0.45 . . . . 0.0 111.046 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.465 ' HD2' HD12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -107.93 139.68 42.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.365 179.498 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.74 HG13 HD21 ' A' ' 124' ' ' LEU . 3.3 mp -105.65 134.08 48.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.91 0.386 . . . . 0.0 111.552 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -85.93 112.27 21.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.625 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -57.52 -27.85 62.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.122 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -60.77 -46.02 92.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.809 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 29.1 t80 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.063 -179.886 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.82 0.343 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -66.94 -39.92 87.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.015 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -57.55 -40.15 78.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.915 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.15 -33.91 69.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.629 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.483 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.3 mt -73.14 -35.24 47.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.783 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -57.23 -35.2 69.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.454 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.1 mttp -67.03 -24.07 65.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.613 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.483 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -62.24 -47.85 82.57 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.645 -179.715 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.5 m . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.777 -179.184 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.444 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.3 m-20 . . . . . 0 CA--C 1.508 -0.644 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.659 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.5 mm -74.14 135.63 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 CA-C-N 113.641 -1.618 . . . . 0.0 112.492 -177.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.985 HG12 HD11 ' A' ' 99' ' ' LEU . 3.4 t -90.81 -58.97 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.436 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.2 p -145.76 158.92 43.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.059 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.402 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -126.36 124.99 41.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.745 0.307 . . . . 0.0 111.528 -179.425 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.725 HG21 ' HE2' ' A' ' 68' ' ' PHE . 26.1 t -94.92 122.68 46.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.923 0.392 . . . . 0.0 110.957 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.855 HG23 HG12 ' A' ' 45' ' ' ILE . 20.7 mt -125.07 120.23 57.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.266 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.545 ' SG ' ' HB ' ' A' ' 43' ' ' ILE . 20.0 m -85.74 99.88 11.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.902 0.382 . . . . 0.0 110.532 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 82.3 p -79.09 -19.73 50.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.14 -178.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.776 HG21 ' OG ' ' A' ' 142' ' ' SER . 10.5 p -79.79 -2.7 44.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.729 0.299 . . . . 0.0 111.354 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.58 71.0 0.98 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.014 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.454 ' HB2' HD21 ' A' ' 141' ' ' LEU . 4.5 mt-30 -140.37 -39.95 0.43 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.764 0.316 . . . . 0.0 111.225 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.78 HG23 ' HD2' ' A' ' 44' ' ' PRO . 4.3 mt -133.88 145.33 55.49 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.668 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.78 ' HD2' HG23 ' A' ' 43' ' ' ILE . 41.9 Cg_endo -69.74 146.16 59.47 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.324 2.016 . . . . 0.0 112.594 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.855 HG12 HG23 ' A' ' 37' ' ' ILE . 36.8 mt -54.26 157.5 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.62 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.483 ' N ' HG22 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -145.69 164.17 32.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.282 179.625 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.402 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.4 OUTLIER -127.58 119.92 27.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.076 0.465 . . . . 0.0 111.902 -179.513 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.795 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.9 mp -95.14 128.6 42.1 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.146 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.984 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -138.37 156.78 47.29 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -179.244 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -146.59 141.89 27.41 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.412 -1.722 . . . . 0.0 110.777 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.225 0 CA-C-O 121.153 0.501 . . . . 0.0 111.071 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.081 0 CA-C-O 120.73 0.3 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.434 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.7 ttpt -145.9 136.41 24.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.292 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.63 HG12 ' HG2' ' A' ' 90' ' ' GLN . 14.9 t -134.06 139.36 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 121.268 0.556 . . . . 0.0 112.003 -179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.795 ' CD2' HD23 ' A' ' 48' ' ' LEU . 18.8 m-90 -103.51 139.29 39.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.226 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.412 HG22 HD11 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -111.45 126.38 54.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.102 0.477 . . . . 0.0 109.832 177.469 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.725 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -111.6 145.6 38.89 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.17 -178.859 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.64 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.39 -176.62 40.28 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.245 -0.978 . . . . 0.0 113.547 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.454 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 1.2 ttp180 -73.23 -7.39 51.26 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.417 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.1 t30 -84.81 135.51 40.07 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.791 0.329 . . . . 0.0 111.322 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 9.7 Cg_exo -70.14 -6.43 18.76 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.957 2.438 . . . . 0.0 112.087 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.409 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.63 -44.17 16.08 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-O 121.971 0.891 . . . . 0.0 108.63 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -41.91 138.7 1.45 Allowed 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 113.537 -1.665 . . . . 0.0 110.416 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -56.26 -19.31 13.5 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.024 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.553 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 21.1 t80 -130.21 122.55 28.33 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.661 179.24 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.403 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.2 t-160 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.774 0.321 . . . . 0.0 110.958 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.662 HD13 ' CD1' ' A' ' 84' ' ' LEU . 2.9 mp . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.81 0.338 . . . . 0.0 110.786 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.4 m -55.22 -36.61 66.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.289 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -61.0 -18.83 59.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.279 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.662 ' CD1' HD13 ' A' ' 81' ' ' ILE . 18.9 mt -102.69 149.34 24.55 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.759 0.314 . . . . 0.0 111.026 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 88.2 p -92.41 167.17 12.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.711 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.64 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.8 m-20 -43.53 -53.25 5.7 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.286 0.565 . . . . 0.0 109.832 179.24 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.431 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 2.7 ptmt -120.88 82.46 1.92 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.553 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.8 t60 -59.62 -47.12 86.85 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.707 -176.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.506 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 28.2 p90 -146.48 159.8 42.94 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.666 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.63 ' HG2' HG12 ' A' ' 65' ' ' VAL . 37.5 tt0 -135.77 141.2 44.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.145 -179.149 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.592 ' O ' HG13 ' A' ' 65' ' ' VAL . 50.8 mt -114.28 131.03 67.49 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.205 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.126 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.603 HD21 ' HB3' ' A' ' 100' ' ' LEU . 0.7 OUTLIER -112.64 149.04 33.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.009 0.433 . . . . 0.0 111.595 -179.674 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.843 HD22 HG11 ' A' ' 33' ' ' VAL . 29.1 tp . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.631 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.985 HD11 HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.916 0.388 . . . . 0.0 110.902 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.645 HD12 ' O ' ' A' ' 99' ' ' LEU . 2.6 mp -133.14 146.56 51.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.151 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.781 HD23 HD11 ' A' ' 130' ' ' ILE . 4.9 mp -112.65 129.35 56.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.259 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 90' ' ' GLN . 53.3 t30 -117.91 115.49 25.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.886 0.374 . . . . 0.0 111.829 -179.196 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.799 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.3 p30 -77.2 140.49 40.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.781 178.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' A' ' 89' ' ' PHE . 19.0 pt -149.5 38.74 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.655 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.1 152.6 19.67 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.095 0.474 . . . . 0.0 111.906 -178.842 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 47.9 m -68.93 -31.45 70.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.731 177.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -98.17 -19.81 17.67 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.655 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.84 157.18 10.55 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.359 -0.924 . . . . 0.0 113.895 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.1 m -117.42 137.88 52.2 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.81 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -116.67 148.37 41.08 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -177.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.897 HD12 HG11 ' A' ' 116' ' ' VAL . 0.9 OUTLIER -124.33 113.56 18.38 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.043 177.384 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 47.43 35.77 4.41 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.141 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.81 -7.41 76.99 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.564 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.8 118.58 37.04 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.059 0.457 . . . . 0.0 110.736 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.81 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -71.52 128.06 34.59 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.219 -179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.897 HG11 HD12 ' A' ' 111' ' ' LEU . 9.8 m -101.34 167.68 2.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.464 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 120' ' ' SER . 4.6 mm-40 -69.91 125.81 27.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.539 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.697 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 68.8 tttt -54.2 162.71 0.97 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.892 0.377 . . . . 0.0 110.618 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.5 m-80 35.21 34.02 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.241 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.29 145.14 40.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.027 179.481 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.592 ' HB3' HD23 ' A' ' 100' ' ' LEU . 4.8 m120 -85.87 132.13 34.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.021 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.426 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 32.5 mm-40 -129.46 146.27 51.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.768 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 124' ' ' LEU . 1.0 OUTLIER -72.98 122.92 22.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.312 179.503 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.757 HD21 HG12 ' A' ' 147' ' ' ILE . 59.6 tp -59.61 155.59 15.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.511 0.672 . . . . 0.0 111.554 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.435 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.8 153.2 42.86 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.33 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.74 120.49 17.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.986 0.422 . . . . 0.0 110.263 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.81 18.4 64.09 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.403 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.537 ' OD1' HD23 ' A' ' 111' ' ' LEU . 13.2 t70 -54.18 170.16 0.15 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.016 0.436 . . . . 0.0 111.257 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 5.0 tt0 -145.23 135.49 24.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.102 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.781 HD11 HD23 ' A' ' 101' ' ' LEU . 14.6 mt -111.27 128.22 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.346 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.634 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.7 m -104.22 139.32 39.42 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.186 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.478 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 34.6 m -140.18 158.25 25.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.086 0.47 . . . . 0.0 112.217 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.67 37.91 12.96 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.908 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.1 t -79.14 140.33 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-O 121.67 0.748 . . . . 0.0 112.33 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.89 -36.97 0.89 Allowed Glycine 0 N--CA 1.436 -1.341 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.02 -179.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.476 HG12 ' H ' ' A' ' 138' ' ' SER . 48.5 t -126.37 123.74 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-N 114.621 -0.79 . . . . 0.0 109.084 178.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.57 -33.21 21.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.691 0.282 . . . . 0.0 111.617 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.476 ' H ' HG12 ' A' ' 136' ' ' VAL . 3.0 m -93.46 6.58 47.69 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.446 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 3.2 t0 -127.34 30.1 5.44 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.634 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.9 mt -106.61 139.68 27.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.797 178.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.762 HD22 HD13 ' A' ' 143' ' ' LEU . 1.0 OUTLIER -115.76 134.55 54.9 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.827 -179.678 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.776 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.3 OUTLIER -116.13 127.06 54.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.218 0.532 . . . . 0.0 111.558 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.762 HD13 HD22 ' A' ' 141' ' ' LEU . 2.3 mp -121.26 138.08 54.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.625 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 21.7 t -110.55 139.31 34.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.866 0.365 . . . . 0.0 111.18 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.463 HD12 HD21 ' A' ' 101' ' ' LEU . 49.0 mt -106.03 138.12 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.197 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.84 116.48 25.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.473 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.757 HG12 HD21 ' A' ' 124' ' ' LEU . 4.9 mt -84.88 134.04 27.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.499 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.18 105.85 15.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.595 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -58.19 -32.96 68.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.091 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -60.38 -46.02 91.44 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.031 0.444 . . . . 0.0 110.775 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 30.3 t80 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.038 -179.831 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.82 0.343 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.9 mmt85 -68.97 -37.2 78.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -58.24 -40.38 81.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.775 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.3 tp -59.37 -31.93 69.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.801 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.465 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -73.02 -35.37 48.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -57.55 -39.59 76.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.37 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.16 -23.86 65.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.672 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.465 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.64 -47.56 79.47 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.199 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.1 p . . . . . 0 C--N 1.326 -0.453 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.833 179.891 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.404 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.3 OUTLIER . . . . . 0 CA--C 1.51 -0.594 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.667 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.6 mm -74.83 135.06 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 CA-C-N 113.694 -1.594 . . . . 0.0 112.532 -177.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.966 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -92.72 -60.84 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.836 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.619 ' SG ' HD22 ' A' ' 48' ' ' LEU . 1.7 p -140.73 164.88 29.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.214 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.411 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -134.45 122.09 22.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.809 0.337 . . . . 0.0 111.322 -179.529 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.704 HG21 ' HE2' ' A' ' 68' ' ' PHE . 40.6 t -93.72 122.78 45.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.815 0.34 . . . . 0.0 111.04 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.831 HG23 HG12 ' A' ' 45' ' ' ILE . 14.0 mt -125.7 117.49 49.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.564 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.428 ' SG ' HD23 ' A' ' 143' ' ' LEU . 3.8 t -81.33 111.23 17.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.834 0.349 . . . . 0.0 110.34 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.1 t -86.89 -22.02 25.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.934 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.636 HG23 ' HB2' ' A' ' 142' ' ' SER . 81.6 p -79.84 -2.77 44.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.731 0.3 . . . . 0.0 111.429 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.24 75.77 0.4 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.882 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -146.9 -40.36 0.2 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.844 0.354 . . . . 0.0 111.02 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.584 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.3 mt -125.9 142.01 41.07 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.033 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.584 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 46.0 Cg_endo -70.48 146.05 54.65 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.172 1.915 . . . . 0.0 112.226 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.831 HG12 HG23 ' A' ' 37' ' ' ILE . 33.7 mt -58.91 149.5 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.824 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.32 163.88 31.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.054 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.411 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.8 OUTLIER -126.06 119.85 28.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.058 0.456 . . . . 0.0 112.011 -179.479 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.797 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.3 mp -89.57 130.89 35.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.246 178.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.966 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -140.8 156.15 46.22 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 122.412 1.101 . . . . 0.0 113.827 -179.578 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.64 141.83 28.49 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 113.352 -1.749 . . . . 0.0 110.64 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 121.159 0.505 . . . . 0.0 111.051 -179.586 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.851 0.358 . . . . 0.0 110.768 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.415 ' CE ' ' O ' ' A' ' 49' ' ' SER . 21.0 ttpt -136.3 137.57 40.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.638 HG12 ' HG2' ' A' ' 90' ' ' GLN . 5.4 t -124.69 138.81 52.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.085 0.469 . . . . 0.0 111.852 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.797 ' CD2' HD23 ' A' ' 48' ' ' LEU . 17.0 m-90 -103.4 138.64 39.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.959 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.475 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.17 127.01 55.82 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 177.801 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.704 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -112.95 145.73 40.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.593 -178.456 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.697 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.45 -174.4 40.49 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.691 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.405 ' HD3' ' HB2' ' A' ' 84' ' ' LEU . 16.5 mtm180 -80.24 -2.82 46.68 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.488 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.0 t30 -84.87 135.99 39.35 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.791 0.329 . . . . 0.0 111.067 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.8 Cg_exo -68.86 -6.88 19.15 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.773 2.315 . . . . 0.0 111.834 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.76 -44.63 15.36 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-O 122.0 0.905 . . . . 0.0 108.56 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.07 136.68 4.72 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.694 -1.594 . . . . 0.0 110.16 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.419 ' OD2' ' CD1' ' A' ' 66' ' ' TRP . 0.7 OUTLIER -56.51 -18.92 13.13 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.89 179.431 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.521 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 53.7 t80 -130.19 130.69 45.01 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.772 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 CA-C-O 120.834 0.35 . . . . 0.0 110.944 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.816 HD13 HD12 ' A' ' 84' ' ' LEU . 3.8 mp . . . . . 0 CA--C 1.526 0.049 0 CA-C-O 120.806 0.336 . . . . 0.0 110.918 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.4 t -58.52 -40.43 82.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.995 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.42 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -61.02 -30.06 70.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.09 -179.82 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.816 HD12 HD13 ' A' ' 81' ' ' ILE . 30.3 mt -94.65 152.12 18.74 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.844 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 89.5 p -95.44 165.24 12.46 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.689 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.697 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.5 m-20 -42.06 -52.8 4.14 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.276 0.56 . . . . 0.0 109.816 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.428 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 5.0 ptmt -120.92 84.29 2.21 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.569 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.6 t60 -61.56 -46.24 90.74 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.971 -1.013 . . . . 0.0 113.055 -176.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.5 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 24.6 p90 -144.72 157.94 43.98 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.136 -0.625 . . . . 0.0 112.105 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.638 ' HG2' HG12 ' A' ' 65' ' ' VAL . 32.8 tt0 -135.91 140.35 44.0 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.018 -179.051 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.523 ' O ' HG13 ' A' ' 65' ' ' VAL . 38.5 mt -113.47 132.3 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 121.134 -0.227 . . . . 0.0 110.855 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.938 HD13 HD12 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -113.81 146.87 39.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.184 0.516 . . . . 0.0 112.022 -179.202 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.808 HD22 HG11 ' A' ' 33' ' ' VAL . 44.4 tp . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.439 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.769 ' HB2' HD21 ' A' ' 124' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.655 0.264 . . . . 0.0 110.696 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.938 HD12 HD13 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -133.22 147.57 51.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.818 0.342 . . . . 0.0 110.768 179.887 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.87 125.26 53.84 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.839 ' HB2' HD11 ' A' ' 92' ' ' LEU . 53.5 t30 -109.27 115.69 30.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.694 -179.021 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.79 ' OD2' HG23 ' A' ' 116' ' ' VAL . 18.3 p30 -76.89 131.76 38.75 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.649 178.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.437 HD13 ' HB2' ' A' ' 90' ' ' GLN . 21.6 pt -139.34 40.54 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -178.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.677 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.54 151.93 20.6 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 120.987 0.422 . . . . 0.0 111.64 -178.97 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.8 m -68.57 -31.87 71.38 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.776 178.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -98.41 -19.63 17.6 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.614 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.677 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.94 157.81 10.97 Favored Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.73 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.0 m -117.36 137.82 52.21 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.862 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -114.08 148.55 36.92 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -178.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.648 HD13 ' OD2' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -124.05 113.4 18.35 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.645 -1.161 . . . . 0.0 108.27 177.389 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.424 ' N ' HD12 ' A' ' 111' ' ' LEU . 81.4 m-20 44.51 43.08 6.1 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.385 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.47 -8.82 75.82 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.829 -0.7 . . . . 0.0 113.43 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -105.17 118.38 36.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.104 0.452 . . . . 0.0 110.764 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.862 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 12.8 tptt -74.0 122.37 22.51 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.247 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.79 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.9 m -94.05 165.56 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.204 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 120' ' ' SER . 9.7 tp10 -69.87 125.95 28.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.598 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.704 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 14.6 tttt -54.13 162.83 0.91 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.955 0.407 . . . . 0.0 110.653 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.7 OUTLIER 37.15 31.27 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.109 -179.171 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.82 144.02 43.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.164 179.203 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -93.42 129.93 39.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.786 0.326 . . . . 0.0 110.287 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -129.0 149.34 50.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.974 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.585 HD13 ' O ' ' A' ' 124' ' ' LEU . 2.1 tm? -72.69 111.64 8.03 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.769 HD21 ' HB2' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -59.88 168.17 1.9 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.318 0.58 . . . . 0.0 111.798 -178.843 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -124.29 153.65 41.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.033 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.05 116.97 11.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.108 0.48 . . . . 0.0 110.257 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.62 18.36 73.78 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.364 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.648 ' OD2' HD13 ' A' ' 111' ' ' LEU . 5.6 t70 -59.84 -179.48 0.1 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.67 0.271 . . . . 0.0 110.62 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.868 ' CG ' HG22 ' A' ' 144' ' ' VAL . 4.1 mt-10 -145.32 135.69 24.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.682 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 1.048 HD11 HD11 ' A' ' 145' ' ' ILE . 14.9 mt -109.68 126.26 66.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.023 178.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.609 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.9 m -104.49 138.68 40.51 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.209 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.52 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.1 m -140.33 158.2 25.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.26 28.28 28.26 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.15 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.492 ' HA ' HG12 ' A' ' 140' ' ' ILE . 69.7 t -70.04 140.3 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-O 121.58 0.705 . . . . 0.0 112.326 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.69 -38.47 0.76 Allowed Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.437 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 49.8 t -126.33 132.94 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 CA-C-N 114.808 -0.696 . . . . 0.0 109.335 178.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -50.54 -39.81 50.17 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.428 ' H ' HG12 ' A' ' 136' ' ' VAL . 5.7 m -93.3 6.49 47.89 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.437 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 15.3 t0 -118.74 26.82 9.29 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -179.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.609 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.5 mt -107.14 139.61 28.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.05 178.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.509 HD23 ' N ' ' A' ' 142' ' ' SER . 8.3 tt -119.3 134.51 55.17 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.582 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.636 ' HB2' HG23 ' A' ' 40' ' ' THR . 0.9 OUTLIER -111.39 135.63 51.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.066 0.46 . . . . 0.0 111.633 -179.673 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 51.0 mt -126.71 152.71 46.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.157 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.868 HG22 ' CG ' ' A' ' 129' ' ' GLU . 21.8 t -115.61 139.78 40.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.025 0.441 . . . . 0.0 111.606 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 1.048 HD11 HD11 ' A' ' 130' ' ' ILE . 18.3 mt -106.5 120.95 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.822 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.33 103.9 12.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.424 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.651 HG12 HD22 ' A' ' 124' ' ' LEU . 7.0 mt -84.86 134.05 27.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.991 0.424 . . . . 0.0 111.58 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -88.53 112.2 22.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.86 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.46 -25.9 68.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.083 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.91 -45.22 90.87 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.053 0.454 . . . . 0.0 110.664 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.0 t80 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.004 179.99 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.889 0.376 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.47 -36.33 82.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.801 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -39.45 79.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.809 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.78 -31.81 70.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.796 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.434 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.5 mt -72.62 -35.4 50.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.855 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -57.42 -42.69 82.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.941 0.401 . . . . 0.0 110.386 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.09 -23.93 65.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.657 179.218 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.434 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.55 -47.52 79.27 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.298 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.809 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.41 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER . . . . . 0 CA--C 1.509 -0.622 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.675 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.4 mm -76.85 135.85 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 CA-C-N 113.708 -1.587 . . . . 0.0 112.571 -177.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.996 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.4 t -90.37 -58.99 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.683 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 30.1 p -150.7 161.27 42.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.014 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.76 138.3 54.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.805 0.336 . . . . 0.0 111.621 -179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.722 HG11 ' CE2' ' A' ' 68' ' ' PHE . 28.4 m -106.85 122.52 60.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.825 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.834 HG23 HG12 ' A' ' 45' ' ' ILE . 19.9 mt -128.62 127.01 66.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.456 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.747 ' HA ' HD13 ' A' ' 143' ' ' LEU . 21.3 t -83.0 100.45 10.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.88 0.371 . . . . 0.0 110.459 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.7 t -69.46 -28.2 65.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.713 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.774 HG23 ' HB2' ' A' ' 142' ' ' SER . 59.5 p -80.08 -2.69 45.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.722 0.296 . . . . 0.0 111.578 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.18 79.84 0.17 Allowed Glycine 0 CA--C 1.517 0.193 0 C-N-CA 120.919 -0.658 . . . . 0.0 113.139 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -147.35 -39.88 0.19 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.78 0.324 . . . . 0.0 111.019 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.601 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.4 mt -123.84 142.58 39.78 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.988 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.601 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 37.8 Cg_endo -68.84 146.08 64.68 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.028 1.819 . . . . 0.0 112.247 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.834 HG12 HG23 ' A' ' 37' ' ' ILE . 35.4 mt -57.59 148.1 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.816 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.89 164.04 31.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.056 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -124.57 119.78 30.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.928 0.394 . . . . 0.0 111.973 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.778 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.6 mp -90.8 125.98 35.88 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.083 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.996 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -135.63 156.82 48.25 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -179.092 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.488 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -148.98 141.79 24.62 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.552 -1.658 . . . . 0.0 110.817 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 121.286 0.565 . . . . 0.0 111.239 -179.553 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.876 0.369 . . . . 0.0 110.842 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.432 ' HE2' ' O ' ' A' ' 49' ' ' SER . 6.7 ttpt -151.43 129.98 12.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.099 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.56 HG13 ' C ' ' A' ' 91' ' ' ILE . 10.9 t -124.04 138.52 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 121.408 0.623 . . . . 0.0 112.021 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.778 ' CD2' HD23 ' A' ' 48' ' ' LEU . 18.1 m-90 -100.97 139.86 36.06 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.824 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.983 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.86 127.68 56.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.0 0.428 . . . . 0.0 109.862 177.936 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.722 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -114.11 145.64 41.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.281 -178.966 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.655 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.68 -174.07 39.0 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.674 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.3 mtp180 -79.66 0.24 31.12 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.668 0.248 . . . . 0.0 111.668 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.687 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 10.2 t-20 -84.7 133.91 43.02 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.68 0.276 . . . . 0.0 111.056 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 13.5 Cg_exo -68.5 -8.61 23.61 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.618 2.212 . . . . 0.0 111.894 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.687 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -83.04 -43.14 16.67 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-O 121.963 0.887 . . . . 0.0 108.855 178.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.8 137.01 2.42 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 113.65 -1.613 . . . . 0.0 110.918 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -56.43 -18.73 12.17 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.016 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.511 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 63.7 t80 -129.79 123.03 29.97 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.896 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t60 . . . . . 0 C--N 1.327 -0.373 0 CA-C-O 120.876 0.369 . . . . 0.0 110.977 -179.917 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.52 HG22 ' H ' ' A' ' 83' ' ' ARG . 26.6 mm . . . . . 0 N--CA 1.458 -0.054 0 CA-C-O 120.861 0.362 . . . . 0.0 110.958 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.6 t -54.94 -30.85 59.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.959 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.52 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -68.72 -26.62 65.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.781 179.854 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.649 HD21 HG23 ' A' ' 132' ' ' VAL . 33.7 mt -97.73 152.22 19.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.93 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.2 166.21 11.85 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.686 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.655 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -42.72 -52.83 4.8 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.471 0.653 . . . . 0.0 109.638 179.172 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.553 ' HB3' HG22 ' A' ' 67' ' ' THR . 6.4 mttt -119.51 84.85 2.27 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 177.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.546 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.2 t60 -61.87 -45.83 92.07 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.877 -177.005 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.52 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 18.9 p90 -145.81 163.24 35.64 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.127 -0.629 . . . . 0.0 112.427 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.983 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.59 136.72 41.3 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.397 -178.878 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.56 ' C ' HG13 ' A' ' 65' ' ' VAL . 35.3 mt -113.38 128.49 70.18 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.342 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.353 178.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.551 HD23 ' HB2' ' A' ' 102' ' ' ASN . 0.7 OUTLIER -114.36 148.35 37.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.086 0.469 . . . . 0.0 111.859 -179.415 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.703 HD13 ' CG1' ' A' ' 33' ' ' VAL . 16.8 tp . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.368 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.696 HD23 HD22 ' A' ' 124' ' ' LEU . 24.0 tp . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.813 0.339 . . . . 0.0 110.796 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.79 HD13 ' O ' ' A' ' 122' ' ' GLN . 4.1 mm? -124.91 145.56 49.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.326 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.787 HD21 HD13 ' A' ' 124' ' ' LEU . 2.0 mt -112.62 124.5 52.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.041 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.551 ' HB2' HD23 ' A' ' 92' ' ' LEU . 50.6 t30 -116.99 115.7 25.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.892 0.377 . . . . 0.0 111.781 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.835 ' OD2' HG23 ' A' ' 116' ' ' VAL . 8.1 p30 -77.71 141.23 39.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.955 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.435 HD12 ' HB2' ' A' ' 87' ' ' LYS . 11.0 pt -148.46 38.33 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.602 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.34 152.35 19.55 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.051 0.453 . . . . 0.0 111.753 -179.093 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 47.6 m -68.92 -31.57 70.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.027 178.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -98.24 -19.75 17.66 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.602 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.18 155.65 9.86 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 120.178 -1.01 . . . . 0.0 113.747 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.505 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.8 m -117.65 137.82 52.39 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.864 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -116.01 148.46 40.12 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -178.221 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.41 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.01 113.52 18.53 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.356 177.575 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 43.93 43.81 5.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.36 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.55 -10.94 67.64 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.448 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.48 118.63 37.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.028 0.442 . . . . 0.0 110.638 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.864 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 12.2 tptp -73.01 122.28 21.48 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.239 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.835 HG23 ' OD2' ' A' ' 103' ' ' ASP . 14.2 m -93.18 164.61 2.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.249 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.5 tp10 -69.88 126.34 29.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.557 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.681 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 87.9 tttt -53.51 161.17 1.07 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.994 0.426 . . . . 0.0 110.727 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 34.85 34.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.437 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.46 145.1 40.78 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.133 179.384 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -86.71 130.48 34.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.66 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.79 ' O ' HD13 ' A' ' 100' ' ' LEU . 6.3 mm100 -129.32 146.49 51.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.756 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.1 tp -72.78 124.84 26.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.073 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.787 HD13 HD21 ' A' ' 101' ' ' LEU . 65.4 tp -57.21 157.34 6.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.427 0.632 . . . . 0.0 111.684 -179.164 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.524 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.4 OUTLIER -124.4 153.69 41.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.333 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.665 ' HA ' HD13 ' A' ' 147' ' ' ILE . 10.0 tp60 -70.96 119.05 14.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.004 0.431 . . . . 0.0 110.318 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.83 24.43 62.5 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.223 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.45 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 23.3 t0 -56.47 169.72 0.43 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.085 0.469 . . . . 0.0 111.107 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 17.2 tt0 -145.35 135.53 23.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.046 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.481 ' CG2' HG22 ' A' ' 109' ' ' THR . 13.4 mt -109.15 128.05 65.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.477 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.694 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.0 m -104.5 139.61 39.16 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.96 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.649 HG23 HD21 ' A' ' 84' ' ' LEU . 34.6 m -140.36 158.52 25.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.95 33.54 23.7 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.734 -0.667 . . . . 0.0 112.234 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.522 ' HA ' HG12 ' A' ' 140' ' ' ILE . 76.4 t -72.95 140.29 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-O 121.587 0.708 . . . . 0.0 112.386 -179.084 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.77 -42.17 0.8 Allowed Glycine 0 N--CA 1.436 -1.334 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -178.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.483 HG12 ' H ' ' A' ' 138' ' ' SER . 42.0 t -126.34 130.55 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-N 114.763 -0.719 . . . . 0.0 109.153 177.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -50.45 -34.0 23.15 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -178.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.483 ' H ' HG12 ' A' ' 136' ' ' VAL . 69.0 m -93.35 6.24 48.79 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.08 22.41 11.45 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -178.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.694 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.3 mt -107.12 139.42 28.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.293 178.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.569 HD22 ' CD2' ' A' ' 143' ' ' LEU . 1.2 tt -122.22 134.41 54.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.273 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.774 ' HB2' HG23 ' A' ' 40' ' ' THR . 0.7 OUTLIER -109.1 140.66 42.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.053 0.454 . . . . 0.0 111.954 -179.134 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.747 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.7 mm? -134.57 136.03 42.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.333 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 18.1 t -110.68 140.22 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.873 0.368 . . . . 0.0 111.395 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 8.4 mt -106.16 134.75 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.918 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.53 116.3 27.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.69 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.665 HD13 ' HA ' ' A' ' 126' ' ' GLN . 4.6 mp -85.6 134.04 28.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.657 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -85.01 114.71 22.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.765 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -61.34 -31.89 71.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.951 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -59.64 -45.74 91.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.954 0.407 . . . . 0.0 110.686 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.6 t80 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.021 -179.91 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.82 0.343 . . . . 0.0 110.963 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -66.04 -36.03 82.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.647 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -59.93 -43.22 95.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.815 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 tp -58.44 -32.98 69.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.716 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.435 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.4 mt -73.1 -35.32 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.922 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -57.07 -38.76 73.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.964 0.411 . . . . 0.0 110.487 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -67.08 -26.8 66.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.404 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.98 -47.57 80.46 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.254 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.993 179.986 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.449 ' O ' ' HB3' ' A' ' 49' ' ' SER . 2.3 m-80 . . . . . 0 CA--C 1.506 -0.748 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.565 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.3 mm -71.55 142.15 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.575 0 CA-C-N 113.744 -1.571 . . . . 0.0 112.634 -176.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.767 HG22 HD13 ' A' ' 93' ' ' LEU . 1.0 OUTLIER -106.54 -50.23 8.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.663 -178.885 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.452 ' N ' HG12 ' A' ' 33' ' ' VAL . 0.5 OUTLIER -154.86 165.5 36.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.351 179.29 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.57 120.83 24.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.757 0.313 . . . . 0.0 111.012 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.824 HG21 ' CZ ' ' A' ' 68' ' ' PHE . 25.0 t -94.7 122.67 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.854 0.359 . . . . 0.0 111.126 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.878 HG23 HG12 ' A' ' 45' ' ' ILE . 13.4 mt -124.49 122.49 64.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.252 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.665 ' HA ' HD13 ' A' ' 143' ' ' LEU . 46.9 t -79.87 127.33 32.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.445 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.9 t -94.31 -29.12 15.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.814 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.552 HG21 ' H ' ' A' ' 142' ' ' SER . 43.2 p -79.87 -2.34 43.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.576 0.226 . . . . 0.0 111.462 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.22 80.86 0.21 Allowed Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.819 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.403 ' OE1' HD11 ' A' ' 141' ' ' LEU . 12.8 mt-30 -147.01 -43.78 0.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.804 0.335 . . . . 0.0 110.888 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.617 HG23 ' HD2' ' A' ' 44' ' ' PRO . 3.8 mp -120.42 142.08 33.23 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.209 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.617 ' HD2' HG23 ' A' ' 43' ' ' ILE . 56.5 Cg_endo -72.55 145.98 43.16 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.221 1.947 . . . . 0.0 112.007 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.878 HG12 HG23 ' A' ' 37' ' ' ILE . 38.2 mt -53.48 134.74 15.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.772 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.17 163.85 24.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.091 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -120.25 119.7 33.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.126 0.489 . . . . 0.0 112.002 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.58 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 5.0 mp -87.22 132.07 34.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.599 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -138.97 156.59 47.12 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 122.426 1.108 . . . . 0.0 113.572 -179.297 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.599 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . -142.99 144.66 32.4 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.831 178.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 121.066 0.46 . . . . 0.0 111.296 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.735 0.302 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.4 ' HE2' ' O ' ' A' ' 49' ' ' SER . 7.2 ttpt -143.39 130.41 20.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.34 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 91' ' ' ILE . 13.0 t -126.32 139.34 51.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.292 0.567 . . . . 0.0 111.895 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.599 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 16.8 m-90 -100.76 139.85 35.87 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.165 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.778 HG23 ' CG ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -108.3 126.26 52.63 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.573 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.824 ' CZ ' HG21 ' A' ' 36' ' ' VAL . 3.0 m-85 -114.47 145.75 41.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.8 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.617 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.39 -174.35 36.28 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.188 -1.006 . . . . 0.0 113.362 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 6.7 mtm105 -75.61 0.49 17.31 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.732 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 9.5 t-20 -84.66 133.35 44.2 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.667 0.27 . . . . 0.0 111.414 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.8 Cg_exo -68.6 -10.46 29.11 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.655 2.236 . . . . 0.0 111.754 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.732 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -83.21 -43.45 16.11 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-O 121.915 0.864 . . . . 0.0 108.781 178.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -41.37 137.75 1.4 Allowed 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.959 179.631 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.32 -18.3 10.33 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.241 179.29 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.558 ' CG ' ' CE2' ' A' ' 68' ' ' PHE . 19.8 t80 -127.21 116.25 20.32 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.811 0.338 . . . . 0.0 110.64 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.2 t60 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.159 -179.729 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.592 HD12 ' CD1' ' A' ' 84' ' ' LEU . 24.8 mt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.877 0.37 . . . . 0.0 111.446 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 40.1 t -62.53 -38.75 91.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.768 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.488 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -62.49 -33.25 74.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.949 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.592 ' CD1' HD12 ' A' ' 81' ' ' ILE . 30.0 mt -91.21 152.24 20.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.015 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 92.3 p -97.14 165.53 12.01 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.53 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.617 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.0 m-20 -42.81 -53.99 4.34 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.314 0.578 . . . . 0.0 109.745 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.545 ' HB2' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -118.22 83.81 2.07 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 177.144 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.558 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.0 t60 -61.19 -45.41 94.7 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.802 -1.09 . . . . 0.0 113.162 -176.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.531 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 29.5 p90 -145.98 163.23 35.83 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 119.966 -0.694 . . . . 0.0 112.552 -179.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.778 ' CG ' HG23 ' A' ' 67' ' ' THR . 8.2 mt-30 -135.35 145.09 47.05 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.382 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.548 ' O ' HG13 ' A' ' 65' ' ' VAL . 3.2 mp -118.62 132.36 68.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 178.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.491 ' CB ' HG22 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -118.01 148.93 41.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.227 0.537 . . . . 0.0 111.988 -179.018 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.767 HD13 HG22 ' A' ' 33' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.037 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.667 ' CD1' HD12 ' A' ' 93' ' ' LEU . 4.0 mm? . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.717 0.294 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.616 HD12 ' O ' ' A' ' 99' ' ' LEU . 2.3 mp -132.69 142.89 49.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.999 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.76 129.47 56.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.341 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.431 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 50.1 t30 -117.8 115.7 25.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.862 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.787 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.0 p30 -78.65 141.41 38.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.999 178.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.463 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 14.9 pt -148.33 38.58 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -178.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.635 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.09 152.99 19.24 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.14 0.495 . . . . 0.0 111.676 -179.162 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 51.1 m -68.87 -31.84 71.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.961 178.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -98.46 -19.92 17.4 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.635 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.59 157.22 10.23 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.267 -0.968 . . . . 0.0 113.797 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.518 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.7 m -117.53 138.05 52.16 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.881 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -115.04 148.49 38.81 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -178.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.424 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.13 113.43 18.33 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.337 177.406 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.3 m120 44.38 43.22 5.97 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.81 -9.96 72.09 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.408 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -105.27 118.57 36.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.007 0.432 . . . . 0.0 110.746 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.881 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 19.1 tptt -73.63 130.25 39.65 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.184 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.787 HG23 ' OD2' ' A' ' 103' ' ' ASP . 8.0 m -103.09 165.95 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.363 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.415 ' HB3' ' HB3' ' A' ' 120' ' ' SER . 5.3 tp10 -69.95 127.0 31.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.564 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.678 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 30.3 tttp -52.62 161.96 0.64 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.739 0.305 . . . . 0.0 110.455 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 35.08 35.68 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.132 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.415 ' HB3' ' HB3' ' A' ' 117' ' ' GLU . 4.2 p -112.01 145.15 40.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.644 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -93.33 129.53 39.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.757 0.313 . . . . 0.0 110.925 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.44 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 59.7 mm-40 -129.21 151.85 49.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.536 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.9 tp -72.6 112.23 8.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.85 0.357 . . . . 0.0 110.288 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.883 HD11 HG21 ' A' ' 145' ' ' ILE . 66.3 tp -53.05 158.91 1.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.266 0.555 . . . . 0.0 111.575 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.412 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.6 OUTLIER -124.11 153.29 41.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.555 -179.779 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.32 122.55 20.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.87 0.367 . . . . 0.0 110.327 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.38 21.23 56.79 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.186 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.406 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 11.1 t70 -56.56 175.8 0.11 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.815 0.34 . . . . 0.0 110.9 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.877 ' CG ' HG22 ' A' ' 144' ' ' VAL . 4.6 mt-10 -145.27 135.75 24.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.242 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.952 HD11 HD11 ' A' ' 145' ' ' ILE . 12.3 mt -112.23 128.26 68.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.523 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.65 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.1 m -104.23 140.16 38.24 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.056 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.478 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 33.3 m -140.22 158.4 25.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.095 0.474 . . . . 0.0 112.233 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.95 44.56 8.98 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.86 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.466 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.3 t -84.33 140.5 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-O 121.684 0.754 . . . . 0.0 112.631 -178.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.64 -41.14 0.59 Allowed Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 138' ' ' SER . 48.2 t -126.45 125.43 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-N 114.674 -0.763 . . . . 0.0 109.07 177.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.46 -30.25 12.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.805 0.336 . . . . 0.0 111.279 -178.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.567 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -93.62 6.48 48.12 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.341 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -126.94 27.74 5.92 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.65 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.6 mt -107.18 139.44 28.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.283 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.605 HD23 ' N ' ' A' ' 142' ' ' SER . 2.7 tt -120.72 134.53 55.28 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.383 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.605 ' N ' HD23 ' A' ' 141' ' ' LEU . 44.0 t -113.58 150.68 32.69 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.694 0.759 . . . . 0.0 112.57 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.665 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.7 mm? -135.78 151.37 50.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.454 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.877 HG22 ' CG ' ' A' ' 129' ' ' GLU . 16.5 t -116.35 135.62 55.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.902 0.382 . . . . 0.0 111.265 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.952 HD11 HD11 ' A' ' 130' ' ' ILE . 40.9 mt -106.45 121.99 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.988 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.52 116.93 31.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.707 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.474 HG12 HD21 ' A' ' 124' ' ' LEU . 5.0 mt -84.82 134.2 27.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.581 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -82.05 115.44 21.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.776 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.89 -28.81 68.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.14 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -59.63 -45.77 90.97 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.989 0.423 . . . . 0.0 110.749 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.8 t80 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.892 -179.863 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.783 0.325 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -60.67 -42.62 97.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.889 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -60.18 -39.11 85.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.909 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 mt -60.27 -44.79 95.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.875 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.3 mm -63.3 -40.15 87.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.168 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -57.91 -33.82 69.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.12 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -65.38 -33.79 76.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.257 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -56.9 -47.46 80.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.062 0.458 . . . . 0.0 111.058 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.5 p . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.787 179.97 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.433 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER . . . . . 0 CA--C 1.509 -0.632 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.663 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 2.7 mm -75.36 134.87 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 CA-C-N 113.897 -1.501 . . . . 0.0 112.363 -177.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.963 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -93.73 -61.19 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.232 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -143.97 154.07 42.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.724 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.17 138.1 51.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.832 0.349 . . . . 0.0 111.135 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.715 HG21 ' CE2' ' A' ' 68' ' ' PHE . 18.8 t -105.29 122.67 58.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.054 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.687 HG23 HG12 ' A' ' 45' ' ' ILE . 19.3 mt -128.84 118.23 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.5 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.655 ' HA ' HD13 ' A' ' 143' ' ' LEU . 38.2 t -80.34 123.37 27.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.313 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.401 HG23 HG21 ' A' ' 144' ' ' VAL . 0.2 OUTLIER -91.59 -25.55 19.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.677 -179.36 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.534 HG21 ' H ' ' A' ' 142' ' ' SER . 43.1 p -79.81 -2.29 42.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.64 0.257 . . . . 0.0 111.541 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.12 75.19 0.41 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.851 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -146.21 -44.24 0.2 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.866 0.365 . . . . 0.0 110.963 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.537 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -114.95 140.88 26.1 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.784 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.537 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.2 Cg_endo -73.28 145.93 39.47 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.183 1.922 . . . . 0.0 112.33 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.687 HG12 HG23 ' A' ' 37' ' ' ILE . 35.2 mt -57.68 141.46 14.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.547 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -137.18 164.02 29.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.313 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.88 119.83 32.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.977 0.418 . . . . 0.0 111.614 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.55 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 6.0 mt -91.35 137.17 32.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.298 178.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.963 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -144.17 157.42 44.31 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 -179.123 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.502 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -151.04 148.49 28.4 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.874 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 121.192 0.52 . . . . 0.0 110.976 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.682 0.277 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.455 ' HE2' ' O ' ' A' ' 49' ' ' SER . 3.7 ttpt -140.85 132.86 27.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.384 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.507 HG13 ' C ' ' A' ' 91' ' ' ILE . 9.6 t -129.34 139.28 52.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.245 0.545 . . . . 0.0 111.808 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.55 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.0 m-90 -100.83 139.73 36.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.7 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.952 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.83 126.85 55.29 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.98 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.893 ' CE1' HD12 ' A' ' 91' ' ' ILE . 1.6 m-85 -110.55 145.71 37.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.422 -178.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.697 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.34 -177.74 39.9 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.955 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -77.33 -2.51 35.32 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -84.85 134.78 40.99 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.656 0.265 . . . . 0.0 111.197 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -68.71 -6.81 18.8 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.76 2.307 . . . . 0.0 111.838 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.83 -43.73 16.3 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-O 121.958 0.885 . . . . 0.0 108.77 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.94 137.67 3.13 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 113.629 -1.623 . . . . 0.0 110.648 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -56.41 -19.21 13.84 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.984 179.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.574 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 29.9 t80 -129.98 116.57 18.78 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.016 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 120.838 0.351 . . . . 0.0 110.359 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.629 ' HB ' HD13 ' A' ' 84' ' ' LEU . 3.7 mp . . . . . 0 N--CA 1.458 -0.058 0 CA-C-O 120.82 0.343 . . . . 0.0 110.838 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 27.3 t -55.06 -31.39 61.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.323 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.507 ' H ' HG22 ' A' ' 81' ' ' ILE . 2.1 mmp_? -60.9 -33.91 73.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.9 0.381 . . . . 0.0 111.131 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.753 HD21 ' CG2' ' A' ' 132' ' ' VAL . 5.8 mp -95.31 153.24 17.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.062 0.458 . . . . 0.0 110.919 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.2 p -94.13 166.3 12.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.739 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.697 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -42.72 -52.33 4.98 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.449 0.642 . . . . 0.0 109.591 179.145 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.585 ' HB3' HG22 ' A' ' 67' ' ' THR . 4.8 mttp -120.5 84.69 2.26 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 177.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.56 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.0 t60 -61.14 -46.06 92.09 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.823 -176.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.543 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 12.3 p90 -145.18 162.37 37.26 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.059 -0.656 . . . . 0.0 112.351 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.952 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.67 136.22 40.74 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.584 -178.709 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.893 HD12 ' CE1' ' A' ' 68' ' ' PHE . 8.0 mt -113.88 129.47 69.72 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.16 178.252 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.668 HD11 HD13 ' A' ' 100' ' ' LEU . 0.6 OUTLIER -112.64 148.84 33.77 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.024 0.44 . . . . 0.0 111.905 -179.249 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.516 ' HG ' HG11 ' A' ' 33' ' ' VAL . 2.3 tm? . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.524 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.843 HD21 HG12 ' A' ' 33' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.233 0.198 0 CA-C-O 120.746 0.308 . . . . 0.0 110.973 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.842 HD22 ' HB3' ' A' ' 121' ' ' ASN . 6.0 mt -130.12 142.17 50.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.484 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.743 HD11 HD11 ' A' ' 130' ' ' ILE . 2.1 tp -112.56 120.92 43.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.153 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.465 ' HB2' HD23 ' A' ' 92' ' ' LEU . 55.1 t30 -115.25 115.7 27.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.007 0.432 . . . . 0.0 111.645 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.789 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.3 p30 -77.36 139.29 39.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.081 178.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.425 HD11 HG22 ' A' ' 67' ' ' THR . 10.5 pt -146.82 38.79 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 -179.143 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.658 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.7 151.73 20.42 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.085 0.469 . . . . 0.0 111.908 -178.711 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 48.1 m -68.79 -31.62 70.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.85 177.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -98.2 -19.78 17.66 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.658 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.97 156.69 10.38 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 120.203 -0.999 . . . . 0.0 113.715 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.0 m -117.62 137.88 52.33 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.819 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -116.3 148.36 40.61 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -178.018 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.811 HD12 HG11 ' A' ' 116' ' ' VAL . 0.7 OUTLIER -124.33 113.72 18.59 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.636 -1.166 . . . . 0.0 108.804 177.494 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 46.61 36.37 3.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.045 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.05 -3.31 80.45 Favored Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 120.854 -0.689 . . . . 0.0 113.557 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -106.56 118.57 37.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.097 0.475 . . . . 0.0 110.767 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.819 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.5 tptp -73.47 119.72 18.08 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.111 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.811 HG11 HD12 ' A' ' 111' ' ' LEU . 10.7 m -95.72 165.59 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.454 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.7 tt0 -69.92 126.37 29.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.637 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.689 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 67.9 tttt -52.9 162.5 0.61 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.811 0.338 . . . . 0.0 110.335 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.9 p-10 35.41 34.66 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.241 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.5 OUTLIER -112.32 137.58 50.26 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.057 179.435 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.842 ' HB3' HD22 ' A' ' 100' ' ' LEU . 2.4 m-80 -82.72 129.16 34.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.954 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.698 ' O ' HD23 ' A' ' 100' ' ' LEU . 45.4 mm-40 -129.51 148.13 51.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.92 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.5 tp -72.87 119.01 16.52 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.009 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.426 ' HA ' HD13 ' A' ' 124' ' ' LEU . 1.2 mm? -58.05 164.86 2.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.816 0.817 . . . . 0.0 111.957 -179.033 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.424 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -125.57 153.16 44.1 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.318 179.253 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.52 118.05 13.85 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 62.75 25.71 67.82 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.789 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.58 ' OD2' HD23 ' A' ' 111' ' ' LEU . 9.2 t70 -57.92 175.36 0.2 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.027 0.441 . . . . 0.0 111.154 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 1.0 OUTLIER -145.11 135.54 24.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.887 179.837 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.743 HD11 HD11 ' A' ' 101' ' ' LEU . 5.7 mt -114.38 128.48 71.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.505 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.632 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.1 m -103.95 139.26 39.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.993 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.753 ' CG2' HD21 ' A' ' 84' ' ' LEU . 34.3 m -140.27 158.38 25.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 82.95 35.85 17.28 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.993 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.478 ' HA ' HG12 ' A' ' 140' ' ' ILE . 56.8 t -76.41 140.49 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-O 121.733 0.778 . . . . 0.0 112.477 -178.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.69 -41.38 0.62 Allowed Glycine 0 N--CA 1.437 -1.262 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.074 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.486 HG12 ' H ' ' A' ' 138' ' ' SER . 46.5 t -126.33 132.19 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 114.787 -0.707 . . . . 0.0 109.204 178.084 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -50.53 -36.38 33.98 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.486 ' H ' HG12 ' A' ' 136' ' ' VAL . 70.0 m -93.61 6.31 48.7 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.418 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 1.1 m-20 -120.2 25.66 9.73 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.632 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.2 mt -106.92 139.41 28.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.224 178.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.413 HD23 ' N ' ' A' ' 142' ' ' SER . 1.3 tt -123.46 134.51 53.92 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.26 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.534 ' H ' HG21 ' A' ' 40' ' ' THR . 47.0 t -112.51 150.42 31.3 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.645 0.736 . . . . 0.0 112.585 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.655 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.4 mm? -135.67 148.46 48.93 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.432 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 23.8 t -117.19 131.14 70.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 0.0 111.174 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.1 mm -106.33 122.07 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.679 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.15 120.03 39.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.092 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.529 HG23 ' CD1' ' A' ' 99' ' ' LEU . 7.3 mt -84.79 129.27 37.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.837 0.351 . . . . 0.0 111.236 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.88 116.19 16.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.973 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -62.86 -30.0 71.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.009 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -57.88 -43.49 86.05 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.076 0.465 . . . . 0.0 110.571 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 30.2 t80 . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.764 179.791 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.855 0.359 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -36.32 79.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.771 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.38 -40.99 88.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.788 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.73 -32.18 72.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.763 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.435 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.0 mt -73.13 -35.41 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -57.46 -41.9 81.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.437 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -67.22 -24.06 65.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.623 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.82 -47.59 79.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.156 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.5 m . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.936 179.89 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.444 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.7 OUTLIER . . . . . 0 CA--C 1.509 -0.627 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.719 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 6.1 mm -75.87 132.14 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 113.702 -1.59 . . . . 0.0 112.587 -177.223 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.039 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.0 t -91.0 -60.93 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.073 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.609 ' SG ' HD12 ' A' ' 48' ' ' LEU . 3.0 p -148.67 152.15 36.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.267 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.09 138.15 50.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.918 0.389 . . . . 0.0 111.191 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.799 HG21 ' CZ ' ' A' ' 68' ' ' PHE . 23.1 t -104.73 122.69 58.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.777 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.801 HG23 HG12 ' A' ' 45' ' ' ILE . 20.0 mt -125.12 120.55 58.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.468 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.724 ' HA ' HD13 ' A' ' 143' ' ' LEU . 34.2 t -80.49 112.29 17.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.489 179.354 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.747 HG21 ' OE2' ' A' ' 129' ' ' GLU . 5.4 t -82.08 -25.87 34.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.652 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.509 HG21 ' H ' ' A' ' 142' ' ' SER . 34.1 p -79.88 -2.18 42.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.582 0.23 . . . . 0.0 111.501 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.74 78.08 0.27 Allowed Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.794 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -146.43 -44.03 0.19 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.945 0.403 . . . . 0.0 110.991 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.57 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.7 mp -120.03 141.47 31.57 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.046 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.57 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.0 Cg_endo -72.09 146.03 45.7 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.246 1.964 . . . . 0.0 112.21 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.801 HG12 HG23 ' A' ' 37' ' ' ILE . 36.3 mt -55.81 128.78 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.809 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.419 ' HG3' ' CE2' ' A' ' 76' ' ' TYR . 19.2 mtt180 -122.85 164.09 19.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.06 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -120.81 119.92 34.09 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.244 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.609 HD12 ' SG ' ' A' ' 34' ' ' CYS . 2.5 mt -93.3 137.29 32.76 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . 1.039 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -147.93 158.04 43.84 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -178.56 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.479 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -140.32 141.79 35.68 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 113.28 -1.782 . . . . 0.0 110.237 178.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 121.197 0.522 . . . . 0.0 111.512 -179.291 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.804 0.335 . . . . 0.0 110.994 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.418 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.0 ttpt -150.11 136.31 18.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.026 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.693 HG12 ' HG2' ' A' ' 90' ' ' GLN . 11.7 t -128.48 139.2 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 121.261 0.553 . . . . 0.0 112.197 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.519 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.2 m-90 -103.24 139.36 38.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.984 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.674 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.88 125.39 53.6 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 177.436 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.799 ' CZ ' HG21 ' A' ' 36' ' ' VAL . 2.6 m-85 -107.9 145.82 33.22 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.606 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.679 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.78 -178.15 40.05 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.916 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.448 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 6.1 mtp-105 -77.47 -3.39 40.19 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.41 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.9 t30 -84.88 135.72 39.66 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.767 0.318 . . . . 0.0 111.133 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.0 Cg_exo -69.07 -6.5 18.41 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.794 2.329 . . . . 0.0 111.884 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.86 -44.06 15.87 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 121.945 0.879 . . . . 0.0 108.651 179.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.86 138.61 2.67 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.734 -1.575 . . . . 0.0 110.41 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -56.27 -18.85 11.76 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.95 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.563 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 45.0 t80 -129.73 119.72 23.93 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.736 0.303 . . . . 0.0 110.818 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.4 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.2 t-160 . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.763 0.316 . . . . 0.0 110.611 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.515 HG22 ' H ' ' A' ' 83' ' ' ARG . 3.6 mt . . . . . 0 CA--C 1.527 0.073 0 CA-C-O 120.839 0.352 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.9 t -54.73 -32.89 60.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.854 0.359 . . . . 0.0 111.246 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.515 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -61.31 -24.06 66.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.952 179.929 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.3 mt -105.53 152.08 23.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.968 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 92.9 p -94.7 166.19 12.13 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.704 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.679 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -43.16 -53.73 4.84 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.333 0.587 . . . . 0.0 109.831 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.536 ' HB2' HD12 ' A' ' 104' ' ' ILE . 5.5 mtpt -118.9 82.86 1.93 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.191 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.567 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.8 t60 -60.13 -46.35 89.93 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.12 -0.946 . . . . 0.0 112.703 -176.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.524 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 20.1 p90 -147.13 159.46 43.59 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.721 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.693 ' HG2' HG12 ' A' ' 65' ' ' VAL . 5.0 tt0 -135.87 141.48 44.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.438 -179.103 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.557 ' C ' HG13 ' A' ' 65' ' ' VAL . 2.7 mp -115.95 126.36 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.834 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.781 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -104.37 151.97 22.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.064 0.459 . . . . 0.0 111.897 -179.552 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.311 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.539 HD21 ' CG1' ' A' ' 33' ' ' VAL . 3.0 mm? . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.806 0.336 . . . . 0.0 110.829 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.849 HD22 ' HB3' ' A' ' 121' ' ' ASN . 8.5 mt -133.1 142.1 48.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.82 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.482 HD21 HD13 ' A' ' 124' ' ' LEU . 1.3 mt -112.87 121.54 44.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.976 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.781 ' HB2' HD11 ' A' ' 92' ' ' LEU . 50.7 t30 -116.84 115.65 25.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.833 0.349 . . . . 0.0 111.853 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.804 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.2 p30 -77.86 139.99 39.32 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.536 HD12 ' HB2' ' A' ' 87' ' ' LYS . 10.3 pt -148.43 39.18 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 111.543 0.201 . . . . 0.0 111.543 -178.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.66 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.02 151.67 20.08 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 120.96 0.409 . . . . 0.0 111.946 -178.879 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 50.3 m -68.69 -31.71 71.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.807 177.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -98.21 -19.69 17.71 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.66 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.81 155.48 10.09 Favored Glycine 0 N--CA 1.438 -1.187 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.596 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.3 m -117.41 137.81 52.24 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.861 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -115.0 148.51 38.73 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 -178.077 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.465 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.05 113.44 18.39 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.293 177.476 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.415 ' N ' HD12 ' A' ' 111' ' ' LEU . 73.8 m-20 44.61 43.04 6.23 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.83 -9.97 72.07 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.433 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.7 mp0 -105.06 118.57 36.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.086 0.469 . . . . 0.0 110.727 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.861 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 10.1 tptm -73.07 118.24 15.78 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.259 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.804 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.3 m -89.69 165.52 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.209 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.408 ' HB3' ' HB3' ' A' ' 120' ' ' SER . 6.2 tt0 -69.9 126.87 30.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.481 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.693 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 29.2 tttt -53.85 163.53 0.71 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.782 0.325 . . . . 0.0 110.438 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.0 m-80 33.72 36.93 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.825 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.408 ' HB3' ' HB3' ' A' ' 117' ' ' GLU . 4.7 p -111.84 144.6 40.88 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.864 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.849 ' HB3' HD22 ' A' ' 100' ' ' LEU . 1.9 m-80 -91.5 128.17 37.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.687 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.647 ' O ' HD23 ' A' ' 100' ' ' LEU . 56.4 mm-40 -129.17 148.75 51.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.749 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.584 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.7 tm? -72.8 128.43 35.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.287 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.745 HD11 HG21 ' A' ' 145' ' ' ILE . 67.4 tp -57.9 155.74 10.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.437 0.637 . . . . 0.0 111.654 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.421 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -124.7 153.1 42.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.637 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.414 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 7.2 mm-40 -71.86 123.32 22.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.917 0.389 . . . . 0.0 110.25 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.24 22.52 50.48 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.071 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.421 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 32.0 t70 -52.36 169.9 0.07 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.981 0.42 . . . . 0.0 111.239 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.92 ' CG ' HG22 ' A' ' 144' ' ' VAL . 2.0 mt-10 -145.12 135.45 24.11 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.946 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.649 HD11 HD11 ' A' ' 145' ' ' ILE . 15.7 mt -116.25 127.24 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-O 120.808 0.337 . . . . 0.0 110.458 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.654 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.7 m -104.43 141.18 36.8 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.164 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.507 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.8 m -140.26 158.49 25.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.05 44.2 9.18 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.821 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.462 ' HA ' HG12 ' A' ' 140' ' ' ILE . 54.0 t -85.23 140.53 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-O 121.677 0.751 . . . . 0.0 112.616 -178.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.11 -41.45 0.68 Allowed Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.607 HG12 ' H ' ' A' ' 138' ' ' SER . 48.9 t -126.48 121.97 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-N 114.567 -0.816 . . . . 0.0 108.998 177.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.48 ' HA ' HD12 ' A' ' 140' ' ' ILE . 13.5 mt-10 -50.33 -25.96 4.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.749 0.309 . . . . 0.0 111.506 -178.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.607 ' H ' HG12 ' A' ' 136' ' ' VAL . 73.8 m -93.55 6.56 47.84 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.298 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -131.42 29.19 4.6 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.654 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.9 mt -106.98 139.23 29.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.077 178.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.678 HD23 ' N ' ' A' ' 142' ' ' SER . 3.0 tt -124.23 134.55 53.23 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.531 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.678 ' N ' HD23 ' A' ' 141' ' ' LEU . 47.5 t -113.52 150.6 32.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.626 0.727 . . . . 0.0 112.42 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.724 HD13 ' HA ' ' A' ' 38' ' ' CYS . 1.8 mm? -135.7 141.84 44.98 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.349 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.92 HG22 ' CG ' ' A' ' 129' ' ' GLU . 13.2 t -110.87 137.74 42.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.813 0.34 . . . . 0.0 111.282 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.745 HG21 HD11 ' A' ' 124' ' ' LEU . 29.9 mt -106.29 128.09 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.142 -179.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.74 119.83 37.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.554 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.662 HG12 HD21 ' A' ' 124' ' ' LEU . 4.3 mt -84.87 134.04 27.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.527 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -90.44 105.58 17.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.798 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.4 -26.59 63.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.235 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.77 -42.21 83.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.014 0.435 . . . . 0.0 110.639 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 12.1 t80 . . . . . 0 N--CA 1.451 -0.384 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.948 179.944 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.791 0.329 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.402 ' HB2' ' NH1' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -61.32 -43.17 99.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.764 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -57.39 -38.49 74.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.822 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.02 -31.84 69.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.742 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.461 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.1 mt -72.69 -35.56 50.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.768 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -57.44 -39.82 77.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.932 0.396 . . . . 0.0 110.416 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.6 mtpt -67.06 -23.84 65.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.797 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.64 -47.36 79.9 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.213 -179.907 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.901 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 . . . . . 0 CA--C 1.513 -0.476 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.655 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 1.1 mm -89.63 96.54 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 CA-C-N 113.964 -1.471 . . . . 0.0 111.578 -177.607 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.775 HG11 HD22 ' A' ' 93' ' ' LEU . 2.3 t -55.38 -65.65 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.278 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.493 ' SG ' HD12 ' A' ' 48' ' ' LEU . 13.8 p -146.39 165.05 30.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.016 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.88 128.17 41.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.093 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.651 HG13 HD11 ' A' ' 48' ' ' LEU . 15.4 m -93.46 122.75 45.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.9 0.381 . . . . 0.0 111.11 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.786 HG23 HG12 ' A' ' 45' ' ' ILE . 21.1 mt -125.6 117.43 49.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.39 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 6.9 t -79.83 118.25 21.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.822 0.344 . . . . 0.0 110.387 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.681 HG23 HG21 ' A' ' 144' ' ' VAL . 0.7 OUTLIER -82.07 -26.45 33.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.857 -179.22 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.538 HG21 ' H ' ' A' ' 142' ' ' SER . 33.5 p -79.93 -2.2 42.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.59 0.233 . . . . 0.0 111.357 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.49 47.42 90.77 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.855 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.477 ' CB ' HD11 ' A' ' 141' ' ' LEU . 3.5 mm-40 -113.81 -29.87 6.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.785 0.326 . . . . 0.0 110.884 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.598 HD12 HD21 ' A' ' 143' ' ' LEU . 2.8 mt -128.16 141.26 40.73 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.71 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.576 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 42.9 Cg_endo -70.46 134.35 26.31 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.125 1.884 . . . . 0.0 112.23 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.786 HG12 HG23 ' A' ' 37' ' ' ILE . 32.6 mt -55.17 130.02 17.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.608 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.8 163.42 17.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.305 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.24 119.74 36.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.989 0.423 . . . . 0.0 111.451 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.751 HD22 ' CD1' ' A' ' 66' ' ' TRP . 7.1 mt -98.45 136.15 39.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.404 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.765 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -148.71 157.76 43.67 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -179.162 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.537 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -144.1 142.0 30.35 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 113.643 -1.617 . . . . 0.0 110.864 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.202 0 CA-C-O 121.129 0.49 . . . . 0.0 111.039 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.903 0.382 . . . . 0.0 110.806 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 49' ' ' SER . 4.1 ttpt -139.85 131.5 27.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.774 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.641 HG12 ' HG2' ' A' ' 90' ' ' GLN . 15.4 t -125.49 139.03 52.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.309 0.576 . . . . 0.0 112.181 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.751 ' CD1' HD22 ' A' ' 48' ' ' LEU . 15.0 m-90 -101.92 139.32 37.72 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.14 -0.937 . . . . 0.0 112.09 179.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.699 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.49 126.52 55.04 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.08 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.545 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.9 OUTLIER -116.91 145.27 43.71 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.376 -178.447 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.574 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 165.18 -176.84 40.8 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.231 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.2 ttp85 -72.69 -3.03 22.57 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.496 HD22 ' HB3' ' A' ' 73' ' ' ALA . 2.3 t30 -84.8 135.04 40.64 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.738 0.304 . . . . 0.0 111.598 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 14.5 Cg_exo -67.57 -11.82 33.46 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.928 2.419 . . . . 0.0 112.036 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.496 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.38 -44.28 16.32 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-O 121.919 0.866 . . . . 0.0 109.029 179.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.41 ' SG ' ' HA ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -41.62 142.36 0.64 Allowed 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 113.746 -1.57 . . . . 0.0 110.854 179.652 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.0 t0 -56.07 -18.57 10.04 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.204 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.478 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 8.1 t80 -129.14 131.12 47.15 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-O 120.771 0.319 . . . . 0.0 110.746 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.423 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.031 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.839 ' HB ' HD13 ' A' ' 84' ' ' LEU . 3.3 mp . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.786 0.327 . . . . 0.0 111.068 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.8 -25.89 43.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.216 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.534 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -60.91 -20.4 62.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.096 -179.867 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.839 HD13 ' HB ' ' A' ' 81' ' ' ILE . 3.8 mp -104.9 153.01 21.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.817 0.341 . . . . 0.0 110.857 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.3 p -93.67 168.66 10.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.689 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.574 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 6.4 m-20 -41.41 -59.21 1.64 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.367 0.603 . . . . 0.0 109.657 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.609 ' HB2' HD12 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -116.04 84.11 2.06 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 176.956 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.557 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.9 t60 -58.92 -46.51 87.74 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.495 -176.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.515 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 27.1 p90 -144.91 159.8 42.33 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.9 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.699 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.4 tt0 -136.16 140.65 43.78 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.357 -179.164 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.697 HG12 HD12 ' A' ' 101' ' ' LEU . 65.9 mt -116.5 127.16 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 C-N-CA 121.164 -0.214 . . . . 0.0 110.809 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.485 HD23 ' HB2' ' A' ' 102' ' ' ASN . 0.6 OUTLIER -113.12 144.94 41.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.02 0.438 . . . . 0.0 111.691 -179.727 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.775 HD22 HG11 ' A' ' 33' ' ' VAL . 24.9 tp . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.555 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.628 ' O ' HD12 ' A' ' 100' ' ' LEU . 14.9 tp . . . . . 0 N--CA 1.46 0.057 0 CA-C-O 120.891 0.377 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.628 HD12 ' O ' ' A' ' 99' ' ' LEU . 6.1 mp -125.55 144.81 50.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.441 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.697 HD12 HG12 ' A' ' 91' ' ' ILE . 2.3 tp -112.54 122.63 48.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.11 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.485 ' HB2' HD23 ' A' ' 92' ' ' LEU . 52.8 t30 -116.88 115.68 25.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.934 0.397 . . . . 0.0 111.921 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.84 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.0 p30 -76.63 138.7 40.25 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.609 HD12 ' HB2' ' A' ' 87' ' ' LYS . 9.5 pt -146.67 39.22 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 111.497 0.184 . . . . 0.0 111.497 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.675 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -97.99 150.94 20.83 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 121.171 0.51 . . . . 0.0 112.039 -178.681 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 42.9 m -68.79 -31.45 70.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.611 177.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -98.05 -19.78 17.77 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.675 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.22 155.23 10.15 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.251 -0.975 . . . . 0.0 113.559 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.498 HG22 ' CG2' ' A' ' 130' ' ' ILE . 5.8 m -117.35 137.69 52.28 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.862 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -115.75 148.55 39.69 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -177.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.02 113.58 18.6 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.385 177.619 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 43.87 43.85 5.45 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.79 -11.42 66.67 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.398 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -104.36 118.61 37.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.034 0.445 . . . . 0.0 110.62 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.862 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 9.1 tptp -72.28 115.89 12.06 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.293 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.84 HG23 ' OD2' ' A' ' 103' ' ' ASP . 16.5 m -84.45 164.24 2.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.13 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.2 tm-20 -69.83 125.03 25.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.496 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.687 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 55.6 tttt -53.02 162.0 0.71 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.914 0.388 . . . . 0.0 110.646 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 34.78 34.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.423 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.29 145.09 40.61 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.089 179.457 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -88.3 129.86 35.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.795 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 41.4 mm-40 -129.6 147.84 51.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.035 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.9 128.98 37.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.983 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.58 HD23 ' HB3' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -58.07 159.6 5.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.415 0.626 . . . . 0.0 111.897 -178.952 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.428 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -125.0 153.26 43.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.156 179.59 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.23 116.74 11.91 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 62.81 25.58 67.79 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.545 -178.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.428 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 33.6 t0 -50.69 168.77 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.104 0.478 . . . . 0.0 111.457 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 15.5 tt0 -145.21 135.49 24.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.872 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.631 HD11 HD11 ' A' ' 145' ' ' ILE . 3.2 mt -114.75 127.35 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.513 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.61 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.2 m -104.64 138.41 41.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.944 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.541 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.2 m -140.2 158.24 25.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 82.24 39.6 11.11 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.944 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.455 ' HA ' HG12 ' A' ' 140' ' ' ILE . 54.9 t -79.41 140.41 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-O 121.688 0.756 . . . . 0.0 112.557 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 156.46 -41.76 0.56 Allowed Glycine 0 N--CA 1.436 -1.318 0 CA-C-N 114.471 -1.241 . . . . 0.0 110.018 -179.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.487 HG12 ' H ' ' A' ' 138' ' ' SER . 45.7 t -126.39 131.21 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-N 114.869 -0.666 . . . . 0.0 109.262 178.003 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -50.41 -35.4 28.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.669 0.271 . . . . 0.0 111.647 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.487 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -93.57 6.44 48.24 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -178.864 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.41 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 51.4 m-20 -121.85 26.75 8.48 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.61 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.0 mt -107.12 139.5 28.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.332 178.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.477 HD11 ' CB ' ' A' ' 42' ' ' GLN . 7.9 tt -120.69 134.5 55.28 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.292 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.538 ' H ' HG21 ' A' ' 40' ' ' THR . 45.4 t -112.89 150.59 31.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.612 0.72 . . . . 0.0 112.716 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.598 HD21 HD12 ' A' ' 43' ' ' ILE . 70.8 mt -135.57 149.58 49.46 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.538 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.681 HG21 HG23 ' A' ' 39' ' ' THR . 25.7 t -120.44 139.95 46.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.795 0.331 . . . . 0.0 111.28 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.631 HD11 HD11 ' A' ' 130' ' ' ILE . 5.4 mt -106.24 130.75 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.807 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.577 ' CD1' HD12 ' A' ' 37' ' ' ILE . 0.4 OUTLIER -115.75 114.43 24.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.106 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.407 HD11 ' O ' ' A' ' 125' ' ' SER . 6.0 mt -85.03 134.16 27.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.349 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -82.59 133.11 35.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.749 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -73.72 -37.75 65.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.209 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -46.13 91.55 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.907 0.384 . . . . 0.0 110.817 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.423 ' CE2' HG13 ' A' ' 33' ' ' VAL . 36.2 t80 . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.16 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.889 0.375 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.2 p -125.85 -60.51 1.29 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.91 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -68.15 -46.49 70.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.909 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -60.4 -45.05 94.96 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.5 -38.22 74.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.837 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.7 tp -60.7 -31.88 71.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.693 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.41 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.3 mt -72.17 -35.54 53.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.857 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -57.4 -44.45 84.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.918 0.39 . . . . 0.0 110.536 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.6 mtmm -67.07 -23.7 65.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.632 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.41 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.65 -47.56 79.49 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.253 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.2 t -76.56 -40.01 51.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.954 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -94.33 88.56 5.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -88.09 126.33 35.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.832 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -65.06 114.13 4.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.977 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.2 mm -82.26 138.35 19.6 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 CA-C-O 121.667 0.746 . . . . 0.0 111.749 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.29 35.88 1.06 Allowed Glycine 0 C--N 1.314 -0.664 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.412 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -77.48 -38.96 48.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.809 0.338 . . . . 0.0 111.019 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.405 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER -171.98 35.23 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -179.751 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.687 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.3 mm -76.62 133.89 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 CA-C-N 113.863 -1.517 . . . . 0.0 112.489 -177.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.962 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -91.7 -61.21 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-N 114.715 -1.129 . . . . 0.0 109.856 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.401 ' SG ' HD22 ' A' ' 48' ' ' LEU . 5.7 p -145.14 160.0 42.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.278 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.73 138.17 54.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.698 0.285 . . . . 0.0 111.37 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.674 HG21 ' HE2' ' A' ' 68' ' ' PHE . 37.0 t -109.66 122.6 64.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.836 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.843 HG23 HG12 ' A' ' 45' ' ' ILE . 17.7 mt -125.14 120.63 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.405 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.722 ' HA ' HD13 ' A' ' 143' ' ' LEU . 49.4 t -80.96 111.96 17.92 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.802 0.334 . . . . 0.0 110.441 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.21 -22.42 35.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.591 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.469 HG23 ' HB3' ' A' ' 142' ' ' SER . 81.2 p -79.94 -2.21 42.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.654 0.264 . . . . 0.0 111.446 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.99 74.23 0.42 Allowed Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.847 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.513 ' HB2' HD11 ' A' ' 141' ' ' LEU . 11.2 mt-30 -146.01 -42.82 0.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.852 0.358 . . . . 0.0 111.065 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.592 ' CD1' HD21 ' A' ' 141' ' ' LEU . 3.2 mt -116.57 141.88 28.73 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.586 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 43.0 Cg_endo -70.37 142.38 45.08 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.143 1.896 . . . . 0.0 112.186 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.843 HG12 HG23 ' A' ' 37' ' ' ILE . 36.6 mt -57.04 135.35 20.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.717 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -130.98 160.06 35.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.084 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.71 119.87 31.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.92 0.391 . . . . 0.0 111.91 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.787 HD23 ' CD2' ' A' ' 66' ' ' TRP . 8.8 mp -82.57 133.05 35.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.514 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.962 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -139.78 155.64 47.18 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 122.287 1.041 . . . . 0.0 113.793 -179.656 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.48 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -143.23 141.92 31.24 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 113.476 -1.693 . . . . 0.0 110.616 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.812 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.9 OUTLIER -77.34 140.46 39.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.207 0.527 . . . . 0.0 111.249 -179.584 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.541 HD13 ' SG ' ' A' ' 154' ' ' CYS . 37.1 mt -64.37 -45.22 96.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.351 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.7 p -56.84 -41.05 77.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.24 0.543 . . . . 0.0 110.895 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.494 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 16.3 mt-30 -68.42 -36.88 79.73 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.654 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 51' ' ' ASP . 47.2 t -68.66 -43.83 82.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.901 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.04 -39.09 72.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.798 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -70.08 -43.02 71.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.904 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.46 107.37 3.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.925 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.99 31.18 3.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.936 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -103.83 -177.45 3.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.848 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.52 -50.28 65.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.958 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.488 HD12 HD12 ' A' ' 92' ' ' LEU . 25.3 mm -116.94 158.76 17.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.133 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.47 ' N ' HG22 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -122.46 -66.18 1.05 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.785 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.408 ' HE2' ' O ' ' A' ' 49' ' ' SER . 4.9 ttpt -128.27 130.55 48.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.856 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.683 HG12 ' HG2' ' A' ' 90' ' ' GLN . 8.4 t -126.52 139.12 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 121.289 0.566 . . . . 0.0 112.175 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.787 ' CD2' HD23 ' A' ' 48' ' ' LEU . 18.2 m-90 -102.98 139.17 38.89 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.969 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.527 HG22 ' HB3' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -113.17 131.09 56.0 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 177.6 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.863 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -118.2 145.82 44.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.259 -178.683 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.624 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.29 -167.78 35.68 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.413 -0.899 . . . . 0.0 113.173 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -79.42 1.78 24.18 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -84.74 127.79 63.67 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.864 -0.153 . . . . 0.0 110.97 -179.804 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -66.18 -12.19 34.46 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.348 2.032 . . . . 0.0 111.563 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.95 -43.15 16.77 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-O 121.834 0.826 . . . . 0.0 108.926 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -39.77 139.62 0.61 Allowed 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.735 179.478 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -56.25 -18.69 11.2 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.04 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.529 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 13.2 t80 -129.64 121.99 28.14 Favored 'General case' 0 N--CA 1.457 -0.086 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.915 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -95.5 107.95 20.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.838 0.352 . . . . 0.0 110.636 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.788 HD13 HD13 ' A' ' 84' ' ' LEU . 77.4 mt -71.97 -77.34 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.142 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 172.69 -102.68 0.18 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.538 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -156.24 64.95 0.56 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.87 0.367 . . . . 0.0 111.082 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.419 HD11 HD13 ' A' ' 141' ' ' LEU . 33.3 mt -111.97 118.82 58.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.99 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.8 m -58.25 -37.19 74.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.1 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.432 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 1.8 mmt180 -61.8 -17.04 54.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.305 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.788 HD13 HD13 ' A' ' 78' ' ' LEU . 20.6 mt -107.25 147.8 29.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.838 0.351 . . . . 0.0 111.251 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 51.6 p -93.08 164.89 13.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.48 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.624 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.0 m-20 -43.19 -52.74 5.43 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.426 0.632 . . . . 0.0 109.893 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.527 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -121.31 81.12 1.75 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 177.453 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.564 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.3 t60 -61.21 -45.93 92.56 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.161 -0.927 . . . . 0.0 113.008 -176.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.524 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 22.3 p90 -146.73 157.77 43.76 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.171 -0.611 . . . . 0.0 112.104 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.683 ' HG2' HG12 ' A' ' 65' ' ' VAL . 22.7 tt0 -135.6 140.85 44.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.24 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.863 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 16.1 mt -117.0 131.12 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.18 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.685 HD21 ' HB2' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -116.65 146.71 42.54 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.153 0.501 . . . . 0.0 111.932 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.776 HD22 ' CG1' ' A' ' 33' ' ' VAL . 15.3 tp -125.19 127.93 47.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.148 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -170.28 -35.36 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.888 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -47.97 172.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.878 0.371 . . . . 0.0 111.283 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.08 68.74 0.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.19 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.56 -23.58 29.72 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.852 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -81.21 172.05 14.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.896 0.379 . . . . 0.0 110.933 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.752 HD21 HG12 ' A' ' 33' ' ' VAL . 3.1 mp -121.79 160.06 25.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.971 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.794 HD23 ' O ' ' A' ' 122' ' ' GLN . 9.3 mt -128.76 136.47 50.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.512 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.83 122.6 48.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.08 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.685 ' HB2' HD21 ' A' ' 92' ' ' LEU . 63.6 t30 -114.85 121.99 44.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.015 0.436 . . . . 0.0 111.857 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.773 ' OD2' HG23 ' A' ' 116' ' ' VAL . 21.9 p30 -82.0 133.72 35.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.905 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.497 HD13 ' HB2' ' A' ' 90' ' ' GLN . 17.2 pt -139.55 37.82 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.654 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -96.34 156.25 16.42 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 120.927 0.394 . . . . 0.0 111.746 -178.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 87.8 m -68.91 -35.83 77.3 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.318 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.432 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -98.58 -19.74 17.42 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.46 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.654 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 121.04 161.57 11.42 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.192 -1.004 . . . . 0.0 113.914 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.548 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.2 m -117.5 138.04 52.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.905 -0.647 . . . . 0.0 109.299 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.84 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -112.22 148.55 33.86 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -177.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.466 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.06 113.32 18.23 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.484 -1.235 . . . . 0.0 108.192 177.216 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.419 ' N ' HD12 ' A' ' 111' ' ' LEU . 93.0 m-20 44.29 43.5 6.0 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.05 -11.36 67.42 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 120.709 -0.758 . . . . 0.0 113.487 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.77 118.5 36.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.031 0.443 . . . . 0.0 110.679 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.84 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -72.36 128.55 35.97 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.371 -179.698 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.773 HG23 ' OD2' ' A' ' 103' ' ' ASP . 8.4 m -98.54 166.11 2.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.057 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 120' ' ' SER . 16.1 tt0 -69.9 126.71 30.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.483 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.693 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 32.6 tttt -54.27 163.4 0.84 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.9 OUTLIER 35.82 35.45 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.746 -179.231 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.7 p -111.9 145.04 40.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.601 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.566 ' HB3' HD22 ' A' ' 100' ' ' LEU . 38.3 m-80 -95.14 129.54 42.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.846 0.355 . . . . 0.0 110.897 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.794 ' O ' HD23 ' A' ' 100' ' ' LEU . 56.2 mm-40 -129.08 150.01 50.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.533 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.1 tp -72.55 132.27 43.59 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.276 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.957 HD11 HG21 ' A' ' 145' ' ' ILE . 61.4 tp -64.11 156.62 27.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.43 0.633 . . . . 0.0 111.633 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.443 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.57 154.09 41.16 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.926 -179.512 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -70.78 121.67 18.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.863 0.363 . . . . 0.0 110.061 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.13 22.85 50.8 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.033 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.443 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 26.5 t70 -53.62 171.77 0.08 Allowed 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.981 0.42 . . . . 0.0 111.037 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -145.26 135.34 23.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.097 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.457 ' CG2' HG22 ' A' ' 109' ' ' THR . 16.0 mt -115.01 127.9 72.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.412 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.513 HG22 ' CG2' ' A' ' 140' ' ' ILE . 23.5 m -104.31 137.16 42.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.985 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.501 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 26.9 m -140.2 158.34 25.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.02 0.438 . . . . 0.0 112.022 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.55 37.67 10.47 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.618 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 140' ' ' ILE . 50.4 t -79.71 140.47 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 121.705 0.764 . . . . 0.0 112.435 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.52 -36.8 0.63 Allowed Glycine 0 N--CA 1.436 -1.337 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.465 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 50.9 t -126.32 133.0 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-N 114.653 -0.774 . . . . 0.0 109.169 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -50.69 -44.64 57.96 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -93.3 6.51 47.86 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.465 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 4.9 t0 -117.25 29.37 7.93 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.513 ' CG2' HG22 ' A' ' 131' ' ' THR . 3.8 mt -107.41 139.32 29.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.921 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.592 HD21 ' CD1' ' A' ' 43' ' ' ILE . 1.0 OUTLIER -116.46 134.43 54.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.588 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.564 ' C ' HD22 ' A' ' 143' ' ' LEU . 38.0 t -114.9 150.38 35.73 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.567 0.698 . . . . 0.0 112.595 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.722 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.5 mm? -136.01 143.44 44.77 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.876 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.35 135.86 49.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.803 0.335 . . . . 0.0 110.957 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.957 HG21 HD11 ' A' ' 124' ' ' LEU . 2.9 mm -106.24 123.96 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.069 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.07 117.1 31.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.481 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.636 HG12 HD21 ' A' ' 124' ' ' LEU . 2.6 mt -84.97 134.04 27.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.451 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.24 109.9 16.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.759 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -60.7 -35.2 75.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.103 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.93 -44.06 91.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.73 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -59.29 -44.0 92.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.04 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -58.48 -36.3 73.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.11 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.01 -46.38 89.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.068 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.541 ' SG ' HD13 ' A' ' 52' ' ' ILE . 10.8 t -64.94 -45.04 87.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.064 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.747 HD21 HG11 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -65.95 -40.31 91.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.017 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.89 -36.39 81.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.058 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -88.36 -37.08 16.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.976 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.9 p30 42.77 71.74 0.21 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.428 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.43 144.71 40.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.868 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.444 HG22 ' H ' ' A' ' 162' ' ' ARG . 8.1 p -103.07 141.13 19.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.052 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -138.68 32.7 2.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.93 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.444 ' H ' HG22 ' A' ' 160' ' ' VAL . 1.0 OUTLIER -147.24 31.08 0.92 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.856 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -94.07 130.66 42.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.064 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.938 179.988 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.793 0.33 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.3 t -138.93 -47.04 0.48 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.905 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.57 -45.73 92.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.882 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.4 mtm180 -59.11 -48.02 83.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.917 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -59.49 -35.01 73.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.88 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.78 -44.03 97.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.92 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.5 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.9 mm -66.64 -35.17 74.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.189 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -57.21 -39.44 75.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.928 0.394 . . . . 0.0 110.334 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.3 tttp -67.28 -23.71 65.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.6 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.5 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.82 -47.48 80.17 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.146 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.2 m -81.02 -38.98 26.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.902 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 60.4 30.32 19.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.789 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -101.01 141.62 33.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.867 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -93.67 142.23 27.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.85 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.3 mm -81.82 138.36 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 CA-C-O 121.661 0.743 . . . . 0.0 111.63 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.439 ' CA ' HG12 ' A' ' 32' ' ' ILE . . . 166.16 115.86 0.34 Allowed Glycine 0 C--N 1.314 -0.658 0 CA-C-N 114.539 -1.21 . . . . 0.0 112.522 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.7 -31.21 68.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.76 0.315 . . . . 0.0 111.036 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.414 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.8 OUTLIER 178.84 38.56 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.663 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.3 mm -74.86 137.2 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 CA-C-N 113.786 -1.552 . . . . 0.0 112.437 -177.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.96 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.5 t -90.54 -58.54 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.745 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.728 ' SG ' HD22 ' A' ' 99' ' ' LEU . 1.8 m -149.8 162.84 39.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.701 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.401 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -127.1 138.09 53.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.754 0.311 . . . . 0.0 111.114 -179.768 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.669 HG21 ' CE2' ' A' ' 68' ' ' PHE . 47.5 t -108.43 122.65 63.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.95 0.405 . . . . 0.0 110.81 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.599 HG23 HG12 ' A' ' 45' ' ' ILE . 15.8 mt -123.77 121.54 62.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.472 -179.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.609 ' HA ' HD23 ' A' ' 143' ' ' LEU . 12.3 t -80.34 100.01 8.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.389 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.484 HG23 HG21 ' A' ' 144' ' ' VAL . 0.4 OUTLIER -63.86 -27.2 69.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.828 -179.261 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.517 HG21 ' H ' ' A' ' 142' ' ' SER . 54.9 p -79.85 -2.2 42.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.734 0.302 . . . . 0.0 111.504 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.72 75.39 0.31 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.018 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.428 ' HB2' HD11 ' A' ' 141' ' ' LEU . 6.9 mt-30 -144.23 -47.56 0.27 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.856 0.36 . . . . 0.0 110.627 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.71 HD12 ' CB ' ' A' ' 78' ' ' LEU . 2.8 mm -104.24 141.74 23.16 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.749 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.62 ' HD2' HG22 ' A' ' 43' ' ' ILE . 53.7 Cg_endo -71.67 138.22 31.57 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.187 1.925 . . . . 0.0 112.164 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.599 HG12 HG23 ' A' ' 37' ' ' ILE . 35.1 mt -55.61 131.99 19.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.609 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.96 164.55 19.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.404 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.401 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.8 OUTLIER -125.51 119.75 29.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.976 0.417 . . . . 0.0 111.957 -179.556 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.818 HD23 ' CD2' ' A' ' 66' ' ' TRP . 6.9 mp -92.22 129.49 38.15 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.96 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -138.49 156.48 47.5 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 122.252 1.025 . . . . 0.0 113.692 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.473 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -154.54 141.89 19.59 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 113.493 -1.685 . . . . 0.0 110.856 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.549 ' HB2' ' HG3' ' A' ' 54' ' ' GLN . 0.5 OUTLIER -82.39 132.92 35.21 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.062 0.458 . . . . 0.0 111.317 -179.733 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.549 ' N ' HD12 ' A' ' 52' ' ' ILE . 2.4 mp -64.32 -41.04 91.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.908 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.8 t -56.32 -38.14 70.9 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.743 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.549 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 0.3 OUTLIER -68.63 -40.58 80.25 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.355 179.719 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.651 HG22 ' HG2' ' A' ' 63' ' ' LYS . 58.1 t -67.69 -42.08 86.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.146 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.1 tp -71.05 -23.69 62.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.212 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.0 mtmm -92.69 -41.65 10.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.161 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -62.96 113.13 2.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.839 0.352 . . . . 0.0 110.947 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.72 -25.53 60.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.025 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -55.04 158.38 2.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.049 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.9 t -70.17 -38.63 75.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.987 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.581 HD11 HG22 ' A' ' 65' ' ' VAL . 10.0 tp -98.53 151.68 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.114 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.651 ' HG2' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -120.5 -65.83 1.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.448 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.9 ttpt -144.03 133.21 23.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.183 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.595 HG12 ' HG2' ' A' ' 90' ' ' GLN . 6.3 t -128.1 137.67 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 121.259 0.552 . . . . 0.0 112.045 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.818 ' CD2' HD23 ' A' ' 48' ' ' LEU . 18.9 m-90 -101.79 139.65 37.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.242 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.654 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -113.1 132.26 55.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.831 0.348 . . . . 0.0 110.157 177.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.722 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -120.32 145.4 47.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.825 -179.315 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.709 ' N ' HD21 ' A' ' 78' ' ' LEU . . . 160.66 -167.03 35.67 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.166 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.428 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 20.0 mtp180 -86.19 36.05 0.67 Allowed 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.549 HD22 ' HB3' ' A' ' 73' ' ' ALA . 2.2 t30 -118.44 132.53 23.76 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.468 0.175 . . . . 0.0 110.998 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.09 -17.06 58.32 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.522 2.148 . . . . 0.0 111.506 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.549 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.99 -42.52 17.46 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 121.806 0.812 . . . . 0.0 109.088 178.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.26 139.39 1.43 Allowed 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.12 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.2 m-20 -56.23 -18.38 10.2 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.059 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.668 ' CE2' HG21 ' A' ' 43' ' ' ILE . 2.5 t80 -129.12 118.67 22.84 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-O 120.914 0.387 . . . . 0.0 110.951 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -96.78 107.84 20.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.628 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.71 ' CB ' HD12 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -116.21 170.64 8.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.025 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.45 144.25 43.42 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.334 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -71.58 88.97 0.96 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.764 0.316 . . . . 0.0 110.998 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.523 HD12 ' CD1' ' A' ' 84' ' ' LEU . 36.0 mt -106.64 125.69 62.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.008 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.83 -35.86 64.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.004 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.461 ' H ' HG22 ' A' ' 81' ' ' ILE . 5.4 mmp_? -63.37 -29.88 71.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.468 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.568 HD21 HG23 ' A' ' 132' ' ' VAL . 23.8 mt -99.99 150.5 22.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.857 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.7 p -98.37 166.69 11.26 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.64 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 m-20 -43.25 -52.54 5.63 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.397 0.618 . . . . 0.0 109.892 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.606 ' CB ' HD12 ' A' ' 104' ' ' ILE . 4.3 mttt -119.0 82.05 1.8 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 177.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.613 ' CE1' ' CG1' ' A' ' 132' ' ' VAL . 61.4 t-80 -58.69 -45.75 88.79 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.847 -177.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.513 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 31.5 p90 -149.38 162.18 40.6 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.583 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.654 ' HG3' HG23 ' A' ' 67' ' ' THR . 3.3 tt0 -136.32 140.84 43.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.298 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.711 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 78.1 mt -115.22 129.08 72.06 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.192 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.779 179.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.426 ' CA ' HG13 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -113.9 146.9 39.38 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.205 0.526 . . . . 0.0 111.937 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.724 HD22 HG11 ' A' ' 33' ' ' VAL . 23.7 tp -125.1 123.12 39.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.067 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -114.41 -150.36 10.12 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.845 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -57.16 155.48 8.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.907 0.384 . . . . 0.0 111.164 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.475 ' HA ' HD12 ' A' ' 155' ' ' LEU . 3.6 m-20 54.94 176.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.101 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.577 ' O ' HD12 ' A' ' 99' ' ' LEU . . . -66.13 -13.69 60.3 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.782 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -53.42 131.92 38.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.864 0.364 . . . . 0.0 111.062 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.728 HD22 ' SG ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -116.11 160.06 20.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.813 HD13 ' O ' ' A' ' 122' ' ' GLN . 4.1 mm? -129.2 142.83 50.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.635 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.546 HD21 HD13 ' A' ' 124' ' ' LEU . 28.0 mt -112.61 122.32 47.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.912 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.42 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 63.4 t30 -117.11 135.61 53.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.152 0.501 . . . . 0.0 111.825 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.811 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.3 p30 -96.82 143.08 28.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.664 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.606 HD12 ' CB ' ' A' ' 87' ' ' LYS . 7.0 pt -147.62 28.28 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.468 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.569 ' HB2' ' CG ' ' A' ' 88' ' ' HIS . 10.8 t -92.26 157.69 16.53 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 121.433 0.635 . . . . 0.0 112.69 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 95.3 m -69.8 -52.12 27.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.954 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -82.84 -0.09 46.49 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.324 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.65 157.75 29.58 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.708 -0.758 . . . . 0.0 113.542 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.514 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.2 m -117.63 137.89 52.33 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.841 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -113.76 148.44 36.49 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -178.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.82 HD12 HG11 ' A' ' 116' ' ' VAL . 0.8 OUTLIER -124.43 113.51 18.26 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.875 177.253 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 47.41 35.96 4.54 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.111 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.9 -7.23 79.26 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.487 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.51 118.39 36.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.979 0.419 . . . . 0.0 110.557 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.841 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 25.3 tptt -72.32 121.92 20.28 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.175 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.82 HG11 HD12 ' A' ' 111' ' ' LEU . 8.3 m -97.67 163.65 2.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.438 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 120' ' ' SER . 25.6 tt0 -69.98 128.13 35.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.453 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.67 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 66.7 tttt -52.56 161.94 0.63 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.789 0.328 . . . . 0.0 110.353 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 35.15 34.89 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.202 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.25 143.18 43.74 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.975 179.469 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.534 ' HB3' HD12 ' A' ' 100' ' ' LEU . 6.0 m-80 -85.39 132.52 34.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.889 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.813 ' O ' HD13 ' A' ' 100' ' ' LEU . 35.0 mm-40 -129.56 147.68 51.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.665 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.76 HD23 ' O ' ' A' ' 124' ' ' LEU . 7.2 tt -72.72 129.2 37.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.26 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.76 ' O ' HD23 ' A' ' 123' ' ' LEU . 66.9 tp -62.16 155.17 25.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.513 0.673 . . . . 0.0 111.677 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.5 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.3 OUTLIER -124.8 153.5 42.41 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.316 179.768 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.613 ' HA ' HD13 ' A' ' 147' ' ' ILE . 13.4 tp60 -71.15 119.79 15.79 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.55 23.95 63.4 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.657 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.437 ' OD2' HD23 ' A' ' 111' ' ' LEU . 22.2 t70 -49.02 167.15 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.921 0.391 . . . . 0.0 111.329 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 13.7 tt0 -145.1 135.4 24.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.965 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.509 HD11 HD11 ' A' ' 145' ' ' ILE . 11.8 mt -114.88 128.36 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.777 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.644 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.3 m -104.18 141.85 35.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.815 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.613 ' CG1' ' CE1' ' A' ' 88' ' ' HIS . 31.2 m -140.29 158.68 25.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.64 44.41 9.37 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.94 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.47 ' HA ' HG12 ' A' ' 140' ' ' ILE . 59.6 t -85.66 140.5 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-O 121.644 0.735 . . . . 0.0 112.459 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.03 -39.08 1.08 Allowed Glycine 0 N--CA 1.435 -1.404 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.565 HG12 ' H ' ' A' ' 138' ' ' SER . 58.8 t -126.51 118.91 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 CA-C-N 114.41 -0.895 . . . . 0.0 108.866 177.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.443 ' HA ' HD12 ' A' ' 140' ' ' ILE . 7.3 pt-20 -50.29 -26.37 4.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.738 0.304 . . . . 0.0 111.607 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.565 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -93.57 6.59 47.75 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -179.243 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.419 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.6 OUTLIER -131.11 29.19 4.7 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -178.901 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.644 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.7 mt -107.14 139.14 29.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.719 178.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.512 HD23 ' C ' ' A' ' 141' ' ' LEU . 9.4 tt -124.16 134.44 53.32 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.39 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.517 ' H ' HG21 ' A' ' 40' ' ' THR . 37.6 t -108.15 150.19 27.54 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.782 0.801 . . . . 0.0 112.532 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.609 HD23 ' HA ' ' A' ' 38' ' ' CYS . 72.2 mt -135.93 145.0 45.78 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.383 -1.281 . . . . 0.0 110.622 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.484 HG21 HG23 ' A' ' 39' ' ' THR . 21.9 t -117.07 139.49 43.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.837 0.351 . . . . 0.0 111.108 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.61 HG21 HD11 ' A' ' 124' ' ' LEU . 15.3 mt -106.17 123.02 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.952 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.04 119.5 39.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.87 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.613 HD13 ' HA ' ' A' ' 126' ' ' GLN . 4.7 mp -89.68 131.43 36.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.363 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.8 114.26 20.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.914 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -60.32 -29.18 68.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.35 -44.01 88.58 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.993 0.425 . . . . 0.0 110.609 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -58.16 -44.05 87.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.841 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 33.1 mttm -60.97 -37.17 81.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.959 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -62.05 -40.76 96.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.068 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.4 t -68.09 -43.47 78.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.94 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.476 HD21 HG13 ' A' ' 52' ' ' ILE . 4.4 mm? -68.55 -35.94 78.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.828 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -64.3 -42.29 96.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.825 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.423 ' O ' ' N ' ' A' ' 159' ' ' LYS . 0.7 OUTLIER -84.56 -33.05 23.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.712 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 42.89 -90.83 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.697 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 157' ' ' GLN . 55.4 tttp -60.81 115.71 3.88 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.89 0.376 . . . . 0.0 110.888 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.2 p -65.87 140.81 18.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.124 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -124.11 119.5 29.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.921 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 61.66 153.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.822 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 29.0 mm -88.89 115.74 29.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.152 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.9 ttm-85 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.902 -179.988 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.864 0.364 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 66.1 p -129.92 -69.92 0.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.975 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -68.7 -35.9 77.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -60.14 -35.96 76.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.825 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.78 -35.0 77.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.825 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.6 mp -63.93 -44.05 94.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.888 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.3 mm -65.75 -35.16 74.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.206 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -57.16 -41.12 78.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.028 0.442 . . . . 0.0 110.351 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.6 mttm -67.21 -23.81 65.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.591 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.473 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.56 -47.56 79.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.109 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.0 p -81.09 -29.97 34.8 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.836 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.17 -73.22 0.08 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.923 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -101.06 120.95 40.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.839 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -104.85 101.84 11.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.939 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.425 HG21 ' NH2' ' A' ' 35' ' ' ARG . 18.2 mm -90.26 138.45 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 121.63 0.729 . . . . 0.0 111.951 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 123.72 33.9 0.78 Allowed Glycine 0 C--N 1.314 -0.64 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.657 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -70.77 -44.72 66.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.911 0.386 . . . . 0.0 110.72 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.406 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.5 OUTLIER -170.08 36.21 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.743 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 2.3 mm -81.86 94.41 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 CA-C-N 113.908 -1.496 . . . . 0.0 112.923 -177.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.913 HG12 HD11 ' A' ' 99' ' ' LEU . 3.5 t -46.88 -61.22 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.906 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.559 ' SG ' HD12 ' A' ' 48' ' ' LEU . 6.1 p -144.74 165.1 29.02 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.777 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.425 ' NH2' HG21 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -128.73 138.15 51.96 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.904 0.383 . . . . 0.0 111.54 -179.496 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.905 HG13 HD11 ' A' ' 48' ' ' LEU . 5.1 m -101.73 122.85 54.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.741 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.838 HG23 HG12 ' A' ' 45' ' ' ILE . 20.8 mt -129.05 118.67 47.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.733 ' HA ' HD13 ' A' ' 143' ' ' LEU . 39.0 t -79.98 122.53 26.84 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.49 -21.99 17.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.798 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.465 HG23 ' HB3' ' A' ' 142' ' ' SER . 76.5 p -79.84 -2.15 42.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.699 0.285 . . . . 0.0 111.43 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.71 73.85 0.57 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.695 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -145.98 -39.08 0.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.715 0.293 . . . . 0.0 111.142 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.563 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.7 mt -125.11 141.47 38.63 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.007 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.563 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 53.4 Cg_endo -72.19 145.94 45.01 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.191 1.927 . . . . 0.0 112.223 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.838 HG12 HG23 ' A' ' 37' ' ' ILE . 37.0 mt -62.4 138.55 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.787 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.62 163.23 25.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.752 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.7 119.67 36.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.009 0.433 . . . . 0.0 111.858 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.905 HD11 HG13 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -96.72 132.51 42.34 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.177 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.743 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -144.24 156.99 44.53 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -178.573 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.628 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -146.57 141.95 27.49 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.304 -1.771 . . . . 0.0 110.827 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.784 ' O ' HG23 ' A' ' 55' ' ' VAL . 5.3 m-20 -81.45 134.54 35.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.025 0.441 . . . . 0.0 110.977 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.717 HG22 HD23 ' A' ' 56' ' ' LEU . 59.7 mt -64.3 -42.6 95.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.313 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.508 ' HA ' HD21 ' A' ' 56' ' ' LEU . 5.3 p -56.94 -42.02 79.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.267 0.556 . . . . 0.0 110.939 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.489 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 3.4 mt-30 -68.57 -37.73 80.14 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.957 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 51' ' ' ASP . 39.0 t -68.74 -49.95 59.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.098 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.717 HD23 HG22 ' A' ' 52' ' ' ILE . 4.5 pp -66.56 -31.0 71.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.871 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.505 ' N ' HD12 ' A' ' 56' ' ' LEU . 4.9 mtmt -66.83 -47.42 72.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.898 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -80.37 134.59 36.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.04 29.84 0.97 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.007 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.2 ttm-85 -125.28 -55.81 1.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.783 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.31 -178.15 3.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.765 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.426 HG12 ' CG2' ' A' ' 65' ' ' VAL . 10.0 tp -59.77 152.64 4.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.069 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.747 ' HG2' HG13 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -89.42 -74.17 0.49 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.127 -179.72 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.5 ttpt -141.5 135.66 30.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.863 0.363 . . . . 0.0 111.316 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.634 HG13 ' O ' ' A' ' 91' ' ' ILE . 18.6 t -133.92 139.13 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-O 121.194 0.521 . . . . 0.0 111.782 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.61 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 16.5 m-90 -102.07 139.06 38.2 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.253 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.506 HG22 ' HB3' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -111.81 128.38 56.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.813 177.635 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.64 ' CD1' ' HB2' ' A' ' 76' ' ' TYR . 9.0 m-85 -120.45 145.57 47.09 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.714 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.703 ' CA ' HD21 ' A' ' 78' ' ' LEU . . . 159.97 -165.96 34.9 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.845 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.434 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 10.3 mtm105 -83.07 6.56 18.57 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.435 ' ND2' ' HD2' ' A' ' 72' ' ' PRO . 3.2 t-20 -84.71 140.04 37.93 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.556 0.217 . . . . 0.0 110.877 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.435 ' HD2' ' ND2' ' A' ' 71' ' ' ASN . 60.3 Cg_endo -73.57 -14.3 24.8 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.356 2.038 . . . . 0.0 111.302 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.1 -43.1 16.63 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -41.78 137.25 1.75 Allowed 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 113.63 -1.623 . . . . 0.0 110.906 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.4 OUTLIER -56.73 -19.23 15.72 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.191 179.162 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.64 ' HB2' ' CD1' ' A' ' 68' ' ' PHE . 15.6 t80 -130.22 120.2 24.11 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.641 0.258 . . . . 0.0 111.097 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -98.23 118.57 35.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.82 0.343 . . . . 0.0 110.724 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.703 HD21 ' CA ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -124.11 73.3 1.22 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.317 -179.713 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 47.36 -129.24 14.12 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.825 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -163.3 84.73 0.5 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.73 0.3 . . . . 0.0 111.072 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 1.066 HD13 HD12 ' A' ' 84' ' ' LEU . 4.1 mp -97.39 141.05 16.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.03 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.1 t -63.71 -36.81 85.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.03 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.547 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -69.52 -21.03 63.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.316 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.066 HD12 HD13 ' A' ' 81' ' ' ILE . 21.2 mt -105.9 148.9 27.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.721 0.296 . . . . 0.0 111.077 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.6 p -95.55 165.62 12.25 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.689 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.592 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.9 m-20 -43.91 -53.68 5.93 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.315 0.579 . . . . 0.0 109.897 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.534 ' HB2' HD12 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -118.54 80.34 1.52 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.362 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.662 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 63.5 t-80 -60.79 -45.94 92.45 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.866 -176.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.455 ' CD1' ' HB2' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -145.05 153.34 41.35 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.047 -0.661 . . . . 0.0 112.171 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.607 ' HG2' HG12 ' A' ' 65' ' ' VAL . 33.8 tt0 -135.5 139.89 44.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.418 -178.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.691 HD11 HD11 ' A' ' 145' ' ' ILE . 24.9 mt -113.97 132.09 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.024 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.4 ' CA ' HG13 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -118.28 144.0 46.15 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.961 0.41 . . . . 0.0 111.603 -179.804 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.646 HD22 HG11 ' A' ' 33' ' ' VAL . 13.8 tp -125.26 125.66 43.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.49 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -165.07 -162.56 16.41 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.505 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 59.42 -171.08 0.13 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.806 0.336 . . . . 0.0 110.902 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -78.81 61.94 3.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.789 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.453 ' HA2' HD11 ' A' ' 155' ' ' LEU . . . 96.84 -164.97 22.98 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.463 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.2 m120 61.66 152.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.762 0.315 . . . . 0.0 111.015 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.913 HD11 HG12 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -112.8 160.02 18.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.723 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.713 HD12 ' O ' ' A' ' 99' ' ' LEU . 5.9 mp -131.07 144.49 51.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.321 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.704 HD11 HD11 ' A' ' 130' ' ' ILE . 0.3 OUTLIER -112.7 123.54 50.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.199 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -114.04 115.9 28.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.018 0.437 . . . . 0.0 111.684 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.875 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.8 p30 -81.01 118.81 22.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.224 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.534 HD12 ' HB2' ' A' ' 87' ' ' LYS . 9.9 pt -124.41 33.83 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.321 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.579 ' HG ' ' CE1' ' A' ' 88' ' ' HIS . 13.7 t -89.57 159.01 17.4 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-O 121.347 0.594 . . . . 0.0 112.444 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 49.5 m -69.59 -52.28 27.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.67 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -92.67 -19.82 21.46 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 136.06 153.33 6.57 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.618 -0.801 . . . . 0.0 114.02 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.459 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.2 m -117.29 137.89 52.11 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.826 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -113.65 148.62 35.96 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -178.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.571 HD13 ' OD2' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -123.95 113.31 18.29 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.204 177.253 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.411 ' N ' HD12 ' A' ' 111' ' ' LEU . 82.6 m-20 45.08 43.05 7.19 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.28 -6.38 81.95 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.751 -0.737 . . . . 0.0 113.451 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -105.46 118.35 36.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.019 0.438 . . . . 0.0 110.76 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.826 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 7.9 tptt -73.42 115.75 13.16 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.267 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.875 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.4 m -92.36 159.56 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.356 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.1 tt0 -69.88 128.78 37.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.437 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.666 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 9.7 tttp -50.5 161.41 0.32 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.887 0.375 . . . . 0.0 110.472 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.459 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.9 p-10 34.23 35.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.186 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.9 OUTLIER -112.04 122.48 47.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.083 179.665 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.682 ' HB3' HD23 ' A' ' 100' ' ' LEU . 6.7 m-80 -68.59 126.03 28.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.032 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -129.38 147.37 51.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.598 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.1 tp -72.9 122.18 21.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.087 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.576 ' CD1' HD12 ' A' ' 101' ' ' LEU . 1.3 mm? -59.23 166.1 2.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.72 0.771 . . . . 0.0 111.888 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.574 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.4 OUTLIER -125.43 153.27 43.72 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.387 179.393 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.655 ' HA ' HD13 ' A' ' 147' ' ' ILE . 15.7 mm100 -71.35 116.25 11.46 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 62.99 27.89 71.15 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.776 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.571 ' OD2' HD13 ' A' ' 111' ' ' LEU . 20.6 t0 -59.31 174.81 0.37 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.018 0.437 . . . . 0.0 111.143 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.934 ' CG ' HG22 ' A' ' 144' ' ' VAL . 2.4 mt-10 -145.21 135.48 24.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.877 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.704 HD11 HD11 ' A' ' 101' ' ' LEU . 5.0 mt -111.33 128.48 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.269 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.664 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.8 m -103.93 141.45 36.13 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.662 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 33.3 m -140.43 158.61 25.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 77.0 44.35 14.3 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.11 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.454 ' HA ' HG12 ' A' ' 140' ' ' ILE . 76.1 t -83.8 140.4 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-O 121.691 0.758 . . . . 0.0 112.411 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.95 -38.92 1.23 Allowed Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.56 HG12 ' H ' ' A' ' 138' ' ' SER . 48.3 t -126.39 119.96 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-N 114.438 -0.881 . . . . 0.0 108.97 177.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.404 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.1 OUTLIER -50.23 -27.64 6.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.743 0.306 . . . . 0.0 111.273 -178.835 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.56 ' H ' HG12 ' A' ' 136' ' ' VAL . 15.2 m -93.56 6.59 47.75 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -127.34 25.81 6.09 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.664 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.9 mt -107.14 138.46 32.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.184 178.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.537 ' O ' HG22 ' A' ' 132' ' ' VAL . 2.6 tt -124.73 134.41 52.84 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.214 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.531 ' N ' HD23 ' A' ' 141' ' ' LEU . 36.7 t -112.72 150.16 31.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.66 0.743 . . . . 0.0 112.666 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.733 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.3 mm? -136.05 142.59 44.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.412 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.934 HG22 ' CG ' ' A' ' 129' ' ' GLU . 17.5 t -110.95 140.13 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.932 0.396 . . . . 0.0 111.334 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.691 HD11 HD11 ' A' ' 91' ' ' ILE . 2.7 mm -106.36 121.05 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.697 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.74 108.74 19.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.959 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.655 HD13 ' HA ' ' A' ' 126' ' ' GLN . 4.3 mp -84.84 129.01 38.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.19 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 32' ' ' ILE . 1.4 t-20 -75.8 128.53 35.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.079 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.08 -29.1 61.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.098 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -43.51 86.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.025 0.44 . . . . 0.0 110.534 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -58.9 -43.21 90.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.762 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.9 mtpt -63.87 -33.87 76.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.037 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -58.77 -47.08 85.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.932 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.9 t -68.0 -44.26 76.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.839 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.453 HD11 ' HA2' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -60.76 -36.25 78.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.805 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -60.15 -43.61 95.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.801 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.79 -37.07 30.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 42.33 88.73 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.506 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -124.97 126.64 45.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.849 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.7 m -81.77 129.71 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.133 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -100.47 78.13 1.99 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.872 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 29.7 mtt85 -134.6 113.62 11.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.959 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.8 mp -92.45 133.07 35.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.106 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.927 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.684 0.278 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.545 ' HB ' ' CB ' ' A' ' 18' ' ' PHE . 0.2 OUTLIER 44.23 78.39 0.06 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.144 179.659 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.79 -47.39 85.89 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.137 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.7 mtm-85 -59.33 -35.89 74.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.229 0.538 . . . . 0.0 109.937 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.545 ' CB ' ' HB ' ' A' ' 15' ' ' THR . 3.0 t80 -60.88 -34.93 75.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.924 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.6 tp -59.14 -41.26 87.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.788 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.554 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 11.5 mm -70.38 -34.96 60.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.051 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -57.01 -33.7 67.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.832 0.348 . . . . 0.0 110.494 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.427 ' HE2' ' CD2' ' A' ' 18' ' ' PHE . 2.5 mptp? -66.65 -23.68 66.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.787 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.554 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.67 -47.55 79.57 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.969 0.414 . . . . 0.0 111.171 -179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.17 -40.74 64.57 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.816 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -63.68 -65.87 0.62 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.826 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -84.98 138.25 32.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.852 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -88.37 116.24 26.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.926 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.6 mm -82.09 138.32 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 CA-C-O 121.621 0.724 . . . . 0.0 111.802 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -159.18 83.87 0.13 Allowed Glycine 0 C--N 1.314 -0.684 0 CA-C-N 114.541 -1.209 . . . . 0.0 112.435 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -60.18 -41.99 94.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.813 0.34 . . . . 0.0 110.966 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.434 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.3 t-20 175.71 39.82 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.708 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -71.85 135.79 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-N 113.667 -1.606 . . . . 0.0 112.408 -177.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.009 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.6 t -91.71 -59.29 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.145 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.6 m -145.32 160.35 41.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.796 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.483 ' NH2' HD13 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -120.77 138.18 54.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.902 0.382 . . . . 0.0 111.216 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.672 HG21 ' CE2' ' A' ' 68' ' ' PHE . 22.0 t -98.52 122.66 50.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.065 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.78 HD12 ' CD1' ' A' ' 146' ' ' PHE . 16.3 mt -129.89 120.57 50.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.123 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.672 ' HA ' HD13 ' A' ' 143' ' ' LEU . 39.7 t -86.29 109.36 18.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.514 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.1 -27.12 48.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.587 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.59 HG21 ' H ' ' A' ' 142' ' ' SER . 8.7 p -79.86 -3.01 46.1 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.692 0.282 . . . . 0.0 111.455 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.25 78.92 0.2 Allowed Glycine 0 CA--C 1.52 0.376 0 C-N-CA 121.079 -0.582 . . . . 0.0 113.798 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -147.71 -45.25 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.902 0.382 . . . . 0.0 110.959 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.551 HD13 ' HB3' ' A' ' 78' ' ' LEU . 8.8 mt -116.38 141.3 27.71 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.228 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.546 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.0 Cg_endo -74.54 146.11 34.25 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.318 2.012 . . . . 0.0 112.094 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.483 HD13 ' NH2' ' A' ' 35' ' ' ARG . 17.2 mt -52.23 153.27 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.252 0.548 . . . . 0.0 111.788 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -142.58 161.69 37.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.93 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -119.62 119.71 34.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.158 0.504 . . . . 0.0 111.817 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.523 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 5.3 mt -101.08 137.06 39.95 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.009 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -144.35 158.45 43.74 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -178.767 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.504 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.4 143.64 30.2 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 113.631 -1.622 . . . . 0.0 110.862 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.805 ' O ' HG23 ' A' ' 55' ' ' VAL . 1.2 m-20 -74.9 120.65 20.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.075 0.464 . . . . 0.0 111.279 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.1 mt -64.62 -43.77 96.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.16 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -57.15 -40.31 76.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.285 0.564 . . . . 0.0 110.739 -179.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.463 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 4.8 mm100 -68.66 -36.84 79.1 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.629 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.89 HG22 ' HG2' ' A' ' 63' ' ' LYS . 45.2 t -66.52 -48.38 80.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.887 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -70.94 -30.51 66.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.93 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.5 -42.53 71.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.013 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -97.31 136.95 37.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.896 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.41 65.56 1.52 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.699 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 -107.32 -68.14 0.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.856 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.69 -59.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.829 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.847 HD11 ' CG2' ' A' ' 65' ' ' VAL . 7.5 tp -104.3 143.0 16.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.036 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.89 ' HG2' HG22 ' A' ' 55' ' ' VAL . 2.3 tppm? -116.57 -66.84 1.04 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.002 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.423 ' CE ' ' O ' ' A' ' 49' ' ' SER . 6.8 ttpt -144.92 132.59 21.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.234 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.847 ' CG2' HD11 ' A' ' 62' ' ' ILE . 15.4 t -128.43 139.42 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 121.373 0.606 . . . . 0.0 112.093 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.547 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 14.8 m-90 -100.57 139.98 35.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.142 -0.936 . . . . 0.0 112.255 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.673 HG23 ' CD ' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -108.9 127.23 53.87 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.17 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.672 ' CE2' HG21 ' A' ' 36' ' ' VAL . 3.4 m-85 -113.27 145.74 40.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.935 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.699 ' CA ' HD21 ' A' ' 78' ' ' LEU . . . 161.6 -173.96 38.06 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.115 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 27.4 mtm180 -79.12 0.75 26.83 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.733 0.271 . . . . 0.0 111.733 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.475 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -84.78 131.95 47.77 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.516 0.198 . . . . 0.0 110.774 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 14.8 Cg_exo -67.84 -8.31 22.14 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.492 2.128 . . . . 0.0 111.792 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.18 -43.55 16.02 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 121.922 0.867 . . . . 0.0 108.896 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -41.37 138.35 1.27 Allowed 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 113.697 -1.592 . . . . 0.0 110.71 179.538 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -56.46 -18.54 11.69 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.134 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.548 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 55.2 t80 -129.15 123.39 31.99 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-O 120.791 0.329 . . . . 0.0 110.756 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -100.98 123.18 44.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.908 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.699 HD21 ' CA ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -109.0 -72.17 0.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.843 179.9 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -170.47 -118.83 0.48 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.531 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -163.81 67.2 0.17 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.922 0.392 . . . . 0.0 110.914 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.622 HD12 ' CD1' ' A' ' 84' ' ' LEU . 30.7 mt -93.96 136.34 25.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.171 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.97 -41.28 96.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.891 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.4 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -62.41 -28.6 69.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.062 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.622 ' CD1' HD12 ' A' ' 81' ' ' ILE . 32.5 mt -96.57 152.1 18.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.055 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 93.0 p -97.55 164.21 12.53 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.529 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.682 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.7 m-20 -41.96 -53.04 3.97 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.326 0.584 . . . . 0.0 109.782 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.465 ' HB3' HD11 ' A' ' 104' ' ' ILE . 25.3 mttt -119.39 85.62 2.41 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 177.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.573 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.2 t60 -65.05 -44.21 89.77 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -176.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.506 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 37.7 p90 -153.26 163.27 40.21 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 119.984 -0.686 . . . . 0.0 112.461 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.673 ' CD ' HG23 ' A' ' 67' ' ' THR . 12.4 mt-30 -135.68 156.81 48.26 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.51 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.496 ' O ' HG13 ' A' ' 65' ' ' VAL . 18.3 mt -127.8 132.35 68.96 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.205 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.649 ' CB ' HG22 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -120.64 148.35 44.03 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.12 0.486 . . . . 0.0 111.791 -179.268 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.804 HD22 ' CG1' ' A' ' 33' ' ' VAL . 48.2 tp -125.06 123.19 39.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.361 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.71 -175.08 30.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.754 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.27 81.06 1.38 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.788 0.328 . . . . 0.0 110.975 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -155.45 -45.16 0.08 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.986 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 137.51 44.25 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.481 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -170.54 162.57 8.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.796 0.331 . . . . 0.0 110.832 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.606 ' HB3' HD13 ' A' ' 124' ' ' LEU . 3.9 mm? -107.27 156.88 18.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.922 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.572 HD12 ' O ' ' A' ' 99' ' ' LEU . 2.9 mp -131.4 143.69 50.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.395 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.494 HD22 HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -114.9 126.06 54.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.479 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.473 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.3 t30 -115.57 115.75 26.97 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.751 -0.379 . . . . 0.0 111.57 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.795 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.3 p30 -79.57 143.19 35.01 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.283 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.503 HG21 ' OE1' ' A' ' 90' ' ' GLN . 11.0 pt -150.3 35.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.624 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -95.1 151.23 19.38 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 120.942 0.401 . . . . 0.0 111.814 -178.876 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 50.6 m -68.8 -31.57 70.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.014 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -98.08 -19.72 17.79 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.624 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.39 154.92 9.63 Favored Glycine 0 N--CA 1.439 -1.164 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.609 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.508 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.5 m -117.53 137.69 52.4 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.857 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -116.39 148.35 40.74 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -178.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.459 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.23 113.43 18.28 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.437 177.482 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.404 ' N ' HD12 ' A' ' 111' ' ' LEU . 3.6 m120 44.89 43.37 7.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.227 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.17 -7.32 78.66 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.838 -0.696 . . . . 0.0 113.47 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -105.61 118.58 36.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.043 0.449 . . . . 0.0 110.724 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.857 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 15.0 tptt -74.02 121.55 21.23 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.239 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.795 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.6 m -95.6 164.03 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.124 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 120' ' ' SER . 28.3 tp10 -69.88 128.98 38.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.474 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.693 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 80.3 tttt -54.61 161.92 1.33 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.989 0.423 . . . . 0.0 110.599 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.455 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.0 m-80 34.67 33.97 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.437 -0.802 . . . . 0.0 112.105 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.4 145.18 40.58 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.025 179.441 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.535 ' HB3' HD23 ' A' ' 100' ' ' LEU . 34.2 m-80 -88.78 131.35 35.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.949 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.451 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 39.9 mm-40 -129.27 150.36 50.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.379 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.3 tp -72.62 111.86 8.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.823 0.344 . . . . 0.0 110.309 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.639 ' CD2' HD11 ' A' ' 147' ' ' ILE . 7.7 tt -55.01 156.78 3.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.287 0.565 . . . . 0.0 111.541 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.29 153.47 41.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.812 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.434 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.5 122.2 20.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.025 0.441 . . . . 0.0 110.531 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.14 18.71 60.73 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.42 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -57.22 173.36 0.24 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.879 0.371 . . . . 0.0 110.973 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 13.0 tt0 -145.04 135.64 24.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.118 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.481 ' CG2' HG22 ' A' ' 109' ' ' THR . 2.6 mt -108.89 128.3 64.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.45 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.482 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 25.4 m -104.24 141.16 36.76 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.102 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.547 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 27.2 m -140.25 158.43 25.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -178.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.55 42.93 8.77 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.241 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.466 ' HA ' HG12 ' A' ' 140' ' ' ILE . 71.7 t -84.59 140.38 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-O 121.617 0.722 . . . . 0.0 112.286 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.86 -40.66 1.12 Allowed Glycine 0 N--CA 1.436 -1.345 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.596 HG12 ' H ' ' A' ' 138' ' ' SER . 48.4 t -126.37 120.83 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 CA-C-N 114.462 -0.869 . . . . 0.0 109.049 177.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.491 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.5 OUTLIER -50.5 -24.98 3.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.664 0.269 . . . . 0.0 111.473 -178.785 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.596 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -93.5 6.51 47.96 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -179.363 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -129.7 26.12 5.31 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.491 HD12 ' HA ' ' A' ' 137' ' ' GLU . 5.9 mt -106.87 139.07 29.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.094 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.428 HD12 ' H ' ' A' ' 142' ' ' SER . 24.9 tp -124.74 134.51 52.79 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.803 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.59 ' H ' HG21 ' A' ' 40' ' ' THR . 0.9 OUTLIER -109.6 133.54 52.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.958 0.409 . . . . 0.0 111.548 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.672 HD13 ' HA ' ' A' ' 38' ' ' CYS . 1.4 mm? -128.29 134.5 48.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.688 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 21.6 t -110.98 135.55 49.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.816 0.341 . . . . 0.0 111.262 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.3 mm -106.31 134.79 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.78 ' CD1' HD12 ' A' ' 37' ' ' ILE . 14.9 m-85 -115.41 119.79 37.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.767 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.639 HD11 ' CD2' ' A' ' 124' ' ' LEU . 5.8 mt -84.82 134.01 27.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.499 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -75.89 116.4 16.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.663 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -58.22 -32.11 67.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.009 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.0 -46.09 90.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.59 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.494 ' CZ ' HD21 ' A' ' 93' ' ' LEU . 11.5 t80 -59.14 -44.19 92.06 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.027 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.6 mtpm? -65.15 -39.72 93.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.986 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -58.81 -44.84 90.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.062 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.6 t -65.48 -44.15 88.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.983 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.94 -36.47 84.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.965 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.37 -34.07 77.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.949 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -89.61 -36.28 15.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.4 p30 42.61 91.69 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.432 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -75.19 118.85 18.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.88 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 10.4 m -81.54 125.98 39.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.175 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -66.73 -35.46 80.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.911 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.94 132.0 51.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.822 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.6 pt -96.3 115.59 36.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.055 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.897 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.785 0.326 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 70.26 -63.72 0.39 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.003 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -59.9 -34.24 72.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.03 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -68.27 -39.17 82.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.857 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -56.99 -41.48 78.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.73 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.6 tp -58.45 -33.76 70.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.571 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.539 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.5 mt -73.16 -35.87 48.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.783 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -33.75 68.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.956 0.408 . . . . 0.0 110.904 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.1 mmpt? -58.73 -26.37 63.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.409 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.539 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.8 -48.48 77.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.268 0.556 . . . . 0.0 111.064 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.1 m -81.15 -21.76 39.51 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.062 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 70.31 98.46 0.06 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.794 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -62.98 130.61 45.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.903 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -84.35 112.13 20.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.93 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.5 mm -81.94 138.45 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 CA-C-O 121.593 0.711 . . . . 0.0 111.692 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -146.13 47.71 0.71 Allowed Glycine 0 C--N 1.314 -0.646 0 CA-C-N 114.594 -1.184 . . . . 0.0 112.656 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -59.11 -42.86 91.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.923 0.392 . . . . 0.0 110.548 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.452 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.9 m-20 -177.29 36.29 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.653 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.5 mm -76.66 136.74 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-N 113.774 -1.557 . . . . 0.0 112.535 -177.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.966 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.1 t -91.05 -59.41 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.682 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 4.8 p -150.41 165.47 33.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.32 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.412 ' CD ' ' CG2' ' A' ' 45' ' ' ILE . 0.2 OUTLIER -128.01 138.15 52.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.804 0.335 . . . . 0.0 111.188 -179.411 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.736 HG11 ' CE2' ' A' ' 68' ' ' PHE . 3.1 m -106.48 122.76 60.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.852 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.675 HG23 HG12 ' A' ' 45' ' ' ILE . 17.3 mt -125.02 122.58 63.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.617 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.764 ' HA ' HD23 ' A' ' 143' ' ' LEU . 50.7 t -79.93 107.34 12.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.809 0.338 . . . . 0.0 110.402 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.3 t -70.97 -28.47 64.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.978 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.518 HG21 ' H ' ' A' ' 142' ' ' SER . 69.8 p -79.87 -2.17 42.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.693 0.283 . . . . 0.0 111.527 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.1 80.56 0.11 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.947 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.543 ' HB2' HD12 ' A' ' 43' ' ' ILE . 9.8 mt-30 -146.86 -41.69 0.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.912 0.386 . . . . 0.0 110.932 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.72 HG12 HD22 ' A' ' 78' ' ' LEU . 5.3 mp -119.41 143.48 34.56 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.218 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.692 ' HD2' HG23 ' A' ' 43' ' ' ILE . 43.9 Cg_endo -70.27 146.11 56.07 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.325 2.017 . . . . 0.0 111.963 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.675 HG12 HG23 ' A' ' 37' ' ' ILE . 32.2 mt -62.81 131.64 28.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.924 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.459 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -117.25 146.36 43.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.91 179.144 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.67 119.66 39.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.986 0.422 . . . . 0.0 111.629 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.829 HD23 ' CD2' ' A' ' 66' ' ' TRP . 6.9 mp -92.05 125.5 36.76 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.966 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -135.82 156.98 47.96 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 122.285 1.04 . . . . 0.0 113.531 -179.427 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.478 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -150.23 141.88 23.59 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 113.613 -1.631 . . . . 0.0 110.721 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.833 ' O ' HG23 ' A' ' 55' ' ' VAL . 3.7 m-20 -75.43 124.15 26.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.029 0.442 . . . . 0.0 111.346 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.4 mt -64.47 -41.89 93.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.428 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.8 m -59.34 -42.16 90.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.296 0.57 . . . . 0.0 111.03 -178.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.48 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 6.9 mt-30 -68.6 -36.78 79.16 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.795 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 51' ' ' ASP . 44.6 t -68.84 -38.37 78.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.844 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.52 -30.51 67.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.862 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.92 -42.62 16.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -63.09 128.92 38.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.831 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.23 30.91 6.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.8 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.6 mtm105 -90.76 -178.13 5.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.963 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.6 t -78.69 -32.76 47.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.086 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.498 HD11 ' HB2' ' A' ' 92' ' ' LEU . 5.9 tp -134.44 160.65 41.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.129 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.753 ' HG3' HG13 ' A' ' 55' ' ' VAL . 1.3 mmtt -109.0 -70.51 0.8 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.465 ' CE ' ' O ' ' A' ' 49' ' ' SER . 30.8 ttpt -144.34 123.05 12.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.853 0.358 . . . . 0.0 111.918 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.698 HG22 ' HG2' ' A' ' 90' ' ' GLN . 13.1 p -110.4 139.76 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.829 ' CD2' HD23 ' A' ' 48' ' ' LEU . 20.6 m-90 -100.81 139.85 35.91 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.033 -1.44 . . . . 0.0 112.227 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.683 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -111.91 133.1 54.32 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 177.859 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.736 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -120.01 145.5 46.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.556 -178.937 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.621 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.81 -169.41 36.47 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.489 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.835 ' NH2' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -85.29 7.48 22.06 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.733 0.267 . . . . 0.0 111.521 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.438 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 6.4 t-20 -84.9 134.17 42.01 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-O 120.532 0.206 . . . . 0.0 110.783 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -65.84 -13.75 41.34 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.547 2.165 . . . . 0.0 111.843 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.438 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -83.2 -44.76 14.66 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 121.936 0.874 . . . . 0.0 109.186 178.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.75 137.63 2.19 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.728 -1.578 . . . . 0.0 111.485 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 67' ' ' THR . 21.9 m-20 -56.82 -18.88 14.53 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.231 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.732 ' CD2' HD21 ' A' ' 78' ' ' LEU . 7.8 t80 -129.8 103.28 6.73 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.817 0.342 . . . . 0.0 110.88 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.583 ' C ' HD23 ' A' ' 78' ' ' LEU . 1.4 t60 -85.89 121.79 29.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.98 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.835 HD12 ' NH2' ' A' ' 70' ' ' ARG . 2.4 mt -103.87 -67.55 0.89 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -173.91 -98.47 0.11 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.607 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.403 ' HA ' ' CB ' ' A' ' 70' ' ' ARG . 0.7 OUTLIER -177.91 46.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.007 0.432 . . . . 0.0 110.8 -179.888 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.59 ' HB ' HD13 ' A' ' 84' ' ' LEU . 42.2 mm -76.51 134.85 28.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.021 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.5 p -65.24 -40.52 94.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.45 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.466 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -60.66 -24.87 65.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.902 0.382 . . . . 0.0 110.646 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.624 ' N ' HD12 ' A' ' 84' ' ' LEU . 3.7 mp -107.5 152.69 23.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.507 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.458 ' O ' ' NH1' ' A' ' 70' ' ' ARG . 59.7 p -98.87 153.86 18.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.89 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.621 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.6 m-20 -30.33 -53.49 0.17 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.361 0.6 . . . . 0.0 110.549 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.674 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.5 OUTLIER -120.16 84.18 2.17 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 177.321 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.565 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.3 t60 -61.55 -46.3 90.5 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.034 -0.985 . . . . 0.0 112.593 -177.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.544 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 22.0 p90 -142.36 160.73 39.69 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.058 -0.657 . . . . 0.0 112.109 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.698 ' HG2' HG22 ' A' ' 65' ' ' VAL . 3.3 tt0 -135.98 143.39 44.8 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.034 -179.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.675 ' C ' HG23 ' A' ' 65' ' ' VAL . 61.6 mt -122.39 132.14 71.73 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.196 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.688 HD21 ' OD1' ' A' ' 121' ' ' ASN . 0.4 OUTLIER -125.66 141.65 51.91 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.014 0.435 . . . . 0.0 111.842 -179.794 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.711 HD22 ' CG1' ' A' ' 33' ' ' VAL . 0.6 OUTLIER -125.36 132.66 52.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.315 179.034 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.458 ' CA ' ' HG2' ' A' ' 63' ' ' LYS . . . 168.51 -137.76 4.75 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.662 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 65.42 -77.57 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.843 0.354 . . . . 0.0 110.969 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -133.48 -46.36 0.82 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.928 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -178.39 -37.19 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.549 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -58.37 170.5 0.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.762 0.315 . . . . 0.0 110.94 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.532 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -108.23 154.34 21.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.84 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.532 HD12 ' O ' ' A' ' 99' ' ' LEU . 2.5 mp -131.21 142.19 50.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.496 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.9 pp -113.42 124.7 53.04 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.187 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.619 ' HB2' HD21 ' A' ' 92' ' ' LEU . 54.8 t30 -116.03 120.29 38.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.056 0.455 . . . . 0.0 111.923 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.76 ' OD2' HG23 ' A' ' 116' ' ' VAL . 20.4 p30 -80.62 137.57 36.37 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.748 178.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.517 HD12 ' HB2' ' A' ' 87' ' ' LYS . 8.3 pt -144.58 39.33 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.565 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -97.12 162.28 13.44 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.073 0.463 . . . . 0.0 111.602 -179.278 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 89.1 m -69.11 -40.92 78.06 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.734 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -98.7 -19.94 17.22 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.096 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.565 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 126.58 160.69 10.66 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 119.948 -1.12 . . . . 0.0 114.205 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.538 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 13.9 m -117.63 138.02 52.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.853 -0.674 . . . . 0.0 109.253 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.876 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -111.97 148.36 33.94 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.405 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.21 113.52 18.41 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.491 -1.231 . . . . 0.0 108.197 177.399 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 44.5 42.79 5.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.47 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.71 -10.1 71.32 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.768 -0.729 . . . . 0.0 113.548 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -104.34 118.5 36.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.079 0.466 . . . . 0.0 110.696 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.876 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.0 tptm -73.82 126.88 31.39 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.194 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.76 HG23 ' OD2' ' A' ' 103' ' ' ASP . 8.7 m -99.51 166.51 2.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.384 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 120' ' ' SER . 3.0 tp10 -69.93 126.21 29.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.607 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.704 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 74.1 tttt -54.58 162.57 1.12 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.04 0.448 . . . . 0.0 110.534 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.0 OUTLIER 37.33 31.44 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.454 -0.793 . . . . 0.0 112.069 -179.218 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.479 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.65 143.94 43.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.847 179.095 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.688 ' OD1' HD21 ' A' ' 92' ' ' LEU . 23.4 m-80 -94.01 135.52 35.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.921 0.391 . . . . 0.0 111.018 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 59.0 mm-40 -129.38 152.32 49.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.393 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.458 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.6 tm? -72.4 118.36 15.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.959 0.409 . . . . 0.0 110.336 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.57 HD21 ' CG1' ' A' ' 147' ' ' ILE . 7.4 tt -52.12 155.59 1.87 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.437 0.637 . . . . 0.0 111.788 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.408 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.7 OUTLIER -124.52 153.23 42.4 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.349 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.605 ' HA ' HD13 ' A' ' 147' ' ' ILE . 27.3 mm100 -71.62 124.55 24.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.88 0.372 . . . . 0.0 110.478 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 56.94 22.08 40.34 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.257 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.408 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 19.9 t70 -54.86 173.14 0.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.946 0.403 . . . . 0.0 110.811 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.9 ' CG ' HG22 ' A' ' 144' ' ' VAL . 1.9 mt-10 -144.29 135.74 25.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.145 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.791 HD11 HD11 ' A' ' 145' ' ' ILE . 12.7 mt -113.11 127.56 70.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.791 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.614 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.0 m -104.45 137.79 41.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.741 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.543 HG23 HD21 ' A' ' 84' ' ' LEU . 33.9 m -140.25 158.29 25.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.68 28.92 25.35 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.135 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.488 ' HA ' HG12 ' A' ' 140' ' ' ILE . 70.4 t -70.89 140.39 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-O 121.62 0.724 . . . . 0.0 112.38 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.1 -38.98 0.83 Allowed Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.492 HG12 ' H ' ' A' ' 138' ' ' SER . 48.2 t -126.49 129.38 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-N 114.641 -0.779 . . . . 0.0 109.117 178.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -50.51 -36.07 32.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.807 0.337 . . . . 0.0 111.567 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.492 ' H ' HG12 ' A' ' 136' ' ' VAL . 3.4 p -93.61 6.54 47.94 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.422 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 9.5 t0 -120.74 25.97 9.39 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.614 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.4 mt -107.1 139.15 29.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.102 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.409 HD23 ' C ' ' A' ' 141' ' ' LEU . 9.6 tt -124.2 134.4 53.29 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.434 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.518 ' H ' HG21 ' A' ' 40' ' ' THR . 38.5 t -108.01 150.24 27.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.721 0.772 . . . . 0.0 112.261 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.764 HD23 ' HA ' ' A' ' 38' ' ' CYS . 76.2 mt -135.87 155.7 49.92 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.903 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.9 HG22 ' CG ' ' A' ' 129' ' ' GLU . 21.5 t -123.6 140.16 47.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.73 0.3 . . . . 0.0 110.918 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.791 HD11 HD11 ' A' ' 130' ' ' ILE . 7.9 mt -106.22 120.87 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-O 120.93 0.395 . . . . 0.0 111.01 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.84 126.3 52.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.452 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.694 ' N ' HD12 ' A' ' 147' ' ' ILE . 2.8 mp -99.19 131.51 46.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.284 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -76.05 112.0 12.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.841 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -58.5 -34.01 70.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.909 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.77 -46.2 91.4 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.741 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -61.53 -44.16 97.56 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.057 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.14 -35.21 80.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.935 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.05 -42.98 91.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.891 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.2 t -65.94 -46.02 79.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.968 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.14 -36.57 82.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.48 -39.43 87.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.79 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -86.64 -37.1 18.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.809 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 44.07 -171.19 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.598 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.4 131.88 36.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.004 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 5.2 m -92.35 123.41 44.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.162 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -81.08 -31.46 34.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.981 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -131.07 126.04 34.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.941 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -85.93 133.01 30.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.097 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.159 -0.924 . . . . 0.0 110.848 -179.959 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.642 ' HB3' ' HD3' ' A' ' 17' ' ' ARG . . . . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.83 0.348 . . . . 0.0 111.068 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.2 t -116.95 -35.83 4.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.087 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -46.94 87.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.986 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.642 ' HD3' ' HB3' ' A' ' 14' ' ' ALA . 3.4 ptm180 -67.7 -35.94 79.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.989 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.7 -42.42 88.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.008 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.32 -44.92 95.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.52 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.7 mm -67.41 -35.0 72.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.269 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -57.17 -35.88 70.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.949 0.404 . . . . 0.0 110.469 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.2 -23.87 65.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.735 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.52 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.7 -47.37 80.07 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.281 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.3 t -64.56 -33.68 76.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -83.42 68.62 9.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -86.04 130.05 34.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.75 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -79.17 106.28 11.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.001 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.5 mm -82.02 138.41 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 CA-C-O 121.651 0.739 . . . . 0.0 111.713 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.09 43.49 32.96 Favored Glycine 0 C--N 1.314 -0.671 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.289 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -72.2 -35.38 68.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.659 0.266 . . . . 0.0 111.265 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.424 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.7 OUTLIER 176.05 39.3 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.663 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 6.0 mm -72.59 135.47 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 CA-C-N 113.612 -1.631 . . . . 0.0 112.638 -177.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.963 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.3 t -91.75 -59.16 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-N 114.68 -1.146 . . . . 0.0 109.715 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.548 ' SG ' HD22 ' A' ' 48' ' ' LEU . 4.9 p -147.31 165.32 30.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.46 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.549 ' NH1' HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -127.06 127.01 44.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.723 0.297 . . . . 0.0 111.263 -179.57 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.693 HG11 ' CE2' ' A' ' 68' ' ' PHE . 4.6 m -94.17 122.8 45.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.916 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.823 HG23 HG12 ' A' ' 45' ' ' ILE . 19.6 mt -129.34 121.84 54.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.634 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.533 ' HA ' HD23 ' A' ' 143' ' ' LEU . 52.3 t -81.27 124.34 29.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.254 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.96 -25.68 21.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.808 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.517 HG23 ' HB3' ' A' ' 142' ' ' SER . 81.8 p -79.87 -2.28 42.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.709 0.29 . . . . 0.0 111.562 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.07 74.42 0.46 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.93 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.455 ' HB2' HD11 ' A' ' 141' ' ' LEU . 7.7 mt-30 -144.43 -46.0 0.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.964 0.411 . . . . 0.0 110.789 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.612 HG12 ' HA ' ' A' ' 78' ' ' LEU . 2.8 mp -111.84 140.76 23.69 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.729 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.553 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.4 Cg_endo -73.4 143.78 35.42 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.147 1.898 . . . . 0.0 112.16 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.823 HG12 HG23 ' A' ' 37' ' ' ILE . 35.7 mt -56.33 142.93 10.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.575 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.452 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.4 OUTLIER -130.37 164.04 25.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.298 179.518 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.42 119.39 33.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.946 0.403 . . . . 0.0 111.529 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.792 HD21 ' HZ ' ' A' ' 68' ' ' PHE . 7.8 mp -94.38 124.71 38.58 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.963 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -136.3 156.15 49.07 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 122.283 1.04 . . . . 0.0 113.67 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.477 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -151.46 141.92 22.54 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.45 -1.705 . . . . 0.0 110.989 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.5 ' HB2' ' HG3' ' A' ' 54' ' ' GLN . 1.2 m-20 -74.95 128.81 36.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.128 0.49 . . . . 0.0 110.894 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.463 HD13 ' SG ' ' A' ' 154' ' ' CYS . 35.6 mt -64.17 -38.01 81.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.973 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 t -56.8 -42.04 78.81 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.886 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.5 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 2.1 mt-30 -68.58 -46.3 69.75 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.853 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.793 HG13 ' HG3' ' A' ' 63' ' ' LYS . 47.4 t -63.87 -38.06 81.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.29 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.7 tt -70.98 -41.99 70.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.301 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -76.96 -40.21 47.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.13 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -63.01 130.94 46.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.799 0.333 . . . . 0.0 110.923 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.97 37.54 2.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.011 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 74.7 mtt180 -107.9 170.96 7.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.019 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.4 p -72.01 -38.0 69.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.867 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.483 HG21 ' CG2' ' A' ' 65' ' ' VAL . 28.2 mm -121.48 143.79 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.039 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.793 ' HG3' HG13 ' A' ' 55' ' ' VAL . 8.6 mmtp -110.33 -59.46 1.94 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.844 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.472 ' HE2' ' O ' ' A' ' 49' ' ' SER . 3.7 ttpt -140.3 130.41 24.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.853 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.737 HG12 ' HG2' ' A' ' 90' ' ' GLN . 9.3 t -124.14 138.34 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 121.26 0.552 . . . . 0.0 112.123 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.649 ' CD2' HD23 ' A' ' 48' ' ' LEU . 17.8 m-90 -100.88 139.6 36.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.127 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.605 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.27 130.47 55.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.043 0.449 . . . . 0.0 109.97 177.922 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.792 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -120.12 145.35 47.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.031 -179.07 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.595 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.35 -168.13 37.9 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.56 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.427 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 0.7 OUTLIER -79.46 -0.7 34.15 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.561 HD22 ' HB3' ' A' ' 73' ' ' ALA . 2.3 t30 -84.8 132.35 46.49 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.663 0.268 . . . . 0.0 111.148 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.8 Cg_exo -66.73 -13.52 40.25 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.639 2.226 . . . . 0.0 111.76 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.561 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.6 -43.06 17.47 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -41.11 141.04 0.69 Allowed 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 113.887 -1.506 . . . . 0.0 110.655 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 67' ' ' THR . 60.6 m-20 -56.31 -18.88 12.0 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.047 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.53 ' CE2' HG21 ' A' ' 43' ' ' ILE . 2.8 t80 -130.06 129.1 43.2 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-O 120.771 0.32 . . . . 0.0 111.325 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -106.79 107.65 18.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.462 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.612 ' HA ' HG12 ' A' ' 43' ' ' ILE . 20.7 mt -72.22 -70.57 0.33 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.385 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 170.5 -89.72 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.601 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -164.49 62.88 0.14 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.95 0.405 . . . . 0.0 111.189 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.815 HD13 HD12 ' A' ' 84' ' ' LEU . 3.9 mp -104.63 111.87 35.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.835 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.1 m -56.11 -37.08 68.93 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.102 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.54 -17.5 59.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.302 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.815 HD12 HD13 ' A' ' 81' ' ' ILE . 20.0 mt -104.56 152.03 22.9 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.681 0.277 . . . . 0.0 111.157 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 57.7 p -96.63 167.97 10.81 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.566 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.595 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 8.1 m-20 -42.84 -58.74 2.24 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.365 0.602 . . . . 0.0 109.81 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.537 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.5 OUTLIER -115.36 82.74 1.8 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 176.975 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.556 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.1 t60 -59.6 -46.86 87.69 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.517 -176.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.532 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 29.8 p90 -145.54 161.49 39.65 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.214 -0.594 . . . . 0.0 112.005 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.737 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.2 tt0 -136.06 144.02 44.98 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.911 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.755 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 81.4 mt -118.88 124.7 73.6 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.272 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.044 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.669 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -102.26 151.27 22.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.964 0.411 . . . . 0.0 111.723 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.776 HD22 HG11 ' A' ' 33' ' ' VAL . 25.4 tp -125.29 122.97 38.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.439 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -172.22 -152.66 8.67 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.629 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 59.33 -173.19 0.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.795 0.331 . . . . 0.0 110.97 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -85.59 90.38 7.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 59.17 54.32 38.95 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.609 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -150.9 155.64 39.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.856 0.36 . . . . 0.0 110.844 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.777 ' HB2' HD22 ' A' ' 124' ' ' LEU . 4.1 mm? -114.17 160.07 19.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.759 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.642 ' HB3' HD12 ' A' ' 92' ' ' LEU . 3.2 mp -131.31 145.46 51.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.689 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.726 HD21 HD12 ' A' ' 145' ' ' ILE . 11.0 mp -112.71 121.07 43.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.028 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.669 ' HB2' HD11 ' A' ' 92' ' ' LEU . 44.2 t30 -115.49 115.44 26.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.93 0.395 . . . . 0.0 111.552 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.828 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.3 p30 -78.59 140.44 38.47 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.536 HD12 ' HB2' ' A' ' 87' ' ' LYS . 10.1 pt -148.99 38.36 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -178.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.648 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.29 152.7 19.14 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 121.013 0.435 . . . . 0.0 112.063 -178.889 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 50.8 m -68.89 -31.44 70.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.875 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -98.21 -19.91 17.58 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -178.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.648 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.91 156.67 10.39 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.355 -0.926 . . . . 0.0 113.713 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.502 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.1 m -117.43 137.78 52.28 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.844 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -115.96 148.58 39.94 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -177.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.12 113.58 18.54 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.483 177.657 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.2 m120 44.72 43.27 6.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.444 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.58 -12.68 62.53 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.722 -0.752 . . . . 0.0 113.468 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.8 118.56 36.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.087 0.444 . . . . 0.0 110.605 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.844 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -71.44 131.71 43.74 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.48 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.828 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.6 m -101.59 165.87 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.966 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.4 mp0 -69.83 126.12 28.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.482 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.69 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 84.4 tttt -54.11 162.52 0.99 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.824 0.345 . . . . 0.0 110.654 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.3 m-80 34.21 35.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.109 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.19 145.17 40.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.035 179.531 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.641 ' HB3' HD23 ' A' ' 100' ' ' LEU . 1.1 m-80 -88.0 132.03 34.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.919 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.477 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 45.1 mm-40 -129.33 150.2 50.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.611 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.6 tp -72.8 136.13 45.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.488 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.854 HD21 HG12 ' A' ' 147' ' ' ILE . 16.2 tp -62.43 152.69 33.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.628 0.727 . . . . 0.0 111.585 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.503 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.4 OUTLIER -125.3 152.59 44.47 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.505 179.442 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.463 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 6.7 mm-40 -72.28 122.57 21.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 0.0 110.177 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.03 23.98 48.73 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.054 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.414 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 28.8 t70 -49.08 167.96 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.93 0.395 . . . . 0.0 111.487 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.938 ' CG ' HG22 ' A' ' 144' ' ' VAL . 2.3 mt-10 -144.27 135.68 25.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.003 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.484 ' CG2' HG22 ' A' ' 109' ' ' THR . 16.2 mt -115.71 127.3 73.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.804 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.589 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.0 m -104.59 139.16 39.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.873 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.533 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.2 m -140.38 158.41 25.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.5 28.86 26.02 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.161 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.488 ' HA ' HG12 ' A' ' 140' ' ' ILE . 78.1 t -71.35 140.39 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-O 121.626 0.727 . . . . 0.0 112.288 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.18 -39.5 0.92 Allowed Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.514 HG12 ' H ' ' A' ' 138' ' ' SER . 46.4 t -126.42 128.26 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 CA-C-N 114.689 -0.755 . . . . 0.0 109.068 177.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.51 -33.85 23.03 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.597 0.237 . . . . 0.0 111.632 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.514 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.8 m -93.53 6.46 48.14 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.01 26.79 7.95 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.589 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.6 mt -107.06 138.96 30.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.102 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.455 HD11 ' HB2' ' A' ' 42' ' ' GLN . 7.0 tt -124.63 134.38 52.93 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.531 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.517 ' HB3' HG23 ' A' ' 40' ' ' THR . 38.0 t -108.59 150.33 27.65 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.567 0.698 . . . . 0.0 112.069 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.599 HD21 HD13 ' A' ' 43' ' ' ILE . 75.9 mt -135.78 155.12 50.84 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.861 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.938 HG22 ' CG ' ' A' ' 129' ' ' GLU . 20.0 t -127.6 138.14 55.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.784 0.326 . . . . 0.0 111.166 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.726 HD12 HD21 ' A' ' 101' ' ' LEU . 19.4 mt -106.45 129.06 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 CA-C-O 120.852 0.358 . . . . 0.0 110.885 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.12 122.92 49.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.916 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.854 HG12 HD21 ' A' ' 124' ' ' LEU . 3.3 mt -91.35 134.14 30.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.474 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.76 112.37 19.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.675 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.71 -31.86 68.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.072 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt -58.95 -45.13 91.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.999 0.428 . . . . 0.0 110.609 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -58.78 -44.17 90.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.985 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.427 ' NZ ' HG21 ' A' ' 147' ' ' ILE . 28.9 mttp -65.26 -35.16 80.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.097 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -58.97 -47.1 86.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.284 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.463 ' SG ' HD13 ' A' ' 52' ' ' ILE . 12.0 t -61.15 -45.93 92.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.006 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.12 -36.53 77.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.925 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.94 -35.27 74.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.698 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -89.58 -34.86 16.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.813 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.6 p30 42.5 92.71 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.591 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.21 136.4 53.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.847 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 30.3 m -64.97 134.92 29.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.225 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -135.45 172.46 12.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.978 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 43.4 ttp85 -162.85 102.98 1.02 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.894 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.9 mp -99.42 135.15 35.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.093 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.123 -0.942 . . . . 0.0 110.936 179.932 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.832 0.349 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.8 p -149.34 -58.87 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -71.21 -46.93 60.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.927 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 -61.63 -44.15 97.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -60.01 -36.49 77.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.063 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.9 tp -63.73 -45.99 87.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.963 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 40.3 mm -63.27 -39.61 85.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.226 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -57.88 -33.89 69.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.234 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -65.15 -30.86 71.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.479 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -57.06 -47.49 80.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.089 0.471 . . . . 0.0 111.116 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.3 m -70.16 -29.53 66.45 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.939 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -43.85 69.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.959 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -78.78 136.84 37.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.976 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -100.35 114.09 27.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.832 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.9 mm -85.01 138.32 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-O 121.603 0.716 . . . . 0.0 111.974 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.414 ' HA2' HG12 ' A' ' 32' ' ' ILE . . . -78.26 65.43 3.34 Favored Glycine 0 C--N 1.313 -0.719 0 CA-C-N 114.546 -1.206 . . . . 0.0 112.327 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -65.53 -41.79 92.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.661 0.267 . . . . 0.0 111.323 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.433 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.1 m120 -178.32 38.1 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.587 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 7.6 mm -71.51 144.52 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 CA-C-N 113.695 -1.593 . . . . 0.0 112.477 -176.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.799 HG22 HD13 ' A' ' 93' ' ' LEU . 1.2 t -105.71 -56.35 5.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.717 -178.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.757 ' SG ' HD12 ' A' ' 48' ' ' LEU . 31.3 p -151.51 164.51 36.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.221 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.41 138.26 53.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.835 0.35 . . . . 0.0 111.477 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.655 HG21 ' CE2' ' A' ' 68' ' ' PHE . 18.3 t -103.81 122.59 56.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.685 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.52 HG23 HG12 ' A' ' 45' ' ' ILE . 20.6 mt -127.0 115.82 42.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.461 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.576 ' HA ' HD13 ' A' ' 143' ' ' LEU . 37.7 t -79.97 124.75 28.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.82 0.343 . . . . 0.0 110.489 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.9 t -92.18 -26.99 17.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.556 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.518 HG21 ' H ' ' A' ' 142' ' ' SER . 25.9 p -79.93 -2.17 42.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.521 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.05 75.7 0.37 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.915 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -146.01 -44.9 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.789 0.328 . . . . 0.0 111.002 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.618 ' CD1' HD21 ' A' ' 143' ' ' LEU . 1.0 OUTLIER -112.73 140.61 24.16 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.831 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.534 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.6 Cg_endo -74.43 141.54 28.6 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.253 1.969 . . . . 0.0 112.361 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.52 HG12 HG23 ' A' ' 37' ' ' ILE . 35.9 mt -56.69 133.99 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.408 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.29 164.46 25.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.551 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.49 119.82 36.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.086 0.47 . . . . 0.0 111.774 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.857 HD22 ' CD1' ' A' ' 66' ' ' TRP . 17.8 mt -92.27 137.9 31.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.107 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.587 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -141.62 158.39 43.89 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 122.283 1.04 . . . . 0.0 113.756 -178.659 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.649 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . -146.5 141.81 27.43 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 113.447 -1.706 . . . . 0.0 110.43 178.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.901 ' O ' HG23 ' A' ' 55' ' ' VAL . 1.6 m-20 -76.74 132.46 39.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.066 0.46 . . . . 0.0 111.289 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.699 HD13 ' SG ' ' A' ' 154' ' ' CYS . 77.9 mt -64.64 -44.15 96.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.488 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.9 t -59.64 -42.37 92.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.245 0.545 . . . . 0.0 111.087 -178.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.497 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 6.3 mt-30 -68.8 -36.8 78.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.084 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 51' ' ' ASP . 56.3 t -69.85 -44.22 79.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.133 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 mp -67.78 -26.17 65.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.094 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -88.44 -52.9 4.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.136 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -67.17 127.34 32.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.039 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.72 39.79 2.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.8 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 76.8 mmt-85 -107.61 76.73 1.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.953 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.2 t 68.44 -68.82 0.16 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.054 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.64 HD13 HD12 ' A' ' 92' ' ' LEU . 9.0 tp -133.06 159.32 43.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.252 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.482 ' HG2' ' HA ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -110.43 -62.94 1.45 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.2 -179.765 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.417 ' HE2' ' O ' ' A' ' 49' ' ' SER . 4.4 ttpt -132.32 135.17 46.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.754 0.312 . . . . 0.0 111.746 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 91' ' ' ILE . 17.0 t -134.03 139.55 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 121.182 0.515 . . . . 0.0 111.805 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.857 ' CD1' HD22 ' A' ' 48' ' ' LEU . 16.4 m-90 -100.42 139.42 36.12 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.019 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.898 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -110.09 132.86 53.78 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.649 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.738 ' HZ ' HD11 ' A' ' 48' ' ' LEU . 2.0 m-85 -115.9 145.7 42.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.478 -178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.693 ' HA2' HD12 ' A' ' 78' ' ' LEU . . . 173.96 -170.3 43.42 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.17 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 26.9 mtm180 -87.5 -13.44 43.08 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.472 ' ND2' ' H ' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -84.32 143.12 41.45 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.927 0.394 . . . . 0.0 111.364 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 7.2 Cg_exo -70.47 1.3 5.04 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.175 2.583 . . . . 0.0 111.958 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.51 -49.07 10.31 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 122.019 0.914 . . . . 0.0 108.838 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.47 ' HB2' ' ND2' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -46.73 140.74 4.32 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 113.596 -1.638 . . . . 0.0 110.774 179.563 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -56.28 -19.5 14.46 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.216 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.542 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 15.7 t80 -129.57 118.38 21.93 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-O 120.654 0.264 . . . . 0.0 110.979 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -86.01 116.83 24.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.588 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.693 HD12 ' HA2' ' A' ' 69' ' ' GLY . 74.1 mt -91.81 -79.19 0.38 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.298 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -171.17 -102.21 0.15 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.541 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.46 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 1.1 p-10 -176.46 61.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.895 0.379 . . . . 0.0 111.13 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.757 HD12 ' CD1' ' A' ' 84' ' ' LEU . 27.5 mt -99.73 125.88 53.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.906 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.28 -40.5 71.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.071 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -22.56 64.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.164 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.757 ' CD1' HD12 ' A' ' 81' ' ' ILE . 47.1 mt -98.83 152.27 19.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.133 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 93.1 p -97.0 167.34 11.13 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.735 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.673 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -43.98 -54.09 5.69 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.424 0.63 . . . . 0.0 109.792 179.136 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.578 ' HB2' HD12 ' A' ' 104' ' ' ILE . 0.4 OUTLIER -118.2 83.09 1.95 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.247 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.568 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.4 t60 -61.77 -45.22 94.81 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.054 -176.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.523 ' HA ' HG12 ' A' ' 104' ' ' ILE . 29.1 p90 -149.19 161.51 41.85 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 119.987 -0.685 . . . . 0.0 112.303 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.898 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.5 mt-30 -135.46 147.19 48.83 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.313 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.661 HD12 ' CE1' ' A' ' 68' ' ' PHE . 19.9 mt -118.92 131.89 70.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.161 178.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.64 HD12 HD13 ' A' ' 62' ' ' ILE . 0.6 OUTLIER -119.7 138.06 53.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.124 0.488 . . . . 0.0 111.964 -178.985 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.799 HD13 HG22 ' A' ' 33' ' ' VAL . 1.4 tt -125.24 131.14 53.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.325 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.401 ' HA3' ' HD3' ' A' ' 63' ' ' LYS . . . 153.13 -22.05 0.77 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.936 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.641 ' HB2' HD23 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -56.98 89.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.872 0.368 . . . . 0.0 111.053 -179.781 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 52.39 30.3 7.99 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.146 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.96 -35.81 4.08 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.54 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -59.21 -171.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.903 0.382 . . . . 0.0 110.832 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.716 ' O ' HD22 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -122.52 144.6 48.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.925 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.89 HD13 ' O ' ' A' ' 122' ' ' GLN . 3.8 mm? -129.96 142.52 50.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.002 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.68 128.14 56.31 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.446 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 52.8 t30 -115.57 117.04 29.23 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.823 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.9 p30 -79.84 140.19 36.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.578 HD12 ' HB2' ' A' ' 87' ' ' LYS . 15.9 pt -145.56 33.81 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 111.574 0.213 . . . . 0.0 111.574 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.676 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -93.96 150.35 20.43 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 120.996 0.427 . . . . 0.0 111.891 -178.832 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.1 m -68.59 -31.48 70.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.765 178.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -98.23 -19.62 17.73 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.676 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.12 156.23 10.02 Favored Glycine 0 N--CA 1.438 -1.21 0 C-N-CA 120.246 -0.978 . . . . 0.0 113.642 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.516 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.5 m -117.4 137.78 52.26 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.877 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -114.02 148.55 36.81 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -177.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.465 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.28 113.4 18.21 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.171 177.386 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.415 ' N ' HD12 ' A' ' 111' ' ' LEU . 3.8 m120 44.66 42.84 6.15 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.341 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.24 -10.52 70.84 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.504 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -104.77 118.54 36.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.078 0.466 . . . . 0.0 110.648 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.877 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.3 tptm -73.33 128.14 34.64 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.23 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.823 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.3 m -100.5 164.76 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.237 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 120' ' ' SER . 30.5 tt0 -70.05 127.09 31.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.514 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.689 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 24.2 tttt -53.09 162.38 0.68 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.857 0.361 . . . . 0.0 110.438 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.0 OUTLIER 35.4 33.99 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.14 -179.166 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.487 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.19 145.12 40.43 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.053 179.395 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.663 ' HB3' HD12 ' A' ' 100' ' ' LEU . 5.6 m-80 -90.35 130.75 36.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.085 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.89 ' O ' HD13 ' A' ' 100' ' ' LEU . 42.3 mm-40 -129.39 148.57 51.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.276 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.4 116.4 12.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.864 0.364 . . . . 0.0 110.354 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.704 HD11 HG21 ' A' ' 145' ' ' ILE . 65.3 tp -56.36 157.54 4.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.435 0.636 . . . . 0.0 111.587 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.471 ' O ' HD11 ' A' ' 147' ' ' ILE . 1.3 t -124.4 153.31 42.08 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.327 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.682 ' HA ' HD13 ' A' ' 147' ' ' ILE . 30.1 mm100 -71.3 123.54 22.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.897 0.379 . . . . 0.0 110.046 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.08 21.55 59.39 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.866 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -55.86 173.92 0.13 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.965 0.412 . . . . 0.0 111.057 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.708 ' HG3' HG22 ' A' ' 144' ' ' VAL . 9.5 tt0 -145.07 135.47 24.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.287 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.763 HD11 HD11 ' A' ' 145' ' ' ILE . 13.5 mt -113.86 128.04 70.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.26 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.674 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.5 m -104.36 138.78 40.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.208 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.5 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 35.4 m -140.19 158.42 25.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.25 34.36 20.7 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.92 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.2 t -75.15 140.45 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-O 121.763 0.792 . . . . 0.0 112.533 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.97 -39.37 0.6 Allowed Glycine 0 N--CA 1.437 -1.249 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.444 HG12 ' H ' ' A' ' 138' ' ' SER . 47.9 t -126.35 131.84 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 114.731 -0.735 . . . . 0.0 109.201 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -50.6 -38.71 47.1 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.444 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.6 OUTLIER -93.37 6.3 48.62 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.852 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.427 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 5.3 t70 -120.11 27.73 8.47 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.674 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.1 mt -107.26 139.5 28.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.022 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.715 HD12 HD11 ' A' ' 81' ' ' ILE . 3.0 tt -122.11 134.34 54.76 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.512 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.697 ' N ' HD23 ' A' ' 141' ' ' LEU . 47.0 t -113.8 150.79 32.98 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.611 0.72 . . . . 0.0 112.638 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.618 HD21 ' CD1' ' A' ' 43' ' ' ILE . 2.1 mm? -135.69 143.55 45.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.487 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.708 HG22 ' HG3' ' A' ' 129' ' ' GLU . 17.4 t -110.97 139.85 32.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.824 0.345 . . . . 0.0 111.138 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.763 HD11 HD11 ' A' ' 130' ' ' ILE . 16.2 mt -106.31 125.16 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.072 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.03 109.89 19.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.816 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.682 HD13 ' HA ' ' A' ' 126' ' ' GLN . 5.0 mp -85.96 134.07 28.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.416 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -86.06 127.7 34.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.844 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -74.03 -23.91 59.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.21 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -45.03 90.99 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.035 0.445 . . . . 0.0 110.649 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -58.82 -44.13 90.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.92 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -65.11 -39.11 92.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.924 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -59.19 -42.57 91.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.985 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.699 ' SG ' HD13 ' A' ' 52' ' ' ILE . 12.0 t -61.19 -45.97 92.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.056 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.11 -35.98 79.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.89 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -67.37 -37.2 82.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.912 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -86.99 -37.05 17.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.939 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.6 p30 42.34 77.39 0.06 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.467 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.05 121.14 27.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.974 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.1 m -78.49 141.0 16.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.164 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -159.33 106.87 1.76 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.866 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.63 -29.25 16.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.949 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 163' ' ' ILE . 0.9 OUTLIER -76.99 123.33 33.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.06 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.915 -179.939 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.787 0.327 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.9 p -135.5 -54.34 0.78 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.901 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.66 -38.65 70.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.805 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.6 mtm-85 -58.84 -46.08 88.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.972 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -61.39 -35.08 76.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.876 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.6 tt -61.18 -45.18 95.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.959 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.435 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 6.1 mm -62.64 -35.23 69.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.156 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.25 -44.59 84.01 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.9 0.381 . . . . 0.0 110.425 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -67.15 -23.74 65.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.419 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.75 -47.45 80.04 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.202 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.12 -47.05 14.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.814 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -175.45 158.32 2.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.882 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -87.25 149.59 24.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.846 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -81.22 101.87 9.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.982 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.5 mm -85.19 138.37 19.2 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 CA-C-O 121.706 0.765 . . . . 0.0 111.811 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.7 84.7 0.42 Allowed Glycine 0 C--N 1.315 -0.606 0 CA-C-N 114.507 -1.224 . . . . 0.0 112.448 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.11 -42.12 66.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.711 0.291 . . . . 0.0 111.022 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.454 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 m-20 179.27 37.88 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.688 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.4 mm -73.02 137.08 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-N 113.598 -1.637 . . . . 0.0 112.658 -177.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.987 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.3 t -93.66 -59.82 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.658 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.94 156.46 42.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.229 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.842 ' NE ' HG21 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -119.88 138.14 53.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.815 0.34 . . . . 0.0 111.031 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.51 HG11 ' CE2' ' A' ' 68' ' ' PHE . 1.8 m -104.66 122.71 58.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.772 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.676 HG23 HG12 ' A' ' 45' ' ' ILE . 14.4 mt -125.0 124.17 67.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.572 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.757 ' HA ' HD13 ' A' ' 143' ' ' LEU . 52.8 t -80.02 108.74 13.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.859 0.361 . . . . 0.0 110.537 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.0 t -74.55 -25.46 59.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.639 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.539 HG23 ' HB3' ' A' ' 142' ' ' SER . 74.7 p -79.86 -2.35 43.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.46 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.15 76.73 0.24 Allowed Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.824 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -146.53 -43.86 0.19 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.913 0.387 . . . . 0.0 110.876 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.554 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.1 mt -117.93 141.3 29.01 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.005 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.554 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 52.5 Cg_endo -72.35 145.85 43.96 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.216 1.944 . . . . 0.0 111.788 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.842 HG21 ' NE ' ' A' ' 35' ' ' ARG . 68.6 mt -54.15 142.46 7.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.049 0.452 . . . . 0.0 111.829 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.507 ' HB2' ' CE2' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -124.67 133.99 53.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.861 178.873 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.08 119.92 32.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.141 0.496 . . . . 0.0 111.863 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.546 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 5.2 mt -98.04 131.96 44.0 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.987 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -143.55 157.55 44.34 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -178.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.495 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -141.07 146.29 36.94 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 113.694 -1.594 . . . . 0.0 110.993 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.893 ' O ' HG23 ' A' ' 55' ' ' VAL . 66.4 m-20 -74.87 114.4 13.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.045 0.45 . . . . 0.0 111.196 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.456 HD13 ' SG ' ' A' ' 154' ' ' CYS . 40.2 mt -64.44 -42.45 95.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.734 -0.667 . . . . 0.0 112.024 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.31 -40.99 79.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.315 0.579 . . . . 0.0 110.586 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.464 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 35.1 mm-40 -68.52 -36.87 79.46 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.548 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 51' ' ' ASP . 21.8 t -67.26 -49.16 74.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.018 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.87 -40.4 91.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.986 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -65.19 -43.79 90.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.907 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.2 108.44 19.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.837 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -86.16 79.47 9.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.796 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.6 mmt85 -118.08 169.19 9.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.98 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.8 t -78.38 -19.73 52.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.217 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.42 HD11 ' CG2' ' A' ' 65' ' ' VAL . 1.4 tp -134.45 138.65 49.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.771 0.32 . . . . 0.0 111.349 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.751 ' HG2' HG22 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -115.68 -71.09 0.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.939 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.441 ' CE ' ' O ' ' A' ' 49' ' ' SER . 26.5 ttpt -141.06 144.09 34.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.016 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.658 HG12 ' HG2' ' A' ' 90' ' ' GLN . 14.4 t -127.72 139.5 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-O 121.29 0.567 . . . . 0.0 112.08 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.546 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 18.9 m-90 -100.77 139.32 36.62 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.144 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.689 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.79 126.97 55.8 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.459 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.521 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -118.06 145.23 44.96 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.79 -178.767 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.603 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.46 -172.69 37.73 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.084 -1.055 . . . . 0.0 113.593 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.455 ' N ' HD11 ' A' ' 78' ' ' LEU . 0.8 OUTLIER -74.28 -0.61 17.53 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.409 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 25.2 t-20 -84.69 132.14 47.42 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.624 0.249 . . . . 0.0 111.29 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 14.7 Cg_exo -67.83 -12.1 34.26 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.58 2.186 . . . . 0.0 111.707 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.02 -43.19 16.63 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-O 121.914 0.864 . . . . 0.0 109.048 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -39.12 139.11 0.52 Allowed 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 113.701 -1.591 . . . . 0.0 111.089 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -56.44 -18.72 12.19 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.122 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.507 ' CE2' ' HB2' ' A' ' 46' ' ' ARG . 56.0 t80 -129.41 119.04 23.15 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.829 0.347 . . . . 0.0 110.915 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -97.63 124.6 41.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.961 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.455 HD11 ' N ' ' A' ' 70' ' ' ARG . 0.6 OUTLIER -121.51 -179.81 4.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.903 179.747 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -55.44 -171.41 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.494 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -110.63 80.45 1.31 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.83 0.348 . . . . 0.0 110.889 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.76 ' HB ' HD13 ' A' ' 84' ' ' LEU . 2.4 mp -112.02 120.85 63.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.193 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.27 -29.65 64.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.196 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.534 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -60.89 -23.25 65.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.059 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.76 HD13 ' HB ' ' A' ' 81' ' ' ILE . 4.1 mp -107.05 152.87 23.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.912 0.387 . . . . 0.0 110.958 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 61.1 p -96.46 166.71 11.56 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.891 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.603 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.2 m-20 -43.32 -53.19 5.4 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.318 0.58 . . . . 0.0 109.799 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.545 ' CB ' HD12 ' A' ' 104' ' ' ILE . 10.9 mttm -118.03 81.36 1.66 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.627 ' CE1' ' CG1' ' A' ' 132' ' ' VAL . 60.8 t-80 -58.81 -47.45 84.73 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.423 -177.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.504 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 32.1 p90 -146.31 159.81 42.86 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.154 -0.618 . . . . 0.0 112.063 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.689 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.0 tt0 -135.59 141.95 45.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.212 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.583 ' O ' HG13 ' A' ' 65' ' ' VAL . 45.7 mt -120.44 131.84 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.297 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.762 HD21 ' OD1' ' A' ' 121' ' ' ASN . 0.5 OUTLIER -120.09 139.73 52.12 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.004 0.43 . . . . 0.0 111.566 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.692 HD23 ' HG ' ' A' ' 99' ' ' LEU . 1.7 tm? -125.24 134.34 52.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.307 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.691 ' N ' HD22 ' A' ' 93' ' ' LEU . . . -128.89 172.55 19.56 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.705 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.8 ' HG3' HG12 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -74.23 106.65 5.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.783 0.325 . . . . 0.0 110.955 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -175.24 -41.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.933 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 134.32 -26.1 3.4 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.474 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -109.38 -178.03 3.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.835 0.35 . . . . 0.0 111.027 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.692 ' HG ' HD23 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -128.12 159.67 34.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.577 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.794 HD23 ' O ' ' A' ' 122' ' ' GLN . 9.0 mt -120.3 142.1 49.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.897 0.38 . . . . 0.0 110.719 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.926 HD11 HD11 ' A' ' 130' ' ' ILE . 3.8 tt -112.95 125.0 53.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.059 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.478 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 59.8 t30 -119.09 115.93 25.3 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.837 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.8 p30 -77.94 137.55 38.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.779 178.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.545 HD12 ' CB ' ' A' ' 87' ' ' LYS . 8.4 pt -141.29 29.52 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 121.127 -0.229 . . . . 0.0 111.58 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.531 ' HB2' ' CG ' ' A' ' 88' ' ' HIS . 12.1 t -93.69 155.49 17.22 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.534 0.683 . . . . 0.0 112.838 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 69.5 m -70.06 -52.04 27.1 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.669 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -80.34 -0.54 37.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.281 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.0 156.24 30.66 Favored Glycine 0 N--CA 1.437 -1.25 0 C-N-CA 120.642 -0.789 . . . . 0.0 113.518 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.502 HG22 ' CG2' ' A' ' 130' ' ' ILE . 5.2 m -117.44 137.89 52.21 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.845 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -113.29 148.47 35.56 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -178.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.409 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.12 113.54 18.49 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.298 177.328 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 45.3 42.7 7.53 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.0 -7.69 76.6 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.462 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.59 118.51 36.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 117.041 0.421 . . . . 0.0 110.624 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.845 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 6.3 tptm -72.46 116.94 13.51 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.259 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.837 HG23 ' OD2' ' A' ' 103' ' ' ASP . 13.1 m -92.42 162.86 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.046 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.421 ' HB3' ' HB3' ' A' ' 120' ' ' SER . 0.6 OUTLIER -69.81 128.92 38.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.46 179.66 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.684 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 45.5 tttt -55.35 163.87 1.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.751 0.31 . . . . 0.0 110.195 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.7 OUTLIER 35.96 34.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.818 -179.162 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.421 ' HB3' ' HB3' ' A' ' 117' ' ' GLU . 2.7 p -112.12 143.58 42.91 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.458 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.762 ' OD1' HD21 ' A' ' 92' ' ' LEU . 18.1 m-80 -94.22 132.28 38.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.045 0.45 . . . . 0.0 111.103 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.794 ' O ' HD23 ' A' ' 100' ' ' LEU . 58.1 mm-40 -129.07 151.23 49.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.446 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 tp -72.56 128.56 35.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.843 0.354 . . . . 0.0 110.464 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.817 HD21 HG12 ' A' ' 147' ' ' ILE . 18.8 tp -57.55 155.28 9.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.375 0.607 . . . . 0.0 111.679 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.518 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -124.71 152.95 43.11 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.304 179.463 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -71.88 119.14 15.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.96 0.41 . . . . 0.0 110.07 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.32 24.71 63.87 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.124 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.402 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 32.0 t70 -52.95 170.31 0.08 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.928 0.394 . . . . 0.0 111.337 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.9 ' CG ' HG22 ' A' ' 144' ' ' VAL . 9.4 mt-10 -145.15 135.61 24.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.06 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.926 HD11 HD11 ' A' ' 101' ' ' LEU . 6.6 mt -111.64 128.08 68.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.459 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.654 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.6 m -104.25 140.39 37.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.01 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.627 ' CG1' ' CE1' ' A' ' 88' ' ' HIS . 22.7 m -140.36 158.75 25.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.44 43.7 10.18 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.167 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 140' ' ' ILE . 74.0 t -83.01 140.44 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-O 121.609 0.719 . . . . 0.0 112.307 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.29 -40.17 0.95 Allowed Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.541 HG12 ' H ' ' A' ' 138' ' ' SER . 48.2 t -126.37 124.95 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-N 114.603 -0.799 . . . . 0.0 108.983 177.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -50.38 -30.73 12.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.769 0.319 . . . . 0.0 111.444 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.541 ' H ' HG12 ' A' ' 136' ' ' VAL . 4.0 m -93.62 6.35 48.56 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -123.52 24.25 8.64 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.654 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.5 mt -107.0 139.07 29.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.313 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.31 134.49 53.17 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.202 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.641 ' C ' HD22 ' A' ' 143' ' ' LEU . 38.1 t -111.12 150.62 29.16 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.73 0.776 . . . . 0.0 112.46 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.757 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.5 mm? -135.66 149.12 49.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.125 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.9 HG22 ' CG ' ' A' ' 129' ' ' GLU . 13.8 t -118.81 140.09 43.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 111.382 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.797 HD11 HD11 ' A' ' 130' ' ' ILE . 28.1 mt -106.29 120.87 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.76 118.38 36.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.654 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.817 HG12 HD21 ' A' ' 124' ' ' LEU . 5.5 mt -84.98 134.03 27.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.495 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.84 115.72 21.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.723 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -63.74 -31.8 73.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.06 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -60.14 -46.06 90.91 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.005 0.431 . . . . 0.0 110.784 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -58.88 -44.07 91.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.983 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -63.78 -37.74 88.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.925 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -59.62 -40.89 89.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.925 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.456 ' SG ' HD13 ' A' ' 52' ' ' ILE . 9.1 t -67.81 -44.21 77.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.953 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.89 -39.84 91.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.911 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -61.28 -44.09 97.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.876 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.68 -37.08 31.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.895 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 42.27 35.07 0.56 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.501 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 9.7 mtmt -111.98 120.45 41.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.878 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 35.0 m -89.36 127.73 41.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.212 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.64 70.72 3.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.9 ttm180 -137.02 98.59 3.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.93 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.544 HD13 ' H ' ' A' ' 163' ' ' ILE . 0.2 OUTLIER -76.83 138.11 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.166 -179.948 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.884 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.796 0.332 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 52.1 p -130.58 -46.06 1.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.855 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -37.38 85.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.932 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -64.8 -41.81 95.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.867 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -57.93 -38.6 76.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.854 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.521 HD13 ' O ' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -60.09 -31.85 70.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.811 179.781 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.439 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.0 mt -72.89 -35.4 49.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.831 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -57.38 -42.39 82.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.984 0.421 . . . . 0.0 110.493 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.1 tttt -67.08 -23.82 65.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.661 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.439 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.68 -47.52 79.67 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.261 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.28 -46.99 59.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.941 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -93.48 64.28 3.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.882 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -79.99 124.12 28.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.907 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -78.9 131.55 36.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.932 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.3 mm -81.96 138.31 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-O 121.654 0.74 . . . . 0.0 111.769 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.41 53.88 0.01 OUTLIER Glycine 0 C--N 1.315 -0.636 0 CA-C-N 114.472 -1.24 . . . . 0.0 112.406 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.34 -41.88 96.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.739 0.304 . . . . 0.0 110.967 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.44 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.7 OUTLIER 178.1 38.17 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 -179.841 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.688 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.1 mm -74.24 135.37 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-N 113.703 -1.589 . . . . 0.0 112.574 -177.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.0 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -93.51 -61.42 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.086 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.711 ' SG ' HD12 ' A' ' 48' ' ' LEU . 2.9 p -144.73 152.09 39.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.252 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.404 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -117.42 128.72 55.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.757 0.313 . . . . 0.0 111.339 -179.486 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.724 HG23 HD11 ' A' ' 48' ' ' LEU . 38.0 t -96.67 122.91 48.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.867 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.863 HG23 HG12 ' A' ' 45' ' ' ILE . 21.6 mt -127.14 127.23 69.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.582 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.528 ' HA ' HD13 ' A' ' 143' ' ' LEU . 11.6 t -91.61 107.67 19.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.446 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.434 ' CG2' HG21 ' A' ' 144' ' ' VAL . 63.0 p -81.24 -24.88 37.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.636 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.536 HG21 ' OG ' ' A' ' 142' ' ' SER . 4.3 p -80.05 -2.71 45.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.662 0.268 . . . . 0.0 111.428 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.92 75.53 0.45 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.069 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.659 ' HB2' HD12 ' A' ' 43' ' ' ILE . 3.5 mt-30 -143.07 -40.88 0.31 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.92 0.39 . . . . 0.0 110.992 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.659 HD12 ' HB2' ' A' ' 42' ' ' GLN . 4.1 mp -125.7 142.15 41.24 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.927 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.566 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 52.7 Cg_endo -72.08 140.81 35.14 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.16 1.907 . . . . 0.0 112.227 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.863 HG12 HG23 ' A' ' 37' ' ' ILE . 33.7 mt -56.16 142.94 10.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.724 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -137.85 161.91 35.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.27 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.404 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 1.1 m-20 -116.05 119.83 37.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.975 0.417 . . . . 0.0 111.746 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.724 HD11 HG23 ' A' ' 36' ' ' VAL . 4.4 mt -94.88 136.25 35.42 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.0 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.81 158.64 43.84 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -178.806 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.5 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -146.28 147.71 31.67 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 113.69 -1.596 . . . . 0.0 110.822 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.717 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.9 OUTLIER -74.95 128.36 35.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.172 0.51 . . . . 0.0 111.261 -179.551 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.741 HD13 ' SG ' ' A' ' 154' ' ' CYS . 92.0 mt -64.54 -43.9 96.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.033 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.8 t -57.08 -38.86 73.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.314 0.578 . . . . 0.0 110.539 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.529 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 6.0 mm-40 -68.47 -36.93 79.67 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.521 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.717 HG23 ' O ' ' A' ' 51' ' ' ASP . 45.2 t -70.32 -47.19 67.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.028 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -29.03 70.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.963 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.9 tptm -82.23 -49.34 10.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.038 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -62.98 121.29 13.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.873 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -138.89 34.98 2.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.853 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.51 -70.65 0.33 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.982 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 78.4 p -93.97 -175.89 3.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.965 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.9 tp -72.3 150.04 8.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.122 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.474 ' HE2' HG13 ' A' ' 55' ' ' VAL . 7.9 mptt -79.62 -67.03 0.8 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.051 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.432 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.4 ttpt -149.93 139.98 22.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.296 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.68 HG12 ' HG2' ' A' ' 90' ' ' GLN . 14.6 t -130.72 139.28 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.311 0.577 . . . . 0.0 112.092 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.563 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.3 m-90 -102.4 139.45 37.99 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.151 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.605 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.18 128.32 56.2 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.561 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.689 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -120.09 145.3 47.01 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.179 -178.759 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.529 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.17 -169.56 37.56 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.176 -1.012 . . . . 0.0 113.733 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.407 ' NE ' ' HA ' ' A' ' 80' ' ' ASN . 3.8 ttt-85 -77.2 0.29 22.42 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 122.56 0.344 . . . . 0.0 111.869 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.743 ' ND2' ' HB3' ' A' ' 73' ' ' ALA . 38.5 t30 -84.76 132.64 45.69 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.632 0.253 . . . . 0.0 111.41 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.423 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 15.4 Cg_exo -67.17 -13.5 39.87 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.573 2.182 . . . . 0.0 111.702 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.743 ' HB3' ' ND2' ' A' ' 71' ' ' ASN . . . -82.73 -44.63 15.39 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-O 121.858 0.837 . . . . 0.0 108.968 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -39.88 141.06 0.47 Allowed 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 113.707 -1.588 . . . . 0.0 110.951 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 67' ' ' THR . 72.0 m-20 -56.32 -19.09 12.86 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.048 179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.508 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 2.2 t80 -129.96 125.36 35.25 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.709 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.423 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.5 t-160 -96.04 107.95 20.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.919 0.39 . . . . 0.0 110.867 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.493 ' HA ' HG12 ' A' ' 43' ' ' ILE . 8.0 mp -92.35 163.82 13.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.877 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.11 165.58 7.1 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.308 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.407 ' HA ' ' NE ' ' A' ' 70' ' ' ARG . 24.8 p-10 -73.89 72.76 1.59 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.88 0.371 . . . . 0.0 111.017 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.404 HD13 HD12 ' A' ' 141' ' ' LEU . 2.3 mp -107.78 119.91 58.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.09 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.88 -33.52 75.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.943 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.6 mmp_? -60.94 -23.36 65.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.099 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.4 mt -101.55 151.2 22.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.979 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 99.3 p -94.29 165.81 12.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.454 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.529 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 m-20 -42.8 -53.93 4.36 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.372 0.606 . . . . 0.0 109.694 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.654 ' HB2' HD12 ' A' ' 104' ' ' ILE . 4.6 mttm -118.82 81.86 1.76 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 177.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.537 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.8 t60 -59.42 -47.18 86.44 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.454 -177.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.51 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 33.3 p90 -143.62 159.86 41.7 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 119.967 -0.693 . . . . 0.0 112.041 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.68 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.6 tt0 -136.0 141.78 44.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.93 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.597 ' C ' HG13 ' A' ' 65' ' ' VAL . 65.5 mt -117.82 128.68 74.94 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.093 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.546 HD11 ' CD2' ' A' ' 100' ' ' LEU . 0.7 OUTLIER -113.94 147.24 38.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.018 0.437 . . . . 0.0 111.43 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.841 HD13 ' CG1' ' A' ' 33' ' ' VAL . 5.2 tp -125.1 132.24 53.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.386 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 164.12 -157.84 30.25 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.334 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 57.18 92.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.756 0.313 . . . . 0.0 110.934 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 63.35 -79.89 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.95 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -174.3 43.69 0.14 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.41 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -121.68 170.14 10.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.87 0.367 . . . . 0.0 110.933 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.708 ' O ' HD12 ' A' ' 100' ' ' LEU . 1.2 mt -107.4 151.01 26.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.802 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.708 HD12 ' O ' ' A' ' 99' ' ' LEU . 4.5 mp -133.0 144.71 50.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.447 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.633 HD11 HD12 ' A' ' 145' ' ' ILE . 0.7 OUTLIER -112.79 121.83 45.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.225 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.516 ' HB2' HD23 ' A' ' 92' ' ' LEU . 49.4 t30 -115.59 115.52 26.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.992 0.425 . . . . 0.0 111.617 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.845 ' OD2' HG23 ' A' ' 116' ' ' VAL . 8.4 p30 -79.1 136.89 37.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.906 178.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.654 HD12 ' HB2' ' A' ' 87' ' ' LYS . 9.0 pt -143.62 38.11 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.636 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.46 151.2 20.85 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 121.066 0.46 . . . . 0.0 111.735 -179.185 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 55.1 m -68.87 -31.63 70.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.996 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -98.09 -19.97 17.63 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.636 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.42 154.61 9.41 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.144 -1.027 . . . . 0.0 113.801 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.508 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.1 m -117.62 137.92 52.3 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.849 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -115.76 148.41 39.85 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -178.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.409 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.15 113.5 18.42 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.08 177.423 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.2 m120 44.65 43.18 6.42 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.15 -8.69 75.65 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.49 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -105.36 118.55 36.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.127 0.489 . . . . 0.0 110.774 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.849 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 14.8 tptp -73.21 119.34 17.31 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.282 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.845 HG23 ' OD2' ' A' ' 103' ' ' ASP . 13.1 m -91.06 164.37 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.278 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 120' ' ' SER . 4.1 tp10 -69.93 126.21 29.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.655 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.685 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 24.7 tttm -52.29 161.51 0.64 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.896 0.379 . . . . 0.0 110.694 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 34.35 35.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.325 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.19 145.01 40.62 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.049 179.362 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.541 ' HB3' HD23 ' A' ' 100' ' ' LEU . 68.8 m-20 -88.92 127.34 35.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.987 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -129.34 146.35 51.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.747 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.434 HD13 ' C ' ' A' ' 123' ' ' LEU . 1.6 tm? -72.82 113.7 10.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.026 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.615 HD11 ' HG ' ' A' ' 101' ' ' LEU . 1.0 OUTLIER -53.42 165.85 0.34 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.679 0.752 . . . . 0.0 112.003 -178.898 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.448 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -125.29 153.3 43.45 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.383 179.347 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.553 ' HA ' HD12 ' A' ' 147' ' ' ILE . 1.0 OUTLIER -71.51 120.08 16.59 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.85 21.39 65.36 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.064 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.448 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 9.4 t70 -57.93 173.69 0.31 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.963 0.411 . . . . 0.0 111.065 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 13.9 tt0 -145.26 135.52 24.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.246 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 1.068 HD11 HD11 ' A' ' 145' ' ' ILE . 4.2 mt -109.52 128.33 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.177 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.668 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.8 m -104.07 139.55 39.01 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.506 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.6 m -140.15 158.36 25.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.24 44.1 10.0 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.885 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.473 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.9 t -83.35 140.41 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-O 121.742 0.782 . . . . 0.0 112.393 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.77 -37.61 0.88 Allowed Glycine 0 N--CA 1.436 -1.319 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.473 HG12 ' H ' ' A' ' 138' ' ' SER . 48.8 t -126.39 123.72 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 114.598 -0.801 . . . . 0.0 109.155 178.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -50.48 -33.41 21.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.623 0.249 . . . . 0.0 111.585 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.473 ' H ' HG12 ' A' ' 136' ' ' VAL . 40.2 t -93.43 6.49 47.99 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.426 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 5.6 t0 -125.51 28.29 6.3 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.668 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.9 mt -107.11 139.56 28.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.874 178.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.674 HD22 ' CD2' ' A' ' 143' ' ' LEU . 1.0 OUTLIER -115.6 134.49 55.0 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.752 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.536 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.8 OUTLIER -112.19 136.75 51.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.03 0.443 . . . . 0.0 111.704 -179.472 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.674 ' CD2' HD22 ' A' ' 141' ' ' LEU . 2.9 mm? -130.88 138.52 49.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.352 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.434 HG21 ' CG2' ' A' ' 39' ' ' THR . 20.8 t -110.76 137.13 44.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.957 0.408 . . . . 0.0 111.608 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 1.068 HD11 HD11 ' A' ' 130' ' ' ILE . 49.6 mt -106.19 127.39 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.086 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.2 115.79 28.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.642 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.553 HD12 ' HA ' ' A' ' 126' ' ' GLN . 6.5 mt -84.76 129.32 37.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.893 0.378 . . . . 0.0 111.331 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.96 116.78 17.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.942 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -65.36 -31.13 72.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.891 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -58.7 -44.35 90.31 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.975 0.417 . . . . 0.0 110.568 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -58.65 -44.02 89.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.777 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -64.33 -39.02 93.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.918 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -60.27 -42.58 95.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.981 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.741 ' SG ' HD13 ' A' ' 52' ' ' ILE . 8.9 t -68.05 -45.03 75.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.94 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.08 -35.95 77.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.891 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -66.35 -47.89 71.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.989 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.52 -37.14 32.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.99 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 44.56 -172.53 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.507 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.88 132.93 51.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.964 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.506 HG12 ' H ' ' A' ' 162' ' ' ARG . 21.5 t -99.25 137.52 26.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.169 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.89 -37.02 85.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.506 ' H ' HG12 ' A' ' 160' ' ' VAL . 0.1 OUTLIER -94.67 146.01 24.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 5.0 mt -87.7 113.83 25.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.098 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.866 -179.927 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.913 0.387 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.5 p -99.23 35.2 1.97 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.988 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -60.0 -47.13 87.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.627 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -71.19 -35.78 71.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.615 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.29 -39.3 82.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.859 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.61 -40.83 93.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.852 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.508 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.2 mm -70.29 -35.1 61.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.199 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -57.03 -37.58 71.95 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.866 0.365 . . . . 0.0 110.454 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -67.29 -23.83 65.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.666 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.508 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.92 -47.27 81.01 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.169 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.11 -30.47 43.8 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.833 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -89.0 53.07 2.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.92 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.67 123.23 25.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.874 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -65.55 137.09 57.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.882 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.4 mm -82.04 138.39 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-O 121.729 0.776 . . . . 0.0 111.733 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 157.7 42.59 0.02 OUTLIER Glycine 0 C--N 1.314 -0.677 0 CA-C-N 114.453 -1.248 . . . . 0.0 112.613 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.56 -43.11 99.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 110.755 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.524 ' O ' ' HB3' ' A' ' 49' ' ' SER . 4.7 m-20 -178.84 37.95 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.682 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 6.9 mm -71.25 142.02 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 CA-C-N 113.678 -1.601 . . . . 0.0 112.495 -176.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.727 HG21 HD22 ' A' ' 93' ' ' LEU . 0.9 OUTLIER -104.38 -46.84 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.551 -178.933 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.67 ' SG ' HD12 ' A' ' 48' ' ' LEU . 28.4 p -163.0 145.56 10.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.127 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.461 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.94 134.68 54.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.874 0.368 . . . . 0.0 111.674 -178.867 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.594 HG13 HD11 ' A' ' 48' ' ' LEU . 3.4 m -99.77 122.71 51.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.469 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.775 HG23 HG12 ' A' ' 45' ' ' ILE . 19.3 mt -128.01 121.03 55.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.605 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.581 ' HA ' HD13 ' A' ' 143' ' ' LEU . 12.6 t -84.04 124.71 31.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.636 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.7 t -95.36 -25.05 16.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.517 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.546 HG21 ' H ' ' A' ' 142' ' ' SER . 17.5 p -79.88 -2.13 42.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.506 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.15 74.13 0.52 Allowed Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.532 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.506 ' CB ' HD11 ' A' ' 141' ' ' LEU . 2.3 mt-30 -145.31 -39.46 0.25 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.777 0.322 . . . . 0.0 111.168 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.81 HD13 HD22 ' A' ' 78' ' ' LEU . 2.2 mt -122.19 140.57 32.67 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.843 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.545 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.3 Cg_endo -73.59 138.93 27.54 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.236 1.957 . . . . 0.0 112.225 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.775 HG12 HG23 ' A' ' 37' ' ' ILE . 39.5 mt -57.49 141.46 14.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.562 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.96 164.28 28.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.343 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.461 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 1.4 p-10 -116.21 119.86 37.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.146 0.498 . . . . 0.0 111.932 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.67 HD12 ' SG ' ' A' ' 34' ' ' CYS . 4.4 mt -98.5 137.27 37.41 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.682 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.6 158.77 43.8 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -178.415 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.708 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . -145.06 141.83 29.2 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.519 -1.673 . . . . 0.0 110.673 178.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.841 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -81.18 136.59 35.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.123 0.487 . . . . 0.0 111.275 -179.544 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.571 ' N ' HD12 ' A' ' 52' ' ' ILE . 2.6 mp -65.34 -44.58 94.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.282 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.6 m -59.52 -43.14 93.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.944 -178.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.546 ' HG3' ' O ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -68.62 -36.88 79.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.946 0.403 . . . . 0.0 110.654 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.847 HG13 ' HG3' ' A' ' 63' ' ' LYS . 59.1 t -68.74 -41.81 82.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.972 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.03 -30.18 66.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.795 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -64.83 -45.82 84.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.981 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -101.79 98.98 9.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.5 33.51 2.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.872 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.8 mtm180 -73.41 -65.21 0.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.942 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.9 m -177.35 -39.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.868 HD11 ' CG2' ' A' ' 65' ' ' VAL . 9.0 tp -115.44 148.55 18.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.995 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.847 ' HG3' HG13 ' A' ' 55' ' ' VAL . 16.1 mmtm -127.08 -63.8 1.04 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.767 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.401 ' HE2' ' O ' ' A' ' 49' ' ' SER . 4.5 ttpt -145.71 130.62 18.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.172 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.868 ' CG2' HD11 ' A' ' 62' ' ' ILE . 13.0 t -126.93 139.11 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 121.264 0.554 . . . . 0.0 112.2 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.613 ' CD1' HD22 ' A' ' 48' ' ' LEU . 16.4 m-90 -100.87 139.8 36.05 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.144 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.973 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.44 127.65 55.75 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.321 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.546 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -119.64 145.21 46.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.96 -178.944 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.548 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.51 -169.66 38.62 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.199 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.56 1.43 22.58 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.914 ' ND2' ' HB3' ' A' ' 73' ' ' ALA . 57.2 t30 -84.97 132.49 45.64 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.578 0.228 . . . . 0.0 111.36 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.43 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 15.9 Cg_exo -67.21 -13.23 38.85 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.678 2.252 . . . . 0.0 111.776 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.914 ' HB3' ' ND2' ' A' ' 71' ' ' ASN . . . -82.85 -43.69 16.33 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-O 121.901 0.858 . . . . 0.0 109.029 178.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.428 ' HG ' ' HA ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -39.66 142.01 0.35 Allowed 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 113.688 -1.596 . . . . 0.0 111.2 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.1 m-20 -56.25 -19.12 12.61 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.981 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.501 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 5.8 t80 -129.63 127.61 40.96 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.666 0.269 . . . . 0.0 110.871 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.43 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.7 t-160 -102.13 108.73 20.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.888 0.375 . . . . 0.0 110.905 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.81 HD22 HD13 ' A' ' 43' ' ' ILE . 14.0 mt -82.61 -174.72 5.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.91 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -68.27 -89.32 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.446 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -179.3 71.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.842 0.353 . . . . 0.0 110.829 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 24.5 mm -108.38 123.77 64.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.001 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.69 -35.28 77.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.984 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.91 -22.08 63.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.261 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.558 HD21 HG23 ' A' ' 132' ' ' VAL . 21.1 mt -96.22 152.08 18.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.014 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 45.6 p -96.87 164.68 12.45 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.515 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.548 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -41.43 -53.61 3.32 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.497 0.665 . . . . 0.0 109.811 179.161 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.634 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.6 OUTLIER -119.86 83.59 2.07 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 177.324 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.567 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.6 t60 -60.53 -46.04 91.63 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.089 -0.959 . . . . 0.0 112.568 -177.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.5 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 18.1 p90 -143.72 162.64 35.47 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 119.863 -0.735 . . . . 0.0 112.441 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.973 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.57 135.06 40.01 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.059 -179.118 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.59 ' C ' HG13 ' A' ' 65' ' ' VAL . 52.0 mt -113.26 129.12 69.56 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.773 178.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.514 ' CB ' HG22 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -113.97 147.99 37.64 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.0 0.429 . . . . 0.0 111.527 -179.582 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.828 HD12 ' HG ' ' A' ' 99' ' ' LEU . 0.9 OUTLIER -125.01 122.9 38.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.517 179.567 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.414 ' HA2' ' CG ' ' A' ' 63' ' ' LYS . . . -151.22 -166.1 13.49 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.472 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 59.12 -172.84 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.772 0.32 . . . . 0.0 110.698 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.65 62.5 3.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.988 0.423 . . . . 0.0 110.927 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 101.2 -18.41 54.26 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.797 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.5 151.12 17.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.92 0.391 . . . . 0.0 110.985 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.828 ' HG ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -126.51 147.81 49.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.657 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.743 HD13 ' O ' ' A' ' 122' ' ' GLN . 4.5 mm? -132.98 145.73 51.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.564 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 1.099 HD21 HD13 ' A' ' 124' ' ' LEU . 6.0 mt -112.7 127.94 56.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.03 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.43 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 47.0 t30 -119.34 115.92 25.12 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.828 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.8 p30 -77.92 135.95 37.94 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.973 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.434 HD12 ' HB2' ' A' ' 87' ' ' LYS . 9.0 pt -143.84 40.1 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 111.56 0.208 . . . . 0.0 111.56 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.713 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.07 150.93 20.9 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-O 120.994 0.426 . . . . 0.0 111.877 -178.77 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 51.0 m -68.67 -31.89 71.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.694 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -98.56 -19.69 17.46 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.713 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.25 157.26 10.29 Favored Glycine 0 N--CA 1.439 -1.125 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.565 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.495 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.3 m -117.48 137.95 52.19 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.824 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -115.83 148.83 39.49 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -177.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.47 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.12 113.38 18.27 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.428 177.654 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.418 ' N ' HD12 ' A' ' 111' ' ' LEU . 3.4 m120 44.21 43.26 5.69 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.84 -17.34 53.51 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.416 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.8 tp60 -103.63 118.46 36.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.042 0.449 . . . . 0.0 110.471 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.824 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -70.4 138.87 51.66 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.264 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.828 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.4 m -105.91 165.81 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.853 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 120' ' ' SER . 22.6 mt-10 -69.8 124.93 25.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.631 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.687 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 14.7 tttt -52.53 163.11 0.46 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.778 0.323 . . . . 0.0 110.778 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.5 m-80 33.38 35.11 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.182 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.26 145.08 40.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.247 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -88.39 129.89 35.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.843 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.743 ' O ' HD13 ' A' ' 100' ' ' LEU . 44.5 mm-40 -129.11 148.47 51.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.672 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.8 tp -72.49 122.12 20.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.876 0.37 . . . . 0.0 110.412 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 1.099 HD13 HD21 ' A' ' 101' ' ' LEU . 67.6 tp -58.86 155.89 12.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.456 0.646 . . . . 0.0 111.61 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.417 ' H ' HD12 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -124.75 153.43 42.43 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.689 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.417 ' OE1' HD12 ' A' ' 147' ' ' ILE . 7.2 mm100 -71.53 121.46 18.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.886 0.374 . . . . 0.0 110.122 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.22 22.22 57.94 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.199 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.411 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 21.8 t0 -54.92 173.93 0.08 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 120.877 0.37 . . . . 0.0 110.893 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.866 ' CG ' HG22 ' A' ' 144' ' ' VAL . 10.4 mt-10 -145.16 135.38 23.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.235 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.887 HD11 HD11 ' A' ' 145' ' ' ILE . 13.6 mt -113.9 128.18 70.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.081 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.566 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.9 m -104.25 138.28 40.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.062 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.558 HG23 HD21 ' A' ' 84' ' ' LEU . 33.5 m -140.28 158.13 25.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.86 32.12 18.95 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.852 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 140' ' ' ILE . 55.3 t -73.79 140.37 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-O 121.679 0.752 . . . . 0.0 112.516 -179.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 159.26 -40.33 0.48 Allowed Glycine 0 N--CA 1.436 -1.307 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.144 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.449 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 49.1 t -126.36 137.51 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -50.69 -43.03 57.48 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.0 t -93.3 6.23 48.82 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.449 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 13.2 t0 -116.09 27.19 9.42 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -178.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.566 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.1 mt -107.43 139.46 29.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.127 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.763 HD23 ' N ' ' A' ' 142' ' ' SER . 4.3 tt -121.37 134.39 55.12 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.449 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.763 ' N ' HD23 ' A' ' 141' ' ' LEU . 48.1 t -111.33 151.08 28.82 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.592 0.711 . . . . 0.0 112.5 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.581 HD13 ' HA ' ' A' ' 38' ' ' CYS . 1.8 mm? -135.39 147.37 49.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.32 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.866 HG22 ' CG ' ' A' ' 129' ' ' GLU . 18.5 t -113.71 137.38 47.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.818 0.342 . . . . 0.0 111.125 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.887 HD11 HD11 ' A' ' 130' ' ' ILE . 39.8 mt -106.31 120.9 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.077 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.35 115.58 29.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.592 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.753 HG12 HD21 ' A' ' 124' ' ' LEU . 3.7 mt -84.65 133.16 29.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.33 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -83.55 108.46 16.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.939 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.19 -25.71 64.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.006 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.6 tptp -57.5 -42.95 83.73 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.013 0.435 . . . . 0.0 110.66 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.423 ' CZ ' HD21 ' A' ' 93' ' ' LEU . 28.4 t80 -59.34 -43.95 92.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.776 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.64 -33.99 74.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.852 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -68.44 -46.46 69.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.858 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 7.6 t -68.07 -41.08 82.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.907 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.0 -41.08 82.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.859 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -59.14 -48.03 83.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -80.59 -32.63 36.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.836 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.0 p30 42.55 92.71 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.555 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.96 130.08 40.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.862 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 9.2 m -82.42 118.4 30.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.186 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.84 -31.14 8.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.917 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 62.14 116.19 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.951 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.7 pt -80.11 138.5 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.126 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 30.4 ttt180 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.865 179.997 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.781 0.324 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.6 p -132.64 -64.31 0.76 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.94 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -71.94 -47.08 54.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.015 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.09 -45.82 89.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.991 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -59.99 -35.0 74.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.956 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.25 -40.71 94.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.886 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.632 HG23 ' CE2' ' A' ' 23' ' ' PHE . 43.0 mm -68.84 -48.17 72.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.037 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.75 -33.67 71.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.4 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -58.74 -47.1 85.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.372 -0.377 . . . . 0.0 112.0 -178.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.632 ' CE2' HG23 ' A' ' 20' ' ' ILE . 4.5 p90 -71.89 -47.38 53.1 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.967 0.413 . . . . 0.0 111.033 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.537 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 1.2 m -58.4 -46.87 85.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.039 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -121.15 108.98 14.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.884 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -66.23 131.65 46.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.816 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.71 106.9 19.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.928 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.6 mm -81.95 138.29 19.75 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-O 121.613 0.721 . . . . 0.0 111.673 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -174.76 66.16 0.1 Allowed Glycine 0 C--N 1.314 -0.683 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.474 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -77.04 -38.36 52.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.802 0.334 . . . . 0.0 110.845 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.439 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 t-20 175.52 39.55 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.686 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.8 mm -71.93 136.16 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 CA-C-N 113.557 -1.656 . . . . 0.0 112.666 -177.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.966 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.8 t -92.28 -58.56 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.545 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.568 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.07 153.89 37.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.83 179.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.462 ' NH2' HD13 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -113.89 138.38 50.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.831 0.348 . . . . 0.0 111.02 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.811 HG21 ' HE2' ' A' ' 68' ' ' PHE . 19.8 t -103.32 122.96 56.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.212 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.698 HG23 HD11 ' A' ' 45' ' ' ILE . 19.8 mt -128.3 119.13 49.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.873 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 50.4 t -84.78 118.6 24.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.205 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.97 -22.11 27.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.911 -179.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.528 HG21 ' H ' ' A' ' 142' ' ' SER . 69.6 p -79.81 -2.09 41.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.687 0.279 . . . . 0.0 111.579 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.14 73.18 0.56 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.83 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.413 ' HB2' HD11 ' A' ' 141' ' ' LEU . 7.8 mt-30 -145.28 -43.3 0.22 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.88 0.371 . . . . 0.0 111.014 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.781 HD13 ' HG ' ' A' ' 78' ' ' LEU . 7.7 mt -115.63 140.61 26.24 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.945 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.529 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 66.2 Cg_endo -76.1 146.08 28.47 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.295 1.997 . . . . 0.0 112.237 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.698 HD11 HG23 ' A' ' 37' ' ' ILE . 14.6 mt -57.35 148.2 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.549 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -139.41 161.76 36.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.348 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.68 119.77 37.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.065 0.459 . . . . 0.0 111.954 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.538 HD22 ' CD1' ' A' ' 66' ' ' TRP . 8.0 mt -95.69 134.46 38.57 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.966 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.91 157.46 43.9 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -178.952 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.484 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -143.63 141.97 30.82 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.421 -1.718 . . . . 0.0 110.505 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.829 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -74.87 141.86 44.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.336 0.589 . . . . 0.0 111.608 -179.197 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.606 HD13 ' SG ' ' A' ' 154' ' ' CYS . 31.3 mt -64.93 -44.65 96.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.236 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.55 -42.39 87.74 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.486 -178.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.457 ' CG ' ' O ' ' A' ' 51' ' ' ASP . 3.1 pt20 -68.27 -36.85 80.03 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.492 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.829 HG23 ' O ' ' A' ' 51' ' ' ASP . 47.5 t -71.54 -41.87 72.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.982 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.05 -38.32 72.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.962 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -43.98 70.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.959 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.19 128.3 33.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.866 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.68 31.09 2.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.056 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.37 -63.1 1.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.885 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.3 t -176.96 -50.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.867 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.622 HD12 HD13 ' A' ' 92' ' ' LEU . 24.7 mm -114.09 150.17 16.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.071 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.96 -59.47 1.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.84 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.435 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.7 ttpt -140.35 131.33 26.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.965 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.678 HG12 ' HG2' ' A' ' 90' ' ' GLN . 7.8 t -127.75 139.06 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-O 121.266 0.555 . . . . 0.0 112.224 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.538 ' CD1' HD22 ' A' ' 48' ' ' LEU . 16.4 m-90 -101.04 139.26 36.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.882 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.632 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -113.04 131.64 55.71 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.69 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.811 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -118.29 145.24 45.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.669 -178.291 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.95 -172.26 36.43 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.312 -0.946 . . . . 0.0 113.932 178.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.734 ' NH2' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -72.32 -3.67 25.2 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.88 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.453 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -84.51 128.85 59.82 Favored Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 121.191 -0.204 . . . . 0.0 111.036 -179.603 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.5 Cg_exo -67.24 -9.36 24.9 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.525 2.15 . . . . 0.0 111.574 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.8 -42.88 17.36 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -40.37 138.25 0.94 Allowed 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 113.879 -1.509 . . . . 0.0 110.247 179.165 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -56.33 -18.77 11.83 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.915 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.568 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 13.3 t80 -129.88 127.18 39.66 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.881 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -101.65 121.14 41.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.572 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.781 ' HG ' HD13 ' A' ' 43' ' ' ILE . 6.5 mp -95.56 -82.48 0.38 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.241 -179.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.98 -135.95 1.96 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.733 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -133.07 57.3 1.81 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.916 0.388 . . . . 0.0 111.191 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.452 HG22 ' H ' ' A' ' 83' ' ' ARG . 16.8 mt -107.06 121.53 60.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.04 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.2 m -60.83 -24.89 66.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.35 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.452 ' H ' HG22 ' A' ' 81' ' ' ILE . 5.2 mmp_? -60.48 -26.71 67.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.642 0.258 . . . . 0.0 111.353 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.736 HD21 ' CG2' ' A' ' 132' ' ' VAL . 4.8 mp -107.05 153.37 22.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.919 0.39 . . . . 0.0 111.184 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 79.9 p -89.28 167.7 12.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.427 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.625 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.5 m-20 -42.48 -54.89 3.68 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.363 0.601 . . . . 0.0 109.75 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.519 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -118.31 84.15 2.13 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 177.009 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.55 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 17.6 t60 -60.39 -46.31 90.43 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.752 -176.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.509 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 30.0 p90 -146.84 160.49 42.22 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.447 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.678 ' HG2' HG12 ' A' ' 65' ' ' VAL . 3.8 tt0 -135.66 143.18 45.34 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.015 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.765 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 56.6 mt -118.52 130.29 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.981 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.622 HD13 HD12 ' A' ' 62' ' ' ILE . 0.5 OUTLIER -111.37 149.6 30.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.025 0.441 . . . . 0.0 111.87 -179.549 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.676 HD22 HG11 ' A' ' 33' ' ' VAL . 36.2 tp -125.13 122.89 38.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.344 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.84 -160.42 19.73 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.706 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.7 172.48 7.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.798 0.332 . . . . 0.0 111.005 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.499 ' C ' HD22 ' A' ' 155' ' ' LEU . 1.1 m-20 58.34 -174.34 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.913 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -91.03 48.05 2.96 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.426 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -126.95 135.67 51.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.876 0.37 . . . . 0.0 110.851 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.805 HD21 HG12 ' A' ' 33' ' ' VAL . 4.8 mp -114.58 160.05 19.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.769 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.942 HD22 ' HB3' ' A' ' 121' ' ' ASN . 4.6 mt -132.84 143.86 49.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.412 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.78 128.43 56.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.244 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.446 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 52.6 t30 -118.58 115.78 25.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.911 0.386 . . . . 0.0 111.745 -179.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.763 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.5 p30 -77.73 139.98 39.45 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.508 HD12 ' HB2' ' A' ' 87' ' ' LYS . 8.3 pt -147.4 38.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 111.538 0.199 . . . . 0.0 111.538 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.688 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.0 150.96 21.44 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.05 0.452 . . . . 0.0 112.127 -178.538 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 39.8 m -68.79 -31.32 70.25 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.573 177.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -97.38 -19.79 18.24 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.609 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.688 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 115.77 156.31 10.93 Favored Glycine 0 N--CA 1.438 -1.21 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.671 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.0 m -117.53 137.84 52.3 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.859 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -114.83 148.5 38.42 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -178.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.475 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.15 113.42 18.31 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.415 177.536 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.415 ' N ' HD12 ' A' ' 111' ' ' LEU . 91.7 m-20 44.37 43.26 5.99 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.74 -10.78 68.66 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.792 -0.718 . . . . 0.0 113.458 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -104.82 118.58 36.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.067 0.46 . . . . 0.0 110.635 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.859 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 15.1 tptp -73.37 122.25 21.75 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.318 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.763 HG23 ' OD2' ' A' ' 103' ' ' ASP . 7.3 m -93.94 165.53 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.242 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 120' ' ' SER . 16.7 mt-10 -69.86 128.51 36.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.522 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.69 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 15.9 tttp -54.47 163.93 0.8 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.9 OUTLIER 34.35 36.41 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.816 -179.183 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.407 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.7 p -111.96 145.09 40.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.914 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.942 ' HB3' HD22 ' A' ' 100' ' ' LEU . 3.4 m-80 -94.62 129.59 41.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.932 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.781 ' O ' HD23 ' A' ' 100' ' ' LEU . 62.5 mm-40 -129.08 149.42 50.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.389 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.522 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.6 tm? -72.63 122.05 20.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.874 0.369 . . . . 0.0 110.26 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.575 HD21 HG12 ' A' ' 147' ' ' ILE . 65.0 tp -54.16 156.44 3.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.397 0.618 . . . . 0.0 111.866 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.401 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.4 OUTLIER -124.55 153.48 42.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.544 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.457 ' HA ' HD12 ' A' ' 147' ' ' ILE . 2.2 tp-100 -71.59 122.26 20.2 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.95 22.58 57.89 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.928 -178.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -52.15 170.7 0.06 Allowed 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.941 0.4 . . . . 0.0 111.095 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.688 ' HG3' HG22 ' A' ' 144' ' ' VAL . 9.5 tt0 -145.11 135.47 24.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.266 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.481 HD11 HD11 ' A' ' 145' ' ' ILE . 17.6 mt -115.6 127.53 73.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.604 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.596 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.5 m -104.49 140.61 37.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.082 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.736 ' CG2' HD21 ' A' ' 84' ' ' LEU . 35.2 m -140.34 158.42 25.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 112.216 0.451 . . . . 0.0 112.216 -178.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.2 43.03 8.92 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.806 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.474 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.9 t -84.72 140.53 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 121.686 0.755 . . . . 0.0 112.502 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.98 -38.32 0.8 Allowed Glycine 0 N--CA 1.435 -1.401 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.533 HG12 ' H ' ' A' ' 138' ' ' SER . 57.7 t -126.39 120.2 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-N 114.518 -0.841 . . . . 0.0 109.001 177.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.408 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -50.45 -28.43 8.29 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.708 0.289 . . . . 0.0 111.494 -178.555 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.533 ' H ' HG12 ' A' ' 136' ' ' VAL . 2.2 p -93.61 6.52 48.0 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.43 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.6 OUTLIER -131.18 31.15 4.45 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -179.017 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.596 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.9 mt -107.16 139.47 28.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.647 178.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.455 HD23 ' C ' ' A' ' 141' ' ' LEU . 9.5 tt -123.64 134.46 53.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.928 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.528 ' H ' HG21 ' A' ' 40' ' ' THR . 45.2 t -109.73 150.4 28.37 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.618 0.723 . . . . 0.0 112.29 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 65.2 mt -135.81 139.12 43.23 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.963 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.688 HG22 ' HG3' ' A' ' 129' ' ' GLU . 19.2 t -112.4 139.08 38.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.858 0.361 . . . . 0.0 111.09 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.481 HD11 HD11 ' A' ' 130' ' ' ILE . 31.4 mt -106.3 129.6 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.029 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.62 ' CD1' HD12 ' A' ' 37' ' ' ILE . 0.9 OUTLIER -113.68 116.29 29.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.832 179.881 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.575 HG12 HD21 ' A' ' 124' ' ' LEU . 6.2 mt -84.88 134.14 27.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.681 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.7 109.77 20.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.699 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -62.36 -30.6 71.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.059 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -42.27 84.39 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.969 0.414 . . . . 0.0 110.721 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -60.66 -44.07 96.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.887 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 16.4 mtmm -64.32 -33.77 76.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.069 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -58.86 -44.09 90.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.118 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.606 ' SG ' HD13 ' A' ' 52' ' ' ILE . 10.8 t -63.79 -46.1 86.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.016 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.499 HD22 ' C ' ' A' ' 96' ' ' ASP . 0.1 OUTLIER -66.46 -35.81 81.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.922 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -61.21 -39.37 89.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.869 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 159' ' ' LYS . 28.8 mt-30 -88.96 -30.77 18.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.28 -90.82 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.63 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 157' ' ' GLN . 0.2 OUTLIER -104.51 127.64 52.26 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.846 0.355 . . . . 0.0 110.945 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.52 ' O ' HG13 ' A' ' 160' ' ' VAL . 12.5 p -77.75 117.94 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.138 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -119.94 124.92 47.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.914 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 69.8 mtt-85 -109.35 79.72 1.24 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 10.8 tt -87.77 140.07 16.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.107 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.795 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.788 0.328 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.98 -53.26 2.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -64.44 -41.46 96.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.938 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -70.94 -36.97 72.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -58.4 -39.88 80.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.793 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.42 -32.53 73.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.746 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.429 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.0 mt -73.04 -35.34 48.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.947 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -57.21 -43.53 82.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.912 0.387 . . . . 0.0 110.612 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -67.09 -24.26 65.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.529 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.429 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -57.0 -47.7 80.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.131 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.2 m -81.11 -41.87 21.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.105 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 66.19 -174.14 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.582 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -62.87 127.92 33.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.893 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -75.87 104.55 6.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.877 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.6 mm -82.05 138.37 19.6 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-O 121.621 0.724 . . . . 0.0 111.685 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.418 ' CA ' HG12 ' A' ' 32' ' ' ILE . . . 147.77 120.23 1.15 Allowed Glycine 0 C--N 1.314 -0.679 0 CA-C-N 114.598 -1.183 . . . . 0.0 112.555 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -75.82 -28.65 58.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.767 0.318 . . . . 0.0 110.976 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.436 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.6 m-20 -178.48 37.16 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.66 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.5 mm -76.26 137.15 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 CA-C-N 113.706 -1.588 . . . . 0.0 112.603 -177.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.965 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.4 t -91.97 -58.47 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.641 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 66.2 m -146.18 165.28 29.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.466 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.74 124.52 31.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.773 0.321 . . . . 0.0 111.171 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.69 HG21 ' HE2' ' A' ' 68' ' ' PHE . 55.7 t -94.9 122.96 46.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.012 0.434 . . . . 0.0 111.132 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.786 HG23 HG12 ' A' ' 45' ' ' ILE . 20.9 mt -124.68 122.69 64.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.057 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.714 ' HA ' HD13 ' A' ' 143' ' ' LEU . 42.3 t -79.96 112.88 17.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.831 0.348 . . . . 0.0 110.544 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.452 ' CG2' HG21 ' A' ' 144' ' ' VAL . 0.3 OUTLIER -80.48 -25.26 38.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.508 -179.301 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.504 HG23 ' HB3' ' A' ' 142' ' ' SER . 82.3 p -80.04 -2.36 43.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.738 0.304 . . . . 0.0 111.422 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.97 76.48 0.25 Allowed Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.924 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.436 ' HB2' HD11 ' A' ' 141' ' ' LEU . 12.5 mt-30 -147.14 -44.12 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.88 0.372 . . . . 0.0 110.931 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.576 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.1 mt -114.99 141.7 27.34 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.944 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.576 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 45.5 Cg_endo -71.15 145.34 48.96 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.2 1.933 . . . . 0.0 112.285 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.786 HG12 HG23 ' A' ' 37' ' ' ILE . 36.0 mt -60.13 138.81 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.722 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.83 164.33 20.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.294 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -120.82 119.68 33.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.997 0.427 . . . . 0.0 111.839 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.764 HD23 ' CD2' ' A' ' 66' ' ' TRP . 6.9 mp -92.14 130.41 37.87 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.965 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -141.58 155.81 45.74 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 122.2 1.0 . . . . 0.0 113.641 -179.581 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.483 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.23 142.06 29.19 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.468 -1.696 . . . . 0.0 110.934 179.049 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.827 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -75.46 127.42 33.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.078 0.466 . . . . 0.0 111.102 -179.657 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.59 HD13 ' SG ' ' A' ' 154' ' ' CYS . 59.3 mt -64.41 -43.1 96.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.029 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 t -61.0 -39.94 91.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.228 0.537 . . . . 0.0 110.581 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.47 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 24.5 mm-40 -68.53 -36.82 79.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.735 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.827 HG23 ' O ' ' A' ' 51' ' ' ASP . 49.1 t -71.83 -42.97 69.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.012 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.5 tt -71.06 -42.02 69.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.981 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 15.0 mmtp -64.47 -38.91 92.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.946 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -73.15 132.35 43.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.879 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -106.04 32.9 4.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.946 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -106.17 178.24 4.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.88 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 75.3 m -86.81 -30.29 21.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.859 HD11 HG22 ' A' ' 65' ' ' VAL . 9.0 tp -108.77 147.2 13.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.087 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.612 ' HG2' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -125.86 -73.67 0.62 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.75 179.867 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.419 ' CE ' ' O ' ' A' ' 49' ' ' SER . 3.9 ttpt -135.81 127.86 29.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.865 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.859 HG22 HD11 ' A' ' 62' ' ' ILE . 6.3 t -121.59 137.14 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 121.283 0.563 . . . . 0.0 111.876 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.764 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.5 m-90 -102.41 139.41 38.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.274 -0.876 . . . . 0.0 112.151 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.663 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.33 130.52 56.25 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 177.699 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.698 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.7 OUTLIER -117.65 145.49 44.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.392 -178.897 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.637 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.0 -169.05 36.52 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.776 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -81.7 4.26 22.48 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -84.77 132.47 46.2 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.469 0.176 . . . . 0.0 111.11 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.33 -13.81 41.47 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.488 2.125 . . . . 0.0 111.612 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.83 -42.7 17.51 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 121.921 0.867 . . . . 0.0 109.03 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -41.88 138.94 1.37 Allowed 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 113.831 -1.531 . . . . 0.0 111.081 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 67' ' ' THR . 20.3 m-20 -56.47 -18.6 11.93 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.981 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.481 ' CZ ' HG21 ' A' ' 43' ' ' ILE . 23.9 t80 -129.52 118.87 22.76 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-O 120.773 0.32 . . . . 0.0 110.998 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -97.46 107.92 20.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.728 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.529 ' HB3' HD13 ' A' ' 43' ' ' ILE . 1.1 pp -112.57 177.33 4.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.812 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.83 ' O ' HD12 ' A' ' 81' ' ' ILE . . . -56.69 146.64 34.28 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.482 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -79.08 87.37 4.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.827 0.346 . . . . 0.0 110.932 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.83 HD12 ' O ' ' A' ' 79' ' ' GLY . 3.8 mp -107.33 126.12 63.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.945 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.8 m -55.22 -33.92 63.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.995 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.522 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -63.96 -28.55 69.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.927 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.468 HD12 HD13 ' A' ' 81' ' ' ILE . 19.1 mt -100.43 151.98 20.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.979 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 91.6 p -95.1 165.61 12.34 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.647 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.637 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -43.09 -52.88 5.21 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.289 0.566 . . . . 0.0 109.641 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.558 ' HB3' HG22 ' A' ' 67' ' ' THR . 2.0 mttp -118.94 82.44 1.86 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.55 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.4 t60 -59.92 -46.67 88.63 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.576 -177.052 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.5 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 26.4 p90 -145.41 160.05 42.15 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.755 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.663 ' HG3' HG23 ' A' ' 67' ' ' THR . 20.9 tt0 -136.03 140.85 44.17 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.32 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.698 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 71.2 mt -115.13 131.08 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.92 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.441 ' CA ' HG13 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -112.59 147.06 37.46 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.141 0.496 . . . . 0.0 111.891 -179.602 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.828 HD22 HG11 ' A' ' 33' ' ' VAL . 28.6 tp -125.21 122.83 38.14 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.438 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 171.82 -177.46 44.57 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.683 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 59.39 81.85 0.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.821 0.343 . . . . 0.0 110.931 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 60.09 -177.38 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.834 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -70.38 65.15 0.77 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.48 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -142.41 153.41 43.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.802 0.334 . . . . 0.0 110.926 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.692 ' O ' HD12 ' A' ' 100' ' ' LEU . 4.3 mm? -115.85 153.87 30.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.862 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.692 HD12 ' O ' ' A' ' 99' ' ' LEU . 3.9 mp -132.99 145.73 51.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.606 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.998 HD11 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -112.85 126.91 55.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.066 179.695 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.43 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 52.0 t30 -119.38 115.74 24.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.964 0.411 . . . . 0.0 112.069 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.836 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.1 p30 -76.38 141.04 41.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.739 178.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.465 HD12 ' HB2' ' A' ' 87' ' ' LYS . 8.3 pt -149.28 39.1 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.618 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.84 153.01 19.1 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-O 121.102 0.477 . . . . 0.0 111.847 -179.062 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.2 m -68.83 -31.72 70.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.058 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -98.29 -19.93 17.51 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.618 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 118.83 157.31 10.38 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.698 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.6 m -117.61 137.81 52.37 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 123.142 0.577 . . . . 0.0 109.492 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.879 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -115.61 148.66 39.37 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.465 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.16 113.62 18.56 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.478 177.535 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.42 ' N ' HD12 ' A' ' 111' ' ' LEU . 52.6 m-20 43.41 43.9 4.59 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.76 -13.64 62.21 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.608 -0.806 . . . . 0.0 113.432 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -103.78 118.52 36.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.976 0.417 . . . . 0.0 110.571 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.879 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 12.0 tptt -72.93 124.2 24.97 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.408 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.836 HG23 ' OD2' ' A' ' 103' ' ' ASP . 15.8 m -90.01 176.59 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.084 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.9 pt-20 -83.25 124.43 30.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.497 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.672 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 20.4 tttt -50.5 159.78 0.47 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.025 0.441 . . . . 0.0 111.086 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.488 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.7 p-10 34.65 33.99 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.621 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.52 145.15 40.78 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.95 179.181 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.629 ' HB3' HD23 ' A' ' 100' ' ' LEU . 77.2 m-20 -87.37 132.43 33.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.861 0.362 . . . . 0.0 110.99 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 10.1 mm100 -129.17 148.13 51.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.536 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.3 tp -72.71 118.53 15.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.056 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.689 HD21 HG12 ' A' ' 147' ' ' ILE . 66.9 tp -52.91 155.85 2.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.411 0.624 . . . . 0.0 111.719 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.445 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.76 153.29 42.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.585 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.416 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 1.2 tp60 -71.79 120.78 17.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.94 0.4 . . . . 0.0 110.417 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.21 24.82 56.11 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.357 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.478 ' HB3' HD13 ' A' ' 145' ' ' ILE . 21.5 t0 -56.67 174.5 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.87 0.367 . . . . 0.0 110.912 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -145.22 135.49 24.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.093 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.998 HD11 HD11 ' A' ' 101' ' ' LEU . 3.9 mt -114.99 128.27 72.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.483 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.673 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.6 m -104.24 140.21 38.16 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.021 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.525 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.1 m -140.31 158.33 25.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.4 35.66 19.54 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.086 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.474 ' HA ' HG12 ' A' ' 140' ' ' ILE . 63.3 t -76.1 140.4 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-O 121.666 0.746 . . . . 0.0 112.474 -179.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.4 -38.87 0.77 Allowed Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.445 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 51.2 t -126.33 132.88 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-N 114.754 -0.723 . . . . 0.0 109.206 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.61 -40.16 52.08 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.408 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -93.39 6.4 48.28 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -178.647 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.445 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 13.0 t0 -116.69 25.1 10.8 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.673 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.9 mt -107.36 139.42 29.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.244 178.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.499 HD21 ' CD1' ' A' ' 43' ' ' ILE . 2.7 tp -124.15 134.46 53.32 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.342 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.551 ' C ' HD22 ' A' ' 143' ' ' LEU . 37.2 t -113.04 150.46 31.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.59 0.71 . . . . 0.0 112.743 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.714 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.5 mm? -135.91 142.33 44.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.646 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.452 HG21 ' CG2' ' A' ' 39' ' ' THR . 21.9 t -114.25 135.34 54.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.86 0.362 . . . . 0.0 111.254 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.594 HD11 HG13 ' A' ' 130' ' ' ILE . 1.2 mp -105.59 127.56 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.375 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.58 120.03 40.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.662 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.689 HG12 HD21 ' A' ' 124' ' ' LEU . 4.9 mt -84.92 134.08 27.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.48 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.4 106.81 13.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.775 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.42 -32.12 68.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.016 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.31 -45.14 92.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.59 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -59.0 -44.23 91.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.915 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.26 -36.52 84.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.072 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -59.0 -46.4 88.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.149 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.59 ' SG ' HD13 ' A' ' 52' ' ' ILE . 11.4 t -59.36 -44.63 92.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.03 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.13 -36.01 77.02 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.886 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.98 -48.15 59.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.987 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.51 -36.51 44.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.949 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 42.63 85.78 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.487 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 11.0 tttt -110.03 115.84 30.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.921 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 5.9 m -100.09 119.98 48.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.116 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 22.8 t0 60.04 108.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.924 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.99 94.93 9.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.809 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.5 mt -79.02 118.92 27.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.078 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.941 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 15' ' ' THR . . . . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.801 0.334 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 14' ' ' ALA . 0.8 OUTLIER -158.92 -74.59 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.946 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -69.11 -46.92 66.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.833 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.4 ttm180 -63.73 -35.96 82.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.98 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -56.87 -42.29 79.51 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.885 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.65 -32.36 68.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.691 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.451 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.3 mt -73.14 -35.2 47.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.84 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -39.77 76.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.92 0.39 . . . . 0.0 110.503 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.416 ' HA ' ' HG3' ' A' ' 25' ' ' GLN . 0.8 OUTLIER -67.1 -24.51 65.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.622 179.303 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.451 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -57.17 -47.59 80.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.619 -179.83 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.34 -47.25 18.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.28 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.416 ' HG3' ' HA ' ' A' ' 22' ' ' LYS . 1.1 pp0? -84.54 114.75 22.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.899 0.381 . . . . 0.0 110.989 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -87.7 142.39 27.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.911 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -77.88 124.17 27.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.6 mm -81.97 138.39 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 CA-C-O 121.654 0.74 . . . . 0.0 111.705 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 140.11 110.26 0.86 Allowed Glycine 0 C--N 1.315 -0.614 0 CA-C-N 114.431 -1.258 . . . . 0.0 112.51 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.4 -28.31 34.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.826 0.346 . . . . 0.0 110.946 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.433 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.8 OUTLIER 178.59 38.29 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.721 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.9 mm -73.21 134.76 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 CA-C-N 113.621 -1.627 . . . . 0.0 112.479 -177.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.037 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -89.91 -60.12 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.829 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.602 ' SG ' HD12 ' A' ' 48' ' ' LEU . 6.7 p -150.13 150.87 32.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.147 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.421 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.85 138.16 50.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.224 -179.416 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.779 HG21 ' HE2' ' A' ' 68' ' ' PHE . 22.7 t -104.65 122.69 57.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.016 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.783 HG23 HG12 ' A' ' 45' ' ' ILE . 16.3 mt -125.78 125.69 68.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.42 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.711 ' HA ' HD13 ' A' ' 143' ' ' LEU . 44.3 t -82.11 120.08 24.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.844 0.354 . . . . 0.0 110.543 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.5 t -86.0 -27.75 24.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.499 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.535 HG21 ' H ' ' A' ' 142' ' ' SER . 42.4 p -79.82 -2.26 42.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.554 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.97 77.91 0.2 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.86 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.607 ' CD ' HD11 ' A' ' 141' ' ' LEU . 11.1 mt-30 -146.73 -44.89 0.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.845 0.355 . . . . 0.0 110.921 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.816 HD13 HD22 ' A' ' 78' ' ' LEU . 3.5 mt -113.93 141.52 26.35 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.062 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.562 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 58.1 Cg_endo -73.32 140.8 31.04 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.156 1.904 . . . . 0.0 112.199 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.783 HG12 HG23 ' A' ' 37' ' ' ILE . 33.6 mt -55.16 141.44 11.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.737 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.425 ' HB2' ' CE2' ' A' ' 76' ' ' TYR . 0.4 OUTLIER -131.49 163.92 26.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.087 179.503 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.421 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.3 OUTLIER -119.35 119.84 35.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.103 0.478 . . . . 0.0 111.78 -179.659 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.608 HD11 HG23 ' A' ' 36' ' ' VAL . 1.3 mt -98.53 135.59 39.86 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.037 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.37 159.52 42.93 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -178.573 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.487 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -141.96 141.68 32.93 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.699 -1.591 . . . . 0.0 110.55 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.866 ' O ' HG23 ' A' ' 55' ' ' VAL . 45.3 m-20 -79.48 131.58 36.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.104 0.478 . . . . 0.0 111.445 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.2 mm -64.48 -45.04 96.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.971 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.6 m -59.41 -40.62 87.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.183 0.516 . . . . 0.0 110.744 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.448 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 10.0 mm-40 -68.45 -36.98 79.78 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.783 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 51' ' ' ASP . 57.5 t -69.48 -41.5 80.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.95 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.19 -33.79 70.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.942 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.46 -44.34 19.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.085 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -62.87 117.43 6.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.007 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.1 -26.73 14.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.923 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -55.24 174.87 0.08 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.006 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.755 ' O ' HG22 ' A' ' 62' ' ' ILE . 59.9 p -69.21 133.08 47.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.01 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.755 HG22 ' O ' ' A' ' 61' ' ' SER . 9.1 tp 54.32 155.52 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.783 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.812 ' HG3' HG13 ' A' ' 55' ' ' VAL . 31.9 mmtm -105.17 -70.06 0.79 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.15 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.424 ' CE ' ' O ' ' A' ' 49' ' ' SER . 29.2 ttpt -134.77 139.72 45.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.866 0.365 . . . . 0.0 111.07 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.666 HG12 ' HG2' ' A' ' 90' ' ' GLN . 11.1 t -127.24 139.28 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 121.166 0.508 . . . . 0.0 111.703 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.55 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 19.2 m-90 -100.94 138.4 38.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.249 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.709 HG22 ' HB3' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -113.46 127.11 55.99 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.364 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.779 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -108.9 145.64 35.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.592 -178.255 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.777 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 173.01 -175.26 45.98 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.512 -0.852 . . . . 0.0 113.196 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.415 ' NH1' ' HB2' ' A' ' 70' ' ' ARG . 5.0 mtp-105 -82.93 -4.67 58.49 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.633 0.254 . . . . 0.0 111.454 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.463 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.6 p30 -88.3 139.56 30.26 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-O 120.789 0.328 . . . . 0.0 111.229 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 9.1 Cg_exo -69.46 -4.41 13.77 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.842 2.361 . . . . 0.0 111.809 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.64 -45.96 13.87 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-O 121.932 0.872 . . . . 0.0 108.936 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.26 139.45 1.91 Allowed 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 113.746 -1.57 . . . . 0.0 110.424 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -56.29 -19.19 13.15 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.013 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.559 ' HE1' HD23 ' A' ' 78' ' ' LEU . 39.3 t80 -130.13 121.44 26.31 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.905 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -88.41 116.51 26.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.804 0.335 . . . . 0.0 110.726 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.816 HD22 HD13 ' A' ' 43' ' ' ILE . 86.6 mt -92.62 -82.87 0.32 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.229 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -170.3 -100.68 0.14 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.468 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -176.64 71.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.845 0.355 . . . . 0.0 111.285 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.541 HD13 HD12 ' A' ' 84' ' ' LEU . 4.6 mp -110.6 121.8 63.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.684 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.95 -38.07 67.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.501 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.0 mmp_? -60.71 -19.93 59.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.764 0.316 . . . . 0.0 110.912 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.541 HD12 HD13 ' A' ' 81' ' ' ILE . 34.7 mt -101.91 152.33 21.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.792 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 86' ' ' ASN . 96.3 p -97.91 170.68 8.78 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.508 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.777 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.3 m-20 -41.05 -80.64 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.709 ' HB3' HG22 ' A' ' 67' ' ' THR . 13.8 mttm -92.86 83.17 4.73 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.547 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 17.3 t60 -57.71 -46.14 84.77 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.033 -177.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.517 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 16.3 p90 -145.87 158.71 43.85 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.486 -0.486 . . . . 0.0 112.076 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.688 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.1 tt0 -135.72 142.04 44.97 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.254 -178.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.592 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 59.3 mt -117.6 131.68 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.671 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.633 HD12 HD13 ' A' ' 62' ' ' ILE . 0.6 OUTLIER -114.2 143.61 44.54 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.041 0.448 . . . . 0.0 111.876 -179.296 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.734 HD23 ' HG ' ' A' ' 99' ' ' LEU . 2.3 tm? -125.34 126.56 45.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.441 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.499 ' N ' HD22 ' A' ' 93' ' ' LEU . . . 169.84 -145.85 9.55 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.443 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 56.82 -172.8 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.643 0.259 . . . . 0.0 110.638 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -69.89 66.15 0.24 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.944 0.402 . . . . 0.0 110.675 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.24 -174.57 55.25 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.432 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 66.82 -178.04 0.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.871 0.367 . . . . 0.0 111.048 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.945 HD11 HG12 ' A' ' 33' ' ' VAL . 1.1 mt -130.86 160.21 35.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.866 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.796 HD13 ' O ' ' A' ' 122' ' ' GLN . 4.0 mm? -129.9 142.35 50.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.275 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.711 HD11 ' HA ' ' A' ' 124' ' ' LEU . 3.5 mp -112.83 128.73 56.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.289 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.411 ' HB2' HD23 ' A' ' 92' ' ' LEU . 47.1 t30 -119.79 115.56 24.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.053 0.454 . . . . 0.0 111.692 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.836 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.1 p30 -78.53 137.04 37.71 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.6 HD12 ' HB2' ' A' ' 87' ' ' LYS . 10.2 pt -145.26 39.19 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -178.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.67 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.35 152.84 19.5 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 121.171 0.51 . . . . 0.0 111.867 -178.98 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 49.1 m -68.83 -31.58 70.66 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.857 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -98.19 -19.97 17.56 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.67 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.7 158.05 10.87 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.788 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.6 m -117.37 137.75 52.25 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.848 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -115.34 148.46 39.24 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -178.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.41 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.21 113.39 18.24 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.538 -1.21 . . . . 0.0 108.246 177.526 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 43.77 43.55 5.08 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.22 -10.99 68.92 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.481 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.69 118.61 37.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.087 0.47 . . . . 0.0 110.612 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.848 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 12.7 tptt -73.17 121.53 20.41 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.197 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.836 HG23 ' OD2' ' A' ' 103' ' ' ASP . 13.2 m -91.0 164.08 2.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.189 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 120' ' ' SER . 4.3 tp10 -69.82 125.35 26.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.572 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.684 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 73.9 tttt -51.96 161.35 0.59 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.858 0.361 . . . . 0.0 110.754 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 34.78 34.75 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.309 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.27 145.17 40.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.078 179.498 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.545 ' HB3' HD12 ' A' ' 100' ' ' LEU . 77.0 m-20 -89.32 129.04 35.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.04 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.796 ' O ' HD13 ' A' ' 100' ' ' LEU . 47.0 mm-40 -129.18 147.43 51.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.556 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 tp -72.7 132.76 44.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.298 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.74 HD21 HG13 ' A' ' 147' ' ' ILE . 65.9 tp -62.78 156.71 23.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.487 0.661 . . . . 0.0 111.624 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.406 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.47 153.31 42.19 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.056 179.707 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.554 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.05 117.88 13.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.024 0.44 . . . . 0.0 110.244 -179.446 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.8 24.42 64.47 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.015 -178.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.406 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 16.9 t70 -53.43 171.92 0.07 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.901 0.381 . . . . 0.0 110.955 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.83 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.8 mt-10 -145.15 135.52 24.13 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.098 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.651 HD11 HD23 ' A' ' 101' ' ' LEU . 13.7 mt -114.25 126.57 71.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.483 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.553 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.3 m -104.42 139.09 39.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.955 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.496 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.2 m -140.25 158.32 25.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.74 32.87 17.31 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.84 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.484 ' HA ' HG12 ' A' ' 140' ' ' ILE . 54.6 t -75.75 140.48 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-O 121.629 0.728 . . . . 0.0 112.478 -179.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.01 -38.39 0.69 Allowed Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.517 HG12 ' H ' ' A' ' 138' ' ' SER . 49.7 t -126.32 124.45 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 CA-C-N 114.666 -0.767 . . . . 0.0 109.125 178.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.47 -32.65 18.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.73 0.3 . . . . 0.0 111.381 -178.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.517 ' H ' HG12 ' A' ' 136' ' ' VAL . 31.3 t -93.45 6.47 48.06 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.414 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 5.7 t0 -127.93 30.62 5.24 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.553 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.6 mt -107.13 139.52 28.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.784 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.607 HD11 ' CD ' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -122.42 134.3 54.61 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.752 -179.793 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.644 ' C ' HD22 ' A' ' 143' ' ' LEU . 46.6 t -110.82 150.58 28.93 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.59 0.709 . . . . 0.0 112.157 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.711 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.5 mm? -136.02 149.42 48.8 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.597 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.83 HG22 ' CG ' ' A' ' 129' ' ' GLU . 11.8 t -117.55 135.76 56.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.712 0.292 . . . . 0.0 110.978 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.657 HG21 HD11 ' A' ' 124' ' ' LEU . 3.6 mt -106.57 124.63 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-O 121.044 0.45 . . . . 0.0 111.046 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.465 ' HD2' HD12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -107.93 139.68 42.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.365 179.498 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.74 HG13 HD21 ' A' ' 124' ' ' LEU . 3.3 mp -105.65 134.08 48.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.91 0.386 . . . . 0.0 111.552 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -85.93 112.27 21.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.625 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -57.52 -27.85 62.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.122 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -60.77 -46.02 92.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.809 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -59.95 -44.18 94.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.063 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.611 ' HE2' HG21 ' A' ' 147' ' ' ILE . 46.7 mttm -64.42 -41.35 96.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.953 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -59.28 -37.01 76.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.897 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.9 t -67.4 -43.84 80.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.923 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -64.71 -37.21 86.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.11 -38.32 90.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.917 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -87.04 -35.75 18.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.953 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 42.5 43.77 3.27 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.459 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -124.79 114.01 18.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.888 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.3 p -87.13 138.31 19.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.098 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -169.6 96.64 0.31 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.935 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -140.01 -52.51 0.51 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.947 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.9 tt -98.02 132.75 42.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.153 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.898 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.796 0.332 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.6 p -151.39 89.74 1.52 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -72.04 -47.05 54.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.941 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -66.94 -39.92 87.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.015 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -57.55 -40.15 78.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.915 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.15 -33.91 69.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.629 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.483 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.3 mt -73.14 -35.24 47.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.783 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -57.23 -35.2 69.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.454 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.438 ' HA ' ' CG ' ' A' ' 25' ' ' GLN . 18.1 mttp -67.03 -24.07 65.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.613 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.483 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -62.24 -47.85 82.57 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.645 -179.715 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.5 m -65.7 -47.25 76.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.777 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.438 ' CG ' ' HA ' ' A' ' 22' ' ' LYS . 3.8 pt20 -68.81 120.13 14.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.93 0.395 . . . . 0.0 111.11 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -101.01 122.46 43.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.921 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -65.03 134.57 54.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.761 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.7 mm -81.99 138.35 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 121.644 0.735 . . . . 0.0 111.69 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -162.92 71.74 0.2 Allowed Glycine 0 C--N 1.314 -0.69 0 CA-C-N 114.559 -1.201 . . . . 0.0 112.578 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.56 -37.88 55.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.863 0.363 . . . . 0.0 110.929 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.444 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.3 m-20 177.99 38.32 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.659 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.5 mm -74.14 135.63 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 CA-C-N 113.641 -1.618 . . . . 0.0 112.492 -177.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.985 HG12 HD11 ' A' ' 99' ' ' LEU . 3.4 t -90.81 -58.97 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.436 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.2 p -145.76 158.92 43.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.059 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.402 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -126.36 124.99 41.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.745 0.307 . . . . 0.0 111.528 -179.425 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.725 HG21 ' HE2' ' A' ' 68' ' ' PHE . 26.1 t -94.92 122.68 46.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.923 0.392 . . . . 0.0 110.957 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.855 HG23 HG12 ' A' ' 45' ' ' ILE . 20.7 mt -125.07 120.23 57.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.266 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.545 ' SG ' ' HB ' ' A' ' 43' ' ' ILE . 20.0 m -85.74 99.88 11.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.902 0.382 . . . . 0.0 110.532 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 82.3 p -79.09 -19.73 50.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.14 -178.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.776 HG21 ' OG ' ' A' ' 142' ' ' SER . 10.5 p -79.79 -2.7 44.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.729 0.299 . . . . 0.0 111.354 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.58 71.0 0.98 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.014 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.454 ' HB2' HD21 ' A' ' 141' ' ' LEU . 4.5 mt-30 -140.37 -39.95 0.43 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.764 0.316 . . . . 0.0 111.225 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.78 HG23 ' HD2' ' A' ' 44' ' ' PRO . 4.3 mt -133.88 145.33 55.49 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.668 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.78 ' HD2' HG23 ' A' ' 43' ' ' ILE . 41.9 Cg_endo -69.74 146.16 59.47 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.324 2.016 . . . . 0.0 112.594 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.855 HG12 HG23 ' A' ' 37' ' ' ILE . 36.8 mt -54.26 157.5 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.62 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.483 ' N ' HG22 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -145.69 164.17 32.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.282 179.625 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.402 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.4 OUTLIER -127.58 119.92 27.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.076 0.465 . . . . 0.0 111.902 -179.513 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.795 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.9 mp -95.14 128.6 42.1 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.146 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.984 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -138.37 156.78 47.29 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -179.244 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -146.59 141.89 27.41 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.412 -1.722 . . . . 0.0 110.777 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.757 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -75.31 141.77 43.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.153 0.501 . . . . 0.0 111.071 -179.676 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.695 HD13 ' SG ' ' A' ' 154' ' ' CYS . 82.2 mt -64.19 -43.8 97.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.171 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 52.6 p -56.76 -42.19 78.91 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.024 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.519 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.6 OUTLIER -68.39 -37.01 79.99 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.827 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 51' ' ' ASP . 39.4 t -72.76 -45.38 56.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.278 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.92 -30.6 66.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.092 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -81.32 -45.55 16.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.186 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.09 127.32 34.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.004 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.05 31.17 0.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.815 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -79.96 -60.98 2.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.975 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.64 -46.24 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.042 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.431 ' CD1' ' HB2' ' A' ' 92' ' ' LEU . 9.2 tp -140.12 154.06 22.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.894 0.378 . . . . 0.0 111.348 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.77 -59.15 2.0 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.913 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.434 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.7 ttpt -145.9 136.41 24.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.292 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.63 HG12 ' HG2' ' A' ' 90' ' ' GLN . 14.9 t -134.06 139.36 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 121.268 0.556 . . . . 0.0 112.003 -179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.795 ' CD2' HD23 ' A' ' 48' ' ' LEU . 18.8 m-90 -103.51 139.29 39.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.226 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.412 HG22 HD11 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -111.45 126.38 54.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.102 0.477 . . . . 0.0 109.832 177.469 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.725 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -111.6 145.6 38.89 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.17 -178.859 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.64 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.39 -176.62 40.28 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.245 -0.978 . . . . 0.0 113.547 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.454 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 1.2 ttp180 -73.23 -7.39 51.26 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.417 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.1 t30 -84.81 135.51 40.07 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.791 0.329 . . . . 0.0 111.322 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 9.7 Cg_exo -70.14 -6.43 18.76 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.957 2.438 . . . . 0.0 112.087 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.409 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.63 -44.17 16.08 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-O 121.971 0.891 . . . . 0.0 108.63 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -41.91 138.7 1.45 Allowed 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 113.537 -1.665 . . . . 0.0 110.416 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -56.26 -19.31 13.5 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.024 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.553 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 21.1 t80 -130.21 122.55 28.33 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.661 179.24 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.403 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.2 t-160 -90.62 140.95 29.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.774 0.321 . . . . 0.0 110.958 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.731 HD23 HD13 ' A' ' 84' ' ' LEU . 8.2 mp -100.17 -89.5 0.33 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.145 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.51 -81.71 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.553 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -176.2 56.42 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.772 0.32 . . . . 0.0 111.426 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.662 HD13 ' CD1' ' A' ' 84' ' ' LEU . 2.9 mp -104.88 111.83 35.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.786 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.4 m -55.22 -36.61 66.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.289 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -61.0 -18.83 59.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.279 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.731 HD13 HD23 ' A' ' 78' ' ' LEU . 18.9 mt -102.69 149.34 24.55 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.759 0.314 . . . . 0.0 111.026 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 88.2 p -92.41 167.17 12.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.711 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.64 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.8 m-20 -43.53 -53.25 5.7 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.286 0.565 . . . . 0.0 109.832 179.24 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.431 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 2.7 ptmt -120.88 82.46 1.92 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.553 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.8 t60 -59.62 -47.12 86.85 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.707 -176.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.506 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 28.2 p90 -146.48 159.8 42.94 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.666 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.63 ' HG2' HG12 ' A' ' 65' ' ' VAL . 37.5 tt0 -135.77 141.2 44.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.145 -179.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.592 ' O ' HG13 ' A' ' 65' ' ' VAL . 50.8 mt -114.28 131.03 67.49 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.205 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.126 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.603 HD21 ' HB3' ' A' ' 100' ' ' LEU . 0.7 OUTLIER -112.64 149.04 33.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.009 0.433 . . . . 0.0 111.595 -179.674 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.843 HD22 HG11 ' A' ' 33' ' ' VAL . 29.1 tp -124.93 123.05 39.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.631 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.0 -163.83 17.81 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.475 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 59.39 20.16 8.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.699 0.285 . . . . 0.0 111.21 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 55.55 97.86 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.249 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.87 -54.61 3.71 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.671 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.41 ' O ' HD12 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -56.61 154.26 9.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.808 0.337 . . . . 0.0 111.075 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.985 HD11 HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -128.9 150.89 50.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.902 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.645 HD12 ' O ' ' A' ' 99' ' ' LEU . 2.6 mp -133.14 146.56 51.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.151 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.781 HD23 HD11 ' A' ' 130' ' ' ILE . 4.9 mp -112.65 129.35 56.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.259 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 90' ' ' GLN . 53.3 t30 -117.91 115.49 25.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.886 0.374 . . . . 0.0 111.829 -179.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.799 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.3 p30 -77.2 140.49 40.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.781 178.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' A' ' 89' ' ' PHE . 19.0 pt -149.5 38.74 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.655 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.1 152.6 19.67 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.095 0.474 . . . . 0.0 111.906 -178.842 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 47.9 m -68.93 -31.45 70.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.731 177.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -98.17 -19.81 17.67 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.655 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.84 157.18 10.55 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.359 -0.924 . . . . 0.0 113.895 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.1 m -117.42 137.88 52.2 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.81 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -116.67 148.37 41.08 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -177.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.897 HD12 HG11 ' A' ' 116' ' ' VAL . 0.9 OUTLIER -124.33 113.56 18.38 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.043 177.384 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 47.43 35.77 4.41 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.141 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.81 -7.41 76.99 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.564 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.8 118.58 37.04 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.059 0.457 . . . . 0.0 110.736 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.81 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -71.52 128.06 34.59 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.219 -179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.897 HG11 HD12 ' A' ' 111' ' ' LEU . 9.8 m -101.34 167.68 2.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.464 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 120' ' ' SER . 4.6 mm-40 -69.91 125.81 27.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.539 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.697 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 68.8 tttt -54.2 162.71 0.97 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.892 0.377 . . . . 0.0 110.618 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.5 m-80 35.21 34.02 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.241 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.29 145.14 40.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.027 179.481 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.592 ' HB3' HD23 ' A' ' 100' ' ' LEU . 4.8 m120 -85.87 132.13 34.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.021 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.426 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 32.5 mm-40 -129.46 146.27 51.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.768 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 124' ' ' LEU . 1.0 OUTLIER -72.98 122.92 22.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.312 179.503 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.757 HD21 HG12 ' A' ' 147' ' ' ILE . 59.6 tp -59.61 155.59 15.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.511 0.672 . . . . 0.0 111.554 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.435 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.8 153.2 42.86 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.33 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.74 120.49 17.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.986 0.422 . . . . 0.0 110.263 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.81 18.4 64.09 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.403 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.537 ' OD1' HD23 ' A' ' 111' ' ' LEU . 13.2 t70 -54.18 170.16 0.15 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.016 0.436 . . . . 0.0 111.257 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 5.0 tt0 -145.23 135.49 24.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.102 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.781 HD11 HD23 ' A' ' 101' ' ' LEU . 14.6 mt -111.27 128.22 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.346 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.634 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.7 m -104.22 139.32 39.42 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.186 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.478 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 34.6 m -140.18 158.25 25.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.086 0.47 . . . . 0.0 112.217 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.67 37.91 12.96 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.908 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.1 t -79.14 140.33 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-O 121.67 0.748 . . . . 0.0 112.33 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.89 -36.97 0.89 Allowed Glycine 0 N--CA 1.436 -1.341 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.02 -179.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.476 HG12 ' H ' ' A' ' 138' ' ' SER . 48.5 t -126.37 123.74 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-N 114.621 -0.79 . . . . 0.0 109.084 178.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.57 -33.21 21.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.691 0.282 . . . . 0.0 111.617 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.476 ' H ' HG12 ' A' ' 136' ' ' VAL . 3.0 m -93.46 6.58 47.69 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.446 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 3.2 t0 -127.34 30.1 5.44 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.634 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.9 mt -106.61 139.68 27.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.797 178.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.762 HD22 HD13 ' A' ' 143' ' ' LEU . 1.0 OUTLIER -115.76 134.55 54.9 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.827 -179.678 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.776 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.3 OUTLIER -116.13 127.06 54.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.218 0.532 . . . . 0.0 111.558 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.762 HD13 HD22 ' A' ' 141' ' ' LEU . 2.3 mp -121.26 138.08 54.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.625 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 21.7 t -110.55 139.31 34.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.866 0.365 . . . . 0.0 111.18 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.463 HD12 HD21 ' A' ' 101' ' ' LEU . 49.0 mt -106.03 138.12 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.197 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.84 116.48 25.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.473 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.757 HG12 HD21 ' A' ' 124' ' ' LEU . 4.9 mt -84.88 134.04 27.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.499 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.18 105.85 15.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.595 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -58.19 -32.96 68.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.091 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -60.38 -46.02 91.44 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.031 0.444 . . . . 0.0 110.775 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -60.12 -44.12 95.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.038 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -65.11 -36.45 84.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.083 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -59.01 -40.54 85.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.102 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.695 ' SG ' HD13 ' A' ' 52' ' ' ILE . 8.4 t -68.25 -43.54 77.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.105 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.464 HD11 ' CG1' ' A' ' 55' ' ' VAL . 4.2 mm? -69.07 -50.09 51.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.385 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -33.66 71.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.073 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -87.25 -37.3 17.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.85 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.2 p30 41.53 33.42 0.29 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.502 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -109.62 135.19 50.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.893 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 30.0 m -87.62 135.32 25.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.069 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -137.43 151.91 49.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.945 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 38.8 mmm-85 -137.3 117.27 13.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.95 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.542 HD13 ' H ' ' A' ' 163' ' ' ILE . 0.2 OUTLIER -76.9 138.67 20.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.167 -179.843 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.864 -179.952 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.879 0.371 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.0 m -137.13 -47.15 0.58 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.893 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -61.53 -38.26 86.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.908 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.9 mmt85 -68.97 -37.2 78.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -58.24 -40.38 81.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.775 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.3 tp -59.37 -31.93 69.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.801 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.465 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -73.02 -35.37 48.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -57.55 -39.59 76.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.37 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.16 -23.86 65.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.672 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.465 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.64 -47.56 79.47 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.199 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.1 p -71.16 -40.6 71.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.833 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 58.44 30.52 19.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.062 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.7 120.98 27.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -109.05 111.64 23.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.7 mm -81.97 138.36 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 CA-C-O 121.657 0.742 . . . . 0.0 111.689 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 164.56 111.6 0.25 Allowed Glycine 0 C--N 1.312 -0.757 0 CA-C-N 114.493 -1.231 . . . . 0.0 112.48 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -82.55 -27.01 31.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.74 0.305 . . . . 0.0 110.938 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.404 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.5 OUTLIER 175.94 39.44 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -179.841 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.667 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.6 mm -74.83 135.06 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 CA-C-N 113.694 -1.594 . . . . 0.0 112.532 -177.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.966 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -92.72 -60.84 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.836 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.619 ' SG ' HD22 ' A' ' 48' ' ' LEU . 1.7 p -140.73 164.88 29.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.214 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.411 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -134.45 122.09 22.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.809 0.337 . . . . 0.0 111.322 -179.529 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.704 HG21 ' HE2' ' A' ' 68' ' ' PHE . 40.6 t -93.72 122.78 45.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.815 0.34 . . . . 0.0 111.04 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.831 HG23 HG12 ' A' ' 45' ' ' ILE . 14.0 mt -125.7 117.49 49.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.564 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.428 ' SG ' HD23 ' A' ' 143' ' ' LEU . 3.8 t -81.33 111.23 17.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.834 0.349 . . . . 0.0 110.34 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.1 t -86.89 -22.02 25.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.934 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.636 HG23 ' HB2' ' A' ' 142' ' ' SER . 81.6 p -79.84 -2.77 44.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.731 0.3 . . . . 0.0 111.429 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.24 75.77 0.4 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.882 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -146.9 -40.36 0.2 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.844 0.354 . . . . 0.0 111.02 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.584 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.3 mt -125.9 142.01 41.07 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.033 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.584 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 46.0 Cg_endo -70.48 146.05 54.65 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.172 1.915 . . . . 0.0 112.226 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.831 HG12 HG23 ' A' ' 37' ' ' ILE . 33.7 mt -58.91 149.5 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.824 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.32 163.88 31.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.054 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.411 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.8 OUTLIER -126.06 119.85 28.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.058 0.456 . . . . 0.0 112.011 -179.479 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.797 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.3 mp -89.57 130.89 35.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.246 178.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.966 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -140.8 156.15 46.22 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 122.412 1.101 . . . . 0.0 113.827 -179.578 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.64 141.83 28.49 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 113.352 -1.749 . . . . 0.0 110.64 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.667 ' O ' HG23 ' A' ' 55' ' ' VAL . 2.2 m-20 -77.4 132.02 38.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.159 0.505 . . . . 0.0 111.051 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.652 HG22 HD23 ' A' ' 56' ' ' LEU . 22.4 mm -64.22 -40.12 87.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.057 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.533 ' HA ' HD21 ' A' ' 56' ' ' LEU . 6.8 t -56.82 -42.09 78.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.906 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.507 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.5 OUTLIER -68.45 -36.97 79.78 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.799 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.898 HG11 HD11 ' A' ' 155' ' ' LEU . 39.7 t -67.54 -50.19 63.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.345 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.652 HD23 HG22 ' A' ' 52' ' ' ILE . 3.9 pp -64.94 -26.05 68.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.105 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.13 -53.82 6.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.907 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.21 118.48 14.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.021 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.17 28.12 4.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.824 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.3 mtt-85 -90.08 -175.76 4.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.758 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.72 31.93 2.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.977 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.677 HD11 HG22 ' A' ' 65' ' ' VAL . 8.5 tp -177.44 145.01 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.318 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.686 ' HG2' HG22 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -118.68 -72.05 0.71 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.768 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.415 ' CE ' ' O ' ' A' ' 49' ' ' SER . 21.0 ttpt -136.3 137.57 40.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.677 HG22 HD11 ' A' ' 62' ' ' ILE . 5.4 t -124.69 138.81 52.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.085 0.469 . . . . 0.0 111.852 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.797 ' CD2' HD23 ' A' ' 48' ' ' LEU . 17.0 m-90 -103.4 138.64 39.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.959 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.475 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.17 127.01 55.82 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 177.801 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.704 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -112.95 145.73 40.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.593 -178.456 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.697 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.45 -174.4 40.49 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.691 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.405 ' HD3' ' HB2' ' A' ' 84' ' ' LEU . 16.5 mtm180 -80.24 -2.82 46.68 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.488 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.0 t30 -84.87 135.99 39.35 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.791 0.329 . . . . 0.0 111.067 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.8 Cg_exo -68.86 -6.88 19.15 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.773 2.315 . . . . 0.0 111.834 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.76 -44.63 15.36 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-O 122.0 0.905 . . . . 0.0 108.56 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.07 136.68 4.72 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.694 -1.594 . . . . 0.0 110.16 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.419 ' OD2' ' CD1' ' A' ' 66' ' ' TRP . 0.7 OUTLIER -56.51 -18.92 13.13 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.89 179.431 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.521 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 53.7 t80 -130.19 130.69 45.01 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.772 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -106.93 136.95 45.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.834 0.35 . . . . 0.0 110.944 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.698 ' O ' HD12 ' A' ' 78' ' ' LEU . 0.7 OUTLIER -140.25 78.43 1.66 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.269 -179.726 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 47.25 -137.54 10.4 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.997 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -157.63 90.79 1.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.803 0.335 . . . . 0.0 111.089 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.816 HD13 HD12 ' A' ' 84' ' ' LEU . 3.8 mp -108.62 132.82 55.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.918 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.4 t -58.52 -40.43 82.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.995 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.42 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -61.02 -30.06 70.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.09 -179.82 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.816 HD12 HD13 ' A' ' 81' ' ' ILE . 30.3 mt -94.65 152.12 18.74 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.844 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 89.5 p -95.44 165.24 12.46 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.689 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.697 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.5 m-20 -42.06 -52.8 4.14 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.276 0.56 . . . . 0.0 109.816 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.428 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 5.0 ptmt -120.92 84.29 2.21 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.569 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.6 t60 -61.56 -46.24 90.74 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.971 -1.013 . . . . 0.0 113.055 -176.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.5 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 24.6 p90 -144.72 157.94 43.98 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.136 -0.625 . . . . 0.0 112.105 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.638 ' HG2' HG12 ' A' ' 65' ' ' VAL . 32.8 tt0 -135.91 140.35 44.0 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.018 -179.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.523 ' O ' HG13 ' A' ' 65' ' ' VAL . 38.5 mt -113.47 132.3 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 121.134 -0.227 . . . . 0.0 110.855 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.938 HD13 HD12 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -113.81 146.87 39.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.184 0.516 . . . . 0.0 112.022 -179.202 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.808 HD22 HG11 ' A' ' 33' ' ' VAL . 44.4 tp -125.26 122.83 38.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.439 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 127.92 127.95 3.05 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.596 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 178.44 -67.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.865 0.364 . . . . 0.0 110.737 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -146.69 -46.86 0.19 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.758 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 178.94 36.04 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.438 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -156.22 -172.17 3.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.773 0.32 . . . . 0.0 110.929 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.769 ' HB2' HD21 ' A' ' 124' ' ' LEU . 0.3 OUTLIER -120.91 155.29 34.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.696 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.938 HD12 HD13 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -133.22 147.57 51.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.818 0.342 . . . . 0.0 110.768 179.887 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.87 125.26 53.84 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.839 ' HB2' HD11 ' A' ' 92' ' ' LEU . 53.5 t30 -109.27 115.69 30.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.694 -179.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.79 ' OD2' HG23 ' A' ' 116' ' ' VAL . 18.3 p30 -76.89 131.76 38.75 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.649 178.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.437 HD13 ' HB2' ' A' ' 90' ' ' GLN . 21.6 pt -139.34 40.54 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -178.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.677 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.54 151.93 20.6 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 120.987 0.422 . . . . 0.0 111.64 -178.97 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.8 m -68.57 -31.87 71.38 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.776 178.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -98.41 -19.63 17.6 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.614 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.677 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.94 157.81 10.97 Favored Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.73 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.0 m -117.36 137.82 52.21 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.862 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -114.08 148.55 36.92 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -178.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.648 HD13 ' OD2' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -124.05 113.4 18.35 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.645 -1.161 . . . . 0.0 108.27 177.389 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.424 ' N ' HD12 ' A' ' 111' ' ' LEU . 81.4 m-20 44.51 43.08 6.1 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.385 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.47 -8.82 75.82 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.829 -0.7 . . . . 0.0 113.43 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -105.17 118.38 36.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.104 0.452 . . . . 0.0 110.764 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.862 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 12.8 tptt -74.0 122.37 22.51 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.247 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.79 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.9 m -94.05 165.56 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.204 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 120' ' ' SER . 9.7 tp10 -69.87 125.95 28.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.598 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.704 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 14.6 tttt -54.13 162.83 0.91 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.955 0.407 . . . . 0.0 110.653 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.7 OUTLIER 37.15 31.27 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.109 -179.171 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.82 144.02 43.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.164 179.203 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -93.42 129.93 39.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.786 0.326 . . . . 0.0 110.287 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -129.0 149.34 50.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.974 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.585 HD13 ' O ' ' A' ' 124' ' ' LEU . 2.1 tm? -72.69 111.64 8.03 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.769 HD21 ' HB2' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -59.88 168.17 1.9 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.318 0.58 . . . . 0.0 111.798 -178.843 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -124.29 153.65 41.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.033 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.05 116.97 11.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.108 0.48 . . . . 0.0 110.257 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.62 18.36 73.78 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.364 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.648 ' OD2' HD13 ' A' ' 111' ' ' LEU . 5.6 t70 -59.84 -179.48 0.1 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.67 0.271 . . . . 0.0 110.62 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.868 ' CG ' HG22 ' A' ' 144' ' ' VAL . 4.1 mt-10 -145.32 135.69 24.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.682 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 1.048 HD11 HD11 ' A' ' 145' ' ' ILE . 14.9 mt -109.68 126.26 66.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.023 178.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.609 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.9 m -104.49 138.68 40.51 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.209 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.52 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.1 m -140.33 158.2 25.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.26 28.28 28.26 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.15 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.492 ' HA ' HG12 ' A' ' 140' ' ' ILE . 69.7 t -70.04 140.3 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-O 121.58 0.705 . . . . 0.0 112.326 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.69 -38.47 0.76 Allowed Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.437 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 49.8 t -126.33 132.94 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 CA-C-N 114.808 -0.696 . . . . 0.0 109.335 178.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -50.54 -39.81 50.17 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.428 ' H ' HG12 ' A' ' 136' ' ' VAL . 5.7 m -93.3 6.49 47.89 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.437 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 15.3 t0 -118.74 26.82 9.29 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -179.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.609 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.5 mt -107.14 139.61 28.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.05 178.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.509 HD23 ' N ' ' A' ' 142' ' ' SER . 8.3 tt -119.3 134.51 55.17 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.582 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.636 ' HB2' HG23 ' A' ' 40' ' ' THR . 0.9 OUTLIER -111.39 135.63 51.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.066 0.46 . . . . 0.0 111.633 -179.673 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 51.0 mt -126.71 152.71 46.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.157 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.868 HG22 ' CG ' ' A' ' 129' ' ' GLU . 21.8 t -115.61 139.78 40.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.025 0.441 . . . . 0.0 111.606 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 1.048 HD11 HD11 ' A' ' 130' ' ' ILE . 18.3 mt -106.5 120.95 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.822 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.33 103.9 12.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.424 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.651 HG12 HD22 ' A' ' 124' ' ' LEU . 7.0 mt -84.86 134.05 27.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.991 0.424 . . . . 0.0 111.58 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -88.53 112.2 22.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.86 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.46 -25.9 68.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.083 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.91 -45.22 90.87 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.053 0.454 . . . . 0.0 110.664 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -58.25 -44.05 88.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.004 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -62.26 -41.21 98.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.954 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -64.74 -40.67 95.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.068 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.0 t -65.7 -45.03 84.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.976 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.898 HD11 HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -67.63 -36.04 80.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.883 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.2 -43.24 98.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.785 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.41 ' O ' ' N ' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -84.67 -31.93 23.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.884 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 42.92 -90.83 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.724 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 157' ' ' GLN . 0.9 OUTLIER -72.93 114.19 10.81 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.802 0.334 . . . . 0.0 110.991 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -87.87 140.89 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.185 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -148.89 -47.35 0.15 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.921 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.81 -57.24 13.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.953 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.6 mp -93.27 137.92 21.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.172 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.945 179.982 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.76 0.314 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 38.6 p -140.26 -50.84 0.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -72.05 -31.43 66.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.99 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.47 -36.33 82.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.801 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -39.45 79.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.809 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.78 -31.81 70.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.796 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.434 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.5 mt -72.62 -35.4 50.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.855 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -57.42 -42.69 82.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.941 0.401 . . . . 0.0 110.386 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.09 -23.93 65.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.657 179.218 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.434 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.55 -47.52 79.27 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.298 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.85 -38.96 83.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.809 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -167.95 99.51 0.46 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.893 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -73.47 127.32 32.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.902 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -82.01 114.43 20.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.818 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.0 mm -82.3 138.35 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 CA-C-O 121.687 0.756 . . . . 0.0 111.834 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -140.03 49.42 0.8 Allowed Glycine 0 C--N 1.316 -0.571 0 CA-C-N 114.435 -1.257 . . . . 0.0 112.419 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -63.63 -40.31 96.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.778 0.323 . . . . 0.0 110.888 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.41 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER -177.99 37.0 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -179.889 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.675 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.4 mm -76.85 135.85 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 CA-C-N 113.708 -1.587 . . . . 0.0 112.571 -177.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.996 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.4 t -90.37 -58.99 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.683 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 30.1 p -150.7 161.27 42.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.014 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.76 138.3 54.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.805 0.336 . . . . 0.0 111.621 -179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.722 HG11 ' CE2' ' A' ' 68' ' ' PHE . 28.4 m -106.85 122.52 60.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.825 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.834 HG23 HG12 ' A' ' 45' ' ' ILE . 19.9 mt -128.62 127.01 66.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.456 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.747 ' HA ' HD13 ' A' ' 143' ' ' LEU . 21.3 t -83.0 100.45 10.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.88 0.371 . . . . 0.0 110.459 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.7 t -69.46 -28.2 65.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.713 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.774 HG23 ' HB2' ' A' ' 142' ' ' SER . 59.5 p -80.08 -2.69 45.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.722 0.296 . . . . 0.0 111.578 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.18 79.84 0.17 Allowed Glycine 0 CA--C 1.517 0.193 0 C-N-CA 120.919 -0.658 . . . . 0.0 113.139 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -147.35 -39.88 0.19 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.78 0.324 . . . . 0.0 111.019 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.601 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.4 mt -123.84 142.58 39.78 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.988 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.601 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 37.8 Cg_endo -68.84 146.08 64.68 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.028 1.819 . . . . 0.0 112.247 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.834 HG12 HG23 ' A' ' 37' ' ' ILE . 35.4 mt -57.59 148.1 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.816 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.89 164.04 31.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.056 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -124.57 119.78 30.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.928 0.394 . . . . 0.0 111.973 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.778 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.6 mp -90.8 125.98 35.88 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.996 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -135.63 156.82 48.25 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -179.092 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.488 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -148.98 141.79 24.62 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.552 -1.658 . . . . 0.0 110.817 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.772 ' O ' HG23 ' A' ' 55' ' ' VAL . 1.4 m-20 -76.81 125.28 29.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.286 0.565 . . . . 0.0 111.239 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.785 HD13 ' SG ' ' A' ' 154' ' ' CYS . 43.1 mt -64.58 -42.83 96.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.69 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.07 -42.29 80.38 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.116 -178.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.566 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -68.72 -37.02 79.17 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.894 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 51' ' ' ASP . 48.9 t -65.9 -44.72 92.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.094 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.99 -30.48 66.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.916 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.5 mttp -73.41 -46.72 47.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.919 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.59 131.52 42.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.32 22.87 8.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.027 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -91.27 170.96 9.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.86 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.74 -53.32 8.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.693 HD12 HD13 ' A' ' 92' ' ' LEU . 26.4 mm -94.52 149.82 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.206 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.67 ' HG2' HG13 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -120.62 -53.97 2.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.842 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.432 ' HE2' ' O ' ' A' ' 49' ' ' SER . 6.7 ttpt -151.43 129.98 12.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.099 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.56 HG13 ' C ' ' A' ' 91' ' ' ILE . 10.9 t -124.04 138.52 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 121.408 0.623 . . . . 0.0 112.021 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.778 ' CD2' HD23 ' A' ' 48' ' ' LEU . 18.1 m-90 -100.97 139.86 36.06 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.824 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.983 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.86 127.68 56.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.0 0.428 . . . . 0.0 109.862 177.936 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.722 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -114.11 145.64 41.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.281 -178.966 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.655 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.68 -174.07 39.0 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.674 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.3 mtp180 -79.66 0.24 31.12 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.668 0.248 . . . . 0.0 111.668 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.687 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 10.2 t-20 -84.7 133.91 43.02 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.68 0.276 . . . . 0.0 111.056 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 13.5 Cg_exo -68.5 -8.61 23.61 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.618 2.212 . . . . 0.0 111.894 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.687 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -83.04 -43.14 16.67 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-O 121.963 0.887 . . . . 0.0 108.855 178.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.8 137.01 2.42 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 113.65 -1.613 . . . . 0.0 110.918 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -56.43 -18.73 12.17 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.016 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.511 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 63.7 t80 -129.79 123.03 29.97 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.896 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -100.71 124.81 46.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.876 0.369 . . . . 0.0 110.977 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.467 ' HB3' HD13 ' A' ' 43' ' ' ILE . 0.9 OUTLIER -125.68 -178.4 4.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.64 149.33 46.48 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.434 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -78.62 93.52 4.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.886 0.374 . . . . 0.0 110.96 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.52 HG22 ' H ' ' A' ' 83' ' ' ARG . 26.6 mm -112.09 122.14 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.958 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.6 t -54.94 -30.85 59.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.959 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.52 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -68.72 -26.62 65.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.781 179.854 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.649 HD21 HG23 ' A' ' 132' ' ' VAL . 33.7 mt -97.73 152.22 19.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.93 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.2 166.21 11.85 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.686 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.655 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -42.72 -52.83 4.8 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.471 0.653 . . . . 0.0 109.638 179.172 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.553 ' HB3' HG22 ' A' ' 67' ' ' THR . 6.4 mttt -119.51 84.85 2.27 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 177.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.546 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.2 t60 -61.87 -45.83 92.07 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.877 -177.005 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.52 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 18.9 p90 -145.81 163.24 35.64 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.127 -0.629 . . . . 0.0 112.427 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.983 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.59 136.72 41.3 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.397 -178.878 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.56 ' C ' HG13 ' A' ' 65' ' ' VAL . 35.3 mt -113.38 128.49 70.18 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.342 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.353 178.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.693 HD13 HD12 ' A' ' 62' ' ' ILE . 0.7 OUTLIER -114.36 148.35 37.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.086 0.469 . . . . 0.0 111.859 -179.415 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.703 HD13 ' CG1' ' A' ' 33' ' ' VAL . 16.8 tp -125.22 123.1 38.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.368 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.68 -156.91 16.75 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.665 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -62.98 168.49 3.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.796 0.331 . . . . 0.0 110.995 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 59.4 -168.27 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.912 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -97.2 28.24 14.88 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.468 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -103.73 129.44 51.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.918 0.39 . . . . 0.0 110.923 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.696 HD23 HD22 ' A' ' 124' ' ' LEU . 24.0 tp -107.2 154.97 20.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.796 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.79 HD13 ' O ' ' A' ' 122' ' ' GLN . 4.1 mm? -124.91 145.56 49.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.326 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.787 HD21 HD13 ' A' ' 124' ' ' LEU . 2.0 mt -112.62 124.5 52.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.041 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.551 ' HB2' HD23 ' A' ' 92' ' ' LEU . 50.6 t30 -116.99 115.7 25.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.892 0.377 . . . . 0.0 111.781 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.835 ' OD2' HG23 ' A' ' 116' ' ' VAL . 8.1 p30 -77.71 141.23 39.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.955 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.435 HD12 ' HB2' ' A' ' 87' ' ' LYS . 11.0 pt -148.46 38.33 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.602 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.34 152.35 19.55 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.051 0.453 . . . . 0.0 111.753 -179.093 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 47.6 m -68.92 -31.57 70.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.027 178.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -98.24 -19.75 17.66 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.602 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.18 155.65 9.86 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 120.178 -1.01 . . . . 0.0 113.747 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.505 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.8 m -117.65 137.82 52.39 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.864 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -116.01 148.46 40.12 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -178.221 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.41 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.01 113.52 18.53 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.356 177.575 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 43.93 43.81 5.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.36 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.55 -10.94 67.64 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.448 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.48 118.63 37.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.028 0.442 . . . . 0.0 110.638 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.864 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 12.2 tptp -73.01 122.28 21.48 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.239 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.835 HG23 ' OD2' ' A' ' 103' ' ' ASP . 14.2 m -93.18 164.61 2.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.249 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.5 tp10 -69.88 126.34 29.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.557 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.681 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 87.9 tttt -53.51 161.17 1.07 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.994 0.426 . . . . 0.0 110.727 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 34.85 34.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.437 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.46 145.1 40.78 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.133 179.384 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -86.71 130.48 34.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.66 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.79 ' O ' HD13 ' A' ' 100' ' ' LEU . 6.3 mm100 -129.32 146.49 51.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.756 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.1 tp -72.78 124.84 26.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.073 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.787 HD13 HD21 ' A' ' 101' ' ' LEU . 65.4 tp -57.21 157.34 6.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.427 0.632 . . . . 0.0 111.684 -179.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.524 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.4 OUTLIER -124.4 153.69 41.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.333 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.665 ' HA ' HD13 ' A' ' 147' ' ' ILE . 10.0 tp60 -70.96 119.05 14.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.004 0.431 . . . . 0.0 110.318 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.83 24.43 62.5 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.223 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.45 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 23.3 t0 -56.47 169.72 0.43 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.085 0.469 . . . . 0.0 111.107 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 17.2 tt0 -145.35 135.53 23.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.046 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.481 ' CG2' HG22 ' A' ' 109' ' ' THR . 13.4 mt -109.15 128.05 65.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.477 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.694 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.0 m -104.5 139.61 39.16 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.96 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.649 HG23 HD21 ' A' ' 84' ' ' LEU . 34.6 m -140.36 158.52 25.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.95 33.54 23.7 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.734 -0.667 . . . . 0.0 112.234 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.522 ' HA ' HG12 ' A' ' 140' ' ' ILE . 76.4 t -72.95 140.29 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-O 121.587 0.708 . . . . 0.0 112.386 -179.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.77 -42.17 0.8 Allowed Glycine 0 N--CA 1.436 -1.334 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -178.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.483 HG12 ' H ' ' A' ' 138' ' ' SER . 42.0 t -126.34 130.55 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-N 114.763 -0.719 . . . . 0.0 109.153 177.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -50.45 -34.0 23.15 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -178.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.483 ' H ' HG12 ' A' ' 136' ' ' VAL . 69.0 m -93.35 6.24 48.79 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.08 22.41 11.45 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -178.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.694 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.3 mt -107.12 139.42 28.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.293 178.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.569 HD22 ' CD2' ' A' ' 143' ' ' LEU . 1.2 tt -122.22 134.41 54.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.273 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.774 ' HB2' HG23 ' A' ' 40' ' ' THR . 0.7 OUTLIER -109.1 140.66 42.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.053 0.454 . . . . 0.0 111.954 -179.134 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.747 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.7 mm? -134.57 136.03 42.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.333 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 18.1 t -110.68 140.22 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.873 0.368 . . . . 0.0 111.395 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 8.4 mt -106.16 134.75 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.918 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.53 116.3 27.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.69 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.665 HD13 ' HA ' ' A' ' 126' ' ' GLN . 4.6 mp -85.6 134.04 28.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.657 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -85.01 114.71 22.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.765 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -61.34 -31.89 71.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.951 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -59.64 -45.74 91.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.954 0.407 . . . . 0.0 110.686 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -58.6 -44.05 89.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.021 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -62.24 -37.51 85.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.962 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -64.57 -47.04 80.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.05 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.785 ' SG ' HD13 ' A' ' 52' ' ' ILE . 12.3 t -63.46 -45.94 88.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.017 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -60.84 -36.09 78.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.878 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -61.61 -34.76 76.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.79 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.8 -37.12 13.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.852 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 44.66 -172.18 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.535 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.57 141.74 28.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.838 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 29.2 m -102.98 131.42 51.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.1 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -102.08 116.46 32.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.894 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.7 162.15 33.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.762 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.0 mt -95.78 124.62 48.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.035 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 44.0 ttm-85 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.869 -179.891 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.414 ' O ' ' CB ' ' A' ' 15' ' ' THR . . . . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.691 0.281 . . . . 0.0 111.048 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.414 ' CB ' ' O ' ' A' ' 14' ' ' ALA . 1.6 m 80.95 -46.75 0.25 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.453 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.69 -30.7 68.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.82 0.343 . . . . 0.0 110.963 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -66.04 -36.03 82.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.647 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -59.93 -43.22 95.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.815 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 tp -58.44 -32.98 69.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.716 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.435 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.4 mt -73.1 -35.32 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.922 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -57.07 -38.76 73.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.964 0.411 . . . . 0.0 110.487 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -67.08 -26.8 66.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.404 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.98 -47.57 80.46 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.254 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.1 m -77.06 -26.36 53.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.993 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -68.75 70.47 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.859 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.459 ' HG3' HD11 ' A' ' 28' ' ' ILE . 4.8 pt-20 -93.26 138.1 31.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -64.98 104.28 0.84 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.887 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.459 HD11 ' HG3' ' A' ' 26' ' ' GLU . 18.5 mm -81.95 138.2 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.442 0 CA-C-O 121.649 0.737 . . . . 0.0 111.617 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -139.2 51.43 0.75 Allowed Glycine 0 C--N 1.313 -0.729 0 CA-C-N 114.456 -1.247 . . . . 0.0 112.641 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.682 ' HG2' HD11 ' A' ' 32' ' ' ILE . 12.8 pt-20 -80.06 -44.02 20.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.807 0.337 . . . . 0.0 110.742 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.449 ' O ' ' HB3' ' A' ' 49' ' ' SER . 2.3 m-80 178.79 38.79 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.682 HD11 ' HG2' ' A' ' 30' ' ' GLU . 5.3 mm -71.55 142.15 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.575 0 CA-C-N 113.744 -1.571 . . . . 0.0 112.634 -176.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.767 HG22 HD13 ' A' ' 93' ' ' LEU . 1.0 OUTLIER -106.54 -50.23 8.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.663 -178.885 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.452 ' N ' HG12 ' A' ' 33' ' ' VAL . 0.5 OUTLIER -154.86 165.5 36.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.351 179.29 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.57 120.83 24.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.757 0.313 . . . . 0.0 111.012 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.824 HG21 ' CZ ' ' A' ' 68' ' ' PHE . 25.0 t -94.7 122.67 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.854 0.359 . . . . 0.0 111.126 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.878 HG23 HG12 ' A' ' 45' ' ' ILE . 13.4 mt -124.49 122.49 64.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.252 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.665 ' HA ' HD13 ' A' ' 143' ' ' LEU . 46.9 t -79.87 127.33 32.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.445 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.9 t -94.31 -29.12 15.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.814 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.552 HG21 ' H ' ' A' ' 142' ' ' SER . 43.2 p -79.87 -2.34 43.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.576 0.226 . . . . 0.0 111.462 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.22 80.86 0.21 Allowed Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.819 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.403 ' OE1' HD11 ' A' ' 141' ' ' LEU . 12.8 mt-30 -147.01 -43.78 0.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.804 0.335 . . . . 0.0 110.888 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.617 HG23 ' HD2' ' A' ' 44' ' ' PRO . 3.8 mp -120.42 142.08 33.23 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.209 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.617 ' HD2' HG23 ' A' ' 43' ' ' ILE . 56.5 Cg_endo -72.55 145.98 43.16 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.221 1.947 . . . . 0.0 112.007 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.878 HG12 HG23 ' A' ' 37' ' ' ILE . 38.2 mt -53.48 134.74 15.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.772 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.17 163.85 24.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.091 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -120.25 119.7 33.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.126 0.489 . . . . 0.0 112.002 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.58 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 5.0 mp -87.22 132.07 34.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.599 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -138.97 156.59 47.12 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 122.426 1.108 . . . . 0.0 113.572 -179.297 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.599 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . -142.99 144.66 32.4 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.831 178.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.884 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.9 OUTLIER -74.84 119.32 18.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.066 0.46 . . . . 0.0 111.296 -179.68 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.9 mt -64.46 -43.75 96.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.071 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.8 m -59.76 -40.64 88.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.223 0.535 . . . . 0.0 110.737 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.463 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 28.4 mm-40 -68.55 -36.81 79.31 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.711 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.884 HG23 ' O ' ' A' ' 51' ' ' ASP . 48.3 t -69.02 -43.41 81.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.93 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.5 HD21 ' HB2' ' A' ' 158' ' ' ASN . 0.9 OUTLIER -71.16 -31.63 67.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.785 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -74.34 -48.29 29.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.921 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -69.94 134.99 48.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.991 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.28 29.48 7.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.93 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.8 mtm-85 -92.31 -172.41 3.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.795 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.3 m -85.96 -55.93 3.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.712 HD11 ' CG2' ' A' ' 65' ' ' VAL . 8.6 tp -92.93 147.22 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.051 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.62 ' HG2' HG22 ' A' ' 55' ' ' VAL . 0.9 OUTLIER -116.98 -68.78 0.89 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.4 ' HE2' ' O ' ' A' ' 49' ' ' SER . 7.2 ttpt -143.39 130.41 20.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.34 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.712 ' CG2' HD11 ' A' ' 62' ' ' ILE . 13.0 t -126.32 139.34 51.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.292 0.567 . . . . 0.0 111.895 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.599 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 16.8 m-90 -100.76 139.85 35.87 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.165 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.778 HG23 ' CG ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -108.3 126.26 52.63 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.573 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.824 ' CZ ' HG21 ' A' ' 36' ' ' VAL . 3.0 m-85 -114.47 145.75 41.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.8 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.617 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.39 -174.35 36.28 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.188 -1.006 . . . . 0.0 113.362 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 6.7 mtm105 -75.61 0.49 17.31 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.732 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 9.5 t-20 -84.66 133.35 44.2 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.667 0.27 . . . . 0.0 111.414 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.8 Cg_exo -68.6 -10.46 29.11 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.655 2.236 . . . . 0.0 111.754 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.732 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -83.21 -43.45 16.11 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-O 121.915 0.864 . . . . 0.0 108.781 178.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -41.37 137.75 1.4 Allowed 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.959 179.631 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.32 -18.3 10.33 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.241 179.29 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.558 ' CG ' ' CE2' ' A' ' 68' ' ' PHE . 19.8 t80 -127.21 116.25 20.32 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.811 0.338 . . . . 0.0 110.64 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -94.14 118.32 31.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.159 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.562 HD21 ' CA ' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -125.43 -178.08 4.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.557 179.689 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -54.42 -175.23 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.231 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -120.27 90.64 3.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.832 0.349 . . . . 0.0 110.607 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.592 HD12 ' CD1' ' A' ' 84' ' ' LEU . 24.8 mt -107.08 137.43 38.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.446 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 40.1 t -62.53 -38.75 91.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.768 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.488 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -62.49 -33.25 74.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.949 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.592 ' CD1' HD12 ' A' ' 81' ' ' ILE . 30.0 mt -91.21 152.24 20.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.015 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 92.3 p -97.14 165.53 12.01 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.53 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.617 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.0 m-20 -42.81 -53.99 4.34 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.314 0.578 . . . . 0.0 109.745 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.545 ' HB2' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -118.22 83.81 2.07 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 177.144 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.558 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.0 t60 -61.19 -45.41 94.7 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.802 -1.09 . . . . 0.0 113.162 -176.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.531 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 29.5 p90 -145.98 163.23 35.83 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 119.966 -0.694 . . . . 0.0 112.552 -179.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.778 ' CG ' HG23 ' A' ' 67' ' ' THR . 8.2 mt-30 -135.35 145.09 47.05 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.382 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.548 ' O ' HG13 ' A' ' 65' ' ' VAL . 3.2 mp -118.62 132.36 68.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 178.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.491 ' CB ' HG22 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -118.01 148.93 41.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.227 0.537 . . . . 0.0 111.988 -179.018 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.767 HD13 HG22 ' A' ' 33' ' ' VAL . 0.5 OUTLIER -125.1 122.88 38.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.037 179.143 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.68 174.64 21.93 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.871 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.63 95.22 9.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.766 0.317 . . . . 0.0 110.849 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -171.89 -41.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.838 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 136.93 -19.07 3.51 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.645 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -102.16 175.46 5.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.752 0.31 . . . . 0.0 110.995 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.667 ' CD1' HD12 ' A' ' 93' ' ' LEU . 4.0 mm? -122.01 160.0 25.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.876 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.616 HD12 ' O ' ' A' ' 99' ' ' LEU . 2.3 mp -132.69 142.89 49.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.999 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.76 129.47 56.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.341 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.431 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 50.1 t30 -117.8 115.7 25.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.862 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.787 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.0 p30 -78.65 141.41 38.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.999 178.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.463 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 14.9 pt -148.33 38.58 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -178.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.635 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.09 152.99 19.24 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.14 0.495 . . . . 0.0 111.676 -179.162 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 51.1 m -68.87 -31.84 71.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.961 178.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -98.46 -19.92 17.4 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.635 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.59 157.22 10.23 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.267 -0.968 . . . . 0.0 113.797 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.518 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.7 m -117.53 138.05 52.16 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.881 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -115.04 148.49 38.81 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -178.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.424 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.13 113.43 18.33 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.337 177.406 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.3 m120 44.38 43.22 5.97 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.81 -9.96 72.09 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.408 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -105.27 118.57 36.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.007 0.432 . . . . 0.0 110.746 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.881 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 19.1 tptt -73.63 130.25 39.65 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.184 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.787 HG23 ' OD2' ' A' ' 103' ' ' ASP . 8.0 m -103.09 165.95 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.363 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.415 ' HB3' ' HB3' ' A' ' 120' ' ' SER . 5.3 tp10 -69.95 127.0 31.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.564 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.678 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 30.3 tttp -52.62 161.96 0.64 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.739 0.305 . . . . 0.0 110.455 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 35.08 35.68 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.132 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.415 ' HB3' ' HB3' ' A' ' 117' ' ' GLU . 4.2 p -112.01 145.15 40.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.644 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -93.33 129.53 39.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.757 0.313 . . . . 0.0 110.925 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.44 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 59.7 mm-40 -129.21 151.85 49.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.536 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.9 tp -72.6 112.23 8.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.85 0.357 . . . . 0.0 110.288 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.883 HD11 HG21 ' A' ' 145' ' ' ILE . 66.3 tp -53.05 158.91 1.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.266 0.555 . . . . 0.0 111.575 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.412 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.6 OUTLIER -124.11 153.29 41.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.555 -179.779 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.32 122.55 20.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.87 0.367 . . . . 0.0 110.327 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.38 21.23 56.79 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.186 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.406 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 11.1 t70 -56.56 175.8 0.11 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.815 0.34 . . . . 0.0 110.9 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.877 ' CG ' HG22 ' A' ' 144' ' ' VAL . 4.6 mt-10 -145.27 135.75 24.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.242 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.952 HD11 HD11 ' A' ' 145' ' ' ILE . 12.3 mt -112.23 128.26 68.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.523 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.65 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.1 m -104.23 140.16 38.24 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.056 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.478 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 33.3 m -140.22 158.4 25.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.095 0.474 . . . . 0.0 112.233 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.95 44.56 8.98 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.86 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.466 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.3 t -84.33 140.5 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-O 121.684 0.754 . . . . 0.0 112.631 -178.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.64 -41.14 0.59 Allowed Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 138' ' ' SER . 48.2 t -126.45 125.43 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-N 114.674 -0.763 . . . . 0.0 109.07 177.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.46 -30.25 12.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.805 0.336 . . . . 0.0 111.279 -178.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.567 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -93.62 6.48 48.12 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.341 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -126.94 27.74 5.92 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.65 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.6 mt -107.18 139.44 28.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.283 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.605 HD23 ' N ' ' A' ' 142' ' ' SER . 2.7 tt -120.72 134.53 55.28 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.383 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.605 ' N ' HD23 ' A' ' 141' ' ' LEU . 44.0 t -113.58 150.68 32.69 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.694 0.759 . . . . 0.0 112.57 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.665 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.7 mm? -135.78 151.37 50.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.454 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.877 HG22 ' CG ' ' A' ' 129' ' ' GLU . 16.5 t -116.35 135.62 55.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.902 0.382 . . . . 0.0 111.265 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.952 HD11 HD11 ' A' ' 130' ' ' ILE . 40.9 mt -106.45 121.99 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.988 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.52 116.93 31.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.707 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.474 HG12 HD21 ' A' ' 124' ' ' LEU . 5.0 mt -84.82 134.2 27.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.581 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -82.05 115.44 21.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.776 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.89 -28.81 68.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.14 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -59.63 -45.77 90.97 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.989 0.423 . . . . 0.0 110.749 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -59.06 -44.13 91.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.892 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 25.9 mtpt -65.0 -34.38 78.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.975 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.12 -44.22 89.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.952 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.2 t -68.07 -42.44 80.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.965 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.82 -37.74 88.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.963 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.67 -40.41 92.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.952 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -87.02 -36.93 17.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.023 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.5 ' HB2' HD21 ' A' ' 56' ' ' LEU . 3.7 p-10 44.8 -172.42 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.599 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -73.69 143.35 46.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.968 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 23.5 m -100.78 134.21 41.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.051 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -111.8 33.08 4.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.887 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 14.9 ttt-85 -95.16 154.59 17.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.942 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.1 mp -77.8 138.08 21.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.13 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 8.5 ttt85 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.977 179.94 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.058 0 CA-C-O 120.859 0.361 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.5 -60.78 0.14 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.962 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -70.4 -44.76 67.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -60.67 -42.62 97.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.889 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -60.18 -39.11 85.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.909 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 mt -60.27 -44.79 95.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.875 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.3 mm -63.3 -40.15 87.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.168 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -57.91 -33.82 69.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.12 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -65.38 -33.79 76.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.257 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -56.9 -47.46 80.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.062 0.458 . . . . 0.0 111.058 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.5 p -64.3 -43.0 96.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.787 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 59.45 100.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.52 ' HG3' HD11 ' A' ' 28' ' ' ILE . 1.0 OUTLIER -81.92 141.69 33.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.846 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.51 107.02 17.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.927 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.52 HD11 ' HG3' ' A' ' 26' ' ' GLU . 20.4 mm -82.33 138.32 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 CA-C-O 121.684 0.754 . . . . 0.0 111.792 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.59 43.54 0.22 Allowed Glycine 0 C--N 1.315 -0.619 0 CA-C-N 114.552 -1.204 . . . . 0.0 112.47 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -78.44 -41.67 32.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.775 0.322 . . . . 0.0 111.09 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.433 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER -171.06 34.72 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -179.822 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.663 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 2.7 mm -75.36 134.87 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 CA-C-N 113.897 -1.501 . . . . 0.0 112.363 -177.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.963 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -93.73 -61.19 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.232 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -143.97 154.07 42.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.724 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.17 138.1 51.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.832 0.349 . . . . 0.0 111.135 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.715 HG21 ' CE2' ' A' ' 68' ' ' PHE . 18.8 t -105.29 122.67 58.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.054 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.687 HG23 HG12 ' A' ' 45' ' ' ILE . 19.3 mt -128.84 118.23 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.5 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.655 ' HA ' HD13 ' A' ' 143' ' ' LEU . 38.2 t -80.34 123.37 27.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.313 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.401 HG23 HG21 ' A' ' 144' ' ' VAL . 0.2 OUTLIER -91.59 -25.55 19.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.677 -179.36 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.534 HG21 ' H ' ' A' ' 142' ' ' SER . 43.1 p -79.81 -2.29 42.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.64 0.257 . . . . 0.0 111.541 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.12 75.19 0.41 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.851 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -146.21 -44.24 0.2 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.866 0.365 . . . . 0.0 110.963 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.537 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -114.95 140.88 26.1 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.784 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.537 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.2 Cg_endo -73.28 145.93 39.47 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.183 1.922 . . . . 0.0 112.33 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.687 HG12 HG23 ' A' ' 37' ' ' ILE . 35.2 mt -57.68 141.46 14.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.547 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -137.18 164.02 29.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.313 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.88 119.83 32.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.977 0.418 . . . . 0.0 111.614 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.55 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 6.0 mt -91.35 137.17 32.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.298 178.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.963 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -144.17 157.42 44.31 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 -179.123 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.502 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -151.04 148.49 28.4 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.874 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.737 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -75.02 125.24 28.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.192 0.52 . . . . 0.0 110.976 -179.727 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.7 mt -64.42 -41.48 92.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.672 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.91 -42.29 79.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.294 0.569 . . . . 0.0 111.074 -178.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.496 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 2.9 mt-30 -68.67 -36.83 79.06 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.013 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 51' ' ' ASP . 30.2 t -72.35 -37.96 59.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.327 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.92 -42.01 70.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.205 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.15 -28.53 63.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.185 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -94.63 119.55 33.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.858 0.361 . . . . 0.0 110.843 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.8 pttt -108.88 -26.45 10.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.986 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 10.0 ttp85 -104.87 159.16 16.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.942 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 58.47 -177.46 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.2 tp -94.53 158.41 2.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.608 ' HD2' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -100.65 -64.65 1.03 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.165 -179.713 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.455 ' HE2' ' O ' ' A' ' 49' ' ' SER . 3.7 ttpt -140.85 132.86 27.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.384 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.507 HG13 ' C ' ' A' ' 91' ' ' ILE . 9.6 t -129.34 139.28 52.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.245 0.545 . . . . 0.0 111.808 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.55 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.0 m-90 -100.83 139.73 36.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.7 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.952 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.83 126.85 55.29 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.98 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.893 ' CE1' HD12 ' A' ' 91' ' ' ILE . 1.6 m-85 -110.55 145.71 37.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.422 -178.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.817 ' HA2' HD12 ' A' ' 78' ' ' LEU . . . 164.34 -177.74 39.9 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.955 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -77.33 -2.51 35.32 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -84.85 134.78 40.99 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.656 0.265 . . . . 0.0 111.197 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -68.71 -6.81 18.8 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.76 2.307 . . . . 0.0 111.838 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.83 -43.73 16.3 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-O 121.958 0.885 . . . . 0.0 108.77 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.94 137.67 3.13 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 113.629 -1.623 . . . . 0.0 110.648 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -56.41 -19.21 13.84 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.984 179.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.574 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 29.9 t80 -129.98 116.57 18.78 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.016 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -86.0 107.87 17.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.838 0.351 . . . . 0.0 110.359 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.817 HD12 ' HA2' ' A' ' 69' ' ' GLY . 81.7 mt -78.37 -82.87 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.354 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.04 -102.92 0.17 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.394 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.439 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 0.8 OUTLIER -175.93 65.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.802 0.334 . . . . 0.0 111.267 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.629 ' HB ' HD13 ' A' ' 84' ' ' LEU . 3.7 mp -112.13 125.49 69.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.838 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 27.3 t -55.06 -31.39 61.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.323 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.507 ' H ' HG22 ' A' ' 81' ' ' ILE . 2.1 mmp_? -60.9 -33.91 73.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.9 0.381 . . . . 0.0 111.131 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.753 HD21 ' CG2' ' A' ' 132' ' ' VAL . 5.8 mp -95.31 153.24 17.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.062 0.458 . . . . 0.0 110.919 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.2 p -94.13 166.3 12.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.739 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.697 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -42.72 -52.33 4.98 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.449 0.642 . . . . 0.0 109.591 179.145 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.585 ' HB3' HG22 ' A' ' 67' ' ' THR . 4.8 mttp -120.5 84.69 2.26 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 177.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.56 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.0 t60 -61.14 -46.06 92.09 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.823 -176.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.543 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 12.3 p90 -145.18 162.37 37.26 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.059 -0.656 . . . . 0.0 112.351 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.952 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.67 136.22 40.74 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.584 -178.709 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.893 HD12 ' CE1' ' A' ' 68' ' ' PHE . 8.0 mt -113.88 129.47 69.72 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.16 178.252 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.668 HD11 HD13 ' A' ' 100' ' ' LEU . 0.6 OUTLIER -112.64 148.84 33.77 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.024 0.44 . . . . 0.0 111.905 -179.249 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.611 HD13 ' N ' ' A' ' 94' ' ' GLY . 2.3 tm? -125.25 124.95 42.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.524 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.611 ' N ' HD13 ' A' ' 93' ' ' LEU . . . 167.38 -167.2 39.76 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.54 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 61.25 95.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.801 0.334 . . . . 0.0 110.95 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 63.13 -80.57 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.975 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.547 ' HA3' HD22 ' A' ' 155' ' ' LEU . . . -177.94 36.19 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.411 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -110.35 168.81 9.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.86 0.362 . . . . 0.0 110.857 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.843 HD21 HG12 ' A' ' 33' ' ' VAL . 0.8 OUTLIER -106.99 145.71 31.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.973 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.842 HD22 ' HB3' ' A' ' 121' ' ' ASN . 6.0 mt -130.12 142.17 50.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.484 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.743 HD11 HD11 ' A' ' 130' ' ' ILE . 2.1 tp -112.56 120.92 43.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.153 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.465 ' HB2' HD23 ' A' ' 92' ' ' LEU . 55.1 t30 -115.25 115.7 27.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.007 0.432 . . . . 0.0 111.645 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.789 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.3 p30 -77.36 139.29 39.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.081 178.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.425 HD11 HG22 ' A' ' 67' ' ' THR . 10.5 pt -146.82 38.79 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 -179.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.658 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.7 151.73 20.42 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.085 0.469 . . . . 0.0 111.908 -178.711 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 48.1 m -68.79 -31.62 70.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.85 177.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -98.2 -19.78 17.66 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.658 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.97 156.69 10.38 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 120.203 -0.999 . . . . 0.0 113.715 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.0 m -117.62 137.88 52.33 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.819 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -116.3 148.36 40.61 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -178.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.811 HD12 HG11 ' A' ' 116' ' ' VAL . 0.7 OUTLIER -124.33 113.72 18.59 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.636 -1.166 . . . . 0.0 108.804 177.494 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 46.61 36.37 3.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.045 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.05 -3.31 80.45 Favored Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 120.854 -0.689 . . . . 0.0 113.557 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -106.56 118.57 37.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.097 0.475 . . . . 0.0 110.767 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.819 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.5 tptp -73.47 119.72 18.08 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.111 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.811 HG11 HD12 ' A' ' 111' ' ' LEU . 10.7 m -95.72 165.59 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.454 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.7 tt0 -69.92 126.37 29.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.637 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.689 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 67.9 tttt -52.9 162.5 0.61 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.811 0.338 . . . . 0.0 110.335 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.9 p-10 35.41 34.66 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.241 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.5 OUTLIER -112.32 137.58 50.26 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.057 179.435 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.842 ' HB3' HD22 ' A' ' 100' ' ' LEU . 2.4 m-80 -82.72 129.16 34.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.954 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.698 ' O ' HD23 ' A' ' 100' ' ' LEU . 45.4 mm-40 -129.51 148.13 51.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.92 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.5 tp -72.87 119.01 16.52 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.009 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.426 ' HA ' HD13 ' A' ' 124' ' ' LEU . 1.2 mm? -58.05 164.86 2.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.816 0.817 . . . . 0.0 111.957 -179.033 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.424 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -125.57 153.16 44.1 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.318 179.253 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.52 118.05 13.85 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 62.75 25.71 67.82 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.789 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.58 ' OD2' HD23 ' A' ' 111' ' ' LEU . 9.2 t70 -57.92 175.36 0.2 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.027 0.441 . . . . 0.0 111.154 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 1.0 OUTLIER -145.11 135.54 24.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.887 179.837 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.743 HD11 HD11 ' A' ' 101' ' ' LEU . 5.7 mt -114.38 128.48 71.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.505 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.632 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.1 m -103.95 139.26 39.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.993 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.753 ' CG2' HD21 ' A' ' 84' ' ' LEU . 34.3 m -140.27 158.38 25.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 82.95 35.85 17.28 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.993 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.478 ' HA ' HG12 ' A' ' 140' ' ' ILE . 56.8 t -76.41 140.49 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-O 121.733 0.778 . . . . 0.0 112.477 -178.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.69 -41.38 0.62 Allowed Glycine 0 N--CA 1.437 -1.262 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.074 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.486 HG12 ' H ' ' A' ' 138' ' ' SER . 46.5 t -126.33 132.19 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 114.787 -0.707 . . . . 0.0 109.204 178.084 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -50.53 -36.38 33.98 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.486 ' H ' HG12 ' A' ' 136' ' ' VAL . 70.0 m -93.61 6.31 48.7 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.418 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 1.1 m-20 -120.2 25.66 9.73 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.632 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.2 mt -106.92 139.41 28.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.224 178.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.413 HD23 ' N ' ' A' ' 142' ' ' SER . 1.3 tt -123.46 134.51 53.92 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.26 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.534 ' H ' HG21 ' A' ' 40' ' ' THR . 47.0 t -112.51 150.42 31.3 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.645 0.736 . . . . 0.0 112.585 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.655 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.4 mm? -135.67 148.46 48.93 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.432 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 23.8 t -117.19 131.14 70.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 0.0 111.174 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.1 mm -106.33 122.07 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.679 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.15 120.03 39.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.092 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.529 HG23 ' CD1' ' A' ' 99' ' ' LEU . 7.3 mt -84.79 129.27 37.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.837 0.351 . . . . 0.0 111.236 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.88 116.19 16.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.973 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -62.86 -30.0 71.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.009 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -57.88 -43.49 86.05 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.076 0.465 . . . . 0.0 110.571 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -58.98 -44.01 91.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.764 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 41.5 tttm -65.11 -41.09 95.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.978 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.23 -45.02 92.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.924 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 13.0 t -60.03 -46.05 90.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.957 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.547 HD22 ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -69.14 -35.89 76.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.62 -36.22 75.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -91.87 -33.61 14.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.868 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.2 p30 42.45 82.13 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.506 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.2 tttm -115.95 138.16 51.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.908 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.1 p -64.98 133.09 30.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.119 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 60.97 161.37 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 62.3 mtm180 -94.57 46.17 1.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.871 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.1 pp -92.62 123.91 44.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.116 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.303 -0.856 . . . . 0.0 110.895 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.79 0.328 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.5 m 70.24 -63.63 0.39 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.975 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -59.93 -31.58 69.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.926 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -36.32 79.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.771 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.38 -40.99 88.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.788 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.73 -32.18 72.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.763 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.435 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.0 mt -73.13 -35.41 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -57.46 -41.9 81.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.437 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -67.22 -24.06 65.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.623 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.82 -47.59 79.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.156 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.5 m -80.99 -27.11 36.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.936 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.99 30.32 11.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.882 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -75.55 139.49 42.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.87 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -65.01 113.71 4.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.839 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.1 mm -81.87 138.4 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-O 121.716 0.769 . . . . 0.0 111.653 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.418 ' HA2' HG12 ' A' ' 32' ' ' ILE . . . 175.25 90.87 0.08 OUTLIER Glycine 0 C--N 1.315 -0.638 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.464 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.12 -39.19 75.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.766 0.317 . . . . 0.0 110.988 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.444 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.7 OUTLIER -170.69 33.8 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.719 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 6.1 mm -75.87 132.14 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 113.702 -1.59 . . . . 0.0 112.587 -177.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.039 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.0 t -91.0 -60.93 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.073 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.609 ' SG ' HD12 ' A' ' 48' ' ' LEU . 3.0 p -148.67 152.15 36.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.267 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.09 138.15 50.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.918 0.389 . . . . 0.0 111.191 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.799 HG21 ' CZ ' ' A' ' 68' ' ' PHE . 23.1 t -104.73 122.69 58.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.777 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.801 HG23 HG12 ' A' ' 45' ' ' ILE . 20.0 mt -125.12 120.55 58.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.468 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.724 ' HA ' HD13 ' A' ' 143' ' ' LEU . 34.2 t -80.49 112.29 17.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.489 179.354 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.747 HG21 ' OE2' ' A' ' 129' ' ' GLU . 5.4 t -82.08 -25.87 34.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.652 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.509 HG21 ' H ' ' A' ' 142' ' ' SER . 34.1 p -79.88 -2.18 42.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.582 0.23 . . . . 0.0 111.501 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.74 78.08 0.27 Allowed Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.794 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -146.43 -44.03 0.19 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.945 0.403 . . . . 0.0 110.991 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.57 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.7 mp -120.03 141.47 31.57 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.046 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.57 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.0 Cg_endo -72.09 146.03 45.7 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.246 1.964 . . . . 0.0 112.21 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.801 HG12 HG23 ' A' ' 37' ' ' ILE . 36.3 mt -55.81 128.78 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.809 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.419 ' HG3' ' CE2' ' A' ' 76' ' ' TYR . 19.2 mtt180 -122.85 164.09 19.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.06 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -120.81 119.92 34.09 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.609 HD12 ' SG ' ' A' ' 34' ' ' CYS . 2.5 mt -93.3 137.29 32.76 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.039 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -147.93 158.04 43.84 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -178.56 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.479 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -140.32 141.79 35.68 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 113.28 -1.782 . . . . 0.0 110.237 178.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.681 ' O ' HG23 ' A' ' 55' ' ' VAL . 51.2 m-20 -82.17 131.82 35.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.197 0.522 . . . . 0.0 111.512 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.582 ' H ' HD12 ' A' ' 52' ' ' ILE . 5.1 mp -64.17 -45.18 97.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.297 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.0 t -56.6 -38.6 72.24 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.282 0.563 . . . . 0.0 110.606 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.475 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 41.2 mm-40 -68.41 -37.1 80.02 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.399 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 51' ' ' ASP . 59.0 t -68.32 -40.38 82.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.799 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.1 tp -70.95 -37.63 72.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.808 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.77 -41.54 64.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.878 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -64.01 123.88 20.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.911 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.9 32.92 3.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.823 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -114.29 176.6 4.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.797 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 99.8 p -80.13 -33.59 38.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.866 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.686 HD11 HG22 ' A' ' 65' ' ' VAL . 8.6 tp -100.4 146.31 9.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.052 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.673 ' HG2' HG13 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -116.33 -62.73 1.55 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.994 -179.955 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.418 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.0 ttpt -150.11 136.31 18.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.026 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.693 HG12 ' HG2' ' A' ' 90' ' ' GLN . 11.7 t -128.48 139.2 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 121.261 0.553 . . . . 0.0 112.197 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.519 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.2 m-90 -103.24 139.36 38.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.984 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.674 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.88 125.39 53.6 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 177.436 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.799 ' CZ ' HG21 ' A' ' 36' ' ' VAL . 2.6 m-85 -107.9 145.82 33.22 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.606 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.817 ' HA2' HD12 ' A' ' 78' ' ' LEU . . . 164.78 -178.15 40.05 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.916 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.448 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 6.1 mtp-105 -77.47 -3.39 40.19 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.41 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.9 t30 -84.88 135.72 39.66 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.767 0.318 . . . . 0.0 111.133 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.0 Cg_exo -69.07 -6.5 18.41 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.794 2.329 . . . . 0.0 111.884 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.86 -44.06 15.87 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 121.945 0.879 . . . . 0.0 108.651 179.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.86 138.61 2.67 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.734 -1.575 . . . . 0.0 110.41 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -56.27 -18.85 11.76 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.95 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.626 ' HE1' HD23 ' A' ' 78' ' ' LEU . 45.0 t80 -129.73 119.72 23.93 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.736 0.303 . . . . 0.0 110.818 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.4 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.2 t-160 -87.66 107.94 18.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.763 0.316 . . . . 0.0 110.611 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.817 HD12 ' HA2' ' A' ' 69' ' ' GLY . 79.9 mt -80.7 -81.93 0.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.255 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.25 -106.9 0.19 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.526 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -172.76 57.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.854 0.359 . . . . 0.0 111.196 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.515 HG22 ' H ' ' A' ' 83' ' ' ARG . 3.6 mt -103.18 125.14 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.822 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.9 t -54.73 -32.89 60.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.854 0.359 . . . . 0.0 111.246 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.515 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -61.31 -24.06 66.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.952 179.929 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.3 mt -105.53 152.08 23.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.968 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 92.9 p -94.7 166.19 12.13 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.704 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.679 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -43.16 -53.73 4.84 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.333 0.587 . . . . 0.0 109.831 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.536 ' HB2' HD12 ' A' ' 104' ' ' ILE . 5.5 mtpt -118.9 82.86 1.93 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.567 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.8 t60 -60.13 -46.35 89.93 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.12 -0.946 . . . . 0.0 112.703 -176.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.524 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 20.1 p90 -147.13 159.46 43.59 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.721 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.693 ' HG2' HG12 ' A' ' 65' ' ' VAL . 5.0 tt0 -135.87 141.48 44.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.438 -179.103 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.557 ' C ' HG13 ' A' ' 65' ' ' VAL . 2.7 mp -115.95 126.36 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.834 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.781 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -104.37 151.97 22.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.064 0.459 . . . . 0.0 111.897 -179.552 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.514 HD23 ' N ' ' A' ' 94' ' ' GLY . 0.5 OUTLIER -123.51 122.87 39.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.311 179.444 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.514 ' N ' HD23 ' A' ' 93' ' ' LEU . . . -157.95 -174.94 28.31 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.568 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 61.03 -167.42 0.19 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.878 0.371 . . . . 0.0 110.905 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.76 98.24 7.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.019 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.549 ' H ' HD22 ' A' ' 155' ' ' LEU . . . 75.04 36.88 44.97 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.707 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -139.7 135.79 33.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.804 0.335 . . . . 0.0 110.764 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.539 HD21 ' CG1' ' A' ' 33' ' ' VAL . 3.0 mm? -110.99 159.36 17.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.829 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.849 HD22 ' HB3' ' A' ' 121' ' ' ASN . 8.5 mt -133.1 142.1 48.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.82 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.482 HD21 HD13 ' A' ' 124' ' ' LEU . 1.3 mt -112.87 121.54 44.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.976 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.781 ' HB2' HD11 ' A' ' 92' ' ' LEU . 50.7 t30 -116.84 115.65 25.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.833 0.349 . . . . 0.0 111.853 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.804 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.2 p30 -77.86 139.99 39.32 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.536 HD12 ' HB2' ' A' ' 87' ' ' LYS . 10.3 pt -148.43 39.18 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 111.543 0.201 . . . . 0.0 111.543 -178.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.66 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.02 151.67 20.08 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 120.96 0.409 . . . . 0.0 111.946 -178.879 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 50.3 m -68.69 -31.71 71.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.807 177.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -98.21 -19.69 17.71 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.66 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.81 155.48 10.09 Favored Glycine 0 N--CA 1.438 -1.187 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.596 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.3 m -117.41 137.81 52.24 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.861 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -115.0 148.51 38.73 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 -178.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.465 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.05 113.44 18.39 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.293 177.476 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.415 ' N ' HD12 ' A' ' 111' ' ' LEU . 73.8 m-20 44.61 43.04 6.23 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.83 -9.97 72.07 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.433 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.7 mp0 -105.06 118.57 36.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.086 0.469 . . . . 0.0 110.727 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.861 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 10.1 tptm -73.07 118.24 15.78 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.259 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.804 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.3 m -89.69 165.52 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.209 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.408 ' HB3' ' HB3' ' A' ' 120' ' ' SER . 6.2 tt0 -69.9 126.87 30.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.481 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.693 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 29.2 tttt -53.85 163.53 0.71 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.782 0.325 . . . . 0.0 110.438 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.0 m-80 33.72 36.93 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.825 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.408 ' HB3' ' HB3' ' A' ' 117' ' ' GLU . 4.7 p -111.84 144.6 40.88 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.864 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.849 ' HB3' HD22 ' A' ' 100' ' ' LEU . 1.9 m-80 -91.5 128.17 37.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.687 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.647 ' O ' HD23 ' A' ' 100' ' ' LEU . 56.4 mm-40 -129.17 148.75 51.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.749 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.584 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.7 tm? -72.8 128.43 35.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.287 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.745 HD11 HG21 ' A' ' 145' ' ' ILE . 67.4 tp -57.9 155.74 10.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.437 0.637 . . . . 0.0 111.654 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.421 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -124.7 153.1 42.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.637 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.414 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 7.2 mm-40 -71.86 123.32 22.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.917 0.389 . . . . 0.0 110.25 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.24 22.52 50.48 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.071 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.421 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 32.0 t70 -52.36 169.9 0.07 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.981 0.42 . . . . 0.0 111.239 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.92 ' CG ' HG22 ' A' ' 144' ' ' VAL . 2.0 mt-10 -145.12 135.45 24.11 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.946 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.649 HD11 HD11 ' A' ' 145' ' ' ILE . 15.7 mt -116.25 127.24 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-O 120.808 0.337 . . . . 0.0 110.458 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.654 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.7 m -104.43 141.18 36.8 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.164 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.507 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.8 m -140.26 158.49 25.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.05 44.2 9.18 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.821 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.462 ' HA ' HG12 ' A' ' 140' ' ' ILE . 54.0 t -85.23 140.53 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-O 121.677 0.751 . . . . 0.0 112.616 -178.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.11 -41.45 0.68 Allowed Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.607 HG12 ' H ' ' A' ' 138' ' ' SER . 48.9 t -126.48 121.97 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-N 114.567 -0.816 . . . . 0.0 108.998 177.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.48 ' HA ' HD12 ' A' ' 140' ' ' ILE . 13.5 mt-10 -50.33 -25.96 4.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.749 0.309 . . . . 0.0 111.506 -178.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.607 ' H ' HG12 ' A' ' 136' ' ' VAL . 73.8 m -93.55 6.56 47.84 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -131.42 29.19 4.6 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.654 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.9 mt -106.98 139.23 29.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.077 178.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.678 HD23 ' N ' ' A' ' 142' ' ' SER . 3.0 tt -124.23 134.55 53.23 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.531 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.678 ' N ' HD23 ' A' ' 141' ' ' LEU . 47.5 t -113.52 150.6 32.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.626 0.727 . . . . 0.0 112.42 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.724 HD13 ' HA ' ' A' ' 38' ' ' CYS . 1.8 mm? -135.7 141.84 44.98 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.349 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.92 HG22 ' CG ' ' A' ' 129' ' ' GLU . 13.2 t -110.87 137.74 42.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.813 0.34 . . . . 0.0 111.282 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.745 HG21 HD11 ' A' ' 124' ' ' LEU . 29.9 mt -106.29 128.09 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.142 -179.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.74 119.83 37.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.554 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.662 HG12 HD21 ' A' ' 124' ' ' LEU . 4.3 mt -84.87 134.04 27.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.527 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -90.44 105.58 17.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.798 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.4 -26.59 63.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.235 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.77 -42.21 83.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.014 0.435 . . . . 0.0 110.639 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -60.71 -43.98 97.14 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.948 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 8.1 mtpt -61.81 -33.97 75.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.975 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.67 -42.91 81.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.883 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.1 t -63.5 -42.28 98.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.911 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.549 HD22 ' H ' ' A' ' 97' ' ' GLY . 0.5 OUTLIER -67.69 -36.7 81.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.012 -179.946 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -60.45 -47.91 84.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.833 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.57 -15.09 59.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.281 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -130.78 79.9 1.92 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.803 0.335 . . . . 0.0 110.93 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -87.01 155.18 20.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.417 ' O ' HG13 ' A' ' 160' ' ' VAL . 12.2 p -69.53 126.39 29.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.036 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 12.1 p30 -154.77 175.49 13.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.978 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.76 118.83 13.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.001 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -96.34 134.25 34.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.135 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.927 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.404 ' O ' HG23 ' A' ' 15' ' ' THR . . . . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.836 0.35 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 14' ' ' ALA . 0.6 OUTLIER -159.48 -45.56 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.9 -37.19 83.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.851 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.402 ' HB2' ' NH1' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -61.32 -43.17 99.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.764 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -57.39 -38.49 74.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.822 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.02 -31.84 69.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.742 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.461 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.1 mt -72.69 -35.56 50.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.768 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -57.44 -39.82 77.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.932 0.396 . . . . 0.0 110.416 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.6 mtpt -67.06 -23.84 65.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.797 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.64 -47.36 79.9 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.213 -179.907 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.56 -30.91 57.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.901 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -81.35 86.54 6.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -94.04 153.41 18.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.006 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.15 127.43 32.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.904 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.8 mm -83.15 138.35 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-O 121.629 0.728 . . . . 0.0 111.88 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.86 63.68 1.23 Allowed Glycine 0 C--N 1.315 -0.635 0 CA-C-N 114.481 -1.236 . . . . 0.0 112.394 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.25 -24.02 43.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.628 0.251 . . . . 0.0 111.181 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 178.14 35.22 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.655 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 1.1 mm -89.63 96.54 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 CA-C-N 113.964 -1.471 . . . . 0.0 111.578 -177.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.775 HG11 HD22 ' A' ' 93' ' ' LEU . 2.3 t -55.38 -65.65 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.278 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.493 ' SG ' HD12 ' A' ' 48' ' ' LEU . 13.8 p -146.39 165.05 30.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.016 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.88 128.17 41.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.093 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.651 HG13 HD11 ' A' ' 48' ' ' LEU . 15.4 m -93.46 122.75 45.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.9 0.381 . . . . 0.0 111.11 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.786 HG23 HG12 ' A' ' 45' ' ' ILE . 21.1 mt -125.6 117.43 49.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.39 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 6.9 t -79.83 118.25 21.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.822 0.344 . . . . 0.0 110.387 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.681 HG23 HG21 ' A' ' 144' ' ' VAL . 0.7 OUTLIER -82.07 -26.45 33.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.857 -179.22 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.538 HG21 ' H ' ' A' ' 142' ' ' SER . 33.5 p -79.93 -2.2 42.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.59 0.233 . . . . 0.0 111.357 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.49 47.42 90.77 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.855 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.477 ' CB ' HD11 ' A' ' 141' ' ' LEU . 3.5 mm-40 -113.81 -29.87 6.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.785 0.326 . . . . 0.0 110.884 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.812 HD13 HD22 ' A' ' 78' ' ' LEU . 2.8 mt -128.16 141.26 40.73 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.71 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.576 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 42.9 Cg_endo -70.46 134.35 26.31 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.125 1.884 . . . . 0.0 112.23 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.786 HG12 HG23 ' A' ' 37' ' ' ILE . 32.6 mt -55.17 130.02 17.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.608 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.8 163.42 17.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.305 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.24 119.74 36.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.989 0.423 . . . . 0.0 111.451 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.751 HD22 ' CD1' ' A' ' 66' ' ' TRP . 7.1 mt -98.45 136.15 39.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.404 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.765 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -148.71 157.76 43.67 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -179.162 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.537 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -144.1 142.0 30.35 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 113.643 -1.617 . . . . 0.0 110.864 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.573 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -78.37 133.27 37.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.129 0.49 . . . . 0.0 111.039 -179.901 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.771 HD13 ' SG ' ' A' ' 154' ' ' CYS . 71.0 mt -63.97 -40.39 88.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.965 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.62 -41.01 76.36 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.926 -178.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.512 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -68.53 -39.62 81.1 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.572 179.776 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.706 HG13 ' HG3' ' A' ' 63' ' ' LYS . 43.8 t -66.45 -41.7 89.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.167 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -71.0 -34.53 71.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.962 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -75.44 -47.55 26.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.901 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.88 115.43 19.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.872 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.06 30.0 7.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.895 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 10.4 mtp180 -105.8 27.46 8.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.999 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.5 m 62.94 141.85 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.972 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.721 HD12 HD13 ' A' ' 92' ' ' LEU . 16.3 mm 64.51 100.02 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.213 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.706 ' HG3' HG13 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -94.36 -57.99 2.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.806 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 49' ' ' SER . 4.1 ttpt -139.85 131.5 27.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.774 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.641 HG12 ' HG2' ' A' ' 90' ' ' GLN . 15.4 t -125.49 139.03 52.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.309 0.576 . . . . 0.0 112.181 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.751 ' CD1' HD22 ' A' ' 48' ' ' LEU . 15.0 m-90 -101.92 139.32 37.72 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.14 -0.937 . . . . 0.0 112.09 179.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.699 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.49 126.52 55.04 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.08 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.545 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.9 OUTLIER -116.91 145.27 43.71 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.376 -178.447 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.574 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 165.18 -176.84 40.8 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.231 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.2 ttp85 -72.69 -3.03 22.57 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.496 HD22 ' HB3' ' A' ' 73' ' ' ALA . 2.3 t30 -84.8 135.04 40.64 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.738 0.304 . . . . 0.0 111.598 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 14.5 Cg_exo -67.57 -11.82 33.46 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.928 2.419 . . . . 0.0 112.036 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.496 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.38 -44.28 16.32 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-O 121.919 0.866 . . . . 0.0 109.029 179.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.41 ' SG ' ' HA ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -41.62 142.36 0.64 Allowed 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 113.746 -1.57 . . . . 0.0 110.854 179.652 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.0 t0 -56.07 -18.57 10.04 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.204 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.478 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 8.1 t80 -129.14 131.12 47.15 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-O 120.771 0.319 . . . . 0.0 110.746 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.423 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 -104.17 115.32 30.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.031 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.812 HD22 HD13 ' A' ' 43' ' ' ILE . 12.4 mt -91.41 177.02 6.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.751 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.63 -92.04 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.361 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -179.19 68.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.849 0.357 . . . . 0.0 110.719 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.839 ' HB ' HD13 ' A' ' 84' ' ' LEU . 3.3 mp -112.12 116.52 52.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.068 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.8 -25.89 43.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.216 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.534 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -60.91 -20.4 62.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.096 -179.867 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.839 HD13 ' HB ' ' A' ' 81' ' ' ILE . 3.8 mp -104.9 153.01 21.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.817 0.341 . . . . 0.0 110.857 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.3 p -93.67 168.66 10.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.689 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.574 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 6.4 m-20 -41.41 -59.21 1.64 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.367 0.603 . . . . 0.0 109.657 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.609 ' HB2' HD12 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -116.04 84.11 2.06 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 176.956 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.557 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.9 t60 -58.92 -46.51 87.74 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.495 -176.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.515 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 27.1 p90 -144.91 159.8 42.33 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.9 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.699 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.4 tt0 -136.16 140.65 43.78 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.357 -179.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.697 HG12 HD12 ' A' ' 101' ' ' LEU . 65.9 mt -116.5 127.16 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 C-N-CA 121.164 -0.214 . . . . 0.0 110.809 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.721 HD13 HD12 ' A' ' 62' ' ' ILE . 0.6 OUTLIER -113.12 144.94 41.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.02 0.438 . . . . 0.0 111.691 -179.727 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.775 HD22 HG11 ' A' ' 33' ' ' VAL . 24.9 tp -125.25 122.97 38.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.555 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.58 -139.23 2.93 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.592 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 66.32 -73.91 0.07 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.787 0.327 . . . . 0.0 110.893 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.407 ' O ' HD12 ' A' ' 155' ' ' LEU . 2.7 m-20 -155.99 -45.14 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.873 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.624 ' HA2' HD12 ' A' ' 155' ' ' LEU . . . -163.13 -40.02 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.545 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -57.86 161.33 3.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.902 0.382 . . . . 0.0 111.086 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.628 ' O ' HD12 ' A' ' 100' ' ' LEU . 14.9 tp -106.95 154.23 21.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.822 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.628 HD12 ' O ' ' A' ' 99' ' ' LEU . 6.1 mp -125.55 144.81 50.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.441 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.697 HD12 HG12 ' A' ' 91' ' ' ILE . 2.3 tp -112.54 122.63 48.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.11 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.485 ' HB2' HD23 ' A' ' 92' ' ' LEU . 52.8 t30 -116.88 115.68 25.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.934 0.397 . . . . 0.0 111.921 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.84 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.0 p30 -76.63 138.7 40.25 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.609 HD12 ' HB2' ' A' ' 87' ' ' LYS . 9.5 pt -146.67 39.22 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 111.497 0.184 . . . . 0.0 111.497 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.675 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -97.99 150.94 20.83 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 121.171 0.51 . . . . 0.0 112.039 -178.681 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 42.9 m -68.79 -31.45 70.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.611 177.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -98.05 -19.78 17.77 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.675 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.22 155.23 10.15 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.251 -0.975 . . . . 0.0 113.559 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.498 HG22 ' CG2' ' A' ' 130' ' ' ILE . 5.8 m -117.35 137.69 52.28 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.862 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -115.75 148.55 39.69 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -177.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.02 113.58 18.6 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.385 177.619 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 43.87 43.85 5.45 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.79 -11.42 66.67 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.398 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -104.36 118.61 37.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.034 0.445 . . . . 0.0 110.62 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.862 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 9.1 tptp -72.28 115.89 12.06 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.293 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.84 HG23 ' OD2' ' A' ' 103' ' ' ASP . 16.5 m -84.45 164.24 2.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.13 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.2 tm-20 -69.83 125.03 25.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.496 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.687 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 55.6 tttt -53.02 162.0 0.71 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.914 0.388 . . . . 0.0 110.646 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.8 p-10 34.78 34.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.423 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.29 145.09 40.61 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.089 179.457 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -88.3 129.86 35.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.795 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 41.4 mm-40 -129.6 147.84 51.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.035 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.9 128.98 37.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.983 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.58 HD23 ' HB3' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -58.07 159.6 5.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.415 0.626 . . . . 0.0 111.897 -178.952 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.428 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -125.0 153.26 43.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.156 179.59 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.23 116.74 11.91 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 62.81 25.58 67.79 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.545 -178.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.428 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 33.6 t0 -50.69 168.77 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.104 0.478 . . . . 0.0 111.457 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 15.5 tt0 -145.21 135.49 24.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.872 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.631 HD11 HD11 ' A' ' 145' ' ' ILE . 3.2 mt -114.75 127.35 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.513 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.61 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.2 m -104.64 138.41 41.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.944 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.541 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.2 m -140.2 158.24 25.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 82.24 39.6 11.11 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.944 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.455 ' HA ' HG12 ' A' ' 140' ' ' ILE . 54.9 t -79.41 140.41 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-O 121.688 0.756 . . . . 0.0 112.557 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 156.46 -41.76 0.56 Allowed Glycine 0 N--CA 1.436 -1.318 0 CA-C-N 114.471 -1.241 . . . . 0.0 110.018 -179.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.487 HG12 ' H ' ' A' ' 138' ' ' SER . 45.7 t -126.39 131.21 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-N 114.869 -0.666 . . . . 0.0 109.262 178.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -50.41 -35.4 28.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.669 0.271 . . . . 0.0 111.647 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.487 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -93.57 6.44 48.24 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -178.864 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.41 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 51.4 m-20 -121.85 26.75 8.48 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.61 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.0 mt -107.12 139.5 28.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.332 178.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.477 HD11 ' CB ' ' A' ' 42' ' ' GLN . 7.9 tt -120.69 134.5 55.28 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.292 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.538 ' H ' HG21 ' A' ' 40' ' ' THR . 45.4 t -112.89 150.59 31.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.612 0.72 . . . . 0.0 112.716 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.598 HD21 HD12 ' A' ' 43' ' ' ILE . 70.8 mt -135.57 149.58 49.46 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.538 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.681 HG21 HG23 ' A' ' 39' ' ' THR . 25.7 t -120.44 139.95 46.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.795 0.331 . . . . 0.0 111.28 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.631 HD11 HD11 ' A' ' 130' ' ' ILE . 5.4 mt -106.24 130.75 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.807 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.577 ' CD1' HD12 ' A' ' 37' ' ' ILE . 0.4 OUTLIER -115.75 114.43 24.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.106 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.407 HD11 ' O ' ' A' ' 125' ' ' SER . 6.0 mt -85.03 134.16 27.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.349 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -82.59 133.11 35.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.749 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -73.72 -37.75 65.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.209 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -46.13 91.55 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.907 0.384 . . . . 0.0 110.817 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.583 ' O ' HD23 ' A' ' 155' ' ' LEU . 36.2 t80 -61.02 -44.02 98.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.16 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -63.09 -40.34 97.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.191 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -59.06 -47.08 86.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.184 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.771 ' SG ' HD13 ' A' ' 52' ' ' ILE . 8.9 t -68.15 -45.47 73.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.089 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.624 HD12 ' HA2' ' A' ' 97' ' ' GLY . 4.0 mm? -61.1 -39.61 90.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.07 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -60.45 -36.41 78.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.012 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -87.83 -36.96 16.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.996 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.0 p30 42.44 62.37 1.72 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.489 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.26 145.83 32.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.855 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.46 ' O ' HG13 ' A' ' 160' ' ' VAL . 12.4 p -74.83 122.97 29.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.095 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -125.97 108.59 11.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.914 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 39.6 ttm-85 -90.94 -54.16 4.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.872 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.1 pt -78.52 132.05 33.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.199 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.919 179.968 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.919 0.39 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -60.4 -45.05 94.96 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.5 -38.22 74.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.837 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.7 tp -60.7 -31.88 71.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.693 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.41 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.3 mt -72.17 -35.54 53.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.857 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -57.4 -44.45 84.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.918 0.39 . . . . 0.0 110.536 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.6 mtmm -67.07 -23.7 65.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.632 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.41 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.65 -47.56 79.49 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.253 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.2 t . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.954 179.991 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.405 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER . . . . . 0 CA--C 1.509 -0.619 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.687 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.3 mm -76.62 133.89 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 CA-C-N 113.863 -1.517 . . . . 0.0 112.489 -177.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.962 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -91.7 -61.21 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-N 114.715 -1.129 . . . . 0.0 109.856 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.401 ' SG ' HD22 ' A' ' 48' ' ' LEU . 5.7 p -145.14 160.0 42.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.278 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.73 138.17 54.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.698 0.285 . . . . 0.0 111.37 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.674 HG21 ' HE2' ' A' ' 68' ' ' PHE . 37.0 t -109.66 122.6 64.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.836 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.843 HG23 HG12 ' A' ' 45' ' ' ILE . 17.7 mt -125.14 120.63 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.405 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.722 ' HA ' HD13 ' A' ' 143' ' ' LEU . 49.4 t -80.96 111.96 17.92 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.802 0.334 . . . . 0.0 110.441 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.21 -22.42 35.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.591 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.469 HG23 ' HB3' ' A' ' 142' ' ' SER . 81.2 p -79.94 -2.21 42.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.654 0.264 . . . . 0.0 111.446 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.99 74.23 0.42 Allowed Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.847 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.513 ' HB2' HD11 ' A' ' 141' ' ' LEU . 11.2 mt-30 -146.01 -42.82 0.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.852 0.358 . . . . 0.0 111.065 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.592 ' CD1' HD21 ' A' ' 141' ' ' LEU . 3.2 mt -116.57 141.88 28.73 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.586 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 43.0 Cg_endo -70.37 142.38 45.08 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.143 1.896 . . . . 0.0 112.186 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.843 HG12 HG23 ' A' ' 37' ' ' ILE . 36.6 mt -57.04 135.35 20.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.717 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -130.98 160.06 35.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.084 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.71 119.87 31.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.92 0.391 . . . . 0.0 111.91 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.787 HD23 ' CD2' ' A' ' 66' ' ' TRP . 8.8 mp -82.57 133.05 35.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.514 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.962 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -139.78 155.64 47.18 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 122.287 1.041 . . . . 0.0 113.793 -179.656 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.48 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -143.23 141.92 31.24 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 113.476 -1.693 . . . . 0.0 110.616 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 121.207 0.527 . . . . 0.0 111.249 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.869 0.366 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.408 ' HE2' ' O ' ' A' ' 49' ' ' SER . 4.9 ttpt -128.27 130.55 48.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.856 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.683 HG12 ' HG2' ' A' ' 90' ' ' GLN . 8.4 t -126.52 139.12 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 121.289 0.566 . . . . 0.0 112.175 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.787 ' CD2' HD23 ' A' ' 48' ' ' LEU . 18.2 m-90 -102.98 139.17 38.89 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.969 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.527 HG22 ' HB3' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -113.17 131.09 56.0 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 177.6 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.863 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -118.2 145.82 44.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.259 -178.683 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.624 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.29 -167.78 35.68 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.413 -0.899 . . . . 0.0 113.173 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -79.42 1.78 24.18 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -84.74 127.79 63.67 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.864 -0.153 . . . . 0.0 110.97 -179.804 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.425 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 18.8 Cg_exo -66.18 -12.19 34.46 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.348 2.032 . . . . 0.0 111.563 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.95 -43.15 16.77 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-O 121.834 0.826 . . . . 0.0 108.926 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -39.77 139.62 0.61 Allowed 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.735 179.478 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -56.25 -18.69 11.2 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.04 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.529 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 13.2 t80 -129.64 121.99 28.14 Favored 'General case' 0 N--CA 1.457 -0.086 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.915 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.425 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.8 t-160 . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 120.838 0.352 . . . . 0.0 110.636 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.419 HD11 HD13 ' A' ' 141' ' ' LEU . 33.3 mt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.795 0.331 . . . . 0.0 110.99 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.8 m -58.25 -37.19 74.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.1 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.432 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 1.8 mmt180 -61.8 -17.04 54.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.305 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.6 mt -107.25 147.8 29.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.838 0.351 . . . . 0.0 111.251 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 51.6 p -93.08 164.89 13.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.48 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.624 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.0 m-20 -43.19 -52.74 5.43 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.426 0.632 . . . . 0.0 109.893 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.527 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -121.31 81.12 1.75 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 177.453 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.564 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.3 t60 -61.21 -45.93 92.56 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.161 -0.927 . . . . 0.0 113.008 -176.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.524 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 22.3 p90 -146.73 157.77 43.76 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.171 -0.611 . . . . 0.0 112.104 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.683 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.7 tt0 -135.6 140.85 44.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.24 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.863 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 16.1 mt -117.0 131.12 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.18 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.685 HD21 ' HB2' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -116.65 146.71 42.54 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.153 0.501 . . . . 0.0 111.932 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.776 HD22 ' CG1' ' A' ' 33' ' ' VAL . 15.3 tp . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.148 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.752 HD21 HG12 ' A' ' 33' ' ' VAL . 3.1 mp . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.838 0.351 . . . . 0.0 110.971 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.794 HD23 ' O ' ' A' ' 122' ' ' GLN . 9.3 mt -128.76 136.47 50.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.512 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.83 122.6 48.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.08 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.685 ' HB2' HD21 ' A' ' 92' ' ' LEU . 63.6 t30 -114.85 121.99 44.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.015 0.436 . . . . 0.0 111.857 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.773 ' OD2' HG23 ' A' ' 116' ' ' VAL . 21.9 p30 -82.0 133.72 35.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.905 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.497 HD13 ' HB2' ' A' ' 90' ' ' GLN . 17.2 pt -139.55 37.82 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.654 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -96.34 156.25 16.42 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 120.927 0.394 . . . . 0.0 111.746 -178.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 87.8 m -68.91 -35.83 77.3 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.318 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.432 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -98.58 -19.74 17.42 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.46 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.654 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 121.04 161.57 11.42 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.192 -1.004 . . . . 0.0 113.914 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.548 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.2 m -117.5 138.04 52.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.905 -0.647 . . . . 0.0 109.299 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.84 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -112.22 148.55 33.86 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -177.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.466 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.06 113.32 18.23 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.484 -1.235 . . . . 0.0 108.192 177.216 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.419 ' N ' HD12 ' A' ' 111' ' ' LEU . 93.0 m-20 44.29 43.5 6.0 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.05 -11.36 67.42 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 120.709 -0.758 . . . . 0.0 113.487 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.77 118.5 36.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.031 0.443 . . . . 0.0 110.679 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.84 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -72.36 128.55 35.97 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.371 -179.698 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.773 HG23 ' OD2' ' A' ' 103' ' ' ASP . 8.4 m -98.54 166.11 2.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.057 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 120' ' ' SER . 16.1 tt0 -69.9 126.71 30.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.483 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.693 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 32.6 tttt -54.27 163.4 0.84 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.9 OUTLIER 35.82 35.45 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.746 -179.231 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.7 p -111.9 145.04 40.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.601 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.566 ' HB3' HD22 ' A' ' 100' ' ' LEU . 24.7 m120 -95.14 129.54 42.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.846 0.355 . . . . 0.0 110.897 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.794 ' O ' HD23 ' A' ' 100' ' ' LEU . 56.2 mm-40 -129.08 150.01 50.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.533 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.1 tp -72.55 132.27 43.59 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.276 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.957 HD11 HG21 ' A' ' 145' ' ' ILE . 61.4 tp -64.11 156.62 27.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.43 0.633 . . . . 0.0 111.633 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.443 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.57 154.09 41.16 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.926 -179.512 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.457 ' NE2' ' HB ' ' A' ' 147' ' ' ILE . 9.3 mm-40 -70.78 121.67 18.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.863 0.363 . . . . 0.0 110.061 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.13 22.85 50.8 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.033 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.443 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 26.5 t70 -53.62 171.77 0.08 Allowed 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.981 0.42 . . . . 0.0 111.037 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -145.26 135.34 23.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.097 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.457 ' CG2' HG22 ' A' ' 109' ' ' THR . 16.0 mt -115.01 127.9 72.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.412 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.513 HG22 ' CG2' ' A' ' 140' ' ' ILE . 23.5 m -104.31 137.16 42.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.985 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.501 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 26.9 m -140.2 158.34 25.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.02 0.438 . . . . 0.0 112.022 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.55 37.67 10.47 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.618 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 140' ' ' ILE . 50.4 t -79.71 140.47 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 121.705 0.764 . . . . 0.0 112.435 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.52 -36.8 0.63 Allowed Glycine 0 N--CA 1.436 -1.337 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.465 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 50.9 t -126.32 133.0 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-N 114.653 -0.774 . . . . 0.0 109.169 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -50.69 -44.64 57.96 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -93.3 6.51 47.86 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.465 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 4.9 t0 -117.25 29.37 7.93 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.513 ' CG2' HG22 ' A' ' 131' ' ' THR . 3.8 mt -107.41 139.32 29.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.921 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.592 HD21 ' CD1' ' A' ' 43' ' ' ILE . 1.0 OUTLIER -116.46 134.43 54.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.588 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.564 ' C ' HD22 ' A' ' 143' ' ' LEU . 38.0 t -114.9 150.38 35.73 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.567 0.698 . . . . 0.0 112.595 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.722 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.5 mm? -136.01 143.44 44.77 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.876 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.35 135.86 49.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.803 0.335 . . . . 0.0 110.957 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.957 HG21 HD11 ' A' ' 124' ' ' LEU . 2.9 mm -106.24 123.96 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.069 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.07 117.1 31.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.481 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.636 HG12 HD21 ' A' ' 124' ' ' LEU . 2.6 mt -84.97 134.04 27.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.451 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.24 109.9 16.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.759 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -60.7 -35.2 75.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.103 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.93 -44.06 91.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.73 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.7 t80 . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.04 -179.937 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.803 0.335 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.4 mtm180 -59.11 -48.02 83.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.917 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -59.49 -35.01 73.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.88 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.78 -44.03 97.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.92 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.5 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.9 mm -66.64 -35.17 74.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.189 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -57.21 -39.44 75.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.928 0.394 . . . . 0.0 110.334 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.3 tttp -67.28 -23.71 65.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.6 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.5 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.82 -47.48 80.17 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.146 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 C--N 1.326 -0.438 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.902 179.823 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.414 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.8 OUTLIER . . . . . 0 CA--C 1.509 -0.607 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.663 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.3 mm -74.86 137.2 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 CA-C-N 113.786 -1.552 . . . . 0.0 112.437 -177.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.96 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.5 t -90.54 -58.54 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.745 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.728 ' SG ' HD22 ' A' ' 99' ' ' LEU . 1.8 m -149.8 162.84 39.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.701 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.401 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -127.1 138.09 53.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.754 0.311 . . . . 0.0 111.114 -179.768 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.669 HG21 ' CE2' ' A' ' 68' ' ' PHE . 47.5 t -108.43 122.65 63.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.95 0.405 . . . . 0.0 110.81 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.599 HG23 HG12 ' A' ' 45' ' ' ILE . 15.8 mt -123.77 121.54 62.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.472 -179.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.609 ' HA ' HD23 ' A' ' 143' ' ' LEU . 12.3 t -80.34 100.01 8.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.389 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.484 HG23 HG21 ' A' ' 144' ' ' VAL . 0.4 OUTLIER -63.86 -27.2 69.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.828 -179.261 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.517 HG21 ' H ' ' A' ' 142' ' ' SER . 54.9 p -79.85 -2.2 42.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.734 0.302 . . . . 0.0 111.504 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.72 75.39 0.31 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.018 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.428 ' HB2' HD11 ' A' ' 141' ' ' LEU . 6.9 mt-30 -144.23 -47.56 0.27 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.856 0.36 . . . . 0.0 110.627 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.668 HG21 ' CE2' ' A' ' 76' ' ' TYR . 2.8 mm -104.24 141.74 23.16 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.749 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.62 ' HD2' HG22 ' A' ' 43' ' ' ILE . 53.7 Cg_endo -71.67 138.22 31.57 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.187 1.925 . . . . 0.0 112.164 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.599 HG12 HG23 ' A' ' 37' ' ' ILE . 35.1 mt -55.61 131.99 19.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.609 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.96 164.55 19.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.404 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.401 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.8 OUTLIER -125.51 119.75 29.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.976 0.417 . . . . 0.0 111.957 -179.556 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.818 HD23 ' CD2' ' A' ' 66' ' ' TRP . 6.9 mp -92.22 129.49 38.15 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.96 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -138.49 156.48 47.5 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 122.252 1.025 . . . . 0.0 113.692 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.473 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -154.54 141.89 19.59 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 113.493 -1.685 . . . . 0.0 110.856 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.178 0 CA-C-O 121.062 0.458 . . . . 0.0 111.317 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.692 0.282 . . . . 0.0 111.053 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.448 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.9 ttpt -144.03 133.21 23.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.183 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.595 HG12 ' HG2' ' A' ' 90' ' ' GLN . 6.3 t -128.1 137.67 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 121.259 0.552 . . . . 0.0 112.045 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.818 ' CD2' HD23 ' A' ' 48' ' ' LEU . 18.9 m-90 -101.79 139.65 37.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.242 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.654 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -113.1 132.26 55.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.831 0.348 . . . . 0.0 110.157 177.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.722 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -120.32 145.4 47.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.825 -179.315 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.64 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.66 -167.03 35.67 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.166 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.428 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 20.0 mtp180 -86.19 36.05 0.67 Allowed 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.549 HD22 ' HB3' ' A' ' 73' ' ' ALA . 2.2 t30 -118.44 132.53 23.76 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.468 0.175 . . . . 0.0 110.998 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.09 -17.06 58.32 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.522 2.148 . . . . 0.0 111.506 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.549 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.99 -42.52 17.46 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 121.806 0.812 . . . . 0.0 109.088 178.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.26 139.39 1.43 Allowed 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.12 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.2 m-20 -56.23 -18.38 10.2 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.059 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.668 ' CE2' HG21 ' A' ' 43' ' ' ILE . 2.5 t80 -129.12 118.67 22.84 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-O 120.914 0.387 . . . . 0.0 110.951 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.628 179.857 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.523 HD12 ' CD1' ' A' ' 84' ' ' LEU . 36.0 mt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.763 0.316 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.83 -35.86 64.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.004 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.461 ' H ' HG22 ' A' ' 81' ' ' ILE . 5.4 mmp_? -63.37 -29.88 71.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.468 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.568 HD21 HG23 ' A' ' 132' ' ' VAL . 23.8 mt -99.99 150.5 22.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.857 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.7 p -98.37 166.69 11.26 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.64 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 m-20 -43.25 -52.54 5.63 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.397 0.618 . . . . 0.0 109.892 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.606 ' CB ' HD12 ' A' ' 104' ' ' ILE . 4.3 mttt -119.0 82.05 1.8 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 177.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.597 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 15.4 t60 -58.69 -45.75 88.79 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.847 -177.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.513 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 31.5 p90 -149.38 162.18 40.6 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.583 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.654 ' HG3' HG23 ' A' ' 67' ' ' THR . 3.3 tt0 -136.32 140.84 43.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.298 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.711 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 78.1 mt -115.22 129.08 72.06 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.192 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.779 179.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.426 ' CA ' HG13 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -113.9 146.9 39.38 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.205 0.526 . . . . 0.0 111.937 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.724 HD22 HG11 ' A' ' 33' ' ' VAL . 23.7 tp . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.067 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.728 HD22 ' SG ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.761 0.315 . . . . 0.0 110.888 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.813 HD13 ' O ' ' A' ' 122' ' ' GLN . 4.1 mm? -129.2 142.83 50.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.635 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.546 HD21 HD13 ' A' ' 124' ' ' LEU . 28.0 mt -112.61 122.32 47.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.912 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.42 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 63.4 t30 -117.11 135.61 53.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.152 0.501 . . . . 0.0 111.825 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.811 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.3 p30 -96.82 143.08 28.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.664 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.606 HD12 ' CB ' ' A' ' 87' ' ' LYS . 7.0 pt -147.62 28.28 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.468 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.583 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 10.8 t -92.26 157.69 16.53 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 121.433 0.635 . . . . 0.0 112.69 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 95.3 m -69.8 -52.12 27.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.954 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -82.84 -0.09 46.49 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.324 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.65 157.75 29.58 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.708 -0.758 . . . . 0.0 113.542 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.514 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.2 m -117.63 137.89 52.33 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.841 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -113.76 148.44 36.49 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -178.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.82 HD12 HG11 ' A' ' 116' ' ' VAL . 0.8 OUTLIER -124.43 113.51 18.26 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.875 177.253 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 47.41 35.96 4.54 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.111 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.9 -7.23 79.26 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.487 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.51 118.39 36.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.979 0.419 . . . . 0.0 110.557 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.841 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 25.3 tptt -72.32 121.92 20.28 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.175 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.82 HG11 HD12 ' A' ' 111' ' ' LEU . 8.3 m -97.67 163.65 2.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.438 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 120' ' ' SER . 25.6 tt0 -69.98 128.13 35.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.453 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.67 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 66.7 tttt -52.56 161.94 0.63 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.789 0.328 . . . . 0.0 110.353 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.8 p30 35.15 34.89 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.202 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.25 143.18 43.74 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.975 179.469 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.534 ' HB3' HD12 ' A' ' 100' ' ' LEU . 5.5 m120 -85.39 132.52 34.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.889 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.813 ' O ' HD13 ' A' ' 100' ' ' LEU . 35.0 mm-40 -129.56 147.68 51.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.665 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.76 HD23 ' O ' ' A' ' 124' ' ' LEU . 7.2 tt -72.72 129.2 37.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.26 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.76 ' O ' HD23 ' A' ' 123' ' ' LEU . 66.9 tp -62.16 155.17 25.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.513 0.673 . . . . 0.0 111.677 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.5 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.3 OUTLIER -124.8 153.5 42.41 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.316 179.768 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.613 ' HA ' HD13 ' A' ' 147' ' ' ILE . 13.4 tp60 -71.15 119.79 15.79 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.55 23.95 63.4 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.657 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.437 ' OD2' HD23 ' A' ' 111' ' ' LEU . 22.2 t70 -49.02 167.15 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.921 0.391 . . . . 0.0 111.329 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 13.7 tt0 -145.1 135.4 24.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.965 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.509 HD11 HD11 ' A' ' 145' ' ' ILE . 11.8 mt -114.88 128.36 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.777 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.644 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.3 m -104.18 141.85 35.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.815 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.597 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 31.2 m -140.29 158.68 25.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.64 44.41 9.37 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.94 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.47 ' HA ' HG12 ' A' ' 140' ' ' ILE . 59.6 t -85.66 140.5 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-O 121.644 0.735 . . . . 0.0 112.459 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.03 -39.08 1.08 Allowed Glycine 0 N--CA 1.435 -1.404 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.565 HG12 ' H ' ' A' ' 138' ' ' SER . 58.8 t -126.51 118.91 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 CA-C-N 114.41 -0.895 . . . . 0.0 108.866 177.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.443 ' HA ' HD12 ' A' ' 140' ' ' ILE . 7.3 pt-20 -50.29 -26.37 4.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.738 0.304 . . . . 0.0 111.607 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.565 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -93.57 6.59 47.75 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -179.243 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.419 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.6 OUTLIER -131.11 29.19 4.7 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -178.901 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.644 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.7 mt -107.14 139.14 29.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.719 178.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.512 HD23 ' C ' ' A' ' 141' ' ' LEU . 9.4 tt -124.16 134.44 53.32 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.39 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.517 ' H ' HG21 ' A' ' 40' ' ' THR . 37.6 t -108.15 150.19 27.54 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.782 0.801 . . . . 0.0 112.532 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.609 HD23 ' HA ' ' A' ' 38' ' ' CYS . 72.2 mt -135.93 145.0 45.78 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.383 -1.281 . . . . 0.0 110.622 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.484 HG21 HG23 ' A' ' 39' ' ' THR . 21.9 t -117.07 139.49 43.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.837 0.351 . . . . 0.0 111.108 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.61 HG21 HD11 ' A' ' 124' ' ' LEU . 15.3 mt -106.17 123.02 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.952 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.04 119.5 39.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.87 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.613 HD13 ' HA ' ' A' ' 126' ' ' GLN . 4.7 mp -89.68 131.43 36.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.363 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.8 114.26 20.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.914 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -60.32 -29.18 68.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.35 -44.01 88.58 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.993 0.425 . . . . 0.0 110.609 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.0 t80 . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.841 179.82 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.84 0.352 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -60.14 -35.96 76.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.825 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.78 -35.0 77.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.825 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.6 mp -63.93 -44.05 94.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.888 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.3 mm -65.75 -35.16 74.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.206 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -57.16 -41.12 78.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.028 0.442 . . . . 0.0 110.351 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.6 mttm -67.21 -23.81 65.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.591 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.473 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.56 -47.56 79.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.109 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.0 p . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.836 179.873 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.406 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.5 OUTLIER . . . . . 0 CA--C 1.509 -0.625 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.743 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 2.3 mm -81.86 94.41 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 CA-C-N 113.908 -1.496 . . . . 0.0 112.923 -177.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.913 HG12 HD11 ' A' ' 99' ' ' LEU . 3.5 t -46.88 -61.22 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.906 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.559 ' SG ' HD12 ' A' ' 48' ' ' LEU . 6.1 p -144.74 165.1 29.02 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.777 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.73 138.15 51.96 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.904 0.383 . . . . 0.0 111.54 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.905 HG13 HD11 ' A' ' 48' ' ' LEU . 5.1 m -101.73 122.85 54.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.741 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.838 HG23 HG12 ' A' ' 45' ' ' ILE . 20.8 mt -129.05 118.67 47.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.733 ' HA ' HD13 ' A' ' 143' ' ' LEU . 39.0 t -79.98 122.53 26.84 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.49 -21.99 17.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.798 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.465 HG23 ' HB3' ' A' ' 142' ' ' SER . 76.5 p -79.84 -2.15 42.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.699 0.285 . . . . 0.0 111.43 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.71 73.85 0.57 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.695 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -145.98 -39.08 0.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.715 0.293 . . . . 0.0 111.142 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.563 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.7 mt -125.11 141.47 38.63 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.007 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.563 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 53.4 Cg_endo -72.19 145.94 45.01 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.191 1.927 . . . . 0.0 112.223 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.838 HG12 HG23 ' A' ' 37' ' ' ILE . 37.0 mt -62.4 138.55 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.787 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.62 163.23 25.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.752 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.7 119.67 36.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.009 0.433 . . . . 0.0 111.858 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.905 HD11 HG13 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -96.72 132.51 42.34 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.177 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.743 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -144.24 156.99 44.53 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -178.573 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.628 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -146.57 141.95 27.49 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.304 -1.771 . . . . 0.0 110.827 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 121.025 0.441 . . . . 0.0 110.977 -179.876 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.678 0.275 . . . . 0.0 111.127 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.5 ttpt -141.5 135.66 30.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.863 0.363 . . . . 0.0 111.316 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.634 HG13 ' O ' ' A' ' 91' ' ' ILE . 18.6 t -133.92 139.13 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-O 121.194 0.521 . . . . 0.0 111.782 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.61 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 16.5 m-90 -102.07 139.06 38.2 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.253 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.506 HG22 ' HB3' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -111.81 128.38 56.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.813 177.635 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.64 ' CD1' ' HB2' ' A' ' 76' ' ' TYR . 9.0 m-85 -120.45 145.57 47.09 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.714 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.592 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.97 -165.96 34.9 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.845 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.434 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 10.3 mtm105 -83.07 6.56 18.57 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.435 ' ND2' ' HD2' ' A' ' 72' ' ' PRO . 3.2 t-20 -84.71 140.04 37.93 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.556 0.217 . . . . 0.0 110.877 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.435 ' HD2' ' ND2' ' A' ' 71' ' ' ASN . 60.3 Cg_endo -73.57 -14.3 24.8 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.356 2.038 . . . . 0.0 111.302 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.1 -43.1 16.63 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -41.78 137.25 1.75 Allowed 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 113.63 -1.623 . . . . 0.0 110.906 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.4 OUTLIER -56.73 -19.23 15.72 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.191 179.162 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.64 ' HB2' ' CD1' ' A' ' 68' ' ' PHE . 15.6 t80 -130.22 120.2 24.11 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.641 0.258 . . . . 0.0 111.097 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.82 0.343 . . . . 0.0 110.724 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 1.066 HD13 HD12 ' A' ' 84' ' ' LEU . 4.1 mp . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.838 0.351 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.1 t -63.71 -36.81 85.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.03 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.547 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -69.52 -21.03 63.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.316 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.066 HD12 HD13 ' A' ' 81' ' ' ILE . 21.2 mt -105.9 148.9 27.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.721 0.296 . . . . 0.0 111.077 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.6 p -95.55 165.62 12.25 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.689 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.592 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.9 m-20 -43.91 -53.68 5.93 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.315 0.579 . . . . 0.0 109.897 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.534 ' HB2' HD12 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -118.54 80.34 1.52 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.362 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.635 ' CD2' ' HB2' ' A' ' 105' ' ' SER . 13.9 t60 -60.79 -45.94 92.45 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.866 -176.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.455 ' CD1' ' HB2' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -145.05 153.34 41.35 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.047 -0.661 . . . . 0.0 112.171 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.607 ' HG2' HG12 ' A' ' 65' ' ' VAL . 5.9 tt0 -135.5 139.89 44.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.418 -178.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.691 HD11 HD11 ' A' ' 145' ' ' ILE . 24.9 mt -113.97 132.09 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.024 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.528 HD21 HD22 ' A' ' 121' ' ' ASN . 0.6 OUTLIER -118.28 144.0 46.15 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.961 0.41 . . . . 0.0 111.603 -179.804 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.646 HD22 HG11 ' A' ' 33' ' ' VAL . 13.8 tp . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.49 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.913 HD11 HG12 ' A' ' 33' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.808 0.337 . . . . 0.0 110.723 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.713 HD12 ' O ' ' A' ' 99' ' ' LEU . 5.9 mp -131.07 144.49 51.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.321 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.704 HD11 HD11 ' A' ' 130' ' ' ILE . 0.3 OUTLIER -112.7 123.54 50.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.199 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -114.04 115.9 28.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.018 0.437 . . . . 0.0 111.684 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.875 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.8 p30 -81.01 118.81 22.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.224 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.534 HD12 ' HB2' ' A' ' 87' ' ' LYS . 9.9 pt -124.41 33.83 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.321 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.635 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 13.7 t -89.57 159.01 17.4 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-O 121.347 0.594 . . . . 0.0 112.444 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 49.5 m -69.59 -52.28 27.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.67 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -92.67 -19.82 21.46 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 136.06 153.33 6.57 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.618 -0.801 . . . . 0.0 114.02 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.459 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.2 m -117.29 137.89 52.11 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.826 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -113.65 148.62 35.96 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -178.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.571 HD13 ' OD2' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -123.95 113.31 18.29 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.204 177.253 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.411 ' N ' HD12 ' A' ' 111' ' ' LEU . 82.6 m-20 45.08 43.05 7.19 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.28 -6.38 81.95 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.751 -0.737 . . . . 0.0 113.451 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -105.46 118.35 36.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.019 0.438 . . . . 0.0 110.76 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.826 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 7.9 tptt -73.42 115.75 13.16 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.267 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.875 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.4 m -92.36 159.56 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.356 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.1 tt0 -69.88 128.78 37.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.437 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.666 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 9.7 tttp -50.5 161.41 0.32 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.887 0.375 . . . . 0.0 110.472 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.459 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 3.6 p30 34.23 35.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.186 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.9 OUTLIER -112.04 122.48 47.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.083 179.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.682 ' HB3' HD23 ' A' ' 100' ' ' LEU . 5.5 m120 -68.59 126.03 28.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.032 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -129.38 147.37 51.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.598 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.1 tp -72.9 122.18 21.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.087 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.576 ' CD1' HD12 ' A' ' 101' ' ' LEU . 1.3 mm? -59.23 166.1 2.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.72 0.771 . . . . 0.0 111.888 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.574 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.4 OUTLIER -125.43 153.27 43.72 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.387 179.393 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.655 ' HA ' HD13 ' A' ' 147' ' ' ILE . 15.7 mm100 -71.35 116.25 11.46 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 62.99 27.89 71.15 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.776 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.571 ' OD2' HD13 ' A' ' 111' ' ' LEU . 20.6 t0 -59.31 174.81 0.37 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.018 0.437 . . . . 0.0 111.143 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.934 ' CG ' HG22 ' A' ' 144' ' ' VAL . 2.4 mt-10 -145.21 135.48 24.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.877 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.704 HD11 HD11 ' A' ' 101' ' ' LEU . 5.0 mt -111.33 128.48 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.269 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.664 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.8 m -103.93 141.45 36.13 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.567 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 33.3 m -140.43 158.61 25.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 77.0 44.35 14.3 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.11 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.454 ' HA ' HG12 ' A' ' 140' ' ' ILE . 76.1 t -83.8 140.4 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-O 121.691 0.758 . . . . 0.0 112.411 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.95 -38.92 1.23 Allowed Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.56 HG12 ' H ' ' A' ' 138' ' ' SER . 48.3 t -126.39 119.96 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-N 114.438 -0.881 . . . . 0.0 108.97 177.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.404 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.1 OUTLIER -50.23 -27.64 6.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.743 0.306 . . . . 0.0 111.273 -178.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.56 ' H ' HG12 ' A' ' 136' ' ' VAL . 15.2 m -93.56 6.59 47.75 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -127.34 25.81 6.09 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.664 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.9 mt -107.14 138.46 32.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.184 178.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.537 ' O ' HG22 ' A' ' 132' ' ' VAL . 2.6 tt -124.73 134.41 52.84 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.214 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.531 ' N ' HD23 ' A' ' 141' ' ' LEU . 36.7 t -112.72 150.16 31.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.66 0.743 . . . . 0.0 112.666 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.733 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.3 mm? -136.05 142.59 44.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.412 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.934 HG22 ' CG ' ' A' ' 129' ' ' GLU . 17.5 t -110.95 140.13 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.932 0.396 . . . . 0.0 111.334 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.691 HD11 HD11 ' A' ' 91' ' ' ILE . 2.7 mm -106.36 121.05 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.697 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.74 108.74 19.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.959 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.655 HD13 ' HA ' ' A' ' 126' ' ' GLN . 4.3 mp -84.84 129.01 38.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.19 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 32' ' ' ILE . 1.4 t-20 -75.8 128.53 35.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.079 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.08 -29.1 61.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.098 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -43.51 86.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.025 0.44 . . . . 0.0 110.534 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.5 t80 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.762 179.898 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.657 0.265 . . . . 0.0 111.137 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.7 mtm-85 -59.33 -35.89 74.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.229 0.538 . . . . 0.0 109.937 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.427 ' CD2' ' HE2' ' A' ' 22' ' ' LYS . 3.0 t80 -60.88 -34.93 75.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.924 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.6 tp -59.14 -41.26 87.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.788 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.554 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 11.5 mm -70.38 -34.96 60.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.051 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -57.01 -33.7 67.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.832 0.348 . . . . 0.0 110.494 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.427 ' HE2' ' CD2' ' A' ' 18' ' ' PHE . 2.5 mptp? -66.65 -23.68 66.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.787 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.554 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.67 -47.55 79.57 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.969 0.414 . . . . 0.0 111.171 -179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.816 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.434 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.3 t-20 . . . . . 0 CA--C 1.508 -0.667 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.708 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -71.85 135.79 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-N 113.667 -1.606 . . . . 0.0 112.408 -177.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.009 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.6 t -91.71 -59.29 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.145 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.6 m -145.32 160.35 41.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.796 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.483 ' NH2' HD13 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -120.77 138.18 54.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.902 0.382 . . . . 0.0 111.216 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.672 HG21 ' CE2' ' A' ' 68' ' ' PHE . 22.0 t -98.52 122.66 50.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.065 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.78 HD12 ' CD1' ' A' ' 146' ' ' PHE . 16.3 mt -129.89 120.57 50.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.123 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.672 ' HA ' HD13 ' A' ' 143' ' ' LEU . 39.7 t -86.29 109.36 18.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.514 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.1 -27.12 48.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.587 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.59 HG21 ' H ' ' A' ' 142' ' ' SER . 8.7 p -79.86 -3.01 46.1 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.692 0.282 . . . . 0.0 111.455 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.25 78.92 0.2 Allowed Glycine 0 CA--C 1.52 0.376 0 C-N-CA 121.079 -0.582 . . . . 0.0 113.798 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.445 HE21 HD13 ' A' ' 141' ' ' LEU . 2.3 mt-30 -147.71 -45.25 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.902 0.382 . . . . 0.0 110.959 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.546 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 8.8 mt -116.38 141.3 27.71 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.228 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.546 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.0 Cg_endo -74.54 146.11 34.25 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.318 2.012 . . . . 0.0 112.094 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.483 HD13 ' NH2' ' A' ' 35' ' ' ARG . 17.2 mt -52.23 153.27 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.252 0.548 . . . . 0.0 111.788 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -142.58 161.69 37.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.93 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -119.62 119.71 34.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.158 0.504 . . . . 0.0 111.817 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.523 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 5.3 mt -101.08 137.06 39.95 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.009 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -144.35 158.45 43.74 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -178.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.504 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.4 143.64 30.2 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 113.631 -1.622 . . . . 0.0 110.862 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 121.075 0.464 . . . . 0.0 111.279 -179.607 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.3 tppm? . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.749 0.309 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.423 ' CE ' ' O ' ' A' ' 49' ' ' SER . 6.8 ttpt -144.92 132.59 21.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.234 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.649 HG22 ' CB ' ' A' ' 92' ' ' LEU . 15.4 t -128.43 139.42 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 121.373 0.606 . . . . 0.0 112.093 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.547 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 14.8 m-90 -100.57 139.98 35.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.142 -0.936 . . . . 0.0 112.255 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.673 HG23 ' CD ' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -108.9 127.23 53.87 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.17 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.672 ' CE2' HG21 ' A' ' 36' ' ' VAL . 3.4 m-85 -113.27 145.74 40.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.935 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.682 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.6 -173.96 38.06 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.115 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 27.4 mtm180 -79.12 0.75 26.83 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.733 0.271 . . . . 0.0 111.733 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.475 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -84.78 131.95 47.77 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.516 0.198 . . . . 0.0 110.774 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 14.8 Cg_exo -67.84 -8.31 22.14 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.492 2.128 . . . . 0.0 111.792 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.18 -43.55 16.02 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 121.922 0.867 . . . . 0.0 108.896 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -41.37 138.35 1.27 Allowed 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 113.697 -1.592 . . . . 0.0 110.71 179.538 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -56.46 -18.54 11.69 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.134 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.548 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 55.2 t80 -129.15 123.39 31.99 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-O 120.791 0.329 . . . . 0.0 110.756 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.908 179.898 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.622 HD12 ' CD1' ' A' ' 84' ' ' LEU . 30.7 mt . . . . . 0 N--CA 1.456 -0.125 0 CA-C-O 120.832 0.349 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.97 -41.28 96.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.891 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.4 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -62.41 -28.6 69.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.062 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.622 ' CD1' HD12 ' A' ' 81' ' ' ILE . 32.5 mt -96.57 152.1 18.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.055 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 93.0 p -97.55 164.21 12.53 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.529 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.682 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.7 m-20 -41.96 -53.04 3.97 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.326 0.584 . . . . 0.0 109.782 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.465 ' HB3' HD11 ' A' ' 104' ' ' ILE . 25.3 mttt -119.39 85.62 2.41 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 177.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.573 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.2 t60 -65.05 -44.21 89.77 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -176.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.506 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 37.7 p90 -153.26 163.27 40.21 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 119.984 -0.686 . . . . 0.0 112.461 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.673 ' CD ' HG23 ' A' ' 67' ' ' THR . 12.4 mt-30 -135.68 156.81 48.26 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.51 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.496 ' O ' HG13 ' A' ' 65' ' ' VAL . 18.3 mt -127.8 132.35 68.96 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.205 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.649 ' CB ' HG22 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -120.64 148.35 44.03 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.12 0.486 . . . . 0.0 111.791 -179.268 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.804 HD22 ' CG1' ' A' ' 33' ' ' VAL . 48.2 tp . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.361 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.606 ' HB3' HD13 ' A' ' 124' ' ' LEU . 3.9 mm? . . . . . 0 N--CA 1.458 -0.068 0 CA-C-O 120.769 0.319 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.572 HD12 ' O ' ' A' ' 99' ' ' LEU . 2.9 mp -131.4 143.69 50.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.395 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.494 HD22 HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -114.9 126.06 54.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.479 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.473 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.3 t30 -115.57 115.75 26.97 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.751 -0.379 . . . . 0.0 111.57 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.795 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.3 p30 -79.57 143.19 35.01 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.283 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.503 HG21 ' OE1' ' A' ' 90' ' ' GLN . 11.0 pt -150.3 35.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.624 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -95.1 151.23 19.38 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 120.942 0.401 . . . . 0.0 111.814 -178.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 50.6 m -68.8 -31.57 70.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.014 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -98.08 -19.72 17.79 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.624 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.39 154.92 9.63 Favored Glycine 0 N--CA 1.439 -1.164 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.609 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.508 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.5 m -117.53 137.69 52.4 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.857 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -116.39 148.35 40.74 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -178.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.459 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.23 113.43 18.28 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.437 177.482 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.404 ' N ' HD12 ' A' ' 111' ' ' LEU . 2.2 m-80 44.89 43.37 7.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.227 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.17 -7.32 78.66 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.838 -0.696 . . . . 0.0 113.47 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -105.61 118.58 36.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.043 0.449 . . . . 0.0 110.724 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.857 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 15.0 tptt -74.02 121.55 21.23 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.239 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.795 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.6 m -95.6 164.03 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.124 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 120' ' ' SER . 28.3 tp10 -69.88 128.98 38.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.474 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.693 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 80.3 tttt -54.61 161.92 1.33 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.989 0.423 . . . . 0.0 110.599 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.455 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.0 m-80 34.67 33.97 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.437 -0.802 . . . . 0.0 112.105 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.4 145.18 40.58 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.025 179.441 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.535 ' HB3' HD23 ' A' ' 100' ' ' LEU . 22.1 m120 -88.78 131.35 35.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.949 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.451 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 39.9 mm-40 -129.27 150.36 50.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.379 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.3 tp -72.62 111.86 8.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.823 0.344 . . . . 0.0 110.309 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.639 ' CD2' HD11 ' A' ' 147' ' ' ILE . 7.7 tt -55.01 156.78 3.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.287 0.565 . . . . 0.0 111.541 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.29 153.47 41.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.812 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.434 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.5 122.2 20.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.025 0.441 . . . . 0.0 110.531 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.14 18.71 60.73 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.42 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -57.22 173.36 0.24 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.879 0.371 . . . . 0.0 110.973 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 13.0 tt0 -145.04 135.64 24.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.118 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.481 ' CG2' HG22 ' A' ' 109' ' ' THR . 2.6 mt -108.89 128.3 64.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.45 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.482 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 25.4 m -104.24 141.16 36.76 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.102 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.547 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 27.2 m -140.25 158.43 25.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -178.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.55 42.93 8.77 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.241 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.466 ' HA ' HG12 ' A' ' 140' ' ' ILE . 71.7 t -84.59 140.38 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-O 121.617 0.722 . . . . 0.0 112.286 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.86 -40.66 1.12 Allowed Glycine 0 N--CA 1.436 -1.345 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.596 HG12 ' H ' ' A' ' 138' ' ' SER . 48.4 t -126.37 120.83 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 CA-C-N 114.462 -0.869 . . . . 0.0 109.049 177.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.491 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.5 OUTLIER -50.5 -24.98 3.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.664 0.269 . . . . 0.0 111.473 -178.785 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.596 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -93.5 6.51 47.96 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -179.363 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -129.7 26.12 5.31 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.491 HD12 ' HA ' ' A' ' 137' ' ' GLU . 5.9 mt -106.87 139.07 29.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.094 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.445 HD13 HE21 ' A' ' 42' ' ' GLN . 24.9 tp -124.74 134.51 52.79 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.803 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.59 ' H ' HG21 ' A' ' 40' ' ' THR . 0.9 OUTLIER -109.6 133.54 52.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.958 0.409 . . . . 0.0 111.548 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.672 HD13 ' HA ' ' A' ' 38' ' ' CYS . 1.4 mm? -128.29 134.5 48.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.688 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 21.6 t -110.98 135.55 49.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.816 0.341 . . . . 0.0 111.262 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.3 mm -106.31 134.79 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.78 ' CD1' HD12 ' A' ' 37' ' ' ILE . 14.9 m-85 -115.41 119.79 37.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.767 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.639 HD11 ' CD2' ' A' ' 124' ' ' LEU . 5.8 mt -84.82 134.01 27.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.499 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -75.89 116.4 16.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.663 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -58.22 -32.11 67.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.009 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.0 -46.09 90.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.59 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.494 ' CZ ' HD21 ' A' ' 93' ' ' LEU . 11.5 t80 . . . . . 0 N--CA 1.452 -0.336 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.027 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 . . . . . 0 N--CA 1.458 -0.062 0 CA-C-O 120.834 0.349 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -68.27 -39.17 82.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.857 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -56.99 -41.48 78.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.73 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.6 tp -58.45 -33.76 70.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.571 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.539 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.5 mt -73.16 -35.87 48.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.783 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -33.75 68.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.956 0.408 . . . . 0.0 110.904 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.1 mmpt? -58.73 -26.37 63.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.409 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.539 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.8 -48.48 77.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.268 0.556 . . . . 0.0 111.064 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 C--N 1.321 -0.635 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.062 179.875 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.452 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.9 m-20 . . . . . 0 CA--C 1.508 -0.654 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.653 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.5 mm -76.66 136.74 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-N 113.774 -1.557 . . . . 0.0 112.535 -177.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.966 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.1 t -91.05 -59.41 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.682 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 4.8 p -150.41 165.47 33.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.32 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.412 ' CD ' ' CG2' ' A' ' 45' ' ' ILE . 0.2 OUTLIER -128.01 138.15 52.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.804 0.335 . . . . 0.0 111.188 -179.411 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.736 HG11 ' CE2' ' A' ' 68' ' ' PHE . 3.1 m -106.48 122.76 60.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.852 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.675 HG23 HG12 ' A' ' 45' ' ' ILE . 17.3 mt -125.02 122.58 63.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.617 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.764 ' HA ' HD23 ' A' ' 143' ' ' LEU . 50.7 t -79.93 107.34 12.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.809 0.338 . . . . 0.0 110.402 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.3 t -70.97 -28.47 64.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.978 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.518 HG21 ' H ' ' A' ' 142' ' ' SER . 69.8 p -79.87 -2.17 42.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.693 0.283 . . . . 0.0 111.527 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.1 80.56 0.11 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.947 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.543 ' HB2' HD12 ' A' ' 43' ' ' ILE . 9.8 mt-30 -146.86 -41.69 0.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.912 0.386 . . . . 0.0 110.932 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.692 HG23 ' HD2' ' A' ' 44' ' ' PRO . 5.3 mp -119.41 143.48 34.56 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.218 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.692 ' HD2' HG23 ' A' ' 43' ' ' ILE . 43.9 Cg_endo -70.27 146.11 56.07 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.325 2.017 . . . . 0.0 111.963 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.675 HG12 HG23 ' A' ' 37' ' ' ILE . 32.2 mt -62.81 131.64 28.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.924 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.459 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -117.25 146.36 43.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.91 179.144 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.67 119.66 39.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.986 0.422 . . . . 0.0 111.629 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.829 HD23 ' CD2' ' A' ' 66' ' ' TRP . 6.9 mp -92.05 125.5 36.76 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.966 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -135.82 156.98 47.96 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 122.285 1.04 . . . . 0.0 113.531 -179.427 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.478 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -150.23 141.88 23.59 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 113.613 -1.631 . . . . 0.0 110.721 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 121.029 0.442 . . . . 0.0 111.346 -179.594 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt . . . . . 0 CA--C 1.528 0.108 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.465 ' CE ' ' O ' ' A' ' 49' ' ' SER . 30.8 ttpt -144.34 123.05 12.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.853 0.358 . . . . 0.0 111.918 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.698 HG22 ' HG2' ' A' ' 90' ' ' GLN . 13.1 p -110.4 139.76 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.829 ' CD2' HD23 ' A' ' 48' ' ' LEU . 20.6 m-90 -100.81 139.85 35.91 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.033 -1.44 . . . . 0.0 112.227 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.683 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -111.91 133.1 54.32 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 177.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.736 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -120.01 145.5 46.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.556 -178.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.621 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.81 -169.41 36.47 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.489 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.542 ' NH2' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -85.29 7.48 22.06 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.733 0.267 . . . . 0.0 111.521 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.438 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 6.4 t-20 -84.9 134.17 42.01 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-O 120.532 0.206 . . . . 0.0 110.783 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -65.84 -13.75 41.34 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.547 2.165 . . . . 0.0 111.843 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.438 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -83.2 -44.76 14.66 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 121.936 0.874 . . . . 0.0 109.186 178.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.75 137.63 2.19 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.728 -1.578 . . . . 0.0 111.485 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 67' ' ' THR . 21.9 m-20 -56.82 -18.88 14.53 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.231 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.459 ' CE1' ' HB2' ' A' ' 46' ' ' ARG . 7.8 t80 -129.8 103.28 6.73 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.817 0.342 . . . . 0.0 110.88 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.98 -179.912 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.59 ' HB ' HD13 ' A' ' 84' ' ' LEU . 42.2 mm . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.884 0.373 . . . . 0.0 111.021 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.5 p -65.24 -40.52 94.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.45 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.466 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -60.66 -24.87 65.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.902 0.382 . . . . 0.0 110.646 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.624 ' N ' HD12 ' A' ' 84' ' ' LEU . 3.7 mp -107.5 152.69 23.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.507 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.458 ' O ' ' NH1' ' A' ' 70' ' ' ARG . 59.7 p -98.87 153.86 18.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.89 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.621 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.6 m-20 -30.33 -53.49 0.17 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.361 0.6 . . . . 0.0 110.549 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.674 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.5 OUTLIER -120.16 84.18 2.17 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 177.321 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.565 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.3 t60 -61.55 -46.3 90.5 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.034 -0.985 . . . . 0.0 112.593 -177.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.544 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 22.0 p90 -142.36 160.73 39.69 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.058 -0.657 . . . . 0.0 112.109 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.698 ' HG2' HG22 ' A' ' 65' ' ' VAL . 3.3 tt0 -135.98 143.39 44.8 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.034 -179.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.675 ' C ' HG23 ' A' ' 65' ' ' VAL . 61.6 mt -122.39 132.14 71.73 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.196 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.688 HD21 ' OD1' ' A' ' 121' ' ' ASN . 0.4 OUTLIER -125.66 141.65 51.91 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.014 0.435 . . . . 0.0 111.842 -179.794 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.711 HD22 ' CG1' ' A' ' 33' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.315 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.532 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.85 0.357 . . . . 0.0 110.84 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.532 HD12 ' O ' ' A' ' 99' ' ' LEU . 2.5 mp -131.21 142.19 50.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.496 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.9 pp -113.42 124.7 53.04 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.187 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.619 ' HB2' HD21 ' A' ' 92' ' ' LEU . 54.8 t30 -116.03 120.29 38.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.056 0.455 . . . . 0.0 111.923 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.76 ' OD2' HG23 ' A' ' 116' ' ' VAL . 20.4 p30 -80.62 137.57 36.37 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.748 178.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.517 HD12 ' HB2' ' A' ' 87' ' ' LYS . 8.3 pt -144.58 39.33 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.565 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.12 162.28 13.44 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.073 0.463 . . . . 0.0 111.602 -179.278 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 89.1 m -69.11 -40.92 78.06 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.734 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -98.7 -19.94 17.22 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.096 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.565 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 126.58 160.69 10.66 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 119.948 -1.12 . . . . 0.0 114.205 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.538 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 13.9 m -117.63 138.02 52.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.853 -0.674 . . . . 0.0 109.253 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.876 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -111.97 148.36 33.94 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.405 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.21 113.52 18.41 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.491 -1.231 . . . . 0.0 108.197 177.399 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 44.5 42.79 5.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.47 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.71 -10.1 71.32 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.768 -0.729 . . . . 0.0 113.548 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -104.34 118.5 36.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.079 0.466 . . . . 0.0 110.696 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.876 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.0 tptm -73.82 126.88 31.39 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.194 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.76 HG23 ' OD2' ' A' ' 103' ' ' ASP . 8.7 m -99.51 166.51 2.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.384 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 120' ' ' SER . 3.0 tp10 -69.93 126.21 29.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.607 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.704 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 74.1 tttt -54.58 162.57 1.12 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.04 0.448 . . . . 0.0 110.534 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.0 OUTLIER 37.33 31.44 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.454 -0.793 . . . . 0.0 112.069 -179.218 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.479 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.65 143.94 43.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.847 179.095 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.688 ' OD1' HD21 ' A' ' 92' ' ' LEU . 23.4 m-80 -94.01 135.52 35.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.921 0.391 . . . . 0.0 111.018 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 59.0 mm-40 -129.38 152.32 49.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.393 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.458 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.6 tm? -72.4 118.36 15.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.959 0.409 . . . . 0.0 110.336 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.57 HD21 ' CG1' ' A' ' 147' ' ' ILE . 7.4 tt -52.12 155.59 1.87 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.437 0.637 . . . . 0.0 111.788 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.408 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.7 OUTLIER -124.52 153.23 42.4 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.349 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.605 ' HA ' HD13 ' A' ' 147' ' ' ILE . 27.3 mm100 -71.62 124.55 24.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.88 0.372 . . . . 0.0 110.478 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 56.94 22.08 40.34 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.257 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.408 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 19.9 t70 -54.86 173.14 0.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.946 0.403 . . . . 0.0 110.811 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.9 ' CG ' HG22 ' A' ' 144' ' ' VAL . 1.9 mt-10 -144.29 135.74 25.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.145 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.791 HD11 HD11 ' A' ' 145' ' ' ILE . 12.7 mt -113.11 127.56 70.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.791 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.614 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.0 m -104.45 137.79 41.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.741 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.543 HG23 HD21 ' A' ' 84' ' ' LEU . 33.9 m -140.25 158.29 25.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.68 28.92 25.35 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.135 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.488 ' HA ' HG12 ' A' ' 140' ' ' ILE . 70.4 t -70.89 140.39 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-O 121.62 0.724 . . . . 0.0 112.38 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.1 -38.98 0.83 Allowed Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.492 HG12 ' H ' ' A' ' 138' ' ' SER . 48.2 t -126.49 129.38 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-N 114.641 -0.779 . . . . 0.0 109.117 178.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -50.51 -36.07 32.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.807 0.337 . . . . 0.0 111.567 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.492 ' H ' HG12 ' A' ' 136' ' ' VAL . 3.4 p -93.61 6.54 47.94 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.422 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 9.5 t0 -120.74 25.97 9.39 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.614 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.4 mt -107.1 139.15 29.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.102 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.409 HD23 ' C ' ' A' ' 141' ' ' LEU . 9.6 tt -124.2 134.4 53.29 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.434 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.518 ' H ' HG21 ' A' ' 40' ' ' THR . 38.5 t -108.01 150.24 27.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.721 0.772 . . . . 0.0 112.261 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.764 HD23 ' HA ' ' A' ' 38' ' ' CYS . 76.2 mt -135.87 155.7 49.92 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.903 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.9 HG22 ' CG ' ' A' ' 129' ' ' GLU . 21.5 t -123.6 140.16 47.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.73 0.3 . . . . 0.0 110.918 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.791 HD11 HD11 ' A' ' 130' ' ' ILE . 7.9 mt -106.22 120.87 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-O 120.93 0.395 . . . . 0.0 111.01 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.84 126.3 52.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.452 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.694 ' N ' HD12 ' A' ' 147' ' ' ILE . 2.8 mp -99.19 131.51 46.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.284 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -76.05 112.0 12.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.841 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -58.5 -34.01 70.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.909 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.77 -46.2 91.4 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.741 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 32.0 t80 . . . . . 0 N--CA 1.452 -0.37 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.057 -179.918 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.795 0.331 . . . . 0.0 110.986 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -67.7 -35.94 79.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.989 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.7 -42.42 88.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.008 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.32 -44.92 95.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.52 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.7 mm -67.41 -35.0 72.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.269 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -57.17 -35.88 70.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.949 0.404 . . . . 0.0 110.469 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.2 -23.87 65.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.735 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.52 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.7 -47.37 80.07 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.281 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.3 t . . . . . 0 C--N 1.325 -0.464 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.889 179.989 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.424 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.7 OUTLIER . . . . . 0 CA--C 1.508 -0.67 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.663 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 6.0 mm -72.59 135.47 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 CA-C-N 113.612 -1.631 . . . . 0.0 112.638 -177.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.963 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.3 t -91.75 -59.16 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-N 114.68 -1.146 . . . . 0.0 109.715 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.548 ' SG ' HD22 ' A' ' 48' ' ' LEU . 4.9 p -147.31 165.32 30.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.46 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.549 ' NH1' HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -127.06 127.01 44.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.723 0.297 . . . . 0.0 111.263 -179.57 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.693 HG11 ' CE2' ' A' ' 68' ' ' PHE . 4.6 m -94.17 122.8 45.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.916 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.823 HG23 HG12 ' A' ' 45' ' ' ILE . 19.6 mt -129.34 121.84 54.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.634 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.533 ' HA ' HD23 ' A' ' 143' ' ' LEU . 52.3 t -81.27 124.34 29.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.254 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.96 -25.68 21.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.808 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.517 HG23 ' HB3' ' A' ' 142' ' ' SER . 81.8 p -79.87 -2.28 42.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.709 0.29 . . . . 0.0 111.562 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.07 74.42 0.46 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.93 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.455 ' HB2' HD11 ' A' ' 141' ' ' LEU . 7.7 mt-30 -144.43 -46.0 0.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.964 0.411 . . . . 0.0 110.789 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.599 HD13 HD21 ' A' ' 143' ' ' LEU . 2.8 mp -111.84 140.76 23.69 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.729 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.553 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.4 Cg_endo -73.4 143.78 35.42 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.147 1.898 . . . . 0.0 112.16 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.823 HG12 HG23 ' A' ' 37' ' ' ILE . 35.7 mt -56.33 142.93 10.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.575 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.452 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.4 OUTLIER -130.37 164.04 25.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.298 179.518 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.42 119.39 33.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.946 0.403 . . . . 0.0 111.529 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.792 HD21 ' HZ ' ' A' ' 68' ' ' PHE . 7.8 mp -94.38 124.71 38.58 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.963 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -136.3 156.15 49.07 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 122.283 1.04 . . . . 0.0 113.67 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.477 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -151.46 141.92 22.54 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.45 -1.705 . . . . 0.0 110.989 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 121.128 0.49 . . . . 0.0 110.894 -179.895 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.847 0.356 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.472 ' HE2' ' O ' ' A' ' 49' ' ' SER . 3.7 ttpt -140.3 130.41 24.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.853 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.737 HG12 ' HG2' ' A' ' 90' ' ' GLN . 9.3 t -124.14 138.34 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 121.26 0.552 . . . . 0.0 112.123 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.649 ' CD2' HD23 ' A' ' 48' ' ' LEU . 17.8 m-90 -100.88 139.6 36.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.127 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.605 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.27 130.47 55.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.043 0.449 . . . . 0.0 109.97 177.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.792 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -120.12 145.35 47.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.031 -179.07 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.595 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.35 -168.13 37.9 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.56 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.427 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 0.7 OUTLIER -79.46 -0.7 34.15 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.561 HD22 ' HB3' ' A' ' 73' ' ' ALA . 2.3 t30 -84.8 132.35 46.49 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.663 0.268 . . . . 0.0 111.148 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.8 Cg_exo -66.73 -13.52 40.25 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.639 2.226 . . . . 0.0 111.76 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.561 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.6 -43.06 17.47 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -41.11 141.04 0.69 Allowed 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 113.887 -1.506 . . . . 0.0 110.655 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 67' ' ' THR . 60.6 m-20 -56.31 -18.88 12.0 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.047 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.53 ' CE2' HG21 ' A' ' 43' ' ' ILE . 2.8 t80 -130.06 129.1 43.2 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-O 120.771 0.32 . . . . 0.0 111.325 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.462 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.815 HD13 HD12 ' A' ' 84' ' ' LEU . 3.9 mp . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.894 0.378 . . . . 0.0 110.835 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.1 m -56.11 -37.08 68.93 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.102 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.54 -17.5 59.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.302 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.815 HD12 HD13 ' A' ' 81' ' ' ILE . 20.0 mt -104.56 152.03 22.9 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.681 0.277 . . . . 0.0 111.157 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 57.7 p -96.63 167.97 10.81 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.566 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.595 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 8.1 m-20 -42.84 -58.74 2.24 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.365 0.602 . . . . 0.0 109.81 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.537 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.5 OUTLIER -115.36 82.74 1.8 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 176.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.556 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.1 t60 -59.6 -46.86 87.69 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.517 -176.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.532 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 29.8 p90 -145.54 161.49 39.65 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.214 -0.594 . . . . 0.0 112.005 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.737 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.2 tt0 -136.06 144.02 44.98 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.911 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.755 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 81.4 mt -118.88 124.7 73.6 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.272 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.044 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.669 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -102.26 151.27 22.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.964 0.411 . . . . 0.0 111.723 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.776 HD22 HG11 ' A' ' 33' ' ' VAL . 25.4 tp . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.439 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.777 ' HB2' HD22 ' A' ' 124' ' ' LEU . 4.1 mm? . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.931 0.396 . . . . 0.0 110.759 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.642 ' HB3' HD12 ' A' ' 92' ' ' LEU . 3.2 mp -131.31 145.46 51.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.689 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.726 HD21 HD12 ' A' ' 145' ' ' ILE . 11.0 mp -112.71 121.07 43.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.028 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.669 ' HB2' HD11 ' A' ' 92' ' ' LEU . 44.2 t30 -115.49 115.44 26.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.93 0.395 . . . . 0.0 111.552 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.828 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.3 p30 -78.59 140.44 38.47 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.536 HD12 ' HB2' ' A' ' 87' ' ' LYS . 10.1 pt -148.99 38.36 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -178.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.648 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.29 152.7 19.14 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 121.013 0.435 . . . . 0.0 112.063 -178.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 50.8 m -68.89 -31.44 70.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.875 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -98.21 -19.91 17.58 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -178.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.648 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.91 156.67 10.39 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.355 -0.926 . . . . 0.0 113.713 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.502 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.1 m -117.43 137.78 52.28 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.844 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -115.96 148.58 39.94 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -177.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.12 113.58 18.54 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.483 177.657 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 44.72 43.27 6.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.444 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.58 -12.68 62.53 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.722 -0.752 . . . . 0.0 113.468 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.8 118.56 36.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.087 0.444 . . . . 0.0 110.605 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.844 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -71.44 131.71 43.74 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.48 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.828 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.6 m -101.59 165.87 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.966 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.4 mp0 -69.83 126.12 28.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.482 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.69 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 84.4 tttt -54.11 162.52 0.99 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.824 0.345 . . . . 0.0 110.654 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.3 m-80 34.21 35.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.109 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.19 145.17 40.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.035 179.531 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.641 ' HB3' HD23 ' A' ' 100' ' ' LEU . 3.5 m120 -88.0 132.03 34.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.919 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.477 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 45.1 mm-40 -129.33 150.2 50.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.611 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.6 tp -72.8 136.13 45.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.488 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.854 HD21 HG12 ' A' ' 147' ' ' ILE . 16.2 tp -62.43 152.69 33.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.628 0.727 . . . . 0.0 111.585 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.503 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.4 OUTLIER -125.3 152.59 44.47 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.505 179.442 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.463 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -72.28 122.57 21.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 0.0 110.177 179.595 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.03 23.98 48.73 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.054 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.414 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 28.8 t70 -49.08 167.96 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.93 0.395 . . . . 0.0 111.487 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.938 ' CG ' HG22 ' A' ' 144' ' ' VAL . 2.3 mt-10 -144.27 135.68 25.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.003 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.484 ' CG2' HG22 ' A' ' 109' ' ' THR . 16.2 mt -115.71 127.3 73.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.804 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.589 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.0 m -104.59 139.16 39.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.873 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.533 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.2 m -140.38 158.41 25.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.5 28.86 26.02 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.161 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.488 ' HA ' HG12 ' A' ' 140' ' ' ILE . 78.1 t -71.35 140.39 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-O 121.626 0.727 . . . . 0.0 112.288 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.18 -39.5 0.92 Allowed Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.514 HG12 ' H ' ' A' ' 138' ' ' SER . 46.4 t -126.42 128.26 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 CA-C-N 114.689 -0.755 . . . . 0.0 109.068 177.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.51 -33.85 23.03 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.597 0.237 . . . . 0.0 111.632 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.514 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.8 m -93.53 6.46 48.14 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.01 26.79 7.95 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.589 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.6 mt -107.06 138.96 30.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.102 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.455 HD11 ' HB2' ' A' ' 42' ' ' GLN . 7.0 tt -124.63 134.38 52.93 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.531 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.517 ' HB3' HG23 ' A' ' 40' ' ' THR . 38.0 t -108.59 150.33 27.65 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.567 0.698 . . . . 0.0 112.069 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.599 HD21 HD13 ' A' ' 43' ' ' ILE . 75.9 mt -135.78 155.12 50.84 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.861 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.938 HG22 ' CG ' ' A' ' 129' ' ' GLU . 20.0 t -127.6 138.14 55.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.784 0.326 . . . . 0.0 111.166 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.726 HD12 HD21 ' A' ' 101' ' ' LEU . 19.4 mt -106.45 129.06 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 CA-C-O 120.852 0.358 . . . . 0.0 110.885 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.12 122.92 49.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.916 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.854 HG12 HD21 ' A' ' 124' ' ' LEU . 3.3 mt -91.35 134.14 30.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.474 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.76 112.37 19.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.675 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.71 -31.86 68.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.072 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt -58.95 -45.13 91.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.999 0.428 . . . . 0.0 110.609 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.0 t80 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.985 -179.997 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.717 0.294 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 -61.63 -44.15 97.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -60.01 -36.49 77.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.063 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.9 tp -63.73 -45.99 87.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.963 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 40.3 mm -63.27 -39.61 85.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.226 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -57.88 -33.89 69.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.234 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -65.15 -30.86 71.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.479 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -57.06 -47.49 80.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.089 0.471 . . . . 0.0 111.116 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 C--N 1.326 -0.436 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.939 179.997 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.433 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.1 m120 . . . . . 0 CA--C 1.505 -0.772 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.587 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 7.6 mm -71.51 144.52 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 CA-C-N 113.695 -1.593 . . . . 0.0 112.477 -176.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.799 HG22 HD13 ' A' ' 93' ' ' LEU . 1.2 t -105.71 -56.35 5.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.717 -178.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.757 ' SG ' HD12 ' A' ' 48' ' ' LEU . 31.3 p -151.51 164.51 36.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.221 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.41 138.26 53.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.835 0.35 . . . . 0.0 111.477 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.655 HG21 ' CE2' ' A' ' 68' ' ' PHE . 18.3 t -103.81 122.59 56.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.685 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.52 HG23 HG12 ' A' ' 45' ' ' ILE . 20.6 mt -127.0 115.82 42.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.461 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.576 ' HA ' HD13 ' A' ' 143' ' ' LEU . 37.7 t -79.97 124.75 28.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.82 0.343 . . . . 0.0 110.489 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.9 t -92.18 -26.99 17.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.556 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.518 HG21 ' H ' ' A' ' 142' ' ' SER . 25.9 p -79.93 -2.17 42.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.521 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.05 75.7 0.37 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.915 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -146.01 -44.9 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.789 0.328 . . . . 0.0 111.002 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.618 ' CD1' HD21 ' A' ' 143' ' ' LEU . 1.0 OUTLIER -112.73 140.61 24.16 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.831 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.534 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.6 Cg_endo -74.43 141.54 28.6 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.253 1.969 . . . . 0.0 112.361 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.52 HG12 HG23 ' A' ' 37' ' ' ILE . 35.9 mt -56.69 133.99 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.408 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.29 164.46 25.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.551 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.49 119.82 36.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.086 0.47 . . . . 0.0 111.774 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.857 HD22 ' CD1' ' A' ' 66' ' ' TRP . 17.8 mt -92.27 137.9 31.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.107 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.587 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -141.62 158.39 43.89 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 122.283 1.04 . . . . 0.0 113.756 -178.659 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.649 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . -146.5 141.81 27.43 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 113.447 -1.706 . . . . 0.0 110.43 178.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--N 1.33 -0.258 0 CA-C-O 121.066 0.46 . . . . 0.0 111.289 -179.456 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.408 ' HD3' ' N ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.635 0.255 . . . . 0.0 111.2 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.417 ' HE2' ' O ' ' A' ' 49' ' ' SER . 4.4 ttpt -132.32 135.17 46.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.754 0.312 . . . . 0.0 111.746 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 91' ' ' ILE . 17.0 t -134.03 139.55 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 121.182 0.515 . . . . 0.0 111.805 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.857 ' CD1' HD22 ' A' ' 48' ' ' LEU . 16.4 m-90 -100.42 139.42 36.12 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.019 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.898 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -110.09 132.86 53.78 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.649 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.738 ' HZ ' HD11 ' A' ' 48' ' ' LEU . 2.0 m-85 -115.9 145.7 42.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.478 -178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.673 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 173.96 -170.3 43.42 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.17 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 26.9 mtm180 -87.5 -13.44 43.08 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.472 ' H ' ' ND2' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -84.32 143.12 41.45 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.927 0.394 . . . . 0.0 111.364 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 7.2 Cg_exo -70.47 1.3 5.04 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.175 2.583 . . . . 0.0 111.958 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.51 -49.07 10.31 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 122.019 0.914 . . . . 0.0 108.838 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.47 ' HB2' ' ND2' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -46.73 140.74 4.32 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 113.596 -1.638 . . . . 0.0 110.774 179.563 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -56.28 -19.5 14.46 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.216 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.542 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 15.7 t80 -129.57 118.38 21.93 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-O 120.654 0.264 . . . . 0.0 110.979 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.588 179.72 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.757 HD12 ' CD1' ' A' ' 84' ' ' LEU . 27.5 mt . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.826 0.346 . . . . 0.0 110.906 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.28 -40.5 71.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.071 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -22.56 64.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.164 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.757 ' CD1' HD12 ' A' ' 81' ' ' ILE . 47.1 mt -98.83 152.27 19.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.133 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 93.1 p -97.0 167.34 11.13 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.735 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.673 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 1.1 m120 -43.98 -54.09 5.69 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.424 0.63 . . . . 0.0 109.792 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.578 ' HB2' HD12 ' A' ' 104' ' ' ILE . 0.4 OUTLIER -118.2 83.09 1.95 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.247 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.568 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.4 t60 -61.77 -45.22 94.81 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.054 -176.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.523 ' HA ' HG12 ' A' ' 104' ' ' ILE . 29.1 p90 -149.19 161.51 41.85 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 119.987 -0.685 . . . . 0.0 112.303 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.898 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.5 mt-30 -135.46 147.19 48.83 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.313 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.661 HD12 ' CE1' ' A' ' 68' ' ' PHE . 19.9 mt -118.92 131.89 70.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.161 178.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.45 ' CB ' HG22 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -119.7 138.06 53.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.124 0.488 . . . . 0.0 111.964 -178.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.799 HD13 HG22 ' A' ' 33' ' ' VAL . 1.4 tt . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.325 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.716 ' O ' HD22 ' A' ' 100' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.9 0.381 . . . . 0.0 110.925 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.89 HD13 ' O ' ' A' ' 122' ' ' GLN . 3.8 mm? -129.96 142.52 50.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.002 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.68 128.14 56.31 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.446 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 52.8 t30 -115.57 117.04 29.23 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.823 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.9 p30 -79.84 140.19 36.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.578 HD12 ' HB2' ' A' ' 87' ' ' LYS . 15.9 pt -145.56 33.81 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 111.574 0.213 . . . . 0.0 111.574 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.676 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -93.96 150.35 20.43 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 120.996 0.427 . . . . 0.0 111.891 -178.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.1 m -68.59 -31.48 70.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.765 178.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -98.23 -19.62 17.73 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.676 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.12 156.23 10.02 Favored Glycine 0 N--CA 1.438 -1.21 0 C-N-CA 120.246 -0.978 . . . . 0.0 113.642 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.516 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.5 m -117.4 137.78 52.26 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.877 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -114.02 148.55 36.81 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -177.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.465 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.28 113.4 18.21 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.171 177.386 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.415 ' N ' HD12 ' A' ' 111' ' ' LEU . 2.3 m-80 44.66 42.84 6.15 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.341 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.24 -10.52 70.84 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.504 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -104.77 118.54 36.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.078 0.466 . . . . 0.0 110.648 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.877 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.3 tptm -73.33 128.14 34.64 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.23 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.823 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.3 m -100.5 164.76 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.237 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 120' ' ' SER . 30.5 tt0 -70.05 127.09 31.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.514 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.689 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 24.2 tttt -53.09 162.38 0.68 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.857 0.361 . . . . 0.0 110.438 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.0 OUTLIER 35.4 33.99 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.14 -179.166 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.487 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.19 145.12 40.43 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.053 179.395 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.663 ' HB3' HD12 ' A' ' 100' ' ' LEU . 6.1 m120 -90.35 130.75 36.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.085 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.89 ' O ' HD13 ' A' ' 100' ' ' LEU . 42.3 mm-40 -129.39 148.57 51.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.276 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.4 116.4 12.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.864 0.364 . . . . 0.0 110.354 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.704 HD11 HG21 ' A' ' 145' ' ' ILE . 65.3 tp -56.36 157.54 4.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.435 0.636 . . . . 0.0 111.587 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.471 ' O ' HD11 ' A' ' 147' ' ' ILE . 1.3 t -124.4 153.31 42.08 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.327 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.682 ' HA ' HD13 ' A' ' 147' ' ' ILE . 30.1 mm100 -71.3 123.54 22.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.897 0.379 . . . . 0.0 110.046 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.08 21.55 59.39 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.866 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -55.86 173.92 0.13 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.965 0.412 . . . . 0.0 111.057 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.708 ' HG3' HG22 ' A' ' 144' ' ' VAL . 9.5 tt0 -145.07 135.47 24.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.287 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.763 HD11 HD11 ' A' ' 145' ' ' ILE . 13.5 mt -113.86 128.04 70.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.26 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.674 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.5 m -104.36 138.78 40.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.208 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.5 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 35.4 m -140.19 158.42 25.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.25 34.36 20.7 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.92 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.2 t -75.15 140.45 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-O 121.763 0.792 . . . . 0.0 112.533 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.97 -39.37 0.6 Allowed Glycine 0 N--CA 1.437 -1.249 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.444 HG12 ' H ' ' A' ' 138' ' ' SER . 47.9 t -126.35 131.84 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 114.731 -0.735 . . . . 0.0 109.201 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -50.6 -38.71 47.1 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.444 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.6 OUTLIER -93.37 6.3 48.62 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.427 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 5.3 t70 -120.11 27.73 8.47 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.674 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.1 mt -107.26 139.5 28.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.022 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.715 HD12 HD11 ' A' ' 81' ' ' ILE . 3.0 tt -122.11 134.34 54.76 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.512 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.697 ' N ' HD23 ' A' ' 141' ' ' LEU . 47.0 t -113.8 150.79 32.98 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.611 0.72 . . . . 0.0 112.638 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.618 HD21 ' CD1' ' A' ' 43' ' ' ILE . 2.1 mm? -135.69 143.55 45.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.487 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.708 HG22 ' HG3' ' A' ' 129' ' ' GLU . 17.4 t -110.97 139.85 32.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.824 0.345 . . . . 0.0 111.138 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.763 HD11 HD11 ' A' ' 130' ' ' ILE . 16.2 mt -106.31 125.16 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.072 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.03 109.89 19.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.816 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.682 HD13 ' HA ' ' A' ' 126' ' ' GLN . 5.0 mp -85.96 134.07 28.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.416 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -86.06 127.7 34.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.844 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -74.03 -23.91 59.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.21 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -45.03 90.99 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.035 0.445 . . . . 0.0 110.649 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.4 t80 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.92 179.965 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.778 0.323 . . . . 0.0 110.805 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.6 mtm-85 -58.84 -46.08 88.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.972 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -61.39 -35.08 76.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.876 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.6 tt -61.18 -45.18 95.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.959 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.435 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 6.1 mm -62.64 -35.23 69.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.156 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.25 -44.59 84.01 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.9 0.381 . . . . 0.0 110.425 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -67.15 -23.74 65.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.419 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.75 -47.45 80.04 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.202 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.814 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.454 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER . . . . . 0 CA--C 1.51 -0.581 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.688 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.4 mm -73.02 137.08 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-N 113.598 -1.637 . . . . 0.0 112.658 -177.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.987 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.3 t -93.66 -59.82 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.658 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.94 156.46 42.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.229 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.842 ' NE ' HG21 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -119.88 138.14 53.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.815 0.34 . . . . 0.0 111.031 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.51 HG11 ' CE2' ' A' ' 68' ' ' PHE . 1.8 m -104.66 122.71 58.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.772 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.676 HG23 HG12 ' A' ' 45' ' ' ILE . 14.4 mt -125.0 124.17 67.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.572 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.757 ' HA ' HD13 ' A' ' 143' ' ' LEU . 52.8 t -80.02 108.74 13.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.859 0.361 . . . . 0.0 110.537 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.0 t -74.55 -25.46 59.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.639 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.539 HG23 ' HB3' ' A' ' 142' ' ' SER . 74.7 p -79.86 -2.35 43.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.46 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.15 76.73 0.24 Allowed Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.824 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -146.53 -43.86 0.19 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.913 0.387 . . . . 0.0 110.876 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.554 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.1 mt -117.93 141.3 29.01 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.005 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.554 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 52.5 Cg_endo -72.35 145.85 43.96 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.216 1.944 . . . . 0.0 111.788 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.842 HG21 ' NE ' ' A' ' 35' ' ' ARG . 68.6 mt -54.15 142.46 7.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.049 0.452 . . . . 0.0 111.829 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.507 ' HB2' ' CE2' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -124.67 133.99 53.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.861 178.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.08 119.92 32.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.141 0.496 . . . . 0.0 111.863 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.546 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 5.2 mt -98.04 131.96 44.0 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.987 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -143.55 157.55 44.34 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -178.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.495 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -141.07 146.29 36.94 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 113.694 -1.594 . . . . 0.0 110.993 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 121.045 0.45 . . . . 0.0 111.196 -179.532 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.767 0.318 . . . . 0.0 110.939 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.441 ' CE ' ' O ' ' A' ' 49' ' ' SER . 26.5 ttpt -141.06 144.09 34.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.016 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.658 HG12 ' HG2' ' A' ' 90' ' ' GLN . 14.4 t -127.72 139.5 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-O 121.29 0.567 . . . . 0.0 112.08 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.546 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 18.9 m-90 -100.77 139.32 36.62 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.144 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.689 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.79 126.97 55.8 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -118.06 145.23 44.96 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.79 -178.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.603 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.46 -172.69 37.73 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.084 -1.055 . . . . 0.0 113.593 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.415 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 0.8 OUTLIER -74.28 -0.61 17.53 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.409 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 25.2 t-20 -84.69 132.14 47.42 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.624 0.249 . . . . 0.0 111.29 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.41 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 14.7 Cg_exo -67.83 -12.1 34.26 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.58 2.186 . . . . 0.0 111.707 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.02 -43.19 16.63 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-O 121.914 0.864 . . . . 0.0 109.048 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -39.12 139.11 0.52 Allowed 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 113.701 -1.591 . . . . 0.0 111.089 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -56.44 -18.72 12.19 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.122 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.507 ' CE2' ' HB2' ' A' ' 46' ' ' ARG . 56.0 t80 -129.41 119.04 23.15 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.829 0.347 . . . . 0.0 110.915 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.41 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.8 t-160 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.961 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.76 ' HB ' HD13 ' A' ' 84' ' ' LEU . 2.4 mp . . . . . 0 CA--C 1.527 0.094 0 CA-C-O 120.795 0.331 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.27 -29.65 64.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.196 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.534 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -60.89 -23.25 65.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.059 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.76 HD13 ' HB ' ' A' ' 81' ' ' ILE . 4.1 mp -107.05 152.87 23.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.912 0.387 . . . . 0.0 110.958 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 61.1 p -96.46 166.71 11.56 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.891 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.603 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.2 m-20 -43.32 -53.19 5.4 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.318 0.58 . . . . 0.0 109.799 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.545 ' CB ' HD12 ' A' ' 104' ' ' ILE . 10.9 mttm -118.03 81.36 1.66 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.588 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 15.8 t60 -58.81 -47.45 84.73 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.423 -177.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.504 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 32.1 p90 -146.31 159.81 42.86 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.154 -0.618 . . . . 0.0 112.063 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.689 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.0 tt0 -135.59 141.95 45.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.212 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.583 ' O ' HG13 ' A' ' 65' ' ' VAL . 45.7 mt -120.44 131.84 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.297 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.762 HD21 ' OD1' ' A' ' 121' ' ' ASN . 0.5 OUTLIER -120.09 139.73 52.12 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.004 0.43 . . . . 0.0 111.566 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.692 HD23 ' HG ' ' A' ' 99' ' ' LEU . 1.7 tm? . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.307 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.692 ' HG ' HD23 ' A' ' 93' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.715 0.293 . . . . 0.0 110.577 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.794 HD23 ' O ' ' A' ' 122' ' ' GLN . 9.0 mt -120.3 142.1 49.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.897 0.38 . . . . 0.0 110.719 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.926 HD11 HD11 ' A' ' 130' ' ' ILE . 3.8 tt -112.95 125.0 53.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.059 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.478 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 59.8 t30 -119.09 115.93 25.3 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.837 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.8 p30 -77.94 137.55 38.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.779 178.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.545 HD12 ' CB ' ' A' ' 87' ' ' LYS . 8.4 pt -141.29 29.52 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 121.127 -0.229 . . . . 0.0 111.58 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.573 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 12.1 t -93.69 155.49 17.22 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.534 0.683 . . . . 0.0 112.838 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 69.5 m -70.06 -52.04 27.1 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.669 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -80.34 -0.54 37.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.281 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.0 156.24 30.66 Favored Glycine 0 N--CA 1.437 -1.25 0 C-N-CA 120.642 -0.789 . . . . 0.0 113.518 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.502 HG22 ' CG2' ' A' ' 130' ' ' ILE . 5.2 m -117.44 137.89 52.21 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.845 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -113.29 148.47 35.56 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -178.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.409 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.12 113.54 18.49 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.298 177.328 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 45.3 42.7 7.53 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.0 -7.69 76.6 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.462 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.59 118.51 36.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 117.041 0.421 . . . . 0.0 110.624 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.845 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 6.3 tptm -72.46 116.94 13.51 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.259 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.837 HG23 ' OD2' ' A' ' 103' ' ' ASP . 13.1 m -92.42 162.86 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.046 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.421 ' HB3' ' HB3' ' A' ' 120' ' ' SER . 0.6 OUTLIER -69.81 128.92 38.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.46 179.66 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.684 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 45.5 tttt -55.35 163.87 1.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.751 0.31 . . . . 0.0 110.195 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.7 OUTLIER 35.96 34.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.818 -179.162 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.421 ' HB3' ' HB3' ' A' ' 117' ' ' GLU . 2.7 p -112.12 143.58 42.91 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.458 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.762 ' OD1' HD21 ' A' ' 92' ' ' LEU . 18.1 m-80 -94.22 132.28 38.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.045 0.45 . . . . 0.0 111.103 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.794 ' O ' HD23 ' A' ' 100' ' ' LEU . 58.1 mm-40 -129.07 151.23 49.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.446 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 tp -72.56 128.56 35.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.843 0.354 . . . . 0.0 110.464 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.817 HD21 HG12 ' A' ' 147' ' ' ILE . 18.8 tp -57.55 155.28 9.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.375 0.607 . . . . 0.0 111.679 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.518 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -124.71 152.95 43.11 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.304 179.463 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.88 119.14 15.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.96 0.41 . . . . 0.0 110.07 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.32 24.71 63.87 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.124 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.402 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 32.0 t70 -52.95 170.31 0.08 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.928 0.394 . . . . 0.0 111.337 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.9 ' CG ' HG22 ' A' ' 144' ' ' VAL . 9.4 mt-10 -145.15 135.61 24.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.06 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.926 HD11 HD11 ' A' ' 101' ' ' LEU . 6.6 mt -111.64 128.08 68.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.459 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.654 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.6 m -104.25 140.39 37.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.01 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.588 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 22.7 m -140.36 158.75 25.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.44 43.7 10.18 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.167 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 140' ' ' ILE . 74.0 t -83.01 140.44 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-O 121.609 0.719 . . . . 0.0 112.307 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.29 -40.17 0.95 Allowed Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.541 HG12 ' H ' ' A' ' 138' ' ' SER . 48.2 t -126.37 124.95 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-N 114.603 -0.799 . . . . 0.0 108.983 177.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -50.38 -30.73 12.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.769 0.319 . . . . 0.0 111.444 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.541 ' H ' HG12 ' A' ' 136' ' ' VAL . 4.0 m -93.62 6.35 48.56 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -123.52 24.25 8.64 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.654 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.5 mt -107.0 139.07 29.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.313 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.31 134.49 53.17 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.202 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.641 ' C ' HD22 ' A' ' 143' ' ' LEU . 38.1 t -111.12 150.62 29.16 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.73 0.776 . . . . 0.0 112.46 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.757 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.5 mm? -135.66 149.12 49.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.125 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.9 HG22 ' CG ' ' A' ' 129' ' ' GLU . 13.8 t -118.81 140.09 43.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 111.382 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.797 HD11 HD11 ' A' ' 130' ' ' ILE . 28.1 mt -106.29 120.87 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.76 118.38 36.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.654 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.817 HG12 HD21 ' A' ' 124' ' ' LEU . 5.5 mt -84.98 134.03 27.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.495 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -81.84 115.72 21.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.723 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -63.74 -31.8 73.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.06 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -60.14 -46.06 90.91 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.005 0.431 . . . . 0.0 110.784 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.7 t80 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.983 -179.898 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.919 0.39 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -64.8 -41.81 95.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.867 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -57.93 -38.6 76.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.854 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.521 HD13 ' O ' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -60.09 -31.85 70.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.811 179.781 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.439 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.0 mt -72.89 -35.4 49.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.831 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -57.38 -42.39 82.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.984 0.421 . . . . 0.0 110.493 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.1 tttt -67.08 -23.82 65.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.661 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.439 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.68 -47.52 79.67 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.261 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.941 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.44 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.7 OUTLIER . . . . . 0 CA--C 1.51 -0.564 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.688 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.1 mm -74.24 135.37 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-N 113.703 -1.589 . . . . 0.0 112.574 -177.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.0 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -93.51 -61.42 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.086 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.711 ' SG ' HD12 ' A' ' 48' ' ' LEU . 2.9 p -144.73 152.09 39.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.252 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.404 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -117.42 128.72 55.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.757 0.313 . . . . 0.0 111.339 -179.486 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.724 HG23 HD11 ' A' ' 48' ' ' LEU . 38.0 t -96.67 122.91 48.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.867 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.863 HG23 HG12 ' A' ' 45' ' ' ILE . 21.6 mt -127.14 127.23 69.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.582 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.528 ' HA ' HD13 ' A' ' 143' ' ' LEU . 11.6 t -91.61 107.67 19.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.446 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.434 ' CG2' HG21 ' A' ' 144' ' ' VAL . 63.0 p -81.24 -24.88 37.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.636 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.536 HG21 ' OG ' ' A' ' 142' ' ' SER . 4.3 p -80.05 -2.71 45.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.662 0.268 . . . . 0.0 111.428 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.92 75.53 0.45 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.069 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.659 ' HB2' HD12 ' A' ' 43' ' ' ILE . 3.5 mt-30 -143.07 -40.88 0.31 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.92 0.39 . . . . 0.0 110.992 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.659 HD12 ' HB2' ' A' ' 42' ' ' GLN . 4.1 mp -125.7 142.15 41.24 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.927 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.566 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 52.7 Cg_endo -72.08 140.81 35.14 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.16 1.907 . . . . 0.0 112.227 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.863 HG12 HG23 ' A' ' 37' ' ' ILE . 33.7 mt -56.16 142.94 10.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.724 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -137.85 161.91 35.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.27 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.404 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 1.1 m-20 -116.05 119.83 37.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.975 0.417 . . . . 0.0 111.746 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.724 HD11 HG23 ' A' ' 36' ' ' VAL . 4.4 mt -94.88 136.25 35.42 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.0 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.81 158.64 43.84 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -178.806 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.5 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -146.28 147.71 31.67 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 113.69 -1.596 . . . . 0.0 110.822 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 121.172 0.51 . . . . 0.0 111.261 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.9 mptt . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.749 0.309 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.432 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.4 ttpt -149.93 139.98 22.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.296 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.68 HG12 ' HG2' ' A' ' 90' ' ' GLN . 14.6 t -130.72 139.28 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.311 0.577 . . . . 0.0 112.092 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.563 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.3 m-90 -102.4 139.45 37.99 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.151 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.605 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.18 128.32 56.2 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.561 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.689 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -120.09 145.3 47.01 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.179 -178.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.529 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.17 -169.56 37.56 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.176 -1.012 . . . . 0.0 113.733 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.8 ttt-85 -77.2 0.29 22.42 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 122.56 0.344 . . . . 0.0 111.869 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.584 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 6.9 t-20 -84.76 132.64 45.69 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.632 0.253 . . . . 0.0 111.41 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.423 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 15.4 Cg_exo -67.17 -13.5 39.87 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.573 2.182 . . . . 0.0 111.702 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.584 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -82.73 -44.63 15.39 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-O 121.858 0.837 . . . . 0.0 108.968 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -39.88 141.06 0.47 Allowed 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 113.707 -1.588 . . . . 0.0 110.951 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 67' ' ' THR . 72.0 m-20 -56.32 -19.09 12.86 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.048 179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.508 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 2.2 t80 -129.96 125.36 35.25 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.709 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.423 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.5 t-160 . . . . . 0 C--N 1.328 -0.359 0 CA-C-O 120.919 0.39 . . . . 0.0 110.867 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.404 HD13 HD12 ' A' ' 141' ' ' LEU . 2.3 mp . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.848 0.356 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.88 -33.52 75.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.943 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.6 mmp_? -60.94 -23.36 65.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.099 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.4 mt -101.55 151.2 22.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.979 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 99.3 p -94.29 165.81 12.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.454 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.529 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 m-20 -42.8 -53.93 4.36 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.372 0.606 . . . . 0.0 109.694 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.654 ' HB2' HD12 ' A' ' 104' ' ' ILE . 4.6 mttm -118.82 81.86 1.76 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 177.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.537 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.8 t60 -59.42 -47.18 86.44 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.454 -177.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.51 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 33.3 p90 -143.62 159.86 41.7 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 119.967 -0.693 . . . . 0.0 112.041 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.68 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.6 tt0 -136.0 141.78 44.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.93 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.597 ' C ' HG13 ' A' ' 65' ' ' VAL . 65.5 mt -117.82 128.68 74.94 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.093 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.616 HD21 HD22 ' A' ' 121' ' ' ASN . 0.7 OUTLIER -113.94 147.24 38.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.018 0.437 . . . . 0.0 111.43 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.841 HD13 ' CG1' ' A' ' 33' ' ' VAL . 5.2 tp . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.386 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.708 ' O ' HD12 ' A' ' 100' ' ' LEU . 1.2 mt . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.792 0.33 . . . . 0.0 110.802 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.708 HD12 ' O ' ' A' ' 99' ' ' LEU . 4.5 mp -133.0 144.71 50.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.447 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.633 HD11 HD12 ' A' ' 145' ' ' ILE . 0.7 OUTLIER -112.79 121.83 45.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.225 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.516 ' HB2' HD23 ' A' ' 92' ' ' LEU . 49.4 t30 -115.59 115.52 26.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.992 0.425 . . . . 0.0 111.617 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.845 ' OD2' HG23 ' A' ' 116' ' ' VAL . 8.4 p30 -79.1 136.89 37.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.906 178.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.654 HD12 ' HB2' ' A' ' 87' ' ' LYS . 9.0 pt -143.62 38.11 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.636 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.46 151.2 20.85 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 121.066 0.46 . . . . 0.0 111.735 -179.185 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 55.1 m -68.87 -31.63 70.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.996 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -98.09 -19.97 17.63 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.636 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.42 154.61 9.41 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.144 -1.027 . . . . 0.0 113.801 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.508 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.1 m -117.62 137.92 52.3 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.849 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -115.76 148.41 39.85 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -178.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.409 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.15 113.5 18.42 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.08 177.423 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.2 m120 44.65 43.18 6.42 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.15 -8.69 75.65 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.49 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -105.36 118.55 36.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.127 0.489 . . . . 0.0 110.774 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.849 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 14.8 tptp -73.21 119.34 17.31 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.282 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.845 HG23 ' OD2' ' A' ' 103' ' ' ASP . 13.1 m -91.06 164.37 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.278 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 120' ' ' SER . 4.1 tp10 -69.93 126.21 29.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.655 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.685 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 24.7 tttm -52.29 161.51 0.64 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.896 0.379 . . . . 0.0 110.694 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.6 p30 34.35 35.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.325 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.19 145.01 40.62 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.049 179.362 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.616 HD22 HD21 ' A' ' 92' ' ' LEU . 19.8 m120 -88.92 127.34 35.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.987 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -129.34 146.35 51.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.747 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.434 HD13 ' C ' ' A' ' 123' ' ' LEU . 1.6 tm? -72.82 113.7 10.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.026 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.615 HD11 ' HG ' ' A' ' 101' ' ' LEU . 1.0 OUTLIER -53.42 165.85 0.34 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.679 0.752 . . . . 0.0 112.003 -178.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.448 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -125.29 153.3 43.45 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.383 179.347 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.553 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.7 OUTLIER -71.51 120.08 16.59 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.85 21.39 65.36 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.064 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.448 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 9.4 t70 -57.93 173.69 0.31 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.963 0.411 . . . . 0.0 111.065 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 13.9 tt0 -145.26 135.52 24.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.246 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 1.068 HD11 HD11 ' A' ' 145' ' ' ILE . 4.2 mt -109.52 128.33 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.177 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.668 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.8 m -104.07 139.55 39.01 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.506 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.6 m -140.15 158.36 25.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.24 44.1 10.0 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.885 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.473 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.9 t -83.35 140.41 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-O 121.742 0.782 . . . . 0.0 112.393 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.77 -37.61 0.88 Allowed Glycine 0 N--CA 1.436 -1.319 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.473 HG12 ' H ' ' A' ' 138' ' ' SER . 48.8 t -126.39 123.72 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 114.598 -0.801 . . . . 0.0 109.155 178.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -50.48 -33.41 21.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.623 0.249 . . . . 0.0 111.585 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.473 ' H ' HG12 ' A' ' 136' ' ' VAL . 40.2 t -93.43 6.49 47.99 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.426 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 5.6 t0 -125.51 28.29 6.3 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.668 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.9 mt -107.11 139.56 28.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.874 178.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.674 HD22 ' CD2' ' A' ' 143' ' ' LEU . 1.0 OUTLIER -115.6 134.49 55.0 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.752 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.536 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.8 OUTLIER -112.19 136.75 51.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.03 0.443 . . . . 0.0 111.704 -179.472 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.674 ' CD2' HD22 ' A' ' 141' ' ' LEU . 2.9 mm? -130.88 138.52 49.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.352 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.434 HG21 ' CG2' ' A' ' 39' ' ' THR . 20.8 t -110.76 137.13 44.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.957 0.408 . . . . 0.0 111.608 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 1.068 HD11 HD11 ' A' ' 130' ' ' ILE . 49.6 mt -106.19 127.39 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.086 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.2 115.79 28.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.642 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.553 HD12 ' HA ' ' A' ' 126' ' ' GLN . 6.5 mt -84.76 129.32 37.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.893 0.378 . . . . 0.0 111.331 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -75.96 116.78 17.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.942 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -65.36 -31.13 72.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.891 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -58.7 -44.35 90.31 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.975 0.417 . . . . 0.0 110.568 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 30.5 t80 . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.777 179.911 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.853 0.359 . . . . 0.0 110.627 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -71.19 -35.78 71.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.615 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.29 -39.3 82.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.859 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.61 -40.83 93.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.852 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.508 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.2 mm -70.29 -35.1 61.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.199 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -57.03 -37.58 71.95 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.866 0.365 . . . . 0.0 110.454 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -67.29 -23.83 65.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.666 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.508 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.92 -47.27 81.01 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.169 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.833 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.524 ' O ' ' HB3' ' A' ' 49' ' ' SER . 4.7 m-20 . . . . . 0 CA--C 1.507 -0.682 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.682 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 6.9 mm -71.25 142.02 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 CA-C-N 113.678 -1.601 . . . . 0.0 112.495 -176.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.727 HG21 HD22 ' A' ' 93' ' ' LEU . 0.9 OUTLIER -104.38 -46.84 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.551 -178.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.67 ' SG ' HD12 ' A' ' 48' ' ' LEU . 28.4 p -163.0 145.56 10.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.127 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.461 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.94 134.68 54.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.874 0.368 . . . . 0.0 111.674 -178.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.594 HG13 HD11 ' A' ' 48' ' ' LEU . 3.4 m -99.77 122.71 51.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.469 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.775 HG23 HG12 ' A' ' 45' ' ' ILE . 19.3 mt -128.01 121.03 55.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.605 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.581 ' HA ' HD13 ' A' ' 143' ' ' LEU . 12.6 t -84.04 124.71 31.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.636 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.7 t -95.36 -25.05 16.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.517 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.546 HG21 ' H ' ' A' ' 142' ' ' SER . 17.5 p -79.88 -2.13 42.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.506 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.15 74.13 0.52 Allowed Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.532 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.506 ' CB ' HD11 ' A' ' 141' ' ' LEU . 2.3 mt-30 -145.31 -39.46 0.25 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.777 0.322 . . . . 0.0 111.168 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.545 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.2 mt -122.19 140.57 32.67 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.843 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.545 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.3 Cg_endo -73.59 138.93 27.54 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.236 1.957 . . . . 0.0 112.225 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.775 HG12 HG23 ' A' ' 37' ' ' ILE . 39.5 mt -57.49 141.46 14.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.562 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.96 164.28 28.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.343 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.461 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 1.4 p-10 -116.21 119.86 37.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.146 0.498 . . . . 0.0 111.932 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.67 HD12 ' SG ' ' A' ' 34' ' ' CYS . 4.4 mt -98.5 137.27 37.41 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.682 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.6 158.77 43.8 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -178.415 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.708 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . -145.06 141.83 29.2 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.519 -1.673 . . . . 0.0 110.673 178.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 121.123 0.487 . . . . 0.0 111.275 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.1 mmtm . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.813 0.34 . . . . 0.0 110.767 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.401 ' HE2' ' O ' ' A' ' 49' ' ' SER . 4.5 ttpt -145.71 130.62 18.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.172 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.59 HG13 ' C ' ' A' ' 91' ' ' ILE . 13.0 t -126.93 139.11 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 121.264 0.554 . . . . 0.0 112.2 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.613 ' CD1' HD22 ' A' ' 48' ' ' LEU . 16.4 m-90 -100.87 139.8 36.05 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.144 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.973 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.44 127.65 55.75 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.321 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.546 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -119.64 145.21 46.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.96 -178.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.548 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.51 -169.66 38.62 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.199 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.56 1.43 22.58 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.764 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 10.5 t-20 -84.97 132.49 45.64 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.578 0.228 . . . . 0.0 111.36 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.43 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 15.9 Cg_exo -67.21 -13.23 38.85 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.678 2.252 . . . . 0.0 111.776 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.764 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -82.85 -43.69 16.33 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-O 121.901 0.858 . . . . 0.0 109.029 178.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.428 ' HG ' ' HA ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -39.66 142.01 0.35 Allowed 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 113.688 -1.596 . . . . 0.0 111.2 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.1 m-20 -56.25 -19.12 12.61 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.981 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.501 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 5.8 t80 -129.63 127.61 40.96 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.666 0.269 . . . . 0.0 110.871 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.43 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.7 t-160 . . . . . 0 C--N 1.328 -0.346 0 CA-C-O 120.888 0.375 . . . . 0.0 110.905 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 24.5 mm . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.824 0.345 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.69 -35.28 77.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.984 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.91 -22.08 63.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.261 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.558 HD21 HG23 ' A' ' 132' ' ' VAL . 21.1 mt -96.22 152.08 18.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.014 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 45.6 p -96.87 164.68 12.45 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.515 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.548 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -41.43 -53.61 3.32 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.497 0.665 . . . . 0.0 109.811 179.161 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.634 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.6 OUTLIER -119.86 83.59 2.07 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 177.324 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.567 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.6 t60 -60.53 -46.04 91.63 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.089 -0.959 . . . . 0.0 112.568 -177.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.5 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 18.1 p90 -143.72 162.64 35.47 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 119.863 -0.735 . . . . 0.0 112.441 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.973 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.57 135.06 40.01 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.059 -179.118 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.59 ' C ' HG13 ' A' ' 65' ' ' VAL . 52.0 mt -113.26 129.12 69.56 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.773 178.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.514 ' CB ' HG22 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -113.97 147.99 37.64 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.0 0.429 . . . . 0.0 111.527 -179.582 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.828 HD12 ' HG ' ' A' ' 99' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.517 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.828 ' HG ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.749 0.309 . . . . 0.0 110.657 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.743 HD13 ' O ' ' A' ' 122' ' ' GLN . 4.5 mm? -132.98 145.73 51.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.564 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 1.099 HD21 HD13 ' A' ' 124' ' ' LEU . 6.0 mt -112.7 127.94 56.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.03 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.43 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 47.0 t30 -119.34 115.92 25.12 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.828 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.8 p30 -77.92 135.95 37.94 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.973 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.434 HD12 ' HB2' ' A' ' 87' ' ' LYS . 9.0 pt -143.84 40.1 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 111.56 0.208 . . . . 0.0 111.56 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.713 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.07 150.93 20.9 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-O 120.994 0.426 . . . . 0.0 111.877 -178.77 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 51.0 m -68.67 -31.89 71.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.694 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -98.56 -19.69 17.46 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.713 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.25 157.26 10.29 Favored Glycine 0 N--CA 1.439 -1.125 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.565 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.495 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.3 m -117.48 137.95 52.19 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.824 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -115.83 148.83 39.49 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -177.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.47 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.12 113.38 18.27 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.428 177.654 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.418 ' N ' HD12 ' A' ' 111' ' ' LEU . 6.5 m-80 44.21 43.26 5.69 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.84 -17.34 53.51 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.416 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.8 tp60 -103.63 118.46 36.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.042 0.449 . . . . 0.0 110.471 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.824 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -70.4 138.87 51.66 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.264 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.828 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.4 m -105.91 165.81 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.853 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 120' ' ' SER . 22.6 mt-10 -69.8 124.93 25.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.631 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.687 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 14.7 tttt -52.53 163.11 0.46 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.778 0.323 . . . . 0.0 110.778 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.5 m-80 33.38 35.11 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.182 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.26 145.08 40.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.247 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -88.39 129.89 35.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.843 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.743 ' O ' HD13 ' A' ' 100' ' ' LEU . 44.5 mm-40 -129.11 148.47 51.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.672 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.8 tp -72.49 122.12 20.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.876 0.37 . . . . 0.0 110.412 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 1.099 HD13 HD21 ' A' ' 101' ' ' LEU . 67.6 tp -58.86 155.89 12.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.456 0.646 . . . . 0.0 111.61 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.417 ' H ' HD12 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -124.75 153.43 42.43 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.689 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.417 ' OE1' HD12 ' A' ' 147' ' ' ILE . 7.2 mm100 -71.53 121.46 18.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.886 0.374 . . . . 0.0 110.122 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.22 22.22 57.94 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.199 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.411 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 21.8 t0 -54.92 173.93 0.08 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 120.877 0.37 . . . . 0.0 110.893 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.866 ' CG ' HG22 ' A' ' 144' ' ' VAL . 10.4 mt-10 -145.16 135.38 23.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.235 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.887 HD11 HD11 ' A' ' 145' ' ' ILE . 13.6 mt -113.9 128.18 70.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.081 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.566 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.9 m -104.25 138.28 40.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.062 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.558 HG23 HD21 ' A' ' 84' ' ' LEU . 33.5 m -140.28 158.13 25.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.86 32.12 18.95 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.852 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 140' ' ' ILE . 55.3 t -73.79 140.37 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-O 121.679 0.752 . . . . 0.0 112.516 -179.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 159.26 -40.33 0.48 Allowed Glycine 0 N--CA 1.436 -1.307 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.144 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.449 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 49.1 t -126.36 137.51 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -50.69 -43.03 57.48 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.0 t -93.3 6.23 48.82 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.449 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 13.2 t0 -116.09 27.19 9.42 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -178.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.566 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.1 mt -107.43 139.46 29.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.127 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.763 HD23 ' N ' ' A' ' 142' ' ' SER . 4.3 tt -121.37 134.39 55.12 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.449 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.763 ' N ' HD23 ' A' ' 141' ' ' LEU . 48.1 t -111.33 151.08 28.82 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.592 0.711 . . . . 0.0 112.5 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.581 HD13 ' HA ' ' A' ' 38' ' ' CYS . 1.8 mm? -135.39 147.37 49.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.32 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.866 HG22 ' CG ' ' A' ' 129' ' ' GLU . 18.5 t -113.71 137.38 47.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.818 0.342 . . . . 0.0 111.125 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.887 HD11 HD11 ' A' ' 130' ' ' ILE . 39.8 mt -106.31 120.9 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.077 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.35 115.58 29.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.592 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.753 HG12 HD21 ' A' ' 124' ' ' LEU . 3.7 mt -84.65 133.16 29.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.33 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -83.55 108.46 16.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.939 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.19 -25.71 64.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.006 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.6 tptp -57.5 -42.95 83.73 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.013 0.435 . . . . 0.0 110.66 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.423 ' CZ ' HD21 ' A' ' 93' ' ' LEU . 28.4 t80 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.776 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.765 0.317 . . . . 0.0 111.015 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.09 -45.82 89.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.991 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -59.99 -35.0 74.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.956 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.25 -40.71 94.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.886 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.632 HG23 ' CE2' ' A' ' 23' ' ' PHE . 43.0 mm -68.84 -48.17 72.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.037 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.75 -33.67 71.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.4 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -58.74 -47.1 85.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.372 -0.377 . . . . 0.0 112.0 -178.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.632 ' CE2' HG23 ' A' ' 20' ' ' ILE . 4.5 p90 -71.89 -47.38 53.1 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.967 0.413 . . . . 0.0 111.033 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.537 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 1.2 m . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.039 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.439 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 t-20 . . . . . 0 CA--C 1.509 -0.615 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.686 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.8 mm -71.93 136.16 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 CA-C-N 113.557 -1.656 . . . . 0.0 112.666 -177.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.966 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.8 t -92.28 -58.56 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.545 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.568 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.07 153.89 37.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.83 179.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.462 ' NH2' HD13 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -113.89 138.38 50.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.831 0.348 . . . . 0.0 111.02 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.811 HG21 ' HE2' ' A' ' 68' ' ' PHE . 19.8 t -103.32 122.96 56.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.212 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.698 HG23 HD11 ' A' ' 45' ' ' ILE . 19.8 mt -128.3 119.13 49.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.873 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 50.4 t -84.78 118.6 24.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.205 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.97 -22.11 27.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.911 -179.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.528 HG21 ' H ' ' A' ' 142' ' ' SER . 69.6 p -79.81 -2.09 41.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.687 0.279 . . . . 0.0 111.579 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.14 73.18 0.56 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.83 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.413 ' HB2' HD11 ' A' ' 141' ' ' LEU . 7.8 mt-30 -145.28 -43.3 0.22 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.88 0.371 . . . . 0.0 111.014 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.529 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 7.7 mt -115.63 140.61 26.24 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.945 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.529 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 66.2 Cg_endo -76.1 146.08 28.47 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.295 1.997 . . . . 0.0 112.237 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.698 HD11 HG23 ' A' ' 37' ' ' ILE . 14.6 mt -57.35 148.2 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.549 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -139.41 161.76 36.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.348 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.68 119.77 37.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.065 0.459 . . . . 0.0 111.954 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.538 HD22 ' CD1' ' A' ' 66' ' ' TRP . 8.0 mt -95.69 134.46 38.57 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.966 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.91 157.46 43.9 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -178.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.484 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -143.63 141.97 30.82 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.421 -1.718 . . . . 0.0 110.505 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-O 121.336 0.589 . . . . 0.0 111.608 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.067 0 CA-C-O 120.813 0.34 . . . . 0.0 110.84 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.435 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.7 ttpt -140.35 131.33 26.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.965 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.678 HG12 ' HG2' ' A' ' 90' ' ' GLN . 7.8 t -127.75 139.06 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-O 121.266 0.555 . . . . 0.0 112.224 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.538 ' CD1' HD22 ' A' ' 48' ' ' LEU . 16.4 m-90 -101.04 139.26 36.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.882 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.632 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -113.04 131.64 55.71 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.69 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.811 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -118.29 145.24 45.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.669 -178.291 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.95 -172.26 36.43 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.312 -0.946 . . . . 0.0 113.932 178.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.734 ' NH2' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -72.32 -3.67 25.2 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.453 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -84.51 128.85 59.82 Favored Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 121.191 -0.204 . . . . 0.0 111.036 -179.603 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.5 Cg_exo -67.24 -9.36 24.9 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.525 2.15 . . . . 0.0 111.574 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.8 -42.88 17.36 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -40.37 138.25 0.94 Allowed 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 113.879 -1.509 . . . . 0.0 110.247 179.165 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -56.33 -18.77 11.83 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.915 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.568 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 13.3 t80 -129.88 127.18 39.66 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.881 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.572 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.452 HG22 ' H ' ' A' ' 83' ' ' ARG . 16.8 mt . . . . . 0 N--CA 1.463 0.185 0 CA-C-O 120.945 0.402 . . . . 0.0 111.04 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.2 m -60.83 -24.89 66.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.35 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.452 ' H ' HG22 ' A' ' 81' ' ' ILE . 5.2 mmp_? -60.48 -26.71 67.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.642 0.258 . . . . 0.0 111.353 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.736 HD21 ' CG2' ' A' ' 132' ' ' VAL . 4.8 mp -107.05 153.37 22.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.919 0.39 . . . . 0.0 111.184 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 79.9 p -89.28 167.7 12.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.427 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.625 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.5 m-20 -42.48 -54.89 3.68 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.363 0.601 . . . . 0.0 109.75 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.519 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -118.31 84.15 2.13 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 177.009 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.55 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 17.6 t60 -60.39 -46.31 90.43 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.752 -176.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.509 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 30.0 p90 -146.84 160.49 42.22 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.447 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.678 ' HG2' HG12 ' A' ' 65' ' ' VAL . 3.8 tt0 -135.66 143.18 45.34 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.015 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.765 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 56.6 mt -118.52 130.29 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.981 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.506 HD11 HD13 ' A' ' 100' ' ' LEU . 0.5 OUTLIER -111.37 149.6 30.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.025 0.441 . . . . 0.0 111.87 -179.549 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.676 HD22 HG11 ' A' ' 33' ' ' VAL . 36.2 tp . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.344 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.805 HD21 HG12 ' A' ' 33' ' ' VAL . 4.8 mp . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.697 0.284 . . . . 0.0 110.769 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.942 HD22 ' HB3' ' A' ' 121' ' ' ASN . 4.6 mt -132.84 143.86 49.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.412 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.78 128.43 56.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.244 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.446 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 52.6 t30 -118.58 115.78 25.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.911 0.386 . . . . 0.0 111.745 -179.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.763 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.5 p30 -77.73 139.98 39.45 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.508 HD12 ' HB2' ' A' ' 87' ' ' LYS . 8.3 pt -147.4 38.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 111.538 0.199 . . . . 0.0 111.538 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.688 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.0 150.96 21.44 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.05 0.452 . . . . 0.0 112.127 -178.538 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 39.8 m -68.79 -31.32 70.25 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.573 177.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -97.38 -19.79 18.24 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.609 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.688 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 115.77 156.31 10.93 Favored Glycine 0 N--CA 1.438 -1.21 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.671 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.0 m -117.53 137.84 52.3 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.859 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -114.83 148.5 38.42 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -178.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.475 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.15 113.42 18.31 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.415 177.536 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.415 ' N ' HD12 ' A' ' 111' ' ' LEU . 91.7 m-20 44.37 43.26 5.99 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.74 -10.78 68.66 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.792 -0.718 . . . . 0.0 113.458 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -104.82 118.58 36.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.067 0.46 . . . . 0.0 110.635 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.859 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 15.1 tptp -73.37 122.25 21.75 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.318 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.763 HG23 ' OD2' ' A' ' 103' ' ' ASP . 7.3 m -93.94 165.53 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.242 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 120' ' ' SER . 16.7 mt-10 -69.86 128.51 36.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.522 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.69 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 15.9 tttp -54.47 163.93 0.8 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.9 OUTLIER 34.35 36.41 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.816 -179.183 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.407 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.7 p -111.96 145.09 40.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.914 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.942 ' HB3' HD22 ' A' ' 100' ' ' LEU . 6.6 m120 -94.62 129.59 41.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.932 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.781 ' O ' HD23 ' A' ' 100' ' ' LEU . 62.5 mm-40 -129.08 149.42 50.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.389 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.522 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.6 tm? -72.63 122.05 20.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.874 0.369 . . . . 0.0 110.26 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.575 HD21 HG12 ' A' ' 147' ' ' ILE . 65.0 tp -54.16 156.44 3.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.397 0.618 . . . . 0.0 111.866 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.401 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.4 OUTLIER -124.55 153.48 42.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.544 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.457 ' HA ' HD12 ' A' ' 147' ' ' ILE . 3.8 tp60 -71.59 122.26 20.2 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.95 22.58 57.89 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.928 -178.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -52.15 170.7 0.06 Allowed 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.941 0.4 . . . . 0.0 111.095 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.688 ' HG3' HG22 ' A' ' 144' ' ' VAL . 9.5 tt0 -145.11 135.47 24.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.266 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.481 HD11 HD11 ' A' ' 145' ' ' ILE . 17.6 mt -115.6 127.53 73.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.604 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.596 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.5 m -104.49 140.61 37.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.082 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.736 ' CG2' HD21 ' A' ' 84' ' ' LEU . 35.2 m -140.34 158.42 25.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 112.216 0.451 . . . . 0.0 112.216 -178.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.2 43.03 8.92 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.806 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.474 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.9 t -84.72 140.53 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 121.686 0.755 . . . . 0.0 112.502 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.98 -38.32 0.8 Allowed Glycine 0 N--CA 1.435 -1.401 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.533 HG12 ' H ' ' A' ' 138' ' ' SER . 57.7 t -126.39 120.2 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-N 114.518 -0.841 . . . . 0.0 109.001 177.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.408 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -50.45 -28.43 8.29 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.708 0.289 . . . . 0.0 111.494 -178.555 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.533 ' H ' HG12 ' A' ' 136' ' ' VAL . 2.2 p -93.61 6.52 48.0 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.43 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.6 OUTLIER -131.18 31.15 4.45 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -179.017 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.596 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.9 mt -107.16 139.47 28.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.647 178.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.455 HD23 ' C ' ' A' ' 141' ' ' LEU . 9.5 tt -123.64 134.46 53.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.928 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.528 ' H ' HG21 ' A' ' 40' ' ' THR . 45.2 t -109.73 150.4 28.37 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.618 0.723 . . . . 0.0 112.29 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 65.2 mt -135.81 139.12 43.23 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.963 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.688 HG22 ' HG3' ' A' ' 129' ' ' GLU . 19.2 t -112.4 139.08 38.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.858 0.361 . . . . 0.0 111.09 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.481 HD11 HD11 ' A' ' 130' ' ' ILE . 31.4 mt -106.3 129.6 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.029 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.62 ' CD1' HD12 ' A' ' 37' ' ' ILE . 0.9 OUTLIER -113.68 116.29 29.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.832 179.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.575 HG12 HD21 ' A' ' 124' ' ' LEU . 6.2 mt -84.88 134.14 27.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.681 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -88.7 109.77 20.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.699 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -62.36 -30.6 71.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.059 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -42.27 84.39 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.969 0.414 . . . . 0.0 110.721 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 22.3 t80 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.887 179.916 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 . . . . . 0 N--CA 1.458 -0.073 0 CA-C-O 120.822 0.344 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -70.94 -36.97 72.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -58.4 -39.88 80.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.793 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.42 -32.53 73.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.746 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.429 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.0 mt -73.04 -35.34 48.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.947 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -57.21 -43.53 82.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.912 0.387 . . . . 0.0 110.612 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -67.09 -24.26 65.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.529 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.429 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -57.0 -47.7 80.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.131 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.2 m . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.105 -179.972 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.436 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER . . . . . 0 CA--C 1.509 -0.598 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.66 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.5 mm -76.26 137.15 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 CA-C-N 113.706 -1.588 . . . . 0.0 112.603 -177.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.965 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.4 t -91.97 -58.47 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.641 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 66.2 m -146.18 165.28 29.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.466 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.74 124.52 31.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.773 0.321 . . . . 0.0 111.171 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.69 HG21 ' HE2' ' A' ' 68' ' ' PHE . 55.7 t -94.9 122.96 46.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.012 0.434 . . . . 0.0 111.132 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.786 HG23 HG12 ' A' ' 45' ' ' ILE . 20.9 mt -124.68 122.69 64.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.057 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.714 ' HA ' HD13 ' A' ' 143' ' ' LEU . 42.3 t -79.96 112.88 17.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.831 0.348 . . . . 0.0 110.544 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.452 ' CG2' HG21 ' A' ' 144' ' ' VAL . 0.3 OUTLIER -80.48 -25.26 38.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.508 -179.301 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.504 HG23 ' HB3' ' A' ' 142' ' ' SER . 82.3 p -80.04 -2.36 43.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.738 0.304 . . . . 0.0 111.422 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.97 76.48 0.25 Allowed Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.924 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.436 ' HB2' HD11 ' A' ' 141' ' ' LEU . 12.5 mt-30 -147.14 -44.12 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.88 0.372 . . . . 0.0 110.931 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.576 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.1 mt -114.99 141.7 27.34 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.944 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.576 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 45.5 Cg_endo -71.15 145.34 48.96 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.2 1.933 . . . . 0.0 112.285 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.786 HG12 HG23 ' A' ' 37' ' ' ILE . 36.0 mt -60.13 138.81 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.722 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.83 164.33 20.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.294 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -120.82 119.68 33.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.997 0.427 . . . . 0.0 111.839 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.764 HD23 ' CD2' ' A' ' 66' ' ' TRP . 6.9 mp -92.14 130.41 37.87 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.965 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -141.58 155.81 45.74 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 122.2 1.0 . . . . 0.0 113.641 -179.581 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.483 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.23 142.06 29.19 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.468 -1.696 . . . . 0.0 110.934 179.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 121.078 0.466 . . . . 0.0 111.102 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.069 0 CA-C-O 120.837 0.351 . . . . 0.0 110.75 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.419 ' CE ' ' O ' ' A' ' 49' ' ' SER . 3.9 ttpt -135.81 127.86 29.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.865 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.626 HG12 ' HG2' ' A' ' 90' ' ' GLN . 6.3 t -121.59 137.14 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 121.283 0.563 . . . . 0.0 111.876 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.764 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.5 m-90 -102.41 139.41 38.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.274 -0.876 . . . . 0.0 112.151 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.663 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.33 130.52 56.25 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 177.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.698 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.7 OUTLIER -117.65 145.49 44.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.392 -178.897 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.637 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.0 -169.05 36.52 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.776 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -81.7 4.26 22.48 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -84.77 132.47 46.2 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.469 0.176 . . . . 0.0 111.11 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.33 -13.81 41.47 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.488 2.125 . . . . 0.0 111.612 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.83 -42.7 17.51 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 121.921 0.867 . . . . 0.0 109.03 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -41.88 138.94 1.37 Allowed 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 113.831 -1.531 . . . . 0.0 111.081 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 67' ' ' THR . 20.3 m-20 -56.47 -18.6 11.93 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.981 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.481 ' CZ ' HG21 ' A' ' 43' ' ' ILE . 23.9 t80 -129.52 118.87 22.76 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-O 120.773 0.32 . . . . 0.0 110.998 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.728 179.851 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.522 HG22 ' H ' ' A' ' 83' ' ' ARG . 3.8 mp . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.805 0.336 . . . . 0.0 110.945 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.8 m -55.22 -33.92 63.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.995 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.522 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -63.96 -28.55 69.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.927 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.468 HD12 HD13 ' A' ' 81' ' ' ILE . 19.1 mt -100.43 151.98 20.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.979 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 91.6 p -95.1 165.61 12.34 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.647 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.637 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -43.09 -52.88 5.21 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.289 0.566 . . . . 0.0 109.641 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.558 ' HB3' HG22 ' A' ' 67' ' ' THR . 2.0 mttp -118.94 82.44 1.86 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.55 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.4 t60 -59.92 -46.67 88.63 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.576 -177.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.5 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 26.4 p90 -145.41 160.05 42.15 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.755 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.663 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.5 tt0 -136.03 140.85 44.17 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.32 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.698 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 71.2 mt -115.13 131.08 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.92 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.498 HD21 HD22 ' A' ' 121' ' ' ASN . 0.6 OUTLIER -112.59 147.06 37.46 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.141 0.496 . . . . 0.0 111.891 -179.602 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.828 HD22 HG11 ' A' ' 33' ' ' VAL . 28.6 tp . . . . . 0 C--O 1.233 0.229 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.438 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.692 ' O ' HD12 ' A' ' 100' ' ' LEU . 4.3 mm? . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.801 0.334 . . . . 0.0 110.862 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.692 HD12 ' O ' ' A' ' 99' ' ' LEU . 3.9 mp -132.99 145.73 51.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.606 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.998 HD11 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -112.85 126.91 55.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.066 179.695 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.43 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 52.0 t30 -119.38 115.74 24.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.964 0.411 . . . . 0.0 112.069 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.836 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.1 p30 -76.38 141.04 41.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.739 178.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.465 HD12 ' HB2' ' A' ' 87' ' ' LYS . 8.3 pt -149.28 39.1 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.618 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.84 153.01 19.1 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-O 121.102 0.477 . . . . 0.0 111.847 -179.062 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.2 m -68.83 -31.72 70.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.058 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -98.29 -19.93 17.51 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.618 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 118.83 157.31 10.38 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.698 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.6 m -117.61 137.81 52.37 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 123.142 0.577 . . . . 0.0 109.492 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.879 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -115.61 148.66 39.37 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.465 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.16 113.62 18.56 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.478 177.535 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.42 ' N ' HD12 ' A' ' 111' ' ' LEU . 52.6 m-20 43.41 43.9 4.59 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.76 -13.64 62.21 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.608 -0.806 . . . . 0.0 113.432 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -103.78 118.52 36.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.976 0.417 . . . . 0.0 110.571 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.879 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 12.0 tptt -72.93 124.2 24.97 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.408 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.836 HG23 ' OD2' ' A' ' 103' ' ' ASP . 15.8 m -90.01 176.59 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.084 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.9 pt-20 -83.25 124.43 30.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.497 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.672 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 20.4 tttt -50.5 159.78 0.47 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.025 0.441 . . . . 0.0 111.086 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.488 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 3.6 p30 34.65 33.99 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.621 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.52 145.15 40.78 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.95 179.181 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.629 ' HB3' HD23 ' A' ' 100' ' ' LEU . 24.5 m120 -87.37 132.43 33.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.861 0.362 . . . . 0.0 110.99 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 43.7 mm-40 -129.17 148.13 51.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.536 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.3 tp -72.71 118.53 15.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.056 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.689 HD21 HG12 ' A' ' 147' ' ' ILE . 66.9 tp -52.91 155.85 2.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.411 0.624 . . . . 0.0 111.719 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.445 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.76 153.29 42.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.585 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.416 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 1.2 tp60 -71.79 120.78 17.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.94 0.4 . . . . 0.0 110.417 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.21 24.82 56.11 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.357 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.478 ' HB3' HD13 ' A' ' 145' ' ' ILE . 21.5 t0 -56.67 174.5 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.87 0.367 . . . . 0.0 110.912 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -145.22 135.49 24.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.093 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.998 HD11 HD11 ' A' ' 101' ' ' LEU . 3.9 mt -114.99 128.27 72.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.483 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.673 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.6 m -104.24 140.21 38.16 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.021 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.525 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.1 m -140.31 158.33 25.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.4 35.66 19.54 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.086 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.474 ' HA ' HG12 ' A' ' 140' ' ' ILE . 63.3 t -76.1 140.4 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-O 121.666 0.746 . . . . 0.0 112.474 -179.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.4 -38.87 0.77 Allowed Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.445 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 51.2 t -126.33 132.88 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-N 114.754 -0.723 . . . . 0.0 109.206 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.61 -40.16 52.08 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.408 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -93.39 6.4 48.28 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -178.647 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.445 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 13.0 t0 -116.69 25.1 10.8 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.673 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.9 mt -107.36 139.42 29.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.244 178.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.499 HD21 ' CD1' ' A' ' 43' ' ' ILE . 2.7 tp -124.15 134.46 53.32 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.342 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.551 ' C ' HD22 ' A' ' 143' ' ' LEU . 37.2 t -113.04 150.46 31.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.59 0.71 . . . . 0.0 112.743 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.714 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.5 mm? -135.91 142.33 44.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.646 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.452 HG21 ' CG2' ' A' ' 39' ' ' THR . 21.9 t -114.25 135.34 54.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.86 0.362 . . . . 0.0 111.254 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.594 HD11 HG13 ' A' ' 130' ' ' ILE . 1.2 mp -105.59 127.56 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.375 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.58 120.03 40.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.662 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.689 HG12 HD21 ' A' ' 124' ' ' LEU . 4.9 mt -84.92 134.08 27.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.48 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.4 106.81 13.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.775 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.42 -32.12 68.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.016 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.31 -45.14 92.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.59 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 17.6 t80 . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.915 179.97 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.911 0.386 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.4 ttm180 -63.73 -35.96 82.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.98 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -56.87 -42.29 79.51 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.885 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.65 -32.36 68.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.691 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.451 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.3 mt -73.14 -35.2 47.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.84 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -39.77 76.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.92 0.39 . . . . 0.0 110.503 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.1 -24.51 65.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.622 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.451 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -57.17 -47.59 80.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.619 -179.83 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.28 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.433 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.8 OUTLIER . . . . . 0 CA--C 1.509 -0.63 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.721 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.9 mm -73.21 134.76 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 CA-C-N 113.621 -1.627 . . . . 0.0 112.479 -177.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.037 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -89.91 -60.12 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.829 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.602 ' SG ' HD12 ' A' ' 48' ' ' LEU . 6.7 p -150.13 150.87 32.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.147 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.421 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.85 138.16 50.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.224 -179.416 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.779 HG21 ' HE2' ' A' ' 68' ' ' PHE . 22.7 t -104.65 122.69 57.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.016 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.783 HG23 HG12 ' A' ' 45' ' ' ILE . 16.3 mt -125.78 125.69 68.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.42 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.711 ' HA ' HD13 ' A' ' 143' ' ' LEU . 44.3 t -82.11 120.08 24.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.844 0.354 . . . . 0.0 110.543 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.5 t -86.0 -27.75 24.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.499 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.535 HG21 ' H ' ' A' ' 142' ' ' SER . 42.4 p -79.82 -2.26 42.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.554 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.97 77.91 0.2 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.86 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.607 ' CD ' HD11 ' A' ' 141' ' ' LEU . 11.1 mt-30 -146.73 -44.89 0.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.845 0.355 . . . . 0.0 110.921 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.562 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.5 mt -113.93 141.52 26.35 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.062 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.562 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 58.1 Cg_endo -73.32 140.8 31.04 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.156 1.904 . . . . 0.0 112.199 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.783 HG12 HG23 ' A' ' 37' ' ' ILE . 33.6 mt -55.16 141.44 11.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.737 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.425 ' HB2' ' CE2' ' A' ' 76' ' ' TYR . 0.4 OUTLIER -131.49 163.92 26.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.087 179.503 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.421 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.3 OUTLIER -119.35 119.84 35.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.103 0.478 . . . . 0.0 111.78 -179.659 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.608 HD11 HG23 ' A' ' 36' ' ' VAL . 1.3 mt -98.53 135.59 39.86 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.037 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.37 159.52 42.93 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -178.573 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.487 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -141.96 141.68 32.93 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.699 -1.591 . . . . 0.0 110.55 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 121.104 0.478 . . . . 0.0 111.445 -179.303 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.9 mmtm . . . . . 0 CA--C 1.528 0.1 0 CA-C-O 120.672 0.272 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.424 ' CE ' ' O ' ' A' ' 49' ' ' SER . 29.2 ttpt -134.77 139.72 45.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.866 0.365 . . . . 0.0 111.07 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.666 HG12 ' HG2' ' A' ' 90' ' ' GLN . 11.1 t -127.24 139.28 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 121.166 0.508 . . . . 0.0 111.703 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.55 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 19.2 m-90 -100.94 138.4 38.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.249 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.709 HG22 ' HB3' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -113.46 127.11 55.99 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.364 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.779 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -108.9 145.64 35.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.592 -178.255 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.777 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 173.01 -175.26 45.98 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.512 -0.852 . . . . 0.0 113.196 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.415 ' HB2' ' NH1' ' A' ' 70' ' ' ARG . 5.0 mtp-105 -82.93 -4.67 58.49 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.633 0.254 . . . . 0.0 111.454 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.463 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.6 p30 -88.3 139.56 30.26 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-O 120.789 0.328 . . . . 0.0 111.229 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 9.1 Cg_exo -69.46 -4.41 13.77 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.842 2.361 . . . . 0.0 111.809 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.64 -45.96 13.87 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-O 121.932 0.872 . . . . 0.0 108.936 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.26 139.45 1.91 Allowed 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 113.746 -1.57 . . . . 0.0 110.424 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -56.29 -19.19 13.15 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.013 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.532 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 39.3 t80 -130.13 121.44 26.31 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.905 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.4 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 . . . . . 0 C--N 1.329 -0.326 0 CA-C-O 120.804 0.335 . . . . 0.0 110.726 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.541 HD13 HD12 ' A' ' 84' ' ' LEU . 4.6 mp . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.821 0.343 . . . . 0.0 110.684 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.95 -38.07 67.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.501 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.0 mmp_? -60.71 -19.93 59.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.764 0.316 . . . . 0.0 110.912 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.541 HD12 HD13 ' A' ' 81' ' ' ILE . 34.7 mt -101.91 152.33 21.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.792 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 86' ' ' ASN . 96.3 p -97.91 170.68 8.78 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.508 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.777 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.3 m-20 -41.05 -80.64 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.709 ' HB3' HG22 ' A' ' 67' ' ' THR . 13.8 mttm -92.86 83.17 4.73 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.547 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 17.3 t60 -57.71 -46.14 84.77 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.033 -177.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.517 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 16.3 p90 -145.87 158.71 43.85 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.486 -0.486 . . . . 0.0 112.076 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.688 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.1 tt0 -135.72 142.04 44.97 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.254 -178.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.592 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 59.3 mt -117.6 131.68 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.671 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.582 HD21 HD22 ' A' ' 121' ' ' ASN . 0.6 OUTLIER -114.2 143.61 44.54 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.041 0.448 . . . . 0.0 111.876 -179.296 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.734 HD23 ' HG ' ' A' ' 99' ' ' LEU . 2.3 tm? . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.441 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.945 HD11 HG12 ' A' ' 33' ' ' VAL . 1.1 mt . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.814 0.34 . . . . 0.0 110.866 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.796 HD13 ' O ' ' A' ' 122' ' ' GLN . 4.0 mm? -129.9 142.35 50.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.275 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.711 HD11 ' HA ' ' A' ' 124' ' ' LEU . 3.5 mp -112.83 128.73 56.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.289 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.411 ' HB2' HD23 ' A' ' 92' ' ' LEU . 47.1 t30 -119.79 115.56 24.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.053 0.454 . . . . 0.0 111.692 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.836 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.1 p30 -78.53 137.04 37.71 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.6 HD12 ' HB2' ' A' ' 87' ' ' LYS . 10.2 pt -145.26 39.19 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -178.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.67 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.35 152.84 19.5 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 121.171 0.51 . . . . 0.0 111.867 -178.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 49.1 m -68.83 -31.58 70.66 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.857 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -98.19 -19.97 17.56 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.67 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.7 158.05 10.87 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.788 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.6 m -117.37 137.75 52.25 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.848 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -115.34 148.46 39.24 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -178.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.41 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.21 113.39 18.24 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.538 -1.21 . . . . 0.0 108.246 177.526 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 43.77 43.55 5.08 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.22 -10.99 68.92 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.481 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.69 118.61 37.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.087 0.47 . . . . 0.0 110.612 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.848 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 12.7 tptt -73.17 121.53 20.41 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.197 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.836 HG23 ' OD2' ' A' ' 103' ' ' ASP . 13.2 m -91.0 164.08 2.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.189 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 120' ' ' SER . 4.3 tp10 -69.82 125.35 26.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.572 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.684 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 73.9 tttt -51.96 161.35 0.59 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.858 0.361 . . . . 0.0 110.754 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.8 p30 34.78 34.75 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.309 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.27 145.17 40.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.078 179.498 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.582 HD22 HD21 ' A' ' 92' ' ' LEU . 25.7 m120 -89.32 129.04 35.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.04 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.796 ' O ' HD13 ' A' ' 100' ' ' LEU . 47.0 mm-40 -129.18 147.43 51.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.556 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 tp -72.7 132.76 44.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.298 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.74 HD21 HG13 ' A' ' 147' ' ' ILE . 65.9 tp -62.78 156.71 23.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.487 0.661 . . . . 0.0 111.624 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.406 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.47 153.31 42.19 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.056 179.707 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.554 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.05 117.88 13.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.024 0.44 . . . . 0.0 110.244 -179.446 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.8 24.42 64.47 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.015 -178.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.406 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 16.9 t70 -53.43 171.92 0.07 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.901 0.381 . . . . 0.0 110.955 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.83 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.8 mt-10 -145.15 135.52 24.13 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.098 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.651 HD11 HD23 ' A' ' 101' ' ' LEU . 13.7 mt -114.25 126.57 71.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.483 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.553 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.3 m -104.42 139.09 39.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.955 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.496 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.2 m -140.25 158.32 25.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.74 32.87 17.31 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.84 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.484 ' HA ' HG12 ' A' ' 140' ' ' ILE . 54.6 t -75.75 140.48 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-O 121.629 0.728 . . . . 0.0 112.478 -179.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.01 -38.39 0.69 Allowed Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.517 HG12 ' H ' ' A' ' 138' ' ' SER . 49.7 t -126.32 124.45 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 CA-C-N 114.666 -0.767 . . . . 0.0 109.125 178.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.47 -32.65 18.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.73 0.3 . . . . 0.0 111.381 -178.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.517 ' H ' HG12 ' A' ' 136' ' ' VAL . 31.3 t -93.45 6.47 48.06 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.414 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 5.7 t0 -127.93 30.62 5.24 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.553 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.6 mt -107.13 139.52 28.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.784 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.607 HD11 ' CD ' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -122.42 134.3 54.61 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.752 -179.793 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.644 ' C ' HD22 ' A' ' 143' ' ' LEU . 46.6 t -110.82 150.58 28.93 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.59 0.709 . . . . 0.0 112.157 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.711 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.5 mm? -136.02 149.42 48.8 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.597 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.83 HG22 ' CG ' ' A' ' 129' ' ' GLU . 11.8 t -117.55 135.76 56.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.712 0.292 . . . . 0.0 110.978 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.657 HG21 HD11 ' A' ' 124' ' ' LEU . 3.6 mt -106.57 124.63 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-O 121.044 0.45 . . . . 0.0 111.046 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.465 ' HD2' HD12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -107.93 139.68 42.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.365 179.498 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.74 HG13 HD21 ' A' ' 124' ' ' LEU . 3.3 mp -105.65 134.08 48.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.91 0.386 . . . . 0.0 111.552 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -85.93 112.27 21.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.625 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -57.52 -27.85 62.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.122 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -60.77 -46.02 92.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.809 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 29.1 t80 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.063 -179.886 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.82 0.343 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -66.94 -39.92 87.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.015 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -57.55 -40.15 78.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.915 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.15 -33.91 69.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.629 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.483 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.3 mt -73.14 -35.24 47.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.783 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -57.23 -35.2 69.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.454 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.1 mttp -67.03 -24.07 65.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.613 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.483 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -62.24 -47.85 82.57 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.645 -179.715 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.5 m . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.777 -179.184 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.444 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.3 m-20 . . . . . 0 CA--C 1.508 -0.644 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.659 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.5 mm -74.14 135.63 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 CA-C-N 113.641 -1.618 . . . . 0.0 112.492 -177.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.985 HG12 HD11 ' A' ' 99' ' ' LEU . 3.4 t -90.81 -58.97 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.436 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.2 p -145.76 158.92 43.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.059 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.402 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -126.36 124.99 41.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.745 0.307 . . . . 0.0 111.528 -179.425 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.725 HG21 ' HE2' ' A' ' 68' ' ' PHE . 26.1 t -94.92 122.68 46.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.923 0.392 . . . . 0.0 110.957 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.855 HG23 HG12 ' A' ' 45' ' ' ILE . 20.7 mt -125.07 120.23 57.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.266 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.545 ' SG ' ' HB ' ' A' ' 43' ' ' ILE . 20.0 m -85.74 99.88 11.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.902 0.382 . . . . 0.0 110.532 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 82.3 p -79.09 -19.73 50.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.14 -178.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.776 HG21 ' OG ' ' A' ' 142' ' ' SER . 10.5 p -79.79 -2.7 44.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.729 0.299 . . . . 0.0 111.354 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.58 71.0 0.98 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.014 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.454 ' HB2' HD21 ' A' ' 141' ' ' LEU . 4.5 mt-30 -140.37 -39.95 0.43 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.764 0.316 . . . . 0.0 111.225 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.78 HG23 ' HD2' ' A' ' 44' ' ' PRO . 4.3 mt -133.88 145.33 55.49 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.668 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.78 ' HD2' HG23 ' A' ' 43' ' ' ILE . 41.9 Cg_endo -69.74 146.16 59.47 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.324 2.016 . . . . 0.0 112.594 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.855 HG12 HG23 ' A' ' 37' ' ' ILE . 36.8 mt -54.26 157.5 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.62 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.483 ' N ' HG22 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -145.69 164.17 32.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.282 179.625 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.402 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.4 OUTLIER -127.58 119.92 27.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.076 0.465 . . . . 0.0 111.902 -179.513 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.795 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.9 mp -95.14 128.6 42.1 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.984 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -138.37 156.78 47.29 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -179.244 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -146.59 141.89 27.41 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.412 -1.722 . . . . 0.0 110.777 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.225 0 CA-C-O 121.153 0.501 . . . . 0.0 111.071 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.081 0 CA-C-O 120.73 0.3 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.434 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.7 ttpt -145.9 136.41 24.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.292 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.63 HG12 ' HG2' ' A' ' 90' ' ' GLN . 14.9 t -134.06 139.36 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 121.268 0.556 . . . . 0.0 112.003 -179.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.795 ' CD2' HD23 ' A' ' 48' ' ' LEU . 18.8 m-90 -103.51 139.29 39.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.226 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.412 HG22 HD11 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -111.45 126.38 54.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.102 0.477 . . . . 0.0 109.832 177.469 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.725 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -111.6 145.6 38.89 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.17 -178.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.64 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.39 -176.62 40.28 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.245 -0.978 . . . . 0.0 113.547 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.454 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 1.2 ttp180 -73.23 -7.39 51.26 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.417 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.1 t30 -84.81 135.51 40.07 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.791 0.329 . . . . 0.0 111.322 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 9.7 Cg_exo -70.14 -6.43 18.76 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.957 2.438 . . . . 0.0 112.087 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.409 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.63 -44.17 16.08 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-O 121.971 0.891 . . . . 0.0 108.63 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -41.91 138.7 1.45 Allowed 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 113.537 -1.665 . . . . 0.0 110.416 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -56.26 -19.31 13.5 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.024 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.553 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 21.1 t80 -130.21 122.55 28.33 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.661 179.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.403 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.2 t-160 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.774 0.321 . . . . 0.0 110.958 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.662 HD13 ' CD1' ' A' ' 84' ' ' LEU . 2.9 mp . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.81 0.338 . . . . 0.0 110.786 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.4 m -55.22 -36.61 66.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.289 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -61.0 -18.83 59.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.279 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.662 ' CD1' HD13 ' A' ' 81' ' ' ILE . 18.9 mt -102.69 149.34 24.55 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.759 0.314 . . . . 0.0 111.026 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 88.2 p -92.41 167.17 12.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.711 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.64 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.8 m-20 -43.53 -53.25 5.7 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.286 0.565 . . . . 0.0 109.832 179.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.431 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 2.7 ptmt -120.88 82.46 1.92 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.553 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.8 t60 -59.62 -47.12 86.85 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.707 -176.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.506 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 28.2 p90 -146.48 159.8 42.94 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.666 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.63 ' HG2' HG12 ' A' ' 65' ' ' VAL . 7.3 tt0 -135.77 141.2 44.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.145 -179.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.592 ' O ' HG13 ' A' ' 65' ' ' VAL . 50.8 mt -114.28 131.03 67.49 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.205 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.126 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.603 HD21 ' HB3' ' A' ' 100' ' ' LEU . 0.7 OUTLIER -112.64 149.04 33.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.009 0.433 . . . . 0.0 111.595 -179.674 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.843 HD22 HG11 ' A' ' 33' ' ' VAL . 29.1 tp . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.631 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.985 HD11 HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.916 0.388 . . . . 0.0 110.902 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.645 HD12 ' O ' ' A' ' 99' ' ' LEU . 2.6 mp -133.14 146.56 51.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.151 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.781 HD23 HD11 ' A' ' 130' ' ' ILE . 4.9 mp -112.65 129.35 56.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.259 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 90' ' ' GLN . 53.3 t30 -117.91 115.49 25.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.886 0.374 . . . . 0.0 111.829 -179.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.799 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.3 p30 -77.2 140.49 40.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.781 178.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' A' ' 89' ' ' PHE . 19.0 pt -149.5 38.74 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.655 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.1 152.6 19.67 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.095 0.474 . . . . 0.0 111.906 -178.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 47.9 m -68.93 -31.45 70.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.731 177.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -98.17 -19.81 17.67 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.655 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.84 157.18 10.55 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.359 -0.924 . . . . 0.0 113.895 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.1 m -117.42 137.88 52.2 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.81 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -116.67 148.37 41.08 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -177.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.897 HD12 HG11 ' A' ' 116' ' ' VAL . 0.9 OUTLIER -124.33 113.56 18.38 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.043 177.384 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 47.43 35.77 4.41 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.141 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.81 -7.41 76.99 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.564 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.8 118.58 37.04 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.059 0.457 . . . . 0.0 110.736 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.81 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -71.52 128.06 34.59 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.219 -179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.897 HG11 HD12 ' A' ' 111' ' ' LEU . 9.8 m -101.34 167.68 2.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.464 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 120' ' ' SER . 4.6 mm-40 -69.91 125.81 27.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.539 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.697 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 68.8 tttt -54.2 162.71 0.97 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.892 0.377 . . . . 0.0 110.618 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.5 m-80 35.21 34.02 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.241 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.29 145.14 40.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.027 179.481 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.592 ' HB3' HD23 ' A' ' 100' ' ' LEU . 4.8 m120 -85.87 132.13 34.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.021 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.426 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 32.5 mm-40 -129.46 146.27 51.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.768 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 124' ' ' LEU . 1.0 OUTLIER -72.98 122.92 22.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.312 179.503 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.757 HD21 HG12 ' A' ' 147' ' ' ILE . 59.6 tp -59.61 155.59 15.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.511 0.672 . . . . 0.0 111.554 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.435 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.8 153.2 42.86 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.33 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -71.74 120.49 17.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.986 0.422 . . . . 0.0 110.263 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.81 18.4 64.09 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.403 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.537 ' OD1' HD23 ' A' ' 111' ' ' LEU . 13.2 t70 -54.18 170.16 0.15 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.016 0.436 . . . . 0.0 111.257 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 5.0 tt0 -145.23 135.49 24.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.102 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.781 HD11 HD23 ' A' ' 101' ' ' LEU . 14.6 mt -111.27 128.22 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.346 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.634 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.7 m -104.22 139.32 39.42 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.186 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.478 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 34.6 m -140.18 158.25 25.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.086 0.47 . . . . 0.0 112.217 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.67 37.91 12.96 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.908 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.1 t -79.14 140.33 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-O 121.67 0.748 . . . . 0.0 112.33 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.89 -36.97 0.89 Allowed Glycine 0 N--CA 1.436 -1.341 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.02 -179.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.476 HG12 ' H ' ' A' ' 138' ' ' SER . 48.5 t -126.37 123.74 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-N 114.621 -0.79 . . . . 0.0 109.084 178.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.57 -33.21 21.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.691 0.282 . . . . 0.0 111.617 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.476 ' H ' HG12 ' A' ' 136' ' ' VAL . 3.0 m -93.46 6.58 47.69 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.446 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 3.2 t0 -127.34 30.1 5.44 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.634 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.9 mt -106.61 139.68 27.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.797 178.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.762 HD22 HD13 ' A' ' 143' ' ' LEU . 1.0 OUTLIER -115.76 134.55 54.9 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.827 -179.678 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.776 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.3 OUTLIER -116.13 127.06 54.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.218 0.532 . . . . 0.0 111.558 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.762 HD13 HD22 ' A' ' 141' ' ' LEU . 2.3 mp -121.26 138.08 54.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.625 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 21.7 t -110.55 139.31 34.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.866 0.365 . . . . 0.0 111.18 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.463 HD12 HD21 ' A' ' 101' ' ' LEU . 49.0 mt -106.03 138.12 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.197 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.84 116.48 25.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.473 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.757 HG12 HD21 ' A' ' 124' ' ' LEU . 4.9 mt -84.88 134.04 27.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.499 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.18 105.85 15.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.595 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -58.19 -32.96 68.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.091 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -60.38 -46.02 91.44 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.031 0.444 . . . . 0.0 110.775 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 30.3 t80 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.038 -179.831 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.82 0.343 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.9 mmt85 -68.97 -37.2 78.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -58.24 -40.38 81.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.775 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.3 tp -59.37 -31.93 69.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.801 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.465 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -73.02 -35.37 48.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -57.55 -39.59 76.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.37 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.16 -23.86 65.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.672 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.465 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.64 -47.56 79.47 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.199 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.1 p . . . . . 0 C--N 1.326 -0.453 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.833 179.891 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.404 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.5 OUTLIER . . . . . 0 CA--C 1.51 -0.594 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.667 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.6 mm -74.83 135.06 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 CA-C-N 113.694 -1.594 . . . . 0.0 112.532 -177.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.966 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -92.72 -60.84 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.836 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.619 ' SG ' HD22 ' A' ' 48' ' ' LEU . 1.7 p -140.73 164.88 29.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.214 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.411 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -134.45 122.09 22.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.809 0.337 . . . . 0.0 111.322 -179.529 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.704 HG21 ' HE2' ' A' ' 68' ' ' PHE . 40.6 t -93.72 122.78 45.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.815 0.34 . . . . 0.0 111.04 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.831 HG23 HG12 ' A' ' 45' ' ' ILE . 14.0 mt -125.7 117.49 49.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.564 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.428 ' SG ' HD23 ' A' ' 143' ' ' LEU . 3.8 t -81.33 111.23 17.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.834 0.349 . . . . 0.0 110.34 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.1 t -86.89 -22.02 25.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.934 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.636 HG23 ' HB2' ' A' ' 142' ' ' SER . 81.6 p -79.84 -2.77 44.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.731 0.3 . . . . 0.0 111.429 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.24 75.77 0.4 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.882 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -146.9 -40.36 0.2 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.844 0.354 . . . . 0.0 111.02 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.584 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.3 mt -125.9 142.01 41.07 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.033 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.584 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 46.0 Cg_endo -70.48 146.05 54.65 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.172 1.915 . . . . 0.0 112.226 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.831 HG12 HG23 ' A' ' 37' ' ' ILE . 33.7 mt -58.91 149.5 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.824 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.32 163.88 31.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.054 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.411 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.8 OUTLIER -126.06 119.85 28.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.058 0.456 . . . . 0.0 112.011 -179.479 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.797 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.3 mp -89.57 130.89 35.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.246 178.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.966 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -140.8 156.15 46.22 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 122.412 1.101 . . . . 0.0 113.827 -179.578 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.64 141.83 28.49 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 113.352 -1.749 . . . . 0.0 110.64 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 121.159 0.505 . . . . 0.0 111.051 -179.586 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.851 0.358 . . . . 0.0 110.768 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.415 ' CE ' ' O ' ' A' ' 49' ' ' SER . 21.0 ttpt -136.3 137.57 40.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.638 HG12 ' HG2' ' A' ' 90' ' ' GLN . 5.4 t -124.69 138.81 52.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.085 0.469 . . . . 0.0 111.852 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.797 ' CD2' HD23 ' A' ' 48' ' ' LEU . 17.0 m-90 -103.4 138.64 39.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.959 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.475 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.17 127.01 55.82 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 177.801 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.704 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -112.95 145.73 40.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.593 -178.456 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.697 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.45 -174.4 40.49 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.691 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.405 ' HD3' ' HB2' ' A' ' 84' ' ' LEU . 16.5 mtm180 -80.24 -2.82 46.68 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.488 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.0 t30 -84.87 135.99 39.35 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.791 0.329 . . . . 0.0 111.067 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.8 Cg_exo -68.86 -6.88 19.15 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.773 2.315 . . . . 0.0 111.834 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.76 -44.63 15.36 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-O 122.0 0.905 . . . . 0.0 108.56 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.07 136.68 4.72 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.694 -1.594 . . . . 0.0 110.16 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.419 ' OD2' ' CD1' ' A' ' 66' ' ' TRP . 0.7 OUTLIER -56.51 -18.92 13.13 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.89 179.431 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.521 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 53.7 t80 -130.19 130.69 45.01 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.772 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 CA-C-O 120.834 0.35 . . . . 0.0 110.944 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.816 HD13 HD12 ' A' ' 84' ' ' LEU . 3.8 mp . . . . . 0 CA--C 1.526 0.049 0 CA-C-O 120.806 0.336 . . . . 0.0 110.918 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.4 t -58.52 -40.43 82.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.995 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.42 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -61.02 -30.06 70.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.09 -179.82 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.816 HD12 HD13 ' A' ' 81' ' ' ILE . 30.3 mt -94.65 152.12 18.74 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.844 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 89.5 p -95.44 165.24 12.46 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.689 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.697 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.5 m-20 -42.06 -52.8 4.14 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.276 0.56 . . . . 0.0 109.816 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.428 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 5.0 ptmt -120.92 84.29 2.21 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.569 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.6 t60 -61.56 -46.24 90.74 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.971 -1.013 . . . . 0.0 113.055 -176.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.5 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 24.6 p90 -144.72 157.94 43.98 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.136 -0.625 . . . . 0.0 112.105 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.638 ' HG2' HG12 ' A' ' 65' ' ' VAL . 5.9 tt0 -135.91 140.35 44.0 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.018 -179.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.523 ' O ' HG13 ' A' ' 65' ' ' VAL . 38.5 mt -113.47 132.3 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 121.134 -0.227 . . . . 0.0 110.855 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.938 HD13 HD12 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -113.81 146.87 39.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.184 0.516 . . . . 0.0 112.022 -179.202 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.808 HD22 HG11 ' A' ' 33' ' ' VAL . 44.4 tp . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.439 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.769 ' HB2' HD21 ' A' ' 124' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.655 0.264 . . . . 0.0 110.696 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.938 HD12 HD13 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -133.22 147.57 51.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.818 0.342 . . . . 0.0 110.768 179.887 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.87 125.26 53.84 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.839 ' HB2' HD11 ' A' ' 92' ' ' LEU . 53.5 t30 -109.27 115.69 30.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.694 -179.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.79 ' OD2' HG23 ' A' ' 116' ' ' VAL . 18.3 p30 -76.89 131.76 38.75 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.649 178.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.437 HD13 ' HB2' ' A' ' 90' ' ' GLN . 21.6 pt -139.34 40.54 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -178.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.677 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.54 151.93 20.6 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 120.987 0.422 . . . . 0.0 111.64 -178.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.8 m -68.57 -31.87 71.38 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.776 178.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -98.41 -19.63 17.6 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.614 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.677 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.94 157.81 10.97 Favored Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.73 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.0 m -117.36 137.82 52.21 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.862 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -114.08 148.55 36.92 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -178.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.648 HD13 ' OD2' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -124.05 113.4 18.35 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.645 -1.161 . . . . 0.0 108.27 177.389 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.424 ' N ' HD12 ' A' ' 111' ' ' LEU . 81.4 m-20 44.51 43.08 6.1 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.385 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.47 -8.82 75.82 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.829 -0.7 . . . . 0.0 113.43 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -105.17 118.38 36.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.104 0.452 . . . . 0.0 110.764 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.862 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 12.8 tptt -74.0 122.37 22.51 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.247 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.79 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.9 m -94.05 165.56 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.204 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 120' ' ' SER . 9.7 tp10 -69.87 125.95 28.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.598 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.704 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 14.6 tttt -54.13 162.83 0.91 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.955 0.407 . . . . 0.0 110.653 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.7 OUTLIER 37.15 31.27 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.109 -179.171 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.82 144.02 43.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.164 179.203 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -93.42 129.93 39.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.786 0.326 . . . . 0.0 110.287 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -129.0 149.34 50.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.974 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.585 HD13 ' O ' ' A' ' 124' ' ' LEU . 2.1 tm? -72.69 111.64 8.03 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.769 HD21 ' HB2' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -59.88 168.17 1.9 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.318 0.58 . . . . 0.0 111.798 -178.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -124.29 153.65 41.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.033 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.05 116.97 11.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.108 0.48 . . . . 0.0 110.257 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.62 18.36 73.78 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.364 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.648 ' OD2' HD13 ' A' ' 111' ' ' LEU . 5.6 t70 -59.84 -179.48 0.1 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.67 0.271 . . . . 0.0 110.62 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.868 ' CG ' HG22 ' A' ' 144' ' ' VAL . 4.1 mt-10 -145.32 135.69 24.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.682 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 1.048 HD11 HD11 ' A' ' 145' ' ' ILE . 14.9 mt -109.68 126.26 66.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.023 178.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.609 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.9 m -104.49 138.68 40.51 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.209 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.52 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.1 m -140.33 158.2 25.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.26 28.28 28.26 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.15 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.492 ' HA ' HG12 ' A' ' 140' ' ' ILE . 69.7 t -70.04 140.3 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-O 121.58 0.705 . . . . 0.0 112.326 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.69 -38.47 0.76 Allowed Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.437 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 49.8 t -126.33 132.94 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 CA-C-N 114.808 -0.696 . . . . 0.0 109.335 178.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -50.54 -39.81 50.17 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.428 ' H ' HG12 ' A' ' 136' ' ' VAL . 5.7 m -93.3 6.49 47.89 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.437 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 15.3 t0 -118.74 26.82 9.29 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -179.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.609 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.5 mt -107.14 139.61 28.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.05 178.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.509 HD23 ' N ' ' A' ' 142' ' ' SER . 8.3 tt -119.3 134.51 55.17 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.582 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.636 ' HB2' HG23 ' A' ' 40' ' ' THR . 0.9 OUTLIER -111.39 135.63 51.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.066 0.46 . . . . 0.0 111.633 -179.673 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 51.0 mt -126.71 152.71 46.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.157 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.868 HG22 ' CG ' ' A' ' 129' ' ' GLU . 21.8 t -115.61 139.78 40.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.025 0.441 . . . . 0.0 111.606 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 1.048 HD11 HD11 ' A' ' 130' ' ' ILE . 18.3 mt -106.5 120.95 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.822 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.33 103.9 12.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.424 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.651 HG12 HD22 ' A' ' 124' ' ' LEU . 7.0 mt -84.86 134.05 27.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.991 0.424 . . . . 0.0 111.58 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -88.53 112.2 22.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.86 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.46 -25.9 68.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.083 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.91 -45.22 90.87 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.053 0.454 . . . . 0.0 110.664 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.0 t80 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.004 179.99 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.889 0.376 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.47 -36.33 82.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.801 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -39.45 79.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.809 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.78 -31.81 70.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.796 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.434 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.5 mt -72.62 -35.4 50.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.855 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -57.42 -42.69 82.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.941 0.401 . . . . 0.0 110.386 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.09 -23.93 65.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.657 179.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.434 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.55 -47.52 79.27 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.298 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.809 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.41 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER . . . . . 0 CA--C 1.509 -0.622 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.675 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.4 mm -76.85 135.85 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 CA-C-N 113.708 -1.587 . . . . 0.0 112.571 -177.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.996 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.4 t -90.37 -58.99 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.683 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 30.1 p -150.7 161.27 42.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.014 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.76 138.3 54.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.805 0.336 . . . . 0.0 111.621 -179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.722 HG11 ' CE2' ' A' ' 68' ' ' PHE . 28.4 m -106.85 122.52 60.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.825 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.834 HG23 HG12 ' A' ' 45' ' ' ILE . 19.9 mt -128.62 127.01 66.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.456 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.747 ' HA ' HD13 ' A' ' 143' ' ' LEU . 21.3 t -83.0 100.45 10.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.88 0.371 . . . . 0.0 110.459 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.7 t -69.46 -28.2 65.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.713 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.774 HG23 ' HB2' ' A' ' 142' ' ' SER . 59.5 p -80.08 -2.69 45.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.722 0.296 . . . . 0.0 111.578 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.18 79.84 0.17 Allowed Glycine 0 CA--C 1.517 0.193 0 C-N-CA 120.919 -0.658 . . . . 0.0 113.139 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -147.35 -39.88 0.19 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.78 0.324 . . . . 0.0 111.019 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.601 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.4 mt -123.84 142.58 39.78 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.988 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.601 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 37.8 Cg_endo -68.84 146.08 64.68 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.028 1.819 . . . . 0.0 112.247 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.834 HG12 HG23 ' A' ' 37' ' ' ILE . 35.4 mt -57.59 148.1 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.816 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.89 164.04 31.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.056 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -124.57 119.78 30.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.928 0.394 . . . . 0.0 111.973 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.778 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.6 mp -90.8 125.98 35.88 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.996 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -135.63 156.82 48.25 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -179.092 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.488 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -148.98 141.79 24.62 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.552 -1.658 . . . . 0.0 110.817 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 121.286 0.565 . . . . 0.0 111.239 -179.553 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.876 0.369 . . . . 0.0 110.842 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.432 ' HE2' ' O ' ' A' ' 49' ' ' SER . 6.7 ttpt -151.43 129.98 12.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.099 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.56 HG13 ' C ' ' A' ' 91' ' ' ILE . 10.9 t -124.04 138.52 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 121.408 0.623 . . . . 0.0 112.021 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.778 ' CD2' HD23 ' A' ' 48' ' ' LEU . 18.1 m-90 -100.97 139.86 36.06 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.824 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.983 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.86 127.68 56.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.0 0.428 . . . . 0.0 109.862 177.936 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.722 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -114.11 145.64 41.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.281 -178.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.655 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.68 -174.07 39.0 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.674 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.3 mtp180 -79.66 0.24 31.12 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.668 0.248 . . . . 0.0 111.668 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.687 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 10.2 t-20 -84.7 133.91 43.02 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.68 0.276 . . . . 0.0 111.056 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 13.5 Cg_exo -68.5 -8.61 23.61 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.618 2.212 . . . . 0.0 111.894 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.687 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -83.04 -43.14 16.67 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-O 121.963 0.887 . . . . 0.0 108.855 178.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.8 137.01 2.42 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 113.65 -1.613 . . . . 0.0 110.918 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -56.43 -18.73 12.17 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.016 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.511 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 63.7 t80 -129.79 123.03 29.97 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.896 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.327 -0.373 0 CA-C-O 120.876 0.369 . . . . 0.0 110.977 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.52 HG22 ' H ' ' A' ' 83' ' ' ARG . 26.6 mm . . . . . 0 N--CA 1.458 -0.054 0 CA-C-O 120.861 0.362 . . . . 0.0 110.958 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.6 t -54.94 -30.85 59.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.959 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.52 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -68.72 -26.62 65.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.781 179.854 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.649 HD21 HG23 ' A' ' 132' ' ' VAL . 33.7 mt -97.73 152.22 19.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.93 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.2 166.21 11.85 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.686 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.655 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -42.72 -52.83 4.8 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.471 0.653 . . . . 0.0 109.638 179.172 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.553 ' HB3' HG22 ' A' ' 67' ' ' THR . 6.4 mttt -119.51 84.85 2.27 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 177.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.546 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.2 t60 -61.87 -45.83 92.07 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.877 -177.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.52 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 18.9 p90 -145.81 163.24 35.64 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.127 -0.629 . . . . 0.0 112.427 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.983 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.59 136.72 41.3 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.397 -178.878 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.56 ' C ' HG13 ' A' ' 65' ' ' VAL . 35.3 mt -113.38 128.49 70.18 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.342 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.353 178.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.551 HD23 ' HB2' ' A' ' 102' ' ' ASN . 0.7 OUTLIER -114.36 148.35 37.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.086 0.469 . . . . 0.0 111.859 -179.415 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.703 HD13 ' CG1' ' A' ' 33' ' ' VAL . 16.8 tp . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.368 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.696 HD23 HD22 ' A' ' 124' ' ' LEU . 24.0 tp . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.813 0.339 . . . . 0.0 110.796 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.79 HD13 ' O ' ' A' ' 122' ' ' GLN . 4.1 mm? -124.91 145.56 49.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.326 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.787 HD21 HD13 ' A' ' 124' ' ' LEU . 2.0 mt -112.62 124.5 52.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.041 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.551 ' HB2' HD23 ' A' ' 92' ' ' LEU . 50.6 t30 -116.99 115.7 25.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.892 0.377 . . . . 0.0 111.781 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.835 ' OD2' HG23 ' A' ' 116' ' ' VAL . 8.1 p30 -77.71 141.23 39.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.955 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.435 HD12 ' HB2' ' A' ' 87' ' ' LYS . 11.0 pt -148.46 38.33 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.602 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.34 152.35 19.55 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.051 0.453 . . . . 0.0 111.753 -179.093 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 47.6 m -68.92 -31.57 70.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.027 178.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -98.24 -19.75 17.66 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.602 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.18 155.65 9.86 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 120.178 -1.01 . . . . 0.0 113.747 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.505 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.8 m -117.65 137.82 52.39 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.864 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -116.01 148.46 40.12 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -178.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.41 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.01 113.52 18.53 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.356 177.575 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 43.93 43.81 5.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.36 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.55 -10.94 67.64 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.448 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.48 118.63 37.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.028 0.442 . . . . 0.0 110.638 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.864 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 12.2 tptp -73.01 122.28 21.48 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.239 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.835 HG23 ' OD2' ' A' ' 103' ' ' ASP . 14.2 m -93.18 164.61 2.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.249 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.5 tp10 -69.88 126.34 29.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.557 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.681 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 87.9 tttt -53.51 161.17 1.07 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.994 0.426 . . . . 0.0 110.727 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.8 p30 34.85 34.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.437 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.46 145.1 40.78 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.133 179.384 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -86.71 130.48 34.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.66 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.79 ' O ' HD13 ' A' ' 100' ' ' LEU . 29.9 mm-40 -129.32 146.49 51.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.756 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.1 tp -72.78 124.84 26.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.073 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.787 HD13 HD21 ' A' ' 101' ' ' LEU . 65.4 tp -57.21 157.34 6.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.427 0.632 . . . . 0.0 111.684 -179.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.524 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.4 OUTLIER -124.4 153.69 41.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.333 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.665 ' HA ' HD13 ' A' ' 147' ' ' ILE . 10.0 tp60 -70.96 119.05 14.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.004 0.431 . . . . 0.0 110.318 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.83 24.43 62.5 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.223 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.45 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 23.3 t0 -56.47 169.72 0.43 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.085 0.469 . . . . 0.0 111.107 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 17.2 tt0 -145.35 135.53 23.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.046 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.481 ' CG2' HG22 ' A' ' 109' ' ' THR . 13.4 mt -109.15 128.05 65.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.477 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.694 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.0 m -104.5 139.61 39.16 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.96 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.649 HG23 HD21 ' A' ' 84' ' ' LEU . 34.6 m -140.36 158.52 25.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.95 33.54 23.7 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.734 -0.667 . . . . 0.0 112.234 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.522 ' HA ' HG12 ' A' ' 140' ' ' ILE . 76.4 t -72.95 140.29 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-O 121.587 0.708 . . . . 0.0 112.386 -179.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.77 -42.17 0.8 Allowed Glycine 0 N--CA 1.436 -1.334 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -178.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.483 HG12 ' H ' ' A' ' 138' ' ' SER . 42.0 t -126.34 130.55 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-N 114.763 -0.719 . . . . 0.0 109.153 177.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -50.45 -34.0 23.15 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -178.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.483 ' H ' HG12 ' A' ' 136' ' ' VAL . 69.0 m -93.35 6.24 48.79 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.08 22.41 11.45 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -178.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.694 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.3 mt -107.12 139.42 28.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.293 178.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.569 HD22 ' CD2' ' A' ' 143' ' ' LEU . 1.2 tt -122.22 134.41 54.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.273 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.774 ' HB2' HG23 ' A' ' 40' ' ' THR . 0.7 OUTLIER -109.1 140.66 42.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.053 0.454 . . . . 0.0 111.954 -179.134 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.747 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.7 mm? -134.57 136.03 42.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.333 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 18.1 t -110.68 140.22 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.873 0.368 . . . . 0.0 111.395 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 8.4 mt -106.16 134.75 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.918 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.53 116.3 27.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.69 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.665 HD13 ' HA ' ' A' ' 126' ' ' GLN . 4.6 mp -85.6 134.04 28.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.657 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -85.01 114.71 22.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.765 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -61.34 -31.89 71.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.951 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -59.64 -45.74 91.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.954 0.407 . . . . 0.0 110.686 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.6 t80 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.021 -179.91 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.82 0.343 . . . . 0.0 110.963 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -66.04 -36.03 82.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.647 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -59.93 -43.22 95.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.815 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 tp -58.44 -32.98 69.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.716 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.435 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.4 mt -73.1 -35.32 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.922 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -57.07 -38.76 73.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.964 0.411 . . . . 0.0 110.487 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -67.08 -26.8 66.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.404 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.98 -47.57 80.46 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.254 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.993 179.986 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.449 ' O ' ' HB3' ' A' ' 49' ' ' SER . 2.3 m-80 . . . . . 0 CA--C 1.506 -0.748 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.565 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.3 mm -71.55 142.15 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.575 0 CA-C-N 113.744 -1.571 . . . . 0.0 112.634 -176.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.767 HG22 HD13 ' A' ' 93' ' ' LEU . 1.0 OUTLIER -106.54 -50.23 8.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.663 -178.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.452 ' N ' HG12 ' A' ' 33' ' ' VAL . 0.5 OUTLIER -154.86 165.5 36.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.351 179.29 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.57 120.83 24.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.757 0.313 . . . . 0.0 111.012 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.824 HG21 ' CZ ' ' A' ' 68' ' ' PHE . 25.0 t -94.7 122.67 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.854 0.359 . . . . 0.0 111.126 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.878 HG23 HG12 ' A' ' 45' ' ' ILE . 13.4 mt -124.49 122.49 64.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.252 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.665 ' HA ' HD13 ' A' ' 143' ' ' LEU . 46.9 t -79.87 127.33 32.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.445 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.9 t -94.31 -29.12 15.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.814 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.552 HG21 ' H ' ' A' ' 142' ' ' SER . 43.2 p -79.87 -2.34 43.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.576 0.226 . . . . 0.0 111.462 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.22 80.86 0.21 Allowed Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.819 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.403 ' OE1' HD11 ' A' ' 141' ' ' LEU . 12.8 mt-30 -147.01 -43.78 0.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.804 0.335 . . . . 0.0 110.888 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.617 HG23 ' HD2' ' A' ' 44' ' ' PRO . 3.8 mp -120.42 142.08 33.23 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.209 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.617 ' HD2' HG23 ' A' ' 43' ' ' ILE . 56.5 Cg_endo -72.55 145.98 43.16 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.221 1.947 . . . . 0.0 112.007 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.878 HG12 HG23 ' A' ' 37' ' ' ILE . 38.2 mt -53.48 134.74 15.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.772 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.17 163.85 24.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.091 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -120.25 119.7 33.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.126 0.489 . . . . 0.0 112.002 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.58 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 5.0 mp -87.22 132.07 34.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.599 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -138.97 156.59 47.12 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 122.426 1.108 . . . . 0.0 113.572 -179.297 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.599 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . -142.99 144.66 32.4 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.831 178.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 121.066 0.46 . . . . 0.0 111.296 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.735 0.302 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.4 ' HE2' ' O ' ' A' ' 49' ' ' SER . 7.2 ttpt -143.39 130.41 20.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.34 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 91' ' ' ILE . 13.0 t -126.32 139.34 51.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.292 0.567 . . . . 0.0 111.895 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.599 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 16.8 m-90 -100.76 139.85 35.87 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.165 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.778 HG23 ' CG ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -108.3 126.26 52.63 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.573 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.824 ' CZ ' HG21 ' A' ' 36' ' ' VAL . 3.0 m-85 -114.47 145.75 41.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.8 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.617 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.39 -174.35 36.28 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.188 -1.006 . . . . 0.0 113.362 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 6.7 mtm105 -75.61 0.49 17.31 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.732 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 9.5 t-20 -84.66 133.35 44.2 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.667 0.27 . . . . 0.0 111.414 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.8 Cg_exo -68.6 -10.46 29.11 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.655 2.236 . . . . 0.0 111.754 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.732 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -83.21 -43.45 16.11 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-O 121.915 0.864 . . . . 0.0 108.781 178.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -41.37 137.75 1.4 Allowed 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.959 179.631 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.32 -18.3 10.33 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.241 179.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.558 ' CG ' ' CE2' ' A' ' 68' ' ' PHE . 19.8 t80 -127.21 116.25 20.32 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.811 0.338 . . . . 0.0 110.64 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.438 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 2.0 t-160 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.159 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.592 HD12 ' CD1' ' A' ' 84' ' ' LEU . 24.8 mt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.877 0.37 . . . . 0.0 111.446 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 40.1 t -62.53 -38.75 91.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.768 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.488 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -62.49 -33.25 74.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.949 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.592 ' CD1' HD12 ' A' ' 81' ' ' ILE . 30.0 mt -91.21 152.24 20.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.015 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 92.3 p -97.14 165.53 12.01 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.53 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.617 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -42.81 -53.99 4.34 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.314 0.578 . . . . 0.0 109.745 179.326 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.545 ' HB2' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -118.22 83.81 2.07 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 177.144 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.558 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.0 t60 -61.19 -45.41 94.7 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.802 -1.09 . . . . 0.0 113.162 -176.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.531 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 29.5 p90 -145.98 163.23 35.83 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 119.966 -0.694 . . . . 0.0 112.552 -179.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.778 ' CG ' HG23 ' A' ' 67' ' ' THR . 8.2 mt-30 -135.35 145.09 47.05 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.382 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.548 ' O ' HG13 ' A' ' 65' ' ' VAL . 3.2 mp -118.62 132.36 68.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 178.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.491 ' CB ' HG22 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -118.01 148.93 41.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.227 0.537 . . . . 0.0 111.988 -179.018 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.767 HD13 HG22 ' A' ' 33' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.037 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.667 ' CD1' HD12 ' A' ' 93' ' ' LEU . 4.0 mm? . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.717 0.294 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.616 HD12 ' O ' ' A' ' 99' ' ' LEU . 2.3 mp -132.69 142.89 49.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.999 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.76 129.47 56.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.341 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.431 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 50.1 t30 -117.8 115.7 25.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.862 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.787 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.0 p30 -78.65 141.41 38.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.999 178.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.463 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 14.9 pt -148.33 38.58 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -178.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.635 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.09 152.99 19.24 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.14 0.495 . . . . 0.0 111.676 -179.162 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 51.1 m -68.87 -31.84 71.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.961 178.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -98.46 -19.92 17.4 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.635 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.59 157.22 10.23 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.267 -0.968 . . . . 0.0 113.797 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.518 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.7 m -117.53 138.05 52.16 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.881 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -115.04 148.49 38.81 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -178.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.504 HD12 HD22 ' A' ' 112' ' ' ASN . 0.2 OUTLIER -124.13 113.43 18.33 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.337 177.406 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.504 HD22 HD12 ' A' ' 111' ' ' LEU . 2.4 m-80 44.38 43.22 5.97 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.81 -9.96 72.09 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.408 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -105.27 118.57 36.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.007 0.432 . . . . 0.0 110.746 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.881 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 19.1 tptt -73.63 130.25 39.65 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.184 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.787 HG23 ' OD2' ' A' ' 103' ' ' ASP . 8.0 m -103.09 165.95 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.363 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.415 ' HB3' ' HB3' ' A' ' 120' ' ' SER . 5.3 tp10 -69.95 127.0 31.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.564 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.678 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 30.3 tttp -52.62 161.96 0.64 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.739 0.305 . . . . 0.0 110.455 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.9 p30 35.08 35.68 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.132 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.415 ' HB3' ' HB3' ' A' ' 117' ' ' GLU . 4.2 p -112.01 145.15 40.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.644 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -93.33 129.53 39.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.757 0.313 . . . . 0.0 110.925 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.44 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 59.7 mm-40 -129.21 151.85 49.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.536 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.9 tp -72.6 112.23 8.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.85 0.357 . . . . 0.0 110.288 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.883 HD11 HG21 ' A' ' 145' ' ' ILE . 66.3 tp -53.05 158.91 1.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.266 0.555 . . . . 0.0 111.575 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.412 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.6 OUTLIER -124.11 153.29 41.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.555 -179.779 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.32 122.55 20.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.87 0.367 . . . . 0.0 110.327 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.38 21.23 56.79 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.186 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.406 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 11.1 t70 -56.56 175.8 0.11 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.815 0.34 . . . . 0.0 110.9 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.877 ' CG ' HG22 ' A' ' 144' ' ' VAL . 4.6 mt-10 -145.27 135.75 24.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.242 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.952 HD11 HD11 ' A' ' 145' ' ' ILE . 12.3 mt -112.23 128.26 68.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.523 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.65 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.1 m -104.23 140.16 38.24 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.056 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.478 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 33.3 m -140.22 158.4 25.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.095 0.474 . . . . 0.0 112.233 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.95 44.56 8.98 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.86 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.466 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.3 t -84.33 140.5 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-O 121.684 0.754 . . . . 0.0 112.631 -178.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.64 -41.14 0.59 Allowed Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 138' ' ' SER . 48.2 t -126.45 125.43 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-N 114.674 -0.763 . . . . 0.0 109.07 177.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.46 -30.25 12.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.805 0.336 . . . . 0.0 111.279 -178.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.567 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -93.62 6.48 48.12 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.341 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -126.94 27.74 5.92 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.65 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.6 mt -107.18 139.44 28.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.283 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.605 HD23 ' N ' ' A' ' 142' ' ' SER . 2.7 tt -120.72 134.53 55.28 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.383 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.605 ' N ' HD23 ' A' ' 141' ' ' LEU . 44.0 t -113.58 150.68 32.69 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.694 0.759 . . . . 0.0 112.57 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.665 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.7 mm? -135.78 151.37 50.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.454 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.877 HG22 ' CG ' ' A' ' 129' ' ' GLU . 16.5 t -116.35 135.62 55.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.902 0.382 . . . . 0.0 111.265 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.952 HD11 HD11 ' A' ' 130' ' ' ILE . 40.9 mt -106.45 121.99 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.988 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.52 116.93 31.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.707 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.474 HG12 HD21 ' A' ' 124' ' ' LEU . 5.0 mt -84.82 134.2 27.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.581 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -82.05 115.44 21.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.776 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.89 -28.81 68.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.14 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -59.63 -45.77 90.97 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.989 0.423 . . . . 0.0 110.749 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.8 t80 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.892 -179.863 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.783 0.325 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -60.67 -42.62 97.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.889 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -60.18 -39.11 85.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.909 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 mt -60.27 -44.79 95.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.875 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.3 mm -63.3 -40.15 87.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.168 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -57.91 -33.82 69.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.12 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -65.38 -33.79 76.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.257 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -56.9 -47.46 80.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.062 0.458 . . . . 0.0 111.058 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.5 p . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.787 179.97 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.433 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER . . . . . 0 CA--C 1.509 -0.632 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.663 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 2.7 mm -75.36 134.87 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 CA-C-N 113.897 -1.501 . . . . 0.0 112.363 -177.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.963 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -93.73 -61.19 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.232 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -143.97 154.07 42.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.724 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.17 138.1 51.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.832 0.349 . . . . 0.0 111.135 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.715 HG21 ' CE2' ' A' ' 68' ' ' PHE . 18.8 t -105.29 122.67 58.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.054 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.687 HG23 HG12 ' A' ' 45' ' ' ILE . 19.3 mt -128.84 118.23 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.5 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.655 ' HA ' HD13 ' A' ' 143' ' ' LEU . 38.2 t -80.34 123.37 27.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.313 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.401 HG23 HG21 ' A' ' 144' ' ' VAL . 0.2 OUTLIER -91.59 -25.55 19.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.677 -179.36 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.534 HG21 ' H ' ' A' ' 142' ' ' SER . 43.1 p -79.81 -2.29 42.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.64 0.257 . . . . 0.0 111.541 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.12 75.19 0.41 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.851 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -146.21 -44.24 0.2 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.866 0.365 . . . . 0.0 110.963 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.537 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -114.95 140.88 26.1 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.784 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.537 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.2 Cg_endo -73.28 145.93 39.47 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.183 1.922 . . . . 0.0 112.33 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.687 HG12 HG23 ' A' ' 37' ' ' ILE . 35.2 mt -57.68 141.46 14.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.547 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -137.18 164.02 29.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.313 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.88 119.83 32.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.977 0.418 . . . . 0.0 111.614 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.55 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 6.0 mt -91.35 137.17 32.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.298 178.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.963 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -144.17 157.42 44.31 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 -179.123 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.502 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -151.04 148.49 28.4 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.874 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 121.192 0.52 . . . . 0.0 110.976 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.682 0.277 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.455 ' HE2' ' O ' ' A' ' 49' ' ' SER . 3.7 ttpt -140.85 132.86 27.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.384 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.507 HG13 ' C ' ' A' ' 91' ' ' ILE . 9.6 t -129.34 139.28 52.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.245 0.545 . . . . 0.0 111.808 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.55 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.0 m-90 -100.83 139.73 36.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.7 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.952 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.83 126.85 55.29 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.893 ' CE1' HD12 ' A' ' 91' ' ' ILE . 1.6 m-85 -110.55 145.71 37.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.422 -178.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.697 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.34 -177.74 39.9 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.955 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -77.33 -2.51 35.32 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -84.85 134.78 40.99 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.656 0.265 . . . . 0.0 111.197 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -68.71 -6.81 18.8 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.76 2.307 . . . . 0.0 111.838 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.83 -43.73 16.3 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-O 121.958 0.885 . . . . 0.0 108.77 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.94 137.67 3.13 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 113.629 -1.623 . . . . 0.0 110.648 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -56.41 -19.21 13.84 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.984 179.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.574 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 29.9 t80 -129.98 116.57 18.78 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.016 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 120.838 0.351 . . . . 0.0 110.359 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.629 ' HB ' HD13 ' A' ' 84' ' ' LEU . 3.7 mp . . . . . 0 N--CA 1.458 -0.058 0 CA-C-O 120.82 0.343 . . . . 0.0 110.838 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 27.3 t -55.06 -31.39 61.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.323 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.507 ' H ' HG22 ' A' ' 81' ' ' ILE . 2.1 mmp_? -60.9 -33.91 73.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.9 0.381 . . . . 0.0 111.131 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.753 HD21 ' CG2' ' A' ' 132' ' ' VAL . 5.8 mp -95.31 153.24 17.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.062 0.458 . . . . 0.0 110.919 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.2 p -94.13 166.3 12.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.739 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.697 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -42.72 -52.33 4.98 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.449 0.642 . . . . 0.0 109.591 179.145 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.585 ' HB3' HG22 ' A' ' 67' ' ' THR . 4.8 mttp -120.5 84.69 2.26 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 177.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.56 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.0 t60 -61.14 -46.06 92.09 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.823 -176.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.543 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 12.3 p90 -145.18 162.37 37.26 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.059 -0.656 . . . . 0.0 112.351 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.952 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.67 136.22 40.74 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.584 -178.709 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.893 HD12 ' CE1' ' A' ' 68' ' ' PHE . 8.0 mt -113.88 129.47 69.72 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.16 178.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.668 HD11 HD13 ' A' ' 100' ' ' LEU . 0.6 OUTLIER -112.64 148.84 33.77 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.024 0.44 . . . . 0.0 111.905 -179.249 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.516 ' HG ' HG11 ' A' ' 33' ' ' VAL . 2.3 tm? . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.524 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.843 HD21 HG12 ' A' ' 33' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.233 0.198 0 CA-C-O 120.746 0.308 . . . . 0.0 110.973 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.842 HD22 ' HB3' ' A' ' 121' ' ' ASN . 6.0 mt -130.12 142.17 50.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.484 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.743 HD11 HD11 ' A' ' 130' ' ' ILE . 2.1 tp -112.56 120.92 43.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.153 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.465 ' HB2' HD23 ' A' ' 92' ' ' LEU . 55.1 t30 -115.25 115.7 27.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.007 0.432 . . . . 0.0 111.645 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.789 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.3 p30 -77.36 139.29 39.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.081 178.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.425 HD11 HG22 ' A' ' 67' ' ' THR . 10.5 pt -146.82 38.79 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 -179.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.658 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.7 151.73 20.42 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.085 0.469 . . . . 0.0 111.908 -178.711 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 48.1 m -68.79 -31.62 70.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.85 177.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -98.2 -19.78 17.66 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.658 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.97 156.69 10.38 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 120.203 -0.999 . . . . 0.0 113.715 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.0 m -117.62 137.88 52.33 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.819 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -116.3 148.36 40.61 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -178.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.811 HD12 HG11 ' A' ' 116' ' ' VAL . 0.7 OUTLIER -124.33 113.72 18.59 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.636 -1.166 . . . . 0.0 108.804 177.494 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 46.61 36.37 3.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.045 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.05 -3.31 80.45 Favored Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 120.854 -0.689 . . . . 0.0 113.557 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -106.56 118.57 37.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.097 0.475 . . . . 0.0 110.767 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.819 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.5 tptp -73.47 119.72 18.08 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.111 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.811 HG11 HD12 ' A' ' 111' ' ' LEU . 10.7 m -95.72 165.59 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.454 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.7 tt0 -69.92 126.37 29.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.637 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.689 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 67.9 tttt -52.9 162.5 0.61 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.811 0.338 . . . . 0.0 110.335 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.0 p30 35.41 34.66 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.241 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.5 OUTLIER -112.32 137.58 50.26 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.057 179.435 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.842 ' HB3' HD22 ' A' ' 100' ' ' LEU . 5.3 m120 -82.72 129.16 34.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.954 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.698 ' O ' HD23 ' A' ' 100' ' ' LEU . 45.4 mm-40 -129.51 148.13 51.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.92 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.5 tp -72.87 119.01 16.52 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.009 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 124' ' ' LEU . 1.2 mm? -58.05 164.86 2.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.816 0.817 . . . . 0.0 111.957 -179.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.424 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -125.57 153.16 44.1 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.318 179.253 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.52 118.05 13.85 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 62.75 25.71 67.82 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.789 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.58 ' OD2' HD23 ' A' ' 111' ' ' LEU . 9.2 t70 -57.92 175.36 0.2 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.027 0.441 . . . . 0.0 111.154 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 1.0 OUTLIER -145.11 135.54 24.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.887 179.837 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.743 HD11 HD11 ' A' ' 101' ' ' LEU . 5.7 mt -114.38 128.48 71.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.505 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.632 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.1 m -103.95 139.26 39.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.993 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.753 ' CG2' HD21 ' A' ' 84' ' ' LEU . 34.3 m -140.27 158.38 25.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 82.95 35.85 17.28 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.993 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.478 ' HA ' HG12 ' A' ' 140' ' ' ILE . 56.8 t -76.41 140.49 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-O 121.733 0.778 . . . . 0.0 112.477 -178.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.69 -41.38 0.62 Allowed Glycine 0 N--CA 1.437 -1.262 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.074 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.486 HG12 ' H ' ' A' ' 138' ' ' SER . 46.5 t -126.33 132.19 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 114.787 -0.707 . . . . 0.0 109.204 178.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -50.53 -36.38 33.98 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.486 ' H ' HG12 ' A' ' 136' ' ' VAL . 70.0 m -93.61 6.31 48.7 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.418 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 1.1 m-20 -120.2 25.66 9.73 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.632 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.2 mt -106.92 139.41 28.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.224 178.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.413 HD23 ' N ' ' A' ' 142' ' ' SER . 1.3 tt -123.46 134.51 53.92 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.26 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.534 ' H ' HG21 ' A' ' 40' ' ' THR . 47.0 t -112.51 150.42 31.3 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.645 0.736 . . . . 0.0 112.585 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.655 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.4 mm? -135.67 148.46 48.93 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.432 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 23.8 t -117.19 131.14 70.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 0.0 111.174 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.1 mm -106.33 122.07 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.679 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.15 120.03 39.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.092 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.529 HG23 ' CD1' ' A' ' 99' ' ' LEU . 7.3 mt -84.79 129.27 37.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.837 0.351 . . . . 0.0 111.236 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -75.88 116.19 16.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.973 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -62.86 -30.0 71.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.009 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -57.88 -43.49 86.05 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.076 0.465 . . . . 0.0 110.571 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 30.2 t80 . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.764 179.791 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.855 0.359 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -36.32 79.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.771 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.38 -40.99 88.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.788 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.73 -32.18 72.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.763 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.435 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.0 mt -73.13 -35.41 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -57.46 -41.9 81.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.437 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -67.22 -24.06 65.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.623 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.82 -47.59 79.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.156 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.5 m . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.936 179.89 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.444 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.7 OUTLIER . . . . . 0 CA--C 1.509 -0.627 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.719 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 6.1 mm -75.87 132.14 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 113.702 -1.59 . . . . 0.0 112.587 -177.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.039 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.0 t -91.0 -60.93 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.073 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.609 ' SG ' HD12 ' A' ' 48' ' ' LEU . 3.0 p -148.67 152.15 36.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.267 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.09 138.15 50.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.918 0.389 . . . . 0.0 111.191 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.799 HG21 ' CZ ' ' A' ' 68' ' ' PHE . 23.1 t -104.73 122.69 58.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.777 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.801 HG23 HG12 ' A' ' 45' ' ' ILE . 20.0 mt -125.12 120.55 58.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.468 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.724 ' HA ' HD13 ' A' ' 143' ' ' LEU . 34.2 t -80.49 112.29 17.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.489 179.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.747 HG21 ' OE2' ' A' ' 129' ' ' GLU . 5.4 t -82.08 -25.87 34.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.652 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.509 HG21 ' H ' ' A' ' 142' ' ' SER . 34.1 p -79.88 -2.18 42.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.582 0.23 . . . . 0.0 111.501 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.74 78.08 0.27 Allowed Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.794 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -146.43 -44.03 0.19 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.945 0.403 . . . . 0.0 110.991 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.57 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.7 mp -120.03 141.47 31.57 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.046 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.57 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.0 Cg_endo -72.09 146.03 45.7 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.246 1.964 . . . . 0.0 112.21 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.801 HG12 HG23 ' A' ' 37' ' ' ILE . 36.3 mt -55.81 128.78 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.809 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.419 ' HG3' ' CE2' ' A' ' 76' ' ' TYR . 19.2 mtt180 -122.85 164.09 19.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.06 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -120.81 119.92 34.09 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.609 HD12 ' SG ' ' A' ' 34' ' ' CYS . 2.5 mt -93.3 137.29 32.76 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 1.039 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -147.93 158.04 43.84 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -178.56 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.479 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -140.32 141.79 35.68 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 113.28 -1.782 . . . . 0.0 110.237 178.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 121.197 0.522 . . . . 0.0 111.512 -179.291 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.804 0.335 . . . . 0.0 110.994 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.418 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.0 ttpt -150.11 136.31 18.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.026 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.693 HG12 ' HG2' ' A' ' 90' ' ' GLN . 11.7 t -128.48 139.2 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 121.261 0.553 . . . . 0.0 112.197 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.519 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.2 m-90 -103.24 139.36 38.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.984 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.674 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.88 125.39 53.6 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 177.436 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.799 ' CZ ' HG21 ' A' ' 36' ' ' VAL . 2.6 m-85 -107.9 145.82 33.22 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.606 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.679 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.78 -178.15 40.05 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.916 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.448 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 6.1 mtp-105 -77.47 -3.39 40.19 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.41 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.9 t30 -84.88 135.72 39.66 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.767 0.318 . . . . 0.0 111.133 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.0 Cg_exo -69.07 -6.5 18.41 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.794 2.329 . . . . 0.0 111.884 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.86 -44.06 15.87 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 121.945 0.879 . . . . 0.0 108.651 179.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.86 138.61 2.67 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.734 -1.575 . . . . 0.0 110.41 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -56.27 -18.85 11.76 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.95 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.563 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 45.0 t80 -129.73 119.72 23.93 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.736 0.303 . . . . 0.0 110.818 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.4 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.2 t-160 . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.763 0.316 . . . . 0.0 110.611 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.515 HG22 ' H ' ' A' ' 83' ' ' ARG . 3.6 mt . . . . . 0 CA--C 1.527 0.073 0 CA-C-O 120.839 0.352 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.9 t -54.73 -32.89 60.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.854 0.359 . . . . 0.0 111.246 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.515 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -61.31 -24.06 66.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.952 179.929 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.3 mt -105.53 152.08 23.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.968 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 92.9 p -94.7 166.19 12.13 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.704 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.679 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -43.16 -53.73 4.84 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.333 0.587 . . . . 0.0 109.831 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.536 ' HB2' HD12 ' A' ' 104' ' ' ILE . 5.5 mtpt -118.9 82.86 1.93 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.567 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.8 t60 -60.13 -46.35 89.93 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.12 -0.946 . . . . 0.0 112.703 -176.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.524 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 20.1 p90 -147.13 159.46 43.59 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.721 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.693 ' HG2' HG12 ' A' ' 65' ' ' VAL . 5.0 tt0 -135.87 141.48 44.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.438 -179.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.557 ' C ' HG13 ' A' ' 65' ' ' VAL . 2.7 mp -115.95 126.36 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.834 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.781 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -104.37 151.97 22.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.064 0.459 . . . . 0.0 111.897 -179.552 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.311 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.539 HD21 ' CG1' ' A' ' 33' ' ' VAL . 3.0 mm? . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.806 0.336 . . . . 0.0 110.829 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.849 HD22 ' HB3' ' A' ' 121' ' ' ASN . 8.5 mt -133.1 142.1 48.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.82 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.482 HD21 HD13 ' A' ' 124' ' ' LEU . 1.3 mt -112.87 121.54 44.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.976 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.781 ' HB2' HD11 ' A' ' 92' ' ' LEU . 50.7 t30 -116.84 115.65 25.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.833 0.349 . . . . 0.0 111.853 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.804 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.2 p30 -77.86 139.99 39.32 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.536 HD12 ' HB2' ' A' ' 87' ' ' LYS . 10.3 pt -148.43 39.18 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 111.543 0.201 . . . . 0.0 111.543 -178.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.66 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.02 151.67 20.08 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 120.96 0.409 . . . . 0.0 111.946 -178.879 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 50.3 m -68.69 -31.71 71.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.807 177.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -98.21 -19.69 17.71 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.66 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.81 155.48 10.09 Favored Glycine 0 N--CA 1.438 -1.187 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.596 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.3 m -117.41 137.81 52.24 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.861 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -115.0 148.51 38.73 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 -178.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.465 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.05 113.44 18.39 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.293 177.476 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.415 ' N ' HD12 ' A' ' 111' ' ' LEU . 73.8 m-20 44.61 43.04 6.23 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.83 -9.97 72.07 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.433 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.7 mp0 -105.06 118.57 36.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.086 0.469 . . . . 0.0 110.727 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.861 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 10.1 tptm -73.07 118.24 15.78 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.259 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.804 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.3 m -89.69 165.52 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.209 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.408 ' HB3' ' HB3' ' A' ' 120' ' ' SER . 6.2 tt0 -69.9 126.87 30.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.481 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.693 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 29.2 tttt -53.85 163.53 0.71 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.782 0.325 . . . . 0.0 110.438 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.0 m-80 33.72 36.93 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.825 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.408 ' HB3' ' HB3' ' A' ' 117' ' ' GLU . 4.7 p -111.84 144.6 40.88 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.864 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.849 ' HB3' HD22 ' A' ' 100' ' ' LEU . 5.2 m120 -91.5 128.17 37.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.687 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.647 ' O ' HD23 ' A' ' 100' ' ' LEU . 56.4 mm-40 -129.17 148.75 51.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.749 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.584 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.7 tm? -72.8 128.43 35.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.287 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.745 HD11 HG21 ' A' ' 145' ' ' ILE . 67.4 tp -57.9 155.74 10.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.437 0.637 . . . . 0.0 111.654 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.421 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -124.7 153.1 42.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.637 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.414 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.1 OUTLIER -71.86 123.32 22.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.917 0.389 . . . . 0.0 110.25 179.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.24 22.52 50.48 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.071 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.421 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 32.0 t70 -52.36 169.9 0.07 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.981 0.42 . . . . 0.0 111.239 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.92 ' CG ' HG22 ' A' ' 144' ' ' VAL . 2.0 mt-10 -145.12 135.45 24.11 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.946 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.649 HD11 HD11 ' A' ' 145' ' ' ILE . 15.7 mt -116.25 127.24 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-O 120.808 0.337 . . . . 0.0 110.458 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.654 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.7 m -104.43 141.18 36.8 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.164 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.507 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.8 m -140.26 158.49 25.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.05 44.2 9.18 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.821 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.462 ' HA ' HG12 ' A' ' 140' ' ' ILE . 54.0 t -85.23 140.53 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-O 121.677 0.751 . . . . 0.0 112.616 -178.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.11 -41.45 0.68 Allowed Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.607 HG12 ' H ' ' A' ' 138' ' ' SER . 48.9 t -126.48 121.97 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-N 114.567 -0.816 . . . . 0.0 108.998 177.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.48 ' HA ' HD12 ' A' ' 140' ' ' ILE . 13.5 mt-10 -50.33 -25.96 4.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.749 0.309 . . . . 0.0 111.506 -178.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.607 ' H ' HG12 ' A' ' 136' ' ' VAL . 73.8 m -93.55 6.56 47.84 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -131.42 29.19 4.6 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.654 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.9 mt -106.98 139.23 29.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.077 178.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.678 HD23 ' N ' ' A' ' 142' ' ' SER . 3.0 tt -124.23 134.55 53.23 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.531 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.678 ' N ' HD23 ' A' ' 141' ' ' LEU . 47.5 t -113.52 150.6 32.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.626 0.727 . . . . 0.0 112.42 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.724 HD13 ' HA ' ' A' ' 38' ' ' CYS . 1.8 mm? -135.7 141.84 44.98 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.349 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.92 HG22 ' CG ' ' A' ' 129' ' ' GLU . 13.2 t -110.87 137.74 42.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.813 0.34 . . . . 0.0 111.282 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.745 HG21 HD11 ' A' ' 124' ' ' LEU . 29.9 mt -106.29 128.09 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.142 -179.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.74 119.83 37.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.554 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.662 HG12 HD21 ' A' ' 124' ' ' LEU . 4.3 mt -84.87 134.04 27.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.527 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -90.44 105.58 17.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.798 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.4 -26.59 63.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.235 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.77 -42.21 83.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.014 0.435 . . . . 0.0 110.639 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 12.1 t80 . . . . . 0 N--CA 1.451 -0.384 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.948 179.944 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.791 0.329 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.402 ' HB2' ' NH1' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -61.32 -43.17 99.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.764 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -57.39 -38.49 74.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.822 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.02 -31.84 69.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.742 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.461 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.1 mt -72.69 -35.56 50.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.768 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -57.44 -39.82 77.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.932 0.396 . . . . 0.0 110.416 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.6 mtpt -67.06 -23.84 65.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.797 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.64 -47.36 79.9 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.213 -179.907 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.901 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 . . . . . 0 CA--C 1.513 -0.476 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.655 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 1.1 mm -89.63 96.54 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 CA-C-N 113.964 -1.471 . . . . 0.0 111.578 -177.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.775 HG11 HD22 ' A' ' 93' ' ' LEU . 2.3 t -55.38 -65.65 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.278 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.493 ' SG ' HD12 ' A' ' 48' ' ' LEU . 13.8 p -146.39 165.05 30.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.016 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.88 128.17 41.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.093 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.651 HG13 HD11 ' A' ' 48' ' ' LEU . 15.4 m -93.46 122.75 45.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.9 0.381 . . . . 0.0 111.11 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.786 HG23 HG12 ' A' ' 45' ' ' ILE . 21.1 mt -125.6 117.43 49.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.39 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 6.9 t -79.83 118.25 21.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.822 0.344 . . . . 0.0 110.387 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.681 HG23 HG21 ' A' ' 144' ' ' VAL . 0.7 OUTLIER -82.07 -26.45 33.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.857 -179.22 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.538 HG21 ' H ' ' A' ' 142' ' ' SER . 33.5 p -79.93 -2.2 42.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.59 0.233 . . . . 0.0 111.357 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.49 47.42 90.77 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.855 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.477 ' CB ' HD11 ' A' ' 141' ' ' LEU . 3.5 mm-40 -113.81 -29.87 6.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.785 0.326 . . . . 0.0 110.884 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.598 HD12 HD21 ' A' ' 143' ' ' LEU . 2.8 mt -128.16 141.26 40.73 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.71 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.576 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 42.9 Cg_endo -70.46 134.35 26.31 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.125 1.884 . . . . 0.0 112.23 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.786 HG12 HG23 ' A' ' 37' ' ' ILE . 32.6 mt -55.17 130.02 17.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.608 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.8 163.42 17.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.305 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.24 119.74 36.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.989 0.423 . . . . 0.0 111.451 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.751 HD22 ' CD1' ' A' ' 66' ' ' TRP . 7.1 mt -98.45 136.15 39.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.404 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.765 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -148.71 157.76 43.67 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -179.162 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.537 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -144.1 142.0 30.35 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 113.643 -1.617 . . . . 0.0 110.864 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.202 0 CA-C-O 121.129 0.49 . . . . 0.0 111.039 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.903 0.382 . . . . 0.0 110.806 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 49' ' ' SER . 4.1 ttpt -139.85 131.5 27.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.774 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.641 HG12 ' HG2' ' A' ' 90' ' ' GLN . 15.4 t -125.49 139.03 52.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.309 0.576 . . . . 0.0 112.181 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.751 ' CD1' HD22 ' A' ' 48' ' ' LEU . 15.0 m-90 -101.92 139.32 37.72 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.14 -0.937 . . . . 0.0 112.09 179.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.699 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.49 126.52 55.04 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.08 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.545 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.9 OUTLIER -116.91 145.27 43.71 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.376 -178.447 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.574 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 165.18 -176.84 40.8 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.231 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.2 ttp85 -72.69 -3.03 22.57 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.496 HD22 ' HB3' ' A' ' 73' ' ' ALA . 2.3 t30 -84.8 135.04 40.64 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.738 0.304 . . . . 0.0 111.598 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 14.5 Cg_exo -67.57 -11.82 33.46 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.928 2.419 . . . . 0.0 112.036 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.496 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.38 -44.28 16.32 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-O 121.919 0.866 . . . . 0.0 109.029 179.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.41 ' SG ' ' HA ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -41.62 142.36 0.64 Allowed 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 113.746 -1.57 . . . . 0.0 110.854 179.652 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.0 t0 -56.07 -18.57 10.04 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.204 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.478 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 8.1 t80 -129.14 131.12 47.15 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-O 120.771 0.319 . . . . 0.0 110.746 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.423 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.031 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.839 ' HB ' HD13 ' A' ' 84' ' ' LEU . 3.3 mp . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.786 0.327 . . . . 0.0 111.068 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.8 -25.89 43.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.216 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.534 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -60.91 -20.4 62.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.096 -179.867 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.839 HD13 ' HB ' ' A' ' 81' ' ' ILE . 3.8 mp -104.9 153.01 21.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.817 0.341 . . . . 0.0 110.857 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.3 p -93.67 168.66 10.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.689 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.574 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 6.4 m-20 -41.41 -59.21 1.64 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.367 0.603 . . . . 0.0 109.657 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.609 ' HB2' HD12 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -116.04 84.11 2.06 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 176.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.557 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.9 t60 -58.92 -46.51 87.74 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.495 -176.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.515 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 27.1 p90 -144.91 159.8 42.33 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.9 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.699 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.4 tt0 -136.16 140.65 43.78 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.357 -179.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.697 HG12 HD12 ' A' ' 101' ' ' LEU . 65.9 mt -116.5 127.16 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 C-N-CA 121.164 -0.214 . . . . 0.0 110.809 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.485 HD23 ' HB2' ' A' ' 102' ' ' ASN . 0.6 OUTLIER -113.12 144.94 41.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.02 0.438 . . . . 0.0 111.691 -179.727 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.775 HD22 HG11 ' A' ' 33' ' ' VAL . 24.9 tp . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.555 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.628 ' O ' HD12 ' A' ' 100' ' ' LEU . 14.9 tp . . . . . 0 N--CA 1.46 0.057 0 CA-C-O 120.891 0.377 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.628 HD12 ' O ' ' A' ' 99' ' ' LEU . 6.1 mp -125.55 144.81 50.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.441 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.697 HD12 HG12 ' A' ' 91' ' ' ILE . 2.3 tp -112.54 122.63 48.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.11 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.485 ' HB2' HD23 ' A' ' 92' ' ' LEU . 52.8 t30 -116.88 115.68 25.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.934 0.397 . . . . 0.0 111.921 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.84 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.0 p30 -76.63 138.7 40.25 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.609 HD12 ' HB2' ' A' ' 87' ' ' LYS . 9.5 pt -146.67 39.22 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 111.497 0.184 . . . . 0.0 111.497 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.675 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -97.99 150.94 20.83 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 121.171 0.51 . . . . 0.0 112.039 -178.681 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 42.9 m -68.79 -31.45 70.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.611 177.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -98.05 -19.78 17.77 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.675 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.22 155.23 10.15 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.251 -0.975 . . . . 0.0 113.559 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.498 HG22 ' CG2' ' A' ' 130' ' ' ILE . 5.8 m -117.35 137.69 52.28 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.862 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -115.75 148.55 39.69 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -177.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.02 113.58 18.6 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.385 177.619 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 43.87 43.85 5.45 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.79 -11.42 66.67 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.398 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -104.36 118.61 37.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.034 0.445 . . . . 0.0 110.62 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.862 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 9.1 tptp -72.28 115.89 12.06 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.293 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.84 HG23 ' OD2' ' A' ' 103' ' ' ASP . 16.5 m -84.45 164.24 2.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.13 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.2 tm-20 -69.83 125.03 25.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.496 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.687 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 55.6 tttt -53.02 162.0 0.71 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.914 0.388 . . . . 0.0 110.646 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.7 p30 34.78 34.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.423 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.29 145.09 40.61 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.089 179.457 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.484 HD22 HD21 ' A' ' 92' ' ' LEU . 5.8 m120 -88.3 129.86 35.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.795 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 41.4 mm-40 -129.6 147.84 51.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.035 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.9 128.98 37.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.983 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.58 HD23 ' HB3' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -58.07 159.6 5.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.415 0.626 . . . . 0.0 111.897 -178.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.428 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -125.0 153.26 43.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.156 179.59 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.23 116.74 11.91 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 62.81 25.58 67.79 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.545 -178.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.428 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 33.6 t0 -50.69 168.77 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.104 0.478 . . . . 0.0 111.457 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 15.5 tt0 -145.21 135.49 24.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.872 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.631 HD11 HD11 ' A' ' 145' ' ' ILE . 3.2 mt -114.75 127.35 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.513 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.61 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.2 m -104.64 138.41 41.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.944 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.541 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.2 m -140.2 158.24 25.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 82.24 39.6 11.11 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.944 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.455 ' HA ' HG12 ' A' ' 140' ' ' ILE . 54.9 t -79.41 140.41 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-O 121.688 0.756 . . . . 0.0 112.557 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 156.46 -41.76 0.56 Allowed Glycine 0 N--CA 1.436 -1.318 0 CA-C-N 114.471 -1.241 . . . . 0.0 110.018 -179.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.487 HG12 ' H ' ' A' ' 138' ' ' SER . 45.7 t -126.39 131.21 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-N 114.869 -0.666 . . . . 0.0 109.262 178.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -50.41 -35.4 28.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.669 0.271 . . . . 0.0 111.647 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.487 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -93.57 6.44 48.24 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -178.864 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.41 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 51.4 m-20 -121.85 26.75 8.48 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.61 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.0 mt -107.12 139.5 28.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.332 178.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.477 HD11 ' CB ' ' A' ' 42' ' ' GLN . 7.9 tt -120.69 134.5 55.28 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.292 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.538 ' H ' HG21 ' A' ' 40' ' ' THR . 45.4 t -112.89 150.59 31.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.612 0.72 . . . . 0.0 112.716 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.598 HD21 HD12 ' A' ' 43' ' ' ILE . 70.8 mt -135.57 149.58 49.46 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.538 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.681 HG21 HG23 ' A' ' 39' ' ' THR . 25.7 t -120.44 139.95 46.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.795 0.331 . . . . 0.0 111.28 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.631 HD11 HD11 ' A' ' 130' ' ' ILE . 5.4 mt -106.24 130.75 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.807 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.577 ' CD1' HD12 ' A' ' 37' ' ' ILE . 0.4 OUTLIER -115.75 114.43 24.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.106 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.407 HD11 ' O ' ' A' ' 125' ' ' SER . 6.0 mt -85.03 134.16 27.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.349 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -82.59 133.11 35.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.749 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -73.72 -37.75 65.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.209 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -46.13 91.55 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.907 0.384 . . . . 0.0 110.817 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.423 ' CE2' HG13 ' A' ' 33' ' ' VAL . 36.2 t80 . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.16 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.889 0.375 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.2 p -125.85 -60.51 1.29 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.91 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -68.15 -46.49 70.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.909 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -60.4 -45.05 94.96 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.5 -38.22 74.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.837 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.7 tp -60.7 -31.88 71.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.693 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.41 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.3 mt -72.17 -35.54 53.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.857 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -57.4 -44.45 84.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.918 0.39 . . . . 0.0 110.536 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.6 mtmm -67.07 -23.7 65.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.632 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.41 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.65 -47.56 79.49 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.253 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.2 t -76.56 -40.01 51.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.954 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -94.33 88.56 5.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -88.09 126.33 35.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.832 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -65.06 114.13 4.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.977 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.2 mm -82.26 138.35 19.6 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 CA-C-O 121.667 0.746 . . . . 0.0 111.749 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.29 35.88 1.06 Allowed Glycine 0 C--N 1.314 -0.664 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.412 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -77.48 -38.96 48.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.809 0.338 . . . . 0.0 111.019 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.405 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER -171.98 35.23 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -179.751 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.687 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.3 mm -76.62 133.89 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 CA-C-N 113.863 -1.517 . . . . 0.0 112.489 -177.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.962 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.8 t -91.7 -61.21 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-N 114.715 -1.129 . . . . 0.0 109.856 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.401 ' SG ' HD22 ' A' ' 48' ' ' LEU . 5.7 p -145.14 160.0 42.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.278 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.73 138.17 54.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.698 0.285 . . . . 0.0 111.37 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.674 HG21 ' HE2' ' A' ' 68' ' ' PHE . 37.0 t -109.66 122.6 64.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.836 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.843 HG23 HG12 ' A' ' 45' ' ' ILE . 17.7 mt -125.14 120.63 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.405 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.722 ' HA ' HD13 ' A' ' 143' ' ' LEU . 49.4 t -80.96 111.96 17.92 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.802 0.334 . . . . 0.0 110.441 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.21 -22.42 35.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.591 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.469 HG23 ' HB3' ' A' ' 142' ' ' SER . 81.2 p -79.94 -2.21 42.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.654 0.264 . . . . 0.0 111.446 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.99 74.23 0.42 Allowed Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.847 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.513 ' HB2' HD11 ' A' ' 141' ' ' LEU . 11.2 mt-30 -146.01 -42.82 0.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.852 0.358 . . . . 0.0 111.065 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.592 ' CD1' HD21 ' A' ' 141' ' ' LEU . 3.2 mt -116.57 141.88 28.73 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.586 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 43.0 Cg_endo -70.37 142.38 45.08 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.143 1.896 . . . . 0.0 112.186 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.843 HG12 HG23 ' A' ' 37' ' ' ILE . 36.6 mt -57.04 135.35 20.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.717 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -130.98 160.06 35.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.084 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.71 119.87 31.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.92 0.391 . . . . 0.0 111.91 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.787 HD23 ' CD2' ' A' ' 66' ' ' TRP . 8.8 mp -82.57 133.05 35.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.514 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.962 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -139.78 155.64 47.18 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 122.287 1.041 . . . . 0.0 113.793 -179.656 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.48 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -143.23 141.92 31.24 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 113.476 -1.693 . . . . 0.0 110.616 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.812 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.9 OUTLIER -77.34 140.46 39.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.207 0.527 . . . . 0.0 111.249 -179.584 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.541 HD13 ' SG ' ' A' ' 154' ' ' CYS . 37.1 mt -64.37 -45.22 96.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.351 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.7 p -56.84 -41.05 77.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.24 0.543 . . . . 0.0 110.895 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.494 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 16.3 mt-30 -68.42 -36.88 79.73 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.654 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 51' ' ' ASP . 47.2 t -68.66 -43.83 82.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.901 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.04 -39.09 72.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.798 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -70.08 -43.02 71.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.904 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.46 107.37 3.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.925 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.99 31.18 3.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.936 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -103.83 -177.45 3.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.848 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.52 -50.28 65.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.958 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.488 HD12 HD12 ' A' ' 92' ' ' LEU . 25.3 mm -116.94 158.76 17.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.133 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.47 ' N ' HG22 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -122.46 -66.18 1.05 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.785 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.408 ' HE2' ' O ' ' A' ' 49' ' ' SER . 4.9 ttpt -128.27 130.55 48.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.856 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.683 HG12 ' HG2' ' A' ' 90' ' ' GLN . 8.4 t -126.52 139.12 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 121.289 0.566 . . . . 0.0 112.175 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.787 ' CD2' HD23 ' A' ' 48' ' ' LEU . 18.2 m-90 -102.98 139.17 38.89 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.969 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.527 HG22 ' HB3' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -113.17 131.09 56.0 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 177.6 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.863 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -118.2 145.82 44.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.259 -178.683 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.624 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.29 -167.78 35.68 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.413 -0.899 . . . . 0.0 113.173 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -79.42 1.78 24.18 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 0.1 OUTLIER -84.74 127.79 63.67 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.864 -0.153 . . . . 0.0 110.97 -179.804 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.425 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 18.8 Cg_exo -66.18 -12.19 34.46 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.348 2.032 . . . . 0.0 111.563 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.95 -43.15 16.77 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-O 121.834 0.826 . . . . 0.0 108.926 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -39.77 139.62 0.61 Allowed 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.735 179.478 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -56.25 -18.69 11.2 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.04 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.529 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 13.2 t80 -129.64 121.99 28.14 Favored 'General case' 0 N--CA 1.457 -0.086 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.915 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.425 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.8 t-160 -95.5 107.95 20.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.838 0.352 . . . . 0.0 110.636 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.788 HD13 HD13 ' A' ' 84' ' ' LEU . 77.4 mt -71.97 -77.34 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.142 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 172.69 -102.68 0.18 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.538 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -156.24 64.95 0.56 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.87 0.367 . . . . 0.0 111.082 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.419 HD11 HD13 ' A' ' 141' ' ' LEU . 33.3 mt -111.97 118.82 58.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.99 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.8 m -58.25 -37.19 74.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.1 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.432 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 1.8 mmt180 -61.8 -17.04 54.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.305 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.788 HD13 HD13 ' A' ' 78' ' ' LEU . 20.6 mt -107.25 147.8 29.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.838 0.351 . . . . 0.0 111.251 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 51.6 p -93.08 164.89 13.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.48 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.624 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.0 m-20 -43.19 -52.74 5.43 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.426 0.632 . . . . 0.0 109.893 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.527 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -121.31 81.12 1.75 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 177.453 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.564 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.3 t60 -61.21 -45.93 92.56 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.161 -0.927 . . . . 0.0 113.008 -176.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.524 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 22.3 p90 -146.73 157.77 43.76 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.171 -0.611 . . . . 0.0 112.104 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.683 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.7 tt0 -135.6 140.85 44.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.24 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.863 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 16.1 mt -117.0 131.12 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.18 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.685 HD21 ' HB2' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -116.65 146.71 42.54 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.153 0.501 . . . . 0.0 111.932 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.776 HD22 ' CG1' ' A' ' 33' ' ' VAL . 15.3 tp -125.19 127.93 47.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.148 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -170.28 -35.36 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.888 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -47.97 172.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.878 0.371 . . . . 0.0 111.283 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.08 68.74 0.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.19 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.56 -23.58 29.72 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.852 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -81.21 172.05 14.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.896 0.379 . . . . 0.0 110.933 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.752 HD21 HG12 ' A' ' 33' ' ' VAL . 3.1 mp -121.79 160.06 25.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.971 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.794 HD23 ' O ' ' A' ' 122' ' ' GLN . 9.3 mt -128.76 136.47 50.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.512 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.83 122.6 48.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.08 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.685 ' HB2' HD21 ' A' ' 92' ' ' LEU . 63.6 t30 -114.85 121.99 44.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.015 0.436 . . . . 0.0 111.857 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.773 ' OD2' HG23 ' A' ' 116' ' ' VAL . 21.9 p30 -82.0 133.72 35.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.905 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.497 HD13 ' HB2' ' A' ' 90' ' ' GLN . 17.2 pt -139.55 37.82 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.654 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -96.34 156.25 16.42 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 120.927 0.394 . . . . 0.0 111.746 -178.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 87.8 m -68.91 -35.83 77.3 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.318 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.432 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -98.58 -19.74 17.42 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.46 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.654 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 121.04 161.57 11.42 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.192 -1.004 . . . . 0.0 113.914 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.548 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.2 m -117.5 138.04 52.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.905 -0.647 . . . . 0.0 109.299 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.84 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -112.22 148.55 33.86 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -177.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.466 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.06 113.32 18.23 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.484 -1.235 . . . . 0.0 108.192 177.216 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.419 ' N ' HD12 ' A' ' 111' ' ' LEU . 93.0 m-20 44.29 43.5 6.0 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.05 -11.36 67.42 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 120.709 -0.758 . . . . 0.0 113.487 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.77 118.5 36.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.031 0.443 . . . . 0.0 110.679 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.84 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -72.36 128.55 35.97 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.371 -179.698 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.773 HG23 ' OD2' ' A' ' 103' ' ' ASP . 8.4 m -98.54 166.11 2.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.057 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 120' ' ' SER . 16.1 tt0 -69.9 126.71 30.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.483 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.693 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 32.6 tttt -54.27 163.4 0.84 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.9 OUTLIER 35.82 35.45 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.746 -179.231 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.7 p -111.9 145.04 40.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.601 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.566 ' HB3' HD22 ' A' ' 100' ' ' LEU . 24.7 m120 -95.14 129.54 42.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.846 0.355 . . . . 0.0 110.897 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.794 ' O ' HD23 ' A' ' 100' ' ' LEU . 56.2 mm-40 -129.08 150.01 50.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.533 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.1 tp -72.55 132.27 43.59 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.276 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.957 HD11 HG21 ' A' ' 145' ' ' ILE . 61.4 tp -64.11 156.62 27.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.43 0.633 . . . . 0.0 111.633 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.443 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.57 154.09 41.16 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.926 -179.512 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.457 ' NE2' ' HB ' ' A' ' 147' ' ' ILE . 9.3 mm-40 -70.78 121.67 18.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.863 0.363 . . . . 0.0 110.061 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.13 22.85 50.8 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.033 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.443 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 26.5 t70 -53.62 171.77 0.08 Allowed 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.981 0.42 . . . . 0.0 111.037 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -145.26 135.34 23.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.097 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.457 ' CG2' HG22 ' A' ' 109' ' ' THR . 16.0 mt -115.01 127.9 72.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.412 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.513 HG22 ' CG2' ' A' ' 140' ' ' ILE . 23.5 m -104.31 137.16 42.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.985 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.501 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 26.9 m -140.2 158.34 25.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.02 0.438 . . . . 0.0 112.022 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.55 37.67 10.47 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.618 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 140' ' ' ILE . 50.4 t -79.71 140.47 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 121.705 0.764 . . . . 0.0 112.435 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.52 -36.8 0.63 Allowed Glycine 0 N--CA 1.436 -1.337 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.465 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 50.9 t -126.32 133.0 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-N 114.653 -0.774 . . . . 0.0 109.169 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -50.69 -44.64 57.96 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -93.3 6.51 47.86 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.465 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 4.9 t0 -117.25 29.37 7.93 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.513 ' CG2' HG22 ' A' ' 131' ' ' THR . 3.8 mt -107.41 139.32 29.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.921 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.592 HD21 ' CD1' ' A' ' 43' ' ' ILE . 1.0 OUTLIER -116.46 134.43 54.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.588 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.564 ' C ' HD22 ' A' ' 143' ' ' LEU . 38.0 t -114.9 150.38 35.73 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.567 0.698 . . . . 0.0 112.595 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.722 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.5 mm? -136.01 143.44 44.77 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.876 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.35 135.86 49.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.803 0.335 . . . . 0.0 110.957 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.957 HG21 HD11 ' A' ' 124' ' ' LEU . 2.9 mm -106.24 123.96 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.069 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.07 117.1 31.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.481 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.636 HG12 HD21 ' A' ' 124' ' ' LEU . 2.6 mt -84.97 134.04 27.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.451 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.24 109.9 16.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.759 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -60.7 -35.2 75.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.103 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.93 -44.06 91.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.73 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -59.29 -44.0 92.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.04 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -58.48 -36.3 73.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.11 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.01 -46.38 89.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.068 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.541 ' SG ' HD13 ' A' ' 52' ' ' ILE . 10.8 t -64.94 -45.04 87.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.064 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.747 HD21 HG11 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -65.95 -40.31 91.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.017 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.89 -36.39 81.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.058 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -88.36 -37.08 16.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.976 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.9 p30 42.77 71.74 0.21 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.428 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.43 144.71 40.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.868 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.444 HG22 ' H ' ' A' ' 162' ' ' ARG . 8.1 p -103.07 141.13 19.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.052 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -138.68 32.7 2.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.93 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.444 ' H ' HG22 ' A' ' 160' ' ' VAL . 1.0 OUTLIER -147.24 31.08 0.92 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.856 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -94.07 130.66 42.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.064 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.938 179.988 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.793 0.33 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.3 t -138.93 -47.04 0.48 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.905 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.57 -45.73 92.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.882 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.4 mtm180 -59.11 -48.02 83.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.917 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -59.49 -35.01 73.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.88 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.78 -44.03 97.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.92 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.5 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.9 mm -66.64 -35.17 74.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.189 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -57.21 -39.44 75.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.928 0.394 . . . . 0.0 110.334 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.3 tttp -67.28 -23.71 65.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.6 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.5 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -56.82 -47.48 80.17 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.146 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.2 m -81.02 -38.98 26.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.902 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 60.4 30.32 19.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.789 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -101.01 141.62 33.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.867 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -93.67 142.23 27.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.85 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.3 mm -81.82 138.36 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 CA-C-O 121.661 0.743 . . . . 0.0 111.63 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.439 ' CA ' HG12 ' A' ' 32' ' ' ILE . . . 166.16 115.86 0.34 Allowed Glycine 0 C--N 1.314 -0.658 0 CA-C-N 114.539 -1.21 . . . . 0.0 112.522 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.7 -31.21 68.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.76 0.315 . . . . 0.0 111.036 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.414 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.8 OUTLIER 178.84 38.56 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.663 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.3 mm -74.86 137.2 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 CA-C-N 113.786 -1.552 . . . . 0.0 112.437 -177.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.96 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.5 t -90.54 -58.54 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.745 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.728 ' SG ' HD22 ' A' ' 99' ' ' LEU . 1.8 m -149.8 162.84 39.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.701 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.401 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -127.1 138.09 53.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.754 0.311 . . . . 0.0 111.114 -179.768 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.669 HG21 ' CE2' ' A' ' 68' ' ' PHE . 47.5 t -108.43 122.65 63.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.95 0.405 . . . . 0.0 110.81 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.599 HG23 HG12 ' A' ' 45' ' ' ILE . 15.8 mt -123.77 121.54 62.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.472 -179.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.609 ' HA ' HD23 ' A' ' 143' ' ' LEU . 12.3 t -80.34 100.01 8.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.389 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.484 HG23 HG21 ' A' ' 144' ' ' VAL . 0.4 OUTLIER -63.86 -27.2 69.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.828 -179.261 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.517 HG21 ' H ' ' A' ' 142' ' ' SER . 54.9 p -79.85 -2.2 42.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.734 0.302 . . . . 0.0 111.504 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.72 75.39 0.31 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.018 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.428 ' HB2' HD11 ' A' ' 141' ' ' LEU . 6.9 mt-30 -144.23 -47.56 0.27 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.856 0.36 . . . . 0.0 110.627 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.71 HD12 ' CB ' ' A' ' 78' ' ' LEU . 2.8 mm -104.24 141.74 23.16 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.749 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.62 ' HD2' HG22 ' A' ' 43' ' ' ILE . 53.7 Cg_endo -71.67 138.22 31.57 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.187 1.925 . . . . 0.0 112.164 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.599 HG12 HG23 ' A' ' 37' ' ' ILE . 35.1 mt -55.61 131.99 19.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.609 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.96 164.55 19.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.404 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.401 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.8 OUTLIER -125.51 119.75 29.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.976 0.417 . . . . 0.0 111.957 -179.556 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.818 HD23 ' CD2' ' A' ' 66' ' ' TRP . 6.9 mp -92.22 129.49 38.15 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.96 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -138.49 156.48 47.5 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 122.252 1.025 . . . . 0.0 113.692 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.473 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -154.54 141.89 19.59 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 113.493 -1.685 . . . . 0.0 110.856 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.549 ' HB2' ' HG3' ' A' ' 54' ' ' GLN . 0.5 OUTLIER -82.39 132.92 35.21 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.062 0.458 . . . . 0.0 111.317 -179.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.549 HD12 ' N ' ' A' ' 52' ' ' ILE . 2.4 mp -64.32 -41.04 91.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.908 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.8 t -56.32 -38.14 70.9 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.743 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.549 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 0.3 OUTLIER -68.63 -40.58 80.25 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.355 179.719 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.651 HG22 ' HG2' ' A' ' 63' ' ' LYS . 58.1 t -67.69 -42.08 86.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.146 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.1 tp -71.05 -23.69 62.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.212 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.0 mtmm -92.69 -41.65 10.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.161 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -62.96 113.13 2.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.839 0.352 . . . . 0.0 110.947 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.72 -25.53 60.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.025 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -55.04 158.38 2.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.049 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.9 t -70.17 -38.63 75.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.987 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.581 HD11 HG22 ' A' ' 65' ' ' VAL . 10.0 tp -98.53 151.68 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.114 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.651 ' HG2' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -120.5 -65.83 1.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.448 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.9 ttpt -144.03 133.21 23.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.183 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.595 HG12 ' HG2' ' A' ' 90' ' ' GLN . 6.3 t -128.1 137.67 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 121.259 0.552 . . . . 0.0 112.045 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.818 ' CD2' HD23 ' A' ' 48' ' ' LEU . 18.9 m-90 -101.79 139.65 37.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.242 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.654 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -113.1 132.26 55.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.831 0.348 . . . . 0.0 110.157 177.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.722 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -120.32 145.4 47.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.825 -179.315 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.709 ' N ' HD21 ' A' ' 78' ' ' LEU . . . 160.66 -167.03 35.67 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.166 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.428 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 20.0 mtp180 -86.19 36.05 0.67 Allowed 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.549 HD22 ' HB3' ' A' ' 73' ' ' ALA . 2.2 t30 -118.44 132.53 23.76 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.468 0.175 . . . . 0.0 110.998 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.09 -17.06 58.32 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.522 2.148 . . . . 0.0 111.506 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.549 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.99 -42.52 17.46 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 121.806 0.812 . . . . 0.0 109.088 178.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.26 139.39 1.43 Allowed 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.12 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.2 m-20 -56.23 -18.38 10.2 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.059 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.668 ' CE2' HG21 ' A' ' 43' ' ' ILE . 2.5 t80 -129.12 118.67 22.84 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-O 120.914 0.387 . . . . 0.0 110.951 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -96.78 107.84 20.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.628 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.71 ' CB ' HD12 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -116.21 170.64 8.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.025 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.45 144.25 43.42 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.334 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -71.58 88.97 0.96 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.764 0.316 . . . . 0.0 110.998 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.523 HD12 ' CD1' ' A' ' 84' ' ' LEU . 36.0 mt -106.64 125.69 62.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.008 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.83 -35.86 64.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.004 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.461 ' H ' HG22 ' A' ' 81' ' ' ILE . 5.4 mmp_? -63.37 -29.88 71.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.468 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.568 HD21 HG23 ' A' ' 132' ' ' VAL . 23.8 mt -99.99 150.5 22.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.857 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.7 p -98.37 166.69 11.26 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.64 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 m-20 -43.25 -52.54 5.63 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.397 0.618 . . . . 0.0 109.892 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.606 ' CB ' HD12 ' A' ' 104' ' ' ILE . 4.3 mttt -119.0 82.05 1.8 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 177.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.597 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 15.4 t60 -58.69 -45.75 88.79 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.847 -177.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.513 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 31.5 p90 -149.38 162.18 40.6 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.583 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.654 ' HG3' HG23 ' A' ' 67' ' ' THR . 3.3 tt0 -136.32 140.84 43.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.298 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.711 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 78.1 mt -115.22 129.08 72.06 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.192 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.779 179.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.426 ' CA ' HG13 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -113.9 146.9 39.38 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.205 0.526 . . . . 0.0 111.937 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.724 HD22 HG11 ' A' ' 33' ' ' VAL . 23.7 tp -125.1 123.12 39.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.067 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -114.41 -150.36 10.12 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.845 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -57.16 155.48 8.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.907 0.384 . . . . 0.0 111.164 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.475 ' HA ' HD12 ' A' ' 155' ' ' LEU . 3.6 m-20 54.94 176.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.101 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.577 ' O ' HD12 ' A' ' 99' ' ' LEU . . . -66.13 -13.69 60.3 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.782 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -53.42 131.92 38.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.864 0.364 . . . . 0.0 111.062 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.728 HD22 ' SG ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -116.11 160.06 20.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.813 HD13 ' O ' ' A' ' 122' ' ' GLN . 4.1 mm? -129.2 142.83 50.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.635 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.546 HD21 HD13 ' A' ' 124' ' ' LEU . 28.0 mt -112.61 122.32 47.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.912 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.42 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 63.4 t30 -117.11 135.61 53.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.152 0.501 . . . . 0.0 111.825 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.811 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.3 p30 -96.82 143.08 28.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.664 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.606 HD12 ' CB ' ' A' ' 87' ' ' LYS . 7.0 pt -147.62 28.28 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.468 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.583 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 10.8 t -92.26 157.69 16.53 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 121.433 0.635 . . . . 0.0 112.69 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 95.3 m -69.8 -52.12 27.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.954 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -82.84 -0.09 46.49 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.324 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.65 157.75 29.58 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.708 -0.758 . . . . 0.0 113.542 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.514 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 6.2 m -117.63 137.89 52.33 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.841 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -113.76 148.44 36.49 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -178.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.82 HD12 HG11 ' A' ' 116' ' ' VAL . 0.8 OUTLIER -124.43 113.51 18.26 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.875 177.253 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 47.41 35.96 4.54 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.111 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.9 -7.23 79.26 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.487 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.51 118.39 36.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.979 0.419 . . . . 0.0 110.557 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.841 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 25.3 tptt -72.32 121.92 20.28 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.175 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.82 HG11 HD12 ' A' ' 111' ' ' LEU . 8.3 m -97.67 163.65 2.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.438 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 120' ' ' SER . 25.6 tt0 -69.98 128.13 35.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.453 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.67 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 66.7 tttt -52.56 161.94 0.63 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.789 0.328 . . . . 0.0 110.353 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.8 p30 35.15 34.89 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.202 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.25 143.18 43.74 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.975 179.469 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.534 ' HB3' HD12 ' A' ' 100' ' ' LEU . 5.5 m120 -85.39 132.52 34.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.889 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.813 ' O ' HD13 ' A' ' 100' ' ' LEU . 35.0 mm-40 -129.56 147.68 51.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.665 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.76 HD23 ' O ' ' A' ' 124' ' ' LEU . 7.2 tt -72.72 129.2 37.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.26 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.76 ' O ' HD23 ' A' ' 123' ' ' LEU . 66.9 tp -62.16 155.17 25.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.513 0.673 . . . . 0.0 111.677 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.5 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.3 OUTLIER -124.8 153.5 42.41 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.316 179.768 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.613 ' HA ' HD13 ' A' ' 147' ' ' ILE . 13.4 tp60 -71.15 119.79 15.79 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.55 23.95 63.4 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.657 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.437 ' OD2' HD23 ' A' ' 111' ' ' LEU . 22.2 t70 -49.02 167.15 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.921 0.391 . . . . 0.0 111.329 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 13.7 tt0 -145.1 135.4 24.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.965 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.509 HD11 HD11 ' A' ' 145' ' ' ILE . 11.8 mt -114.88 128.36 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.777 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.644 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.3 m -104.18 141.85 35.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.815 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.597 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 31.2 m -140.29 158.68 25.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.64 44.41 9.37 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.94 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.47 ' HA ' HG12 ' A' ' 140' ' ' ILE . 59.6 t -85.66 140.5 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-O 121.644 0.735 . . . . 0.0 112.459 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.03 -39.08 1.08 Allowed Glycine 0 N--CA 1.435 -1.404 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.565 HG12 ' H ' ' A' ' 138' ' ' SER . 58.8 t -126.51 118.91 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 CA-C-N 114.41 -0.895 . . . . 0.0 108.866 177.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.443 ' HA ' HD12 ' A' ' 140' ' ' ILE . 7.3 pt-20 -50.29 -26.37 4.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.738 0.304 . . . . 0.0 111.607 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.565 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -93.57 6.59 47.75 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -179.243 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.419 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.6 OUTLIER -131.11 29.19 4.7 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -178.901 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.644 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.7 mt -107.14 139.14 29.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.719 178.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.512 HD23 ' C ' ' A' ' 141' ' ' LEU . 9.4 tt -124.16 134.44 53.32 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.39 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.517 ' H ' HG21 ' A' ' 40' ' ' THR . 37.6 t -108.15 150.19 27.54 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.782 0.801 . . . . 0.0 112.532 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.609 HD23 ' HA ' ' A' ' 38' ' ' CYS . 72.2 mt -135.93 145.0 45.78 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.383 -1.281 . . . . 0.0 110.622 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.484 HG21 HG23 ' A' ' 39' ' ' THR . 21.9 t -117.07 139.49 43.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.837 0.351 . . . . 0.0 111.108 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.61 HG21 HD11 ' A' ' 124' ' ' LEU . 15.3 mt -106.17 123.02 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.952 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.04 119.5 39.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.87 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.613 HD13 ' HA ' ' A' ' 126' ' ' GLN . 4.7 mp -89.68 131.43 36.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.363 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.8 114.26 20.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.914 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -60.32 -29.18 68.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.35 -44.01 88.58 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.993 0.425 . . . . 0.0 110.609 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -58.16 -44.05 87.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.841 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 33.1 mttm -60.97 -37.17 81.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.959 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -62.05 -40.76 96.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.068 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.4 t -68.09 -43.47 78.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.94 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.476 HD21 HG13 ' A' ' 52' ' ' ILE . 4.4 mm? -68.55 -35.94 78.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.828 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -64.3 -42.29 96.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.825 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.423 ' O ' ' N ' ' A' ' 159' ' ' LYS . 0.7 OUTLIER -84.56 -33.05 23.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.712 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 42.89 -90.83 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.697 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 157' ' ' GLN . 55.4 tttp -60.81 115.71 3.88 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.89 0.376 . . . . 0.0 110.888 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.2 p -65.87 140.81 18.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.124 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -124.11 119.5 29.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.921 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 61.66 153.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.822 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 29.0 mm -88.89 115.74 29.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.152 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.9 ttm-85 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.902 -179.988 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.864 0.364 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 66.1 p -129.92 -69.92 0.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.975 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -68.7 -35.9 77.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -60.14 -35.96 76.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.825 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.78 -35.0 77.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.825 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.6 mp -63.93 -44.05 94.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.888 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.3 mm -65.75 -35.16 74.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.206 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -57.16 -41.12 78.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.028 0.442 . . . . 0.0 110.351 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.6 mttm -67.21 -23.81 65.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.591 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.473 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.56 -47.56 79.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.109 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.0 p -81.09 -29.97 34.8 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.836 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.17 -73.22 0.08 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.923 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -101.06 120.95 40.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.839 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -104.85 101.84 11.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.939 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.425 HG21 ' NH2' ' A' ' 35' ' ' ARG . 18.2 mm -90.26 138.45 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 121.63 0.729 . . . . 0.0 111.951 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 123.72 33.9 0.78 Allowed Glycine 0 C--N 1.314 -0.64 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.657 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -70.77 -44.72 66.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.911 0.386 . . . . 0.0 110.72 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.406 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.5 OUTLIER -170.08 36.21 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.743 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 2.3 mm -81.86 94.41 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 CA-C-N 113.908 -1.496 . . . . 0.0 112.923 -177.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.913 HG12 HD11 ' A' ' 99' ' ' LEU . 3.5 t -46.88 -61.22 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.906 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.559 ' SG ' HD12 ' A' ' 48' ' ' LEU . 6.1 p -144.74 165.1 29.02 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.777 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.425 ' NH2' HG21 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -128.73 138.15 51.96 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.904 0.383 . . . . 0.0 111.54 -179.496 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.905 HG13 HD11 ' A' ' 48' ' ' LEU . 5.1 m -101.73 122.85 54.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.741 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.838 HG23 HG12 ' A' ' 45' ' ' ILE . 20.8 mt -129.05 118.67 47.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.733 ' HA ' HD13 ' A' ' 143' ' ' LEU . 39.0 t -79.98 122.53 26.84 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.49 -21.99 17.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.798 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.465 HG23 ' HB3' ' A' ' 142' ' ' SER . 76.5 p -79.84 -2.15 42.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.699 0.285 . . . . 0.0 111.43 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.71 73.85 0.57 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.695 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -145.98 -39.08 0.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.715 0.293 . . . . 0.0 111.142 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.563 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.7 mt -125.11 141.47 38.63 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.007 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.563 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 53.4 Cg_endo -72.19 145.94 45.01 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.191 1.927 . . . . 0.0 112.223 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.838 HG12 HG23 ' A' ' 37' ' ' ILE . 37.0 mt -62.4 138.55 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.787 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.62 163.23 25.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.752 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.7 119.67 36.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.009 0.433 . . . . 0.0 111.858 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.905 HD11 HG13 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -96.72 132.51 42.34 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.177 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.743 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -144.24 156.99 44.53 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -178.573 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.628 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -146.57 141.95 27.49 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.304 -1.771 . . . . 0.0 110.827 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.784 ' O ' HG23 ' A' ' 55' ' ' VAL . 5.3 m-20 -81.45 134.54 35.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.025 0.441 . . . . 0.0 110.977 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.717 HG22 HD23 ' A' ' 56' ' ' LEU . 59.7 mt -64.3 -42.6 95.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.313 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.508 ' HA ' HD21 ' A' ' 56' ' ' LEU . 5.3 p -56.94 -42.02 79.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.267 0.556 . . . . 0.0 110.939 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.489 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 3.4 mt-30 -68.57 -37.73 80.14 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.957 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 51' ' ' ASP . 39.0 t -68.74 -49.95 59.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.098 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.717 HD23 HG22 ' A' ' 52' ' ' ILE . 4.5 pp -66.56 -31.0 71.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.871 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.505 ' N ' HD12 ' A' ' 56' ' ' LEU . 4.9 mtmt -66.83 -47.42 72.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.898 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -80.37 134.59 36.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.04 29.84 0.97 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.007 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.2 ttm-85 -125.28 -55.81 1.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.783 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.31 -178.15 3.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.765 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.426 HG12 ' CG2' ' A' ' 65' ' ' VAL . 10.0 tp -59.77 152.64 4.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.069 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.747 ' HG2' HG13 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -89.42 -74.17 0.49 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.127 -179.72 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 49' ' ' SER . 1.5 ttpt -141.5 135.66 30.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.863 0.363 . . . . 0.0 111.316 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.634 HG13 ' O ' ' A' ' 91' ' ' ILE . 18.6 t -133.92 139.13 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-O 121.194 0.521 . . . . 0.0 111.782 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.61 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 16.5 m-90 -102.07 139.06 38.2 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.253 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.506 HG22 ' HB3' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -111.81 128.38 56.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.813 177.635 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.64 ' CD1' ' HB2' ' A' ' 76' ' ' TYR . 9.0 m-85 -120.45 145.57 47.09 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.714 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.703 ' CA ' HD21 ' A' ' 78' ' ' LEU . . . 159.97 -165.96 34.9 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.845 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.434 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 10.3 mtm105 -83.07 6.56 18.57 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.435 ' ND2' ' HD2' ' A' ' 72' ' ' PRO . 3.2 t-20 -84.71 140.04 37.93 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.556 0.217 . . . . 0.0 110.877 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.435 ' HD2' ' ND2' ' A' ' 71' ' ' ASN . 60.3 Cg_endo -73.57 -14.3 24.8 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.356 2.038 . . . . 0.0 111.302 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.1 -43.1 16.63 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -41.78 137.25 1.75 Allowed 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 113.63 -1.623 . . . . 0.0 110.906 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.4 OUTLIER -56.73 -19.23 15.72 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.191 179.162 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.64 ' HB2' ' CD1' ' A' ' 68' ' ' PHE . 15.6 t80 -130.22 120.2 24.11 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.641 0.258 . . . . 0.0 111.097 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -98.23 118.57 35.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.82 0.343 . . . . 0.0 110.724 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.703 HD21 ' CA ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -124.11 73.3 1.22 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.317 -179.713 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 47.36 -129.24 14.12 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.825 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -163.3 84.73 0.5 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.73 0.3 . . . . 0.0 111.072 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 1.066 HD13 HD12 ' A' ' 84' ' ' LEU . 4.1 mp -97.39 141.05 16.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.03 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.1 t -63.71 -36.81 85.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.03 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.547 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -69.52 -21.03 63.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.316 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.066 HD12 HD13 ' A' ' 81' ' ' ILE . 21.2 mt -105.9 148.9 27.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.721 0.296 . . . . 0.0 111.077 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.6 p -95.55 165.62 12.25 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.689 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.592 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.9 m-20 -43.91 -53.68 5.93 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.315 0.579 . . . . 0.0 109.897 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.534 ' HB2' HD12 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -118.54 80.34 1.52 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.362 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.635 ' CD2' ' HB2' ' A' ' 105' ' ' SER . 13.9 t60 -60.79 -45.94 92.45 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.866 -176.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.455 ' CD1' ' HB2' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -145.05 153.34 41.35 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.047 -0.661 . . . . 0.0 112.171 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.607 ' HG2' HG12 ' A' ' 65' ' ' VAL . 5.9 tt0 -135.5 139.89 44.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.418 -178.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.691 HD11 HD11 ' A' ' 145' ' ' ILE . 24.9 mt -113.97 132.09 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.024 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.528 HD21 HD22 ' A' ' 121' ' ' ASN . 0.6 OUTLIER -118.28 144.0 46.15 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.961 0.41 . . . . 0.0 111.603 -179.804 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.646 HD22 HG11 ' A' ' 33' ' ' VAL . 13.8 tp -125.26 125.66 43.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.49 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -165.07 -162.56 16.41 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.505 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 59.42 -171.08 0.13 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.806 0.336 . . . . 0.0 110.902 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -78.81 61.94 3.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.789 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.453 ' HA2' HD11 ' A' ' 155' ' ' LEU . . . 96.84 -164.97 22.98 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.463 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.2 m120 61.66 152.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.762 0.315 . . . . 0.0 111.015 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.913 HD11 HG12 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -112.8 160.02 18.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.723 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.713 HD12 ' O ' ' A' ' 99' ' ' LEU . 5.9 mp -131.07 144.49 51.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.321 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.704 HD11 HD11 ' A' ' 130' ' ' ILE . 0.3 OUTLIER -112.7 123.54 50.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.199 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -114.04 115.9 28.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.018 0.437 . . . . 0.0 111.684 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.875 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.8 p30 -81.01 118.81 22.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.224 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.534 HD12 ' HB2' ' A' ' 87' ' ' LYS . 9.9 pt -124.41 33.83 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.321 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.635 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 13.7 t -89.57 159.01 17.4 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-O 121.347 0.594 . . . . 0.0 112.444 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 49.5 m -69.59 -52.28 27.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.67 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -92.67 -19.82 21.46 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 136.06 153.33 6.57 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.618 -0.801 . . . . 0.0 114.02 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.459 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 12.2 m -117.29 137.89 52.11 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.826 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -113.65 148.62 35.96 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -178.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.571 HD13 ' OD2' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -123.95 113.31 18.29 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.204 177.253 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.411 ' N ' HD12 ' A' ' 111' ' ' LEU . 82.6 m-20 45.08 43.05 7.19 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.28 -6.38 81.95 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.751 -0.737 . . . . 0.0 113.451 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -105.46 118.35 36.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.019 0.438 . . . . 0.0 110.76 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.826 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 7.9 tptt -73.42 115.75 13.16 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.267 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.875 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.4 m -92.36 159.56 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.356 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.1 tt0 -69.88 128.78 37.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.437 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.666 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 9.7 tttp -50.5 161.41 0.32 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.887 0.375 . . . . 0.0 110.472 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.459 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 3.6 p30 34.23 35.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.186 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.9 OUTLIER -112.04 122.48 47.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.083 179.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.682 ' HB3' HD23 ' A' ' 100' ' ' LEU . 5.5 m120 -68.59 126.03 28.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.032 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -129.38 147.37 51.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.598 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.1 tp -72.9 122.18 21.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.087 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.576 ' CD1' HD12 ' A' ' 101' ' ' LEU . 1.3 mm? -59.23 166.1 2.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.72 0.771 . . . . 0.0 111.888 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.574 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.4 OUTLIER -125.43 153.27 43.72 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.387 179.393 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.655 ' HA ' HD13 ' A' ' 147' ' ' ILE . 15.7 mm100 -71.35 116.25 11.46 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 62.99 27.89 71.15 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.776 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.571 ' OD2' HD13 ' A' ' 111' ' ' LEU . 20.6 t0 -59.31 174.81 0.37 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.018 0.437 . . . . 0.0 111.143 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.934 ' CG ' HG22 ' A' ' 144' ' ' VAL . 2.4 mt-10 -145.21 135.48 24.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.877 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.704 HD11 HD11 ' A' ' 101' ' ' LEU . 5.0 mt -111.33 128.48 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.269 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.664 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.8 m -103.93 141.45 36.13 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.567 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 33.3 m -140.43 158.61 25.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 77.0 44.35 14.3 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.11 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.454 ' HA ' HG12 ' A' ' 140' ' ' ILE . 76.1 t -83.8 140.4 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-O 121.691 0.758 . . . . 0.0 112.411 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.95 -38.92 1.23 Allowed Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.56 HG12 ' H ' ' A' ' 138' ' ' SER . 48.3 t -126.39 119.96 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-N 114.438 -0.881 . . . . 0.0 108.97 177.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.404 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.1 OUTLIER -50.23 -27.64 6.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.743 0.306 . . . . 0.0 111.273 -178.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.56 ' H ' HG12 ' A' ' 136' ' ' VAL . 15.2 m -93.56 6.59 47.75 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -127.34 25.81 6.09 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.664 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.9 mt -107.14 138.46 32.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.184 178.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.537 ' O ' HG22 ' A' ' 132' ' ' VAL . 2.6 tt -124.73 134.41 52.84 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.214 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.531 ' N ' HD23 ' A' ' 141' ' ' LEU . 36.7 t -112.72 150.16 31.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.66 0.743 . . . . 0.0 112.666 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.733 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.3 mm? -136.05 142.59 44.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.412 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.934 HG22 ' CG ' ' A' ' 129' ' ' GLU . 17.5 t -110.95 140.13 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.932 0.396 . . . . 0.0 111.334 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.691 HD11 HD11 ' A' ' 91' ' ' ILE . 2.7 mm -106.36 121.05 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.697 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.74 108.74 19.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.959 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.655 HD13 ' HA ' ' A' ' 126' ' ' GLN . 4.3 mp -84.84 129.01 38.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.19 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 32' ' ' ILE . 1.4 t-20 -75.8 128.53 35.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.079 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.08 -29.1 61.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.098 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -43.51 86.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.025 0.44 . . . . 0.0 110.534 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -58.9 -43.21 90.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.762 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.9 mtpt -63.87 -33.87 76.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.037 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -58.77 -47.08 85.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.932 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.9 t -68.0 -44.26 76.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.839 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.453 HD11 ' HA2' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -60.76 -36.25 78.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.805 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -60.15 -43.61 95.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.801 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.79 -37.07 30.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.6 p30 42.33 88.73 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.506 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -124.97 126.64 45.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.849 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.7 m -81.77 129.71 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.133 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -100.47 78.13 1.99 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.872 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 29.7 mtt85 -134.6 113.62 11.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.959 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.8 mp -92.45 133.07 35.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.106 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.927 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.684 0.278 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.545 ' HB ' ' CB ' ' A' ' 18' ' ' PHE . 0.2 OUTLIER 44.23 78.39 0.06 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.144 179.659 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.79 -47.39 85.89 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.137 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.7 mtm-85 -59.33 -35.89 74.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.229 0.538 . . . . 0.0 109.937 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.545 ' CB ' ' HB ' ' A' ' 15' ' ' THR . 3.0 t80 -60.88 -34.93 75.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.924 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.6 tp -59.14 -41.26 87.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.788 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.554 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 11.5 mm -70.38 -34.96 60.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.051 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -57.01 -33.7 67.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.832 0.348 . . . . 0.0 110.494 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.427 ' HE2' ' CD2' ' A' ' 18' ' ' PHE . 2.5 mptp? -66.65 -23.68 66.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.787 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.554 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.67 -47.55 79.57 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.969 0.414 . . . . 0.0 111.171 -179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.17 -40.74 64.57 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.816 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -63.68 -65.87 0.62 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.826 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -84.98 138.25 32.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.852 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -88.37 116.24 26.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.926 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.6 mm -82.09 138.32 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 CA-C-O 121.621 0.724 . . . . 0.0 111.802 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -159.18 83.87 0.13 Allowed Glycine 0 C--N 1.314 -0.684 0 CA-C-N 114.541 -1.209 . . . . 0.0 112.435 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -60.18 -41.99 94.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.813 0.34 . . . . 0.0 110.966 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.434 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.3 t-20 175.71 39.82 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.708 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.2 mm -71.85 135.79 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-N 113.667 -1.606 . . . . 0.0 112.408 -177.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.009 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.6 t -91.71 -59.29 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.145 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.6 m -145.32 160.35 41.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.796 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.483 ' NH2' HD13 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -120.77 138.18 54.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.902 0.382 . . . . 0.0 111.216 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.672 HG21 ' CE2' ' A' ' 68' ' ' PHE . 22.0 t -98.52 122.66 50.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.065 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.78 HD12 ' CD1' ' A' ' 146' ' ' PHE . 16.3 mt -129.89 120.57 50.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.123 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.672 ' HA ' HD13 ' A' ' 143' ' ' LEU . 39.7 t -86.29 109.36 18.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.514 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.1 -27.12 48.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.587 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.59 HG21 ' H ' ' A' ' 142' ' ' SER . 8.7 p -79.86 -3.01 46.1 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.692 0.282 . . . . 0.0 111.455 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.25 78.92 0.2 Allowed Glycine 0 CA--C 1.52 0.376 0 C-N-CA 121.079 -0.582 . . . . 0.0 113.798 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.445 HE21 HD13 ' A' ' 141' ' ' LEU . 2.3 mt-30 -147.71 -45.25 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.902 0.382 . . . . 0.0 110.959 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.551 HD13 ' HB3' ' A' ' 78' ' ' LEU . 8.8 mt -116.38 141.3 27.71 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.228 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.546 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.0 Cg_endo -74.54 146.11 34.25 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.318 2.012 . . . . 0.0 112.094 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.483 HD13 ' NH2' ' A' ' 35' ' ' ARG . 17.2 mt -52.23 153.27 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.252 0.548 . . . . 0.0 111.788 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -142.58 161.69 37.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.93 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -119.62 119.71 34.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.158 0.504 . . . . 0.0 111.817 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.523 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 5.3 mt -101.08 137.06 39.95 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.009 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -144.35 158.45 43.74 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -178.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.504 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.4 143.64 30.2 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 113.631 -1.622 . . . . 0.0 110.862 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.805 ' O ' HG23 ' A' ' 55' ' ' VAL . 1.2 m-20 -74.9 120.65 20.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.075 0.464 . . . . 0.0 111.279 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.1 mt -64.62 -43.77 96.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.16 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -57.15 -40.31 76.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.285 0.564 . . . . 0.0 110.739 -179.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.463 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 9.1 mm-40 -68.66 -36.84 79.1 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.629 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.89 HG22 ' HG2' ' A' ' 63' ' ' LYS . 45.2 t -66.52 -48.38 80.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.887 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -70.94 -30.51 66.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.93 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.5 -42.53 71.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.013 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -97.31 136.95 37.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.896 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.41 65.56 1.52 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.699 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 -107.32 -68.14 0.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.856 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.69 -59.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.829 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.847 HD11 ' CG2' ' A' ' 65' ' ' VAL . 7.5 tp -104.3 143.0 16.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.036 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.89 ' HG2' HG22 ' A' ' 55' ' ' VAL . 2.3 tppm? -116.57 -66.84 1.04 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.002 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.423 ' CE ' ' O ' ' A' ' 49' ' ' SER . 6.8 ttpt -144.92 132.59 21.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.234 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.847 ' CG2' HD11 ' A' ' 62' ' ' ILE . 15.4 t -128.43 139.42 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 121.373 0.606 . . . . 0.0 112.093 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.547 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 14.8 m-90 -100.57 139.98 35.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.142 -0.936 . . . . 0.0 112.255 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.673 HG23 ' CD ' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -108.9 127.23 53.87 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.17 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.672 ' CE2' HG21 ' A' ' 36' ' ' VAL . 3.4 m-85 -113.27 145.74 40.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.935 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.699 ' CA ' HD21 ' A' ' 78' ' ' LEU . . . 161.6 -173.96 38.06 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.115 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 27.4 mtm180 -79.12 0.75 26.83 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.733 0.271 . . . . 0.0 111.733 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.475 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -84.78 131.95 47.77 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.516 0.198 . . . . 0.0 110.774 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 14.8 Cg_exo -67.84 -8.31 22.14 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.492 2.128 . . . . 0.0 111.792 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.18 -43.55 16.02 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 121.922 0.867 . . . . 0.0 108.896 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -41.37 138.35 1.27 Allowed 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 113.697 -1.592 . . . . 0.0 110.71 179.538 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -56.46 -18.54 11.69 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.134 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.548 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 55.2 t80 -129.15 123.39 31.99 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-O 120.791 0.329 . . . . 0.0 110.756 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -100.98 123.18 44.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.908 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.699 HD21 ' CA ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -109.0 -72.17 0.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.843 179.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -170.47 -118.83 0.48 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.531 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -163.81 67.2 0.17 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.922 0.392 . . . . 0.0 110.914 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.622 HD12 ' CD1' ' A' ' 84' ' ' LEU . 30.7 mt -93.96 136.34 25.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.171 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.97 -41.28 96.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.891 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.4 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -62.41 -28.6 69.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.062 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.622 ' CD1' HD12 ' A' ' 81' ' ' ILE . 32.5 mt -96.57 152.1 18.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.055 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 93.0 p -97.55 164.21 12.53 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.529 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.682 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.7 m-20 -41.96 -53.04 3.97 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.326 0.584 . . . . 0.0 109.782 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.465 ' HB3' HD11 ' A' ' 104' ' ' ILE . 25.3 mttt -119.39 85.62 2.41 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 177.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.573 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.2 t60 -65.05 -44.21 89.77 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -176.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.506 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 37.7 p90 -153.26 163.27 40.21 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 119.984 -0.686 . . . . 0.0 112.461 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.673 ' CD ' HG23 ' A' ' 67' ' ' THR . 12.4 mt-30 -135.68 156.81 48.26 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.51 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.496 ' O ' HG13 ' A' ' 65' ' ' VAL . 18.3 mt -127.8 132.35 68.96 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.205 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.649 ' CB ' HG22 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -120.64 148.35 44.03 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.12 0.486 . . . . 0.0 111.791 -179.268 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.804 HD22 ' CG1' ' A' ' 33' ' ' VAL . 48.2 tp -125.06 123.19 39.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.361 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.71 -175.08 30.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.754 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.27 81.06 1.38 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.788 0.328 . . . . 0.0 110.975 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -155.45 -45.16 0.08 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.986 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 137.51 44.25 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.481 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -170.54 162.57 8.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.796 0.331 . . . . 0.0 110.832 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.606 ' HB3' HD13 ' A' ' 124' ' ' LEU . 3.9 mm? -107.27 156.88 18.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.922 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.572 HD12 ' O ' ' A' ' 99' ' ' LEU . 2.9 mp -131.4 143.69 50.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.395 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.494 HD22 HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -114.9 126.06 54.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.479 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.473 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 49.3 t30 -115.57 115.75 26.97 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.751 -0.379 . . . . 0.0 111.57 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.795 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.3 p30 -79.57 143.19 35.01 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.283 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.503 HG21 ' OE1' ' A' ' 90' ' ' GLN . 11.0 pt -150.3 35.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.624 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -95.1 151.23 19.38 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 120.942 0.401 . . . . 0.0 111.814 -178.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 50.6 m -68.8 -31.57 70.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.014 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -98.08 -19.72 17.79 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.624 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.39 154.92 9.63 Favored Glycine 0 N--CA 1.439 -1.164 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.609 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.508 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.5 m -117.53 137.69 52.4 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.857 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -116.39 148.35 40.74 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -178.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.459 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.23 113.43 18.28 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.437 177.482 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.404 ' N ' HD12 ' A' ' 111' ' ' LEU . 2.2 m-80 44.89 43.37 7.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.227 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.17 -7.32 78.66 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.838 -0.696 . . . . 0.0 113.47 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -105.61 118.58 36.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.043 0.449 . . . . 0.0 110.724 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.857 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 15.0 tptt -74.02 121.55 21.23 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.239 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.795 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.6 m -95.6 164.03 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.124 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 120' ' ' SER . 28.3 tp10 -69.88 128.98 38.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.474 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.693 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 80.3 tttt -54.61 161.92 1.33 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.989 0.423 . . . . 0.0 110.599 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.455 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.0 m-80 34.67 33.97 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.437 -0.802 . . . . 0.0 112.105 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.4 145.18 40.58 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.025 179.441 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.535 ' HB3' HD23 ' A' ' 100' ' ' LEU . 22.1 m120 -88.78 131.35 35.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.949 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.451 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 39.9 mm-40 -129.27 150.36 50.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.379 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.3 tp -72.62 111.86 8.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.823 0.344 . . . . 0.0 110.309 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.639 ' CD2' HD11 ' A' ' 147' ' ' ILE . 7.7 tt -55.01 156.78 3.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.287 0.565 . . . . 0.0 111.541 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.29 153.47 41.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.812 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.434 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.5 122.2 20.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.025 0.441 . . . . 0.0 110.531 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.14 18.71 60.73 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.42 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -57.22 173.36 0.24 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.879 0.371 . . . . 0.0 110.973 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 13.0 tt0 -145.04 135.64 24.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.118 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.481 ' CG2' HG22 ' A' ' 109' ' ' THR . 2.6 mt -108.89 128.3 64.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.45 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.482 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 25.4 m -104.24 141.16 36.76 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.102 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.547 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 27.2 m -140.25 158.43 25.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -178.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.55 42.93 8.77 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.241 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.466 ' HA ' HG12 ' A' ' 140' ' ' ILE . 71.7 t -84.59 140.38 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-O 121.617 0.722 . . . . 0.0 112.286 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.86 -40.66 1.12 Allowed Glycine 0 N--CA 1.436 -1.345 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.596 HG12 ' H ' ' A' ' 138' ' ' SER . 48.4 t -126.37 120.83 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 CA-C-N 114.462 -0.869 . . . . 0.0 109.049 177.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.491 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.5 OUTLIER -50.5 -24.98 3.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.664 0.269 . . . . 0.0 111.473 -178.785 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.596 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -93.5 6.51 47.96 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -179.363 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -129.7 26.12 5.31 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.491 HD12 ' HA ' ' A' ' 137' ' ' GLU . 5.9 mt -106.87 139.07 29.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.094 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.445 HD13 HE21 ' A' ' 42' ' ' GLN . 24.9 tp -124.74 134.51 52.79 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.803 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.59 ' H ' HG21 ' A' ' 40' ' ' THR . 0.9 OUTLIER -109.6 133.54 52.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.958 0.409 . . . . 0.0 111.548 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.672 HD13 ' HA ' ' A' ' 38' ' ' CYS . 1.4 mm? -128.29 134.5 48.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.688 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 21.6 t -110.98 135.55 49.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.816 0.341 . . . . 0.0 111.262 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.3 mm -106.31 134.79 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.78 ' CD1' HD12 ' A' ' 37' ' ' ILE . 14.9 m-85 -115.41 119.79 37.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.767 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.639 HD11 ' CD2' ' A' ' 124' ' ' LEU . 5.8 mt -84.82 134.01 27.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.499 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -75.89 116.4 16.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.663 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -58.22 -32.11 67.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.009 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.0 -46.09 90.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.59 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.494 ' CZ ' HD21 ' A' ' 93' ' ' LEU . 11.5 t80 -59.14 -44.19 92.06 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.027 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.6 mtpm? -65.15 -39.72 93.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.986 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -58.81 -44.84 90.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.062 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.6 t -65.48 -44.15 88.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.983 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.94 -36.47 84.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.965 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.37 -34.07 77.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.949 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -89.61 -36.28 15.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.4 p30 42.61 91.69 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.432 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -75.19 118.85 18.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.88 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 10.4 m -81.54 125.98 39.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.175 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -66.73 -35.46 80.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.911 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.94 132.0 51.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.822 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.6 pt -96.3 115.59 36.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.055 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.897 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.785 0.326 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 70.26 -63.72 0.39 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.003 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -59.9 -34.24 72.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.03 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -68.27 -39.17 82.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.857 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -56.99 -41.48 78.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.73 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.6 tp -58.45 -33.76 70.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.571 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.539 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.5 mt -73.16 -35.87 48.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.783 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -33.75 68.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.956 0.408 . . . . 0.0 110.904 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.1 mmpt? -58.73 -26.37 63.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.409 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.539 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.8 -48.48 77.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.268 0.556 . . . . 0.0 111.064 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.1 m -81.15 -21.76 39.51 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.062 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 70.31 98.46 0.06 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.794 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -62.98 130.61 45.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.903 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -84.35 112.13 20.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.93 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.5 mm -81.94 138.45 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 CA-C-O 121.593 0.711 . . . . 0.0 111.692 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -146.13 47.71 0.71 Allowed Glycine 0 C--N 1.314 -0.646 0 CA-C-N 114.594 -1.184 . . . . 0.0 112.656 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -59.11 -42.86 91.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.923 0.392 . . . . 0.0 110.548 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.452 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.9 m-20 -177.29 36.29 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.653 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.5 mm -76.66 136.74 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-N 113.774 -1.557 . . . . 0.0 112.535 -177.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.966 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.1 t -91.05 -59.41 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.682 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 4.8 p -150.41 165.47 33.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.32 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.412 ' CD ' ' CG2' ' A' ' 45' ' ' ILE . 0.2 OUTLIER -128.01 138.15 52.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.804 0.335 . . . . 0.0 111.188 -179.411 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.736 HG11 ' CE2' ' A' ' 68' ' ' PHE . 3.1 m -106.48 122.76 60.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.852 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.675 HG23 HG12 ' A' ' 45' ' ' ILE . 17.3 mt -125.02 122.58 63.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.617 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.764 ' HA ' HD23 ' A' ' 143' ' ' LEU . 50.7 t -79.93 107.34 12.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.809 0.338 . . . . 0.0 110.402 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.3 t -70.97 -28.47 64.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.978 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.518 HG21 ' H ' ' A' ' 142' ' ' SER . 69.8 p -79.87 -2.17 42.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.693 0.283 . . . . 0.0 111.527 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.1 80.56 0.11 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.947 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.543 ' HB2' HD12 ' A' ' 43' ' ' ILE . 9.8 mt-30 -146.86 -41.69 0.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.912 0.386 . . . . 0.0 110.932 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.72 HG12 HD22 ' A' ' 78' ' ' LEU . 5.3 mp -119.41 143.48 34.56 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.218 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.692 ' HD2' HG23 ' A' ' 43' ' ' ILE . 43.9 Cg_endo -70.27 146.11 56.07 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.325 2.017 . . . . 0.0 111.963 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.675 HG12 HG23 ' A' ' 37' ' ' ILE . 32.2 mt -62.81 131.64 28.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.924 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.459 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -117.25 146.36 43.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.91 179.144 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.67 119.66 39.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.986 0.422 . . . . 0.0 111.629 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.829 HD23 ' CD2' ' A' ' 66' ' ' TRP . 6.9 mp -92.05 125.5 36.76 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.966 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -135.82 156.98 47.96 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 122.285 1.04 . . . . 0.0 113.531 -179.427 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.478 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -150.23 141.88 23.59 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 113.613 -1.631 . . . . 0.0 110.721 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.833 ' O ' HG23 ' A' ' 55' ' ' VAL . 3.7 m-20 -75.43 124.15 26.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.029 0.442 . . . . 0.0 111.346 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.4 mt -64.47 -41.89 93.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.428 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.8 m -59.34 -42.16 90.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.296 0.57 . . . . 0.0 111.03 -178.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.48 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 6.9 mt-30 -68.6 -36.78 79.16 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.795 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 51' ' ' ASP . 44.6 t -68.84 -38.37 78.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.844 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.52 -30.51 67.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.862 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.92 -42.62 16.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -63.09 128.92 38.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.831 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.23 30.91 6.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.8 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.6 mtm105 -90.76 -178.13 5.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.963 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.6 t -78.69 -32.76 47.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.086 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.498 HD11 ' HB2' ' A' ' 92' ' ' LEU . 5.9 tp -134.44 160.65 41.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.129 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.753 ' HG3' HG13 ' A' ' 55' ' ' VAL . 1.3 mmtt -109.0 -70.51 0.8 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.465 ' CE ' ' O ' ' A' ' 49' ' ' SER . 30.8 ttpt -144.34 123.05 12.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.853 0.358 . . . . 0.0 111.918 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.698 HG22 ' HG2' ' A' ' 90' ' ' GLN . 13.1 p -110.4 139.76 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.829 ' CD2' HD23 ' A' ' 48' ' ' LEU . 20.6 m-90 -100.81 139.85 35.91 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.033 -1.44 . . . . 0.0 112.227 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.683 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -111.91 133.1 54.32 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 177.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.736 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -120.01 145.5 46.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.556 -178.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.621 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 160.81 -169.41 36.47 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.489 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.835 ' NH2' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -85.29 7.48 22.06 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.733 0.267 . . . . 0.0 111.521 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.438 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 6.4 t-20 -84.9 134.17 42.01 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-O 120.532 0.206 . . . . 0.0 110.783 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -65.84 -13.75 41.34 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.547 2.165 . . . . 0.0 111.843 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.438 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -83.2 -44.76 14.66 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 121.936 0.874 . . . . 0.0 109.186 178.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.75 137.63 2.19 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.728 -1.578 . . . . 0.0 111.485 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 67' ' ' THR . 21.9 m-20 -56.82 -18.88 14.53 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.231 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.732 ' CD2' HD21 ' A' ' 78' ' ' LEU . 7.8 t80 -129.8 103.28 6.73 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.817 0.342 . . . . 0.0 110.88 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.583 ' C ' HD23 ' A' ' 78' ' ' LEU . 2.2 t-160 -85.89 121.79 29.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.98 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.835 HD12 ' NH2' ' A' ' 70' ' ' ARG . 2.4 mt -103.87 -67.55 0.89 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -173.91 -98.47 0.11 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.607 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.403 ' HA ' ' CB ' ' A' ' 70' ' ' ARG . 0.7 OUTLIER -177.91 46.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.007 0.432 . . . . 0.0 110.8 -179.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.59 ' HB ' HD13 ' A' ' 84' ' ' LEU . 42.2 mm -76.51 134.85 28.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.021 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.5 p -65.24 -40.52 94.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.45 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.466 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -60.66 -24.87 65.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.902 0.382 . . . . 0.0 110.646 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.624 ' N ' HD12 ' A' ' 84' ' ' LEU . 3.7 mp -107.5 152.69 23.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.507 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.458 ' O ' ' NH1' ' A' ' 70' ' ' ARG . 59.7 p -98.87 153.86 18.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.89 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.621 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.6 m-20 -30.33 -53.49 0.17 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.361 0.6 . . . . 0.0 110.549 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.674 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.5 OUTLIER -120.16 84.18 2.17 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 177.321 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.565 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.3 t60 -61.55 -46.3 90.5 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.034 -0.985 . . . . 0.0 112.593 -177.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.544 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 22.0 p90 -142.36 160.73 39.69 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.058 -0.657 . . . . 0.0 112.109 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.698 ' HG2' HG22 ' A' ' 65' ' ' VAL . 3.3 tt0 -135.98 143.39 44.8 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.034 -179.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.675 ' C ' HG23 ' A' ' 65' ' ' VAL . 61.6 mt -122.39 132.14 71.73 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.196 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.688 HD21 ' OD1' ' A' ' 121' ' ' ASN . 0.4 OUTLIER -125.66 141.65 51.91 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.014 0.435 . . . . 0.0 111.842 -179.794 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.711 HD22 ' CG1' ' A' ' 33' ' ' VAL . 0.6 OUTLIER -125.36 132.66 52.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.315 179.034 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.458 ' CA ' ' HG2' ' A' ' 63' ' ' LYS . . . 168.51 -137.76 4.75 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.662 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 65.42 -77.57 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.843 0.354 . . . . 0.0 110.969 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -133.48 -46.36 0.82 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.928 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -178.39 -37.19 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.549 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -58.37 170.5 0.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.762 0.315 . . . . 0.0 110.94 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.532 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -108.23 154.34 21.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.84 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.532 HD12 ' O ' ' A' ' 99' ' ' LEU . 2.5 mp -131.21 142.19 50.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.496 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.9 pp -113.42 124.7 53.04 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.187 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.619 ' HB2' HD21 ' A' ' 92' ' ' LEU . 54.8 t30 -116.03 120.29 38.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.056 0.455 . . . . 0.0 111.923 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.76 ' OD2' HG23 ' A' ' 116' ' ' VAL . 20.4 p30 -80.62 137.57 36.37 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.748 178.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.517 HD12 ' HB2' ' A' ' 87' ' ' LYS . 8.3 pt -144.58 39.33 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.565 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -97.12 162.28 13.44 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.073 0.463 . . . . 0.0 111.602 -179.278 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 89.1 m -69.11 -40.92 78.06 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.734 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -98.7 -19.94 17.22 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.096 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.565 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 126.58 160.69 10.66 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 119.948 -1.12 . . . . 0.0 114.205 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.538 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 13.9 m -117.63 138.02 52.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.853 -0.674 . . . . 0.0 109.253 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.876 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -111.97 148.36 33.94 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.405 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.21 113.52 18.41 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.491 -1.231 . . . . 0.0 108.197 177.399 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 44.5 42.79 5.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.47 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.71 -10.1 71.32 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.768 -0.729 . . . . 0.0 113.548 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -104.34 118.5 36.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.079 0.466 . . . . 0.0 110.696 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.876 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.0 tptm -73.82 126.88 31.39 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.194 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.76 HG23 ' OD2' ' A' ' 103' ' ' ASP . 8.7 m -99.51 166.51 2.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.384 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 120' ' ' SER . 3.0 tp10 -69.93 126.21 29.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.607 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.704 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 74.1 tttt -54.58 162.57 1.12 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.04 0.448 . . . . 0.0 110.534 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.0 OUTLIER 37.33 31.44 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.454 -0.793 . . . . 0.0 112.069 -179.218 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.479 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.65 143.94 43.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.847 179.095 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.688 ' OD1' HD21 ' A' ' 92' ' ' LEU . 23.4 m-80 -94.01 135.52 35.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.921 0.391 . . . . 0.0 111.018 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 59.0 mm-40 -129.38 152.32 49.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.393 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.458 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.6 tm? -72.4 118.36 15.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.959 0.409 . . . . 0.0 110.336 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.57 HD21 ' CG1' ' A' ' 147' ' ' ILE . 7.4 tt -52.12 155.59 1.87 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.437 0.637 . . . . 0.0 111.788 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.408 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.7 OUTLIER -124.52 153.23 42.4 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.349 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.605 ' HA ' HD13 ' A' ' 147' ' ' ILE . 27.3 mm100 -71.62 124.55 24.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.88 0.372 . . . . 0.0 110.478 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 56.94 22.08 40.34 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.257 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.408 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 19.9 t70 -54.86 173.14 0.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.946 0.403 . . . . 0.0 110.811 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.9 ' CG ' HG22 ' A' ' 144' ' ' VAL . 1.9 mt-10 -144.29 135.74 25.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.145 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.791 HD11 HD11 ' A' ' 145' ' ' ILE . 12.7 mt -113.11 127.56 70.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.791 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.614 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.0 m -104.45 137.79 41.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.741 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.543 HG23 HD21 ' A' ' 84' ' ' LEU . 33.9 m -140.25 158.29 25.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.68 28.92 25.35 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.135 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.488 ' HA ' HG12 ' A' ' 140' ' ' ILE . 70.4 t -70.89 140.39 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-O 121.62 0.724 . . . . 0.0 112.38 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.1 -38.98 0.83 Allowed Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.492 HG12 ' H ' ' A' ' 138' ' ' SER . 48.2 t -126.49 129.38 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-N 114.641 -0.779 . . . . 0.0 109.117 178.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -50.51 -36.07 32.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.807 0.337 . . . . 0.0 111.567 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.492 ' H ' HG12 ' A' ' 136' ' ' VAL . 3.4 p -93.61 6.54 47.94 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.422 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 9.5 t0 -120.74 25.97 9.39 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.614 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.4 mt -107.1 139.15 29.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.102 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.409 HD23 ' C ' ' A' ' 141' ' ' LEU . 9.6 tt -124.2 134.4 53.29 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.434 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.518 ' H ' HG21 ' A' ' 40' ' ' THR . 38.5 t -108.01 150.24 27.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.721 0.772 . . . . 0.0 112.261 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.764 HD23 ' HA ' ' A' ' 38' ' ' CYS . 76.2 mt -135.87 155.7 49.92 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.903 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.9 HG22 ' CG ' ' A' ' 129' ' ' GLU . 21.5 t -123.6 140.16 47.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.73 0.3 . . . . 0.0 110.918 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.791 HD11 HD11 ' A' ' 130' ' ' ILE . 7.9 mt -106.22 120.87 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-O 120.93 0.395 . . . . 0.0 111.01 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.84 126.3 52.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.452 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.694 ' N ' HD12 ' A' ' 147' ' ' ILE . 2.8 mp -99.19 131.51 46.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.284 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -76.05 112.0 12.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.841 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -58.5 -34.01 70.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.909 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.77 -46.2 91.4 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.741 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -61.53 -44.16 97.56 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.057 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.14 -35.21 80.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.935 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.05 -42.98 91.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.891 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.2 t -65.94 -46.02 79.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.968 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.14 -36.57 82.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.48 -39.43 87.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.79 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -86.64 -37.1 18.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.809 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.6 p30 44.07 -171.19 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.598 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.4 131.88 36.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.004 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 5.2 m -92.35 123.41 44.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.162 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -81.08 -31.46 34.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.981 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -131.07 126.04 34.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.941 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -85.93 133.01 30.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.097 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.159 -0.924 . . . . 0.0 110.848 -179.959 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.642 ' HB3' ' HD3' ' A' ' 17' ' ' ARG . . . . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.83 0.348 . . . . 0.0 111.068 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.2 t -116.95 -35.83 4.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.087 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -46.94 87.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.986 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.642 ' HD3' ' HB3' ' A' ' 14' ' ' ALA . 3.4 ptm180 -67.7 -35.94 79.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.989 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.7 -42.42 88.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.008 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.32 -44.92 95.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.52 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.7 mm -67.41 -35.0 72.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.269 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -57.17 -35.88 70.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.949 0.404 . . . . 0.0 110.469 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.2 -23.87 65.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.735 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.52 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.7 -47.37 80.07 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.281 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.3 t -64.56 -33.68 76.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -83.42 68.62 9.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -86.04 130.05 34.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.75 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -79.17 106.28 11.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.001 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.5 mm -82.02 138.41 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 CA-C-O 121.651 0.739 . . . . 0.0 111.713 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.09 43.49 32.96 Favored Glycine 0 C--N 1.314 -0.671 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.289 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -72.2 -35.38 68.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.659 0.266 . . . . 0.0 111.265 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.424 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.7 OUTLIER 176.05 39.3 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.663 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 6.0 mm -72.59 135.47 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 CA-C-N 113.612 -1.631 . . . . 0.0 112.638 -177.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.963 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.3 t -91.75 -59.16 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-N 114.68 -1.146 . . . . 0.0 109.715 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.548 ' SG ' HD22 ' A' ' 48' ' ' LEU . 4.9 p -147.31 165.32 30.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.46 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.549 ' NH1' HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -127.06 127.01 44.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.723 0.297 . . . . 0.0 111.263 -179.57 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.693 HG11 ' CE2' ' A' ' 68' ' ' PHE . 4.6 m -94.17 122.8 45.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.916 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.823 HG23 HG12 ' A' ' 45' ' ' ILE . 19.6 mt -129.34 121.84 54.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.634 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.533 ' HA ' HD23 ' A' ' 143' ' ' LEU . 52.3 t -81.27 124.34 29.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.254 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.96 -25.68 21.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.808 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.517 HG23 ' HB3' ' A' ' 142' ' ' SER . 81.8 p -79.87 -2.28 42.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.709 0.29 . . . . 0.0 111.562 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.07 74.42 0.46 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.93 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.455 ' HB2' HD11 ' A' ' 141' ' ' LEU . 7.7 mt-30 -144.43 -46.0 0.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.964 0.411 . . . . 0.0 110.789 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.612 HG12 ' HA ' ' A' ' 78' ' ' LEU . 2.8 mp -111.84 140.76 23.69 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.729 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.553 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.4 Cg_endo -73.4 143.78 35.42 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.147 1.898 . . . . 0.0 112.16 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.823 HG12 HG23 ' A' ' 37' ' ' ILE . 35.7 mt -56.33 142.93 10.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.575 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.452 ' HB2' ' CE1' ' A' ' 76' ' ' TYR . 0.4 OUTLIER -130.37 164.04 25.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.298 179.518 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.42 119.39 33.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.946 0.403 . . . . 0.0 111.529 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.792 HD21 ' HZ ' ' A' ' 68' ' ' PHE . 7.8 mp -94.38 124.71 38.58 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.963 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -136.3 156.15 49.07 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 122.283 1.04 . . . . 0.0 113.67 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.477 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -151.46 141.92 22.54 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.45 -1.705 . . . . 0.0 110.989 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.5 ' HB2' ' HG3' ' A' ' 54' ' ' GLN . 1.2 m-20 -74.95 128.81 36.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.128 0.49 . . . . 0.0 110.894 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.463 HD13 ' SG ' ' A' ' 154' ' ' CYS . 35.6 mt -64.17 -38.01 81.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.973 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 t -56.8 -42.04 78.81 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.886 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.5 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 2.1 mt-30 -68.58 -46.3 69.75 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.853 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.793 HG13 ' HG3' ' A' ' 63' ' ' LYS . 47.4 t -63.87 -38.06 81.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.29 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.7 tt -70.98 -41.99 70.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.301 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -76.96 -40.21 47.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.13 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -63.01 130.94 46.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.799 0.333 . . . . 0.0 110.923 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.97 37.54 2.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.011 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 74.7 mtt180 -107.9 170.96 7.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.019 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.4 p -72.01 -38.0 69.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.867 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.483 HG21 ' CG2' ' A' ' 65' ' ' VAL . 28.2 mm -121.48 143.79 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.039 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.793 ' HG3' HG13 ' A' ' 55' ' ' VAL . 8.6 mmtp -110.33 -59.46 1.94 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.844 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.472 ' HE2' ' O ' ' A' ' 49' ' ' SER . 3.7 ttpt -140.3 130.41 24.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.853 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.737 HG12 ' HG2' ' A' ' 90' ' ' GLN . 9.3 t -124.14 138.34 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 121.26 0.552 . . . . 0.0 112.123 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.649 ' CD2' HD23 ' A' ' 48' ' ' LEU . 17.8 m-90 -100.88 139.6 36.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.127 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.605 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.27 130.47 55.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.043 0.449 . . . . 0.0 109.97 177.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.792 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -120.12 145.35 47.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.031 -179.07 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.595 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.35 -168.13 37.9 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.56 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.427 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 0.7 OUTLIER -79.46 -0.7 34.15 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.561 HD22 ' HB3' ' A' ' 73' ' ' ALA . 2.3 t30 -84.8 132.35 46.49 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.663 0.268 . . . . 0.0 111.148 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.8 Cg_exo -66.73 -13.52 40.25 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.639 2.226 . . . . 0.0 111.76 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.561 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.6 -43.06 17.47 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -41.11 141.04 0.69 Allowed 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 113.887 -1.506 . . . . 0.0 110.655 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 67' ' ' THR . 60.6 m-20 -56.31 -18.88 12.0 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.047 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.53 ' CE2' HG21 ' A' ' 43' ' ' ILE . 2.8 t80 -130.06 129.1 43.2 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-O 120.771 0.32 . . . . 0.0 111.325 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -106.79 107.65 18.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.462 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.612 ' HA ' HG12 ' A' ' 43' ' ' ILE . 20.7 mt -72.22 -70.57 0.33 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.385 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 170.5 -89.72 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.601 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -164.49 62.88 0.14 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.95 0.405 . . . . 0.0 111.189 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.815 HD13 HD12 ' A' ' 84' ' ' LEU . 3.9 mp -104.63 111.87 35.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.835 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.1 m -56.11 -37.08 68.93 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.102 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.54 -17.5 59.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.302 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.815 HD12 HD13 ' A' ' 81' ' ' ILE . 20.0 mt -104.56 152.03 22.9 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.681 0.277 . . . . 0.0 111.157 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 57.7 p -96.63 167.97 10.81 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.566 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.595 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 8.1 m-20 -42.84 -58.74 2.24 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.365 0.602 . . . . 0.0 109.81 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.537 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.5 OUTLIER -115.36 82.74 1.8 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 176.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.556 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.1 t60 -59.6 -46.86 87.69 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.517 -176.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.532 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 29.8 p90 -145.54 161.49 39.65 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.214 -0.594 . . . . 0.0 112.005 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.737 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.2 tt0 -136.06 144.02 44.98 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.911 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.755 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 81.4 mt -118.88 124.7 73.6 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.272 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.044 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.669 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -102.26 151.27 22.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.964 0.411 . . . . 0.0 111.723 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.776 HD22 HG11 ' A' ' 33' ' ' VAL . 25.4 tp -125.29 122.97 38.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.439 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -172.22 -152.66 8.67 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.629 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 59.33 -173.19 0.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.795 0.331 . . . . 0.0 110.97 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -85.59 90.38 7.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 59.17 54.32 38.95 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.609 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -150.9 155.64 39.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.856 0.36 . . . . 0.0 110.844 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.777 ' HB2' HD22 ' A' ' 124' ' ' LEU . 4.1 mm? -114.17 160.07 19.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.759 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.642 ' HB3' HD12 ' A' ' 92' ' ' LEU . 3.2 mp -131.31 145.46 51.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.689 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.726 HD21 HD12 ' A' ' 145' ' ' ILE . 11.0 mp -112.71 121.07 43.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.028 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.669 ' HB2' HD11 ' A' ' 92' ' ' LEU . 44.2 t30 -115.49 115.44 26.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.93 0.395 . . . . 0.0 111.552 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.828 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.3 p30 -78.59 140.44 38.47 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.536 HD12 ' HB2' ' A' ' 87' ' ' LYS . 10.1 pt -148.99 38.36 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -178.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.648 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.29 152.7 19.14 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 121.013 0.435 . . . . 0.0 112.063 -178.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 50.8 m -68.89 -31.44 70.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.875 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -98.21 -19.91 17.58 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -178.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.648 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.91 156.67 10.39 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.355 -0.926 . . . . 0.0 113.713 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.502 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.1 m -117.43 137.78 52.28 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.844 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -115.96 148.58 39.94 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -177.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.12 113.58 18.54 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.483 177.657 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 44.72 43.27 6.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.444 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.58 -12.68 62.53 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.722 -0.752 . . . . 0.0 113.468 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.8 118.56 36.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.087 0.444 . . . . 0.0 110.605 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.844 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -71.44 131.71 43.74 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.48 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.828 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.6 m -101.59 165.87 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.966 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.4 mp0 -69.83 126.12 28.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.482 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.69 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 84.4 tttt -54.11 162.52 0.99 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.824 0.345 . . . . 0.0 110.654 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 103' ' ' ASP . 2.3 m-80 34.21 35.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.109 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.19 145.17 40.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.035 179.531 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.641 ' HB3' HD23 ' A' ' 100' ' ' LEU . 3.5 m120 -88.0 132.03 34.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.919 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.477 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 45.1 mm-40 -129.33 150.2 50.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.611 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.6 tp -72.8 136.13 45.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.488 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.854 HD21 HG12 ' A' ' 147' ' ' ILE . 16.2 tp -62.43 152.69 33.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.628 0.727 . . . . 0.0 111.585 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.503 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.4 OUTLIER -125.3 152.59 44.47 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.505 179.442 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.463 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -72.28 122.57 21.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 0.0 110.177 179.595 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.03 23.98 48.73 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.054 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.414 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 28.8 t70 -49.08 167.96 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.93 0.395 . . . . 0.0 111.487 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.938 ' CG ' HG22 ' A' ' 144' ' ' VAL . 2.3 mt-10 -144.27 135.68 25.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.003 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.484 ' CG2' HG22 ' A' ' 109' ' ' THR . 16.2 mt -115.71 127.3 73.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.804 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.589 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.0 m -104.59 139.16 39.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.873 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.533 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.2 m -140.38 158.41 25.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.5 28.86 26.02 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.161 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.488 ' HA ' HG12 ' A' ' 140' ' ' ILE . 78.1 t -71.35 140.39 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-O 121.626 0.727 . . . . 0.0 112.288 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.18 -39.5 0.92 Allowed Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.514 HG12 ' H ' ' A' ' 138' ' ' SER . 46.4 t -126.42 128.26 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 CA-C-N 114.689 -0.755 . . . . 0.0 109.068 177.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.51 -33.85 23.03 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.597 0.237 . . . . 0.0 111.632 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.514 ' H ' HG12 ' A' ' 136' ' ' VAL . 1.8 m -93.53 6.46 48.14 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.01 26.79 7.95 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.589 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.6 mt -107.06 138.96 30.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.102 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.455 HD11 ' HB2' ' A' ' 42' ' ' GLN . 7.0 tt -124.63 134.38 52.93 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.531 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.517 ' HB3' HG23 ' A' ' 40' ' ' THR . 38.0 t -108.59 150.33 27.65 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.567 0.698 . . . . 0.0 112.069 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.599 HD21 HD13 ' A' ' 43' ' ' ILE . 75.9 mt -135.78 155.12 50.84 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.861 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.938 HG22 ' CG ' ' A' ' 129' ' ' GLU . 20.0 t -127.6 138.14 55.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.784 0.326 . . . . 0.0 111.166 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.726 HD12 HD21 ' A' ' 101' ' ' LEU . 19.4 mt -106.45 129.06 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 CA-C-O 120.852 0.358 . . . . 0.0 110.885 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.12 122.92 49.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.916 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.854 HG12 HD21 ' A' ' 124' ' ' LEU . 3.3 mt -91.35 134.14 30.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.474 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.76 112.37 19.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.675 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.71 -31.86 68.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.072 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt -58.95 -45.13 91.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.999 0.428 . . . . 0.0 110.609 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -58.78 -44.17 90.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.985 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.427 ' NZ ' HG21 ' A' ' 147' ' ' ILE . 28.9 mttp -65.26 -35.16 80.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.097 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -58.97 -47.1 86.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.284 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.463 ' SG ' HD13 ' A' ' 52' ' ' ILE . 12.0 t -61.15 -45.93 92.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.006 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.12 -36.53 77.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.925 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.94 -35.27 74.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.698 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -89.58 -34.86 16.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.813 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.6 p30 42.5 92.71 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.591 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.21 136.4 53.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.847 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 30.3 m -64.97 134.92 29.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.225 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -135.45 172.46 12.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.978 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 43.4 ttp85 -162.85 102.98 1.02 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.894 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.9 mp -99.42 135.15 35.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.093 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.123 -0.942 . . . . 0.0 110.936 179.932 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.832 0.349 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.8 p -149.34 -58.87 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -71.21 -46.93 60.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.927 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 -61.63 -44.15 97.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -60.01 -36.49 77.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.063 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.9 tp -63.73 -45.99 87.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.963 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 40.3 mm -63.27 -39.61 85.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.226 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -57.88 -33.89 69.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.234 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -65.15 -30.86 71.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.479 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -57.06 -47.49 80.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.089 0.471 . . . . 0.0 111.116 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.3 m -70.16 -29.53 66.45 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.939 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -43.85 69.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.959 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -78.78 136.84 37.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.976 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -100.35 114.09 27.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.832 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.9 mm -85.01 138.32 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-O 121.603 0.716 . . . . 0.0 111.974 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.414 ' HA2' HG12 ' A' ' 32' ' ' ILE . . . -78.26 65.43 3.34 Favored Glycine 0 C--N 1.313 -0.719 0 CA-C-N 114.546 -1.206 . . . . 0.0 112.327 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -65.53 -41.79 92.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.661 0.267 . . . . 0.0 111.323 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.433 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.1 m120 -178.32 38.1 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.587 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 7.6 mm -71.51 144.52 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 CA-C-N 113.695 -1.593 . . . . 0.0 112.477 -176.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.799 HG22 HD13 ' A' ' 93' ' ' LEU . 1.2 t -105.71 -56.35 5.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.717 -178.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.757 ' SG ' HD12 ' A' ' 48' ' ' LEU . 31.3 p -151.51 164.51 36.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.221 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.41 138.26 53.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.835 0.35 . . . . 0.0 111.477 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.655 HG21 ' CE2' ' A' ' 68' ' ' PHE . 18.3 t -103.81 122.59 56.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.685 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.52 HG23 HG12 ' A' ' 45' ' ' ILE . 20.6 mt -127.0 115.82 42.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.461 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.576 ' HA ' HD13 ' A' ' 143' ' ' LEU . 37.7 t -79.97 124.75 28.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.82 0.343 . . . . 0.0 110.489 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.9 t -92.18 -26.99 17.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.556 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.518 HG21 ' H ' ' A' ' 142' ' ' SER . 25.9 p -79.93 -2.17 42.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.521 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.05 75.7 0.37 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.915 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -146.01 -44.9 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.789 0.328 . . . . 0.0 111.002 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.618 ' CD1' HD21 ' A' ' 143' ' ' LEU . 1.0 OUTLIER -112.73 140.61 24.16 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.831 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.534 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 59.6 Cg_endo -74.43 141.54 28.6 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.253 1.969 . . . . 0.0 112.361 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.52 HG12 HG23 ' A' ' 37' ' ' ILE . 35.9 mt -56.69 133.99 20.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.408 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.29 164.46 25.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.551 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -116.49 119.82 36.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.086 0.47 . . . . 0.0 111.774 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.857 HD22 ' CD1' ' A' ' 66' ' ' TRP . 17.8 mt -92.27 137.9 31.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.107 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.587 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -141.62 158.39 43.89 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 122.283 1.04 . . . . 0.0 113.756 -178.659 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.649 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . -146.5 141.81 27.43 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 113.447 -1.706 . . . . 0.0 110.43 178.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.901 ' O ' HG23 ' A' ' 55' ' ' VAL . 1.6 m-20 -76.74 132.46 39.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.066 0.46 . . . . 0.0 111.289 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.699 HD13 ' SG ' ' A' ' 154' ' ' CYS . 77.9 mt -64.64 -44.15 96.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.488 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.9 t -59.64 -42.37 92.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.245 0.545 . . . . 0.0 111.087 -178.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.497 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 6.3 mt-30 -68.8 -36.8 78.71 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.084 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 51' ' ' ASP . 56.3 t -69.85 -44.22 79.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.133 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 mp -67.78 -26.17 65.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.094 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -88.44 -52.9 4.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.136 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -67.17 127.34 32.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.039 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.72 39.79 2.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.8 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 76.8 mmt-85 -107.61 76.73 1.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.953 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.2 t 68.44 -68.82 0.16 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.054 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.64 HD13 HD12 ' A' ' 92' ' ' LEU . 9.0 tp -133.06 159.32 43.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.252 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.482 ' HG2' ' HA ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -110.43 -62.94 1.45 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.2 -179.765 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.417 ' HE2' ' O ' ' A' ' 49' ' ' SER . 4.4 ttpt -132.32 135.17 46.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.754 0.312 . . . . 0.0 111.746 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 91' ' ' ILE . 17.0 t -134.03 139.55 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 121.182 0.515 . . . . 0.0 111.805 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.857 ' CD1' HD22 ' A' ' 48' ' ' LEU . 16.4 m-90 -100.42 139.42 36.12 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.019 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.898 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -110.09 132.86 53.78 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.649 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.738 ' HZ ' HD11 ' A' ' 48' ' ' LEU . 2.0 m-85 -115.9 145.7 42.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.478 -178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.693 ' HA2' HD12 ' A' ' 78' ' ' LEU . . . 173.96 -170.3 43.42 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.17 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 26.9 mtm180 -87.5 -13.44 43.08 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.472 ' H ' ' ND2' ' A' ' 71' ' ' ASN . 0.2 OUTLIER -84.32 143.12 41.45 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.927 0.394 . . . . 0.0 111.364 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 7.2 Cg_exo -70.47 1.3 5.04 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.175 2.583 . . . . 0.0 111.958 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.51 -49.07 10.31 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 122.019 0.914 . . . . 0.0 108.838 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.47 ' HB2' ' ND2' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -46.73 140.74 4.32 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 113.596 -1.638 . . . . 0.0 110.774 179.563 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -56.28 -19.5 14.46 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.216 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.542 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 15.7 t80 -129.57 118.38 21.93 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-O 120.654 0.264 . . . . 0.0 110.979 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -86.01 116.83 24.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.588 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.693 HD12 ' HA2' ' A' ' 69' ' ' GLY . 74.1 mt -91.81 -79.19 0.38 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.298 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -171.17 -102.21 0.15 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.541 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -176.46 61.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.895 0.379 . . . . 0.0 111.13 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.757 HD12 ' CD1' ' A' ' 84' ' ' LEU . 27.5 mt -99.73 125.88 53.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.906 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.28 -40.5 71.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.071 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -22.56 64.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.164 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.757 ' CD1' HD12 ' A' ' 81' ' ' ILE . 47.1 mt -98.83 152.27 19.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.133 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 93.1 p -97.0 167.34 11.13 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.735 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.673 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 1.1 m120 -43.98 -54.09 5.69 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.424 0.63 . . . . 0.0 109.792 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.578 ' HB2' HD12 ' A' ' 104' ' ' ILE . 0.4 OUTLIER -118.2 83.09 1.95 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.247 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.568 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.4 t60 -61.77 -45.22 94.81 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.054 -176.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.523 ' HA ' HG12 ' A' ' 104' ' ' ILE . 29.1 p90 -149.19 161.51 41.85 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 119.987 -0.685 . . . . 0.0 112.303 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.898 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.5 mt-30 -135.46 147.19 48.83 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.313 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.661 HD12 ' CE1' ' A' ' 68' ' ' PHE . 19.9 mt -118.92 131.89 70.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.161 178.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.64 HD12 HD13 ' A' ' 62' ' ' ILE . 0.6 OUTLIER -119.7 138.06 53.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.124 0.488 . . . . 0.0 111.964 -178.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.799 HD13 HG22 ' A' ' 33' ' ' VAL . 1.4 tt -125.24 131.14 53.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.325 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.401 ' HA3' ' HD3' ' A' ' 63' ' ' LYS . . . 153.13 -22.05 0.77 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.936 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.641 ' HB2' HD23 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -56.98 89.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.872 0.368 . . . . 0.0 111.053 -179.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 52.39 30.3 7.99 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.146 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.96 -35.81 4.08 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.54 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -59.21 -171.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.903 0.382 . . . . 0.0 110.832 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.716 ' O ' HD22 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -122.52 144.6 48.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.925 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.89 HD13 ' O ' ' A' ' 122' ' ' GLN . 3.8 mm? -129.96 142.52 50.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.002 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.68 128.14 56.31 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.446 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 52.8 t30 -115.57 117.04 29.23 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.823 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.9 p30 -79.84 140.19 36.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.578 HD12 ' HB2' ' A' ' 87' ' ' LYS . 15.9 pt -145.56 33.81 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 111.574 0.213 . . . . 0.0 111.574 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.676 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -93.96 150.35 20.43 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 120.996 0.427 . . . . 0.0 111.891 -178.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.1 m -68.59 -31.48 70.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.765 178.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -98.23 -19.62 17.73 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.676 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.12 156.23 10.02 Favored Glycine 0 N--CA 1.438 -1.21 0 C-N-CA 120.246 -0.978 . . . . 0.0 113.642 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.516 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.5 m -117.4 137.78 52.26 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.877 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -114.02 148.55 36.81 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -177.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.465 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.28 113.4 18.21 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.171 177.386 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.415 ' N ' HD12 ' A' ' 111' ' ' LEU . 2.3 m-80 44.66 42.84 6.15 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.341 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.24 -10.52 70.84 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.504 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -104.77 118.54 36.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.078 0.466 . . . . 0.0 110.648 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.877 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.3 tptm -73.33 128.14 34.64 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.23 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.823 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.3 m -100.5 164.76 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.237 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 120' ' ' SER . 30.5 tt0 -70.05 127.09 31.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.514 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.689 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 24.2 tttt -53.09 162.38 0.68 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.857 0.361 . . . . 0.0 110.438 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.0 OUTLIER 35.4 33.99 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.14 -179.166 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.487 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.19 145.12 40.43 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.053 179.395 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.663 ' HB3' HD12 ' A' ' 100' ' ' LEU . 6.1 m120 -90.35 130.75 36.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.085 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.89 ' O ' HD13 ' A' ' 100' ' ' LEU . 42.3 mm-40 -129.39 148.57 51.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.276 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.4 116.4 12.81 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.864 0.364 . . . . 0.0 110.354 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.704 HD11 HG21 ' A' ' 145' ' ' ILE . 65.3 tp -56.36 157.54 4.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.435 0.636 . . . . 0.0 111.587 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.471 ' O ' HD11 ' A' ' 147' ' ' ILE . 1.3 t -124.4 153.31 42.08 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.327 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.682 ' HA ' HD13 ' A' ' 147' ' ' ILE . 30.1 mm100 -71.3 123.54 22.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.897 0.379 . . . . 0.0 110.046 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.08 21.55 59.39 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.866 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -55.86 173.92 0.13 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.965 0.412 . . . . 0.0 111.057 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.708 ' HG3' HG22 ' A' ' 144' ' ' VAL . 9.5 tt0 -145.07 135.47 24.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.287 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.763 HD11 HD11 ' A' ' 145' ' ' ILE . 13.5 mt -113.86 128.04 70.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.26 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.674 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.5 m -104.36 138.78 40.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.208 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.5 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 35.4 m -140.19 158.42 25.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.25 34.36 20.7 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.92 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.2 t -75.15 140.45 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-O 121.763 0.792 . . . . 0.0 112.533 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.97 -39.37 0.6 Allowed Glycine 0 N--CA 1.437 -1.249 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.444 HG12 ' H ' ' A' ' 138' ' ' SER . 47.9 t -126.35 131.84 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 114.731 -0.735 . . . . 0.0 109.201 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -50.6 -38.71 47.1 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.444 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.6 OUTLIER -93.37 6.3 48.62 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.427 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 5.3 t70 -120.11 27.73 8.47 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.674 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.1 mt -107.26 139.5 28.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.022 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.715 HD12 HD11 ' A' ' 81' ' ' ILE . 3.0 tt -122.11 134.34 54.76 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.512 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.697 ' N ' HD23 ' A' ' 141' ' ' LEU . 47.0 t -113.8 150.79 32.98 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.611 0.72 . . . . 0.0 112.638 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.618 HD21 ' CD1' ' A' ' 43' ' ' ILE . 2.1 mm? -135.69 143.55 45.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.487 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.708 HG22 ' HG3' ' A' ' 129' ' ' GLU . 17.4 t -110.97 139.85 32.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.824 0.345 . . . . 0.0 111.138 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.763 HD11 HD11 ' A' ' 130' ' ' ILE . 16.2 mt -106.31 125.16 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.072 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.03 109.89 19.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.816 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.682 HD13 ' HA ' ' A' ' 126' ' ' GLN . 5.0 mp -85.96 134.07 28.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.416 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -86.06 127.7 34.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.844 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -74.03 -23.91 59.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.21 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -45.03 90.99 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.035 0.445 . . . . 0.0 110.649 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -58.82 -44.13 90.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.92 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -65.11 -39.11 92.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.924 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -59.19 -42.57 91.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.985 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.699 ' SG ' HD13 ' A' ' 52' ' ' ILE . 12.0 t -61.19 -45.97 92.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.056 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.11 -35.98 79.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.89 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -67.37 -37.2 82.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.912 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -86.99 -37.05 17.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.939 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.6 p30 42.34 77.39 0.06 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.467 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.05 121.14 27.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.974 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.1 m -78.49 141.0 16.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.164 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -159.33 106.87 1.76 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.866 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.63 -29.25 16.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.949 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 163' ' ' ILE . 0.9 OUTLIER -76.99 123.33 33.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.06 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.915 -179.939 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.787 0.327 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.9 p -135.5 -54.34 0.78 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.901 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.66 -38.65 70.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.805 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.6 mtm-85 -58.84 -46.08 88.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.972 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -61.39 -35.08 76.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.876 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.6 tt -61.18 -45.18 95.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.959 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.435 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 6.1 mm -62.64 -35.23 69.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.156 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.25 -44.59 84.01 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.9 0.381 . . . . 0.0 110.425 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -67.15 -23.74 65.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.419 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.75 -47.45 80.04 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.202 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.12 -47.05 14.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.814 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -175.45 158.32 2.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.882 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -87.25 149.59 24.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.846 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -81.22 101.87 9.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.982 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.5 mm -85.19 138.37 19.2 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 CA-C-O 121.706 0.765 . . . . 0.0 111.811 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.7 84.7 0.42 Allowed Glycine 0 C--N 1.315 -0.606 0 CA-C-N 114.507 -1.224 . . . . 0.0 112.448 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.11 -42.12 66.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.711 0.291 . . . . 0.0 111.022 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.454 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER 179.27 37.88 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.688 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.4 mm -73.02 137.08 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-N 113.598 -1.637 . . . . 0.0 112.658 -177.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.987 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.3 t -93.66 -59.82 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.658 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.94 156.46 42.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.229 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.842 ' NE ' HG21 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -119.88 138.14 53.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.815 0.34 . . . . 0.0 111.031 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.51 HG11 ' CE2' ' A' ' 68' ' ' PHE . 1.8 m -104.66 122.71 58.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.772 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.676 HG23 HG12 ' A' ' 45' ' ' ILE . 14.4 mt -125.0 124.17 67.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.572 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.757 ' HA ' HD13 ' A' ' 143' ' ' LEU . 52.8 t -80.02 108.74 13.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.859 0.361 . . . . 0.0 110.537 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.0 t -74.55 -25.46 59.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.639 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.539 HG23 ' HB3' ' A' ' 142' ' ' SER . 74.7 p -79.86 -2.35 43.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.46 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.15 76.73 0.24 Allowed Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.824 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -146.53 -43.86 0.19 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.913 0.387 . . . . 0.0 110.876 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.554 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.1 mt -117.93 141.3 29.01 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.005 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.554 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 52.5 Cg_endo -72.35 145.85 43.96 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.216 1.944 . . . . 0.0 111.788 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.842 HG21 ' NE ' ' A' ' 35' ' ' ARG . 68.6 mt -54.15 142.46 7.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.049 0.452 . . . . 0.0 111.829 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.507 ' HB2' ' CE2' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -124.67 133.99 53.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.861 178.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.08 119.92 32.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.141 0.496 . . . . 0.0 111.863 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.546 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 5.2 mt -98.04 131.96 44.0 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.987 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -143.55 157.55 44.34 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -178.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.495 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -141.07 146.29 36.94 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 113.694 -1.594 . . . . 0.0 110.993 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.893 ' O ' HG23 ' A' ' 55' ' ' VAL . 66.4 m-20 -74.87 114.4 13.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.045 0.45 . . . . 0.0 111.196 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.456 HD13 ' SG ' ' A' ' 154' ' ' CYS . 40.2 mt -64.44 -42.45 95.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.734 -0.667 . . . . 0.0 112.024 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.31 -40.99 79.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.315 0.579 . . . . 0.0 110.586 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.464 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 35.1 mm-40 -68.52 -36.87 79.46 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.548 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 51' ' ' ASP . 21.8 t -67.26 -49.16 74.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.018 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.87 -40.4 91.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.986 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -65.19 -43.79 90.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.907 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.2 108.44 19.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.837 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -86.16 79.47 9.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.796 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.6 mmt85 -118.08 169.19 9.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.98 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.8 t -78.38 -19.73 52.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.217 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.42 HD11 ' CG2' ' A' ' 65' ' ' VAL . 1.4 tp -134.45 138.65 49.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.771 0.32 . . . . 0.0 111.349 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.751 ' HG2' HG22 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -115.68 -71.09 0.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.939 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.441 ' CE ' ' O ' ' A' ' 49' ' ' SER . 26.5 ttpt -141.06 144.09 34.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.016 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.658 HG12 ' HG2' ' A' ' 90' ' ' GLN . 14.4 t -127.72 139.5 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-O 121.29 0.567 . . . . 0.0 112.08 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.546 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 18.9 m-90 -100.77 139.32 36.62 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.144 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.689 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.79 126.97 55.8 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -118.06 145.23 44.96 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.79 -178.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.603 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.46 -172.69 37.73 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.084 -1.055 . . . . 0.0 113.593 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.455 ' N ' HD11 ' A' ' 78' ' ' LEU . 0.8 OUTLIER -74.28 -0.61 17.53 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.409 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 25.2 t-20 -84.69 132.14 47.42 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.624 0.249 . . . . 0.0 111.29 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.41 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 14.7 Cg_exo -67.83 -12.1 34.26 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.58 2.186 . . . . 0.0 111.707 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.02 -43.19 16.63 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-O 121.914 0.864 . . . . 0.0 109.048 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -39.12 139.11 0.52 Allowed 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 113.701 -1.591 . . . . 0.0 111.089 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -56.44 -18.72 12.19 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.122 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.507 ' CE2' ' HB2' ' A' ' 46' ' ' ARG . 56.0 t80 -129.41 119.04 23.15 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.829 0.347 . . . . 0.0 110.915 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.41 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.8 t-160 -97.63 124.6 41.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.961 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.455 HD11 ' N ' ' A' ' 70' ' ' ARG . 0.6 OUTLIER -121.51 -179.81 4.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.903 179.747 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -55.44 -171.41 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.494 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -110.63 80.45 1.31 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.83 0.348 . . . . 0.0 110.889 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.76 ' HB ' HD13 ' A' ' 84' ' ' LEU . 2.4 mp -112.02 120.85 63.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.193 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.27 -29.65 64.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.196 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.534 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -60.89 -23.25 65.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.059 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.76 HD13 ' HB ' ' A' ' 81' ' ' ILE . 4.1 mp -107.05 152.87 23.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.912 0.387 . . . . 0.0 110.958 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 61.1 p -96.46 166.71 11.56 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.891 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.603 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.2 m-20 -43.32 -53.19 5.4 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.318 0.58 . . . . 0.0 109.799 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.545 ' CB ' HD12 ' A' ' 104' ' ' ILE . 10.9 mttm -118.03 81.36 1.66 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.588 ' CE1' ' HB ' ' A' ' 132' ' ' VAL . 15.8 t60 -58.81 -47.45 84.73 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.423 -177.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.504 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 32.1 p90 -146.31 159.81 42.86 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.154 -0.618 . . . . 0.0 112.063 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.689 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.0 tt0 -135.59 141.95 45.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.212 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.583 ' O ' HG13 ' A' ' 65' ' ' VAL . 45.7 mt -120.44 131.84 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.297 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.762 HD21 ' OD1' ' A' ' 121' ' ' ASN . 0.5 OUTLIER -120.09 139.73 52.12 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.004 0.43 . . . . 0.0 111.566 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.692 HD23 ' HG ' ' A' ' 99' ' ' LEU . 1.7 tm? -125.24 134.34 52.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.307 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.691 ' N ' HD22 ' A' ' 93' ' ' LEU . . . -128.89 172.55 19.56 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.705 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.8 ' HG3' HG12 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -74.23 106.65 5.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.783 0.325 . . . . 0.0 110.955 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -175.24 -41.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.933 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 134.32 -26.1 3.4 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.474 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -109.38 -178.03 3.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.835 0.35 . . . . 0.0 111.027 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.692 ' HG ' HD23 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -128.12 159.67 34.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.577 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.794 HD23 ' O ' ' A' ' 122' ' ' GLN . 9.0 mt -120.3 142.1 49.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.897 0.38 . . . . 0.0 110.719 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.926 HD11 HD11 ' A' ' 130' ' ' ILE . 3.8 tt -112.95 125.0 53.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.059 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.478 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 59.8 t30 -119.09 115.93 25.3 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.837 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.8 p30 -77.94 137.55 38.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.779 178.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.545 HD12 ' CB ' ' A' ' 87' ' ' LYS . 8.4 pt -141.29 29.52 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 121.127 -0.229 . . . . 0.0 111.58 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.573 ' HB2' ' CD2' ' A' ' 88' ' ' HIS . 12.1 t -93.69 155.49 17.22 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.534 0.683 . . . . 0.0 112.838 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 69.5 m -70.06 -52.04 27.1 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.669 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -80.34 -0.54 37.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.281 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.0 156.24 30.66 Favored Glycine 0 N--CA 1.437 -1.25 0 C-N-CA 120.642 -0.789 . . . . 0.0 113.518 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.502 HG22 ' CG2' ' A' ' 130' ' ' ILE . 5.2 m -117.44 137.89 52.21 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.845 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -113.29 148.47 35.56 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -178.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.409 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.12 113.54 18.49 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.298 177.328 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 45.3 42.7 7.53 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.0 -7.69 76.6 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.462 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.59 118.51 36.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 117.041 0.421 . . . . 0.0 110.624 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.845 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 6.3 tptm -72.46 116.94 13.51 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.259 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.837 HG23 ' OD2' ' A' ' 103' ' ' ASP . 13.1 m -92.42 162.86 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.046 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.421 ' HB3' ' HB3' ' A' ' 120' ' ' SER . 0.6 OUTLIER -69.81 128.92 38.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.46 179.66 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.684 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 45.5 tttt -55.35 163.87 1.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.751 0.31 . . . . 0.0 110.195 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.7 OUTLIER 35.96 34.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.818 -179.162 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.421 ' HB3' ' HB3' ' A' ' 117' ' ' GLU . 2.7 p -112.12 143.58 42.91 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.458 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.762 ' OD1' HD21 ' A' ' 92' ' ' LEU . 18.1 m-80 -94.22 132.28 38.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.045 0.45 . . . . 0.0 111.103 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.794 ' O ' HD23 ' A' ' 100' ' ' LEU . 58.1 mm-40 -129.07 151.23 49.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.446 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 tp -72.56 128.56 35.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.843 0.354 . . . . 0.0 110.464 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.817 HD21 HG12 ' A' ' 147' ' ' ILE . 18.8 tp -57.55 155.28 9.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.375 0.607 . . . . 0.0 111.679 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.518 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -124.71 152.95 43.11 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.304 179.463 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.88 119.14 15.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.96 0.41 . . . . 0.0 110.07 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.32 24.71 63.87 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.124 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.402 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 32.0 t70 -52.95 170.31 0.08 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.928 0.394 . . . . 0.0 111.337 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.9 ' CG ' HG22 ' A' ' 144' ' ' VAL . 9.4 mt-10 -145.15 135.61 24.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.06 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.926 HD11 HD11 ' A' ' 101' ' ' LEU . 6.6 mt -111.64 128.08 68.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.459 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.654 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.6 m -104.25 140.39 37.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.01 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.588 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 22.7 m -140.36 158.75 25.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.44 43.7 10.18 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.167 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 140' ' ' ILE . 74.0 t -83.01 140.44 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-O 121.609 0.719 . . . . 0.0 112.307 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.29 -40.17 0.95 Allowed Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.541 HG12 ' H ' ' A' ' 138' ' ' SER . 48.2 t -126.37 124.95 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-N 114.603 -0.799 . . . . 0.0 108.983 177.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -50.38 -30.73 12.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.769 0.319 . . . . 0.0 111.444 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.541 ' H ' HG12 ' A' ' 136' ' ' VAL . 4.0 m -93.62 6.35 48.56 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -123.52 24.25 8.64 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.654 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.5 mt -107.0 139.07 29.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.313 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.31 134.49 53.17 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.202 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.641 ' C ' HD22 ' A' ' 143' ' ' LEU . 38.1 t -111.12 150.62 29.16 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.73 0.776 . . . . 0.0 112.46 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.757 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.5 mm? -135.66 149.12 49.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.125 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.9 HG22 ' CG ' ' A' ' 129' ' ' GLU . 13.8 t -118.81 140.09 43.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 111.382 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.797 HD11 HD11 ' A' ' 130' ' ' ILE . 28.1 mt -106.29 120.87 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.76 118.38 36.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.654 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.817 HG12 HD21 ' A' ' 124' ' ' LEU . 5.5 mt -84.98 134.03 27.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.495 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -81.84 115.72 21.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.723 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -63.74 -31.8 73.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.06 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -60.14 -46.06 90.91 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.005 0.431 . . . . 0.0 110.784 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -58.88 -44.07 91.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.983 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -63.78 -37.74 88.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.925 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -59.62 -40.89 89.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.925 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.456 ' SG ' HD13 ' A' ' 52' ' ' ILE . 9.1 t -67.81 -44.21 77.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.953 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.89 -39.84 91.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.911 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -61.28 -44.09 97.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.876 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.68 -37.08 31.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.895 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.6 p30 42.27 35.07 0.56 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.501 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 9.7 mtmt -111.98 120.45 41.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.878 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 35.0 m -89.36 127.73 41.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.212 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.64 70.72 3.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.9 ttm180 -137.02 98.59 3.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.93 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.544 HD13 ' H ' ' A' ' 163' ' ' ILE . 0.2 OUTLIER -76.83 138.11 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.166 -179.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.884 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.796 0.332 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 52.1 p -130.58 -46.06 1.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.855 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -37.38 85.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.932 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -64.8 -41.81 95.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.867 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -57.93 -38.6 76.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.854 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.521 HD13 ' O ' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -60.09 -31.85 70.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.811 179.781 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.439 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.0 mt -72.89 -35.4 49.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.831 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -57.38 -42.39 82.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.984 0.421 . . . . 0.0 110.493 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.1 tttt -67.08 -23.82 65.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.661 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.439 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.68 -47.52 79.67 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.261 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.28 -46.99 59.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.941 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -93.48 64.28 3.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.882 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -79.99 124.12 28.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.907 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -78.9 131.55 36.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.932 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.3 mm -81.96 138.31 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-O 121.654 0.74 . . . . 0.0 111.769 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.41 53.88 0.01 OUTLIER Glycine 0 C--N 1.315 -0.636 0 CA-C-N 114.472 -1.24 . . . . 0.0 112.406 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.34 -41.88 96.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.739 0.304 . . . . 0.0 110.967 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.44 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.7 OUTLIER 178.1 38.17 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 -179.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.688 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.1 mm -74.24 135.37 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-N 113.703 -1.589 . . . . 0.0 112.574 -177.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.0 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -93.51 -61.42 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.086 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.711 ' SG ' HD12 ' A' ' 48' ' ' LEU . 2.9 p -144.73 152.09 39.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.252 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.404 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -117.42 128.72 55.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.757 0.313 . . . . 0.0 111.339 -179.486 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.724 HG23 HD11 ' A' ' 48' ' ' LEU . 38.0 t -96.67 122.91 48.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.867 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.863 HG23 HG12 ' A' ' 45' ' ' ILE . 21.6 mt -127.14 127.23 69.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.582 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.528 ' HA ' HD13 ' A' ' 143' ' ' LEU . 11.6 t -91.61 107.67 19.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.446 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.434 ' CG2' HG21 ' A' ' 144' ' ' VAL . 63.0 p -81.24 -24.88 37.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.636 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.536 HG21 ' OG ' ' A' ' 142' ' ' SER . 4.3 p -80.05 -2.71 45.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.662 0.268 . . . . 0.0 111.428 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.92 75.53 0.45 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.069 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.659 ' HB2' HD12 ' A' ' 43' ' ' ILE . 3.5 mt-30 -143.07 -40.88 0.31 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.92 0.39 . . . . 0.0 110.992 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.659 HD12 ' HB2' ' A' ' 42' ' ' GLN . 4.1 mp -125.7 142.15 41.24 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.927 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.566 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 52.7 Cg_endo -72.08 140.81 35.14 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.16 1.907 . . . . 0.0 112.227 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.863 HG12 HG23 ' A' ' 37' ' ' ILE . 33.7 mt -56.16 142.94 10.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.724 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -137.85 161.91 35.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.27 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.404 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 1.1 m-20 -116.05 119.83 37.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.975 0.417 . . . . 0.0 111.746 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.724 HD11 HG23 ' A' ' 36' ' ' VAL . 4.4 mt -94.88 136.25 35.42 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.0 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.81 158.64 43.84 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -178.806 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.5 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -146.28 147.71 31.67 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 113.69 -1.596 . . . . 0.0 110.822 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.717 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.9 OUTLIER -74.95 128.36 35.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.172 0.51 . . . . 0.0 111.261 -179.551 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.741 HD13 ' SG ' ' A' ' 154' ' ' CYS . 92.0 mt -64.54 -43.9 96.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.033 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.8 t -57.08 -38.86 73.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.314 0.578 . . . . 0.0 110.539 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.529 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 6.0 mm-40 -68.47 -36.93 79.67 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.521 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.717 HG23 ' O ' ' A' ' 51' ' ' ASP . 45.2 t -70.32 -47.19 67.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.028 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -29.03 70.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.963 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.9 tptm -82.23 -49.34 10.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.038 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -62.98 121.29 13.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.873 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -138.89 34.98 2.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.853 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.51 -70.65 0.33 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.982 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 78.4 p -93.97 -175.89 3.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.965 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.9 tp -72.3 150.04 8.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.122 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.474 ' HE2' HG13 ' A' ' 55' ' ' VAL . 7.9 mptt -79.62 -67.03 0.8 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.051 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.432 ' CE ' ' O ' ' A' ' 49' ' ' SER . 7.4 ttpt -149.93 139.98 22.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.296 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.68 HG12 ' HG2' ' A' ' 90' ' ' GLN . 14.6 t -130.72 139.28 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.311 0.577 . . . . 0.0 112.092 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.563 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.3 m-90 -102.4 139.45 37.99 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.151 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.605 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.18 128.32 56.2 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.561 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.689 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -120.09 145.3 47.01 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.179 -178.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.529 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.17 -169.56 37.56 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.176 -1.012 . . . . 0.0 113.733 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.407 ' NE ' ' HA ' ' A' ' 80' ' ' ASN . 3.8 ttt-85 -77.2 0.29 22.42 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 122.56 0.344 . . . . 0.0 111.869 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.584 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 6.9 t-20 -84.76 132.64 45.69 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.632 0.253 . . . . 0.0 111.41 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.423 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 15.4 Cg_exo -67.17 -13.5 39.87 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.573 2.182 . . . . 0.0 111.702 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.584 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -82.73 -44.63 15.39 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-O 121.858 0.837 . . . . 0.0 108.968 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -39.88 141.06 0.47 Allowed 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 113.707 -1.588 . . . . 0.0 110.951 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 67' ' ' THR . 72.0 m-20 -56.32 -19.09 12.86 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.048 179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.508 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 2.2 t80 -129.96 125.36 35.25 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.709 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.423 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.5 t-160 -96.04 107.95 20.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.919 0.39 . . . . 0.0 110.867 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.493 ' HA ' HG12 ' A' ' 43' ' ' ILE . 8.0 mp -92.35 163.82 13.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.877 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.11 165.58 7.1 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.308 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.407 ' HA ' ' NE ' ' A' ' 70' ' ' ARG . 24.8 p-10 -73.89 72.76 1.59 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.88 0.371 . . . . 0.0 111.017 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.404 HD13 HD12 ' A' ' 141' ' ' LEU . 2.3 mp -107.78 119.91 58.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.09 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.88 -33.52 75.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.943 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.6 mmp_? -60.94 -23.36 65.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.099 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.4 mt -101.55 151.2 22.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.979 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 99.3 p -94.29 165.81 12.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.454 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.529 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.4 m-20 -42.8 -53.93 4.36 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.372 0.606 . . . . 0.0 109.694 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.654 ' HB2' HD12 ' A' ' 104' ' ' ILE . 4.6 mttm -118.82 81.86 1.76 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 177.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.537 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.8 t60 -59.42 -47.18 86.44 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.454 -177.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.51 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 33.3 p90 -143.62 159.86 41.7 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 119.967 -0.693 . . . . 0.0 112.041 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.68 ' HG2' HG12 ' A' ' 65' ' ' VAL . 4.6 tt0 -136.0 141.78 44.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.93 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.597 ' C ' HG13 ' A' ' 65' ' ' VAL . 65.5 mt -117.82 128.68 74.94 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.093 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.616 HD21 HD22 ' A' ' 121' ' ' ASN . 0.7 OUTLIER -113.94 147.24 38.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.018 0.437 . . . . 0.0 111.43 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.841 HD13 ' CG1' ' A' ' 33' ' ' VAL . 5.2 tp -125.1 132.24 53.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.386 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 164.12 -157.84 30.25 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.334 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 57.18 92.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.756 0.313 . . . . 0.0 110.934 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 63.35 -79.89 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.95 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -174.3 43.69 0.14 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.41 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -121.68 170.14 10.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.87 0.367 . . . . 0.0 110.933 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.708 ' O ' HD12 ' A' ' 100' ' ' LEU . 1.2 mt -107.4 151.01 26.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.802 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.708 HD12 ' O ' ' A' ' 99' ' ' LEU . 4.5 mp -133.0 144.71 50.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.447 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.633 HD11 HD12 ' A' ' 145' ' ' ILE . 0.7 OUTLIER -112.79 121.83 45.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.225 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.516 ' HB2' HD23 ' A' ' 92' ' ' LEU . 49.4 t30 -115.59 115.52 26.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.992 0.425 . . . . 0.0 111.617 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.845 ' OD2' HG23 ' A' ' 116' ' ' VAL . 8.4 p30 -79.1 136.89 37.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.906 178.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.654 HD12 ' HB2' ' A' ' 87' ' ' LYS . 9.0 pt -143.62 38.11 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.636 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.46 151.2 20.85 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 121.066 0.46 . . . . 0.0 111.735 -179.185 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 55.1 m -68.87 -31.63 70.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.996 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -98.09 -19.97 17.63 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.636 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 120.42 154.61 9.41 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.144 -1.027 . . . . 0.0 113.801 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.508 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.1 m -117.62 137.92 52.3 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.849 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -115.76 148.41 39.85 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -178.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.409 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.15 113.5 18.42 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.08 177.423 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.2 m120 44.65 43.18 6.42 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.15 -8.69 75.65 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.49 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -105.36 118.55 36.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.127 0.489 . . . . 0.0 110.774 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.849 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 14.8 tptp -73.21 119.34 17.31 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.282 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.845 HG23 ' OD2' ' A' ' 103' ' ' ASP . 13.1 m -91.06 164.37 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.278 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 120' ' ' SER . 4.1 tp10 -69.93 126.21 29.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.655 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.685 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 24.7 tttm -52.29 161.51 0.64 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.896 0.379 . . . . 0.0 110.694 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.6 p30 34.35 35.25 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.325 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.19 145.01 40.62 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.049 179.362 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.616 HD22 HD21 ' A' ' 92' ' ' LEU . 19.8 m120 -88.92 127.34 35.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.987 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -129.34 146.35 51.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.747 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.434 HD13 ' C ' ' A' ' 123' ' ' LEU . 1.6 tm? -72.82 113.7 10.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.026 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.615 HD11 ' HG ' ' A' ' 101' ' ' LEU . 1.0 OUTLIER -53.42 165.85 0.34 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.679 0.752 . . . . 0.0 112.003 -178.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.448 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -125.29 153.3 43.45 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.383 179.347 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.553 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.7 OUTLIER -71.51 120.08 16.59 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.85 21.39 65.36 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.064 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.448 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 9.4 t70 -57.93 173.69 0.31 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.963 0.411 . . . . 0.0 111.065 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 13.9 tt0 -145.26 135.52 24.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.246 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 1.068 HD11 HD11 ' A' ' 145' ' ' ILE . 4.2 mt -109.52 128.33 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.177 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.668 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.8 m -104.07 139.55 39.01 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.506 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.6 m -140.15 158.36 25.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.24 44.1 10.0 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.885 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.473 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.9 t -83.35 140.41 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-O 121.742 0.782 . . . . 0.0 112.393 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.77 -37.61 0.88 Allowed Glycine 0 N--CA 1.436 -1.319 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.473 HG12 ' H ' ' A' ' 138' ' ' SER . 48.8 t -126.39 123.72 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 114.598 -0.801 . . . . 0.0 109.155 178.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -50.48 -33.41 21.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.623 0.249 . . . . 0.0 111.585 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.473 ' H ' HG12 ' A' ' 136' ' ' VAL . 40.2 t -93.43 6.49 47.99 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.426 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 5.6 t0 -125.51 28.29 6.3 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.668 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.9 mt -107.11 139.56 28.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.874 178.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.674 HD22 ' CD2' ' A' ' 143' ' ' LEU . 1.0 OUTLIER -115.6 134.49 55.0 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.752 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.536 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.8 OUTLIER -112.19 136.75 51.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.03 0.443 . . . . 0.0 111.704 -179.472 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.674 ' CD2' HD22 ' A' ' 141' ' ' LEU . 2.9 mm? -130.88 138.52 49.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.352 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.434 HG21 ' CG2' ' A' ' 39' ' ' THR . 20.8 t -110.76 137.13 44.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.957 0.408 . . . . 0.0 111.608 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 1.068 HD11 HD11 ' A' ' 130' ' ' ILE . 49.6 mt -106.19 127.39 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.086 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.2 115.79 28.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.642 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.553 HD12 ' HA ' ' A' ' 126' ' ' GLN . 6.5 mt -84.76 129.32 37.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.893 0.378 . . . . 0.0 111.331 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -75.96 116.78 17.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.942 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -65.36 -31.13 72.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.891 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -58.7 -44.35 90.31 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.975 0.417 . . . . 0.0 110.568 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -58.65 -44.02 89.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.777 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -64.33 -39.02 93.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.918 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -60.27 -42.58 95.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.981 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.741 ' SG ' HD13 ' A' ' 52' ' ' ILE . 8.9 t -68.05 -45.03 75.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.94 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.08 -35.95 77.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.891 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -66.35 -47.89 71.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.989 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.52 -37.14 32.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.99 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.1 p30 44.56 -172.53 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.507 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.88 132.93 51.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.964 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.506 HG12 ' H ' ' A' ' 162' ' ' ARG . 21.5 t -99.25 137.52 26.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.169 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.89 -37.02 85.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.506 ' H ' HG12 ' A' ' 160' ' ' VAL . 0.1 OUTLIER -94.67 146.01 24.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 5.0 mt -87.7 113.83 25.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.098 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.866 -179.927 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.913 0.387 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.5 p -99.23 35.2 1.97 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.988 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -60.0 -47.13 87.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.627 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -71.19 -35.78 71.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.615 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.29 -39.3 82.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.859 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.61 -40.83 93.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.852 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.508 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 8.2 mm -70.29 -35.1 61.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.199 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -57.03 -37.58 71.95 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.866 0.365 . . . . 0.0 110.454 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -67.29 -23.83 65.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.666 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.508 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -56.92 -47.27 81.01 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.169 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.11 -30.47 43.8 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.833 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -89.0 53.07 2.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.92 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.67 123.23 25.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.874 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -65.55 137.09 57.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.882 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.4 mm -82.04 138.39 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-O 121.729 0.776 . . . . 0.0 111.733 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 157.7 42.59 0.02 OUTLIER Glycine 0 C--N 1.314 -0.677 0 CA-C-N 114.453 -1.248 . . . . 0.0 112.613 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.56 -43.11 99.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 110.755 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.524 ' O ' ' HB3' ' A' ' 49' ' ' SER . 4.7 m-20 -178.84 37.95 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.682 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 6.9 mm -71.25 142.02 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 CA-C-N 113.678 -1.601 . . . . 0.0 112.495 -176.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.727 HG21 HD22 ' A' ' 93' ' ' LEU . 0.9 OUTLIER -104.38 -46.84 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.551 -178.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.67 ' SG ' HD12 ' A' ' 48' ' ' LEU . 28.4 p -163.0 145.56 10.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.127 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.461 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.94 134.68 54.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.874 0.368 . . . . 0.0 111.674 -178.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.594 HG13 HD11 ' A' ' 48' ' ' LEU . 3.4 m -99.77 122.71 51.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.469 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.775 HG23 HG12 ' A' ' 45' ' ' ILE . 19.3 mt -128.01 121.03 55.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.605 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.581 ' HA ' HD13 ' A' ' 143' ' ' LEU . 12.6 t -84.04 124.71 31.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.636 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.7 t -95.36 -25.05 16.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.517 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.546 HG21 ' H ' ' A' ' 142' ' ' SER . 17.5 p -79.88 -2.13 42.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.506 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.15 74.13 0.52 Allowed Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.532 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.506 ' CB ' HD11 ' A' ' 141' ' ' LEU . 2.3 mt-30 -145.31 -39.46 0.25 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.777 0.322 . . . . 0.0 111.168 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.81 HD13 HD22 ' A' ' 78' ' ' LEU . 2.2 mt -122.19 140.57 32.67 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.843 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.545 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.3 Cg_endo -73.59 138.93 27.54 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.236 1.957 . . . . 0.0 112.225 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.775 HG12 HG23 ' A' ' 37' ' ' ILE . 39.5 mt -57.49 141.46 14.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.562 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.96 164.28 28.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.343 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.461 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 1.4 p-10 -116.21 119.86 37.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.146 0.498 . . . . 0.0 111.932 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.67 HD12 ' SG ' ' A' ' 34' ' ' CYS . 4.4 mt -98.5 137.27 37.41 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.682 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -145.6 158.77 43.8 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -178.415 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.708 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . -145.06 141.83 29.2 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.519 -1.673 . . . . 0.0 110.673 178.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.841 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -81.18 136.59 35.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.123 0.487 . . . . 0.0 111.275 -179.544 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.571 HD12 ' N ' ' A' ' 52' ' ' ILE . 2.6 mp -65.34 -44.58 94.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.282 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.6 m -59.52 -43.14 93.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.944 -178.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.546 ' HG3' ' O ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -68.62 -36.88 79.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.946 0.403 . . . . 0.0 110.654 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.847 HG13 ' HG3' ' A' ' 63' ' ' LYS . 59.1 t -68.74 -41.81 82.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.972 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.03 -30.18 66.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.795 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -64.83 -45.82 84.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.981 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -101.79 98.98 9.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.5 33.51 2.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.872 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.8 mtm180 -73.41 -65.21 0.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.942 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.9 m -177.35 -39.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.868 HD11 ' CG2' ' A' ' 65' ' ' VAL . 9.0 tp -115.44 148.55 18.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.995 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.847 ' HG3' HG13 ' A' ' 55' ' ' VAL . 16.1 mmtm -127.08 -63.8 1.04 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.767 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.401 ' HE2' ' O ' ' A' ' 49' ' ' SER . 4.5 ttpt -145.71 130.62 18.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.172 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.868 ' CG2' HD11 ' A' ' 62' ' ' ILE . 13.0 t -126.93 139.11 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 121.264 0.554 . . . . 0.0 112.2 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.613 ' CD1' HD22 ' A' ' 48' ' ' LEU . 16.4 m-90 -100.87 139.8 36.05 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.144 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.973 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.44 127.65 55.75 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.321 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.546 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -119.64 145.21 46.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.96 -178.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.548 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 163.51 -169.66 38.62 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.199 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.56 1.43 22.58 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.764 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 10.5 t-20 -84.97 132.49 45.64 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.578 0.228 . . . . 0.0 111.36 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.43 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 15.9 Cg_exo -67.21 -13.23 38.85 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.678 2.252 . . . . 0.0 111.776 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.764 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -82.85 -43.69 16.33 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-O 121.901 0.858 . . . . 0.0 109.029 178.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.428 ' HG ' ' HA ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -39.66 142.01 0.35 Allowed 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 113.688 -1.596 . . . . 0.0 111.2 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.1 m-20 -56.25 -19.12 12.61 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.981 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.501 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 5.8 t80 -129.63 127.61 40.96 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.666 0.269 . . . . 0.0 110.871 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.43 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.7 t-160 -102.13 108.73 20.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.888 0.375 . . . . 0.0 110.905 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.81 HD22 HD13 ' A' ' 43' ' ' ILE . 14.0 mt -82.61 -174.72 5.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.91 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -68.27 -89.32 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.446 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -179.3 71.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.842 0.353 . . . . 0.0 110.829 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 24.5 mm -108.38 123.77 64.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.001 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.69 -35.28 77.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.984 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.91 -22.08 63.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.261 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.558 HD21 HG23 ' A' ' 132' ' ' VAL . 21.1 mt -96.22 152.08 18.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.014 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 45.6 p -96.87 164.68 12.45 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.515 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.548 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -41.43 -53.61 3.32 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.497 0.665 . . . . 0.0 109.811 179.161 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.634 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.6 OUTLIER -119.86 83.59 2.07 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 177.324 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.567 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 10.6 t60 -60.53 -46.04 91.63 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.089 -0.959 . . . . 0.0 112.568 -177.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.5 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 18.1 p90 -143.72 162.64 35.47 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 119.863 -0.735 . . . . 0.0 112.441 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.973 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.57 135.06 40.01 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.059 -179.118 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.59 ' C ' HG13 ' A' ' 65' ' ' VAL . 52.0 mt -113.26 129.12 69.56 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.773 178.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.514 ' CB ' HG22 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -113.97 147.99 37.64 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.0 0.429 . . . . 0.0 111.527 -179.582 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.828 HD12 ' HG ' ' A' ' 99' ' ' LEU . 0.9 OUTLIER -125.01 122.9 38.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.517 179.567 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.414 ' HA2' ' CG ' ' A' ' 63' ' ' LYS . . . -151.22 -166.1 13.49 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.472 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 59.12 -172.84 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.772 0.32 . . . . 0.0 110.698 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.65 62.5 3.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.988 0.423 . . . . 0.0 110.927 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 101.2 -18.41 54.26 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.797 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.5 151.12 17.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.92 0.391 . . . . 0.0 110.985 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.828 ' HG ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -126.51 147.81 49.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.657 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.743 HD13 ' O ' ' A' ' 122' ' ' GLN . 4.5 mm? -132.98 145.73 51.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.564 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 1.099 HD21 HD13 ' A' ' 124' ' ' LEU . 6.0 mt -112.7 127.94 56.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.03 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.43 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 47.0 t30 -119.34 115.92 25.12 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.828 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.8 p30 -77.92 135.95 37.94 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.973 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.434 HD12 ' HB2' ' A' ' 87' ' ' LYS . 9.0 pt -143.84 40.1 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 111.56 0.208 . . . . 0.0 111.56 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.713 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.07 150.93 20.9 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-O 120.994 0.426 . . . . 0.0 111.877 -178.77 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 51.0 m -68.67 -31.89 71.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.694 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -98.56 -19.69 17.46 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.713 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.25 157.26 10.29 Favored Glycine 0 N--CA 1.439 -1.125 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.565 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.495 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.3 m -117.48 137.95 52.19 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.824 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -115.83 148.83 39.49 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -177.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.47 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.12 113.38 18.27 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.428 177.654 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.418 ' N ' HD12 ' A' ' 111' ' ' LEU . 6.5 m-80 44.21 43.26 5.69 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.84 -17.34 53.51 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.416 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.8 tp60 -103.63 118.46 36.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.042 0.449 . . . . 0.0 110.471 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.824 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -70.4 138.87 51.66 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.264 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.828 HG23 ' OD2' ' A' ' 103' ' ' ASP . 12.4 m -105.91 165.81 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.853 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 120' ' ' SER . 22.6 mt-10 -69.8 124.93 25.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.631 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.687 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 14.7 tttt -52.53 163.11 0.46 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.778 0.323 . . . . 0.0 110.778 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.5 m-80 33.38 35.11 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.182 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.26 145.08 40.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.247 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -88.39 129.89 35.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.843 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.743 ' O ' HD13 ' A' ' 100' ' ' LEU . 44.5 mm-40 -129.11 148.47 51.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.672 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.8 tp -72.49 122.12 20.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.876 0.37 . . . . 0.0 110.412 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 1.099 HD13 HD21 ' A' ' 101' ' ' LEU . 67.6 tp -58.86 155.89 12.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.456 0.646 . . . . 0.0 111.61 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.417 ' H ' HD12 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -124.75 153.43 42.43 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.689 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.417 ' OE1' HD12 ' A' ' 147' ' ' ILE . 7.2 mm100 -71.53 121.46 18.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.886 0.374 . . . . 0.0 110.122 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.22 22.22 57.94 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.199 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.411 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 21.8 t0 -54.92 173.93 0.08 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 120.877 0.37 . . . . 0.0 110.893 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.866 ' CG ' HG22 ' A' ' 144' ' ' VAL . 10.4 mt-10 -145.16 135.38 23.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.235 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.887 HD11 HD11 ' A' ' 145' ' ' ILE . 13.6 mt -113.9 128.18 70.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.081 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.566 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.9 m -104.25 138.28 40.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.062 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.558 HG23 HD21 ' A' ' 84' ' ' LEU . 33.5 m -140.28 158.13 25.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.86 32.12 18.95 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.852 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 140' ' ' ILE . 55.3 t -73.79 140.37 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-O 121.679 0.752 . . . . 0.0 112.516 -179.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 159.26 -40.33 0.48 Allowed Glycine 0 N--CA 1.436 -1.307 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.144 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.449 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 49.1 t -126.36 137.51 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -50.69 -43.03 57.48 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.0 t -93.3 6.23 48.82 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.449 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 13.2 t0 -116.09 27.19 9.42 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -178.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.566 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.1 mt -107.43 139.46 29.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.127 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.763 HD23 ' N ' ' A' ' 142' ' ' SER . 4.3 tt -121.37 134.39 55.12 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.449 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.763 ' N ' HD23 ' A' ' 141' ' ' LEU . 48.1 t -111.33 151.08 28.82 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.592 0.711 . . . . 0.0 112.5 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.581 HD13 ' HA ' ' A' ' 38' ' ' CYS . 1.8 mm? -135.39 147.37 49.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.32 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.866 HG22 ' CG ' ' A' ' 129' ' ' GLU . 18.5 t -113.71 137.38 47.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.818 0.342 . . . . 0.0 111.125 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.887 HD11 HD11 ' A' ' 130' ' ' ILE . 39.8 mt -106.31 120.9 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.077 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.35 115.58 29.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.592 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.753 HG12 HD21 ' A' ' 124' ' ' LEU . 3.7 mt -84.65 133.16 29.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.33 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -83.55 108.46 16.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.939 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.19 -25.71 64.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.006 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.6 tptp -57.5 -42.95 83.73 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.013 0.435 . . . . 0.0 110.66 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.423 ' CZ ' HD21 ' A' ' 93' ' ' LEU . 28.4 t80 -59.34 -43.95 92.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.776 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.64 -33.99 74.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.852 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -68.44 -46.46 69.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.858 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 7.6 t -68.07 -41.08 82.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.907 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.0 -41.08 82.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.859 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -59.14 -48.03 83.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -80.59 -32.63 36.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.836 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.0 p30 42.55 92.71 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.555 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.96 130.08 40.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.862 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 9.2 m -82.42 118.4 30.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.186 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.84 -31.14 8.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.917 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 62.14 116.19 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.951 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.7 pt -80.11 138.5 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.126 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 30.4 ttt180 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.865 179.997 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.781 0.324 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.6 p -132.64 -64.31 0.76 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.94 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -71.94 -47.08 54.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.015 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.09 -45.82 89.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.991 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -59.99 -35.0 74.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.956 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.25 -40.71 94.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.886 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.632 HG23 ' CE2' ' A' ' 23' ' ' PHE . 43.0 mm -68.84 -48.17 72.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.037 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.75 -33.67 71.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.4 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -58.74 -47.1 85.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.372 -0.377 . . . . 0.0 112.0 -178.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.632 ' CE2' HG23 ' A' ' 20' ' ' ILE . 4.5 p90 -71.89 -47.38 53.1 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.967 0.413 . . . . 0.0 111.033 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.537 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 1.2 m -58.4 -46.87 85.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.039 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -121.15 108.98 14.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.884 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -66.23 131.65 46.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.816 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.71 106.9 19.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.928 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.6 mm -81.95 138.29 19.75 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-O 121.613 0.721 . . . . 0.0 111.673 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -174.76 66.16 0.1 Allowed Glycine 0 C--N 1.314 -0.683 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.474 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -77.04 -38.36 52.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.802 0.334 . . . . 0.0 110.845 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.439 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.2 t-20 175.52 39.55 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.686 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.8 mm -71.93 136.16 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 CA-C-N 113.557 -1.656 . . . . 0.0 112.666 -177.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.966 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.8 t -92.28 -58.56 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.545 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.568 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.07 153.89 37.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.83 179.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.462 ' NH2' HD13 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -113.89 138.38 50.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.831 0.348 . . . . 0.0 111.02 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.811 HG21 ' HE2' ' A' ' 68' ' ' PHE . 19.8 t -103.32 122.96 56.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.212 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.698 HG23 HD11 ' A' ' 45' ' ' ILE . 19.8 mt -128.3 119.13 49.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.873 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 50.4 t -84.78 118.6 24.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.205 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.97 -22.11 27.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.911 -179.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.528 HG21 ' H ' ' A' ' 142' ' ' SER . 69.6 p -79.81 -2.09 41.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.687 0.279 . . . . 0.0 111.579 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.14 73.18 0.56 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.83 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.413 ' HB2' HD11 ' A' ' 141' ' ' LEU . 7.8 mt-30 -145.28 -43.3 0.22 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.88 0.371 . . . . 0.0 111.014 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.781 HD13 ' HG ' ' A' ' 78' ' ' LEU . 7.7 mt -115.63 140.61 26.24 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.945 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.529 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 66.2 Cg_endo -76.1 146.08 28.47 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.295 1.997 . . . . 0.0 112.237 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.698 HD11 HG23 ' A' ' 37' ' ' ILE . 14.6 mt -57.35 148.2 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.549 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -139.41 161.76 36.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.348 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.68 119.77 37.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.065 0.459 . . . . 0.0 111.954 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.538 HD22 ' CD1' ' A' ' 66' ' ' TRP . 8.0 mt -95.69 134.46 38.57 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.966 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.91 157.46 43.9 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -178.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.484 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -143.63 141.97 30.82 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.421 -1.718 . . . . 0.0 110.505 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.829 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -74.87 141.86 44.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.336 0.589 . . . . 0.0 111.608 -179.197 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.606 HD13 ' SG ' ' A' ' 154' ' ' CYS . 31.3 mt -64.93 -44.65 96.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.236 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.55 -42.39 87.74 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.486 -178.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.457 ' CG ' ' O ' ' A' ' 51' ' ' ASP . 3.1 pt20 -68.27 -36.85 80.03 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.492 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.829 HG23 ' O ' ' A' ' 51' ' ' ASP . 47.5 t -71.54 -41.87 72.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.982 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.05 -38.32 72.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.962 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -43.98 70.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.959 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.19 128.3 33.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.866 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.68 31.09 2.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.056 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.37 -63.1 1.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.885 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.3 t -176.96 -50.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.867 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.622 HD12 HD13 ' A' ' 92' ' ' LEU . 24.7 mm -114.09 150.17 16.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.071 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.96 -59.47 1.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.84 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.435 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.7 ttpt -140.35 131.33 26.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.965 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.678 HG12 ' HG2' ' A' ' 90' ' ' GLN . 7.8 t -127.75 139.06 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-O 121.266 0.555 . . . . 0.0 112.224 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.538 ' CD1' HD22 ' A' ' 48' ' ' LEU . 16.4 m-90 -101.04 139.26 36.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.882 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.632 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -113.04 131.64 55.71 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.69 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.811 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -118.29 145.24 45.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.669 -178.291 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.95 -172.26 36.43 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.312 -0.946 . . . . 0.0 113.932 178.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.734 ' NH2' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -72.32 -3.67 25.2 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.453 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -84.51 128.85 59.82 Favored Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 121.191 -0.204 . . . . 0.0 111.036 -179.603 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 16.5 Cg_exo -67.24 -9.36 24.9 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.525 2.15 . . . . 0.0 111.574 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.8 -42.88 17.36 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -40.37 138.25 0.94 Allowed 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 113.879 -1.509 . . . . 0.0 110.247 179.165 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -56.33 -18.77 11.83 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.915 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.568 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 13.3 t80 -129.88 127.18 39.66 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.881 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -101.65 121.14 41.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.572 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.781 ' HG ' HD13 ' A' ' 43' ' ' ILE . 6.5 mp -95.56 -82.48 0.38 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.241 -179.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.98 -135.95 1.96 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.733 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -133.07 57.3 1.81 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.916 0.388 . . . . 0.0 111.191 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.452 HG22 ' H ' ' A' ' 83' ' ' ARG . 16.8 mt -107.06 121.53 60.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.04 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.2 m -60.83 -24.89 66.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.35 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.452 ' H ' HG22 ' A' ' 81' ' ' ILE . 5.2 mmp_? -60.48 -26.71 67.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.642 0.258 . . . . 0.0 111.353 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.736 HD21 ' CG2' ' A' ' 132' ' ' VAL . 4.8 mp -107.05 153.37 22.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.919 0.39 . . . . 0.0 111.184 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 79.9 p -89.28 167.7 12.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.427 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.625 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.5 m-20 -42.48 -54.89 3.68 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.363 0.601 . . . . 0.0 109.75 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.519 ' HB3' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -118.31 84.15 2.13 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 177.009 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.55 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 17.6 t60 -60.39 -46.31 90.43 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.752 -176.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.509 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 30.0 p90 -146.84 160.49 42.22 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.447 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.678 ' HG2' HG12 ' A' ' 65' ' ' VAL . 3.8 tt0 -135.66 143.18 45.34 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.015 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.765 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 56.6 mt -118.52 130.29 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.981 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.622 HD13 HD12 ' A' ' 62' ' ' ILE . 0.5 OUTLIER -111.37 149.6 30.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.025 0.441 . . . . 0.0 111.87 -179.549 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.676 HD22 HG11 ' A' ' 33' ' ' VAL . 36.2 tp -125.13 122.89 38.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.344 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.84 -160.42 19.73 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.706 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.7 172.48 7.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.798 0.332 . . . . 0.0 111.005 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.499 ' C ' HD22 ' A' ' 155' ' ' LEU . 1.1 m-20 58.34 -174.34 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.913 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -91.03 48.05 2.96 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.426 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -126.95 135.67 51.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.876 0.37 . . . . 0.0 110.851 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.805 HD21 HG12 ' A' ' 33' ' ' VAL . 4.8 mp -114.58 160.05 19.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.769 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.942 HD22 ' HB3' ' A' ' 121' ' ' ASN . 4.6 mt -132.84 143.86 49.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.412 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.78 128.43 56.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.244 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.446 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 52.6 t30 -118.58 115.78 25.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.911 0.386 . . . . 0.0 111.745 -179.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.763 ' OD2' HG23 ' A' ' 116' ' ' VAL . 13.5 p30 -77.73 139.98 39.45 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.508 HD12 ' HB2' ' A' ' 87' ' ' LYS . 8.3 pt -147.4 38.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 111.538 0.199 . . . . 0.0 111.538 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.688 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.0 150.96 21.44 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.05 0.452 . . . . 0.0 112.127 -178.538 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 39.8 m -68.79 -31.32 70.25 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.573 177.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -97.38 -19.79 18.24 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.609 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.688 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 115.77 156.31 10.93 Favored Glycine 0 N--CA 1.438 -1.21 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.671 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.0 m -117.53 137.84 52.3 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.859 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -114.83 148.5 38.42 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -178.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.475 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.15 113.42 18.31 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.415 177.536 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.415 ' N ' HD12 ' A' ' 111' ' ' LEU . 91.7 m-20 44.37 43.26 5.99 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.74 -10.78 68.66 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.792 -0.718 . . . . 0.0 113.458 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -104.82 118.58 36.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.067 0.46 . . . . 0.0 110.635 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.859 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 15.1 tptp -73.37 122.25 21.75 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.318 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.763 HG23 ' OD2' ' A' ' 103' ' ' ASP . 7.3 m -93.94 165.53 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.242 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 120' ' ' SER . 16.7 mt-10 -69.86 128.51 36.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.522 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.69 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 15.9 tttp -54.47 163.93 0.8 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.9 OUTLIER 34.35 36.41 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.816 -179.183 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.407 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 4.7 p -111.96 145.09 40.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.914 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.942 ' HB3' HD22 ' A' ' 100' ' ' LEU . 6.6 m120 -94.62 129.59 41.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.932 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.781 ' O ' HD23 ' A' ' 100' ' ' LEU . 62.5 mm-40 -129.08 149.42 50.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.389 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.522 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.6 tm? -72.63 122.05 20.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.874 0.369 . . . . 0.0 110.26 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.575 HD21 HG12 ' A' ' 147' ' ' ILE . 65.0 tp -54.16 156.44 3.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.397 0.618 . . . . 0.0 111.866 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.401 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.4 OUTLIER -124.55 153.48 42.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.544 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.457 ' HA ' HD12 ' A' ' 147' ' ' ILE . 3.8 tp60 -71.59 122.26 20.2 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 59.95 22.58 57.89 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.928 -178.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -52.15 170.7 0.06 Allowed 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.941 0.4 . . . . 0.0 111.095 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.688 ' HG3' HG22 ' A' ' 144' ' ' VAL . 9.5 tt0 -145.11 135.47 24.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.266 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.481 HD11 HD11 ' A' ' 145' ' ' ILE . 17.6 mt -115.6 127.53 73.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.604 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.596 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.5 m -104.49 140.61 37.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.082 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.736 ' CG2' HD21 ' A' ' 84' ' ' LEU . 35.2 m -140.34 158.42 25.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 112.216 0.451 . . . . 0.0 112.216 -178.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.2 43.03 8.92 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.806 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.474 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.9 t -84.72 140.53 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 121.686 0.755 . . . . 0.0 112.502 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.98 -38.32 0.8 Allowed Glycine 0 N--CA 1.435 -1.401 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.533 HG12 ' H ' ' A' ' 138' ' ' SER . 57.7 t -126.39 120.2 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-N 114.518 -0.841 . . . . 0.0 109.001 177.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.408 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -50.45 -28.43 8.29 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.708 0.289 . . . . 0.0 111.494 -178.555 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.533 ' H ' HG12 ' A' ' 136' ' ' VAL . 2.2 p -93.61 6.52 48.0 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.43 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 0.6 OUTLIER -131.18 31.15 4.45 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -179.017 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.596 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.9 mt -107.16 139.47 28.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.647 178.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.455 HD23 ' C ' ' A' ' 141' ' ' LEU . 9.5 tt -123.64 134.46 53.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.928 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.528 ' H ' HG21 ' A' ' 40' ' ' THR . 45.2 t -109.73 150.4 28.37 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.618 0.723 . . . . 0.0 112.29 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 65.2 mt -135.81 139.12 43.23 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.963 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.688 HG22 ' HG3' ' A' ' 129' ' ' GLU . 19.2 t -112.4 139.08 38.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.858 0.361 . . . . 0.0 111.09 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.481 HD11 HD11 ' A' ' 130' ' ' ILE . 31.4 mt -106.3 129.6 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.029 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.62 ' CD1' HD12 ' A' ' 37' ' ' ILE . 0.9 OUTLIER -113.68 116.29 29.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.832 179.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.575 HG12 HD21 ' A' ' 124' ' ' LEU . 6.2 mt -84.88 134.14 27.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.681 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -88.7 109.77 20.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.699 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -62.36 -30.6 71.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.059 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -42.27 84.39 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.969 0.414 . . . . 0.0 110.721 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -60.66 -44.07 96.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.887 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 16.4 mtmm -64.32 -33.77 76.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.069 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -58.86 -44.09 90.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.118 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.606 ' SG ' HD13 ' A' ' 52' ' ' ILE . 10.8 t -63.79 -46.1 86.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.016 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.499 HD22 ' C ' ' A' ' 96' ' ' ASP . 0.1 OUTLIER -66.46 -35.81 81.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.922 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -61.21 -39.37 89.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.869 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 159' ' ' LYS . 28.8 mt-30 -88.96 -30.77 18.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.28 -90.82 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.63 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 157' ' ' GLN . 0.2 OUTLIER -104.51 127.64 52.26 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.846 0.355 . . . . 0.0 110.945 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.52 ' O ' HG13 ' A' ' 160' ' ' VAL . 12.5 p -77.75 117.94 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.138 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -119.94 124.92 47.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.914 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 69.8 mtt-85 -109.35 79.72 1.24 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 10.8 tt -87.77 140.07 16.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.107 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.795 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.788 0.328 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.98 -53.26 2.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -64.44 -41.46 96.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.938 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -70.94 -36.97 72.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -58.4 -39.88 80.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.793 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.42 -32.53 73.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.746 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.429 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.0 mt -73.04 -35.34 48.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.947 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -57.21 -43.53 82.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.912 0.387 . . . . 0.0 110.612 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -67.09 -24.26 65.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.529 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.429 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -57.0 -47.7 80.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.131 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.2 m -81.11 -41.87 21.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.105 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 66.19 -174.14 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.582 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -62.87 127.92 33.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.893 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -75.87 104.55 6.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.877 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.6 mm -82.05 138.37 19.6 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-O 121.621 0.724 . . . . 0.0 111.685 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.418 ' CA ' HG12 ' A' ' 32' ' ' ILE . . . 147.77 120.23 1.15 Allowed Glycine 0 C--N 1.314 -0.679 0 CA-C-N 114.598 -1.183 . . . . 0.0 112.555 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -75.82 -28.65 58.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.767 0.318 . . . . 0.0 110.976 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.436 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER -178.48 37.16 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.66 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.5 mm -76.26 137.15 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 CA-C-N 113.706 -1.588 . . . . 0.0 112.603 -177.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.965 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.4 t -91.97 -58.47 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.641 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 48' ' ' LEU . 66.2 m -146.18 165.28 29.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.466 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.74 124.52 31.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.773 0.321 . . . . 0.0 111.171 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.69 HG21 ' HE2' ' A' ' 68' ' ' PHE . 55.7 t -94.9 122.96 46.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.012 0.434 . . . . 0.0 111.132 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.786 HG23 HG12 ' A' ' 45' ' ' ILE . 20.9 mt -124.68 122.69 64.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.057 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.714 ' HA ' HD13 ' A' ' 143' ' ' LEU . 42.3 t -79.96 112.88 17.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.831 0.348 . . . . 0.0 110.544 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.452 ' CG2' HG21 ' A' ' 144' ' ' VAL . 0.3 OUTLIER -80.48 -25.26 38.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.508 -179.301 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.504 HG23 ' HB3' ' A' ' 142' ' ' SER . 82.3 p -80.04 -2.36 43.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.738 0.304 . . . . 0.0 111.422 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.97 76.48 0.25 Allowed Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.924 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.436 ' HB2' HD11 ' A' ' 141' ' ' LEU . 12.5 mt-30 -147.14 -44.12 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.88 0.372 . . . . 0.0 110.931 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.576 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.1 mt -114.99 141.7 27.34 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.944 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.576 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 45.5 Cg_endo -71.15 145.34 48.96 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.2 1.933 . . . . 0.0 112.285 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.786 HG12 HG23 ' A' ' 37' ' ' ILE . 36.0 mt -60.13 138.81 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.722 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.83 164.33 20.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.294 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -120.82 119.68 33.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.997 0.427 . . . . 0.0 111.839 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.764 HD23 ' CD2' ' A' ' 66' ' ' TRP . 6.9 mp -92.14 130.41 37.87 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.965 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -141.58 155.81 45.74 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 122.2 1.0 . . . . 0.0 113.641 -179.581 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.483 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.23 142.06 29.19 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.468 -1.696 . . . . 0.0 110.934 179.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.827 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -75.46 127.42 33.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.078 0.466 . . . . 0.0 111.102 -179.657 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.59 HD13 ' SG ' ' A' ' 154' ' ' CYS . 59.3 mt -64.41 -43.1 96.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.029 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 t -61.0 -39.94 91.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.228 0.537 . . . . 0.0 110.581 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.47 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 24.5 mm-40 -68.53 -36.82 79.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.735 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.827 HG23 ' O ' ' A' ' 51' ' ' ASP . 49.1 t -71.83 -42.97 69.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.012 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.5 tt -71.06 -42.02 69.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.981 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 15.0 mmtp -64.47 -38.91 92.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.946 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -73.15 132.35 43.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.879 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -106.04 32.9 4.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.946 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -106.17 178.24 4.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.88 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 75.3 m -86.81 -30.29 21.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.859 HD11 HG22 ' A' ' 65' ' ' VAL . 9.0 tp -108.77 147.2 13.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.087 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.612 ' HG2' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -125.86 -73.67 0.62 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.75 179.867 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.419 ' CE ' ' O ' ' A' ' 49' ' ' SER . 3.9 ttpt -135.81 127.86 29.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.865 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.859 HG22 HD11 ' A' ' 62' ' ' ILE . 6.3 t -121.59 137.14 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 121.283 0.563 . . . . 0.0 111.876 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.764 ' CD2' HD23 ' A' ' 48' ' ' LEU . 19.5 m-90 -102.41 139.41 38.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.274 -0.876 . . . . 0.0 112.151 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.663 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.33 130.52 56.25 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 177.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.698 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.7 OUTLIER -117.65 145.49 44.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.392 -178.897 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.637 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.0 -169.05 36.52 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.776 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -81.7 4.26 22.48 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -84.77 132.47 46.2 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.469 0.176 . . . . 0.0 111.11 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.33 -13.81 41.47 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.488 2.125 . . . . 0.0 111.612 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.83 -42.7 17.51 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 121.921 0.867 . . . . 0.0 109.03 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -41.88 138.94 1.37 Allowed 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 113.831 -1.531 . . . . 0.0 111.081 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 67' ' ' THR . 20.3 m-20 -56.47 -18.6 11.93 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.981 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.481 ' CZ ' HG21 ' A' ' 43' ' ' ILE . 23.9 t80 -129.52 118.87 22.76 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-O 120.773 0.32 . . . . 0.0 110.998 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -97.46 107.92 20.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.728 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.529 ' HB3' HD13 ' A' ' 43' ' ' ILE . 1.1 pp -112.57 177.33 4.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.812 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.83 ' O ' HD12 ' A' ' 81' ' ' ILE . . . -56.69 146.64 34.28 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.482 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -79.08 87.37 4.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.827 0.346 . . . . 0.0 110.932 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.83 HD12 ' O ' ' A' ' 79' ' ' GLY . 3.8 mp -107.33 126.12 63.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.945 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.8 m -55.22 -33.92 63.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.995 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.522 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -63.96 -28.55 69.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.927 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.468 HD12 HD13 ' A' ' 81' ' ' ILE . 19.1 mt -100.43 151.98 20.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.979 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 91.6 p -95.1 165.61 12.34 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.647 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.637 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -43.09 -52.88 5.21 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.289 0.566 . . . . 0.0 109.641 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.558 ' HB3' HG22 ' A' ' 67' ' ' THR . 2.0 mttp -118.94 82.44 1.86 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.55 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.4 t60 -59.92 -46.67 88.63 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.576 -177.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.5 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 26.4 p90 -145.41 160.05 42.15 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.755 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.663 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.5 tt0 -136.03 140.85 44.17 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.32 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.698 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 71.2 mt -115.13 131.08 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.92 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.498 HD21 HD22 ' A' ' 121' ' ' ASN . 0.6 OUTLIER -112.59 147.06 37.46 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.141 0.496 . . . . 0.0 111.891 -179.602 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.828 HD22 HG11 ' A' ' 33' ' ' VAL . 28.6 tp -125.21 122.83 38.14 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.438 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 171.82 -177.46 44.57 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.683 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 59.39 81.85 0.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.821 0.343 . . . . 0.0 110.931 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 60.09 -177.38 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.834 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -70.38 65.15 0.77 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.48 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -142.41 153.41 43.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.802 0.334 . . . . 0.0 110.926 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.692 ' O ' HD12 ' A' ' 100' ' ' LEU . 4.3 mm? -115.85 153.87 30.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.862 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.692 HD12 ' O ' ' A' ' 99' ' ' LEU . 3.9 mp -132.99 145.73 51.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.606 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.998 HD11 HD11 ' A' ' 130' ' ' ILE . 0.4 OUTLIER -112.85 126.91 55.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.066 179.695 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.43 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 52.0 t30 -119.38 115.74 24.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.964 0.411 . . . . 0.0 112.069 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.836 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.1 p30 -76.38 141.04 41.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.739 178.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.465 HD12 ' HB2' ' A' ' 87' ' ' LYS . 8.3 pt -149.28 39.1 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.618 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.84 153.01 19.1 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-O 121.102 0.477 . . . . 0.0 111.847 -179.062 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.2 m -68.83 -31.72 70.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.058 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -98.29 -19.93 17.51 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.618 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 118.83 157.31 10.38 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.698 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.6 m -117.61 137.81 52.37 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 123.142 0.577 . . . . 0.0 109.492 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.879 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -115.61 148.66 39.37 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.465 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.16 113.62 18.56 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.478 177.535 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.42 ' N ' HD12 ' A' ' 111' ' ' LEU . 52.6 m-20 43.41 43.9 4.59 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.76 -13.64 62.21 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.608 -0.806 . . . . 0.0 113.432 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -103.78 118.52 36.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.976 0.417 . . . . 0.0 110.571 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.879 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 12.0 tptt -72.93 124.2 24.97 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.408 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.836 HG23 ' OD2' ' A' ' 103' ' ' ASP . 15.8 m -90.01 176.59 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.084 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.9 pt-20 -83.25 124.43 30.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.497 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.672 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 20.4 tttt -50.5 159.78 0.47 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.025 0.441 . . . . 0.0 111.086 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.488 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 3.6 p30 34.65 33.99 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.621 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.52 145.15 40.78 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.95 179.181 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.629 ' HB3' HD23 ' A' ' 100' ' ' LEU . 24.5 m120 -87.37 132.43 33.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.861 0.362 . . . . 0.0 110.99 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 43.7 mm-40 -129.17 148.13 51.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.536 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.3 tp -72.71 118.53 15.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.056 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.689 HD21 HG12 ' A' ' 147' ' ' ILE . 66.9 tp -52.91 155.85 2.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.411 0.624 . . . . 0.0 111.719 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.445 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.76 153.29 42.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.585 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.416 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 1.2 tp60 -71.79 120.78 17.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.94 0.4 . . . . 0.0 110.417 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.21 24.82 56.11 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.357 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.478 ' HB3' HD13 ' A' ' 145' ' ' ILE . 21.5 t0 -56.67 174.5 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.87 0.367 . . . . 0.0 110.912 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -145.22 135.49 24.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.093 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.998 HD11 HD11 ' A' ' 101' ' ' LEU . 3.9 mt -114.99 128.27 72.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.483 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.673 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.6 m -104.24 140.21 38.16 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.021 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.525 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.1 m -140.31 158.33 25.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.4 35.66 19.54 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.086 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.474 ' HA ' HG12 ' A' ' 140' ' ' ILE . 63.3 t -76.1 140.4 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-O 121.666 0.746 . . . . 0.0 112.474 -179.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.4 -38.87 0.77 Allowed Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.445 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 51.2 t -126.33 132.88 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-N 114.754 -0.723 . . . . 0.0 109.206 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.61 -40.16 52.08 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.408 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -93.39 6.4 48.28 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -178.647 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.445 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 13.0 t0 -116.69 25.1 10.8 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.673 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.9 mt -107.36 139.42 29.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.244 178.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.499 HD21 ' CD1' ' A' ' 43' ' ' ILE . 2.7 tp -124.15 134.46 53.32 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.342 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.551 ' C ' HD22 ' A' ' 143' ' ' LEU . 37.2 t -113.04 150.46 31.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.59 0.71 . . . . 0.0 112.743 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.714 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.5 mm? -135.91 142.33 44.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.646 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.452 HG21 ' CG2' ' A' ' 39' ' ' THR . 21.9 t -114.25 135.34 54.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.86 0.362 . . . . 0.0 111.254 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.594 HD11 HG13 ' A' ' 130' ' ' ILE . 1.2 mp -105.59 127.56 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.375 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.58 120.03 40.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.662 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.689 HG12 HD21 ' A' ' 124' ' ' LEU . 4.9 mt -84.92 134.08 27.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.48 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.4 106.81 13.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.775 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.42 -32.12 68.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.016 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.31 -45.14 92.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.59 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -59.0 -44.23 91.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.915 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.26 -36.52 84.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.072 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -59.0 -46.4 88.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.149 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.59 ' SG ' HD13 ' A' ' 52' ' ' ILE . 11.4 t -59.36 -44.63 92.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.03 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.13 -36.01 77.02 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.886 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.98 -48.15 59.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.987 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.51 -36.51 44.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.949 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.4 p30 42.63 85.78 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.487 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 11.0 tttt -110.03 115.84 30.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.921 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 5.9 m -100.09 119.98 48.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.116 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 22.8 t0 60.04 108.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.924 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.99 94.93 9.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.809 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.5 mt -79.02 118.92 27.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.078 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.941 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.418 ' O ' HG23 ' A' ' 15' ' ' THR . . . . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.801 0.334 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 14' ' ' ALA . 0.8 OUTLIER -158.92 -74.59 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.946 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -69.11 -46.92 66.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.833 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.4 ttm180 -63.73 -35.96 82.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.98 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -56.87 -42.29 79.51 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.885 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.65 -32.36 68.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.691 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.451 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.3 mt -73.14 -35.2 47.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.84 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -39.77 76.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.92 0.39 . . . . 0.0 110.503 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.416 ' HA ' ' HG3' ' A' ' 25' ' ' GLN . 0.8 OUTLIER -67.1 -24.51 65.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.622 179.303 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.451 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -57.17 -47.59 80.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.619 -179.83 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.34 -47.25 18.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.28 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.416 ' HG3' ' HA ' ' A' ' 22' ' ' LYS . 1.1 pp0? -84.54 114.75 22.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.899 0.381 . . . . 0.0 110.989 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -87.7 142.39 27.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.911 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -77.88 124.17 27.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.6 mm -81.97 138.39 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 CA-C-O 121.654 0.74 . . . . 0.0 111.705 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 140.11 110.26 0.86 Allowed Glycine 0 C--N 1.315 -0.614 0 CA-C-N 114.431 -1.258 . . . . 0.0 112.51 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.4 -28.31 34.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.826 0.346 . . . . 0.0 110.946 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.433 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.8 OUTLIER 178.59 38.29 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.721 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 4.9 mm -73.21 134.76 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 CA-C-N 113.621 -1.627 . . . . 0.0 112.479 -177.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.037 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.2 t -89.91 -60.12 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.829 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.602 ' SG ' HD12 ' A' ' 48' ' ' LEU . 6.7 p -150.13 150.87 32.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.147 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.421 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -113.85 138.16 50.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.224 -179.416 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.779 HG21 ' HE2' ' A' ' 68' ' ' PHE . 22.7 t -104.65 122.69 57.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.016 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.783 HG23 HG12 ' A' ' 45' ' ' ILE . 16.3 mt -125.78 125.69 68.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.42 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.711 ' HA ' HD13 ' A' ' 143' ' ' LEU . 44.3 t -82.11 120.08 24.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.844 0.354 . . . . 0.0 110.543 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.5 t -86.0 -27.75 24.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.499 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.535 HG21 ' H ' ' A' ' 142' ' ' SER . 42.4 p -79.82 -2.26 42.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.554 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.97 77.91 0.2 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.86 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.607 ' CD ' HD11 ' A' ' 141' ' ' LEU . 11.1 mt-30 -146.73 -44.89 0.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.845 0.355 . . . . 0.0 110.921 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.816 HD13 HD22 ' A' ' 78' ' ' LEU . 3.5 mt -113.93 141.52 26.35 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.062 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.562 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 58.1 Cg_endo -73.32 140.8 31.04 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.156 1.904 . . . . 0.0 112.199 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.783 HG12 HG23 ' A' ' 37' ' ' ILE . 33.6 mt -55.16 141.44 11.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.737 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.425 ' HB2' ' CE2' ' A' ' 76' ' ' TYR . 0.4 OUTLIER -131.49 163.92 26.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.087 179.503 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.421 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.3 OUTLIER -119.35 119.84 35.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.103 0.478 . . . . 0.0 111.78 -179.659 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.608 HD11 HG23 ' A' ' 36' ' ' VAL . 1.3 mt -98.53 135.59 39.86 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.037 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -145.37 159.52 42.93 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -178.573 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.487 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -141.96 141.68 32.93 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.699 -1.591 . . . . 0.0 110.55 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.866 ' O ' HG23 ' A' ' 55' ' ' VAL . 45.3 m-20 -79.48 131.58 36.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.104 0.478 . . . . 0.0 111.445 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.2 mm -64.48 -45.04 96.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.971 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.6 m -59.41 -40.62 87.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.183 0.516 . . . . 0.0 110.744 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.448 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 10.0 mm-40 -68.45 -36.98 79.78 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.783 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 51' ' ' ASP . 57.5 t -69.48 -41.5 80.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.95 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.19 -33.79 70.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.942 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.46 -44.34 19.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.085 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -62.87 117.43 6.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.007 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.1 -26.73 14.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.923 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -55.24 174.87 0.08 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.006 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.755 ' O ' HG22 ' A' ' 62' ' ' ILE . 59.9 p -69.21 133.08 47.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.01 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.755 HG22 ' O ' ' A' ' 61' ' ' SER . 9.1 tp 54.32 155.52 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.783 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.812 ' HG3' HG13 ' A' ' 55' ' ' VAL . 31.9 mmtm -105.17 -70.06 0.79 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.15 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.424 ' CE ' ' O ' ' A' ' 49' ' ' SER . 29.2 ttpt -134.77 139.72 45.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.866 0.365 . . . . 0.0 111.07 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.666 HG12 ' HG2' ' A' ' 90' ' ' GLN . 11.1 t -127.24 139.28 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 121.166 0.508 . . . . 0.0 111.703 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.55 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 19.2 m-90 -100.94 138.4 38.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.249 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.709 HG22 ' HB3' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -113.46 127.11 55.99 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.364 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.779 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -108.9 145.64 35.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.592 -178.255 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.777 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 173.01 -175.26 45.98 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.512 -0.852 . . . . 0.0 113.196 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.415 ' HB2' ' NH1' ' A' ' 70' ' ' ARG . 5.0 mtp-105 -82.93 -4.67 58.49 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.633 0.254 . . . . 0.0 111.454 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.463 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.6 p30 -88.3 139.56 30.26 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-O 120.789 0.328 . . . . 0.0 111.229 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 9.1 Cg_exo -69.46 -4.41 13.77 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.842 2.361 . . . . 0.0 111.809 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.64 -45.96 13.87 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-O 121.932 0.872 . . . . 0.0 108.936 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.26 139.45 1.91 Allowed 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 113.746 -1.57 . . . . 0.0 110.424 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -56.29 -19.19 13.15 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.013 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.559 ' HE1' HD23 ' A' ' 78' ' ' LEU . 39.3 t80 -130.13 121.44 26.31 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.905 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.4 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 -88.41 116.51 26.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.804 0.335 . . . . 0.0 110.726 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.816 HD22 HD13 ' A' ' 43' ' ' ILE . 86.6 mt -92.62 -82.87 0.32 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.229 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -170.3 -100.68 0.14 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.468 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -176.64 71.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.845 0.355 . . . . 0.0 111.285 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.541 HD13 HD12 ' A' ' 84' ' ' LEU . 4.6 mp -110.6 121.8 63.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.684 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.95 -38.07 67.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.501 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.0 mmp_? -60.71 -19.93 59.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.764 0.316 . . . . 0.0 110.912 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.541 HD12 HD13 ' A' ' 81' ' ' ILE . 34.7 mt -101.91 152.33 21.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.792 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 86' ' ' ASN . 96.3 p -97.91 170.68 8.78 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.508 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.777 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.3 m-20 -41.05 -80.64 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.709 ' HB3' HG22 ' A' ' 67' ' ' THR . 13.8 mttm -92.86 83.17 4.73 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.547 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 17.3 t60 -57.71 -46.14 84.77 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.033 -177.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.517 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 16.3 p90 -145.87 158.71 43.85 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.486 -0.486 . . . . 0.0 112.076 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.688 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.1 tt0 -135.72 142.04 44.97 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.254 -178.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.592 HD12 ' CZ ' ' A' ' 68' ' ' PHE . 59.3 mt -117.6 131.68 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.671 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.633 HD12 HD13 ' A' ' 62' ' ' ILE . 0.6 OUTLIER -114.2 143.61 44.54 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.041 0.448 . . . . 0.0 111.876 -179.296 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.734 HD23 ' HG ' ' A' ' 99' ' ' LEU . 2.3 tm? -125.34 126.56 45.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.441 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.499 ' N ' HD22 ' A' ' 93' ' ' LEU . . . 169.84 -145.85 9.55 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.443 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 56.82 -172.8 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.643 0.259 . . . . 0.0 110.638 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -69.89 66.15 0.24 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.944 0.402 . . . . 0.0 110.675 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.24 -174.57 55.25 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.432 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 66.82 -178.04 0.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.871 0.367 . . . . 0.0 111.048 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.945 HD11 HG12 ' A' ' 33' ' ' VAL . 1.1 mt -130.86 160.21 35.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.866 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.796 HD13 ' O ' ' A' ' 122' ' ' GLN . 4.0 mm? -129.9 142.35 50.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.275 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.711 HD11 ' HA ' ' A' ' 124' ' ' LEU . 3.5 mp -112.83 128.73 56.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.289 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.411 ' HB2' HD23 ' A' ' 92' ' ' LEU . 47.1 t30 -119.79 115.56 24.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.053 0.454 . . . . 0.0 111.692 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.836 ' OD2' HG23 ' A' ' 116' ' ' VAL . 11.1 p30 -78.53 137.04 37.71 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.6 HD12 ' HB2' ' A' ' 87' ' ' LYS . 10.2 pt -145.26 39.19 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -178.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.67 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.35 152.84 19.5 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 121.171 0.51 . . . . 0.0 111.867 -178.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 49.1 m -68.83 -31.58 70.66 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.857 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -98.19 -19.97 17.56 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.67 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.7 158.05 10.87 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.788 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.6 m -117.37 137.75 52.25 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.848 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -115.34 148.46 39.24 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -178.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.41 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.21 113.39 18.24 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.538 -1.21 . . . . 0.0 108.246 177.526 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 43.77 43.55 5.08 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.22 -10.99 68.92 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.481 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.69 118.61 37.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.087 0.47 . . . . 0.0 110.612 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.848 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 12.7 tptt -73.17 121.53 20.41 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.197 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.836 HG23 ' OD2' ' A' ' 103' ' ' ASP . 13.2 m -91.0 164.08 2.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.189 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 120' ' ' SER . 4.3 tp10 -69.82 125.35 26.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.572 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.684 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 73.9 tttt -51.96 161.35 0.59 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.858 0.361 . . . . 0.0 110.754 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.8 p30 34.78 34.75 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.309 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.27 145.17 40.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.078 179.498 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.582 HD22 HD21 ' A' ' 92' ' ' LEU . 25.7 m120 -89.32 129.04 35.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.04 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.796 ' O ' HD13 ' A' ' 100' ' ' LEU . 47.0 mm-40 -129.18 147.43 51.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.556 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 tp -72.7 132.76 44.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.298 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.74 HD21 HG13 ' A' ' 147' ' ' ILE . 65.9 tp -62.78 156.71 23.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.487 0.661 . . . . 0.0 111.624 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.406 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.47 153.31 42.19 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.056 179.707 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.554 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.05 117.88 13.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.024 0.44 . . . . 0.0 110.244 -179.446 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 61.8 24.42 64.47 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.015 -178.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.406 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 16.9 t70 -53.43 171.92 0.07 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.901 0.381 . . . . 0.0 110.955 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.83 ' CG ' HG22 ' A' ' 144' ' ' VAL . 3.8 mt-10 -145.15 135.52 24.13 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.098 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.651 HD11 HD23 ' A' ' 101' ' ' LEU . 13.7 mt -114.25 126.57 71.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.483 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.553 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.3 m -104.42 139.09 39.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.955 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.496 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 35.2 m -140.25 158.32 25.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.74 32.87 17.31 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.84 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.484 ' HA ' HG12 ' A' ' 140' ' ' ILE . 54.6 t -75.75 140.48 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-O 121.629 0.728 . . . . 0.0 112.478 -179.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.01 -38.39 0.69 Allowed Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.517 HG12 ' H ' ' A' ' 138' ' ' SER . 49.7 t -126.32 124.45 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 CA-C-N 114.666 -0.767 . . . . 0.0 109.125 178.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.47 -32.65 18.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.73 0.3 . . . . 0.0 111.381 -178.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.517 ' H ' HG12 ' A' ' 136' ' ' VAL . 31.3 t -93.45 6.47 48.06 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.414 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 5.7 t0 -127.93 30.62 5.24 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.553 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.6 mt -107.13 139.52 28.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.784 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.607 HD11 ' CD ' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -122.42 134.3 54.61 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.752 -179.793 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.644 ' C ' HD22 ' A' ' 143' ' ' LEU . 46.6 t -110.82 150.58 28.93 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.59 0.709 . . . . 0.0 112.157 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.711 HD13 ' HA ' ' A' ' 38' ' ' CYS . 3.5 mm? -136.02 149.42 48.8 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.597 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.83 HG22 ' CG ' ' A' ' 129' ' ' GLU . 11.8 t -117.55 135.76 56.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.712 0.292 . . . . 0.0 110.978 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.657 HG21 HD11 ' A' ' 124' ' ' LEU . 3.6 mt -106.57 124.63 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-O 121.044 0.45 . . . . 0.0 111.046 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.465 ' HD2' HD12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -107.93 139.68 42.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.365 179.498 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.74 HG13 HD21 ' A' ' 124' ' ' LEU . 3.3 mp -105.65 134.08 48.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.91 0.386 . . . . 0.0 111.552 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -85.93 112.27 21.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.625 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -57.52 -27.85 62.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.122 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -60.77 -46.02 92.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.809 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -59.95 -44.18 94.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.063 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.611 ' HE2' HG21 ' A' ' 147' ' ' ILE . 46.7 mttm -64.42 -41.35 96.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.953 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -59.28 -37.01 76.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.897 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.9 t -67.4 -43.84 80.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.923 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -64.71 -37.21 86.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.11 -38.32 90.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.917 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -87.04 -35.75 18.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.953 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.6 p30 42.5 43.77 3.27 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.459 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -124.79 114.01 18.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.888 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.3 p -87.13 138.31 19.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.098 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -169.6 96.64 0.31 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.935 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -140.01 -52.51 0.51 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.947 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.9 tt -98.02 132.75 42.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.153 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.898 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.796 0.332 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.6 p -151.39 89.74 1.52 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -72.04 -47.05 54.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.941 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -66.94 -39.92 87.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.015 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -57.55 -40.15 78.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.915 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.15 -33.91 69.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.629 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.483 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.3 mt -73.14 -35.24 47.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.783 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -57.23 -35.2 69.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.454 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.438 ' HA ' ' CG ' ' A' ' 25' ' ' GLN . 18.1 mttp -67.03 -24.07 65.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.613 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.483 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -62.24 -47.85 82.57 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.645 -179.715 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.5 m -65.7 -47.25 76.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.777 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.438 ' CG ' ' HA ' ' A' ' 22' ' ' LYS . 3.8 pt20 -68.81 120.13 14.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.93 0.395 . . . . 0.0 111.11 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -101.01 122.46 43.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.921 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -65.03 134.57 54.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.761 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.7 mm -81.99 138.35 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 121.644 0.735 . . . . 0.0 111.69 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -162.92 71.74 0.2 Allowed Glycine 0 C--N 1.314 -0.69 0 CA-C-N 114.559 -1.201 . . . . 0.0 112.578 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.56 -37.88 55.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.863 0.363 . . . . 0.0 110.929 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.444 ' O ' ' HB3' ' A' ' 49' ' ' SER . 1.3 m-20 177.99 38.32 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.659 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.5 mm -74.14 135.63 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 CA-C-N 113.641 -1.618 . . . . 0.0 112.492 -177.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.985 HG12 HD11 ' A' ' 99' ' ' LEU . 3.4 t -90.81 -58.97 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.436 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.2 p -145.76 158.92 43.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.059 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.402 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -126.36 124.99 41.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.745 0.307 . . . . 0.0 111.528 -179.425 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.725 HG21 ' HE2' ' A' ' 68' ' ' PHE . 26.1 t -94.92 122.68 46.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.923 0.392 . . . . 0.0 110.957 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.855 HG23 HG12 ' A' ' 45' ' ' ILE . 20.7 mt -125.07 120.23 57.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.266 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.545 ' SG ' ' HB ' ' A' ' 43' ' ' ILE . 20.0 m -85.74 99.88 11.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.902 0.382 . . . . 0.0 110.532 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 82.3 p -79.09 -19.73 50.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.14 -178.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.776 HG21 ' OG ' ' A' ' 142' ' ' SER . 10.5 p -79.79 -2.7 44.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.729 0.299 . . . . 0.0 111.354 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.58 71.0 0.98 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.014 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.454 ' HB2' HD21 ' A' ' 141' ' ' LEU . 4.5 mt-30 -140.37 -39.95 0.43 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.764 0.316 . . . . 0.0 111.225 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.78 HG23 ' HD2' ' A' ' 44' ' ' PRO . 4.3 mt -133.88 145.33 55.49 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.668 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.78 ' HD2' HG23 ' A' ' 43' ' ' ILE . 41.9 Cg_endo -69.74 146.16 59.47 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.324 2.016 . . . . 0.0 112.594 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.855 HG12 HG23 ' A' ' 37' ' ' ILE . 36.8 mt -54.26 157.5 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.62 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.483 ' N ' HG22 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -145.69 164.17 32.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.282 179.625 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.402 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.4 OUTLIER -127.58 119.92 27.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.076 0.465 . . . . 0.0 111.902 -179.513 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.795 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.9 mp -95.14 128.6 42.1 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.984 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -138.37 156.78 47.29 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -179.244 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -146.59 141.89 27.41 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.412 -1.722 . . . . 0.0 110.777 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.757 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -75.31 141.77 43.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.153 0.501 . . . . 0.0 111.071 -179.676 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.695 HD13 ' SG ' ' A' ' 154' ' ' CYS . 82.2 mt -64.19 -43.8 97.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.171 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 52.6 p -56.76 -42.19 78.91 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.024 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.519 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.6 OUTLIER -68.39 -37.01 79.99 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.827 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 51' ' ' ASP . 39.4 t -72.76 -45.38 56.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.278 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.92 -30.6 66.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.092 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -81.32 -45.55 16.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.186 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.09 127.32 34.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.004 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.05 31.17 0.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.815 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -79.96 -60.98 2.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.975 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.64 -46.24 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.042 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.431 ' CD1' ' HB2' ' A' ' 92' ' ' LEU . 9.2 tp -140.12 154.06 22.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.894 0.378 . . . . 0.0 111.348 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.77 -59.15 2.0 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.913 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.434 ' HE2' ' O ' ' A' ' 49' ' ' SER . 2.7 ttpt -145.9 136.41 24.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.292 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.63 HG12 ' HG2' ' A' ' 90' ' ' GLN . 14.9 t -134.06 139.36 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 121.268 0.556 . . . . 0.0 112.003 -179.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.795 ' CD2' HD23 ' A' ' 48' ' ' LEU . 18.8 m-90 -103.51 139.29 39.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.226 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.412 HG22 HD11 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -111.45 126.38 54.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.102 0.477 . . . . 0.0 109.832 177.469 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.725 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -111.6 145.6 38.89 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.17 -178.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.64 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.39 -176.62 40.28 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.245 -0.978 . . . . 0.0 113.547 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.454 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 1.2 ttp180 -73.23 -7.39 51.26 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.417 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.1 t30 -84.81 135.51 40.07 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.791 0.329 . . . . 0.0 111.322 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 9.7 Cg_exo -70.14 -6.43 18.76 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.957 2.438 . . . . 0.0 112.087 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.409 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.63 -44.17 16.08 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-O 121.971 0.891 . . . . 0.0 108.63 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -41.91 138.7 1.45 Allowed 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 113.537 -1.665 . . . . 0.0 110.416 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -56.26 -19.31 13.5 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.024 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.553 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 21.1 t80 -130.21 122.55 28.33 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.661 179.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.403 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.2 t-160 -90.62 140.95 29.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.774 0.321 . . . . 0.0 110.958 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.731 HD23 HD13 ' A' ' 84' ' ' LEU . 8.2 mp -100.17 -89.5 0.33 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.145 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.51 -81.71 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.553 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -176.2 56.42 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.772 0.32 . . . . 0.0 111.426 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.662 HD13 ' CD1' ' A' ' 84' ' ' LEU . 2.9 mp -104.88 111.83 35.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.786 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.4 m -55.22 -36.61 66.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.289 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -61.0 -18.83 59.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.279 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.731 HD13 HD23 ' A' ' 78' ' ' LEU . 18.9 mt -102.69 149.34 24.55 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.759 0.314 . . . . 0.0 111.026 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 88.2 p -92.41 167.17 12.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.711 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.64 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.8 m-20 -43.53 -53.25 5.7 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.286 0.565 . . . . 0.0 109.832 179.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.431 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 2.7 ptmt -120.88 82.46 1.92 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.553 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.8 t60 -59.62 -47.12 86.85 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.707 -176.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.506 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 28.2 p90 -146.48 159.8 42.94 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.666 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.63 ' HG2' HG12 ' A' ' 65' ' ' VAL . 7.3 tt0 -135.77 141.2 44.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.145 -179.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.592 ' O ' HG13 ' A' ' 65' ' ' VAL . 50.8 mt -114.28 131.03 67.49 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.205 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.126 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.603 HD21 ' HB3' ' A' ' 100' ' ' LEU . 0.7 OUTLIER -112.64 149.04 33.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.009 0.433 . . . . 0.0 111.595 -179.674 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.843 HD22 HG11 ' A' ' 33' ' ' VAL . 29.1 tp -124.93 123.05 39.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.631 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.0 -163.83 17.81 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.475 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 59.39 20.16 8.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.699 0.285 . . . . 0.0 111.21 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 55.55 97.86 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.249 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.87 -54.61 3.71 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.671 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.41 ' O ' HD12 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -56.61 154.26 9.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.808 0.337 . . . . 0.0 111.075 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.985 HD11 HG12 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -128.9 150.89 50.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.902 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.645 HD12 ' O ' ' A' ' 99' ' ' LEU . 2.6 mp -133.14 146.56 51.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.151 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.781 HD23 HD11 ' A' ' 130' ' ' ILE . 4.9 mp -112.65 129.35 56.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.259 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 90' ' ' GLN . 53.3 t30 -117.91 115.49 25.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.886 0.374 . . . . 0.0 111.829 -179.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.799 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.3 p30 -77.2 140.49 40.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.781 178.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' A' ' 89' ' ' PHE . 19.0 pt -149.5 38.74 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.655 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.1 152.6 19.67 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.095 0.474 . . . . 0.0 111.906 -178.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 47.9 m -68.93 -31.45 70.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.731 177.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -98.17 -19.81 17.67 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.655 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.84 157.18 10.55 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.359 -0.924 . . . . 0.0 113.895 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 8.1 m -117.42 137.88 52.2 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.81 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -116.67 148.37 41.08 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -177.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.897 HD12 HG11 ' A' ' 116' ' ' VAL . 0.9 OUTLIER -124.33 113.56 18.38 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.043 177.384 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 47.43 35.77 4.41 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.141 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.81 -7.41 76.99 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.564 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.8 118.58 37.04 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.059 0.457 . . . . 0.0 110.736 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.81 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -71.52 128.06 34.59 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.219 -179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.897 HG11 HD12 ' A' ' 111' ' ' LEU . 9.8 m -101.34 167.68 2.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.464 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 120' ' ' SER . 4.6 mm-40 -69.91 125.81 27.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.539 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.697 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 68.8 tttt -54.2 162.71 0.97 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.892 0.377 . . . . 0.0 110.618 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' A' ' 103' ' ' ASP . 1.5 m-80 35.21 34.02 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.241 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.29 145.14 40.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.027 179.481 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.592 ' HB3' HD23 ' A' ' 100' ' ' LEU . 4.8 m120 -85.87 132.13 34.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.021 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.426 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 32.5 mm-40 -129.46 146.27 51.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.768 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 124' ' ' LEU . 1.0 OUTLIER -72.98 122.92 22.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.312 179.503 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.757 HD21 HG12 ' A' ' 147' ' ' ILE . 59.6 tp -59.61 155.59 15.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.511 0.672 . . . . 0.0 111.554 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.435 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -124.8 153.2 42.86 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.33 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -71.74 120.49 17.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.986 0.422 . . . . 0.0 110.263 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.81 18.4 64.09 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.403 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.537 ' OD1' HD23 ' A' ' 111' ' ' LEU . 13.2 t70 -54.18 170.16 0.15 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.016 0.436 . . . . 0.0 111.257 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 5.0 tt0 -145.23 135.49 24.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.102 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.781 HD11 HD23 ' A' ' 101' ' ' LEU . 14.6 mt -111.27 128.22 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.346 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.634 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.7 m -104.22 139.32 39.42 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.186 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.478 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 34.6 m -140.18 158.25 25.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.086 0.47 . . . . 0.0 112.217 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.67 37.91 12.96 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.908 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.1 t -79.14 140.33 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-O 121.67 0.748 . . . . 0.0 112.33 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.89 -36.97 0.89 Allowed Glycine 0 N--CA 1.436 -1.341 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.02 -179.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.476 HG12 ' H ' ' A' ' 138' ' ' SER . 48.5 t -126.37 123.74 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-N 114.621 -0.79 . . . . 0.0 109.084 178.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.57 -33.21 21.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.691 0.282 . . . . 0.0 111.617 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.476 ' H ' HG12 ' A' ' 136' ' ' VAL . 3.0 m -93.46 6.58 47.69 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.446 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 3.2 t0 -127.34 30.1 5.44 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.634 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.9 mt -106.61 139.68 27.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.797 178.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.762 HD22 HD13 ' A' ' 143' ' ' LEU . 1.0 OUTLIER -115.76 134.55 54.9 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.827 -179.678 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.776 ' OG ' HG21 ' A' ' 40' ' ' THR . 0.3 OUTLIER -116.13 127.06 54.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.218 0.532 . . . . 0.0 111.558 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.762 HD13 HD22 ' A' ' 141' ' ' LEU . 2.3 mp -121.26 138.08 54.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.625 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 21.7 t -110.55 139.31 34.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.866 0.365 . . . . 0.0 111.18 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.463 HD12 HD21 ' A' ' 101' ' ' LEU . 49.0 mt -106.03 138.12 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.197 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.84 116.48 25.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.473 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.757 HG12 HD21 ' A' ' 124' ' ' LEU . 4.9 mt -84.88 134.04 27.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.499 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.18 105.85 15.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.595 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -58.19 -32.96 68.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.091 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -60.38 -46.02 91.44 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.031 0.444 . . . . 0.0 110.775 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -60.12 -44.12 95.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.038 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -65.11 -36.45 84.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.083 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -59.01 -40.54 85.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.102 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.695 ' SG ' HD13 ' A' ' 52' ' ' ILE . 8.4 t -68.25 -43.54 77.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.105 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.464 HD11 ' CG1' ' A' ' 55' ' ' VAL . 4.2 mm? -69.07 -50.09 51.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.385 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -33.66 71.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.073 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -87.25 -37.3 17.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.85 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.2 p30 41.53 33.42 0.29 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.502 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -109.62 135.19 50.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.893 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 30.0 m -87.62 135.32 25.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.069 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -137.43 151.91 49.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.945 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 38.8 mmm-85 -137.3 117.27 13.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.95 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.542 HD13 ' H ' ' A' ' 163' ' ' ILE . 0.2 OUTLIER -76.9 138.67 20.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.167 -179.843 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.864 -179.952 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.879 0.371 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.0 m -137.13 -47.15 0.58 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.893 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -61.53 -38.26 86.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.908 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.9 mmt85 -68.97 -37.2 78.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -58.24 -40.38 81.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.775 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.3 tp -59.37 -31.93 69.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.801 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.465 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.2 mt -73.02 -35.37 48.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -57.55 -39.59 76.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.37 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.16 -23.86 65.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.672 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.465 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.64 -47.56 79.47 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.199 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.1 p -71.16 -40.6 71.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.833 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 58.44 30.52 19.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.062 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.7 120.98 27.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -109.05 111.64 23.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.7 mm -81.97 138.36 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 CA-C-O 121.657 0.742 . . . . 0.0 111.689 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 164.56 111.6 0.25 Allowed Glycine 0 C--N 1.312 -0.757 0 CA-C-N 114.493 -1.231 . . . . 0.0 112.48 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -82.55 -27.01 31.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.74 0.305 . . . . 0.0 110.938 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.404 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.5 OUTLIER 175.94 39.44 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -179.841 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.667 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 3.6 mm -74.83 135.06 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 CA-C-N 113.694 -1.594 . . . . 0.0 112.532 -177.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.966 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -92.72 -60.84 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.836 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.619 ' SG ' HD22 ' A' ' 48' ' ' LEU . 1.7 p -140.73 164.88 29.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.214 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.411 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -134.45 122.09 22.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.809 0.337 . . . . 0.0 111.322 -179.529 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.704 HG21 ' HE2' ' A' ' 68' ' ' PHE . 40.6 t -93.72 122.78 45.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.815 0.34 . . . . 0.0 111.04 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.831 HG23 HG12 ' A' ' 45' ' ' ILE . 14.0 mt -125.7 117.49 49.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.564 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.428 ' SG ' HD23 ' A' ' 143' ' ' LEU . 3.8 t -81.33 111.23 17.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.834 0.349 . . . . 0.0 110.34 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.1 t -86.89 -22.02 25.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.934 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.636 HG23 ' HB2' ' A' ' 142' ' ' SER . 81.6 p -79.84 -2.77 44.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.731 0.3 . . . . 0.0 111.429 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.24 75.77 0.4 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.882 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -146.9 -40.36 0.2 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.844 0.354 . . . . 0.0 111.02 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.584 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 4.3 mt -125.9 142.01 41.07 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.033 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.584 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 46.0 Cg_endo -70.48 146.05 54.65 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.172 1.915 . . . . 0.0 112.226 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.831 HG12 HG23 ' A' ' 37' ' ' ILE . 33.7 mt -58.91 149.5 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.824 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.32 163.88 31.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.054 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.411 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 0.8 OUTLIER -126.06 119.85 28.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.058 0.456 . . . . 0.0 112.011 -179.479 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.797 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.3 mp -89.57 130.89 35.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.246 178.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.966 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -140.8 156.15 46.22 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 122.412 1.101 . . . . 0.0 113.827 -179.578 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -145.64 141.83 28.49 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 113.352 -1.749 . . . . 0.0 110.64 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.667 ' O ' HG23 ' A' ' 55' ' ' VAL . 2.2 m-20 -77.4 132.02 38.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.159 0.505 . . . . 0.0 111.051 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.652 HG22 HD23 ' A' ' 56' ' ' LEU . 22.4 mm -64.22 -40.12 87.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.057 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.533 ' HA ' HD21 ' A' ' 56' ' ' LEU . 6.8 t -56.82 -42.09 78.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.906 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.507 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.5 OUTLIER -68.45 -36.97 79.78 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.799 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.898 HG11 HD11 ' A' ' 155' ' ' LEU . 39.7 t -67.54 -50.19 63.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.345 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.652 HD23 HG22 ' A' ' 52' ' ' ILE . 3.9 pp -64.94 -26.05 68.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.105 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.13 -53.82 6.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.907 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.21 118.48 14.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.021 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.17 28.12 4.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.824 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.3 mtt-85 -90.08 -175.76 4.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.758 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.72 31.93 2.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.977 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.677 HD11 HG22 ' A' ' 65' ' ' VAL . 8.5 tp -177.44 145.01 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.318 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.686 ' HG2' HG22 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -118.68 -72.05 0.71 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.768 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.415 ' CE ' ' O ' ' A' ' 49' ' ' SER . 21.0 ttpt -136.3 137.57 40.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.677 HG22 HD11 ' A' ' 62' ' ' ILE . 5.4 t -124.69 138.81 52.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.085 0.469 . . . . 0.0 111.852 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.797 ' CD2' HD23 ' A' ' 48' ' ' LEU . 17.0 m-90 -103.4 138.64 39.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.959 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.475 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.17 127.01 55.82 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 177.801 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.704 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -112.95 145.73 40.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.593 -178.456 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.697 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 164.45 -174.4 40.49 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.691 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.405 ' HD3' ' HB2' ' A' ' 84' ' ' LEU . 16.5 mtm180 -80.24 -2.82 46.68 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.488 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 2.0 t30 -84.87 135.99 39.35 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.791 0.329 . . . . 0.0 111.067 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 11.8 Cg_exo -68.86 -6.88 19.15 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.773 2.315 . . . . 0.0 111.834 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.76 -44.63 15.36 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-O 122.0 0.905 . . . . 0.0 108.56 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.07 136.68 4.72 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.694 -1.594 . . . . 0.0 110.16 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.419 ' OD2' ' CD1' ' A' ' 66' ' ' TRP . 0.7 OUTLIER -56.51 -18.92 13.13 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.89 179.431 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.521 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 53.7 t80 -130.19 130.69 45.01 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.772 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -106.93 136.95 45.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.834 0.35 . . . . 0.0 110.944 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.698 ' O ' HD12 ' A' ' 78' ' ' LEU . 0.7 OUTLIER -140.25 78.43 1.66 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.269 -179.726 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 47.25 -137.54 10.4 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.997 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -157.63 90.79 1.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.803 0.335 . . . . 0.0 111.089 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.816 HD13 HD12 ' A' ' 84' ' ' LEU . 3.8 mp -108.62 132.82 55.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.918 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.4 t -58.52 -40.43 82.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.995 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.42 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -61.02 -30.06 70.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.09 -179.82 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.816 HD12 HD13 ' A' ' 81' ' ' ILE . 30.3 mt -94.65 152.12 18.74 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.844 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 89.5 p -95.44 165.24 12.46 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.689 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.697 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.5 m-20 -42.06 -52.8 4.14 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.276 0.56 . . . . 0.0 109.816 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.428 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 5.0 ptmt -120.92 84.29 2.21 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.569 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 11.6 t60 -61.56 -46.24 90.74 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.971 -1.013 . . . . 0.0 113.055 -176.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.5 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 24.6 p90 -144.72 157.94 43.98 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.136 -0.625 . . . . 0.0 112.105 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.638 ' HG2' HG12 ' A' ' 65' ' ' VAL . 5.9 tt0 -135.91 140.35 44.0 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.018 -179.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.523 ' O ' HG13 ' A' ' 65' ' ' VAL . 38.5 mt -113.47 132.3 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 121.134 -0.227 . . . . 0.0 110.855 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.938 HD13 HD12 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -113.81 146.87 39.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.184 0.516 . . . . 0.0 112.022 -179.202 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.808 HD22 HG11 ' A' ' 33' ' ' VAL . 44.4 tp -125.26 122.83 38.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.439 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 127.92 127.95 3.05 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.596 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 178.44 -67.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.865 0.364 . . . . 0.0 110.737 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -146.69 -46.86 0.19 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.758 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 178.94 36.04 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.438 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -156.22 -172.17 3.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.773 0.32 . . . . 0.0 110.929 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.769 ' HB2' HD21 ' A' ' 124' ' ' LEU . 0.3 OUTLIER -120.91 155.29 34.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.696 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.938 HD12 HD13 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -133.22 147.57 51.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.818 0.342 . . . . 0.0 110.768 179.887 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.87 125.26 53.84 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.839 ' HB2' HD11 ' A' ' 92' ' ' LEU . 53.5 t30 -109.27 115.69 30.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.694 -179.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.79 ' OD2' HG23 ' A' ' 116' ' ' VAL . 18.3 p30 -76.89 131.76 38.75 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.649 178.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.437 HD13 ' HB2' ' A' ' 90' ' ' GLN . 21.6 pt -139.34 40.54 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -178.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.677 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.54 151.93 20.6 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 120.987 0.422 . . . . 0.0 111.64 -178.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.8 m -68.57 -31.87 71.38 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.776 178.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -98.41 -19.63 17.6 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.614 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.677 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 116.94 157.81 10.97 Favored Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.73 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.0 m -117.36 137.82 52.21 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.862 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -114.08 148.55 36.92 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -178.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.648 HD13 ' OD2' ' A' ' 128' ' ' ASP . 0.2 OUTLIER -124.05 113.4 18.35 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.645 -1.161 . . . . 0.0 108.27 177.389 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.424 ' N ' HD12 ' A' ' 111' ' ' LEU . 81.4 m-20 44.51 43.08 6.1 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.385 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.47 -8.82 75.82 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.829 -0.7 . . . . 0.0 113.43 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -105.17 118.38 36.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.104 0.452 . . . . 0.0 110.764 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.862 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 12.8 tptt -74.0 122.37 22.51 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.247 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.79 HG23 ' OD2' ' A' ' 103' ' ' ASP . 10.9 m -94.05 165.56 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.204 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 120' ' ' SER . 9.7 tp10 -69.87 125.95 28.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.598 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.704 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 14.6 tttt -54.13 162.83 0.91 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.955 0.407 . . . . 0.0 110.653 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 103' ' ' ASP . 0.7 OUTLIER 37.15 31.27 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.109 -179.171 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.82 144.02 43.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.164 179.203 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -93.42 129.93 39.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.786 0.326 . . . . 0.0 110.287 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -129.0 149.34 50.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.974 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.585 HD13 ' O ' ' A' ' 124' ' ' LEU . 2.1 tm? -72.69 111.64 8.03 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.769 HD21 ' HB2' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -59.88 168.17 1.9 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.318 0.58 . . . . 0.0 111.798 -178.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -124.29 153.65 41.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.033 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.05 116.97 11.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.108 0.48 . . . . 0.0 110.257 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.62 18.36 73.78 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.364 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.648 ' OD2' HD13 ' A' ' 111' ' ' LEU . 5.6 t70 -59.84 -179.48 0.1 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.67 0.271 . . . . 0.0 110.62 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.868 ' CG ' HG22 ' A' ' 144' ' ' VAL . 4.1 mt-10 -145.32 135.69 24.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.682 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 1.048 HD11 HD11 ' A' ' 145' ' ' ILE . 14.9 mt -109.68 126.26 66.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.023 178.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.609 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.9 m -104.49 138.68 40.51 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.209 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.52 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.1 m -140.33 158.2 25.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.26 28.28 28.26 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.15 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.492 ' HA ' HG12 ' A' ' 140' ' ' ILE . 69.7 t -70.04 140.3 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-O 121.58 0.705 . . . . 0.0 112.326 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.69 -38.47 0.76 Allowed Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.437 ' HB ' ' CB ' ' A' ' 139' ' ' ASP . 49.8 t -126.33 132.94 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 CA-C-N 114.808 -0.696 . . . . 0.0 109.335 178.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -50.54 -39.81 50.17 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.428 ' H ' HG12 ' A' ' 136' ' ' VAL . 5.7 m -93.3 6.49 47.89 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.437 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 15.3 t0 -118.74 26.82 9.29 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -179.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.609 ' CG2' HG22 ' A' ' 131' ' ' THR . 6.5 mt -107.14 139.61 28.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.05 178.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.509 HD23 ' N ' ' A' ' 142' ' ' SER . 8.3 tt -119.3 134.51 55.17 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.582 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.636 ' HB2' HG23 ' A' ' 40' ' ' THR . 0.9 OUTLIER -111.39 135.63 51.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.066 0.46 . . . . 0.0 111.633 -179.673 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 51.0 mt -126.71 152.71 46.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.157 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.868 HG22 ' CG ' ' A' ' 129' ' ' GLU . 21.8 t -115.61 139.78 40.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.025 0.441 . . . . 0.0 111.606 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 1.048 HD11 HD11 ' A' ' 130' ' ' ILE . 18.3 mt -106.5 120.95 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.822 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.33 103.9 12.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.424 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.651 HG12 HD22 ' A' ' 124' ' ' LEU . 7.0 mt -84.86 134.05 27.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.991 0.424 . . . . 0.0 111.58 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -88.53 112.2 22.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.86 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.46 -25.9 68.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.083 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.91 -45.22 90.87 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.053 0.454 . . . . 0.0 110.664 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -58.25 -44.05 88.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.004 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -62.26 -41.21 98.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.954 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -64.74 -40.67 95.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.068 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.0 t -65.7 -45.03 84.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.976 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.898 HD11 HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -67.63 -36.04 80.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.883 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.2 -43.24 98.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.785 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.41 ' O ' ' N ' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -84.67 -31.93 23.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.884 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 42.92 -90.83 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.724 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 157' ' ' GLN . 0.9 OUTLIER -72.93 114.19 10.81 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.802 0.334 . . . . 0.0 110.991 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -87.87 140.89 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.185 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -148.89 -47.35 0.15 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.921 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.81 -57.24 13.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.953 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.6 mp -93.27 137.92 21.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.172 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.945 179.982 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.76 0.314 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 38.6 p -140.26 -50.84 0.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -72.05 -31.43 66.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.99 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.47 -36.33 82.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.801 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -39.45 79.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.809 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.78 -31.81 70.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.796 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.434 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.5 mt -72.62 -35.4 50.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.855 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -57.42 -42.69 82.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.941 0.401 . . . . 0.0 110.386 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.09 -23.93 65.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.657 179.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.434 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -56.55 -47.52 79.27 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.298 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.85 -38.96 83.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.809 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -167.95 99.51 0.46 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.893 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -73.47 127.32 32.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.902 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -82.01 114.43 20.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.818 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.0 mm -82.3 138.35 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 CA-C-O 121.687 0.756 . . . . 0.0 111.834 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -140.03 49.42 0.8 Allowed Glycine 0 C--N 1.316 -0.571 0 CA-C-N 114.435 -1.257 . . . . 0.0 112.419 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -63.63 -40.31 96.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.778 0.323 . . . . 0.0 110.888 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.41 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.6 OUTLIER -177.99 37.0 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -179.889 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.675 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 5.4 mm -76.85 135.85 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 CA-C-N 113.708 -1.587 . . . . 0.0 112.571 -177.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.996 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.4 t -90.37 -58.99 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.683 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 30.1 p -150.7 161.27 42.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.014 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.76 138.3 54.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.805 0.336 . . . . 0.0 111.621 -179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.722 HG11 ' CE2' ' A' ' 68' ' ' PHE . 28.4 m -106.85 122.52 60.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.825 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.834 HG23 HG12 ' A' ' 45' ' ' ILE . 19.9 mt -128.62 127.01 66.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.456 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.747 ' HA ' HD13 ' A' ' 143' ' ' LEU . 21.3 t -83.0 100.45 10.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.88 0.371 . . . . 0.0 110.459 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.7 t -69.46 -28.2 65.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.713 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.774 HG23 ' HB2' ' A' ' 142' ' ' SER . 59.5 p -80.08 -2.69 45.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.722 0.296 . . . . 0.0 111.578 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.18 79.84 0.17 Allowed Glycine 0 CA--C 1.517 0.193 0 C-N-CA 120.919 -0.658 . . . . 0.0 113.139 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -147.35 -39.88 0.19 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.78 0.324 . . . . 0.0 111.019 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.601 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 3.4 mt -123.84 142.58 39.78 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.988 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.601 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 37.8 Cg_endo -68.84 146.08 64.68 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.028 1.819 . . . . 0.0 112.247 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.834 HG12 HG23 ' A' ' 37' ' ' ILE . 35.4 mt -57.59 148.1 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.816 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.89 164.04 31.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.056 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -124.57 119.78 30.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.928 0.394 . . . . 0.0 111.973 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.778 HD23 ' CD2' ' A' ' 66' ' ' TRP . 7.6 mp -90.8 125.98 35.88 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.996 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -135.63 156.82 48.25 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -179.092 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.488 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -148.98 141.79 24.62 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.552 -1.658 . . . . 0.0 110.817 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.772 ' O ' HG23 ' A' ' 55' ' ' VAL . 1.4 m-20 -76.81 125.28 29.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.286 0.565 . . . . 0.0 111.239 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.785 HD13 ' SG ' ' A' ' 154' ' ' CYS . 43.1 mt -64.58 -42.83 96.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.69 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.07 -42.29 80.38 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.116 -178.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.566 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -68.72 -37.02 79.17 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.894 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 51' ' ' ASP . 48.9 t -65.9 -44.72 92.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.094 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.99 -30.48 66.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.916 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.5 mttp -73.41 -46.72 47.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.919 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.59 131.52 42.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.32 22.87 8.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.027 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -91.27 170.96 9.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.86 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.74 -53.32 8.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.693 HD12 HD13 ' A' ' 92' ' ' LEU . 26.4 mm -94.52 149.82 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.206 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.67 ' HG2' HG13 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -120.62 -53.97 2.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.842 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.432 ' HE2' ' O ' ' A' ' 49' ' ' SER . 6.7 ttpt -151.43 129.98 12.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.099 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.56 HG13 ' C ' ' A' ' 91' ' ' ILE . 10.9 t -124.04 138.52 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 121.408 0.623 . . . . 0.0 112.021 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.778 ' CD2' HD23 ' A' ' 48' ' ' LEU . 18.1 m-90 -100.97 139.86 36.06 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.824 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.983 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -112.86 127.68 56.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.0 0.428 . . . . 0.0 109.862 177.936 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.722 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -114.11 145.64 41.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.281 -178.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.655 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 162.68 -174.07 39.0 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.674 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.3 mtp180 -79.66 0.24 31.12 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.668 0.248 . . . . 0.0 111.668 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.687 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 10.2 t-20 -84.7 133.91 43.02 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.68 0.276 . . . . 0.0 111.056 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 13.5 Cg_exo -68.5 -8.61 23.61 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.618 2.212 . . . . 0.0 111.894 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.687 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -83.04 -43.14 16.67 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-O 121.963 0.887 . . . . 0.0 108.855 178.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -42.8 137.01 2.42 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 113.65 -1.613 . . . . 0.0 110.918 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -56.43 -18.73 12.17 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.016 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.511 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 63.7 t80 -129.79 123.03 29.97 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.896 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -100.71 124.81 46.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.876 0.369 . . . . 0.0 110.977 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.467 ' HB3' HD13 ' A' ' 43' ' ' ILE . 0.9 OUTLIER -125.68 -178.4 4.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.64 149.33 46.48 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.434 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -78.62 93.52 4.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.886 0.374 . . . . 0.0 110.96 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.52 HG22 ' H ' ' A' ' 83' ' ' ARG . 26.6 mm -112.09 122.14 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.958 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.6 t -54.94 -30.85 59.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.959 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.52 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -68.72 -26.62 65.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.781 179.854 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.649 HD21 HG23 ' A' ' 132' ' ' VAL . 33.7 mt -97.73 152.22 19.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.93 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.2 166.21 11.85 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.686 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.655 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -42.72 -52.83 4.8 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.471 0.653 . . . . 0.0 109.638 179.172 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.553 ' HB3' HG22 ' A' ' 67' ' ' THR . 6.4 mttt -119.51 84.85 2.27 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 177.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.546 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.2 t60 -61.87 -45.83 92.07 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.877 -177.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.52 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 18.9 p90 -145.81 163.24 35.64 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.127 -0.629 . . . . 0.0 112.427 -179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.983 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.59 136.72 41.3 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.397 -178.878 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.56 ' C ' HG13 ' A' ' 65' ' ' VAL . 35.3 mt -113.38 128.49 70.18 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.342 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.353 178.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.693 HD13 HD12 ' A' ' 62' ' ' ILE . 0.7 OUTLIER -114.36 148.35 37.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.086 0.469 . . . . 0.0 111.859 -179.415 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.703 HD13 ' CG1' ' A' ' 33' ' ' VAL . 16.8 tp -125.22 123.1 38.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.368 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.68 -156.91 16.75 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.665 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -62.98 168.49 3.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.796 0.331 . . . . 0.0 110.995 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 59.4 -168.27 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.912 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -97.2 28.24 14.88 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.468 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -103.73 129.44 51.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.918 0.39 . . . . 0.0 110.923 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.696 HD23 HD22 ' A' ' 124' ' ' LEU . 24.0 tp -107.2 154.97 20.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.796 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.79 HD13 ' O ' ' A' ' 122' ' ' GLN . 4.1 mm? -124.91 145.56 49.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.326 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.787 HD21 HD13 ' A' ' 124' ' ' LEU . 2.0 mt -112.62 124.5 52.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.041 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.551 ' HB2' HD23 ' A' ' 92' ' ' LEU . 50.6 t30 -116.99 115.7 25.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.892 0.377 . . . . 0.0 111.781 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.835 ' OD2' HG23 ' A' ' 116' ' ' VAL . 8.1 p30 -77.71 141.23 39.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.955 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.435 HD12 ' HB2' ' A' ' 87' ' ' LYS . 11.0 pt -148.46 38.33 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.602 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.34 152.35 19.55 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.051 0.453 . . . . 0.0 111.753 -179.093 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 47.6 m -68.92 -31.57 70.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.027 178.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -98.24 -19.75 17.66 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.602 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.18 155.65 9.86 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 120.178 -1.01 . . . . 0.0 113.747 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.505 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.8 m -117.65 137.82 52.39 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.864 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -116.01 148.46 40.12 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -178.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.41 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.01 113.52 18.53 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.356 177.575 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 43.93 43.81 5.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.36 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.55 -10.94 67.64 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.448 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.48 118.63 37.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.028 0.442 . . . . 0.0 110.638 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.864 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 12.2 tptp -73.01 122.28 21.48 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.239 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.835 HG23 ' OD2' ' A' ' 103' ' ' ASP . 14.2 m -93.18 164.61 2.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.249 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.5 tp10 -69.88 126.34 29.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.557 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.681 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 87.9 tttt -53.51 161.17 1.07 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.994 0.426 . . . . 0.0 110.727 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.8 p30 34.85 34.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.437 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -112.46 145.1 40.78 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.133 179.384 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -86.71 130.48 34.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.66 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.79 ' O ' HD13 ' A' ' 100' ' ' LEU . 29.9 mm-40 -129.32 146.49 51.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.756 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.1 tp -72.78 124.84 26.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.073 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.787 HD13 HD21 ' A' ' 101' ' ' LEU . 65.4 tp -57.21 157.34 6.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.427 0.632 . . . . 0.0 111.684 -179.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.524 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.4 OUTLIER -124.4 153.69 41.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.333 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.665 ' HA ' HD13 ' A' ' 147' ' ' ILE . 10.0 tp60 -70.96 119.05 14.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.004 0.431 . . . . 0.0 110.318 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.83 24.43 62.5 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.223 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.45 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 23.3 t0 -56.47 169.72 0.43 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.085 0.469 . . . . 0.0 111.107 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 17.2 tt0 -145.35 135.53 23.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.046 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.481 ' CG2' HG22 ' A' ' 109' ' ' THR . 13.4 mt -109.15 128.05 65.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.477 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.694 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.0 m -104.5 139.61 39.16 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.96 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.649 HG23 HD21 ' A' ' 84' ' ' LEU . 34.6 m -140.36 158.52 25.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.95 33.54 23.7 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.734 -0.667 . . . . 0.0 112.234 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.522 ' HA ' HG12 ' A' ' 140' ' ' ILE . 76.4 t -72.95 140.29 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-O 121.587 0.708 . . . . 0.0 112.386 -179.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.77 -42.17 0.8 Allowed Glycine 0 N--CA 1.436 -1.334 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -178.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.483 HG12 ' H ' ' A' ' 138' ' ' SER . 42.0 t -126.34 130.55 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-N 114.763 -0.719 . . . . 0.0 109.153 177.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -50.45 -34.0 23.15 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -178.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.483 ' H ' HG12 ' A' ' 136' ' ' VAL . 69.0 m -93.35 6.24 48.79 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.08 22.41 11.45 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -178.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.694 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.3 mt -107.12 139.42 28.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.293 178.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.569 HD22 ' CD2' ' A' ' 143' ' ' LEU . 1.2 tt -122.22 134.41 54.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.273 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.774 ' HB2' HG23 ' A' ' 40' ' ' THR . 0.7 OUTLIER -109.1 140.66 42.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.053 0.454 . . . . 0.0 111.954 -179.134 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.747 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.7 mm? -134.57 136.03 42.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.333 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 18.1 t -110.68 140.22 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.873 0.368 . . . . 0.0 111.395 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 8.4 mt -106.16 134.75 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.918 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.53 116.3 27.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.69 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.665 HD13 ' HA ' ' A' ' 126' ' ' GLN . 4.6 mp -85.6 134.04 28.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.657 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -85.01 114.71 22.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.765 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -61.34 -31.89 71.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.951 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -59.64 -45.74 91.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.954 0.407 . . . . 0.0 110.686 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -58.6 -44.05 89.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.021 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -62.24 -37.51 85.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.962 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -64.57 -47.04 80.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.05 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.785 ' SG ' HD13 ' A' ' 52' ' ' ILE . 12.3 t -63.46 -45.94 88.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.017 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -60.84 -36.09 78.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.878 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -61.61 -34.76 76.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.79 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.8 -37.12 13.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.852 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.9 p30 44.66 -172.18 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.535 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.57 141.74 28.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.838 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 29.2 m -102.98 131.42 51.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.1 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -102.08 116.46 32.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.894 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.7 162.15 33.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.762 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.0 mt -95.78 124.62 48.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.035 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 44.0 ttm-85 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.869 -179.891 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.414 ' O ' ' CB ' ' A' ' 15' ' ' THR . . . . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.691 0.281 . . . . 0.0 111.048 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.414 ' CB ' ' O ' ' A' ' 14' ' ' ALA . 1.6 m 80.95 -46.75 0.25 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.453 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.69 -30.7 68.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.82 0.343 . . . . 0.0 110.963 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -66.04 -36.03 82.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.647 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -59.93 -43.22 95.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.815 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 tp -58.44 -32.98 69.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.716 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.435 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 1.4 mt -73.1 -35.32 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.922 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -57.07 -38.76 73.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.964 0.411 . . . . 0.0 110.487 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -67.08 -26.8 66.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.404 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.98 -47.57 80.46 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.254 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.1 m -77.06 -26.36 53.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.993 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -68.75 70.47 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.859 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.459 ' HG3' HD11 ' A' ' 28' ' ' ILE . 4.8 pt-20 -93.26 138.1 31.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -64.98 104.28 0.84 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.887 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.459 HD11 ' HG3' ' A' ' 26' ' ' GLU . 18.5 mm -81.95 138.2 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.442 0 CA-C-O 121.649 0.737 . . . . 0.0 111.617 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -139.2 51.43 0.75 Allowed Glycine 0 C--N 1.313 -0.729 0 CA-C-N 114.456 -1.247 . . . . 0.0 112.641 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.682 ' HG2' HD11 ' A' ' 32' ' ' ILE . 12.8 pt-20 -80.06 -44.02 20.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.807 0.337 . . . . 0.0 110.742 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.449 ' O ' ' HB3' ' A' ' 49' ' ' SER . 2.3 m-80 178.79 38.79 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.682 HD11 ' HG2' ' A' ' 30' ' ' GLU . 5.3 mm -71.55 142.15 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.575 0 CA-C-N 113.744 -1.571 . . . . 0.0 112.634 -176.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.767 HG22 HD13 ' A' ' 93' ' ' LEU . 1.0 OUTLIER -106.54 -50.23 8.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.663 -178.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.452 ' N ' HG12 ' A' ' 33' ' ' VAL . 0.5 OUTLIER -154.86 165.5 36.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.351 179.29 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.57 120.83 24.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.757 0.313 . . . . 0.0 111.012 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.824 HG21 ' CZ ' ' A' ' 68' ' ' PHE . 25.0 t -94.7 122.67 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.854 0.359 . . . . 0.0 111.126 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.878 HG23 HG12 ' A' ' 45' ' ' ILE . 13.4 mt -124.49 122.49 64.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.252 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.665 ' HA ' HD13 ' A' ' 143' ' ' LEU . 46.9 t -79.87 127.33 32.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.445 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.9 t -94.31 -29.12 15.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.814 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.552 HG21 ' H ' ' A' ' 142' ' ' SER . 43.2 p -79.87 -2.34 43.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.576 0.226 . . . . 0.0 111.462 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.22 80.86 0.21 Allowed Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.819 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.403 ' OE1' HD11 ' A' ' 141' ' ' LEU . 12.8 mt-30 -147.01 -43.78 0.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.804 0.335 . . . . 0.0 110.888 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.617 HG23 ' HD2' ' A' ' 44' ' ' PRO . 3.8 mp -120.42 142.08 33.23 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.209 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.617 ' HD2' HG23 ' A' ' 43' ' ' ILE . 56.5 Cg_endo -72.55 145.98 43.16 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.221 1.947 . . . . 0.0 112.007 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.878 HG12 HG23 ' A' ' 37' ' ' ILE . 38.2 mt -53.48 134.74 15.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.772 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.17 163.85 24.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.091 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -120.25 119.7 33.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.126 0.489 . . . . 0.0 112.002 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.58 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 5.0 mp -87.22 132.07 34.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.599 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -138.97 156.59 47.12 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 122.426 1.108 . . . . 0.0 113.572 -179.297 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.599 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . . . -142.99 144.66 32.4 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.831 178.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.884 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.9 OUTLIER -74.84 119.32 18.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.066 0.46 . . . . 0.0 111.296 -179.68 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.9 mt -64.46 -43.75 96.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.071 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.8 m -59.76 -40.64 88.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.223 0.535 . . . . 0.0 110.737 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.463 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 28.4 mm-40 -68.55 -36.81 79.31 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.711 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.884 HG23 ' O ' ' A' ' 51' ' ' ASP . 48.3 t -69.02 -43.41 81.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.93 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.5 HD21 ' HB2' ' A' ' 158' ' ' ASN . 0.9 OUTLIER -71.16 -31.63 67.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.785 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -74.34 -48.29 29.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.921 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -69.94 134.99 48.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.991 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.28 29.48 7.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.93 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.8 mtm-85 -92.31 -172.41 3.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.795 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.3 m -85.96 -55.93 3.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.712 HD11 ' CG2' ' A' ' 65' ' ' VAL . 8.6 tp -92.93 147.22 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.051 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.62 ' HG2' HG22 ' A' ' 55' ' ' VAL . 0.9 OUTLIER -116.98 -68.78 0.89 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.4 ' HE2' ' O ' ' A' ' 49' ' ' SER . 7.2 ttpt -143.39 130.41 20.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.34 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.712 ' CG2' HD11 ' A' ' 62' ' ' ILE . 13.0 t -126.32 139.34 51.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.292 0.567 . . . . 0.0 111.895 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.599 ' HZ2' ' O ' ' A' ' 49' ' ' SER . 16.8 m-90 -100.76 139.85 35.87 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.165 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.778 HG23 ' CG ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -108.3 126.26 52.63 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.573 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.824 ' CZ ' HG21 ' A' ' 36' ' ' VAL . 3.0 m-85 -114.47 145.75 41.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.8 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.617 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 159.39 -174.35 36.28 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.188 -1.006 . . . . 0.0 113.362 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 70' ' ' ARG . 6.7 mtm105 -75.61 0.49 17.31 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.732 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 9.5 t-20 -84.66 133.35 44.2 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.667 0.27 . . . . 0.0 111.414 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.8 Cg_exo -68.6 -10.46 29.11 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.655 2.236 . . . . 0.0 111.754 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.732 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -83.21 -43.45 16.11 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-O 121.915 0.864 . . . . 0.0 108.781 178.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -41.37 137.75 1.4 Allowed 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.959 179.631 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.32 -18.3 10.33 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.241 179.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.558 ' CG ' ' CE2' ' A' ' 68' ' ' PHE . 19.8 t80 -127.21 116.25 20.32 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.811 0.338 . . . . 0.0 110.64 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.438 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 2.0 t-160 -94.14 118.32 31.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.159 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.562 HD21 ' CA ' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -125.43 -178.08 4.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.557 179.689 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -54.42 -175.23 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.231 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -120.27 90.64 3.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.832 0.349 . . . . 0.0 110.607 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.592 HD12 ' CD1' ' A' ' 84' ' ' LEU . 24.8 mt -107.08 137.43 38.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.446 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 40.1 t -62.53 -38.75 91.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.768 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.488 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -62.49 -33.25 74.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.949 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.592 ' CD1' HD12 ' A' ' 81' ' ' ILE . 30.0 mt -91.21 152.24 20.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.015 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 92.3 p -97.14 165.53 12.01 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.53 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.617 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.4 OUTLIER -42.81 -53.99 4.34 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.314 0.578 . . . . 0.0 109.745 179.326 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.545 ' HB2' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -118.22 83.81 2.07 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 177.144 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.558 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.0 t60 -61.19 -45.41 94.7 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.802 -1.09 . . . . 0.0 113.162 -176.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.531 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 29.5 p90 -145.98 163.23 35.83 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 119.966 -0.694 . . . . 0.0 112.552 -179.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.778 ' CG ' HG23 ' A' ' 67' ' ' THR . 8.2 mt-30 -135.35 145.09 47.05 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.382 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.548 ' O ' HG13 ' A' ' 65' ' ' VAL . 3.2 mp -118.62 132.36 68.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 178.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.491 ' CB ' HG22 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -118.01 148.93 41.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.227 0.537 . . . . 0.0 111.988 -179.018 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.767 HD13 HG22 ' A' ' 33' ' ' VAL . 0.5 OUTLIER -125.1 122.88 38.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.037 179.143 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.68 174.64 21.93 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.871 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.63 95.22 9.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.766 0.317 . . . . 0.0 110.849 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -171.89 -41.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.838 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 136.93 -19.07 3.51 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.645 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -102.16 175.46 5.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.752 0.31 . . . . 0.0 110.995 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.667 ' CD1' HD12 ' A' ' 93' ' ' LEU . 4.0 mm? -122.01 160.0 25.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.876 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.616 HD12 ' O ' ' A' ' 99' ' ' LEU . 2.3 mp -132.69 142.89 49.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.999 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.76 129.47 56.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.341 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.431 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 50.1 t30 -117.8 115.7 25.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.862 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.787 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.0 p30 -78.65 141.41 38.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.999 178.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.463 ' CD1' ' HB2' ' A' ' 87' ' ' LYS . 14.9 pt -148.33 38.58 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -178.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.635 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.09 152.99 19.24 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-O 121.14 0.495 . . . . 0.0 111.676 -179.162 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 51.1 m -68.87 -31.84 71.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.961 178.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -98.46 -19.92 17.4 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.635 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 119.59 157.22 10.23 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.267 -0.968 . . . . 0.0 113.797 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.518 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 10.7 m -117.53 138.05 52.16 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.881 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -115.04 148.49 38.81 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -178.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.504 HD12 HD22 ' A' ' 112' ' ' ASN . 0.2 OUTLIER -124.13 113.43 18.33 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.337 177.406 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.504 HD22 HD12 ' A' ' 111' ' ' LEU . 2.4 m-80 44.38 43.22 5.97 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.81 -9.96 72.09 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.408 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -105.27 118.57 36.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.007 0.432 . . . . 0.0 110.746 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.881 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 19.1 tptt -73.63 130.25 39.65 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.184 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.787 HG23 ' OD2' ' A' ' 103' ' ' ASP . 8.0 m -103.09 165.95 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.363 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.415 ' HB3' ' HB3' ' A' ' 120' ' ' SER . 5.3 tp10 -69.95 127.0 31.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.564 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.678 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 30.3 tttp -52.62 161.96 0.64 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.739 0.305 . . . . 0.0 110.455 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.9 p30 35.08 35.68 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.132 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.415 ' HB3' ' HB3' ' A' ' 117' ' ' GLU . 4.2 p -112.01 145.15 40.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.644 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -93.33 129.53 39.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.757 0.313 . . . . 0.0 110.925 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.44 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 59.7 mm-40 -129.21 151.85 49.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.536 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.9 tp -72.6 112.23 8.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.85 0.357 . . . . 0.0 110.288 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.883 HD11 HG21 ' A' ' 145' ' ' ILE . 66.3 tp -53.05 158.91 1.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.266 0.555 . . . . 0.0 111.575 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.412 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.6 OUTLIER -124.11 153.29 41.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.555 -179.779 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.32 122.55 20.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.87 0.367 . . . . 0.0 110.327 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.38 21.23 56.79 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.186 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.406 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 11.1 t70 -56.56 175.8 0.11 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.815 0.34 . . . . 0.0 110.9 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.877 ' CG ' HG22 ' A' ' 144' ' ' VAL . 4.6 mt-10 -145.27 135.75 24.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.242 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.952 HD11 HD11 ' A' ' 145' ' ' ILE . 12.3 mt -112.23 128.26 68.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.523 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.65 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.1 m -104.23 140.16 38.24 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.056 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.478 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 33.3 m -140.22 158.4 25.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.095 0.474 . . . . 0.0 112.233 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.95 44.56 8.98 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.86 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.466 ' HA ' HG12 ' A' ' 140' ' ' ILE . 53.3 t -84.33 140.5 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-O 121.684 0.754 . . . . 0.0 112.631 -178.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.64 -41.14 0.59 Allowed Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 138' ' ' SER . 48.2 t -126.45 125.43 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-N 114.674 -0.763 . . . . 0.0 109.07 177.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.46 -30.25 12.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.805 0.336 . . . . 0.0 111.279 -178.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.567 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -93.62 6.48 48.12 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.341 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -126.94 27.74 5.92 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.65 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.6 mt -107.18 139.44 28.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.283 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.605 HD23 ' N ' ' A' ' 142' ' ' SER . 2.7 tt -120.72 134.53 55.28 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.383 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.605 ' N ' HD23 ' A' ' 141' ' ' LEU . 44.0 t -113.58 150.68 32.69 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.694 0.759 . . . . 0.0 112.57 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.665 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.7 mm? -135.78 151.37 50.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.454 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.877 HG22 ' CG ' ' A' ' 129' ' ' GLU . 16.5 t -116.35 135.62 55.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.902 0.382 . . . . 0.0 111.265 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.952 HD11 HD11 ' A' ' 130' ' ' ILE . 40.9 mt -106.45 121.99 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.988 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.52 116.93 31.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.707 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.474 HG12 HD21 ' A' ' 124' ' ' LEU . 5.0 mt -84.82 134.2 27.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.581 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -82.05 115.44 21.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.776 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.89 -28.81 68.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.14 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -59.63 -45.77 90.97 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.989 0.423 . . . . 0.0 110.749 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -59.06 -44.13 91.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.892 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 25.9 mtpt -65.0 -34.38 78.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.975 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.12 -44.22 89.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.952 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 8.2 t -68.07 -42.44 80.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.965 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.82 -37.74 88.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.963 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.67 -40.41 92.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.952 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -87.02 -36.93 17.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.023 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.5 ' HB2' HD21 ' A' ' 56' ' ' LEU . 4.6 p30 44.8 -172.42 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.599 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -73.69 143.35 46.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.968 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 23.5 m -100.78 134.21 41.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.051 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -111.8 33.08 4.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.887 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 14.9 ttt-85 -95.16 154.59 17.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.942 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.1 mp -77.8 138.08 21.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.13 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 8.5 ttt85 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.977 179.94 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.058 0 CA-C-O 120.859 0.361 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.5 -60.78 0.14 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.962 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -70.4 -44.76 67.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -60.67 -42.62 97.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.889 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -60.18 -39.11 85.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.909 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 mt -60.27 -44.79 95.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.875 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.3 mm -63.3 -40.15 87.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.168 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -57.91 -33.82 69.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.12 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -65.38 -33.79 76.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.257 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -56.9 -47.46 80.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.062 0.458 . . . . 0.0 111.058 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.5 p -64.3 -43.0 96.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.787 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 59.45 100.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.52 ' HG3' HD11 ' A' ' 28' ' ' ILE . 1.0 OUTLIER -81.92 141.69 33.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.846 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.51 107.02 17.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.927 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.52 HD11 ' HG3' ' A' ' 26' ' ' GLU . 20.4 mm -82.33 138.32 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 CA-C-O 121.684 0.754 . . . . 0.0 111.792 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.59 43.54 0.22 Allowed Glycine 0 C--N 1.315 -0.619 0 CA-C-N 114.552 -1.204 . . . . 0.0 112.47 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -78.44 -41.67 32.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.775 0.322 . . . . 0.0 111.09 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.433 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER -171.06 34.72 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -179.822 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.663 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 2.7 mm -75.36 134.87 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 CA-C-N 113.897 -1.501 . . . . 0.0 112.363 -177.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.963 HG23 ' HA ' ' A' ' 49' ' ' SER . 2.9 t -93.73 -61.19 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.232 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -143.97 154.07 42.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.724 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.17 138.1 51.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.832 0.349 . . . . 0.0 111.135 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.715 HG21 ' CE2' ' A' ' 68' ' ' PHE . 18.8 t -105.29 122.67 58.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.054 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.687 HG23 HG12 ' A' ' 45' ' ' ILE . 19.3 mt -128.84 118.23 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.5 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.655 ' HA ' HD13 ' A' ' 143' ' ' LEU . 38.2 t -80.34 123.37 27.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.313 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.401 HG23 HG21 ' A' ' 144' ' ' VAL . 0.2 OUTLIER -91.59 -25.55 19.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.677 -179.36 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.534 HG21 ' H ' ' A' ' 142' ' ' SER . 43.1 p -79.81 -2.29 42.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.64 0.257 . . . . 0.0 111.541 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.12 75.19 0.41 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.851 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -146.21 -44.24 0.2 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.866 0.365 . . . . 0.0 110.963 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.537 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -114.95 140.88 26.1 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.784 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.537 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 57.2 Cg_endo -73.28 145.93 39.47 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.183 1.922 . . . . 0.0 112.33 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.687 HG12 HG23 ' A' ' 37' ' ' ILE . 35.2 mt -57.68 141.46 14.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.547 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -137.18 164.02 29.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.313 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.88 119.83 32.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.977 0.418 . . . . 0.0 111.614 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.55 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 6.0 mt -91.35 137.17 32.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.298 178.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.963 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -144.17 157.42 44.31 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 -179.123 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.502 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -151.04 148.49 28.4 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.874 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.737 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -75.02 125.24 28.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.192 0.52 . . . . 0.0 110.976 -179.727 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.7 mt -64.42 -41.48 92.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.672 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.91 -42.29 79.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.294 0.569 . . . . 0.0 111.074 -178.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.496 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 2.9 mt-30 -68.67 -36.83 79.06 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.013 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 51' ' ' ASP . 30.2 t -72.35 -37.96 59.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.327 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.92 -42.01 70.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.205 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.15 -28.53 63.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.185 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -94.63 119.55 33.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.858 0.361 . . . . 0.0 110.843 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.8 pttt -108.88 -26.45 10.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.986 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 10.0 ttp85 -104.87 159.16 16.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.942 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 58.47 -177.46 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.2 tp -94.53 158.41 2.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.608 ' HD2' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -100.65 -64.65 1.03 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.165 -179.713 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.455 ' HE2' ' O ' ' A' ' 49' ' ' SER . 3.7 ttpt -140.85 132.86 27.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.384 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.507 HG13 ' C ' ' A' ' 91' ' ' ILE . 9.6 t -129.34 139.28 52.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.245 0.545 . . . . 0.0 111.808 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.55 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 16.0 m-90 -100.83 139.73 36.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.7 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.952 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.83 126.85 55.29 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.893 ' CE1' HD12 ' A' ' 91' ' ' ILE . 1.6 m-85 -110.55 145.71 37.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.422 -178.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.817 ' HA2' HD12 ' A' ' 78' ' ' LEU . . . 164.34 -177.74 39.9 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.955 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -77.33 -2.51 35.32 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -84.85 134.78 40.99 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.656 0.265 . . . . 0.0 111.197 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -68.71 -6.81 18.8 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.76 2.307 . . . . 0.0 111.838 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.83 -43.73 16.3 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-O 121.958 0.885 . . . . 0.0 108.77 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.94 137.67 3.13 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 113.629 -1.623 . . . . 0.0 110.648 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -56.41 -19.21 13.84 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.984 179.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.574 ' CG ' ' CD2' ' A' ' 68' ' ' PHE . 29.9 t80 -129.98 116.57 18.78 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.016 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -86.0 107.87 17.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.838 0.351 . . . . 0.0 110.359 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.817 HD12 ' HA2' ' A' ' 69' ' ' GLY . 81.7 mt -78.37 -82.87 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.354 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.04 -102.92 0.17 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.394 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -175.93 65.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.802 0.334 . . . . 0.0 111.267 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.629 ' HB ' HD13 ' A' ' 84' ' ' LEU . 3.7 mp -112.13 125.49 69.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.838 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 27.3 t -55.06 -31.39 61.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.323 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.507 ' H ' HG22 ' A' ' 81' ' ' ILE . 2.1 mmp_? -60.9 -33.91 73.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.9 0.381 . . . . 0.0 111.131 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.753 HD21 ' CG2' ' A' ' 132' ' ' VAL . 5.8 mp -95.31 153.24 17.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.062 0.458 . . . . 0.0 110.919 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.2 p -94.13 166.3 12.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.739 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.697 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -42.72 -52.33 4.98 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.449 0.642 . . . . 0.0 109.591 179.145 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.585 ' HB3' HG22 ' A' ' 67' ' ' THR . 4.8 mttp -120.5 84.69 2.26 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 177.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.56 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.0 t60 -61.14 -46.06 92.09 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.823 -176.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.543 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 12.3 p90 -145.18 162.37 37.26 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.059 -0.656 . . . . 0.0 112.351 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.952 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -135.67 136.22 40.74 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.584 -178.709 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.893 HD12 ' CE1' ' A' ' 68' ' ' PHE . 8.0 mt -113.88 129.47 69.72 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.16 178.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.668 HD11 HD13 ' A' ' 100' ' ' LEU . 0.6 OUTLIER -112.64 148.84 33.77 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.024 0.44 . . . . 0.0 111.905 -179.249 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.611 HD13 ' N ' ' A' ' 94' ' ' GLY . 2.3 tm? -125.25 124.95 42.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.524 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.611 ' N ' HD13 ' A' ' 93' ' ' LEU . . . 167.38 -167.2 39.76 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.54 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 61.25 95.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.801 0.334 . . . . 0.0 110.95 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 63.13 -80.57 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.975 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.547 ' HA3' HD22 ' A' ' 155' ' ' LEU . . . -177.94 36.19 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.411 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -110.35 168.81 9.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.86 0.362 . . . . 0.0 110.857 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.843 HD21 HG12 ' A' ' 33' ' ' VAL . 0.8 OUTLIER -106.99 145.71 31.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.973 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.842 HD22 ' HB3' ' A' ' 121' ' ' ASN . 6.0 mt -130.12 142.17 50.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.484 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.743 HD11 HD11 ' A' ' 130' ' ' ILE . 2.1 tp -112.56 120.92 43.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.153 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.465 ' HB2' HD23 ' A' ' 92' ' ' LEU . 55.1 t30 -115.25 115.7 27.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.007 0.432 . . . . 0.0 111.645 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.789 ' OD2' HG23 ' A' ' 116' ' ' VAL . 14.3 p30 -77.36 139.29 39.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.081 178.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.425 HD11 HG22 ' A' ' 67' ' ' THR . 10.5 pt -146.82 38.79 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 -179.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.658 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.7 151.73 20.42 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.085 0.469 . . . . 0.0 111.908 -178.711 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 48.1 m -68.79 -31.62 70.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.85 177.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -98.2 -19.78 17.66 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.658 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.97 156.69 10.38 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 120.203 -0.999 . . . . 0.0 113.715 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 9.0 m -117.62 137.88 52.33 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.819 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -116.3 148.36 40.61 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -178.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.811 HD12 HG11 ' A' ' 116' ' ' VAL . 0.7 OUTLIER -124.33 113.72 18.59 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.636 -1.166 . . . . 0.0 108.804 177.494 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 46.61 36.37 3.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.045 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.05 -3.31 80.45 Favored Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 120.854 -0.689 . . . . 0.0 113.557 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -106.56 118.57 37.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.097 0.475 . . . . 0.0 110.767 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.819 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 8.5 tptp -73.47 119.72 18.08 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.111 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.811 HG11 HD12 ' A' ' 111' ' ' LEU . 10.7 m -95.72 165.59 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.454 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.7 tt0 -69.92 126.37 29.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.637 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.689 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 67.9 tttt -52.9 162.5 0.61 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.811 0.338 . . . . 0.0 110.335 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.0 p30 35.41 34.66 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.241 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.5 OUTLIER -112.32 137.58 50.26 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.057 179.435 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.842 ' HB3' HD22 ' A' ' 100' ' ' LEU . 5.3 m120 -82.72 129.16 34.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.954 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.698 ' O ' HD23 ' A' ' 100' ' ' LEU . 45.4 mm-40 -129.51 148.13 51.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.92 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.5 tp -72.87 119.01 16.52 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.009 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 124' ' ' LEU . 1.2 mm? -58.05 164.86 2.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.816 0.817 . . . . 0.0 111.957 -179.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.424 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -125.57 153.16 44.1 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.318 179.253 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.52 118.05 13.85 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 62.75 25.71 67.82 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.789 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.58 ' OD2' HD23 ' A' ' 111' ' ' LEU . 9.2 t70 -57.92 175.36 0.2 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.027 0.441 . . . . 0.0 111.154 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 1.0 OUTLIER -145.11 135.54 24.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.887 179.837 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.743 HD11 HD11 ' A' ' 101' ' ' LEU . 5.7 mt -114.38 128.48 71.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.505 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.632 HG22 ' CG2' ' A' ' 140' ' ' ILE . 3.1 m -103.95 139.26 39.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.993 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.753 ' CG2' HD21 ' A' ' 84' ' ' LEU . 34.3 m -140.27 158.38 25.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 82.95 35.85 17.28 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.993 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.478 ' HA ' HG12 ' A' ' 140' ' ' ILE . 56.8 t -76.41 140.49 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-O 121.733 0.778 . . . . 0.0 112.477 -178.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.69 -41.38 0.62 Allowed Glycine 0 N--CA 1.437 -1.262 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.074 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.486 HG12 ' H ' ' A' ' 138' ' ' SER . 46.5 t -126.33 132.19 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-N 114.787 -0.707 . . . . 0.0 109.204 178.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -50.53 -36.38 33.98 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.486 ' H ' HG12 ' A' ' 136' ' ' VAL . 70.0 m -93.61 6.31 48.7 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.418 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 1.1 m-20 -120.2 25.66 9.73 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.632 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.2 mt -106.92 139.41 28.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.224 178.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.413 HD23 ' N ' ' A' ' 142' ' ' SER . 1.3 tt -123.46 134.51 53.92 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.26 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.534 ' H ' HG21 ' A' ' 40' ' ' THR . 47.0 t -112.51 150.42 31.3 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.645 0.736 . . . . 0.0 112.585 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.655 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.4 mm? -135.67 148.46 48.93 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.432 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 23.8 t -117.19 131.14 70.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 0.0 111.174 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.1 mm -106.33 122.07 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.679 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.15 120.03 39.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.092 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.529 HG23 ' CD1' ' A' ' 99' ' ' LEU . 7.3 mt -84.79 129.27 37.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.837 0.351 . . . . 0.0 111.236 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -75.88 116.19 16.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.973 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -62.86 -30.0 71.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.009 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -57.88 -43.49 86.05 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.076 0.465 . . . . 0.0 110.571 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -58.98 -44.01 91.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.764 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 41.5 tttm -65.11 -41.09 95.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.978 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.23 -45.02 92.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.924 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 13.0 t -60.03 -46.05 90.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.957 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.547 HD22 ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -69.14 -35.89 76.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.62 -36.22 75.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -91.87 -33.61 14.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.868 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.2 p30 42.45 82.13 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.506 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.2 tttm -115.95 138.16 51.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.908 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.1 p -64.98 133.09 30.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.119 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 60.97 161.37 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 62.3 mtm180 -94.57 46.17 1.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.871 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.1 pp -92.62 123.91 44.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.116 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.303 -0.856 . . . . 0.0 110.895 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.79 0.328 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.5 m 70.24 -63.63 0.39 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.975 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -59.93 -31.58 69.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.926 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -36.32 79.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.771 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.38 -40.99 88.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.788 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.73 -32.18 72.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.763 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.435 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.0 mt -73.13 -35.41 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -57.46 -41.9 81.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.437 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -67.22 -24.06 65.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.623 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -56.82 -47.59 79.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.156 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.5 m -80.99 -27.11 36.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.936 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.99 30.32 11.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.882 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -75.55 139.49 42.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.87 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -65.01 113.71 4.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.839 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.1 mm -81.87 138.4 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-O 121.716 0.769 . . . . 0.0 111.653 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.418 ' HA2' HG12 ' A' ' 32' ' ' ILE . . . 175.25 90.87 0.08 OUTLIER Glycine 0 C--N 1.315 -0.638 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.464 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.12 -39.19 75.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.766 0.317 . . . . 0.0 110.988 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.444 ' O ' ' HB3' ' A' ' 49' ' ' SER . 0.7 OUTLIER -170.69 33.8 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.719 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 6.1 mm -75.87 132.14 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 113.702 -1.59 . . . . 0.0 112.587 -177.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.039 HG23 ' HA ' ' A' ' 49' ' ' SER . 3.0 t -91.0 -60.93 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.073 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.609 ' SG ' HD12 ' A' ' 48' ' ' LEU . 3.0 p -148.67 152.15 36.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.267 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.09 138.15 50.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.918 0.389 . . . . 0.0 111.191 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.799 HG21 ' CZ ' ' A' ' 68' ' ' PHE . 23.1 t -104.73 122.69 58.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.777 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.801 HG23 HG12 ' A' ' 45' ' ' ILE . 20.0 mt -125.12 120.55 58.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.468 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.724 ' HA ' HD13 ' A' ' 143' ' ' LEU . 34.2 t -80.49 112.29 17.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.489 179.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.747 HG21 ' OE2' ' A' ' 129' ' ' GLU . 5.4 t -82.08 -25.87 34.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.652 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.509 HG21 ' H ' ' A' ' 142' ' ' SER . 34.1 p -79.88 -2.18 42.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.582 0.23 . . . . 0.0 111.501 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.74 78.08 0.27 Allowed Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.794 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -146.43 -44.03 0.19 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.945 0.403 . . . . 0.0 110.991 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.57 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.7 mp -120.03 141.47 31.57 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.046 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.57 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.0 Cg_endo -72.09 146.03 45.7 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.246 1.964 . . . . 0.0 112.21 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.801 HG12 HG23 ' A' ' 37' ' ' ILE . 36.3 mt -55.81 128.78 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.809 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.419 ' HG3' ' CE2' ' A' ' 76' ' ' TYR . 19.2 mtt180 -122.85 164.09 19.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.06 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -120.81 119.92 34.09 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.609 HD12 ' SG ' ' A' ' 34' ' ' CYS . 2.5 mt -93.3 137.29 32.76 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.039 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -147.93 158.04 43.84 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -178.56 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.479 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -140.32 141.79 35.68 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 113.28 -1.782 . . . . 0.0 110.237 178.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.681 ' O ' HG23 ' A' ' 55' ' ' VAL . 51.2 m-20 -82.17 131.82 35.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.197 0.522 . . . . 0.0 111.512 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.582 ' H ' HD12 ' A' ' 52' ' ' ILE . 5.1 mp -64.17 -45.18 97.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.297 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.0 t -56.6 -38.6 72.24 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.282 0.563 . . . . 0.0 110.606 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.475 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 41.2 mm-40 -68.41 -37.1 80.02 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.399 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 51' ' ' ASP . 59.0 t -68.32 -40.38 82.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.799 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.1 tp -70.95 -37.63 72.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.808 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.77 -41.54 64.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.878 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -64.01 123.88 20.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.911 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.9 32.92 3.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.823 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -114.29 176.6 4.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.797 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 99.8 p -80.13 -33.59 38.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.866 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.686 HD11 HG22 ' A' ' 65' ' ' VAL . 8.6 tp -100.4 146.31 9.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.052 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.673 ' HG2' HG13 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -116.33 -62.73 1.55 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.994 -179.955 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.418 ' CE ' ' O ' ' A' ' 49' ' ' SER . 5.0 ttpt -150.11 136.31 18.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.026 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.693 HG12 ' HG2' ' A' ' 90' ' ' GLN . 11.7 t -128.48 139.2 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 121.261 0.553 . . . . 0.0 112.197 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.519 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.2 m-90 -103.24 139.36 38.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.984 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.674 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.88 125.39 53.6 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 177.436 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.799 ' CZ ' HG21 ' A' ' 36' ' ' VAL . 2.6 m-85 -107.9 145.82 33.22 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.606 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.817 ' HA2' HD12 ' A' ' 78' ' ' LEU . . . 164.78 -178.15 40.05 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.916 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.448 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 6.1 mtp-105 -77.47 -3.39 40.19 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.41 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.9 t30 -84.88 135.72 39.66 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.767 0.318 . . . . 0.0 111.133 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 12.0 Cg_exo -69.07 -6.5 18.41 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.794 2.329 . . . . 0.0 111.884 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.86 -44.06 15.87 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 121.945 0.879 . . . . 0.0 108.651 179.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.86 138.61 2.67 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.734 -1.575 . . . . 0.0 110.41 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -56.27 -18.85 11.76 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.95 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.626 ' HE1' HD23 ' A' ' 78' ' ' LEU . 45.0 t80 -129.73 119.72 23.93 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.736 0.303 . . . . 0.0 110.818 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.4 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.2 t-160 -87.66 107.94 18.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.763 0.316 . . . . 0.0 110.611 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.817 HD12 ' HA2' ' A' ' 69' ' ' GLY . 79.9 mt -80.7 -81.93 0.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.255 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.25 -106.9 0.19 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.526 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -172.76 57.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.854 0.359 . . . . 0.0 111.196 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.515 HG22 ' H ' ' A' ' 83' ' ' ARG . 3.6 mt -103.18 125.14 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.822 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.9 t -54.73 -32.89 60.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.854 0.359 . . . . 0.0 111.246 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.515 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -61.31 -24.06 66.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.952 179.929 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.3 mt -105.53 152.08 23.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.968 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 92.9 p -94.7 166.19 12.13 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.704 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.679 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 2.3 m-20 -43.16 -53.73 4.84 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.333 0.587 . . . . 0.0 109.831 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.536 ' HB2' HD12 ' A' ' 104' ' ' ILE . 5.5 mtpt -118.9 82.86 1.93 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.567 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.8 t60 -60.13 -46.35 89.93 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.12 -0.946 . . . . 0.0 112.703 -176.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.524 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 20.1 p90 -147.13 159.46 43.59 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.721 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.693 ' HG2' HG12 ' A' ' 65' ' ' VAL . 5.0 tt0 -135.87 141.48 44.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.438 -179.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.557 ' C ' HG13 ' A' ' 65' ' ' VAL . 2.7 mp -115.95 126.36 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.834 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.781 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -104.37 151.97 22.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.064 0.459 . . . . 0.0 111.897 -179.552 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.514 HD23 ' N ' ' A' ' 94' ' ' GLY . 0.5 OUTLIER -123.51 122.87 39.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.311 179.444 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.514 ' N ' HD23 ' A' ' 93' ' ' LEU . . . -157.95 -174.94 28.31 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.568 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 61.03 -167.42 0.19 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.878 0.371 . . . . 0.0 110.905 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.76 98.24 7.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.019 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.549 ' H ' HD22 ' A' ' 155' ' ' LEU . . . 75.04 36.88 44.97 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.707 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -139.7 135.79 33.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.804 0.335 . . . . 0.0 110.764 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.539 HD21 ' CG1' ' A' ' 33' ' ' VAL . 3.0 mm? -110.99 159.36 17.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.829 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.849 HD22 ' HB3' ' A' ' 121' ' ' ASN . 8.5 mt -133.1 142.1 48.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.82 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.482 HD21 HD13 ' A' ' 124' ' ' LEU . 1.3 mt -112.87 121.54 44.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.976 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.781 ' HB2' HD11 ' A' ' 92' ' ' LEU . 50.7 t30 -116.84 115.65 25.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.833 0.349 . . . . 0.0 111.853 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.804 ' OD2' HG23 ' A' ' 116' ' ' VAL . 12.2 p30 -77.86 139.99 39.32 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.536 HD12 ' HB2' ' A' ' 87' ' ' LYS . 10.3 pt -148.43 39.18 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 111.543 0.201 . . . . 0.0 111.543 -178.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.66 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -98.02 151.67 20.08 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 120.96 0.409 . . . . 0.0 111.946 -178.879 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 50.3 m -68.69 -31.71 71.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.807 177.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -98.21 -19.69 17.71 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.66 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.81 155.48 10.09 Favored Glycine 0 N--CA 1.438 -1.187 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.596 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 7.3 m -117.41 137.81 52.24 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.861 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -115.0 148.51 38.73 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 -178.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.465 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.05 113.44 18.39 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.293 177.476 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.415 ' N ' HD12 ' A' ' 111' ' ' LEU . 73.8 m-20 44.61 43.04 6.23 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.83 -9.97 72.07 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.433 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.7 mp0 -105.06 118.57 36.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.086 0.469 . . . . 0.0 110.727 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.861 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 10.1 tptm -73.07 118.24 15.78 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.259 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.804 HG23 ' OD2' ' A' ' 103' ' ' ASP . 11.3 m -89.69 165.52 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.209 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.408 ' HB3' ' HB3' ' A' ' 120' ' ' SER . 6.2 tt0 -69.9 126.87 30.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.481 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.693 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 29.2 tttt -53.85 163.53 0.71 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.782 0.325 . . . . 0.0 110.438 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.0 m-80 33.72 36.93 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.825 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.408 ' HB3' ' HB3' ' A' ' 117' ' ' GLU . 4.7 p -111.84 144.6 40.88 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.864 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.849 ' HB3' HD22 ' A' ' 100' ' ' LEU . 5.2 m120 -91.5 128.17 37.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.687 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.647 ' O ' HD23 ' A' ' 100' ' ' LEU . 56.4 mm-40 -129.17 148.75 51.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.749 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.584 HD13 ' N ' ' A' ' 124' ' ' LEU . 1.7 tm? -72.8 128.43 35.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.287 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.745 HD11 HG21 ' A' ' 145' ' ' ILE . 67.4 tp -57.9 155.74 10.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.437 0.637 . . . . 0.0 111.654 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.421 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -124.7 153.1 42.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.637 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.414 ' HA ' ' CD1' ' A' ' 147' ' ' ILE . 0.1 OUTLIER -71.86 123.32 22.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.917 0.389 . . . . 0.0 110.25 179.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 58.24 22.52 50.48 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.071 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.421 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 32.0 t70 -52.36 169.9 0.07 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.981 0.42 . . . . 0.0 111.239 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.92 ' CG ' HG22 ' A' ' 144' ' ' VAL . 2.0 mt-10 -145.12 135.45 24.11 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.946 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.649 HD11 HD11 ' A' ' 145' ' ' ILE . 15.7 mt -116.25 127.24 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-O 120.808 0.337 . . . . 0.0 110.458 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.654 HG22 ' CG2' ' A' ' 140' ' ' ILE . 2.7 m -104.43 141.18 36.8 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.164 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.507 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 32.8 m -140.26 158.49 25.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.05 44.2 9.18 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.821 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.462 ' HA ' HG12 ' A' ' 140' ' ' ILE . 54.0 t -85.23 140.53 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-O 121.677 0.751 . . . . 0.0 112.616 -178.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.11 -41.45 0.68 Allowed Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.607 HG12 ' H ' ' A' ' 138' ' ' SER . 48.9 t -126.48 121.97 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-N 114.567 -0.816 . . . . 0.0 108.998 177.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.48 ' HA ' HD12 ' A' ' 140' ' ' ILE . 13.5 mt-10 -50.33 -25.96 4.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.749 0.309 . . . . 0.0 111.506 -178.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.607 ' H ' HG12 ' A' ' 136' ' ' VAL . 73.8 m -93.55 6.56 47.84 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -131.42 29.19 4.6 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.654 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.9 mt -106.98 139.23 29.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.077 178.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.678 HD23 ' N ' ' A' ' 142' ' ' SER . 3.0 tt -124.23 134.55 53.23 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.531 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.678 ' N ' HD23 ' A' ' 141' ' ' LEU . 47.5 t -113.52 150.6 32.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.626 0.727 . . . . 0.0 112.42 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.724 HD13 ' HA ' ' A' ' 38' ' ' CYS . 1.8 mm? -135.7 141.84 44.98 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.349 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.92 HG22 ' CG ' ' A' ' 129' ' ' GLU . 13.2 t -110.87 137.74 42.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.813 0.34 . . . . 0.0 111.282 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.745 HG21 HD11 ' A' ' 124' ' ' LEU . 29.9 mt -106.29 128.09 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.142 -179.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.74 119.83 37.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.554 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.662 HG12 HD21 ' A' ' 124' ' ' LEU . 4.3 mt -84.87 134.04 27.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.527 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -90.44 105.58 17.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.798 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.4 -26.59 63.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.235 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.77 -42.21 83.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.014 0.435 . . . . 0.0 110.639 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -60.71 -43.98 97.14 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.948 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 8.1 mtpt -61.81 -33.97 75.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.975 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.67 -42.91 81.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.883 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.1 t -63.5 -42.28 98.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.911 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.549 HD22 ' H ' ' A' ' 97' ' ' GLY . 0.5 OUTLIER -67.69 -36.7 81.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.012 -179.946 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -60.45 -47.91 84.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.833 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.57 -15.09 59.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.281 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -130.78 79.9 1.92 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.803 0.335 . . . . 0.0 110.93 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -87.01 155.18 20.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.417 ' O ' HG13 ' A' ' 160' ' ' VAL . 12.2 p -69.53 126.39 29.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.036 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 12.1 p30 -154.77 175.49 13.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.978 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.76 118.83 13.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.001 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -96.34 134.25 34.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.135 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.927 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.404 ' O ' HG23 ' A' ' 15' ' ' THR . . . . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.836 0.35 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 14' ' ' ALA . 0.6 OUTLIER -159.48 -45.56 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.9 -37.19 83.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.851 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.402 ' HB2' ' NH1' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -61.32 -43.17 99.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.764 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -57.39 -38.49 74.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.822 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.02 -31.84 69.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.742 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.461 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.1 mt -72.69 -35.56 50.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.768 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -57.44 -39.82 77.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.932 0.396 . . . . 0.0 110.416 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.6 mtpt -67.06 -23.84 65.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.797 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -56.64 -47.36 79.9 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.213 -179.907 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.56 -30.91 57.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.901 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -81.35 86.54 6.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -94.04 153.41 18.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.006 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.15 127.43 32.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.904 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.8 mm -83.15 138.35 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-O 121.629 0.728 . . . . 0.0 111.88 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.86 63.68 1.23 Allowed Glycine 0 C--N 1.315 -0.635 0 CA-C-N 114.481 -1.236 . . . . 0.0 112.394 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.25 -24.02 43.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.628 0.251 . . . . 0.0 111.181 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 178.14 35.22 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.655 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 1.1 mm -89.63 96.54 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 CA-C-N 113.964 -1.471 . . . . 0.0 111.578 -177.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.775 HG11 HD22 ' A' ' 93' ' ' LEU . 2.3 t -55.38 -65.65 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.278 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.493 ' SG ' HD12 ' A' ' 48' ' ' LEU . 13.8 p -146.39 165.05 30.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.016 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.88 128.17 41.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.093 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.651 HG13 HD11 ' A' ' 48' ' ' LEU . 15.4 m -93.46 122.75 45.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.9 0.381 . . . . 0.0 111.11 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.786 HG23 HG12 ' A' ' 45' ' ' ILE . 21.1 mt -125.6 117.43 49.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.39 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 6.9 t -79.83 118.25 21.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.822 0.344 . . . . 0.0 110.387 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.681 HG23 HG21 ' A' ' 144' ' ' VAL . 0.7 OUTLIER -82.07 -26.45 33.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.857 -179.22 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.538 HG21 ' H ' ' A' ' 142' ' ' SER . 33.5 p -79.93 -2.2 42.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.59 0.233 . . . . 0.0 111.357 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.49 47.42 90.77 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.855 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.477 ' CB ' HD11 ' A' ' 141' ' ' LEU . 3.5 mm-40 -113.81 -29.87 6.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.785 0.326 . . . . 0.0 110.884 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.812 HD13 HD22 ' A' ' 78' ' ' LEU . 2.8 mt -128.16 141.26 40.73 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.71 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.576 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 42.9 Cg_endo -70.46 134.35 26.31 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.125 1.884 . . . . 0.0 112.23 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.786 HG12 HG23 ' A' ' 37' ' ' ILE . 32.6 mt -55.17 130.02 17.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.608 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.8 163.42 17.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.305 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.24 119.74 36.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.989 0.423 . . . . 0.0 111.451 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.751 HD22 ' CD1' ' A' ' 66' ' ' TRP . 7.1 mt -98.45 136.15 39.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.404 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.765 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -148.71 157.76 43.67 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -179.162 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.537 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -144.1 142.0 30.35 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 113.643 -1.617 . . . . 0.0 110.864 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.573 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -78.37 133.27 37.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.129 0.49 . . . . 0.0 111.039 -179.901 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.771 HD13 ' SG ' ' A' ' 154' ' ' CYS . 71.0 mt -63.97 -40.39 88.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.965 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.62 -41.01 76.36 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.926 -178.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.512 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -68.53 -39.62 81.1 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.572 179.776 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.706 HG13 ' HG3' ' A' ' 63' ' ' LYS . 43.8 t -66.45 -41.7 89.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.167 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -71.0 -34.53 71.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.962 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -75.44 -47.55 26.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.901 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.88 115.43 19.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.872 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.06 30.0 7.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.895 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 10.4 mtp180 -105.8 27.46 8.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.999 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.5 m 62.94 141.85 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.972 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.721 HD12 HD13 ' A' ' 92' ' ' LEU . 16.3 mm 64.51 100.02 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.213 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.706 ' HG3' HG13 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -94.36 -57.99 2.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.806 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 49' ' ' SER . 4.1 ttpt -139.85 131.5 27.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.774 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.641 HG12 ' HG2' ' A' ' 90' ' ' GLN . 15.4 t -125.49 139.03 52.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.309 0.576 . . . . 0.0 112.181 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.751 ' CD1' HD22 ' A' ' 48' ' ' LEU . 15.0 m-90 -101.92 139.32 37.72 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.14 -0.937 . . . . 0.0 112.09 179.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.699 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -114.49 126.52 55.04 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.08 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.545 ' CZ ' HD12 ' A' ' 91' ' ' ILE . 0.9 OUTLIER -116.91 145.27 43.71 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.376 -178.447 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.574 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 165.18 -176.84 40.8 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.231 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.2 ttp85 -72.69 -3.03 22.57 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.496 HD22 ' HB3' ' A' ' 73' ' ' ALA . 2.3 t30 -84.8 135.04 40.64 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.738 0.304 . . . . 0.0 111.598 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 14.5 Cg_exo -67.57 -11.82 33.46 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.928 2.419 . . . . 0.0 112.036 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.496 ' HB3' HD22 ' A' ' 71' ' ' ASN . . . -82.38 -44.28 16.32 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-O 121.919 0.866 . . . . 0.0 109.029 179.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.41 ' SG ' ' HA ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -41.62 142.36 0.64 Allowed 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 113.746 -1.57 . . . . 0.0 110.854 179.652 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.0 t0 -56.07 -18.57 10.04 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.204 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.478 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 8.1 t80 -129.14 131.12 47.15 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-O 120.771 0.319 . . . . 0.0 110.746 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.423 ' CD2' ' HA ' ' A' ' 72' ' ' PRO . 1.4 t-160 -104.17 115.32 30.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.031 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.812 HD22 HD13 ' A' ' 43' ' ' ILE . 12.4 mt -91.41 177.02 6.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.751 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.63 -92.04 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.361 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -179.19 68.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.849 0.357 . . . . 0.0 110.719 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.839 ' HB ' HD13 ' A' ' 84' ' ' LEU . 3.3 mp -112.12 116.52 52.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.068 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.8 -25.89 43.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.216 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.534 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -60.91 -20.4 62.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.096 -179.867 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.839 HD13 ' HB ' ' A' ' 81' ' ' ILE . 3.8 mp -104.9 153.01 21.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.817 0.341 . . . . 0.0 110.857 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.3 p -93.67 168.66 10.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.689 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.574 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 6.4 m-20 -41.41 -59.21 1.64 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.367 0.603 . . . . 0.0 109.657 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.609 ' HB2' HD12 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -116.04 84.11 2.06 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 176.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.557 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 13.9 t60 -58.92 -46.51 87.74 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.495 -176.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.515 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 27.1 p90 -144.91 159.8 42.33 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.9 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.699 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.4 tt0 -136.16 140.65 43.78 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.357 -179.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.697 HG12 HD12 ' A' ' 101' ' ' LEU . 65.9 mt -116.5 127.16 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 C-N-CA 121.164 -0.214 . . . . 0.0 110.809 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.721 HD13 HD12 ' A' ' 62' ' ' ILE . 0.6 OUTLIER -113.12 144.94 41.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.02 0.438 . . . . 0.0 111.691 -179.727 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.775 HD22 HG11 ' A' ' 33' ' ' VAL . 24.9 tp -125.25 122.97 38.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.555 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.58 -139.23 2.93 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.592 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 66.32 -73.91 0.07 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.787 0.327 . . . . 0.0 110.893 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.407 ' O ' HD12 ' A' ' 155' ' ' LEU . 2.7 m-20 -155.99 -45.14 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.873 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.624 ' HA2' HD12 ' A' ' 155' ' ' LEU . . . -163.13 -40.02 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.545 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -57.86 161.33 3.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.902 0.382 . . . . 0.0 111.086 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.628 ' O ' HD12 ' A' ' 100' ' ' LEU . 14.9 tp -106.95 154.23 21.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.822 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.628 HD12 ' O ' ' A' ' 99' ' ' LEU . 6.1 mp -125.55 144.81 50.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.441 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.697 HD12 HG12 ' A' ' 91' ' ' ILE . 2.3 tp -112.54 122.63 48.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.11 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.485 ' HB2' HD23 ' A' ' 92' ' ' LEU . 52.8 t30 -116.88 115.68 25.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.934 0.397 . . . . 0.0 111.921 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.84 ' OD2' HG23 ' A' ' 116' ' ' VAL . 10.0 p30 -76.63 138.7 40.25 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.609 HD12 ' HB2' ' A' ' 87' ' ' LYS . 9.5 pt -146.67 39.22 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 111.497 0.184 . . . . 0.0 111.497 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.675 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -97.99 150.94 20.83 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 121.171 0.51 . . . . 0.0 112.039 -178.681 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 42.9 m -68.79 -31.45 70.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.611 177.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -98.05 -19.78 17.77 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.675 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.22 155.23 10.15 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.251 -0.975 . . . . 0.0 113.559 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.498 HG22 ' CG2' ' A' ' 130' ' ' ILE . 5.8 m -117.35 137.69 52.28 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.862 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -115.75 148.55 39.69 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -177.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.02 113.58 18.6 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.385 177.619 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 43.87 43.85 5.45 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.79 -11.42 66.67 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.398 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -104.36 118.61 37.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.034 0.445 . . . . 0.0 110.62 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.862 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 9.1 tptp -72.28 115.89 12.06 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.293 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.84 HG23 ' OD2' ' A' ' 103' ' ' ASP . 16.5 m -84.45 164.24 2.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.13 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 120' ' ' SER . 1.2 tm-20 -69.83 125.03 25.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.496 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.687 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 55.6 tttt -53.02 162.0 0.71 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.914 0.388 . . . . 0.0 110.646 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 103' ' ' ASP . 3.7 p30 34.78 34.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.423 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.3 OUTLIER -112.29 145.09 40.61 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.089 179.457 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.484 HD22 HD21 ' A' ' 92' ' ' LEU . 5.8 m120 -88.3 129.86 35.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.795 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 41.4 mm-40 -129.6 147.84 51.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.035 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.9 128.98 37.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.983 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.58 HD23 ' HB3' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -58.07 159.6 5.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.415 0.626 . . . . 0.0 111.897 -178.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.428 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.4 OUTLIER -125.0 153.26 43.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.156 179.59 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.23 116.74 11.91 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 62.81 25.58 67.79 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.545 -178.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.428 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 33.6 t0 -50.69 168.77 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.104 0.478 . . . . 0.0 111.457 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 15.5 tt0 -145.21 135.49 24.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.872 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.631 HD11 HD11 ' A' ' 145' ' ' ILE . 3.2 mt -114.75 127.35 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.513 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.61 HG22 ' CG2' ' A' ' 140' ' ' ILE . 4.2 m -104.64 138.41 41.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.944 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.541 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.2 m -140.2 158.24 25.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 82.24 39.6 11.11 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.944 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.455 ' HA ' HG12 ' A' ' 140' ' ' ILE . 54.9 t -79.41 140.41 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-O 121.688 0.756 . . . . 0.0 112.557 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 156.46 -41.76 0.56 Allowed Glycine 0 N--CA 1.436 -1.318 0 CA-C-N 114.471 -1.241 . . . . 0.0 110.018 -179.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.487 HG12 ' H ' ' A' ' 138' ' ' SER . 45.7 t -126.39 131.21 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-N 114.869 -0.666 . . . . 0.0 109.262 178.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -50.41 -35.4 28.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.669 0.271 . . . . 0.0 111.647 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.487 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -93.57 6.44 48.24 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -178.864 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.41 ' HB2' ' HB ' ' A' ' 136' ' ' VAL . 51.4 m-20 -121.85 26.75 8.48 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.61 ' CG2' HG22 ' A' ' 131' ' ' THR . 5.0 mt -107.12 139.5 28.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.332 178.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.477 HD11 ' CB ' ' A' ' 42' ' ' GLN . 7.9 tt -120.69 134.5 55.28 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.292 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.538 ' H ' HG21 ' A' ' 40' ' ' THR . 45.4 t -112.89 150.59 31.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.612 0.72 . . . . 0.0 112.716 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.598 HD21 HD12 ' A' ' 43' ' ' ILE . 70.8 mt -135.57 149.58 49.46 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.538 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.681 HG21 HG23 ' A' ' 39' ' ' THR . 25.7 t -120.44 139.95 46.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.795 0.331 . . . . 0.0 111.28 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.631 HD11 HD11 ' A' ' 130' ' ' ILE . 5.4 mt -106.24 130.75 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.807 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.577 ' CD1' HD12 ' A' ' 37' ' ' ILE . 0.4 OUTLIER -115.75 114.43 24.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.106 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.407 HD11 ' O ' ' A' ' 125' ' ' SER . 6.0 mt -85.03 134.16 27.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.349 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -82.59 133.11 35.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.749 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -73.72 -37.75 65.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.209 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -46.13 91.55 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.907 0.384 . . . . 0.0 110.817 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.583 ' O ' HD23 ' A' ' 155' ' ' LEU . 36.2 t80 -61.02 -44.02 98.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.16 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -63.09 -40.34 97.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.191 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -59.06 -47.08 86.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.184 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.771 ' SG ' HD13 ' A' ' 52' ' ' ILE . 8.9 t -68.15 -45.47 73.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.089 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.624 HD12 ' HA2' ' A' ' 97' ' ' GLY . 4.0 mm? -61.1 -39.61 90.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.07 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -60.45 -36.41 78.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.012 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -87.83 -36.96 16.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.996 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.0 p30 42.44 62.37 1.72 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.489 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.26 145.83 32.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.855 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.46 ' O ' HG13 ' A' ' 160' ' ' VAL . 12.4 p -74.83 122.97 29.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.095 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -125.97 108.59 11.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.914 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 39.6 ttm-85 -90.94 -54.16 4.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.872 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.1 pt -78.52 132.05 33.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.199 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.919 179.968 . . . . . . . . 0 0 . 1 stop_ save_